data_6fzk_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6fzk _Structure_validation_residue.Date_analyzed 2019-02-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.568 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 7.1 ptm180 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 114.638 1.347 . . . . 5.09 114.638 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 60.9 ttp -140.44 121.74 14.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.557 -0.457 . . . . 3.06 111.515 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 105.7 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 122.246 1.022 . . . . 1.41 113.566 173.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -159.79 106.2 1.63 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.248 -2.13 . . . . 1.73 105.248 159.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 11.5 mt -82.8 103.64 12.44 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.425 -0.51 . . . . 2.04 110.169 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -145.08 99.46 4.62 Favored Pre-proline 0 N--CA 1.429 -1.492 0 C-N-CA 119.37 -0.932 . . . . 1.93 110.431 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.6 ' HA ' ' CD2' ' A' ' 180' ' ' LEU . 0.5 OUTLIER -34.14 139.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.644 1 C-N-CA 125.668 4.245 . . . . 0.73 115.011 -178.84 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.4 t70 77.22 35.56 0.34 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.834 -1.53 . . . . 0.72 109.408 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.433 ' HE1' HD12 ' A' ' 180' ' ' LEU . 10.8 ptt? -114.56 155.13 27.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.401 -1.272 . . . . 2.33 109.879 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 m -101.71 103.74 14.52 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.079 -1.082 . . . . 1.11 108.079 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.587 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.4 tt -136.56 166.66 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.277 -0.874 . . . . 1.14 110.566 -165.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.514 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.6 m -141.42 176.24 9.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.738 -0.838 . . . . 0.89 108.738 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.525 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -28.0 68.85 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.53 -0.915 . . . . 2.86 108.53 166.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.572 ' O ' HG12 ' A' ' 125' ' ' VAL . 0.3 OUTLIER -84.23 -19.14 34.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.127 -1.397 . . . . 1.68 113.485 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.521 ' CB ' HG13 ' A' ' 119' ' ' ILE . 1.5 mt-10 -87.6 -54.22 4.38 Favored 'General case' 0 N--CA 1.422 -1.839 0 O-C-N 120.444 -1.41 . . . . 2.06 108.994 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.751 ' SD ' HD23 ' A' ' 173' ' ' LEU . 2.1 tpp -59.76 -16.36 27.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.767 -1.56 . . . . 3.58 111.147 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 122' ' ' ASN . 15.0 p -43.81 -41.24 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 122.185 0.993 . . . . 1.11 110.228 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -65.3 -42.54 92.96 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.927 -1.488 . . . . 1.32 113.031 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.511 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.8 OUTLIER -50.82 -33.88 25.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.814 0.816 . . . . 2.45 110.595 169.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 124' ' ' MET . 20.2 mt -84.6 -35.87 22.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.553 -1.203 . . . . 1.13 109.654 -171.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.36 -24.95 63.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.483 -1.235 . . . . 1.96 110.31 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.41 -42.13 45.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.504 -1.225 . . . . 1.18 110.924 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.41 HG21 ' HA ' ' A' ' 128' ' ' LEU . 14.4 t -87.11 1.31 53.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 123.531 1.634 . . . . 1.27 107.32 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 46.39 51.98 11.11 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 110.924 -2.853 . . . . 2.22 112.249 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.626 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.9 t80 -135.31 176.5 8.62 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.478 0.548 . . . . 0.9 112.478 -172.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.545 ' HD3' ' N ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -140.21 142.06 35.88 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.947 -1.501 . . . . 5.25 106.947 177.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.592 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 14.6 tm0? -48.98 142.16 6.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.26 1.208 . . . . 2.03 114.26 -168.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.608 ' CG1' ' HH ' ' A' ' 133' ' ' TYR . 3.1 m -125.5 155.62 34.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.779 -2.01 . . . . 1.73 110.953 -176.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -61.36 -35.74 78.29 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.737 1.256 . . . . 1.74 108.446 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 5.6 tmmm? -159.87 133.18 6.94 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.65 -2.068 . . . . 2.0 109.816 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.532 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.34 135.86 54.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.577 -1.192 . . . . 1.27 111.31 -177.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.706 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -161.57 97.89 1.1 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.668 1.223 . . . . 1.26 110.718 149.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.706 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.07 161.73 20.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 112.7 -2.045 . . . . 2.11 106.313 164.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.38 130.94 28.3 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.299 1.332 . . . . 0.99 111.4 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.88 49.3 3.38 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.306 -0.95 . . . . 0.51 112.948 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.626 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 48.7 mt-10 -141.09 178.1 7.61 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.907 0.384 . . . . 2.16 111.357 175.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.848 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 50.2 p90 -165.73 175.59 8.68 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.063 -1.088 . . . . 0.28 108.063 169.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 25.6 p -142.3 126.13 17.1 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.471 0.653 . . . . 1.12 111.169 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.592 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.7 p -125.37 109.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.235 -0.893 . . . . 1.1 109.886 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -142.61 -60.8 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.65 -0.42 . . . . 3.64 111.607 -171.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.92 -92.43 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.49 0.552 . . . . 2.21 112.49 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -104.83 -0.11 27.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.11 0.481 . . . . 1.95 111.173 -171.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 5.2 p -146.82 160.05 42.76 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.314 0.857 . . . . 0.63 113.314 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.62 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 60.5 mt -110.53 109.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 106.816 -1.55 . . . . 1.19 106.816 162.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.848 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.8 mp0 -89.38 175.91 7.13 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.015 -1.476 . . . . 1.13 107.015 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.586 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 25.6 ptm -168.67 154.66 6.76 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 123.496 0.498 . . . . 2.37 111.108 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.571 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 21.7 mt -127.62 110.16 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.753 -0.658 . . . . 1.14 110.309 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.828 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 28.2 mtp180 . . . . . 0 C--N 1.316 -0.867 0 CA-C-N 116.186 -0.461 . . . . 3.61 110.759 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.828 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.6 tt0 . . . . . 0 N--CA 1.425 -1.707 0 N-CA-C 113.502 0.927 . . . . 2.3 113.502 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 50.1 t -154.37 133.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.689 -1.141 . . . . 1.12 109.519 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 154' ' ' MET . 8.5 mtm180 -91.12 115.16 27.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.814 0.34 . . . . 3.33 110.399 169.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.04 145.39 43.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.812 0.815 . . . . 1.02 111.353 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.751 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.2 tpt180 -111.49 98.66 7.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.838 -1.528 . . . . 2.43 110.501 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.751 HD23 ' SD ' ' A' ' 124' ' ' MET . 4.5 mp -91.76 94.48 9.37 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.247 -0.279 . . . . 1.36 110.247 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.1 126.26 43.47 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.438 1.114 . . . . 1.04 111.653 -171.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.657 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.2 m-85 -89.82 138.34 31.57 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 112.859 -1.973 . . . . 1.03 111.07 -177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.485 ' HB2' ' HB1' ' A' ' 181' ' ' ALA . 30.9 t70 -79.39 64.49 4.29 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.027 -1.842 . . . . 1.09 106.027 160.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.7 -98.37 1.05 Allowed Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 118.879 -1.629 . . . . 0.5 110.713 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -79.14 -24.8 43.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.023 0.749 . . . . 0.83 113.023 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -134.68 129.99 35.63 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.951 -0.7 . . . . 2.01 110.844 -169.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.27 128.15 27.13 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.743 -1.572 . . . . 1.35 110.546 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 176' ' ' ASP . . . -106.23 -41.48 5.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.492 -0.776 . . . . 1.08 110.486 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.1 p -145.49 166.86 24.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.226 -0.443 . . . . 1.12 110.921 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.751 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 39.5 mt -136.18 145.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.108 -1.812 . . . . 1.48 106.108 169.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 45.0 t -137.26 140.17 42.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.277 0.56 . . . . 1.12 110.186 -174.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.462 ' CB ' ' HG2' ' A' ' 190' ' ' ARG . 2.1 t-20 -81.13 100.97 9.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.733 -1.21 . . . . 1.77 107.733 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.513 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 49.3 mtm -64.27 -2.76 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.403 0.89 . . . . 1.26 113.403 -164.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.434 ' HG3' ' OD1' ' A' ' 188' ' ' ASN . 10.9 pt-20 -91.92 -40.06 11.36 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.812 0.815 . . . . 1.02 111.225 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.434 ' OD1' ' HG3' ' A' ' 187' ' ' GLU . 5.8 m-20 -105.78 -25.36 12.22 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.449 -1.251 . . . . 1.98 109.495 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 73.86 33.91 0.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 112.429 -2.169 . . . . 2.0 108.041 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.462 ' HG2' ' CB ' ' A' ' 185' ' ' ASN . 3.9 ptm180 -93.33 161.88 14.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.03 -1.441 . . . . 2.78 110.082 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.3 140.84 29.13 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.542 -1.208 . . . . 1.9 113.518 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.59 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 8.8 m-85 -106.44 -166.02 1.14 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.834 -1.984 . . . . 1.18 107.286 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.538 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.99 -6.73 3.46 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 107.83 -2.108 . . . . 1.89 107.83 -149.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -154.71 112.61 3.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.878 -1.161 . . . . 3.47 111.507 157.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.729 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t80 -129.18 101.6 6.09 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.702 -0.799 . . . . 0.89 109.965 162.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -100.06 128.75 46.1 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.03 -1.044 . . . . 5.49 111.948 -171.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.418 ' CD1' HD13 ' A' ' 127' ' ' LEU . 8.9 mt -107.76 171.27 7.49 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.174 -0.466 . . . . 2.15 111.129 173.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 108.727 -0.842 . . . . 2.66 108.727 175.408 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.543 ' NH1' HG21 ' A' ' 125' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.717 0.294 . . . . 5.09 111.263 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.637 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 48.2 tpp -143.63 138.78 29.24 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.361 -0.536 . . . . 3.06 110.961 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.77 104.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.374 1.083 . . . . 1.41 113.059 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -158.85 107.76 1.92 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 112.962 -1.926 . . . . 1.73 106.177 167.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 6.6 mt -91.3 100.62 13.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.5 -0.48 . . . . 2.04 110.111 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 117' ' ' MET . 5.2 tm-20 -150.34 109.44 3.19 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.377 0.608 . . . . 1.93 109.677 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.833 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 10.6 Cg_exo -34.77 146.3 0.05 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.849 1 C-N-CA 126.876 5.05 . . . . 0.73 115.43 -173.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.57 39.61 2.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.089 -1.414 . . . . 0.72 109.019 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.52 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 10.5 ptt? -117.57 154.37 31.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.655 -1.157 . . . . 2.33 109.485 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.1 m -101.81 79.33 1.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.152 0.977 . . . . 1.11 108.599 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.664 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -97.1 156.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 113.936 -1.484 . . . . 1.14 109.384 -171.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.516 ' H ' HG13 ' A' ' 119' ' ' ILE . 10.8 m -141.95 174.15 10.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.156 -0.683 . . . . 0.89 109.156 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.628 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 35.2 mtpt -49.43 -33.49 14.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.38 0.609 . . . . 2.86 110.175 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.636 ' O ' HG11 ' A' ' 125' ' ' VAL . 63.0 t30 -84.49 -16.18 43.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.335 1.235 . . . . 1.68 114.335 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.637 ' CG ' ' HB3' ' A' ' 110' ' ' MET . 6.2 tt0 -86.31 -60.53 1.97 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.374 -1.453 . . . . 2.06 107.894 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.753 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -54.7 -17.59 3.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.457 -1.701 . . . . 3.58 111.105 173.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 122' ' ' ASN . 13.7 p -42.35 -40.57 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-O 122.018 0.914 . . . . 1.11 110.34 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.653 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.7 -42.72 81.55 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.129 -1.396 . . . . 1.32 113.699 177.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.533 ' HA ' ' CD1' ' A' ' 197' ' ' LEU . 2.8 tm? -50.86 -34.78 29.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.568 0.699 . . . . 2.45 110.359 168.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.753 ' HG ' ' O ' ' A' ' 124' ' ' MET . 7.3 mt -85.36 -34.86 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.568 -0.742 . . . . 1.13 110.143 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.29 -25.77 66.21 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.154 -1.385 . . . . 1.96 110.778 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -77.38 -45.39 26.11 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.978 -1.464 . . . . 1.18 111.272 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.97 -5.99 46.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 123.637 1.684 . . . . 1.27 107.471 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.54 55.34 5.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 110.983 -2.826 . . . . 2.22 112.464 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.889 ' HH ' ' CG1' ' A' ' 136' ' ' VAL . 2.5 t80 -132.15 176.38 8.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.853 0.686 . . . . 0.9 112.853 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -142.86 141.57 31.6 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.949 -1.5 . . . . 5.25 106.949 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.472 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -49.04 144.79 4.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 115.627 1.714 . . . . 2.03 115.627 -165.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.889 ' CG1' ' HH ' ' A' ' 133' ' ' TYR . 3.1 m -129.51 162.67 36.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 112.223 -2.262 . . . . 1.73 110.862 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -73.0 -35.55 66.84 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.591 -1.263 . . . . 1.74 107.591 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -145.46 124.84 13.06 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 112.795 -2.002 . . . . 2.0 110.513 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.576 ' CB ' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -117.93 128.87 55.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.093 -1.412 . . . . 1.27 110.047 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 96.03 1.68 Allowed 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.044 1.402 . . . . 1.26 109.364 155.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.576 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -167.61 161.26 10.16 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 111.979 -2.373 . . . . 2.11 105.771 167.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.19 126.32 9.77 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.675 1.583 . . . . 0.99 111.865 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.623 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 103.43 19.41 12.41 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 119.904 -1.141 . . . . 0.51 112.328 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.716 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 13.4 mp0 -128.33 173.19 10.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.661 0.267 . . . . 2.16 110.682 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.824 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 54.9 p90 -165.9 175.85 8.31 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.707 -1.22 . . . . 0.28 107.707 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.56 HG23 ' HB3' ' A' ' 139' ' ' MET . 3.5 p -138.1 132.59 32.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 120.227 -0.589 . . . . 1.12 110.823 170.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 135' ' ' GLN . 14.6 p -124.14 109.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 122.347 1.07 . . . . 1.1 111.813 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -99.18 -74.99 0.57 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.523 -1.217 . . . . 3.64 109.313 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.62 -46.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.016 -0.993 . . . . 2.21 109.328 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.36 -11.42 57.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.408 -0.814 . . . . 1.95 111.236 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 14.6 p -158.89 152.28 22.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.125 0.964 . . . . 0.63 112.829 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.645 HG21 ' SD ' ' A' ' 124' ' ' MET . 68.5 mt -116.59 113.72 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 112.977 -1.92 . . . . 1.19 107.554 164.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.824 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -92.88 165.56 12.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.565 -1.643 . . . . 1.13 106.565 173.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 14.5 ptp -166.37 151.43 8.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 123.835 0.71 . . . . 2.37 110.764 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.655 HG12 ' HG3' ' A' ' 170' ' ' ARG . 7.5 mt -129.63 110.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.65 -0.705 . . . . 1.14 110.265 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 33.7 mtp180 . . . . . 0 C--N 1.317 -0.837 0 C-N-CA 120.483 -0.487 . . . . 3.61 110.354 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.558 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.94 0 N-CA-C 112.715 0.635 . . . . 2.3 112.715 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 95.4 t -151.86 127.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.179 -0.918 . . . . 1.12 110.089 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.655 ' HG3' HG12 ' A' ' 155' ' ' ILE . 3.7 mtm180 -85.77 115.46 23.43 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.468 -0.787 . . . . 3.33 110.262 169.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.44 139.8 50.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.313 -0.955 . . . . 1.02 111.591 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.743 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 13.2 tpt180 -104.48 98.57 8.32 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.982 -1.463 . . . . 2.43 110.781 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 151' ' ' SER . 8.3 mp -88.16 103.25 15.58 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.237 -0.283 . . . . 1.36 110.237 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.21 119.57 39.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.4 1.095 . . . . 1.04 111.675 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.526 ' CZ ' HG23 ' A' ' 119' ' ' ILE . 2.0 m-85 -83.31 140.6 32.37 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 112.955 -1.93 . . . . 1.03 111.147 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.23 65.2 5.3 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.065 -1.828 . . . . 1.09 106.065 159.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.84 -97.99 1.27 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 118.572 -1.775 . . . . 0.5 110.697 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.87 -25.38 40.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.032 0.753 . . . . 0.83 113.032 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -132.81 129.69 38.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.972 0.891 . . . . 2.01 111.726 -167.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.664 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 3.0 tm? -51.07 120.59 5.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.872 -1.967 . . . . 1.35 109.868 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -106.14 -37.25 6.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.764 -0.653 . . . . 1.08 110.63 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 17.7 p -143.88 164.38 30.73 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.102 -0.499 . . . . 1.12 110.742 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.743 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 21.1 mt -138.93 143.97 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 105.831 -1.914 . . . . 1.48 105.831 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 30.3 t -132.79 135.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.946 0.403 . . . . 1.12 110.472 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.497 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 1.8 m120 -76.24 101.1 5.29 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 107.131 -1.433 . . . . 1.77 107.131 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.574 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 41.1 mtm -67.38 -1.41 4.71 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.34 0.59 . . . . 1.26 111.654 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.497 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 16.9 pt-20 -73.85 -43.96 57.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.193 -0.912 . . . . 1.02 110.988 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -113.26 -25.67 8.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.228 -1.351 . . . . 1.98 109.367 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 75.53 36.47 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.179 -2.282 . . . . 2.0 107.858 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.452 ' HG2' ' HB2' ' A' ' 185' ' ' ASN . 12.2 ptt180 -97.33 170.7 8.9 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 114.167 -1.379 . . . . 2.78 108.819 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -86.05 144.92 27.3 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.433 1.111 . . . . 1.9 113.916 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -116.91 -166.79 1.2 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 105.222 -2.14 . . . . 1.18 105.222 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.833 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 136.19 8.19 1.62 Allowed Glycine 0 N--CA 1.412 -2.934 0 N-CA-C 109.994 -1.242 . . . . 1.89 109.994 -160.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.406 ' HB2' ' NH1' ' A' ' 196' ' ' ARG . 20.7 p90 -152.39 101.95 2.71 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.151 -1.525 . . . . 3.47 110.438 151.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.64 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 3.9 t80 -118.45 99.75 7.03 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.892 -0.781 . . . . 0.89 108.892 168.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 1.4 mpt_? -100.62 123.06 44.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 5.49 111.33 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -93.1 172.57 8.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.336 1.606 . . . . 2.15 115.336 -170.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 . . . . . 0 N--CA 1.445 -0.696 0 CA-C-N 112.813 -1.994 . . . . 2.66 110.031 177.786 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 22.4 mtt180 . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 107.361 -1.348 . . . . 5.09 107.361 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.676 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.3 tpt -143.58 118.06 9.71 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 114.162 1.171 . . . . 3.06 114.162 -160.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.479 ' CG1' ' HB2' ' A' ' 127' ' ' LEU . 0.8 OUTLIER -104.19 109.29 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 C-N-CA 119.246 -0.982 . . . . 1.41 112.681 179.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -155.03 109.82 3.0 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.146 -1.798 . . . . 1.73 106.146 167.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.671 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.1 mp -98.33 113.69 25.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.596 -0.89 . . . . 2.04 108.596 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.614 ' CB ' ' HE2' ' A' ' 117' ' ' MET . 15.1 tt0 -146.09 108.99 4.3 Favored Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.732 -0.787 . . . . 1.93 109.79 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.475 ' HG3' HG12 ' A' ' 183' ' ' ILE . 33.3 Cg_exo -35.76 130.83 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.407 0 C-N-CA 124.903 3.735 . . . . 0.73 114.473 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 73.71 45.47 0.24 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 122.403 1.097 . . . . 0.72 110.624 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.614 ' HE2' ' CB ' ' A' ' 114' ' ' GLU . 6.1 ptp -121.28 158.57 27.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.286 -1.324 . . . . 2.33 111.416 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 m -102.29 100.14 10.29 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.779 -0.823 . . . . 1.11 108.779 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 12.2 tt -137.93 169.3 18.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.97 -1.013 . . . . 1.14 109.577 -167.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.453 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.5 m -139.88 175.33 9.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.821 0.737 . . . . 0.89 111.45 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.618 ' HA ' HD13 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -20.6 63.02 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.49 -0.929 . . . . 2.86 108.49 167.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.772 ' O ' HG11 ' A' ' 125' ' ' VAL . 6.3 t30 -83.17 -22.64 33.19 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 113.979 -1.464 . . . . 1.68 112.475 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.676 ' HA ' ' H ' ' A' ' 110' ' ' MET . 1.1 mp0 -84.28 -50.01 8.25 Favored 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 120.025 -1.672 . . . . 2.06 107.923 173.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.756 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -61.67 -18.51 59.83 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.511 -1.222 . . . . 3.58 111.268 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.772 HG11 ' O ' ' A' ' 122' ' ' ASN . 11.1 p -47.28 -41.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.114 0.959 . . . . 1.11 110.808 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.521 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.2 mmpt? -69.93 -36.97 75.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.323 -1.308 . . . . 1.32 112.771 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.598 ' HG ' HD12 ' A' ' 197' ' ' LEU . 2.4 tm? -55.42 -33.88 63.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.686 0.755 . . . . 2.45 110.27 167.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' A' ' 124' ' ' MET . 17.4 mt -84.36 -32.6 24.14 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.95 0.881 . . . . 1.13 109.189 -172.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.98 -39.43 89.57 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.901 -1.499 . . . . 1.96 110.219 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.431 ' O ' ' HG3' ' A' ' 132' ' ' GLN . . . -70.5 -43.19 70.2 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.524 -1.671 . . . . 1.18 112.283 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.49 3.9 54.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 124.538 2.113 . . . . 1.27 106.281 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 130' ' ' ALA . 17.9 mt-30 52.35 49.16 21.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 110.262 -3.154 . . . . 2.22 112.679 168.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.952 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -139.24 175.74 9.3 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.759 -0.776 . . . . 0.9 112.778 -172.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.41 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 79.6 ttt180 -138.69 155.11 48.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.558 -1.275 . . . . 5.25 107.558 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.479 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -49.17 141.36 8.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.427 1.108 . . . . 2.03 113.375 -168.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.569 ' HB ' ' HE1' ' A' ' 133' ' ' TYR . 11.3 p -143.39 135.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.033 -1.894 . . . . 1.73 109.931 -164.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -33.52 70.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.233 1.016 . . . . 1.74 109.475 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -151.8 121.57 7.01 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 113.109 -1.86 . . . . 2.0 109.697 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.543 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -111.09 122.75 48.68 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.188 -1.369 . . . . 1.27 110.855 -177.469 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.503 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.3 OUTLIER -158.94 97.16 1.39 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.824 1.297 . . . . 1.26 109.769 161.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.442 ' HD3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -166.65 165.2 9.95 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.508 -2.133 . . . . 2.11 106.127 161.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.61 116.74 3.72 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 120.973 1.115 . . . . 0.99 109.885 167.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.42 47.25 3.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.834 -1.174 . . . . 0.51 113.424 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.952 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.3 mt-10 -142.41 147.96 37.04 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.769 -0.826 . . . . 2.16 108.769 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.834 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 35.5 p90 -152.59 159.22 43.26 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.432 -0.951 . . . . 0.28 108.432 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.554 HG21 ' CG1' ' A' ' 136' ' ' VAL . 3.6 p -126.95 127.66 45.19 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.92 -0.712 . . . . 1.12 110.954 175.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 135' ' ' GLN . 8.6 p -111.81 110.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.908 0.861 . . . . 1.1 111.322 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -113.65 16.01 18.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.909 -1.041 . . . . 3.64 110.738 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.65 -50.05 0.7 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.81 0.694 . . . . 2.21 111.28 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -81.88 -5.21 58.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.13 0.49 . . . . 1.95 110.175 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -166.39 144.87 5.53 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.444 -0.798 . . . . 0.63 112.073 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 121' ' ' LYS . 37.2 mt -116.1 112.47 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.279 -1.328 . . . . 1.19 107.684 164.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.834 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 65.7 mt-10 -90.82 163.54 14.39 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.373 -2.084 . . . . 1.13 105.373 175.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 24.0 ptm -167.83 154.27 7.76 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.524 0.515 . . . . 2.37 110.514 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 36.2 mt -129.08 115.25 35.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.982 -0.554 . . . . 1.14 110.797 166.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.654 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 74.7 mtp180 . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.646 . . . . 3.61 110.539 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 9.5 tt0 . . . . . 0 N--CA 1.416 -2.151 0 CA-C-O 121.165 0.507 . . . . 2.3 111.938 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 70.0 t -151.93 128.89 2.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.091 -0.959 . . . . 1.12 109.191 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.7 ' HG2' ' CE ' ' A' ' 186' ' ' MET . 32.6 ttp180 -92.63 102.3 14.72 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.114 -0.948 . . . . 3.33 108.518 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.46 147.9 36.97 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.821 0.82 . . . . 1.02 111.859 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.496 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 10.1 tpt180 -114.36 100.68 8.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.929 -1.487 . . . . 2.43 110.318 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -88.87 96.03 10.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.736 -0.839 . . . . 1.36 108.736 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 117.38 31.67 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.125 0.964 . . . . 1.04 111.316 -171.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -89.88 135.74 33.46 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.225 -1.807 . . . . 1.03 110.487 -179.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -78.95 65.67 4.2 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.362 -1.718 . . . . 1.09 106.362 164.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.3 -99.32 1.18 Allowed Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 118.986 -1.578 . . . . 0.5 110.61 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.46 -24.86 42.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 113.075 0.768 . . . . 0.83 113.075 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -131.27 129.08 41.09 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.299 -0.96 . . . . 2.01 110.934 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.3 tt -53.14 129.32 30.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.457 -1.701 . . . . 1.35 110.049 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.68 -37.75 6.33 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.591 -0.731 . . . . 1.08 110.189 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.7 p -148.12 165.04 32.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.092 -0.504 . . . . 1.12 111.422 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.583 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.7 mm -117.53 149.01 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 105.226 -2.138 . . . . 1.48 105.226 163.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -138.89 128.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.461 0.648 . . . . 1.12 110.065 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.473 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 34.1 t-20 -80.97 102.84 10.4 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.829 -1.174 . . . . 1.77 107.829 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.7 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 38.0 mtm -66.35 -0.73 2.82 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 113.053 0.76 . . . . 1.26 113.053 -166.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 10.7 pt-20 -79.33 -40.95 29.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.127 0.965 . . . . 1.02 111.018 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.486 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 67.6 m-20 -112.27 -26.31 8.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.148 -1.387 . . . . 1.98 109.484 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 185' ' ' ASN . 25.2 t-20 78.2 32.15 0.36 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.611 -2.086 . . . . 2.0 107.872 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 0.1 OUTLIER -91.43 164.55 13.78 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 113.471 -1.695 . . . . 2.78 109.119 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 76.1 mt-30 -85.05 136.02 33.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.491 -0.777 . . . . 1.9 110.132 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.583 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -107.3 90.99 3.47 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 118.86 -0.591 . . . . 1.18 110.177 -175.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.44 -59.2 0.0 OUTLIER Glycine 0 N--CA 1.47 0.91 0 C-N-CA 125.039 1.304 . . . . 1.89 116.268 147.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.442 ' HD2' ' NH1' ' A' ' 196' ' ' ARG . 0.3 OUTLIER -164.86 171.55 14.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.879 -1.661 . . . . 3.47 108.125 174.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.671 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -140.36 130.03 24.31 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.356 0.526 . . . . 0.89 109.66 162.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.666 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -120.43 130.53 54.38 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.667 -0.646 . . . . 5.49 110.659 -170.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.598 HD12 ' HG ' ' A' ' 127' ' ' LEU . 68.1 mt -136.55 171.37 14.59 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.799 1.037 . . . . 2.15 113.799 -166.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 114.415 -1.266 . . . . 2.66 110.451 -176.05 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.409 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 13.3 mtm180 . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.711 0.634 . . . . 5.09 112.711 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.563 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 24.9 ttt -141.82 135.54 29.72 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.493 -0.776 . . . . 3.06 111.974 -168.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.0 m -118.18 106.4 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 122.268 1.032 . . . . 1.41 112.953 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -160.1 106.73 1.59 Allowed 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 105.749 -1.945 . . . . 1.73 105.749 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.839 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 3.5 mp -97.13 111.41 23.66 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.474 -0.935 . . . . 2.04 108.474 -173.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 117' ' ' MET . 21.0 tt0 -143.72 107.38 5.05 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-N 114.963 -1.017 . . . . 1.93 110.549 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.489 ' HD3' HD11 ' A' ' 183' ' ' ILE . 29.5 Cg_exo -36.75 129.03 0.49 Allowed 'Trans proline' 0 CA--C 1.515 -0.427 0 C-N-CA 124.476 3.451 . . . . 0.73 113.427 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.9 t70 75.41 50.1 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.685 1.231 . . . . 0.72 109.768 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.584 ' CE ' HD11 ' A' ' 180' ' ' LEU . 13.1 ptt? -122.47 157.24 32.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 113.789 -1.551 . . . . 2.33 110.116 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.3 m -100.01 113.9 26.81 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.299 -1.0 . . . . 1.11 108.299 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.581 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -142.75 159.84 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 116.046 -0.524 . . . . 1.14 111.457 -165.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.504 ' H ' HG13 ' A' ' 119' ' ' ILE . 49.2 m -143.06 179.87 6.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.914 -0.314 . . . . 0.89 110.167 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.566 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 6.9 mtmp? -59.14 -28.12 66.27 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.677 -0.86 . . . . 2.86 108.677 166.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.527 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 4.4 t-20 -85.73 -17.34 36.19 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.996 -1.456 . . . . 1.68 114.446 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.563 ' HG3' ' HB3' ' A' ' 110' ' ' MET . 1.2 tp10 -84.39 -62.28 1.6 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.498 -1.297 . . . . 2.06 107.498 169.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.832 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 14.8 mmt -57.82 -15.81 9.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.627 -2.078 . . . . 3.58 111.765 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 14.6 p -43.19 -41.88 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 122.176 0.989 . . . . 1.11 110.191 175.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.746 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -69.27 -41.58 76.67 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.047 -1.433 . . . . 1.32 113.224 177.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 197' ' ' LEU . 1.1 tt -49.41 -34.3 16.07 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.528 0.68 . . . . 2.45 111.387 167.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.832 ' HG ' ' O ' ' A' ' 124' ' ' MET . 13.9 mt -85.43 -32.53 22.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.158 -0.928 . . . . 1.13 108.824 -171.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.63 -36.53 84.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.11 -1.405 . . . . 1.96 109.814 167.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.7 -42.91 63.7 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.871 -1.513 . . . . 1.18 111.977 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -5.84 56.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 123.648 1.689 . . . . 1.27 106.991 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 58.33 55.51 4.97 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 110.761 -2.927 . . . . 2.22 112.473 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.648 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 3.2 t80 -139.56 176.73 8.48 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 113.126 0.787 . . . . 0.9 113.126 -177.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.457 ' HA ' ' CZ ' ' A' ' 145' ' ' PHE . 14.1 ptm180 -142.19 150.34 40.89 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.091 -1.078 . . . . 5.25 108.091 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 15.0 tm0? -50.37 143.37 8.94 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.802 1.408 . . . . 2.03 114.802 -166.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.603 HG21 ' CB ' ' A' ' 139' ' ' MET . 1.3 m -125.65 159.52 33.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 112.805 -1.998 . . . . 1.73 111.875 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -63.31 -35.79 81.52 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.68 1.229 . . . . 1.74 108.089 169.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 139' ' ' MET . 2.3 ttpt -159.34 132.98 7.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.348 -2.205 . . . . 2.0 109.521 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.603 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -118.6 135.42 54.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.262 -0.881 . . . . 1.27 111.199 176.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.57 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -156.9 97.61 1.7 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.954 1.359 . . . . 1.26 108.892 152.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.57 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -166.12 161.59 12.63 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 112.207 -2.27 . . . . 2.11 106.1 168.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.469 ' HA ' ' CG2' ' A' ' 155' ' ' ILE . 62.8 Cg_endo -75.67 128.17 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.209 1.273 . . . . 0.99 111.979 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 99.3 23.29 11.4 Favored Glycine 0 C--N 1.351 1.4 0 C-N-CA 119.975 -1.107 . . . . 0.51 112.35 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.648 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 15.4 mp0 -128.79 172.34 11.37 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.75 -0.463 . . . . 2.16 109.75 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.86 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.9 p90 -163.06 175.11 11.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.237 -1.023 . . . . 0.28 108.237 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.564 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 8.0 p -141.96 126.59 17.93 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 120.11 -0.636 . . . . 1.12 111.598 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.563 HG23 ' HG2' ' A' ' 121' ' ' LYS . 12.4 p -125.56 110.07 23.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.709 0.766 . . . . 1.1 111.849 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -110.03 -58.79 2.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.734 -0.666 . . . . 3.64 110.779 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -163.36 -60.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.922 0.341 . . . . 2.21 111.922 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -92.57 4.36 53.75 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.404 0.52 . . . . 1.95 112.404 -172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.7 p -161.08 155.93 23.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.683 0.754 . . . . 0.63 112.478 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 43.7 mt -115.24 108.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.297 -1.742 . . . . 1.19 106.297 161.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.86 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.6 mp0 -90.59 163.98 14.37 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.521 -2.029 . . . . 1.13 105.521 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 8.7 ptp -165.07 154.31 12.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.83 0.706 . . . . 2.37 111.324 -171.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.643 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 34.6 mt -126.25 110.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.615 0.721 . . . . 1.14 111.141 170.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.811 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 113.957 -1.474 . . . . 3.61 109.838 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.811 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.9 tt0 . . . . . 0 N--CA 1.436 -1.15 0 N-CA-C 113.419 0.896 . . . . 2.3 113.419 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 41.3 t -152.92 131.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.727 -1.124 . . . . 1.12 109.959 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.625 ' HG3' HG12 ' A' ' 155' ' ' ILE . 5.7 ttm180 -93.39 111.74 23.48 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.82 -0.807 . . . . 3.33 108.82 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.8 141.33 47.44 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.264 -0.974 . . . . 1.02 111.429 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.707 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 5.2 tpt180 -102.45 101.31 11.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.134 -1.394 . . . . 2.43 110.665 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -91.36 96.53 10.58 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.787 -0.365 . . . . 1.36 110.055 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 117.65 31.21 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-O 122.472 1.13 . . . . 1.04 111.494 -173.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.625 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -85.88 131.84 34.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 112.632 -2.076 . . . . 1.03 109.784 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 35.8 t70 -75.91 65.85 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.716 -1.587 . . . . 1.09 106.716 164.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.71 -99.26 1.74 Allowed Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 119.104 -1.522 . . . . 0.5 110.223 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -88.54 -17.62 29.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 113.01 0.744 . . . . 0.83 113.01 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -133.28 126.62 31.86 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 119.163 -1.015 . . . . 2.01 110.693 -168.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.1 tt -52.93 129.47 30.47 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.458 -1.701 . . . . 1.35 110.629 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -38.34 6.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.992 -1.004 . . . . 1.08 109.755 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.1 p -147.72 157.69 43.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.819 -0.628 . . . . 1.12 111.245 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.8 mt -124.86 146.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.707 -1.96 . . . . 1.48 105.707 166.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 43.1 t -136.56 133.58 49.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.448 0.642 . . . . 1.12 109.947 -175.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -79.43 94.0 5.47 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.712 -1.588 . . . . 1.77 106.712 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.562 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 47.6 mtm -66.38 -1.97 4.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.995 0.809 . . . . 1.26 113.095 -162.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.0 pt-20 -81.45 -39.29 25.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.127 0.965 . . . . 1.02 110.682 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 9.1 m120 -108.43 -26.46 10.46 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.779 -1.555 . . . . 1.98 109.117 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.5 t30 75.48 32.02 0.74 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.338 -2.21 . . . . 2.0 108.416 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.9 ptm180 -93.73 155.22 17.36 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.197 -1.365 . . . . 2.78 109.234 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -77.7 131.19 37.59 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.909 -1.041 . . . . 1.9 108.636 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -105.63 89.53 3.12 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.469 -0.892 . . . . 1.18 110.548 -170.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -57.74 0.0 OUTLIER Glycine 0 N--CA 1.467 0.718 0 C-N-CA 125.376 1.465 . . . . 1.89 116.48 146.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.559 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 18.1 p90 -163.88 175.43 10.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.153 -1.523 . . . . 3.47 109.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.839 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.5 t80 -149.08 100.22 3.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.378 0.608 . . . . 0.89 110.445 159.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.559 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 5.2 mmm180 -95.63 141.87 28.61 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 120.628 -1.295 . . . . 5.49 111.666 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.527 HD11 ' HG ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -109.82 173.33 6.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.202 1.556 . . . . 2.15 115.202 -175.381 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 CA--C 1.535 0.387 0 CA-C-N 112.806 -1.997 . . . . 2.66 110.559 178.513 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.409 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 115.849 1.796 . . . . 5.09 115.849 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.59 ' HB3' ' HG2' ' A' ' 123' ' ' GLU . 16.7 tpt -139.35 117.01 11.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.035 -1.066 . . . . 3.06 112.65 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 197' ' ' LEU . 15.9 m -111.5 107.41 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.42 1.105 . . . . 1.41 112.965 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.473 ' C ' HD13 ' A' ' 113' ' ' LEU . 40.3 t30 -160.14 136.16 8.58 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 113.667 -1.606 . . . . 1.73 106.985 168.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 9.0 mp -114.65 100.2 8.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.121 0.486 . . . . 2.04 109.829 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.476 ' N ' ' HE2' ' A' ' 117' ' ' MET . 20.3 tt0 -156.93 97.54 2.08 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-N 115.23 -0.895 . . . . 1.93 109.816 -169.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.818 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 9.6 Cg_exo -34.27 149.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.796 1 C-N-CA 127.396 5.398 . . . . 0.73 115.356 -173.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 29.1 t70 70.55 31.26 2.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.216 -1.356 . . . . 0.72 108.877 -174.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.514 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 8.3 ptp -110.27 154.15 23.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.691 -1.14 . . . . 2.33 109.733 175.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -106.51 76.61 1.14 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.849 -1.167 . . . . 1.11 107.849 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.614 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 1.5 tt -104.15 159.25 5.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.152 -1.386 . . . . 1.14 110.507 -165.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.424 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 37.7 m -141.76 179.91 6.57 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.738 -0.785 . . . . 0.89 110.425 -168.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.608 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 14.5 mttp -64.52 -20.77 66.42 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.025 -1.102 . . . . 2.86 108.025 169.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.839 ' O ' HG13 ' A' ' 125' ' ' VAL . 2.1 t30 -84.46 -25.05 29.22 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.11 -1.405 . . . . 1.68 113.936 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.614 ' OE1' ' HA ' ' A' ' 119' ' ' ILE . 27.5 mt-10 -86.45 -53.9 4.73 Favored 'General case' 0 N--CA 1.412 -2.369 0 O-C-N 120.694 -1.254 . . . . 2.06 108.671 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.814 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.1 mmt -60.62 -18.25 52.08 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.129 -1.85 . . . . 3.58 111.478 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.839 HG13 ' O ' ' A' ' 122' ' ' ASN . 9.2 p -44.75 -44.17 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-O 121.953 0.882 . . . . 1.11 110.534 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.628 ' N ' HG12 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -67.66 -41.98 82.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.297 -1.319 . . . . 1.32 113.082 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 197' ' ' LEU . 2.9 tm? -50.67 -34.67 27.45 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.666 0.604 . . . . 2.45 110.415 169.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.814 ' HG ' ' O ' ' A' ' 124' ' ' MET . 16.3 mt -84.92 -36.74 21.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.659 0.743 . . . . 1.13 109.572 -170.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -64.02 -32.74 74.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.179 -1.373 . . . . 1.96 109.988 168.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.577 ' HB1' ' NH2' ' A' ' 156' ' ' ARG . . . -76.59 -39.85 51.32 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.683 -1.599 . . . . 1.18 111.975 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 127' ' ' LEU . 0.3 OUTLIER -89.71 -5.3 57.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 124.021 1.867 . . . . 1.27 106.397 -178.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 58.35 51.57 8.17 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 110.488 -3.051 . . . . 2.22 112.361 170.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.812 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.6 t80 -135.47 175.4 9.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.278 0.561 . . . . 0.9 112.097 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.85 151.6 48.23 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.204 -1.406 . . . . 5.25 107.204 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.453 ' HB2' HG11 ' A' ' 147' ' ' VAL . 9.7 tm0? -49.67 138.45 14.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.686 1.231 . . . . 2.03 112.704 -170.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 145' ' ' PHE . 15.0 p -134.82 145.72 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 112.597 -2.092 . . . . 1.73 110.613 -162.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.97 -34.62 72.02 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.772 1.272 . . . . 1.74 109.493 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 11.2 ttpt -160.46 129.57 4.92 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 112.31 -2.223 . . . . 2.0 109.015 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.633 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -114.41 121.76 44.55 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.622 -0.717 . . . . 1.27 111.009 -179.412 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 155' ' ' ILE . 1.7 t -158.14 98.39 1.58 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 122.946 1.355 . . . . 1.26 110.062 153.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.549 ' O ' HD11 ' A' ' 155' ' ' ILE . 0.4 OUTLIER -164.42 161.82 15.74 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 112.552 -2.113 . . . . 2.11 106.328 163.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.503 ' HB3' ' NE2' ' A' ' 168' ' ' GLN . 38.4 Cg_exo -60.71 114.55 2.19 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.332 1.355 . . . . 0.99 111.569 173.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 104.6 32.53 4.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 120.396 -0.906 . . . . 0.51 113.625 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.812 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -131.48 169.84 15.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.697 -0.482 . . . . 2.16 109.697 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.841 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.7 p90 -167.35 165.74 14.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.982 -1.118 . . . . 0.28 107.982 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.633 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 17.2 p -134.47 126.86 30.3 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.743 -0.783 . . . . 1.12 111.05 173.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.556 HG22 ' HG2' ' A' ' 121' ' ' LYS . 10.5 p -116.81 112.28 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.591 0.71 . . . . 1.1 111.242 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.74 132.75 3.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.361 -0.836 . . . . 3.64 111.101 -176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 58.56 -88.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.474 0.916 . . . . 2.21 113.474 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -124.57 23.0 8.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.526 0.565 . . . . 1.95 112.526 -170.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.1 p -160.27 149.72 17.63 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.826 1.047 . . . . 0.63 113.826 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.573 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 28.8 mt -113.33 107.57 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 113.392 -1.731 . . . . 1.19 106.56 159.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 4.2 mt-10 -92.73 170.16 9.92 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.871 -1.9 . . . . 1.13 105.871 175.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.549 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 20.7 ptp -167.6 166.32 14.1 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 123.887 0.742 . . . . 2.37 109.708 -171.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 6.4 mt -128.0 92.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.984 0.897 . . . . 1.14 108.733 165.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.667 ' NH1' ' HB3' ' A' ' 198' ' ' ASP . 12.3 tpp180 . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 113.738 -1.573 . . . . 3.61 112.28 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.507 ' HG2' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.424 -1.74 0 N-CA-C 112.945 0.72 . . . . 2.3 112.945 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 1.9 t -137.05 132.9 47.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 112.966 0.728 . . . . 1.12 112.966 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 154' ' ' MET . 20.9 ttt180 -88.03 110.11 20.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 116.128 -0.487 . . . . 3.33 109.738 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.44 138.67 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.735 0.779 . . . . 1.02 111.661 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.781 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 12.9 tpt180 -103.17 99.57 9.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.181 -1.372 . . . . 2.43 111.088 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.573 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 5.8 mp -91.26 104.5 17.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.388 -0.597 . . . . 1.36 109.388 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.7 114.64 28.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.656 1.217 . . . . 1.04 111.849 -173.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -86.12 131.32 34.28 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 112.516 -2.129 . . . . 1.03 109.45 -178.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.552 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 35.3 t70 -75.61 67.27 2.07 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.634 -1.617 . . . . 1.09 106.634 165.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.37 -98.76 1.27 Allowed Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 119.017 -1.563 . . . . 0.5 110.281 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -82.89 -24.59 33.1 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.852 0.686 . . . . 0.83 112.852 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.552 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 8.0 p-80 -131.74 126.42 34.42 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 119.717 -0.793 . . . . 2.01 111.374 -165.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.35 127.9 26.44 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.661 -1.608 . . . . 1.35 111.058 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -108.14 -38.91 5.64 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.869 -1.059 . . . . 1.08 110.516 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 183' ' ' ILE . 24.0 p -146.03 168.46 20.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.26 -0.427 . . . . 1.12 111.12 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.781 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 2.4 mt -140.82 143.12 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.748 -1.945 . . . . 1.48 105.748 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.7 t -137.06 136.35 47.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.228 0.537 . . . . 1.12 110.154 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.512 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 36.0 t-20 -86.29 100.58 12.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 108.088 -1.079 . . . . 1.77 108.088 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.482 ' HE2' ' HG2' ' A' ' 170' ' ' ARG . 39.1 mtm -64.34 -2.38 2.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 114.021 1.119 . . . . 1.26 114.021 -165.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.512 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.7 pt-20 -80.82 -44.13 18.94 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.861 0.838 . . . . 1.02 110.79 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.497 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 86.5 m-20 -106.45 -25.57 11.81 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.997 -1.456 . . . . 1.98 108.942 -176.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.2 27.8 1.93 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.326 -2.215 . . . . 2.0 107.599 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.414 ' HD2' HD21 ' A' ' 188' ' ' ASN . 0.1 OUTLIER -84.12 166.81 17.33 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.478 -1.692 . . . . 2.78 108.823 178.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -88.25 145.2 26.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.715 1.245 . . . . 1.9 112.67 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.614 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 1.7 m-85 -116.46 -169.34 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.282 -2.235 . . . . 1.18 105.359 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.818 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 134.94 -0.72 3.72 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.256 -1.138 . . . . 1.89 110.256 -163.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -148.65 97.63 2.76 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.138 -1.531 . . . . 3.47 108.369 154.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.597 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.3 t80 -132.15 118.96 20.26 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.004 -0.739 . . . . 0.89 109.004 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.426 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 9.0 mmt180 -105.81 142.49 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.941 -0.392 . . . . 5.49 109.941 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.61 ' CD2' ' HG2' ' A' ' 156' ' ' ARG . 33.7 mt -113.42 154.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.933 -0.576 . . . . 2.15 111.404 -171.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.667 ' HB3' ' NH1' ' A' ' 156' ' ' ARG . 13.4 t70 . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 109.297 -0.631 . . . . 2.66 109.297 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 52.6 mtm180 . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 107.818 -1.179 . . . . 5.09 107.818 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.511 ' O ' ' HB2' ' A' ' 126' ' ' LYS . 12.4 tpt -143.69 159.74 41.95 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.068 -1.053 . . . . 3.06 113.589 -166.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.594 HG11 ' N ' ' A' ' 127' ' ' LEU . 2.6 m -133.33 102.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 122.637 1.208 . . . . 1.41 109.475 159.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -164.22 111.6 1.1 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.691 -1.141 . . . . 1.73 108.194 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 4.4 mt -96.4 103.87 15.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.498 -0.481 . . . . 2.04 110.009 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 117' ' ' MET . 25.3 tt0 -155.88 106.15 2.12 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 119.817 -0.753 . . . . 1.93 110.63 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.561 ' HD3' HD13 ' A' ' 183' ' ' ILE . 18.8 Cg_exo -35.33 144.91 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.78 1 C-N-CA 125.94 4.426 . . . . 0.73 115.721 -175.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 67.74 40.19 2.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.055 -1.43 . . . . 0.72 109.536 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.569 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 10.9 ptt? -113.63 154.05 27.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.438 -1.255 . . . . 2.33 109.416 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -102.9 93.08 4.85 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.98 -1.119 . . . . 1.11 107.98 -173.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.568 HG13 ' CB ' ' A' ' 123' ' ' GLU . 2.2 tt -126.54 162.05 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 114.601 -1.181 . . . . 1.14 110.945 -163.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.8 m -142.55 179.36 7.01 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.771 -0.826 . . . . 0.89 108.771 -169.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.574 ' HA ' HD13 ' A' ' 152' ' ' ILE . 13.0 mtpp -53.95 -35.24 61.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.06 -0.718 . . . . 2.86 109.06 166.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 0.2 OUTLIER -81.87 -32.52 31.01 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.433 -1.258 . . . . 1.68 112.623 -177.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.568 ' CB ' HG13 ' A' ' 119' ' ' ILE . 19.8 mt-10 -85.5 -20.7 29.29 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 119.653 -1.905 . . . . 2.06 109.167 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.731 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 18.7 mmt -85.4 -18.72 32.86 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.072 -1.422 . . . . 3.58 110.881 166.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 9.6 p -54.12 -36.28 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 CA-C-O 121.749 0.785 . . . . 1.11 111.285 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.576 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.5 mmpt? -71.44 -40.2 70.54 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.787 -1.097 . . . . 1.32 112.0 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.615 ' HB3' ' O ' ' A' ' 124' ' ' MET . 1.5 tm? -49.57 -36.05 22.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.777 0.798 . . . . 2.45 109.163 166.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 124' ' ' MET . 24.4 mt -86.11 -34.35 20.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.394 -0.821 . . . . 1.13 110.08 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.76 -34.89 71.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.184 -1.371 . . . . 1.96 109.216 167.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -73.69 -37.79 65.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.508 -1.678 . . . . 1.18 112.128 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.546 HG23 ' HA ' ' A' ' 128' ' ' LEU . 10.8 t -89.18 -5.26 57.85 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 123.819 1.771 . . . . 1.27 107.079 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 56.82 53.26 8.41 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.048 -2.796 . . . . 2.22 112.71 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.76 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.1 t80 -136.37 176.99 8.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.209 -0.597 . . . . 0.9 112.181 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 41.5 ttt180 -134.37 155.24 50.61 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 5.25 107.603 172.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -50.42 140.24 14.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.623 1.201 . . . . 2.03 112.89 -169.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 146' ' ' THR . 12.7 p -141.14 136.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.77 -2.014 . . . . 1.73 109.487 -166.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.5 t -59.43 -30.9 68.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 122.46 1.124 . . . . 1.74 109.578 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -159.22 120.12 3.24 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 112.858 -1.974 . . . . 2.0 108.95 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -111.22 120.63 42.93 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.074 -1.421 . . . . 1.27 110.167 -177.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.28 96.17 2.02 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.275 1.512 . . . . 1.26 109.067 157.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.555 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.2 OUTLIER -166.69 163.04 11.2 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 111.586 -2.552 . . . . 2.11 105.124 165.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.6 127.8 13.6 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 CA-C-N 120.63 1.261 . . . . 0.99 111.791 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 97.03 30.12 7.64 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 120.381 -0.914 . . . . 0.51 113.909 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.76 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -128.0 174.46 9.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.295 0.547 . . . . 2.16 110.125 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.883 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 p90 -169.06 163.93 11.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.273 -1.01 . . . . 0.28 108.273 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.593 HG23 HG13 ' A' ' 136' ' ' VAL . 22.3 p -132.86 126.35 32.02 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.176 -0.609 . . . . 1.12 110.956 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 121' ' ' LYS . 6.1 p -112.18 110.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 120.026 -0.669 . . . . 1.1 111.801 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -132.45 43.58 2.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.433 -0.803 . . . . 3.64 111.456 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.54 -54.34 0.67 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.531 0.937 . . . . 2.21 113.531 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -80.98 -15.09 57.19 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.393 0.616 . . . . 1.95 110.288 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.2 p -164.74 154.6 13.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.154 -0.93 . . . . 0.63 111.441 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.635 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 28.4 mt -114.67 110.87 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 113.496 -1.683 . . . . 1.19 106.555 164.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.883 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -88.95 174.87 7.68 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.53 -1.656 . . . . 1.13 106.53 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 28.2 ptm -168.89 159.34 9.45 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 123.501 0.501 . . . . 2.37 110.734 -172.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.4 mt -130.92 110.17 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.098 -0.501 . . . . 1.14 111.321 167.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.755 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 1.4 tpt180 . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.605 -0.725 . . . . 3.61 110.042 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.755 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.3 tt0 . . . . . 0 N--CA 1.426 -1.645 0 N-CA-C 115.203 1.556 . . . . 2.3 115.203 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 51.1 t -153.5 125.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 113.748 -1.569 . . . . 1.12 110.448 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.591 ' HG3' HG12 ' A' ' 155' ' ' ILE . 4.1 ttm180 -84.52 110.63 18.83 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.467 -0.568 . . . . 3.33 109.467 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.422 ' HB1' ' CG ' ' A' ' 154' ' ' MET . . . -116.27 147.71 41.23 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.729 -0.788 . . . . 1.02 111.603 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.787 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.4 tpp180 -109.77 98.97 8.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.552 -1.203 . . . . 2.43 110.84 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.653 HD22 ' CE ' ' A' ' 124' ' ' MET . 1.4 mp -88.7 94.34 9.87 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.438 -0.949 . . . . 1.36 108.438 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.02 120.45 35.24 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 122.443 1.116 . . . . 1.04 111.672 -170.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-30 -90.91 130.07 36.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.746 -2.025 . . . . 1.03 109.962 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.564 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 30.7 t70 -78.68 64.83 3.78 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.224 -1.769 . . . . 1.09 106.224 165.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.99 -99.7 0.96 Allowed Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 119.332 -1.414 . . . . 0.5 110.735 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.65 -25.54 49.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.865 0.691 . . . . 0.83 112.865 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.564 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 6.8 p-80 -133.84 127.18 32.08 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.917 -0.713 . . . . 2.01 110.587 -167.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.0 tt -54.75 130.85 42.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.126 -1.397 . . . . 1.35 110.194 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.15 -39.16 6.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.93 -1.032 . . . . 1.08 109.827 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.8 p -152.56 169.51 22.47 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.029 -0.532 . . . . 1.12 111.244 -173.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.787 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mt -135.81 144.34 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.191 -2.151 . . . . 1.48 105.191 167.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.64 140.17 39.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 117.992 0.36 . . . . 1.12 110.296 -174.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.602 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 37.5 t-20 -81.15 107.91 14.35 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.32 -1.363 . . . . 1.77 107.32 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.411 ' HE2' ' HG2' ' A' ' 170' ' ' ARG . 59.3 mtm -69.16 -1.52 8.04 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 112.586 0.587 . . . . 1.26 112.586 -166.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.602 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 12.1 pt-20 -85.26 -44.54 12.79 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.753 0.787 . . . . 1.02 111.237 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.526 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.7 m-20 -106.37 -26.09 11.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.513 -1.222 . . . . 1.98 109.093 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 185' ' ' ASN . 13.7 t30 77.31 31.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.536 -2.12 . . . . 2.0 107.304 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 ptm180 -89.0 159.24 17.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.736 -1.575 . . . . 2.78 108.889 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.75 149.77 25.53 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.208 1.004 . . . . 1.9 112.732 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.92 -174.04 3.48 Favored 'General case' 0 CA--C 1.472 -2.039 0 CA-C-N 113.246 -1.797 . . . . 1.18 107.754 -173.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.555 ' CA ' ' HD3' ' A' ' 115' ' ' PRO . . . 129.9 24.92 0.94 Allowed Glycine 1 N--CA 1.393 -4.177 0 CA-C-N 114.101 -1.409 . . . . 1.89 112.725 -178.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.36 94.69 2.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.452 -1.874 . . . . 3.47 106.824 145.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.614 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -129.99 101.36 5.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.693 -0.854 . . . . 0.89 108.693 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 3.2 mpt_? -105.35 127.36 52.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.191 0.52 . . . . 5.49 110.888 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.481 HD13 HD21 ' A' ' 127' ' ' LEU . 4.5 mt -104.15 172.55 6.74 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.434 -0.803 . . . . 2.15 111.9 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.445 -0.718 0 CA-C-N 114.268 -1.333 . . . . 2.66 108.66 173.427 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.43 ' HB3' ' HE3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 114.731 1.382 . . . . 5.09 114.731 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.446 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 34.7 ttp -142.45 124.86 15.63 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.35 -0.94 . . . . 3.06 111.793 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.9 m -110.7 104.91 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-O 122.817 1.294 . . . . 1.41 113.128 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.562 ' O ' ' HE2' ' A' ' 117' ' ' MET . 28.0 t-20 -160.01 109.9 1.83 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 112.587 -2.097 . . . . 1.73 106.054 165.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.3 mp -99.51 123.69 44.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.825 -0.805 . . . . 2.04 108.825 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.601 ' N ' ' HE3' ' A' ' 117' ' ' MET . 1.5 tm-20 -152.22 100.37 2.83 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.499 -0.926 . . . . 1.93 108.499 -172.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 24.5 Cg_exo -35.43 137.66 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.366 1 C-N-CA 125.361 4.041 . . . . 0.73 114.314 -173.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.2 47.57 0.28 Allowed 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.488 1.137 . . . . 0.72 109.795 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.601 ' HE3' ' N ' ' A' ' 114' ' ' GLU . 5.8 ptp -122.36 156.31 34.22 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.537 -1.211 . . . . 2.33 110.867 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.2 m -102.7 77.74 1.63 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.334 1.064 . . . . 1.11 108.471 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.459 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 15.2 tt -106.7 168.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 113.287 -1.779 . . . . 1.14 109.482 -171.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.497 ' O ' ' SD ' ' A' ' 124' ' ' MET . 3.8 m -137.59 162.9 32.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.223 -0.591 . . . . 0.89 109.464 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.529 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -50.34 -26.52 4.97 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 122.009 0.909 . . . . 2.86 108.817 170.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.603 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 4.0 t-20 -82.79 -14.69 53.94 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.826 -1.988 . . . . 1.68 114.535 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.453 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -84.7 -63.63 1.3 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.74 -1.225 . . . . 2.06 109.969 168.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.681 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -64.28 -9.87 20.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.074 -0.966 . . . . 3.58 110.727 174.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 12.4 p -41.7 -41.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.853 0.835 . . . . 1.11 110.62 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.553 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.3 mmpt? -66.13 -37.31 85.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.807 -1.088 . . . . 1.32 113.116 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.646 ' HB3' ' O ' ' A' ' 124' ' ' MET . 2.5 tm? -54.2 -33.58 58.54 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.618 0.723 . . . . 2.45 109.894 167.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.761 ' HB3' ' CE2' ' A' ' 145' ' ' PHE . 15.9 mt -82.44 -34.96 27.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.452 -0.944 . . . . 1.13 108.452 -172.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -60.14 -39.33 85.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.843 -1.526 . . . . 1.96 109.943 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 132' ' ' GLN . . . -70.32 -42.76 71.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.989 -1.459 . . . . 1.18 112.544 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.451 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -88.6 -0.62 57.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 124.284 1.992 . . . . 1.27 105.812 -177.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 130' ' ' ALA . 11.5 mm-40 57.01 49.51 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 110.628 -2.987 . . . . 2.22 111.856 170.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.965 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 1.9 t80 -141.31 174.49 10.49 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 119.484 -0.886 . . . . 0.9 113.198 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 23.4 ptt-85 -137.49 158.15 45.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.142 -1.39 . . . . 5.25 107.585 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.69 140.42 14.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.194 0.997 . . . . 2.03 112.523 -171.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.585 ' HB ' ' CE1' ' A' ' 133' ' ' TYR . 11.9 p -139.85 134.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 113.512 -1.676 . . . . 1.73 110.192 -163.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.02 -33.36 68.89 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.7 1.238 . . . . 1.74 109.602 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.592 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -160.14 131.35 5.82 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 112.308 -2.224 . . . . 2.0 107.801 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.523 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 1.4 ptt? -119.0 137.93 53.18 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 115.023 -0.99 . . . . 1.27 111.127 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -162.31 98.58 1.03 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 122.34 1.067 . . . . 1.26 109.846 152.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -167.62 155.75 8.5 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 113.371 -1.74 . . . . 2.11 106.74 163.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.27 119.62 6.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.051 1.167 . . . . 0.99 110.017 169.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.451 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 93.67 44.17 3.73 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.476 -1.345 . . . . 0.51 112.744 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.965 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.4 mt-10 -145.57 148.85 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.326 -0.99 . . . . 2.16 108.326 172.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.761 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 40.7 p90 -152.85 156.78 39.65 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.758 -0.83 . . . . 0.28 108.758 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.541 HG22 ' CG1' ' A' ' 136' ' ' VAL . 21.3 p -126.04 126.28 43.99 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.679 -0.692 . . . . 1.12 110.663 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.579 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 9.1 p -125.08 109.88 23.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.966 -1.016 . . . . 1.1 111.511 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -110.27 -66.1 1.1 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.17 -0.468 . . . . 3.64 110.775 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.39 -61.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.076 0.399 . . . . 2.21 112.076 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -93.13 -1.78 56.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.615 0.598 . . . . 1.95 112.615 -171.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.4 p -163.28 152.6 14.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.529 0.937 . . . . 0.63 113.529 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.534 HD13 ' SD ' ' A' ' 124' ' ' MET . 20.7 mt -109.97 110.94 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 113.508 -1.678 . . . . 1.19 107.259 164.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -97.92 107.43 19.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.857 -1.164 . . . . 1.13 107.857 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 7.9 ptm -115.7 139.42 50.15 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.625 0.726 . . . . 2.37 112.124 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.56 HG12 ' CG ' ' A' ' 170' ' ' ARG . 68.4 mt -99.13 108.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.636 -1.165 . . . . 1.14 109.535 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 37.9 ttp180 . . . . . 0 C--N 1.31 -1.11 0 CA-C-N 114.689 -1.141 . . . . 3.61 109.978 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 113.386 0.884 . . . . 2.3 113.386 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.451 ' N ' ' HG2' ' A' ' 168' ' ' GLN . 44.0 t -151.21 128.7 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 114.834 -1.075 . . . . 1.12 109.192 173.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.56 ' CG ' HG12 ' A' ' 155' ' ' ILE . 32.6 mtm180 -91.14 109.35 20.6 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 120.941 0.4 . . . . 3.33 110.386 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -114.15 134.14 55.1 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.956 0.884 . . . . 1.02 111.544 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.8 tpp180 -95.0 98.04 10.4 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 113.569 -1.651 . . . . 2.43 110.75 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 151' ' ' SER . 2.8 mp -86.21 93.28 9.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.079 -0.711 . . . . 1.36 109.079 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 114.25 25.92 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 122.012 0.911 . . . . 1.04 111.497 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-85 -87.02 131.48 34.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.446 -1.707 . . . . 1.03 110.197 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.502 ' HB2' ' HB1' ' A' ' 181' ' ' ALA . 38.7 t70 -77.38 65.38 2.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.567 -1.642 . . . . 1.09 106.567 164.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.29 -98.54 1.25 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.911 -1.614 . . . . 0.5 110.379 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.71 -22.93 37.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.906 0.706 . . . . 0.83 112.906 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -133.89 128.42 34.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 119.685 -0.806 . . . . 2.01 111.431 -168.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 5.6 tt -52.77 125.93 18.39 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.899 -1.5 . . . . 1.35 109.648 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 176' ' ' ASP . . . -106.11 -37.74 6.51 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.408 -0.814 . . . . 1.08 109.442 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.4 p -146.13 161.23 40.65 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.533 -0.758 . . . . 1.12 111.001 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.4 mt -128.59 145.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.214 -2.143 . . . . 1.48 105.214 167.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.6 t -142.22 132.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.392 0.615 . . . . 1.12 109.998 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.483 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 32.3 t-20 -79.21 105.26 10.41 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 107.495 -1.298 . . . . 1.77 107.495 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.468 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 38.6 mtm -66.95 -1.48 4.1 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.782 0.676 . . . . 1.26 112.642 -167.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.578 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.9 pt-20 -79.71 -44.14 21.35 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.85 0.833 . . . . 1.02 110.819 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.578 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 70.6 m-20 -107.49 -26.59 10.86 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.293 -1.321 . . . . 1.98 109.454 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 185' ' ' ASN . 53.8 t30 77.02 33.13 0.46 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.534 -2.121 . . . . 2.0 107.586 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.5 ptm180 -91.83 161.47 14.84 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.581 -1.645 . . . . 2.78 109.18 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.62 137.76 32.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.103 -0.953 . . . . 1.9 109.358 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -110.85 89.92 3.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.779 -0.769 . . . . 1.18 110.795 -174.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.54 -58.69 0.0 OUTLIER Glycine 0 N--CA 1.469 0.863 0 C-N-CA 125.173 1.368 . . . . 1.89 116.233 145.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 192' ' ' PHE . 23.6 p90 -164.07 174.4 11.37 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.952 -1.624 . . . . 3.47 107.709 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.756 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.7 t80 -138.31 101.59 4.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.637 0.732 . . . . 0.89 110.626 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -81.92 137.52 35.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.834 -0.621 . . . . 5.49 110.09 -177.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.58 HD12 ' HG ' ' A' ' 127' ' ' LEU . 92.5 mt -134.24 170.48 15.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.493 0.923 . . . . 2.15 113.493 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 114.268 -1.333 . . . . 2.66 109.874 -178.707 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 115.084 1.513 . . . . 5.09 115.084 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.631 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 57.4 ttm -142.3 110.87 6.13 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.153 -0.619 . . . . 3.06 112.326 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.8 m -107.81 106.66 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-O 122.459 1.123 . . . . 1.41 113.08 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -158.46 108.64 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.185 -1.825 . . . . 1.73 107.008 163.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.761 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.8 mp -95.18 116.85 29.27 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.059 -0.719 . . . . 2.04 109.059 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 117' ' ' MET . 9.3 tt0 -148.3 107.34 3.6 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 119.766 -0.774 . . . . 1.93 110.176 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.508 ' HG3' HG12 ' A' ' 183' ' ' ILE . 37.7 Cg_exo -35.43 130.49 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 124.287 3.325 . . . . 0.73 113.799 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 24.3 t70 68.83 54.33 0.48 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.512 1.149 . . . . 0.72 110.01 -174.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.684 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 14.1 ptt? -121.73 156.18 33.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.972 -1.467 . . . . 2.33 110.364 172.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.51 96.37 6.69 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.496 -0.927 . . . . 1.11 108.496 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.484 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 15.8 tt -136.98 169.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.613 -1.176 . . . . 1.14 109.831 -165.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.581 ' O ' ' HG2' ' A' ' 124' ' ' MET . 20.2 m -139.75 175.94 9.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.809 0.731 . . . . 0.89 111.118 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.575 ' H ' ' HD2' ' A' ' 121' ' ' LYS . 3.2 mptt -62.34 -19.82 63.74 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.123 0.963 . . . . 2.86 108.556 169.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.801 ' O ' HG13 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -81.5 -23.44 37.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.31 -1.768 . . . . 1.68 112.627 177.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.631 ' HA ' ' H ' ' A' ' 110' ' ' MET . 19.6 mt-10 -88.45 -44.01 11.04 Favored 'General case' 0 N--CA 1.408 -2.556 0 O-C-N 120.812 -1.18 . . . . 2.06 108.93 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.717 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 14.1 mmt -63.89 -18.76 64.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.96 -1.473 . . . . 3.58 110.557 169.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -48.96 -41.57 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-O 122.089 0.947 . . . . 1.11 110.287 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.509 ' N ' HG12 ' A' ' 125' ' ' VAL . 8.7 mmpt? -66.67 -38.21 86.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.204 -1.362 . . . . 1.32 113.404 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.639 ' HB3' ' O ' ' A' ' 124' ' ' MET . 13.5 tp -49.85 -40.15 41.46 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.857 0.837 . . . . 2.45 110.114 166.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.2 mt -82.44 -30.84 29.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.016 -0.993 . . . . 1.13 109.259 -167.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.49 -39.3 94.08 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.844 -1.526 . . . . 1.96 110.241 165.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -72.3 -41.93 66.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.497 -1.683 . . . . 1.18 112.083 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER -97.0 6.79 47.98 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 124.558 2.123 . . . . 1.27 105.784 -177.148 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 46.29 50.67 12.02 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 110.023 -3.262 . . . . 2.22 113.008 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.547 ' HB3' ' CD2' ' A' ' 145' ' ' PHE . 2.8 t80 -136.07 175.03 9.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.879 -0.728 . . . . 0.9 112.437 -173.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 2.2 tmm_? -137.05 147.96 46.49 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.459 -1.682 . . . . 5.25 106.459 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.543 ' N ' ' HD2' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -47.92 140.7 6.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.846 1.308 . . . . 2.03 113.388 -170.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.556 HG13 HG21 ' A' ' 146' ' ' THR . 11.8 p -140.88 137.73 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 112.638 -2.074 . . . . 1.73 109.423 -163.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -59.29 -33.22 70.82 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.343 1.068 . . . . 1.74 109.057 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.16 129.01 5.63 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.997 -1.91 . . . . 2.0 109.082 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.528 ' O ' ' HG2' ' A' ' 139' ' ' MET . 0.0 OUTLIER -118.66 129.62 55.4 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.293 -1.321 . . . . 1.27 111.59 -172.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.489 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 1.8 t -160.57 99.33 1.28 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 122.907 1.337 . . . . 1.26 110.867 155.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.421 ' H ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.14 162.32 14.19 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.737 -2.029 . . . . 2.11 105.985 161.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.96 120.47 8.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.102 1.201 . . . . 0.99 110.379 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.02 48.56 3.32 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.548 -1.31 . . . . 0.51 112.964 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.541 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 31.7 mt-10 -142.25 167.51 21.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.343 -0.614 . . . . 2.16 109.343 169.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.856 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 46.8 p90 -167.76 163.13 14.18 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.234 -1.024 . . . . 0.28 108.234 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.556 HG21 HG13 ' A' ' 136' ' ' VAL . 25.7 p -130.34 125.89 35.78 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.822 -0.751 . . . . 1.12 111.147 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.511 HG13 ' HB2' ' A' ' 135' ' ' GLN . 7.7 p -115.24 110.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 122.002 0.906 . . . . 1.1 111.133 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -122.73 31.16 6.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.101 -0.954 . . . . 3.64 110.784 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.91 -47.04 0.66 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.485 -0.78 . . . . 2.21 112.211 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -81.67 -16.29 51.79 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.102 0.477 . . . . 1.95 110.569 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.8 p -162.49 154.21 18.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.434 -0.803 . . . . 0.63 112.296 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.559 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 20.2 mt -117.98 107.68 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.696 -1.593 . . . . 1.19 107.346 165.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.856 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.8 mp0 -90.9 168.35 11.76 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.176 -2.157 . . . . 1.13 105.176 174.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.04 157.9 10.01 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.783 0.677 . . . . 2.37 110.291 -169.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 140' ' ' THR . 15.1 mt -127.15 109.99 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 115.425 -0.807 . . . . 1.14 110.347 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.703 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 3.9 tpt180 . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 115.029 -0.987 . . . . 3.61 109.675 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.703 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 9.4 tt0 . . . . . 0 N--CA 1.425 -1.722 0 N-CA-C 115.473 1.657 . . . . 2.3 115.473 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 46.5 t -153.08 131.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 113.998 -1.456 . . . . 1.12 109.856 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 35.9 mtm180 -87.14 116.63 25.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.07 -0.514 . . . . 3.33 110.192 168.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.54 153.1 38.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.613 0.721 . . . . 1.02 111.414 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.693 ' CB ' ' HB ' ' A' ' 184' ' ' VAL . 0.0 OUTLIER -120.57 101.8 8.0 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.264 -1.335 . . . . 2.43 111.147 -172.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.682 HD22 ' SD ' ' A' ' 124' ' ' MET . 1.1 mp -90.72 90.12 7.81 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.443 -0.577 . . . . 1.36 109.443 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.0 125.03 38.39 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.297 1.046 . . . . 1.04 111.139 -175.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 24.4 m-85 -98.45 136.54 38.44 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.158 -1.837 . . . . 1.03 111.354 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -78.28 64.74 3.47 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.813 -1.551 . . . . 1.09 106.813 161.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.24 -99.27 1.17 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 118.71 -1.71 . . . . 0.5 110.599 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.26 -20.49 32.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.913 0.708 . . . . 0.83 112.913 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.16 123.08 27.78 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 119.001 -1.08 . . . . 2.01 110.082 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -56.53 134.48 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.2 -1.818 . . . . 1.35 110.799 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.03 -41.43 5.38 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.509 -1.223 . . . . 1.08 110.517 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.7 p -150.51 158.88 44.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.342 -0.39 . . . . 1.12 111.606 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 1.8 mm -109.98 150.01 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 104.855 -2.276 . . . . 1.48 104.855 163.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.693 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 42.3 t -133.6 131.31 57.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 118.761 0.71 . . . . 1.12 110.255 177.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -80.42 94.34 6.16 Favored 'General case' 0 CA--C 1.476 -1.873 0 N-CA-C 106.8 -1.556 . . . . 1.77 106.8 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.549 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.0 mtm -63.68 -2.53 1.76 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 124.149 0.905 . . . . 1.26 113.39 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.4 pt-20 -83.5 -41.46 17.96 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.784 0.802 . . . . 1.02 110.672 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.441 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.6 m-20 -102.73 -25.93 13.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.262 -1.335 . . . . 1.98 108.549 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.8 t30 73.97 32.82 1.03 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.936 -2.393 . . . . 2.0 107.887 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.8 ptm180 -95.75 162.43 13.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.701 -1.59 . . . . 2.78 109.466 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 77.1 mt-30 -80.83 127.81 32.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.183 -0.917 . . . . 1.9 109.535 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.555 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -100.82 93.01 5.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.747 -0.644 . . . . 1.18 110.303 -171.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 20.87 -58.23 0.0 OUTLIER Glycine 0 N--CA 1.471 0.975 0 N-CA-C 116.542 1.377 . . . . 1.89 116.542 148.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 192' ' ' PHE . 34.0 p90 -162.99 175.14 11.45 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.296 -1.452 . . . . 3.47 108.755 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.761 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -145.06 127.95 16.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.556 -0.535 . . . . 0.89 109.556 156.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.552 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 1.6 mpt_? -112.02 141.56 45.53 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 120.88 -1.138 . . . . 5.49 111.507 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.511 ' HA ' ' NH1' ' A' ' 156' ' ' ARG . 40.6 mt -136.72 163.42 30.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.702 -0.681 . . . . 2.15 112.162 -172.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 114.866 -1.061 . . . . 2.66 110.214 -177.494 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.687 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 32.4 mtt180 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.404 -0.961 . . . . 5.09 108.404 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.3 ttt -142.75 132.24 23.67 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.194 -1.003 . . . . 3.06 113.531 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.489 ' O ' HG22 ' A' ' 111' ' ' VAL . 32.6 m -124.22 101.6 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 123.148 1.452 . . . . 1.41 111.399 164.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.584 ' C ' HD13 ' A' ' 113' ' ' LEU . 43.0 t30 -162.51 119.99 2.06 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 105.007 -2.22 . . . . 1.73 105.007 170.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.639 ' N ' HD13 ' A' ' 113' ' ' LEU . 5.6 mp -109.45 80.21 1.29 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.298 -1.001 . . . . 2.04 108.298 -172.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.526 ' H ' ' HE1' ' A' ' 117' ' ' MET . 27.4 tt0 -123.98 111.02 29.07 Favored Pre-proline 0 C--N 1.29 -2.02 0 C-N-CA 118.946 -1.102 . . . . 1.93 110.295 -169.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.475 ' HG3' HG12 ' A' ' 183' ' ' ILE . 39.2 Cg_exo -35.78 131.98 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 124.886 3.724 . . . . 0.73 114.298 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 t70 72.76 50.03 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.552 1.168 . . . . 0.72 110.457 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.526 ' HE1' ' H ' ' A' ' 114' ' ' GLU . 10.6 ptp -122.84 155.57 36.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.166 -1.379 . . . . 2.33 110.924 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -96.67 85.58 3.88 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.933 0.873 . . . . 1.11 108.959 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.602 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -110.18 163.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.397 -1.274 . . . . 1.14 109.924 -172.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.518 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.5 m -140.87 173.92 11.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.673 -0.492 . . . . 0.89 109.673 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.554 ' HG2' ' CG2' ' A' ' 147' ' ' VAL . 44.2 mttp -53.99 -32.74 55.02 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 108.575 -0.898 . . . . 2.86 108.575 164.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.598 ' O ' HG11 ' A' ' 125' ' ' VAL . 41.6 t30 -84.24 -19.19 34.33 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 114.053 -1.43 . . . . 1.68 114.733 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.518 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.3 mp0 -84.9 -63.28 1.36 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 119.755 -1.841 . . . . 2.06 107.183 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.741 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -56.36 -13.47 2.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 112.858 -1.974 . . . . 3.58 111.361 172.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.598 HG11 ' O ' ' A' ' 122' ' ' ASN . 14.5 p -43.19 -43.07 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.2 1.0 . . . . 1.11 110.117 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.687 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.7 -37.54 82.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.115 -1.402 . . . . 1.32 112.774 176.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.645 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -50.94 -33.83 26.11 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.723 0.773 . . . . 2.45 110.873 168.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 124' ' ' MET . 16.0 mt -84.55 -32.62 23.75 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.931 -1.032 . . . . 1.13 109.229 -172.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.23 -35.0 77.27 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.352 -1.295 . . . . 1.96 109.644 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.26 -42.04 72.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.252 -1.794 . . . . 1.18 111.904 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.484 HG23 ' HA ' ' A' ' 128' ' ' LEU . 11.6 t -90.33 -2.66 58.01 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 123.384 1.564 . . . . 1.27 107.368 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 55.23 54.85 8.21 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 110.974 -2.83 . . . . 2.22 112.103 172.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.868 ' HH ' ' CG1' ' A' ' 136' ' ' VAL . 3.8 t80 -138.97 177.85 7.59 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 113.095 0.776 . . . . 0.9 113.095 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.41 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -141.31 139.27 33.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.539 -1.282 . . . . 5.25 107.539 177.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.6 OUTLIER -49.06 139.47 10.51 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.35 1.241 . . . . 2.03 114.35 -168.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.868 ' CG1' ' HH ' ' A' ' 133' ' ' TYR . 3.8 m -124.23 156.41 31.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.933 -1.939 . . . . 1.73 111.52 -175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -59.67 -37.48 78.87 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.516 1.15 . . . . 1.74 107.958 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -158.46 134.97 9.45 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 112.611 -2.086 . . . . 2.0 109.397 -177.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.05 136.42 54.58 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.0 -1.0 . . . . 1.27 111.311 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.7 t -159.0 100.59 1.57 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.684 1.231 . . . . 1.26 109.675 151.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.531 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -163.62 170.15 7.56 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.82 -1.991 . . . . 2.11 106.534 165.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.5 117.13 3.66 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.661 1.574 . . . . 0.99 112.604 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 105.94 36.53 2.73 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.947 -0.644 . . . . 0.51 112.366 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.704 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 12.8 mp0 -130.95 176.82 7.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.171 -0.307 . . . . 2.16 110.171 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.866 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -166.56 175.95 7.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.0 -0.741 . . . . 0.28 109.0 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.593 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 61.7 p -140.98 126.32 18.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.967 -0.56 . . . . 1.12 110.898 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.554 ' CG2' ' HG2' ' A' ' 121' ' ' LYS . 14.4 p -125.41 126.44 70.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.435 0.636 . . . . 1.1 112.241 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -132.36 -74.69 0.51 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.009 -0.541 . . . . 3.64 110.26 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.05 -50.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.893 0.331 . . . . 2.21 111.893 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.88 -11.47 55.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.418 -0.355 . . . . 1.95 111.516 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 10.9 p -165.13 154.72 12.94 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.868 0.842 . . . . 0.63 112.915 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.633 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 63.2 mt -114.61 108.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.597 -1.631 . . . . 1.19 106.597 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.866 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.24 166.61 13.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.703 -1.962 . . . . 1.13 105.703 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.574 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 7.6 ptm -167.53 151.67 6.59 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 124.014 0.821 . . . . 2.37 110.183 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.547 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.3 mt -128.24 113.57 30.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.159 -0.473 . . . . 1.14 110.439 172.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.779 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 13.1 mtp-105 . . . . . 0 C--N 1.316 -0.881 0 O-C-N 123.347 0.404 . . . . 3.61 110.613 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.779 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 25.4 tt0 . . . . . 0 N--CA 1.413 -2.279 0 N-CA-C 113.02 0.748 . . . . 2.3 113.02 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 61.9 t -154.96 124.43 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.131 -1.395 . . . . 1.12 109.364 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 50.5 mtm180 -81.58 124.74 29.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.548 -0.538 . . . . 3.33 109.548 166.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -129.05 137.18 51.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.654 0.74 . . . . 1.02 110.346 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.1 tpp180 -104.82 106.54 17.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.195 -1.366 . . . . 2.43 110.936 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 5.1 mp -92.31 98.21 11.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.3 -0.63 . . . . 1.36 109.3 174.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.57 120.99 40.86 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.188 0.994 . . . . 1.04 111.499 -171.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -88.57 134.96 33.72 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.953 -1.93 . . . . 1.03 110.229 -177.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 37.4 t70 -77.21 66.15 2.94 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.676 -1.602 . . . . 1.09 106.676 163.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.81 -98.97 1.73 Allowed Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 118.801 -1.666 . . . . 0.5 110.233 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.65 -26.02 30.24 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.878 0.695 . . . . 0.83 112.878 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -128.37 128.81 45.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.442 -0.903 . . . . 2.01 110.865 -166.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.2 tt -52.14 129.13 26.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.433 -1.712 . . . . 1.35 110.546 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.91 -39.32 5.8 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.04 -0.982 . . . . 1.08 110.059 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 167.37 24.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.144 -0.48 . . . . 1.12 111.853 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.55 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 2.0 mm -118.6 147.8 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 105.444 -2.058 . . . . 1.48 105.444 164.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -139.82 128.34 26.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.579 0.704 . . . . 1.12 110.072 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.448 ' CB ' ' HG2' ' A' ' 190' ' ' ARG . 2.4 t-20 -69.4 105.13 2.48 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 107.523 -1.288 . . . . 1.77 107.523 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.607 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 6.7 mtm -65.33 -3.56 4.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.845 0.683 . . . . 1.26 112.845 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.451 ' HG3' ' ND2' ' A' ' 188' ' ' ASN . 11.2 pt-20 -96.12 -37.44 10.59 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.695 0.76 . . . . 1.02 111.303 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.451 ' ND2' ' HG3' ' A' ' 187' ' ' GLU . 48.9 m-80 -104.4 -26.53 12.39 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.541 -1.208 . . . . 1.98 109.893 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 185' ' ' ASN . 25.4 t-20 75.39 31.83 0.76 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.745 -2.025 . . . . 2.0 108.362 -177.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 13.5 ptt180 -92.93 156.46 16.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.454 -1.248 . . . . 2.78 109.503 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -84.69 127.44 34.1 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.87 -1.059 . . . . 1.9 109.692 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.55 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -103.77 92.81 4.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.918 -0.713 . . . . 1.18 110.451 -171.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 18.27 -58.5 0.0 OUTLIER Glycine 0 N--CA 1.468 0.826 0 N-CA-C 115.905 1.122 . . . . 1.89 115.905 145.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -163.32 174.21 12.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.043 -1.578 . . . . 3.47 108.399 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.608 ' HB3' ' CD2' ' A' ' 113' ' ' LEU . 1.9 t80 -142.82 152.71 42.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.086 -1.079 . . . . 0.89 108.086 156.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.542 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.42 147.53 34.75 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 122.058 -0.401 . . . . 5.49 111.422 -172.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.479 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 5.4 mt -132.87 172.43 12.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.636 0.976 . . . . 2.15 113.636 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-N 113.399 -1.728 . . . . 2.66 108.667 169.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.412 ' CB ' ' HG3' ' A' ' 126' ' ' LYS . 3.4 ptm180 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 119.209 -0.424 . . . . 5.09 110.642 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.3 ttp -141.14 125.52 17.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 118.306 -1.358 . . . . 3.06 113.732 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 111' ' ' VAL . 26.8 m -114.0 101.53 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 122.763 1.268 . . . . 1.41 110.947 167.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.502 ' C ' HD11 ' A' ' 113' ' ' LEU . 53.0 t30 -163.02 109.75 1.19 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.576 -1.647 . . . . 1.73 106.763 171.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.655 HD11 ' N ' ' A' ' 113' ' ' LEU . 4.9 mp -104.02 77.38 1.43 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.937 -0.764 . . . . 2.04 108.937 -169.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -121.81 107.64 35.7 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 119.342 -0.943 . . . . 1.93 110.311 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.509 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.4 Cg_exo -34.04 130.25 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.542 3.494 . . . . 0.73 114.407 -172.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 23.1 t0 77.72 39.22 0.18 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.456 1.122 . . . . 0.72 110.811 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.621 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -115.05 155.51 26.88 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.867 -1.06 . . . . 2.33 110.577 172.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 m -92.91 86.6 5.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.964 0.887 . . . . 1.11 109.205 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.7 tt -116.46 162.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.076 -1.42 . . . . 1.14 109.718 -171.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.547 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.6 m -142.26 178.03 7.85 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.96 -0.756 . . . . 0.89 108.96 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.606 ' HG2' ' CG2' ' A' ' 147' ' ' VAL . 28.9 mtpt -57.45 -28.58 63.47 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 108.525 -0.917 . . . . 2.86 108.525 163.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.627 ' O ' HG12 ' A' ' 125' ' ' VAL . 32.9 t30 -85.32 -18.44 33.83 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-N 113.851 -1.522 . . . . 1.68 114.774 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.547 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.0 mp0 -86.9 -62.08 1.58 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 119.82 -1.8 . . . . 2.06 108.289 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.811 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.7 tpt -53.58 -17.03 1.8 Allowed 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 112.8 -2.0 . . . . 3.58 110.779 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 122' ' ' ASN . 14.9 p -43.98 -44.92 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.288 1.042 . . . . 1.11 110.447 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.544 ' H ' HG11 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -69.18 -36.29 77.19 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.937 -1.483 . . . . 1.32 112.838 177.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.593 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.7 OUTLIER -51.1 -35.08 33.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 122.028 0.918 . . . . 2.45 110.54 168.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.811 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.2 mt -84.82 -28.6 26.0 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.754 -1.112 . . . . 1.13 109.152 -171.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.69 -20.47 50.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.136 -1.393 . . . . 1.96 110.341 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -80.62 -43.87 19.82 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.07 -1.423 . . . . 1.18 111.215 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.91 -6.17 54.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 123.653 1.692 . . . . 1.27 107.094 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.12 56.41 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 110.976 -2.829 . . . . 2.22 112.945 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.716 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -135.15 176.72 8.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.615 -0.721 . . . . 0.9 111.817 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -136.98 149.95 47.84 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.126 -1.435 . . . . 5.25 107.126 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -48.88 137.0 13.24 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.737 1.256 . . . . 2.03 112.836 -170.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.69 ' CG2' ' HH ' ' A' ' 133' ' ' TYR . 11.6 p -137.6 140.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 112.349 -2.205 . . . . 1.73 109.677 -164.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 m -63.5 -31.72 72.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.096 0.951 . . . . 1.74 109.3 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -152.6 117.72 5.19 Favored 'General case' 0 CA--C 1.485 -1.539 0 CA-C-N 113.352 -1.749 . . . . 2.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.579 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -109.59 117.88 35.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 113.81 -1.541 . . . . 1.27 110.12 179.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.416 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -151.12 95.59 2.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.24 1.495 . . . . 1.26 108.399 156.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.522 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -168.31 155.87 7.63 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 111.546 -2.57 . . . . 2.11 105.029 168.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.419 ' HA ' HG22 ' A' ' 155' ' ' ILE . 14.6 Cg_exo -71.17 123.6 9.77 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.526 1.484 . . . . 0.99 112.18 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.681 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 106.15 20.14 9.48 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 120.579 -0.82 . . . . 0.51 111.781 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.716 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.8 mp0 -125.99 173.82 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.807 -0.442 . . . . 2.16 109.807 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.858 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 47.6 p90 -168.42 168.17 11.38 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.506 -1.294 . . . . 0.28 107.506 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.583 HG23 HG11 ' A' ' 136' ' ' VAL . 34.9 p -133.19 127.27 33.43 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.713 -0.795 . . . . 1.12 110.499 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.606 ' CG2' ' HG2' ' A' ' 121' ' ' LYS . 10.7 p -122.93 121.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.715 -0.794 . . . . 1.1 112.861 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -111.02 -77.47 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.973 . . . . 3.64 109.74 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -176.73 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.261 -0.881 . . . . 2.21 109.092 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.45 -19.32 39.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.97 -1.014 . . . . 1.95 110.128 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 21.0 p -160.6 155.03 23.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.149 -0.932 . . . . 0.63 111.751 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.545 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 53.4 mt -121.11 113.82 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.487 -1.671 . . . . 1.19 106.487 163.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.858 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -89.82 169.99 10.79 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.374 -1.713 . . . . 1.13 106.374 175.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.23 150.54 5.36 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 123.802 0.689 . . . . 2.37 110.672 -174.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.587 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.3 mt -128.71 119.47 49.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.763 -0.653 . . . . 1.14 109.938 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 82.6 mtp180 . . . . . 0 C--N 1.32 -0.695 0 O-C-N 123.458 0.474 . . . . 3.61 110.719 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.706 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 5.3 tt0 . . . . . 0 N--CA 1.425 -1.685 0 CA-C-O 121.301 0.572 . . . . 2.3 112.064 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 53.7 t -153.69 130.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.712 -1.131 . . . . 1.12 108.711 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.636 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 51.4 mtm180 -87.25 122.82 31.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.225 0.536 . . . . 3.33 110.152 169.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -130.25 128.45 41.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.091 0.948 . . . . 1.02 110.791 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.512 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 9.0 tpp180 -96.26 120.88 37.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.496 -1.683 . . . . 2.43 110.251 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.566 HD21 ' CG ' ' A' ' 113' ' ' LEU . 7.4 mp -111.54 103.99 12.36 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.422 0.63 . . . . 1.36 111.045 174.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.75 124.87 47.01 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.777 -1.101 . . . . 1.04 111.284 -174.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -97.9 139.6 33.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.137 -1.847 . . . . 1.03 110.683 -175.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.1 64.06 4.81 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 106.754 -1.573 . . . . 1.09 106.754 160.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.84 -98.82 0.64 Allowed Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 118.78 -1.676 . . . . 0.5 110.926 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.41 -25.47 59.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.939 0.718 . . . . 0.83 112.939 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -136.28 133.89 37.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.768 -0.773 . . . . 2.01 109.824 -169.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -60.1 138.79 57.81 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.115 -1.402 . . . . 1.35 110.0 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.34 -45.21 4.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.043 -0.98 . . . . 1.08 110.513 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.8 p -148.66 158.8 44.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 111.698 0.259 . . . . 1.12 111.698 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.2 mm -107.42 148.32 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 104.966 -2.235 . . . . 1.48 104.966 165.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.5 t -140.05 126.88 23.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.532 0.682 . . . . 1.12 110.077 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -69.72 107.48 3.49 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.356 -1.349 . . . . 1.77 107.356 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.651 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 20.3 mtm -64.66 -8.33 14.01 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 112.862 0.69 . . . . 1.26 112.862 -165.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -91.66 -41.83 10.51 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.768 0.794 . . . . 1.02 111.45 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -98.24 -25.47 14.86 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.391 -1.277 . . . . 1.98 109.381 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.1 t30 70.09 35.47 2.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.912 -2.404 . . . . 2.0 108.015 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.675 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.5 ptm180 -96.42 157.78 15.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.604 -1.634 . . . . 2.78 108.833 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 87.8 mt-30 -85.94 129.43 34.84 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.336 -0.847 . . . . 1.9 109.221 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.549 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -104.1 91.91 4.15 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.259 -0.576 . . . . 1.18 110.547 -170.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.33 -59.09 0.0 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 116.26 1.264 . . . . 1.89 116.26 147.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 192' ' ' PHE . 26.2 p90 -164.75 171.08 14.74 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.639 -1.281 . . . . 3.47 109.137 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -139.19 151.87 46.92 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.842 -1.17 . . . . 0.89 107.842 159.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.697 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.23 148.46 36.48 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.906 -0.496 . . . . 5.49 110.465 -175.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.588 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 3.5 mt -130.15 172.07 12.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.282 1.039 . . . . 2.15 113.728 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-N 113.207 -1.815 . . . . 2.66 108.249 170.546 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.432 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.114 -0.699 . . . . 5.09 109.114 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.568 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 26.2 ttt -144.23 136.92 26.93 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.423 -0.511 . . . . 3.06 111.882 -170.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 126' ' ' LYS . 2.0 m -119.8 104.4 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 122.569 1.175 . . . . 1.41 113.41 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -159.74 108.23 1.76 Allowed 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.939 -1.937 . . . . 1.73 106.895 163.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.815 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.2 mp -98.17 113.21 25.05 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.517 0.675 . . . . 2.04 109.295 -173.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -139.97 100.77 7.17 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.76 -1.109 . . . . 1.93 109.031 -173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.44 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 23.5 Cg_exo -35.12 133.68 0.19 Allowed 'Trans proline' 0 CA--C 1.515 -0.46 0 C-N-CA 124.452 3.435 . . . . 0.73 113.997 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 31.4 t70 74.74 47.06 0.12 Allowed 'General case' 0 CA--C 1.529 0.135 0 O-C-N 124.583 1.177 . . . . 0.72 109.91 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.561 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 12.4 ptt? -121.12 155.79 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.266 -1.333 . . . . 2.33 110.339 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 179' ' ' HIS . 56.5 m -101.59 102.75 13.52 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.532 -0.914 . . . . 1.11 108.532 -176.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.505 ' CG2' ' HE2' ' A' ' 124' ' ' MET . 16.6 tt -138.93 167.76 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.212 -0.904 . . . . 1.14 110.64 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.6 m -140.84 174.33 10.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.765 0.711 . . . . 0.89 110.785 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.481 ' HA ' HD12 ' A' ' 152' ' ' ILE . 11.9 mttp -57.49 -26.19 60.91 Favored 'General case' 0 C--O 1.211 -0.944 0 N-CA-C 109.089 -0.708 . . . . 2.86 109.089 165.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.623 ' O ' HG11 ' A' ' 125' ' ' VAL . 40.6 t30 -84.44 -17.1 40.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.316 -1.311 . . . . 1.68 114.052 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.568 ' CG ' ' HB3' ' A' ' 110' ' ' MET . 1.8 tt0 -87.18 -60.25 2.03 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.658 -1.238 . . . . 2.06 107.658 168.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.825 ' SD ' HD11 ' A' ' 152' ' ' ILE . 61.2 mtt -54.86 -15.91 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.832 -1.985 . . . . 3.58 111.906 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.623 HG11 ' O ' ' A' ' 122' ' ' ASN . 12.9 p -44.16 -40.63 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 122.141 0.972 . . . . 1.11 109.967 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.67 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.77 -40.7 84.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.066 -1.425 . . . . 1.32 112.743 176.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.58 ' HA ' HD12 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -49.74 -33.71 16.97 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.686 0.755 . . . . 2.45 111.041 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.6 mt -85.96 -34.27 20.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.856 -1.065 . . . . 1.13 109.607 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.59 -34.6 76.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.448 -1.251 . . . . 1.96 109.854 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.89 67.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.512 -1.676 . . . . 1.18 111.451 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.402 ' O ' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -89.64 -0.42 57.51 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 123.976 1.846 . . . . 1.27 106.969 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 55.75 54.6 8.03 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 111.079 -2.782 . . . . 2.22 112.693 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.562 ' CE1' ' HB ' ' A' ' 136' ' ' VAL . 2.7 t80 -141.38 174.93 10.08 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.022 -0.535 . . . . 0.9 111.864 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -137.1 156.46 48.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.949 -1.13 . . . . 5.25 107.949 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.414 ' HB2' HG13 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.86 139.73 16.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.31 1.052 . . . . 2.03 112.172 -170.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 145' ' ' PHE . 14.0 p -138.61 142.5 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 112.998 -1.91 . . . . 1.73 110.205 -164.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.12 -33.41 69.11 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.519 1.152 . . . . 1.74 109.616 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 1.4 ttpt -160.54 129.19 4.73 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 112.521 -2.127 . . . . 2.0 108.262 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.573 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -116.32 128.86 55.91 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.919 -0.582 . . . . 1.27 111.541 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.0 OUTLIER -161.68 98.56 1.11 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.551 1.167 . . . . 1.26 110.279 157.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.2 OUTLIER -166.66 167.07 8.39 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 112.891 -1.959 . . . . 2.11 105.833 161.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.59 127.76 21.63 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 120.866 1.044 . . . . 0.99 110.416 170.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 131' ' ' THR . . . 86.25 42.69 6.52 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.428 -1.367 . . . . 0.51 112.96 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 28.2 mt-10 -140.76 166.15 25.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.843 -0.428 . . . . 2.16 109.843 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.757 ' O ' HG13 ' A' ' 136' ' ' VAL . 46.2 p90 -167.85 161.46 13.1 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.825 -0.806 . . . . 0.28 108.825 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.547 HG22 ' SD ' ' A' ' 139' ' ' MET . 71.4 p -123.35 130.73 53.13 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.284 0.564 . . . . 1.12 110.461 171.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 135' ' ' GLN . 9.8 p -120.54 108.53 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.984 0.897 . . . . 1.1 110.374 172.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -109.62 -68.2 0.94 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 3.64 110.296 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.6 -53.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.933 0.346 . . . . 2.21 111.933 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -102.17 1.83 36.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.545 0.572 . . . . 1.95 112.545 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 2.8 p -163.93 153.16 14.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.554 0.693 . . . . 0.63 112.807 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.825 HD11 ' SD ' ' A' ' 124' ' ' MET . 52.6 mt -112.11 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.287 -1.324 . . . . 1.19 107.683 165.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 2.4 mt-10 -95.65 103.22 15.09 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.371 -0.831 . . . . 1.13 109.325 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -113.62 166.65 11.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.396 -0.82 . . . . 2.37 111.848 -169.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.581 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 14.7 mt -127.63 106.64 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 114.616 -1.175 . . . . 1.14 110.297 173.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.702 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 53.4 ttt180 . . . . . 0 C--N 1.32 -0.702 0 O-C-N 124.025 0.828 . . . . 3.61 110.08 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.702 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 121.306 0.574 . . . . 2.3 112.413 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 59.6 t -151.45 127.43 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.049 -0.978 . . . . 1.12 110.154 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.57 ' HG3' HG12 ' A' ' 155' ' ' ILE . 8.6 mtt180 -82.8 110.74 18.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.059 -0.519 . . . . 3.33 109.901 169.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.97 137.63 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.992 0.901 . . . . 1.02 111.693 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.683 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 3.7 tpp180 -101.83 101.35 11.79 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.74 -1.573 . . . . 2.43 110.798 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.581 HD23 ' SD ' ' A' ' 124' ' ' MET . 2.9 mp -88.97 92.24 9.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.425 -0.583 . . . . 1.36 109.425 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.02 39.6 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.532 1.158 . . . . 1.04 111.902 -171.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-85 -88.81 137.58 32.19 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.647 -2.069 . . . . 1.03 110.89 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.541 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 30.9 t70 -81.93 65.1 6.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.987 -1.857 . . . . 1.09 105.987 160.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 73.59 -99.43 1.01 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 118.66 -1.733 . . . . 0.5 110.743 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -75.96 -26.99 57.34 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 112.773 0.657 . . . . 0.83 112.773 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.401 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 13.1 p-80 -133.12 129.74 38.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.862 -0.735 . . . . 2.01 111.181 -168.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.9 tt -52.6 126.52 19.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.286 -1.325 . . . . 1.35 109.756 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -103.0 -38.7 7.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.432 -0.803 . . . . 1.08 109.453 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.2 p -147.16 161.5 40.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.284 -0.871 . . . . 1.12 110.463 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.683 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 24.9 mt -126.17 147.66 30.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 104.212 -2.514 . . . . 1.48 104.212 167.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 3.8 t -136.71 134.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.855 -0.738 . . . . 1.12 111.692 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.54 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 12.1 m120 -72.53 97.74 2.17 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.424 -1.695 . . . . 1.77 106.424 174.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.474 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 46.1 mtm -65.95 -2.91 4.39 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.277 0.561 . . . . 1.26 112.345 -168.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 14.1 pt-20 -74.38 -42.85 58.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.046 0.927 . . . . 1.02 110.829 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -105.41 -25.52 12.33 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.277 -1.329 . . . . 1.98 108.814 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 185' ' ' ASN . 5.7 t30 73.47 36.47 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 111.834 -2.439 . . . . 2.0 108.063 -174.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 11.5 ptt180 -100.1 161.14 13.8 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.466 -1.243 . . . . 2.78 110.337 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -76.93 134.42 38.93 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.082 -0.963 . . . . 1.9 110.666 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.77 91.14 3.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.888 -0.577 . . . . 1.18 110.206 -174.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.46 -57.47 0.0 OUTLIER Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.68 1.432 . . . . 1.89 116.68 144.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -162.52 176.26 10.61 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.297 -1.451 . . . . 3.47 109.129 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.815 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 10.9 t80 -149.34 100.43 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.445 0.64 . . . . 0.89 110.197 156.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -98.86 139.18 34.92 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.546 -0.721 . . . . 5.49 111.128 -175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.58 HD12 ' HA ' ' A' ' 127' ' ' LEU . 2.0 mt -109.81 172.44 6.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 113.639 0.977 . . . . 2.15 113.639 -175.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 N--CA 1.443 -0.815 0 CA-C-N 113.382 -1.736 . . . . 2.66 109.276 -179.851 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.548 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 21.3 mtm180 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 119.285 -0.388 . . . . 5.09 110.112 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.546 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 34.8 tpp -141.57 133.04 26.8 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.703 -1.599 . . . . 3.06 115.209 -169.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.423 HG13 ' HE3' ' A' ' 124' ' ' MET . 17.3 m -121.11 107.84 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.111 0.958 . . . . 1.41 113.126 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -158.64 109.7 2.12 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.262 -1.384 . . . . 1.73 107.262 167.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.668 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 5.8 mp -95.34 101.16 12.87 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.205 0.526 . . . . 2.04 110.315 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -145.56 95.74 4.92 Favored Pre-proline 0 N--CA 1.429 -1.502 0 C-N-CA 119.781 -0.768 . . . . 1.93 109.455 -174.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -33.53 142.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.589 1 C-N-CA 126.356 4.704 . . . . 0.73 115.422 -174.331 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.1 40.06 0.74 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.698 -1.592 . . . . 0.72 109.197 -170.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.566 ' CE ' HD13 ' A' ' 180' ' ' LEU . 9.6 ptt? -118.09 154.84 31.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 113.993 -1.458 . . . . 2.33 109.734 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.5 m -101.46 81.04 2.14 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.298 1.047 . . . . 1.11 108.593 -175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.615 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -104.88 161.94 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.464 -1.698 . . . . 1.14 109.871 -169.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.505 ' H ' HG13 ' A' ' 119' ' ' ILE . 23.1 m -143.34 179.3 7.17 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 119.634 -0.826 . . . . 0.89 110.583 -173.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 1.2 mttm -61.62 -24.77 66.92 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.79 -1.189 . . . . 2.86 107.79 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.672 ' O ' HG13 ' A' ' 125' ' ' VAL . 4.3 t30 -83.77 -24.19 31.2 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 114.102 -1.408 . . . . 1.68 113.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 110' ' ' MET . 0.9 OUTLIER -80.48 -60.63 2.24 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.153 -2.217 . . . . 2.06 106.769 175.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.812 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.4 mmt -57.86 -17.26 15.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.767 -2.015 . . . . 3.58 111.943 173.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 122' ' ' ASN . 9.4 p -43.5 -42.16 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 122.0 0.905 . . . . 1.11 110.518 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.548 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.93 -37.66 81.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.366 -1.288 . . . . 1.32 113.806 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.561 ' CG ' HD12 ' A' ' 197' ' ' LEU . 2.9 tm? -56.34 -34.15 66.32 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.455 0.645 . . . . 2.45 109.943 167.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.812 ' HG ' ' O ' ' A' ' 124' ' ' MET . 11.8 mt -84.06 -31.38 25.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.948 0.88 . . . . 1.13 108.932 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.5 -31.25 68.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.796 -1.547 . . . . 1.96 110.043 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -72.75 -44.56 61.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.956 -1.474 . . . . 1.18 111.387 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.94 -1.43 56.71 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.294 -1.743 . . . . 1.27 106.294 -177.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.94 50.8 15.97 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.696 -2.502 . . . . 2.22 111.826 169.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.822 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.8 t80 -129.92 175.22 9.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.506 0.67 . . . . 0.9 112.125 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -141.1 149.54 41.72 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.305 -1.739 . . . . 5.25 106.305 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.768 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 20.7 tm0? -51.26 140.97 15.75 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.952 1.358 . . . . 2.03 113.765 -167.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 145' ' ' PHE . 14.6 p -136.93 144.91 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 112.27 -2.241 . . . . 1.73 110.51 -161.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -59.07 -34.2 71.7 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 122.684 1.231 . . . . 1.74 109.095 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 139' ' ' MET . 2.3 ttpt -159.55 128.61 5.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.57 -2.105 . . . . 2.0 109.104 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.601 ' SD ' ' HA ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -116.14 124.31 50.02 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.47 -0.786 . . . . 1.27 111.165 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.8 t -158.13 97.92 1.55 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.678 1.228 . . . . 1.26 109.68 153.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.59 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -166.23 161.05 12.59 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 112.699 -2.046 . . . . 2.11 106.469 164.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.36 116.79 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 121.404 1.403 . . . . 0.99 111.259 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.597 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 108.32 21.44 7.65 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 119.804 -1.189 . . . . 0.51 113.087 -173.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.822 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 11.5 mp0 -134.48 159.44 41.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.256 0.528 . . . . 2.16 111.647 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.78 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.0 p90 -163.57 167.86 20.78 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.999 -1.111 . . . . 0.28 107.999 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.579 HG22 ' CG1' ' A' ' 136' ' ' VAL . 6.0 p -133.34 126.93 32.43 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.768 -0.773 . . . . 1.12 111.56 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.768 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.8 p -125.56 127.45 71.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.401 0.619 . . . . 1.1 112.142 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -133.71 -77.06 0.48 Allowed 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.008 -0.433 . . . . 3.64 110.088 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.44 -57.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.376 -0.375 . . . . 2.21 111.31 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -90.74 3.9 53.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.618 0.599 . . . . 1.95 112.618 -173.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.0 p -167.93 152.01 6.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.017 0.913 . . . . 0.63 113.292 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 42.0 mt -114.5 109.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 113.608 -1.633 . . . . 1.19 106.694 161.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.78 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.5 mp0 -91.91 159.54 15.71 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 105.427 -2.064 . . . . 1.13 105.427 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.653 ' HE1' ' SD ' ' A' ' 124' ' ' MET . 17.8 ptp -164.16 162.43 22.77 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.828 0.705 . . . . 2.37 110.785 -172.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.47 HG12 ' HG3' ' A' ' 170' ' ' ARG . 11.9 mt -111.35 108.27 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.008 -0.997 . . . . 1.14 110.531 163.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 195' ' ' PHE . 12.7 tpt180 . . . . . 0 CA--C 1.506 -0.741 0 CA-C-N 113.511 -1.677 . . . . 3.61 110.076 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.439 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 7.0 tt0 . . . . . 0 N--CA 1.437 -1.091 0 N-CA-C 113.292 0.849 . . . . 2.3 113.292 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 156' ' ' ARG . 53.9 t -154.4 120.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.053 -1.43 . . . . 1.12 109.212 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 154' ' ' MET . 0.0 OUTLIER -76.84 114.23 15.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.55 -0.537 . . . . 3.33 109.55 170.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.05 131.86 54.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.883 -1.127 . . . . 1.02 110.761 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.754 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.1 tpp180 -93.32 97.66 10.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.174 -1.375 . . . . 2.43 110.45 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -87.28 91.46 8.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.853 -0.425 . . . . 1.36 109.853 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.4 114.67 27.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.551 1.167 . . . . 1.04 111.936 -173.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -82.75 134.32 35.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.556 -2.111 . . . . 1.03 110.11 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.514 ' HB2' ' HB1' ' A' ' 181' ' ' ALA . 34.0 t70 -77.14 66.16 2.89 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.649 -1.611 . . . . 1.09 106.649 163.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.5 -98.09 1.63 Allowed Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 118.678 -1.725 . . . . 0.5 110.158 -174.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -92.23 -13.43 30.49 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.384 0.883 . . . . 0.83 113.384 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -136.09 125.07 24.23 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 119.109 -1.036 . . . . 2.01 110.899 -171.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.4 tt -53.61 127.67 26.31 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.217 -1.811 . . . . 1.35 111.047 -176.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 176' ' ' ASP . . . -106.45 -38.32 6.22 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.079 -0.964 . . . . 1.08 110.283 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -147.26 166.96 25.46 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.918 -0.583 . . . . 1.12 110.734 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 32.6 mt -137.12 145.17 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 106.348 -1.723 . . . . 1.48 106.348 168.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 47.5 t -139.11 134.49 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 109.533 -0.543 . . . . 1.12 109.533 -174.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.666 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 42.2 t-20 -81.12 103.81 11.18 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.439 -1.319 . . . . 1.77 107.439 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.493 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 33.5 mtm -67.04 -2.51 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.875 0.695 . . . . 1.26 112.875 -165.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.666 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.7 pt-20 -83.55 -41.93 17.37 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 122.055 0.931 . . . . 1.02 111.06 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.52 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 0.9 OUTLIER -108.26 -25.36 11.08 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.255 -1.339 . . . . 1.98 109.313 -177.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 185' ' ' ASN . 20.5 t-20 75.56 32.59 0.7 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 112.365 -2.198 . . . . 2.0 107.69 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.8 ptm180 -88.86 162.28 16.24 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 113.673 -1.603 . . . . 2.78 109.633 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -88.98 139.67 30.22 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.609 -1.178 . . . . 1.9 113.128 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.638 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 5.3 m-85 -105.74 -166.45 1.21 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.889 -1.959 . . . . 1.18 107.691 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.567 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 138.22 -9.17 3.54 Favored Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 107.791 -2.123 . . . . 1.89 107.791 -147.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.9 109.32 2.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.045 -1.077 . . . . 3.47 111.071 155.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.8 t80 -125.12 137.75 54.17 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.228 -0.92 . . . . 0.89 109.342 163.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.664 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.2 mpt_? -123.07 146.4 47.73 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.069 -0.394 . . . . 5.49 110.52 -176.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.561 HD12 ' CG ' ' A' ' 127' ' ' LEU . 38.2 mt -137.48 171.1 14.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.869 0.366 . . . . 2.15 111.757 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.609 -0.723 . . . . 2.66 109.62 -178.605 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.43 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 112.026 0.38 . . . . 5.09 112.026 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 54.2 ttm -143.04 138.33 29.89 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.847 0.684 . . . . 3.06 112.847 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.12 102.12 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 122.524 1.154 . . . . 1.41 112.819 166.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -163.08 109.06 1.14 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.95 -1.87 . . . . 1.73 105.95 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.631 ' CD1' ' HB3' ' A' ' 195' ' ' PHE . 40.3 mt -93.16 113.58 25.85 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.425 -0.51 . . . . 2.04 110.022 -169.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 117' ' ' MET . 38.5 tt0 -138.78 104.77 7.5 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.512 -0.475 . . . . 1.93 110.773 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 31.5 Cg_exo -36.59 128.88 0.46 Allowed 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 124.032 3.155 . . . . 0.73 113.317 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.8 t70 71.94 50.84 0.23 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 122.6 1.19 . . . . 0.72 110.026 -173.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.544 ' HE1' HD11 ' A' ' 180' ' ' LEU . 14.0 ptt? -121.45 155.75 34.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.232 -1.349 . . . . 2.33 110.51 174.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.93 85.93 3.89 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.814 0.816 . . . . 1.11 109.682 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -111.23 161.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.598 -1.183 . . . . 1.14 110.083 -173.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.599 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.9 m -141.44 176.6 8.74 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.125 -0.695 . . . . 0.89 109.125 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.563 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 7.3 mtpp -55.8 -30.55 61.53 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.439 -0.578 . . . . 2.86 109.439 166.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.597 ' O ' HG11 ' A' ' 125' ' ' VAL . 57.5 t30 -86.02 -17.49 35.11 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.979 1.474 . . . . 1.68 114.979 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.599 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.7 mp0 -85.4 -62.63 1.49 Allowed 'General case' 0 N--CA 1.425 -1.703 0 O-C-N 120.581 -1.325 . . . . 2.06 107.749 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.767 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 3.6 ttm -59.9 -13.26 10.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.03 -1.895 . . . . 3.58 111.23 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 122' ' ' ASN . 14.8 p -42.81 -41.82 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 122.075 0.941 . . . . 1.11 110.306 171.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.627 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -68.87 -39.32 79.9 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.391 -1.277 . . . . 1.32 112.549 177.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.646 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -49.07 -34.0 12.79 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.639 0.733 . . . . 2.45 110.968 168.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.767 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.6 mt -84.91 -30.34 24.43 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.934 -1.03 . . . . 1.13 109.529 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.9 -19.23 52.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.046 -1.434 . . . . 1.96 110.502 170.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.38 -40.91 25.64 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.981 -1.463 . . . . 1.18 110.788 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.539 HG21 ' HA ' ' A' ' 128' ' ' LEU . 15.0 t -91.53 2.69 56.26 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.25 1.5 . . . . 1.27 107.407 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 43.99 54.41 5.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 111.438 -2.619 . . . . 2.22 112.948 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.724 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.6 t80 -134.27 177.45 7.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.813 -0.63 . . . . 0.9 111.087 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -136.29 148.63 48.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.777 -1.194 . . . . 5.25 107.777 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.38 135.2 17.91 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.745 1.26 . . . . 2.03 111.374 -172.153 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 145' ' ' PHE . 12.3 p -128.3 133.11 67.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 112.58 -2.1 . . . . 1.73 109.006 -165.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -58.97 -31.85 69.12 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.736 1.255 . . . . 1.74 109.496 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 4.1 tmmm? -160.33 132.66 6.26 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 112.297 -2.229 . . . . 2.0 107.498 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.635 ' HB2' ' CD ' ' A' ' 144' ' ' GLU . 8.6 ptt? -115.35 133.04 56.4 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.868 -1.06 . . . . 1.27 112.993 -168.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.492 ' HA ' ' OE1' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -162.51 100.36 1.04 Allowed 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.992 0.901 . . . . 1.26 108.668 152.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.459 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.61 150.01 7.56 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.825 -1.534 . . . . 2.11 108.83 169.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.54 134.57 41.85 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.197 1.265 . . . . 0.99 110.036 170.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.43 54.21 5.19 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.898 -1.144 . . . . 0.51 111.873 -173.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.724 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -144.73 178.15 8.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.691 -0.195 . . . . 2.16 110.636 177.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.829 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 53.0 p90 -168.84 170.64 9.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.222 -1.029 . . . . 0.28 108.222 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 136' ' ' VAL . 19.0 p -132.98 126.74 32.64 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.148 -0.621 . . . . 1.12 110.864 171.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.477 ' CG2' ' HG2' ' A' ' 121' ' ' LYS . 8.7 p -124.64 112.76 33.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.693 0.758 . . . . 1.1 112.004 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -116.7 -66.02 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.772 -0.649 . . . . 3.64 110.596 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.65 -69.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.276 . . . . 2.21 111.634 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -83.07 10.9 7.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 112.439 0.533 . . . . 1.95 112.439 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -170.42 151.14 3.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.925 0.869 . . . . 0.63 112.792 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.657 ' HB ' ' SD ' ' A' ' 124' ' ' MET . 59.7 mt -120.28 115.74 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.707 -1.588 . . . . 1.19 106.961 165.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.829 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 6.9 mp0 -89.64 176.01 7.04 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.558 -1.275 . . . . 1.13 107.558 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 12.8 ptm -169.23 160.82 9.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.76 0.663 . . . . 2.37 111.208 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 29.3 mt -127.78 115.06 38.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 122.76 0.424 . . . . 1.14 110.81 165.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.789 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 77.6 mtp180 . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 116.399 -0.364 . . . . 3.61 110.52 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.789 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.8 tt0 . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 115.342 1.608 . . . . 2.3 115.342 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 78.9 t -154.58 129.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 113.067 -1.878 . . . . 1.12 109.229 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.632 ' HG2' ' CE ' ' A' ' 186' ' ' MET . 16.0 ttm180 -91.86 102.33 14.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.908 -0.775 . . . . 3.33 108.908 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.407 ' C ' ' HE3' ' A' ' 186' ' ' MET . . . -105.34 143.74 33.1 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.244 -0.983 . . . . 1.02 112.054 -173.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.655 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 11.7 tpp180 -99.95 113.62 26.31 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.947 -1.479 . . . . 2.43 110.206 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.707 HD22 ' SD ' ' A' ' 124' ' ' MET . 7.2 mp -107.7 102.14 11.39 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.039 -0.664 . . . . 1.36 110.578 175.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.65 125.33 47.06 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 114.938 -1.028 . . . . 1.04 111.721 -170.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-30 -89.51 133.26 34.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.855 -1.975 . . . . 1.03 110.212 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.2 t70 -74.25 65.78 1.22 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.609 -1.626 . . . . 1.09 106.609 161.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.07 -98.27 1.59 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.673 -1.727 . . . . 0.5 110.368 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -86.92 -20.31 27.55 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.094 0.775 . . . . 0.83 113.094 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -133.15 130.67 39.5 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.742 -0.783 . . . . 2.01 110.727 -169.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.597 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 4.4 tt -52.64 129.35 29.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.933 -1.485 . . . . 1.35 110.803 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.61 -38.24 6.2 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.873 -1.058 . . . . 1.08 109.816 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.3 p -148.34 158.29 44.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.841 -0.618 . . . . 1.12 111.502 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.655 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 17.1 mt -125.02 146.58 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 105.827 -1.916 . . . . 1.48 105.827 167.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.5 t -142.09 135.44 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.665 0.745 . . . . 1.12 110.743 -171.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.24 95.95 7.1 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.497 -1.297 . . . . 1.77 107.497 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.632 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 28.3 mtm -62.35 -2.94 1.15 Allowed 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 114.028 1.122 . . . . 1.26 114.028 -164.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 9.6 pt-20 -81.53 -43.33 18.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.822 0.82 . . . . 1.02 110.705 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.534 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.3 m-20 -105.7 -25.7 12.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.314 -1.312 . . . . 1.98 109.034 -177.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 75.72 31.77 0.71 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.316 -2.22 . . . . 2.0 108.318 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 4.0 ptm180 -91.01 156.12 18.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.147 -1.388 . . . . 2.78 109.778 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.99 132.82 35.4 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.729 -1.123 . . . . 1.9 109.72 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -107.45 91.29 3.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.796 -0.762 . . . . 1.18 111.35 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -58.1 0.0 OUTLIER Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.506 1.362 . . . . 1.89 116.506 145.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 192' ' ' PHE . 99.7 m-85 -160.34 175.52 12.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.916 -1.642 . . . . 3.47 107.435 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.635 ' C ' ' HD3' ' A' ' 196' ' ' ARG . 2.1 t80 -142.77 145.41 33.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.244 -1.021 . . . . 0.89 108.244 153.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.635 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -130.52 138.57 50.28 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.15 -0.969 . . . . 5.49 110.798 -171.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 196' ' ' ARG . 2.3 mt -125.52 171.29 10.64 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 113.533 0.938 . . . . 2.15 113.533 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.446 -0.635 0 CA-C-N 113.205 -1.816 . . . . 2.66 110.057 176.555 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 2.0 mtt180 . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 109.241 -0.651 . . . . 5.09 109.241 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.6 mtt -138.82 127.28 23.07 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.498 -0.881 . . . . 3.06 112.687 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.4 m -121.32 103.22 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 122.496 1.141 . . . . 1.41 112.139 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -161.1 108.35 1.48 Allowed 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.402 -1.726 . . . . 1.73 106.77 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 mp -97.07 78.94 2.81 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.493 -0.929 . . . . 2.04 108.493 -174.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -113.66 95.58 37.39 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.429 -0.805 . . . . 1.93 110.279 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.547 ' HG3' HG12 ' A' ' 183' ' ' ILE . 25.3 Cg_exo -33.68 125.87 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.523 3.482 . . . . 0.73 114.147 -171.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.1 t70 77.62 48.62 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 124.813 1.321 . . . . 0.72 110.125 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.71 154.95 36.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.832 -1.076 . . . . 2.33 110.42 171.173 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -94.6 93.77 7.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.477 -0.783 . . . . 1.11 109.037 -170.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.52 HG21 ' HE3' ' A' ' 117' ' ' MET . 19.7 tt -139.74 169.97 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 114.68 -1.146 . . . . 1.14 110.729 -166.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.544 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 m -137.98 174.25 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.947 -0.761 . . . . 0.89 108.947 -177.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.476 ' HB2' HD13 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -66.67 -19.31 65.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.179 -1.045 . . . . 2.86 108.179 169.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.586 ' O ' HG13 ' A' ' 125' ' ' VAL . 1.8 t30 -83.68 -18.06 39.29 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-N 114.401 -1.272 . . . . 1.68 113.596 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.6 mp0 -86.25 -54.94 4.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 120.483 -1.385 . . . . 2.06 107.32 167.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.702 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.2 mmt -53.8 -13.56 0.74 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.974 -1.921 . . . . 3.58 111.771 168.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 122' ' ' ASN . 14.9 p -43.36 -42.78 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 122.31 1.052 . . . . 1.11 109.58 171.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -65.37 -39.66 92.58 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.715 -1.584 . . . . 1.32 112.939 176.152 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.59 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -51.25 -32.49 24.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.731 0.777 . . . . 2.45 110.94 170.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 124' ' ' MET . 16.7 mt -85.83 -33.42 21.32 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.005 -0.998 . . . . 1.13 109.568 -172.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' A' ' 126' ' ' LYS . 2.8 mt-10 -72.26 -23.71 61.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.982 -1.463 . . . . 1.96 110.011 169.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -76.94 -44.3 32.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.679 -1.6 . . . . 1.18 111.598 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -86.28 -6.57 58.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.538 1.637 . . . . 1.27 107.538 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 58.59 53.46 6.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 111.156 -2.747 . . . . 2.22 112.348 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.708 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.9 t80 -136.3 176.35 8.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.882 -0.599 . . . . 0.9 111.769 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -135.59 152.14 50.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.043 -1.466 . . . . 5.25 107.043 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.478 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.68 137.65 15.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.579 1.18 . . . . 2.03 112.512 -170.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.735 HG11 ' O ' ' A' ' 145' ' ' PHE . 14.7 p -135.35 142.0 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.519 -2.128 . . . . 1.73 109.751 -166.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.71 -34.12 70.96 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.684 1.23 . . . . 1.74 109.129 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 5.5 ttpt -159.86 126.14 4.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.424 -2.171 . . . . 2.0 108.385 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.614 ' SD ' HG21 ' A' ' 146' ' ' THR . 0.0 OUTLIER -112.68 130.14 56.15 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.606 -0.725 . . . . 1.27 110.536 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.476 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 0.9 OUTLIER -158.4 98.15 1.53 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.836 1.303 . . . . 1.26 109.431 152.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -164.93 167.2 10.12 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 112.23 -2.259 . . . . 2.11 106.048 167.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.26 126.18 11.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.426 1.417 . . . . 0.99 112.102 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 95.72 26.04 12.42 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 120.438 -0.887 . . . . 0.51 113.415 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.708 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 6.1 mp0 -126.82 171.42 11.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.1 0.45 . . . . 2.16 110.439 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.735 ' O ' HG11 ' A' ' 136' ' ' VAL . 43.1 p90 -168.4 165.09 12.82 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.481 -0.933 . . . . 0.28 108.481 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.614 HG21 ' SD ' ' A' ' 139' ' ' MET . 53.9 p -126.29 128.95 47.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.029 -0.532 . . . . 1.12 110.659 171.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.478 ' CG1' ' HG3' ' A' ' 135' ' ' GLN . 8.5 p -112.76 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.513 0.673 . . . . 1.1 111.093 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -122.95 36.96 4.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.523 -0.762 . . . . 3.64 110.484 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.38 -54.51 0.67 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.446 -0.797 . . . . 2.21 112.687 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -87.26 -10.43 52.43 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.895 0.379 . . . . 1.95 111.517 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -161.61 141.99 10.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.904 0.859 . . . . 0.63 112.716 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 146' ' ' THR . 35.4 mt -112.56 109.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.576 -1.647 . . . . 1.19 108.033 169.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 23.6 mt-10 -101.74 103.07 13.81 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.765 -0.828 . . . . 1.13 108.765 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.537 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 23.4 ptm -106.66 163.87 12.55 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.301 -0.863 . . . . 2.37 111.764 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.629 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 47.2 mt -130.08 112.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.166 -0.924 . . . . 1.14 110.817 168.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.665 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 56.6 mtm180 . . . . . 0 C--N 1.318 -0.77 0 CA-C-N 116.291 -0.413 . . . . 3.61 110.357 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.431 -1.408 0 CA-C-O 121.255 0.55 . . . . 2.3 112.48 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 55.5 t -153.09 129.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.128 -0.942 . . . . 1.12 109.663 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.523 ' HG2' ' CE ' ' A' ' 186' ' ' MET . 9.3 ttt180 -88.6 107.55 18.97 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 109.202 -0.666 . . . . 3.33 109.202 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.53 137.14 53.42 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 119.275 -0.97 . . . . 1.02 111.986 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 15.5 tpp85 -99.09 107.37 19.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.762 -1.563 . . . . 2.43 111.455 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 151' ' ' SER . 4.7 mp -94.25 96.27 9.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.055 -0.52 . . . . 1.36 109.912 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.08 118.15 34.04 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.539 1.161 . . . . 1.04 110.9 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 41.9 m-85 -92.31 127.04 37.65 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 112.847 -1.979 . . . . 1.03 110.038 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.477 ' HB2' ' HB1' ' A' ' 181' ' ' ALA . 17.3 t70 -75.73 65.59 1.91 Allowed 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.643 -1.614 . . . . 1.09 106.643 167.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.32 -100.18 0.78 Allowed Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.404 -1.379 . . . . 0.5 110.897 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.44 -21.63 48.88 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.24 0.829 . . . . 0.83 113.24 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 16.3 p-80 -135.82 128.65 31.12 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 119.822 -0.751 . . . . 2.01 110.287 -170.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.9 tt -60.26 130.03 44.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.294 -1.321 . . . . 1.35 109.664 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 176' ' ' ASP . . . -103.02 -40.93 6.28 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.675 -0.693 . . . . 1.08 110.74 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 158.49 43.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.167 0.432 . . . . 1.12 112.167 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 3.1 mm -115.28 148.28 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 105.139 -2.171 . . . . 1.48 105.139 164.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.711 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.1 t -139.05 126.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.41 0.624 . . . . 1.12 110.33 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.593 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.6 t-20 -78.1 99.05 5.99 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.488 -1.301 . . . . 1.77 107.488 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.523 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 32.8 mtm -64.36 -2.17 2.08 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.816 1.043 . . . . 1.26 113.816 -166.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.593 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.9 pt-20 -80.36 -43.05 21.77 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.039 0.923 . . . . 1.02 110.645 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.52 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 7.8 m120 -109.03 -25.63 10.6 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.995 -1.457 . . . . 1.98 109.579 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 77.56 27.35 0.62 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.689 -2.05 . . . . 2.0 108.044 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.711 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 33.9 mtp180 -74.04 160.67 30.96 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.76 -1.564 . . . . 2.78 109.68 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 96.4 mt-30 -95.38 118.07 31.46 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.484 -1.234 . . . . 1.9 108.462 175.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.604 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -93.63 91.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.748 -0.781 . . . . 1.18 110.552 -166.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.98 -57.39 0.0 OUTLIER Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.277 1.418 . . . . 1.89 116.407 145.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 192' ' ' PHE . 48.3 p90 -163.73 174.73 11.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.701 -1.75 . . . . 3.47 107.584 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.722 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.0 t80 -151.41 98.69 2.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.28 0.562 . . . . 0.89 109.595 158.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.479 ' O ' ' HD2' ' A' ' 196' ' ' ARG . 2.8 ppt_? -90.29 145.57 24.88 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.412 -0.805 . . . . 5.49 111.222 -176.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 127' ' ' LEU . 1.8 mt -119.0 171.82 7.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.027 0.917 . . . . 2.15 113.291 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 113.439 -1.709 . . . . 2.66 110.165 176.186 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.72 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 13.8 mmt180 . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.816 0.673 . . . . 5.09 112.816 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.674 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.5 tpt -139.94 124.63 18.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.392 0.886 . . . . 3.06 113.392 -165.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.659 HG12 ' N ' ' A' ' 127' ' ' LEU . 0.6 OUTLIER -126.66 107.65 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 114.21 1.189 . . . . 1.41 114.21 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -157.86 107.03 2.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.158 -1.793 . . . . 1.73 106.158 163.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.797 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.2 mp -85.68 112.66 21.23 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.728 -0.669 . . . . 2.04 110.781 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 33.2 tt0 -156.43 102.07 2.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 114.957 -1.019 . . . . 1.93 109.911 -176.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.678 ' HD3' ' CD1' ' A' ' 183' ' ' ILE . 9.7 Cg_exo -30.48 138.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 125.654 4.236 . . . . 0.73 114.593 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.6 t70 76.05 40.98 0.24 Allowed 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.778 1.299 . . . . 0.72 109.331 -171.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.522 ' CE ' HD12 ' A' ' 180' ' ' LEU . 11.9 ptt? -121.63 154.94 36.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.401 -1.272 . . . . 2.33 109.623 174.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.61 87.36 2.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.836 -1.172 . . . . 1.11 107.836 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.586 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 tt -111.08 157.18 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.084 -1.416 . . . . 1.14 110.316 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.701 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.9 m -141.24 176.76 8.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.12 -0.696 . . . . 0.89 109.12 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.829 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 5.8 mtpm? -56.27 -28.26 58.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.266 0.555 . . . . 2.86 109.511 165.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.72 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.6 t30 -84.26 -19.04 34.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.062 1.134 . . . . 1.68 114.062 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.701 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -88.22 -62.01 1.59 Allowed 'General case' 0 N--CA 1.415 -2.197 0 O-C-N 120.769 -1.207 . . . . 2.06 108.931 176.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.829 ' SD ' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -58.11 -16.69 14.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 112.994 -1.912 . . . . 3.58 110.382 172.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 122' ' ' ASN . 11.3 p -42.63 -43.33 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.288 1.042 . . . . 1.11 110.712 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.504 ' N ' HG12 ' A' ' 125' ' ' VAL . 10.1 mmpt? -69.65 -35.92 75.61 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.22 -1.354 . . . . 1.32 113.132 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.659 ' N ' HG12 ' A' ' 111' ' ' VAL . 9.0 tt -52.92 -34.04 53.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.571 0.7 . . . . 2.45 110.085 168.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.696 ' HB3' ' CE2' ' A' ' 145' ' ' PHE . 6.3 mt -83.86 -34.31 24.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.471 -0.937 . . . . 1.13 108.471 -171.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.97 -33.23 75.55 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.919 -1.491 . . . . 1.96 109.728 169.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 127' ' ' LEU . . . -72.75 -45.95 56.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.967 -1.47 . . . . 1.18 111.766 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.87 -1.73 58.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 123.747 1.737 . . . . 1.27 107.741 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 55.5 54.46 8.45 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 110.817 -2.902 . . . . 2.22 112.666 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.576 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 3.2 t80 -137.84 175.67 9.38 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.9 112.455 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 30.1 tpt180 -139.17 151.95 47.02 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.57 -1.27 . . . . 5.25 107.57 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 1.5 tm0? -49.22 142.4 7.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.335 1.064 . . . . 2.03 113.05 -168.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.6 p -141.6 139.98 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 113.215 -1.811 . . . . 1.73 110.169 -163.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -59.8 -32.31 70.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.511 1.148 . . . . 1.74 109.791 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -159.35 127.78 5.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.754 -2.021 . . . . 2.0 108.825 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.567 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -117.49 124.02 47.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.728 -1.124 . . . . 1.27 111.098 -177.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.704 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.3 t -158.7 95.23 1.3 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 123.236 1.493 . . . . 1.26 110.473 154.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.704 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.39 155.39 16.99 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 111.71 -2.495 . . . . 2.11 105.706 163.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.13 126.05 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.15 1.233 . . . . 0.99 110.807 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.8 45.04 3.74 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 119.878 -1.153 . . . . 0.51 112.995 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 37.0 mt-10 -141.88 174.45 10.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.903 0.351 . . . . 2.16 110.534 173.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.854 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -170.47 164.7 8.6 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.66 -1.237 . . . . 0.28 107.66 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.567 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 1.1 p -134.41 129.17 34.92 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 119.328 -0.949 . . . . 1.12 110.757 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.504 HG21 ' HG2' ' A' ' 121' ' ' LYS . 10.6 p -122.58 109.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.878 0.846 . . . . 1.1 111.832 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -106.89 -72.33 0.72 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.299 -0.864 . . . . 3.64 110.031 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.61 -53.97 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.72 0.295 . . . . 2.21 111.75 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -82.68 -12.63 57.46 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.491 -0.322 . . . . 1.95 111.721 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 15.9 p -160.33 153.26 21.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.13 0.967 . . . . 0.63 112.397 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.774 HD12 ' SD ' ' A' ' 124' ' ' MET . 74.6 mt -110.99 114.24 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.33 -1.759 . . . . 1.19 107.002 165.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.854 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.2 mp0 -90.59 165.85 13.52 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.978 -1.86 . . . . 1.13 105.978 174.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.591 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -167.64 156.76 9.87 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 124.123 0.89 . . . . 2.37 109.818 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.577 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 13.5 mt -127.28 105.44 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.054 -0.521 . . . . 1.14 110.19 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.771 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.2 ttt-85 . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 115.159 -0.928 . . . . 3.61 109.919 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.771 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.3 tt0 . . . . . 0 N--CA 1.433 -1.294 0 CA-C-O 121.393 0.616 . . . . 2.3 112.399 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 45.6 t -153.23 129.55 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.074 . . . . 1.12 109.519 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.583 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 27.5 mtm180 -82.82 118.32 23.33 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.049 -0.523 . . . . 3.33 109.847 168.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.3 131.05 56.35 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.654 0.74 . . . . 1.02 111.27 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.747 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 8.8 tpp180 -98.21 100.71 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.376 -1.283 . . . . 2.43 111.104 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.8 mp -87.0 92.38 9.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.175 -0.305 . . . . 1.36 110.175 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.83 120.83 35.7 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 122.626 1.203 . . . . 1.04 111.635 -175.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-30 -86.93 136.21 33.02 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.792 -2.004 . . . . 1.03 111.049 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 39.9 t0 -78.82 65.19 3.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.076 -1.824 . . . . 1.09 106.076 161.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.93 1.52 Allowed Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 118.944 -1.598 . . . . 0.5 110.497 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -82.42 -27.47 31.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.723 0.638 . . . . 0.83 112.723 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -129.85 129.54 44.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.77 0.795 . . . . 2.01 110.615 -167.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.9 tt -53.38 128.9 30.18 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.449 -1.705 . . . . 1.35 111.235 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.12 -38.35 6.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.83 -1.077 . . . . 1.08 110.047 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.7 p -146.15 162.58 37.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.655 -0.702 . . . . 1.12 110.648 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.747 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 26.8 mt -134.31 145.2 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 105.735 -1.95 . . . . 1.48 105.735 167.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 43.1 t -136.98 135.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 109.683 -0.488 . . . . 1.12 109.683 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.617 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 47.2 t-20 -76.94 108.08 9.73 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 106.809 -1.552 . . . . 1.77 106.809 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.583 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 36.3 mtm -67.94 -2.41 7.44 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.545 -0.462 . . . . 1.26 111.976 -169.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.617 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.0 pt-20 -85.65 -45.98 11.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.482 0.658 . . . . 1.02 111.321 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.583 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -102.16 -26.24 13.42 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 114.802 -1.09 . . . . 1.98 109.36 -176.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 185' ' ' ASN . 52.7 t30 76.48 27.16 0.83 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 112.446 -2.161 . . . . 2.0 107.559 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 17.6 ptt180 -84.56 162.85 19.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.14 -1.391 . . . . 2.78 109.249 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -91.98 139.14 30.94 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.562 1.172 . . . . 1.9 112.734 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.65 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 2.6 m-85 -100.75 -165.73 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.908 -1.951 . . . . 1.18 108.324 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.592 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.14 -5.64 3.61 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.644 -2.183 . . . . 1.89 107.644 -148.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -153.79 119.43 5.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.928 -1.136 . . . . 3.47 111.333 157.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.797 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 5.1 t80 -140.77 100.58 3.88 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.17 -0.678 . . . . 0.89 109.17 161.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -102.13 110.47 22.44 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.466 -0.771 . . . . 5.49 111.203 -170.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.96 168.2 17.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.548 0.69 . . . . 2.15 112.45 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 114.439 -1.255 . . . . 2.66 108.074 172.05 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.73 -0.841 . . . . 5.09 108.73 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.433 ' HB2' ' HG3' ' A' ' 123' ' ' GLU . 21.9 mmt -140.85 135.82 31.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 113.787 1.032 . . . . 3.06 113.787 -166.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.57 105.68 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.447 1.118 . . . . 1.41 113.876 172.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -160.01 107.75 1.67 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.955 -1.93 . . . . 1.73 105.809 161.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.9 mp -87.67 108.7 19.22 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.987 -0.746 . . . . 2.04 108.987 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.2 tt0 -142.78 112.33 5.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.309 -0.956 . . . . 1.93 111.123 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.486 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.1 Cg_exo -35.9 127.79 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.012 3.141 . . . . 0.73 113.016 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.3 t70 75.74 43.83 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 O-C-N 124.476 1.11 . . . . 0.72 110.536 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.571 ' HE1' HD11 ' A' ' 180' ' ' LEU . 16.7 ptt? -114.06 154.99 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.818 -1.083 . . . . 2.33 110.14 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -102.77 98.56 8.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.15 -1.056 . . . . 1.11 108.15 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.592 HG13 ' CB ' ' A' ' 123' ' ' GLU . 1.5 tt -134.34 168.68 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 114.821 -1.081 . . . . 1.14 110.573 -164.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.527 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.3 m -141.36 175.55 9.57 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.207 -0.664 . . . . 0.89 109.207 -174.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.46 ' HA ' HD11 ' A' ' 152' ' ' ILE . 19.1 mttp -57.62 -32.72 67.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.304 -0.998 . . . . 2.86 108.304 164.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.576 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 34.6 t30 -83.02 -19.35 37.11 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 113.78 -1.555 . . . . 1.68 114.2 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.592 ' CB ' HG13 ' A' ' 119' ' ' ILE . 2.1 mp0 -82.49 -57.83 3.18 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.542 -1.974 . . . . 2.06 106.74 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.662 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 2.3 tpp -54.99 -13.76 1.24 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.381 -1.736 . . . . 3.58 111.969 170.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 13.1 p -45.24 -39.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 122.246 1.022 . . . . 1.11 110.09 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.7 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -66.76 -40.12 88.14 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.93 -1.487 . . . . 1.32 112.685 176.041 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.657 ' HA ' ' CD1' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -49.63 -33.34 15.12 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.378 0.608 . . . . 2.45 111.172 167.239 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 124' ' ' MET . 7.1 mt -83.97 -37.75 21.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.246 -0.888 . . . . 1.13 109.187 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.2 -43.26 92.26 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.288 -1.324 . . . . 1.96 110.221 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.44 -45.09 80.99 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.29 -1.777 . . . . 1.18 112.056 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.3 t -86.4 -2.63 58.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 123.664 1.697 . . . . 1.27 107.155 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 53.44 51.02 16.12 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.13 -2.759 . . . . 2.22 112.584 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.766 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -136.97 176.5 8.65 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.093 0.473 . . . . 0.9 111.782 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.8 153.84 49.62 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.758 -1.201 . . . . 5.25 107.758 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 19.3 tm0? -51.03 139.05 18.39 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.539 1.161 . . . . 2.03 112.341 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.666 HG11 ' O ' ' A' ' 145' ' ' PHE . 14.8 p -136.67 140.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 112.718 -2.037 . . . . 1.73 109.781 -164.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -58.95 -32.22 69.42 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.347 1.07 . . . . 1.74 109.439 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 27.3 ttpt -160.88 121.29 2.8 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.962 -1.927 . . . . 2.0 109.109 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.585 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -109.88 118.64 37.01 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.996 -1.002 . . . . 1.27 110.894 -177.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.08 96.52 2.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.948 1.356 . . . . 1.26 108.993 157.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.513 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -166.39 169.52 6.38 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.04 -2.345 . . . . 2.11 105.548 167.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.87 125.12 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.486 1.457 . . . . 0.99 112.471 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 94.54 38.18 5.08 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 120.654 -0.784 . . . . 0.51 113.311 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.766 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 9.4 mp0 -131.69 173.44 11.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 122.604 -0.351 . . . . 2.16 110.079 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.854 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.9 p90 -169.0 166.65 11.01 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.601 -1.259 . . . . 0.28 107.601 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.585 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 11.9 p -134.52 126.49 29.47 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.739 -0.784 . . . . 1.12 110.751 173.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 152' ' ' ILE . 11.1 p -117.68 110.29 30.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.827 0.823 . . . . 1.1 111.121 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -106.25 -75.82 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 3.64 110.204 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.68 -58.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.469 . . . . 2.21 110.545 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -92.24 7.49 42.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.122 -0.49 . . . . 1.95 111.924 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -161.25 152.14 18.33 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.938 0.875 . . . . 0.63 112.612 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.641 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 67.6 mt -120.32 109.9 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.371 -1.741 . . . . 1.19 106.742 163.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.854 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.11 170.96 9.88 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.292 -1.744 . . . . 1.13 106.292 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.62 ' SD ' HD11 ' A' ' 127' ' ' LEU . 10.6 ptm -167.29 158.18 11.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.679 0.612 . . . . 2.37 110.869 -173.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.56 HG12 ' HG3' ' A' ' 170' ' ' ARG . 13.0 mt -129.27 112.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.466 -0.788 . . . . 1.14 110.501 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.79 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 34.6 mtp180 . . . . . 0 CA--C 1.502 -0.889 0 C-N-CA 120.033 -0.667 . . . . 3.61 109.748 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.79 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 51.7 tt0 . . . . . 0 N--CA 1.42 -1.945 0 N-CA-C 114.692 1.367 . . . . 2.3 114.692 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 66.2 t -153.06 131.38 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.377 -1.283 . . . . 1.12 109.884 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.56 ' HG3' HG12 ' A' ' 155' ' ' ILE . 17.3 mtm180 -91.38 111.56 23.11 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.097 -0.502 . . . . 3.33 110.395 169.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.75 146.99 41.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.026 0.917 . . . . 1.02 111.619 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.472 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 7.3 tpt180 -111.77 103.79 12.08 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.586 -1.643 . . . . 2.43 110.323 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.65 HD23 ' SD ' ' A' ' 124' ' ' MET . 5.5 mp -92.77 94.33 8.92 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.755 -0.461 . . . . 1.36 109.755 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.68 127.85 40.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.582 1.182 . . . . 1.04 111.83 -173.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.672 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-85 -94.16 135.46 35.51 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 112.653 -2.067 . . . . 1.03 110.801 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.524 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 18.7 t70 -80.99 64.39 5.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.925 -1.88 . . . . 1.09 105.925 162.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.72 -99.51 1.13 Allowed Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.219 -1.467 . . . . 0.5 111.004 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.66 -24.69 41.66 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.721 0.637 . . . . 0.83 112.721 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -132.34 128.64 38.13 Favored 'General case' 0 N--CA 1.426 -1.666 0 C-N-CA 119.577 -0.849 . . . . 2.01 110.645 -170.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.8 tt -53.92 130.72 38.38 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.585 -1.643 . . . . 1.35 110.26 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.93 -38.48 6.04 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.443 -0.799 . . . . 1.08 110.499 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -146.03 164.31 32.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.189 -0.46 . . . . 1.12 111.785 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.529 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.6 mm -116.45 148.93 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 105.114 -2.18 . . . . 1.48 105.114 164.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.1 t -139.78 128.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.416 0.627 . . . . 1.12 109.844 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.568 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 46.6 t-20 -75.94 111.55 11.44 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 107.123 -1.436 . . . . 1.77 107.123 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.504 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.2 mtm -70.22 -1.22 9.64 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.478 -0.489 . . . . 1.26 112.101 -169.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.568 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 7.4 pt-20 -83.18 -45.8 13.48 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.614 0.721 . . . . 1.02 111.265 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.522 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -103.67 -25.81 13.01 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.948 -1.023 . . . . 1.98 109.236 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 185' ' ' ASN . 47.6 t-20 74.28 36.17 0.68 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 112.278 -2.237 . . . . 2.0 107.127 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 7.2 ptm180 -93.27 161.53 14.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.422 -1.717 . . . . 2.78 109.387 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 78.4 mt-30 -88.17 125.23 34.51 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.99 -1.004 . . . . 1.9 109.46 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.529 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.7 92.28 4.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.884 -0.579 . . . . 1.18 110.446 -170.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.82 -58.03 0.0 OUTLIER Glycine 0 N--CA 1.469 0.881 0 C-N-CA 125.066 1.317 . . . . 1.89 116.334 146.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' PHE . 38.4 p90 -163.62 175.38 10.68 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.347 -1.426 . . . . 3.47 108.685 175.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.579 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.5 t80 -140.79 154.56 46.31 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.911 -1.144 . . . . 0.89 107.911 157.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.627 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -136.04 139.74 43.31 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.636 -0.665 . . . . 5.49 109.992 -170.667 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.657 ' CD1' ' HA ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -114.41 172.49 6.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 114.967 1.469 . . . . 2.15 114.967 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.444 -0.755 0 CA-C-N 111.902 -2.408 . . . . 2.66 108.723 176.792 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.836 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 72.6 mtt180 . . . . . 0 CA--C 1.497 -1.093 0 N-CA-C 108.529 -0.915 . . . . 5.09 108.529 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.602 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 27.0 ttt -143.89 131.1 20.72 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.96 -1.018 . . . . 3.06 113.203 -163.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.7 m -116.58 105.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 122.301 1.048 . . . . 1.41 112.883 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -159.92 106.22 1.61 Allowed 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.292 -1.776 . . . . 1.73 106.247 165.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.826 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.7 mp -97.3 111.52 23.73 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 119.958 -0.697 . . . . 2.04 109.528 -172.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -140.0 104.84 6.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.223 -0.899 . . . . 1.93 109.856 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.513 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 13.1 Cg_exo -33.63 129.74 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 125.157 3.905 . . . . 0.73 114.21 -172.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.6 t70 79.61 44.01 0.06 Allowed 'General case' 0 C--N 1.341 0.214 0 O-C-N 124.967 1.417 . . . . 0.72 110.529 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.658 ' SD ' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.35 155.65 34.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.876 -1.056 . . . . 2.33 110.774 173.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 29.2 m -93.36 77.87 4.47 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 122.282 1.039 . . . . 1.11 109.547 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.687 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -96.17 161.09 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.496 -1.684 . . . . 1.14 109.296 -174.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.578 ' H ' HG13 ' A' ' 119' ' ' ILE . 7.6 m -141.78 177.09 8.41 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 118.612 0.642 . . . . 0.89 109.925 -173.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.634 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 34.3 mttp -53.42 -33.66 54.8 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.149 -1.056 . . . . 2.86 108.149 163.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.836 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 41.1 t30 -81.88 -18.85 42.36 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 114.311 -1.313 . . . . 1.68 114.177 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.602 ' HA ' ' H ' ' A' ' 110' ' ' MET . 3.4 tt0 -85.64 -62.18 1.59 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.151 -1.593 . . . . 2.06 107.918 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.744 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -58.74 -16.78 18.24 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.455 -1.702 . . . . 3.58 111.143 172.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' ' 122' ' ' ASN . 9.6 p -42.81 -42.73 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.99 0.9 . . . . 1.11 111.071 176.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.55 ' CE ' HG12 ' A' ' 125' ' ' VAL . 10.5 mmpt? -67.7 -41.15 84.03 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.44 -1.254 . . . . 1.32 112.154 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.554 ' CG ' HD11 ' A' ' 197' ' ' LEU . 2.5 tm? -53.12 -32.44 47.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.396 0.617 . . . . 2.45 110.392 167.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.764 HD23 ' CD2' ' A' ' 145' ' ' PHE . 26.2 mt -82.16 -34.0 29.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.756 0.789 . . . . 1.13 109.066 -171.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.18 -37.25 85.17 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.235 -1.348 . . . . 1.96 110.164 167.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 127' ' ' LEU . . . -68.6 -41.94 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.675 -1.602 . . . . 1.18 112.512 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.408 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.13 -1.52 57.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 124.176 1.941 . . . . 1.27 106.107 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 56.13 55.19 7.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 110.714 -2.948 . . . . 2.22 111.927 170.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.536 ' CE1' ' HB ' ' A' ' 136' ' ' VAL . 2.5 t80 -138.3 174.94 10.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.479 0.657 . . . . 0.9 112.407 -176.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.1 ptt85 -141.86 147.61 37.44 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.948 -1.501 . . . . 5.25 106.948 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.83 135.05 20.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.763 1.268 . . . . 2.03 112.455 -171.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 145' ' ' PHE . 12.5 p -134.37 141.04 44.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.386 -2.188 . . . . 1.73 110.14 -162.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -58.74 -34.28 71.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.493 1.139 . . . . 1.74 109.61 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -160.12 128.5 4.81 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.782 -2.008 . . . . 2.0 109.101 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.563 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -118.43 133.79 55.59 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.838 -1.074 . . . . 1.27 111.612 -173.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.552 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.8 t -162.92 100.21 0.99 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.491 1.138 . . . . 1.26 110.957 153.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.3 OUTLIER -164.51 160.67 15.86 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 113.161 -1.836 . . . . 2.11 106.211 161.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.428 ' HA ' HG21 ' A' ' 155' ' ' ILE . 23.3 Cg_exo -62.94 120.92 8.61 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 121.055 1.17 . . . . 0.99 109.839 170.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 95.54 38.37 4.75 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 119.716 -1.231 . . . . 0.51 113.102 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 42.1 mt-10 -140.94 167.55 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.889 -0.411 . . . . 2.16 109.889 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.764 ' CD2' HD23 ' A' ' 128' ' ' LEU . 51.3 p90 -167.67 163.43 14.41 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.395 -0.965 . . . . 0.28 108.395 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.576 HG21 HG12 ' A' ' 136' ' ' VAL . 53.6 p -128.87 127.34 41.65 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.061 0.457 . . . . 1.12 110.703 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.484 HG23 ' HG2' ' A' ' 121' ' ' LYS . 11.8 p -121.51 116.65 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.555 0.693 . . . . 1.1 111.813 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.498 ' HG3' ' H ' ' A' ' 149' ' ' ALA . 11.0 pt20 -117.43 -62.34 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.863 -0.608 . . . . 3.64 111.247 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.498 ' H ' ' HG3' ' A' ' 148' ' ' GLN . . . -168.97 -63.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 2.21 110.791 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -83.0 4.65 25.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.365 -0.379 . . . . 1.95 111.798 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.687 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 16.4 p -165.47 150.0 8.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.978 0.894 . . . . 0.63 112.992 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.461 HG12 ' CG2' ' A' ' 147' ' ' VAL . 65.6 mt -116.5 107.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.333 -1.758 . . . . 1.19 106.326 160.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.535 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 5.5 mt-10 -99.42 102.2 13.7 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.57 -0.9 . . . . 1.13 108.57 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 8.6 ptm -109.38 156.94 19.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.157 -0.929 . . . . 2.37 112.149 -170.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.614 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.8 mt -123.5 119.07 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.322 -1.308 . . . . 1.14 109.991 172.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.7 mtm180 . . . . . 0 C--N 1.32 -0.681 0 O-C-N 123.437 0.461 . . . . 3.61 110.444 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.614 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 6.6 tt0 . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 113.276 0.843 . . . . 2.3 113.276 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 43.1 t -153.23 128.53 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.979 -1.01 . . . . 1.12 109.542 174.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.548 ' HB3' ' CE ' ' A' ' 186' ' ' MET . 15.0 mtt180 -89.86 114.09 25.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 120.9 0.381 . . . . 3.33 110.469 170.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.79 129.86 56.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.342 1.067 . . . . 1.02 111.278 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.5 tpt180 -96.09 100.28 11.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.219 -1.809 . . . . 2.43 110.925 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 151' ' ' SER . 10.7 mp -85.08 93.96 8.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.737 -0.468 . . . . 1.36 109.737 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.527 HG21 ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -94.59 113.44 25.26 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.504 1.145 . . . . 1.04 111.687 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -82.77 135.43 34.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.679 -2.055 . . . . 1.03 110.347 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 36.9 t70 -76.59 65.85 2.47 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.345 -1.724 . . . . 1.09 106.345 161.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 -98.37 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 118.877 -1.63 . . . . 0.5 110.78 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.79 -17.56 37.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.505 0.928 . . . . 0.83 113.505 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -139.45 130.27 26.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.506 -0.877 . . . . 2.01 110.628 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.687 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 4.8 tt -53.66 128.51 29.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.122 -1.399 . . . . 1.35 110.568 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -100.89 -39.02 7.98 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.717 -1.129 . . . . 1.08 108.994 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 26.2 p -150.8 158.96 44.78 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.475 -0.784 . . . . 1.12 110.592 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 16.1 mt -120.29 146.67 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 105.063 -2.199 . . . . 1.48 105.063 168.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 22.6 t -138.77 129.73 34.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.36 0.6 . . . . 1.12 110.152 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.591 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.3 t-20 -75.15 101.94 4.77 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 106.817 -1.549 . . . . 1.77 106.817 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.548 ' CE ' ' HB3' ' A' ' 170' ' ' ARG . 36.2 mtm -65.51 -3.09 3.95 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.653 0.595 . . . . 1.26 112.516 -167.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.591 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 8.5 pt-20 -80.1 -43.62 21.4 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.756 0.789 . . . . 1.02 110.813 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.582 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 8.9 m120 -104.91 -25.72 12.48 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 114.464 -1.244 . . . . 1.98 109.367 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 185' ' ' ASN . 58.0 t30 76.19 33.29 0.57 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 112.59 -2.096 . . . . 2.0 107.873 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.3 ptm180 -96.14 157.6 15.82 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 2.78 109.846 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.6 126.53 31.84 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.814 -1.084 . . . . 1.9 109.308 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.23 90.5 3.94 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.321 -0.552 . . . . 1.18 110.875 -168.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.27 -57.75 0.0 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 116.635 1.414 . . . . 1.89 116.635 145.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.476 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 3.4 p90 -164.08 175.58 10.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.525 -1.337 . . . . 3.47 109.671 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.826 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.3 t80 -148.34 103.42 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.206 0.526 . . . . 0.89 110.899 159.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 1.6 mmm180 -95.45 133.65 39.18 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.441 -0.787 . . . . 5.49 110.465 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.554 HD11 ' CG ' ' A' ' 127' ' ' LEU . 69.0 mt -122.89 171.44 9.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 114.388 1.255 . . . . 2.15 114.388 -166.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.22 -0.476 0 CA-C-N 113.935 -1.484 . . . . 2.66 110.554 -176.161 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.732 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 122.218 1.008 . . . . 5.09 113.36 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 15.6 tpt -142.44 129.92 21.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.61 -1.177 . . . . 3.06 111.786 -175.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 111' ' ' VAL . 20.9 m -118.56 102.63 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.731 1.253 . . . . 1.41 111.904 168.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -162.44 109.59 1.3 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.111 -1.859 . . . . 1.73 106.244 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 52.2 mt -96.38 108.04 20.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.418 -0.586 . . . . 2.04 109.418 -175.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 117' ' ' MET . 2.6 tm-20 -142.88 110.14 5.58 Favored Pre-proline 0 C--N 1.309 -1.192 0 C-N-CA 119.298 -0.961 . . . . 1.93 110.442 -175.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 27.9 Cg_exo -35.11 126.61 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 124.25 3.3 . . . . 0.73 113.777 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 22.3 t0 75.9 49.61 0.07 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.762 1.267 . . . . 0.72 110.37 -174.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.569 ' HE3' HD13 ' A' ' 180' ' ' LEU . 13.5 ptt? -119.27 155.71 31.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.983 -1.462 . . . . 2.33 109.529 172.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.0 m -101.76 83.88 2.47 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.365 -0.976 . . . . 1.11 108.365 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.57 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -109.0 161.41 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.821 -1.536 . . . . 1.14 110.071 -170.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.615 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.4 m -142.79 174.17 10.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.623 -0.881 . . . . 0.89 108.623 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.966 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 19.4 mtpp -54.93 -28.37 50.52 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.671 0.748 . . . . 2.86 109.723 163.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.554 ' O ' HG13 ' A' ' 125' ' ' VAL . 32.4 t30 -85.93 -18.68 32.01 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 114.692 1.367 . . . . 1.68 114.692 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.615 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.0 OUTLIER -86.09 -62.91 1.41 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.565 1.174 . . . . 2.06 108.134 171.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.966 ' SD ' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -58.12 -14.04 6.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 112.347 -2.206 . . . . 3.58 110.871 173.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 122' ' ' ASN . 12.1 p -41.89 -42.32 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.91 0.862 . . . . 1.11 109.637 170.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.732 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -68.37 -39.96 81.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.579 -1.191 . . . . 1.32 113.834 174.456 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.552 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.7 OUTLIER -49.9 -32.2 14.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.446 0.641 . . . . 2.45 111.0 170.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 124' ' ' MET . 8.6 mt -85.67 -37.68 19.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 1.13 108.984 -172.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.61 -36.19 77.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.94 -1.482 . . . . 1.96 109.672 168.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.417 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -72.66 -41.27 65.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.879 -1.509 . . . . 1.18 112.208 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.5 t -89.04 -0.77 57.71 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 123.255 1.502 . . . . 1.27 107.641 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 52.16 52.21 14.79 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.173 -2.739 . . . . 2.22 112.337 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.753 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.3 t80 -138.99 176.19 8.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.9 112.022 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -139.18 153.0 47.84 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.682 -1.229 . . . . 5.25 107.682 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 17.8 tm0? -50.84 138.95 17.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.535 1.16 . . . . 2.03 112.591 -169.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.5 p -136.22 140.94 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.802 -1.999 . . . . 1.73 109.972 -163.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -58.35 -32.77 68.85 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.714 1.245 . . . . 1.74 109.478 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 7.0 ttpt -160.22 127.12 4.36 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 112.417 -2.174 . . . . 2.0 108.663 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -112.91 124.02 51.65 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.227 -0.897 . . . . 1.27 110.767 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.16 97.88 1.82 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.99 1.376 . . . . 1.26 109.105 154.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.575 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -165.64 169.51 6.94 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 112.251 -2.249 . . . . 2.11 105.662 166.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.88 123.9 7.71 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 120.777 1.313 . . . . 0.99 112.311 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 98.25 39.76 3.66 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 120.678 -0.772 . . . . 0.51 113.279 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.753 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 12.4 mp0 -135.48 173.78 11.33 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 122.829 0.452 . . . . 2.16 110.585 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.85 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.3 p90 -169.19 168.62 9.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.245 -1.02 . . . . 0.28 108.245 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 40.5 p -135.27 126.46 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.357 -0.537 . . . . 1.12 111.955 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.628 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.8 p -125.37 129.05 73.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.956 -0.565 . . . . 1.1 111.804 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.488 ' HA ' ' OE1' ' A' ' 148' ' ' GLN . 6.1 tp60 -144.2 -70.18 0.3 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.326 -0.55 . . . . 3.64 111.534 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.28 -67.46 0.54 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 2.21 112.633 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -87.27 -11.76 48.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.807 0.669 . . . . 1.95 112.807 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 20.6 p -165.05 157.77 16.15 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.873 0.844 . . . . 0.63 112.933 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.662 HD13 ' SD ' ' A' ' 124' ' ' MET . 50.2 mt -114.61 115.76 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.079 -1.419 . . . . 1.19 107.613 167.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.85 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.3 mp0 -89.33 171.39 9.79 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 106.51 -1.663 . . . . 1.13 106.51 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.598 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 26.7 ptm -167.96 154.16 7.49 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.739 0.649 . . . . 2.37 110.348 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.552 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.5 mt -128.75 114.32 32.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.33 -0.395 . . . . 1.14 110.826 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.722 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 10.0 mtp-105 . . . . . 0 C--N 1.316 -0.863 0 C-N-CA 120.664 -0.414 . . . . 3.61 111.209 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.722 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.2 tt0 . . . . . 0 N--CA 1.42 -1.961 0 N-CA-C 114.412 1.264 . . . . 2.3 114.412 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 44.2 t -154.5 130.29 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.707 -1.588 . . . . 1.12 109.99 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.601 ' HB3' ' HE2' ' A' ' 186' ' ' MET . 35.7 mtm180 -86.9 114.77 23.81 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 116.189 -0.46 . . . . 3.33 110.325 168.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -117.0 132.43 56.71 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.844 0.83 . . . . 1.02 111.289 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.513 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 11.5 tpp180 -99.28 109.08 21.76 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.039 -1.437 . . . . 2.43 111.034 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 5.4 mp -91.59 91.48 8.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.12 -0.491 . . . . 1.36 109.968 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.7 125.59 37.39 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.283 1.04 . . . . 1.04 111.844 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.666 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 2.0 m-85 -89.59 138.15 31.72 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.953 -1.93 . . . . 1.03 111.579 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.514 ' HB2' ' HB1' ' A' ' 181' ' ' ALA . 30.3 t70 -81.96 64.99 6.89 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 105.833 -1.914 . . . . 1.09 105.833 159.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.16 -98.75 1.02 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 118.892 -1.623 . . . . 0.5 111.144 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.34 -25.57 46.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.521 0.563 . . . . 0.83 112.521 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -135.46 132.88 37.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.369 0.604 . . . . 2.01 110.132 -168.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -54.59 134.02 46.62 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.1 -1.409 . . . . 1.35 110.617 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 176' ' ' ASP . . . -106.78 -41.54 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.925 -1.034 . . . . 1.08 110.081 -176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 p -147.21 163.8 35.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.027 -0.533 . . . . 1.12 111.705 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.509 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.6 mm -111.14 148.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.144 -2.169 . . . . 1.48 105.144 165.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.8 t -141.51 131.79 25.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.407 0.622 . . . . 1.12 109.947 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.566 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 40.7 t-20 -79.44 110.11 14.43 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.124 -1.065 . . . . 1.77 108.124 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.601 ' HE2' ' HB3' ' A' ' 170' ' ' ARG . 16.3 mtp -65.91 -2.46 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.036 0.754 . . . . 1.26 113.036 -171.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.566 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 8.3 pt-20 -81.18 -42.53 20.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.817 0.818 . . . . 1.02 111.153 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.482 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 6.1 m-20 -111.24 -26.55 9.11 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.391 -1.277 . . . . 1.98 109.738 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 185' ' ' ASN . 9.2 t30 76.28 34.47 0.5 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.519 -2.128 . . . . 2.0 107.642 -177.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 5.2 ptm180 -90.31 162.92 14.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.427 -1.715 . . . . 2.78 108.641 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -88.02 140.17 29.77 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.727 -0.67 . . . . 1.9 110.001 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.509 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -114.08 92.31 3.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.701 -0.666 . . . . 1.18 110.523 -176.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.08 -58.63 0.0 OUTLIER Glycine 0 N--CA 1.469 0.839 0 N-CA-C 116.15 1.22 . . . . 1.89 116.15 146.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 192' ' ' PHE . 35.0 p90 -163.42 174.23 12.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.702 -1.249 . . . . 3.47 109.25 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.509 ' HB3' ' CD1' ' A' ' 113' ' ' LEU . 1.4 t80 -140.31 154.45 46.8 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.201 -0.666 . . . . 0.89 109.201 159.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.599 ' H ' ' HD2' ' A' ' 196' ' ' ARG . 0.1 OUTLIER -138.53 153.97 48.76 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.806 -0.559 . . . . 5.49 111.933 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 127' ' ' LEU . 5.1 mt -129.55 172.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.425 1.268 . . . . 2.15 114.425 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.443 -0.814 0 CA-C-N 112.38 -2.191 . . . . 2.66 111.03 -175.715 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.417 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 113.68 0.993 . . . . 5.09 113.68 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.2 tpt -141.37 132.57 26.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.332 -0.547 . . . . 3.06 112.015 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 13.3 m -121.88 104.29 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 122.814 1.292 . . . . 1.41 113.037 171.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.643 ' O ' ' HE1' ' A' ' 117' ' ' MET . 63.1 t30 -161.01 110.72 1.67 Allowed 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 105.011 -2.218 . . . . 1.73 105.011 166.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 59.1 mt -97.16 115.22 27.16 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.967 -0.693 . . . . 2.04 110.963 -174.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.419 ' N ' ' HE2' ' A' ' 117' ' ' MET . 21.9 tt0 -155.34 91.26 2.86 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 121.649 0.738 . . . . 1.93 109.279 -173.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.643 ' HA ' ' CD2' ' A' ' 180' ' ' LEU . 0.3 OUTLIER -31.49 144.22 0.03 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.76 1 C-N-CA 126.671 4.914 . . . . 0.73 115.536 -175.946 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.3 t70 78.05 36.61 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 113.757 -1.565 . . . . 0.72 109.057 -170.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.643 ' HE1' ' O ' ' A' ' 112' ' ' ASN . 7.2 ptp -121.09 155.43 34.46 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.768 -1.106 . . . . 2.33 111.09 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.7 m -101.37 84.47 2.62 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.224 -1.028 . . . . 1.11 108.224 -175.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.615 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -110.03 163.91 6.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.055 -1.43 . . . . 1.14 109.854 -168.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.532 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.8 m -140.87 177.41 8.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.064 -0.655 . . . . 0.89 109.913 -172.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.605 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -60.97 -27.07 68.01 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 108.145 -1.057 . . . . 2.86 108.145 165.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.508 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER -84.54 -17.73 37.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.996 -1.456 . . . . 1.68 114.416 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.532 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.9 mp0 -85.48 -62.39 1.54 Allowed 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 120.56 -1.337 . . . . 2.06 108.421 170.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.766 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 mmt -57.02 -16.52 7.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.166 -1.834 . . . . 3.58 111.901 173.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 14.9 p -42.34 -42.82 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.219 1.009 . . . . 1.11 110.797 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.68 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -67.83 -41.24 83.3 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.947 -1.478 . . . . 1.32 113.087 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.489 ' HB3' ' O ' ' A' ' 124' ' ' MET . 2.9 tm? -52.61 -32.73 43.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.29 0.567 . . . . 2.45 110.273 167.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.8 mt -82.34 -35.92 27.4 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.442 0.639 . . . . 1.13 109.541 -172.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -44.7 86.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.664 -1.153 . . . . 1.96 109.944 164.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 127' ' ' LEU . . . -65.09 -39.64 93.46 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.209 -1.814 . . . . 1.18 112.636 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 128' ' ' LEU . 2.8 t -93.19 3.92 54.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.191 -1.781 . . . . 1.27 106.191 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.84 52.24 9.88 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 110.84 -2.891 . . . . 2.22 111.88 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.579 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 2.6 t80 -136.7 175.17 9.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 119.901 -0.72 . . . . 0.9 112.725 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -139.67 149.9 44.26 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.664 -1.606 . . . . 5.25 106.664 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.505 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -49.92 141.52 10.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.534 1.159 . . . . 2.03 113.136 -169.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.571 HG12 HG22 ' A' ' 146' ' ' THR . 14.1 p -139.91 141.46 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.957 -1.929 . . . . 1.73 110.07 -162.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m -58.85 -34.59 71.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 122.607 1.194 . . . . 1.74 109.232 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 4.9 tmmm? -160.81 130.29 4.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.491 -2.141 . . . . 2.0 109.259 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 139' ' ' MET . 0.0 OUTLIER -119.08 125.82 50.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.624 -1.171 . . . . 1.27 112.117 -172.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.475 ' HA ' HD13 ' A' ' 155' ' ' ILE . 1.7 t -160.64 99.79 1.28 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.931 1.348 . . . . 1.26 110.865 156.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -165.73 157.89 12.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 105.501 -2.037 . . . . 2.11 105.501 163.379 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -61.13 113.68 1.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.088 1.424 . . . . 0.99 109.727 171.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.422 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 105.45 47.71 1.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.214 -0.993 . . . . 0.51 113.272 -175.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.579 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 44.3 mt-10 -145.73 170.7 15.97 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 122.532 0.333 . . . . 2.16 110.264 172.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.845 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 49.8 p90 -167.8 165.31 14.09 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.918 -1.141 . . . . 0.28 107.918 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.611 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 35.9 p -132.17 126.11 32.83 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.862 -0.735 . . . . 1.12 110.843 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 135' ' ' GLN . 8.6 p -125.18 169.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.798 -0.637 . . . . 1.1 111.413 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? 78.05 75.56 0.06 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.637 0.775 . . . . 3.64 110.215 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -177.85 -94.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.373 -1.285 . . . . 2.21 109.167 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -135.68 11.89 3.43 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.13 0.491 . . . . 1.95 110.443 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 3.3 p -165.8 158.06 14.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.63 112.265 -171.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.641 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 38.5 mt -107.69 106.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 106.458 -1.682 . . . . 1.19 106.458 159.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.845 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.7 mt-10 -91.07 164.18 14.04 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 104.779 -2.304 . . . . 1.13 104.779 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 19.2 ptp -166.06 164.0 18.16 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.871 0.732 . . . . 2.37 110.221 -170.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.801 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.2 mt -127.95 94.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.854 0.835 . . . . 1.14 110.698 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.701 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 1.3 tmt_? . . . . . 0 N--CA 1.438 -1.072 0 CA-C-N 114.496 -1.229 . . . . 3.61 111.857 -173.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.502 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 2.6 pm0 . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 114.821 1.415 . . . . 2.3 114.821 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.801 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 4.0 t -155.5 127.69 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 113.706 -1.588 . . . . 1.12 110.334 -169.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 154' ' ' MET . 22.2 mtm180 -93.63 115.24 27.7 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.583 0.23 . . . . 3.33 110.551 171.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -112.9 130.2 56.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.93 0.872 . . . . 1.02 110.904 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.754 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.8 tpt180 -96.09 98.48 10.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.762 -1.563 . . . . 2.43 110.901 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.641 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 7.0 mp -88.49 97.8 11.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 110.169 -0.308 . . . . 1.36 110.169 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.19 117.11 30.67 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.576 1.179 . . . . 1.04 111.672 -173.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -85.45 131.92 34.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.689 -2.05 . . . . 1.03 110.03 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 38.2 t70 -76.9 65.3 2.56 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.199 -1.778 . . . . 1.09 106.199 164.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.96 -98.55 0.88 Allowed Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 119.138 -1.506 . . . . 0.5 110.526 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.71 -26.34 54.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.88 0.696 . . . . 0.83 112.88 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.468 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 5.7 p-80 -137.34 130.02 30.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.636 0.732 . . . . 2.01 111.187 -167.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 5.3 tt -53.13 127.75 25.31 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.93 -1.487 . . . . 1.35 110.87 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -39.39 5.88 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.253 -0.885 . . . . 1.08 110.186 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.8 p -145.96 166.66 25.38 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.965 -0.562 . . . . 1.12 110.885 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 38.5 mt -136.59 145.48 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 106.025 -1.843 . . . . 1.48 106.025 169.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 38.8 t -139.16 132.94 39.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.295 0.569 . . . . 1.12 109.996 -173.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.431 ' CB ' ' HG2' ' A' ' 190' ' ' ARG . 0.2 OUTLIER -80.55 103.34 10.33 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.577 -1.268 . . . . 1.77 107.577 -176.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.566 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 29.5 mtm -65.92 -1.59 3.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 123.861 0.726 . . . . 1.26 112.722 -166.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 188' ' ' ASN . 11.7 pt-20 -77.13 -45.62 26.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.015 0.912 . . . . 1.02 110.696 174.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 190' ' ' ARG . 27.0 t-20 -108.65 -26.31 10.43 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.125 -1.398 . . . . 1.98 109.249 -174.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.3 t30 78.09 26.93 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.654 -2.066 . . . . 2.0 107.109 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 16.7 ptt180 -85.0 160.64 20.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.841 -1.527 . . . . 2.78 109.651 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.66 141.41 28.54 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.457 -1.247 . . . . 1.9 113.518 -172.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.669 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 5.8 m-85 -106.85 -166.56 1.18 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 112.635 -2.075 . . . . 1.18 107.092 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.528 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.55 -10.72 3.75 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.591 -2.203 . . . . 1.89 107.591 -149.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 196' ' ' ARG . 27.4 p90 -155.76 105.39 2.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.196 -1.002 . . . . 3.47 111.267 156.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.586 ' C ' ' HD2' ' A' ' 196' ' ' ARG . 4.0 t80 -119.57 132.75 55.8 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.13 -0.981 . . . . 0.89 109.325 166.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.586 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.1 mpt_? -115.92 146.35 42.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.867 -0.42 . . . . 5.49 109.867 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 33.0 mt -127.73 162.78 25.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.431 -0.35 . . . . 2.15 111.577 -171.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 2.66 110.61 -177.466 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.985 -0.376 . . . . 5.09 109.985 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.613 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 9.2 ttt -137.65 97.64 3.49 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 118.098 -1.441 . . . . 3.06 113.748 -163.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.6 m -101.42 107.79 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 113.548 0.944 . . . . 1.41 113.548 -178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.466 ' O ' ' HE1' ' A' ' 117' ' ' MET . 7.4 p30 -159.2 110.88 2.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.922 -1.881 . . . . 1.73 105.922 166.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.795 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.4 mp -100.72 116.15 31.94 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.461 -0.496 . . . . 2.04 110.406 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 0.3 OUTLIER -154.01 90.24 3.3 Favored Pre-proline 0 N--CA 1.432 -1.371 0 N-CA-C 109.089 -0.708 . . . . 1.93 109.089 -177.187 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.68 ' HD3' ' CD1' ' A' ' 183' ' ' ILE . 1.3 Cg_exo -29.04 144.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 1 C-N-CA 126.755 4.97 . . . . 0.73 116.467 -175.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.9 t70 74.68 37.66 0.52 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.791 -1.55 . . . . 0.72 108.781 -172.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.466 ' HE1' ' O ' ' A' ' 112' ' ' ASN . 5.8 ptp -120.9 155.88 33.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.199 -1.364 . . . . 2.33 110.893 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.1 m -101.33 82.25 2.3 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 122.42 1.105 . . . . 1.11 108.33 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.521 HG12 ' SD ' ' A' ' 124' ' ' MET . 17.8 tt -121.54 165.11 17.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.349 -1.75 . . . . 1.14 108.668 -169.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.492 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 4.2 m -140.1 175.66 9.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.713 -0.795 . . . . 0.89 111.405 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 121' ' ' LYS . 1.8 mptt -59.95 -20.14 55.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.044 -0.98 . . . . 2.86 108.91 169.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.6 ' O ' HG13 ' A' ' 125' ' ' VAL . 9.2 t30 -83.03 -21.87 33.71 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 114.062 -1.426 . . . . 1.68 112.757 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.613 ' HG3' ' HB3' ' A' ' 110' ' ' MET . 1.2 mp0 -85.94 -48.46 8.68 Favored 'General case' 0 N--CA 1.408 -2.533 0 O-C-N 120.01 -1.681 . . . . 2.06 107.825 173.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.735 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -62.59 -18.03 61.32 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 113.762 -1.563 . . . . 3.58 111.264 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -47.34 -40.74 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 122.324 1.059 . . . . 1.11 110.569 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.606 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -66.94 -41.04 87.63 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.872 -1.513 . . . . 1.32 113.351 177.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.534 ' CG ' HD13 ' A' ' 197' ' ' LEU . 2.9 tm? -52.11 -34.93 46.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.532 0.682 . . . . 2.45 110.156 168.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 124' ' ' MET . 18.0 mt -83.23 -36.24 24.76 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.783 0.801 . . . . 1.13 109.054 -170.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.82 -39.64 92.49 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.114 -1.403 . . . . 1.96 109.468 167.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.34 -43.29 81.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.306 -1.315 . . . . 1.18 112.252 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.46 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.52 2.98 56.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 124.373 2.035 . . . . 1.27 106.336 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 56.09 46.37 21.76 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 110.341 -3.118 . . . . 2.22 112.409 169.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.893 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -136.77 174.88 10.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.84 -0.744 . . . . 0.9 112.753 -173.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.426 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 31.8 ttm180 -142.97 154.72 44.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.016 -1.476 . . . . 5.25 107.016 177.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 13.6 tm0? -49.43 142.88 7.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.593 1.187 . . . . 2.03 113.714 -167.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.719 HG11 ' O ' ' A' ' 145' ' ' PHE . 13.3 p -142.97 142.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 112.752 -2.022 . . . . 1.73 110.304 -163.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 -34.05 70.01 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.718 1.247 . . . . 1.74 109.17 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -158.86 123.05 3.98 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.508 -2.133 . . . . 2.0 108.653 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.641 ' SD ' HG21 ' A' ' 146' ' ' THR . 0.0 OUTLIER -111.2 128.55 55.95 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.095 -0.957 . . . . 1.27 110.209 -178.545 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.592 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -160.89 99.15 1.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.756 1.265 . . . . 1.26 109.97 158.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -165.18 168.52 8.38 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 112.595 -2.093 . . . . 2.11 105.618 162.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.463 ' HG3' ' OE1' ' A' ' 168' ' ' GLN . 14.9 Cg_exo -66.02 119.25 6.25 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 N-CA-C 109.192 -1.118 . . . . 0.99 109.192 167.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 90.94 47.96 3.5 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.513 -1.327 . . . . 0.51 113.161 -171.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.893 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.1 mt-10 -150.62 147.17 27.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.845 -0.798 . . . . 2.16 108.845 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.719 ' O ' HG11 ' A' ' 136' ' ' VAL . 38.4 p90 -154.19 160.64 41.96 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.729 -0.841 . . . . 0.28 108.729 -177.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.641 HG21 ' SD ' ' A' ' 139' ' ' MET . 39.1 p -125.24 127.64 47.06 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.496 0.665 . . . . 1.12 110.606 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 12.8 p -121.43 113.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.187 -0.915 . . . . 1.1 110.911 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -111.53 -80.78 0.58 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.62 -0.718 . . . . 3.64 110.321 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.09 -54.84 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.72 -0.673 . . . . 2.21 110.049 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -96.47 8.24 44.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 1.95 112.264 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.697 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 23.1 p -164.13 147.01 9.34 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.947 1.092 . . . . 0.63 113.947 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 146' ' ' THR . 54.9 mt -115.03 107.8 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 112.907 -1.951 . . . . 1.19 106.852 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.543 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 6.4 mt-10 -102.29 103.68 14.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.466 -0.939 . . . . 1.13 108.466 -176.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.459 ' SD ' ' HE1' ' A' ' 195' ' ' PHE . 6.0 ptm -117.04 155.19 29.64 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.928 -1.033 . . . . 2.37 112.465 -167.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 38.4 mt -118.79 124.41 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 114.482 -1.235 . . . . 1.14 110.307 170.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.697 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 58.6 mtm180 . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 109.67 -0.493 . . . . 3.61 109.67 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.697 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 49.3 tt0 . . . . . 0 N--CA 1.423 -1.812 0 N-CA-C 114.46 1.282 . . . . 2.3 114.46 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 31.0 t -153.59 133.81 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.884 -1.507 . . . . 1.12 110.081 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.505 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 18.5 mtm180 -94.8 115.67 27.78 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.962 -0.563 . . . . 3.33 110.397 168.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.33 134.17 55.13 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.075 0.94 . . . . 1.02 112.161 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.765 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 16.2 tpt180 -96.25 95.74 8.31 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.22 -1.809 . . . . 2.43 110.255 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.697 ' O ' ' HA ' ' A' ' 151' ' ' SER . 3.9 mp -87.31 95.88 10.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.171 -0.677 . . . . 1.36 109.171 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.44 111.01 22.98 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.377 1.084 . . . . 1.04 111.556 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 52.7 m-85 -87.28 129.71 34.88 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.992 -1.913 . . . . 1.03 110.438 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 35.5 t70 -78.85 66.12 4.24 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 106.539 -1.652 . . . . 1.09 106.539 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.27 -99.32 1.18 Allowed Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 119.227 -1.463 . . . . 0.5 110.329 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.71 -24.82 33.43 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.937 0.717 . . . . 0.83 112.937 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.5 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 9.5 p-80 -130.49 123.03 28.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.636 0.731 . . . . 2.01 110.763 -166.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.9 tt -54.11 128.52 31.11 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.772 -1.558 . . . . 1.35 110.883 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.39 -39.06 6.01 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.105 -0.952 . . . . 1.08 110.33 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.469 ' HA ' ' HB3' ' A' ' 115' ' ' PRO . 19.3 p -149.4 163.31 38.1 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.214 -0.448 . . . . 1.12 111.092 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.765 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 44.5 mt -136.43 145.44 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 105.889 -1.893 . . . . 1.48 105.889 168.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 49.1 t -138.86 136.77 43.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.821 -0.437 . . . . 1.12 109.821 -174.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.538 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.0 t-20 -85.31 97.66 10.08 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.511 -1.292 . . . . 1.77 107.511 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.543 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 57.6 mtm -64.61 -3.1 2.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 124.182 0.926 . . . . 1.26 113.239 -162.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.0 pt-20 -80.53 -40.6 25.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.855 0.836 . . . . 1.02 110.802 177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.498 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 77.0 m-20 -113.58 -25.29 8.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.287 -1.324 . . . . 1.98 109.335 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 80.72 28.57 0.22 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.733 -2.031 . . . . 2.0 108.283 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.538 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 0.6 OUTLIER -83.28 155.57 23.56 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.656 -1.611 . . . . 2.78 110.637 176.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -84.74 140.97 30.88 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.641 -1.163 . . . . 1.9 112.917 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . 0.642 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 3.9 m-85 -103.27 -166.67 1.29 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.942 -1.936 . . . . 1.18 107.97 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.526 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 136.09 -2.38 3.58 Favored Glycine 0 CA--C 1.482 -1.986 0 N-CA-C 107.736 -2.146 . . . . 1.89 107.736 -151.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.48 ' O ' ' HD2' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -156.81 100.06 1.88 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 113.698 -1.251 . . . . 3.47 111.903 151.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.795 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 t80 -116.68 100.78 8.06 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.87 -1.132 . . . . 0.89 109.952 168.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -96.88 138.49 34.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.295 -0.412 . . . . 5.49 110.579 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.534 HD13 ' CG ' ' A' ' 127' ' ' LEU . 45.8 mt -132.42 160.68 35.68 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.255 0.55 . . . . 2.15 112.189 -170.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.229 -0.896 . . . . 2.66 109.375 175.86 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 69.3 mtm . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.851 0.358 . . . . 26.61 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.07 129.72 3.48 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.841 -0.695 . . . . 24.26 111.62 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 t 57.99 57.13 4.25 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.518 0.675 . . . . 23.88 110.013 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 m -87.79 96.03 10.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.644 -0.707 . . . . 23.12 110.612 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -88.69 112.98 23.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.754 -0.657 . . . . 22.4 109.433 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -91.0 -158.12 0.54 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.419 -0.355 . . . . 22.38 111.093 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.4 m80 65.86 51.64 1.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.198 0.523 . . . . 20.96 110.603 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -91.02 76.6 6.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.052 -0.522 . . . . 18.66 110.885 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -81.96 102.03 10.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.025 -0.534 . . . . 18.21 109.838 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -69.97 136.51 50.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.254 -0.43 . . . . 18.15 110.399 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 p -82.77 84.1 7.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.044 -0.526 . . . . 16.83 110.487 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 m -68.07 97.74 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 16.32 110.121 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.57 54.14 1.59 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.637 -0.792 . . . . 14.64 111.357 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.7 tp -75.06 75.05 2.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.278 0.561 . . . . 16.04 110.609 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 59.0 t -87.49 -53.25 0.39 Allowed Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.67 -0.695 . . . . 12.96 110.737 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 104' ' ' GLY . 60.9 Cg_endo -71.56 175.81 8.98 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.753 1.636 . . . . 12.74 111.867 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 74.42 -32.1 0.23 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.58 0.752 . . . . 12.74 111.667 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 102' ' ' PRO . . . 103.57 -173.83 22.28 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.179 -0.534 . . . . 8.95 112.211 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.5 t -80.64 130.62 35.21 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.277 -0.638 . . . . 8.16 109.277 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -135.58 62.85 1.62 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.079 0.466 . . . . 8.44 110.965 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 63.0 mtt -100.15 -52.89 3.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.198 -0.667 . . . . 6.56 109.198 173.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.82 -31.76 2.75 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-O 118.816 -0.991 . . . . 1.91 114.722 169.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.568 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 7.1 ptm180 -17.26 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.638 1.347 . . . . 5.09 114.638 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 60.9 ttp -140.44 121.74 14.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.557 -0.457 . . . . 3.06 111.515 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 105.7 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 122.246 1.022 . . . . 1.41 113.566 173.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -159.79 106.2 1.63 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.248 -2.13 . . . . 1.73 105.248 159.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 11.5 mt -82.8 103.64 12.44 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.425 -0.51 . . . . 2.04 110.169 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -145.08 99.46 4.62 Favored Pre-proline 0 N--CA 1.429 -1.492 0 C-N-CA 119.37 -0.932 . . . . 1.93 110.431 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.6 ' HA ' ' CD2' ' A' ' 180' ' ' LEU . 0.5 OUTLIER -34.14 139.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.644 1 C-N-CA 125.668 4.245 . . . . 0.73 115.011 -178.84 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.4 t70 77.22 35.56 0.34 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.834 -1.53 . . . . 0.72 109.408 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.433 ' HE1' HD12 ' A' ' 180' ' ' LEU . 10.8 ptt? -114.56 155.13 27.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.401 -1.272 . . . . 2.33 109.879 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 m -101.71 103.74 14.52 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.079 -1.082 . . . . 1.11 108.079 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.587 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.4 tt -136.56 166.66 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.277 -0.874 . . . . 1.14 110.566 -165.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.514 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.6 m -141.42 176.24 9.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.738 -0.838 . . . . 0.89 108.738 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.525 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -28.0 68.85 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.53 -0.915 . . . . 2.86 108.53 166.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.572 ' O ' HG12 ' A' ' 125' ' ' VAL . 0.3 OUTLIER -84.23 -19.14 34.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.127 -1.397 . . . . 1.68 113.485 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.521 ' CB ' HG13 ' A' ' 119' ' ' ILE . 1.5 mt-10 -87.6 -54.22 4.38 Favored 'General case' 0 N--CA 1.422 -1.839 0 O-C-N 120.444 -1.41 . . . . 2.06 108.994 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.751 ' SD ' HD23 ' A' ' 173' ' ' LEU . 2.1 tpp -59.76 -16.36 27.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.767 -1.56 . . . . 3.58 111.147 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 122' ' ' ASN . 15.0 p -43.81 -41.24 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 122.185 0.993 . . . . 1.11 110.228 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -65.3 -42.54 92.96 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.927 -1.488 . . . . 1.32 113.031 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.511 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.8 OUTLIER -50.82 -33.88 25.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.814 0.816 . . . . 2.45 110.595 169.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 124' ' ' MET . 20.2 mt -84.6 -35.87 22.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.553 -1.203 . . . . 1.13 109.654 -171.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.36 -24.95 63.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.483 -1.235 . . . . 1.96 110.31 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.41 -42.13 45.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.504 -1.225 . . . . 1.18 110.924 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.41 HG21 ' HA ' ' A' ' 128' ' ' LEU . 14.4 t -87.11 1.31 53.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 123.531 1.634 . . . . 1.27 107.32 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 46.39 51.98 11.11 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 110.924 -2.853 . . . . 2.22 112.249 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.626 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.9 t80 -135.31 176.5 8.62 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.478 0.548 . . . . 0.9 112.478 -172.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.545 ' HD3' ' N ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -140.21 142.06 35.88 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.947 -1.501 . . . . 5.25 106.947 177.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.592 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 14.6 tm0? -48.98 142.16 6.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.26 1.208 . . . . 2.03 114.26 -168.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.608 ' CG1' ' HH ' ' A' ' 133' ' ' TYR . 3.1 m -125.5 155.62 34.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.779 -2.01 . . . . 1.73 110.953 -176.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -61.36 -35.74 78.29 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.737 1.256 . . . . 1.74 108.446 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 5.6 tmmm? -159.87 133.18 6.94 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.65 -2.068 . . . . 2.0 109.816 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.532 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.34 135.86 54.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.577 -1.192 . . . . 1.27 111.31 -177.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.706 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -161.57 97.89 1.1 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.668 1.223 . . . . 1.26 110.718 149.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.706 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.07 161.73 20.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 112.7 -2.045 . . . . 2.11 106.313 164.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.38 130.94 28.3 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.299 1.332 . . . . 0.99 111.4 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.605 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 89.88 49.3 3.38 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.306 -0.95 . . . . 0.51 112.948 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.626 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 48.7 mt-10 -141.09 178.1 7.61 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.907 0.384 . . . . 2.16 111.357 175.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.848 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 50.2 p90 -165.73 175.59 8.68 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.063 -1.088 . . . . 0.28 108.063 169.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 25.6 p -142.3 126.13 17.1 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.471 0.653 . . . . 1.12 111.169 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.592 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.7 p -125.37 109.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.235 -0.893 . . . . 1.1 109.886 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -142.61 -60.8 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.65 -0.42 . . . . 3.64 111.607 -171.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.92 -92.43 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.49 0.552 . . . . 2.21 112.49 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -104.83 -0.11 27.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.11 0.481 . . . . 1.95 111.173 -171.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 5.2 p -146.82 160.05 42.76 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.314 0.857 . . . . 0.63 113.314 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.62 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 60.5 mt -110.53 109.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 106.816 -1.55 . . . . 1.19 106.816 162.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.848 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.8 mp0 -89.38 175.91 7.13 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.015 -1.476 . . . . 1.13 107.015 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.586 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 25.6 ptm -168.67 154.66 6.76 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 123.496 0.498 . . . . 2.37 111.108 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.571 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 21.7 mt -127.62 110.16 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.753 -0.658 . . . . 1.14 110.309 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.828 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 28.2 mtp180 -63.87 106.39 1.0 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.186 -0.461 . . . . 3.61 110.759 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.605 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 63.6 ttt180 -71.15 147.56 93.54 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 107.617 -1.253 . . . . 6.8 107.617 170.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -47.2 125.97 11.02 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 121.235 1.29 . . . . 2.5 110.602 168.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 22.4 m-85 -128.35 132.98 48.58 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.302 -1.317 . . . . 2.1 108.448 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -95.66 76.72 3.26 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.744 1.259 . . . . 3.66 111.116 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.496 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 18.1 m-85 -115.82 139.52 25.01 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 113.614 -1.63 . . . . 3.96 108.957 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.0 Cg_exo -57.71 -31.24 91.57 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 124.472 3.448 . . . . 4.73 112.632 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.407 ' C ' ' HG ' ' A' ' 164' ' ' SER . 15.1 t70 -98.49 -7.83 27.74 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.786 -1.097 . . . . 5.26 111.108 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.407 ' HG ' ' C ' ' A' ' 163' ' ' ASP . 71.1 m -159.88 98.72 1.35 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.446 -0.343 . . . . 3.82 111.404 -175.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.66 97.58 2.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.597 0.713 . . . . 3.83 109.717 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -146.42 -175.29 4.72 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.873 -1.058 . . . . 3.14 110.894 -173.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.37 173.49 54.87 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 114.264 -1.335 . . . . 1.22 112.14 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.828 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.6 tt0 -62.49 152.73 33.75 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.41 -1.395 . . . . 2.3 113.502 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 50.1 t -154.37 133.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.689 -1.141 . . . . 1.12 109.519 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 154' ' ' MET . 8.5 mtm180 -91.12 115.16 27.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.814 0.34 . . . . 3.33 110.399 169.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.04 145.39 43.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.812 0.815 . . . . 1.02 111.353 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.751 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.2 tpt180 -111.49 98.66 7.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.838 -1.528 . . . . 2.43 110.501 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.751 HD23 ' SD ' ' A' ' 124' ' ' MET . 4.5 mp -91.76 94.48 9.37 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.247 -0.279 . . . . 1.36 110.247 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.1 126.26 43.47 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.438 1.114 . . . . 1.04 111.653 -171.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.657 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.2 m-85 -89.82 138.34 31.57 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 112.859 -1.973 . . . . 1.03 111.07 -177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.485 ' HB2' ' HB1' ' A' ' 181' ' ' ALA . 30.9 t70 -79.39 64.49 4.29 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.027 -1.842 . . . . 1.09 106.027 160.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.7 -98.37 1.05 Allowed Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 118.879 -1.629 . . . . 0.5 110.713 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -79.14 -24.8 43.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.023 0.749 . . . . 0.83 113.023 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -134.68 129.99 35.63 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.951 -0.7 . . . . 2.01 110.844 -169.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.27 128.15 27.13 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.743 -1.572 . . . . 1.35 110.546 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 176' ' ' ASP . . . -106.23 -41.48 5.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.492 -0.776 . . . . 1.08 110.486 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.1 p -145.49 166.86 24.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.226 -0.443 . . . . 1.12 110.921 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.751 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 39.5 mt -136.18 145.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.108 -1.812 . . . . 1.48 106.108 169.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 45.0 t -137.26 140.17 42.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.277 0.56 . . . . 1.12 110.186 -174.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.462 ' CB ' ' HG2' ' A' ' 190' ' ' ARG . 2.1 t-20 -81.13 100.97 9.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.733 -1.21 . . . . 1.77 107.733 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.513 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 49.3 mtm -64.27 -2.76 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.403 0.89 . . . . 1.26 113.403 -164.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.434 ' HG3' ' OD1' ' A' ' 188' ' ' ASN . 10.9 pt-20 -91.92 -40.06 11.36 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.812 0.815 . . . . 1.02 111.225 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.434 ' OD1' ' HG3' ' A' ' 187' ' ' GLU . 5.8 m-20 -105.78 -25.36 12.22 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.449 -1.251 . . . . 1.98 109.495 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 73.86 33.91 0.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 112.429 -2.169 . . . . 2.0 108.041 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.462 ' HG2' ' CB ' ' A' ' 185' ' ' ASN . 3.9 ptm180 -93.33 161.88 14.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.03 -1.441 . . . . 2.78 110.082 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.3 140.84 29.13 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.542 -1.208 . . . . 1.9 113.518 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.59 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 8.8 m-85 -106.44 -166.02 1.14 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.834 -1.984 . . . . 1.18 107.286 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.538 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.99 -6.73 3.46 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 107.83 -2.108 . . . . 1.89 107.83 -149.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -154.71 112.61 3.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.878 -1.161 . . . . 3.47 111.507 157.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.729 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t80 -129.18 101.6 6.09 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.702 -0.799 . . . . 0.89 109.965 162.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -100.06 128.75 46.1 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.03 -1.044 . . . . 5.49 111.948 -171.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.418 ' CD1' HD13 ' A' ' 127' ' ' LEU . 8.9 mt -107.76 171.27 7.49 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.174 -0.466 . . . . 2.15 111.129 173.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -116.28 97.68 50.13 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.727 -0.842 . . . . 2.66 108.727 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -46.49 118.52 2.6 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.503 2.802 . . . . 2.4 115.253 -168.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 125.35 1.46 . . . . 5.84 110.166 170.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 111.382 0.141 . . . . 26.61 111.382 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.06 -93.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 24.26 111.966 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.6 t -82.62 63.8 6.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.385 0.612 . . . . 23.88 109.674 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 m -112.28 20.0 17.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.997 -0.547 . . . . 23.12 111.478 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -107.75 96.03 6.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.078 0.466 . . . . 22.4 110.252 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -81.85 135.05 35.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.571 -0.529 . . . . 22.38 109.571 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -75.55 105.89 6.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.37 -0.377 . . . . 20.96 110.161 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -138.23 38.4 2.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.005 0.431 . . . . 18.66 111.139 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -142.33 152.59 43.09 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.756 -0.461 . . . . 18.21 109.756 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -55.41 107.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.528 0.518 . . . . 18.15 110.163 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.2 m -97.84 126.31 43.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.817 -0.629 . . . . 16.83 111.213 -174.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.8 m -143.52 158.66 43.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.532 -0.758 . . . . 16.32 109.28 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.422 ' HA3' ' HG2' ' A' ' 102' ' ' PRO . . . -158.23 152.83 24.02 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.159 -1.02 . . . . 14.64 112.736 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.0 tp -79.47 -46.0 18.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.086 0.47 . . . . 16.04 110.023 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.467 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 51.3 t -90.36 -53.15 0.31 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.711 -0.677 . . . . 12.96 111.035 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 61.9 Cg_endo -75.28 55.76 4.2 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.908 1.739 . . . . 12.74 111.685 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -83.71 91.98 7.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.641 -0.709 . . . . 12.74 110.371 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -173.77 -146.7 5.66 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.383 -0.687 . . . . 8.95 111.383 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.2 m 72.89 -44.19 0.59 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.627 0.771 . . . . 8.16 111.606 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -83.28 43.1 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.989 0.423 . . . . 8.44 111.121 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 93.0 mmm -117.87 138.06 52.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.043 -0.526 . . . . 6.56 110.139 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 123' ' ' GLU . . . 86.29 -32.53 3.83 Favored Glycine 0 C--O 1.22 -0.748 0 CA-C-N 116.039 -0.528 . . . . 1.91 113.122 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.543 ' NH1' HG21 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -53.08 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.824 0.85 . . . . 5.09 111.263 175.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.637 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 48.2 tpp -143.63 138.78 29.24 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.361 -0.536 . . . . 3.06 110.961 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.77 104.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.374 1.083 . . . . 1.41 113.059 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -158.85 107.76 1.92 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 112.962 -1.926 . . . . 1.73 106.177 167.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 6.6 mt -91.3 100.62 13.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.5 -0.48 . . . . 2.04 110.111 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 117' ' ' MET . 5.2 tm-20 -150.34 109.44 3.19 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.377 0.608 . . . . 1.93 109.677 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.833 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 10.6 Cg_exo -34.77 146.3 0.05 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.849 1 C-N-CA 126.876 5.05 . . . . 0.73 115.43 -173.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.57 39.61 2.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.089 -1.414 . . . . 0.72 109.019 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.52 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 10.5 ptt? -117.57 154.37 31.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.655 -1.157 . . . . 2.33 109.485 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.1 m -101.81 79.33 1.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.152 0.977 . . . . 1.11 108.599 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.664 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -97.1 156.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 113.936 -1.484 . . . . 1.14 109.384 -171.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.516 ' H ' HG13 ' A' ' 119' ' ' ILE . 10.8 m -141.95 174.15 10.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.156 -0.683 . . . . 0.89 109.156 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.628 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 35.2 mtpt -49.43 -33.49 14.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.38 0.609 . . . . 2.86 110.175 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.636 ' O ' HG11 ' A' ' 125' ' ' VAL . 63.0 t30 -84.49 -16.18 43.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.335 1.235 . . . . 1.68 114.335 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.637 ' CG ' ' HB3' ' A' ' 110' ' ' MET . 6.2 tt0 -86.31 -60.53 1.97 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.374 -1.453 . . . . 2.06 107.894 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.753 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -54.7 -17.59 3.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.457 -1.701 . . . . 3.58 111.105 173.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 122' ' ' ASN . 13.7 p -42.35 -40.57 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-O 122.018 0.914 . . . . 1.11 110.34 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.653 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.7 -42.72 81.55 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.129 -1.396 . . . . 1.32 113.699 177.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.533 ' HA ' ' CD1' ' A' ' 197' ' ' LEU . 2.8 tm? -50.86 -34.78 29.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.568 0.699 . . . . 2.45 110.359 168.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.753 ' HG ' ' O ' ' A' ' 124' ' ' MET . 7.3 mt -85.36 -34.86 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.568 -0.742 . . . . 1.13 110.143 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.29 -25.77 66.21 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.154 -1.385 . . . . 1.96 110.778 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -77.38 -45.39 26.11 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.978 -1.464 . . . . 1.18 111.272 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.97 -5.99 46.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 123.637 1.684 . . . . 1.27 107.471 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.54 55.34 5.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 110.983 -2.826 . . . . 2.22 112.464 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.889 ' HH ' ' CG1' ' A' ' 136' ' ' VAL . 2.5 t80 -132.15 176.38 8.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.853 0.686 . . . . 0.9 112.853 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -142.86 141.57 31.6 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.949 -1.5 . . . . 5.25 106.949 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.472 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -49.04 144.79 4.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 115.627 1.714 . . . . 2.03 115.627 -165.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.889 ' CG1' ' HH ' ' A' ' 133' ' ' TYR . 3.1 m -129.51 162.67 36.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 112.223 -2.262 . . . . 1.73 110.862 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -73.0 -35.55 66.84 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.591 -1.263 . . . . 1.74 107.591 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -145.46 124.84 13.06 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 112.795 -2.002 . . . . 2.0 110.513 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.576 ' CB ' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -117.93 128.87 55.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.093 -1.412 . . . . 1.27 110.047 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 96.03 1.68 Allowed 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.044 1.402 . . . . 1.26 109.364 155.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.576 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -167.61 161.26 10.16 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 111.979 -2.373 . . . . 2.11 105.771 167.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.19 126.32 9.77 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.675 1.583 . . . . 0.99 111.865 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.623 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 103.43 19.41 12.41 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 119.904 -1.141 . . . . 0.51 112.328 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.716 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 13.4 mp0 -128.33 173.19 10.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.661 0.267 . . . . 2.16 110.682 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.824 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 54.9 p90 -165.9 175.85 8.31 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.707 -1.22 . . . . 0.28 107.707 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.56 HG23 ' HB3' ' A' ' 139' ' ' MET . 3.5 p -138.1 132.59 32.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 120.227 -0.589 . . . . 1.12 110.823 170.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 135' ' ' GLN . 14.6 p -124.14 109.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 122.347 1.07 . . . . 1.1 111.813 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -99.18 -74.99 0.57 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.523 -1.217 . . . . 3.64 109.313 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.62 -46.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.016 -0.993 . . . . 2.21 109.328 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.36 -11.42 57.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.408 -0.814 . . . . 1.95 111.236 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 14.6 p -158.89 152.28 22.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.125 0.964 . . . . 0.63 112.829 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.645 HG21 ' SD ' ' A' ' 124' ' ' MET . 68.5 mt -116.59 113.72 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 112.977 -1.92 . . . . 1.19 107.554 164.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.824 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -92.88 165.56 12.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.565 -1.643 . . . . 1.13 106.565 173.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 14.5 ptp -166.37 151.43 8.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 123.835 0.71 . . . . 2.37 110.764 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.655 HG12 ' HG3' ' A' ' 170' ' ' ARG . 7.5 mt -129.63 110.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.65 -0.705 . . . . 1.14 110.265 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 33.7 mtp180 -68.2 101.26 1.14 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.483 -0.487 . . . . 3.61 110.354 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.568 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 50.1 ttt180 -54.44 146.56 32.68 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 107.052 -1.462 . . . . 6.8 107.052 166.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -70.89 124.75 10.9 Favored 'Trans proline' 0 N--CA 1.432 -2.146 0 CA-C-N 120.316 1.148 . . . . 2.5 109.23 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 17.5 m-85 -118.19 163.1 17.15 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.126 -1.397 . . . . 2.1 108.396 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -110.9 76.93 1.0 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.27 1.033 . . . . 3.66 111.239 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 34.2 m-85 -116.5 147.85 40.56 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 114.153 -1.385 . . . . 3.96 110.354 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 31.8 Cg_exo -59.04 -31.95 96.57 Favored 'Trans proline' 0 CA--C 1.501 -1.146 0 C-N-CA 125.009 3.806 . . . . 4.73 113.651 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.423 ' C ' ' HG ' ' A' ' 164' ' ' SER . 21.5 t70 -95.44 -13.53 24.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.23 -0.896 . . . . 5.26 111.008 -178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.425 ' HB2' ' OD1' ' A' ' 198' ' ' ASP . 21.5 m -157.67 103.09 1.9 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.989 -0.55 . . . . 3.82 111.574 -172.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -147.11 86.38 1.63 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.894 0.854 . . . . 3.83 109.022 173.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.08 -170.3 3.59 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.208 -1.36 . . . . 3.14 111.11 -173.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -70.72 155.36 52.86 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.879 -0.601 . . . . 1.22 112.624 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.558 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -60.63 164.4 4.63 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.632 -0.784 . . . . 2.3 112.715 -178.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 95.4 t -151.86 127.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.179 -0.918 . . . . 1.12 110.089 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.655 ' HG3' HG12 ' A' ' 155' ' ' ILE . 3.7 mtm180 -85.77 115.46 23.43 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.468 -0.787 . . . . 3.33 110.262 169.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.44 139.8 50.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.313 -0.955 . . . . 1.02 111.591 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.743 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 13.2 tpt180 -104.48 98.57 8.32 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.982 -1.463 . . . . 2.43 110.781 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 151' ' ' SER . 8.3 mp -88.16 103.25 15.58 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.237 -0.283 . . . . 1.36 110.237 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.21 119.57 39.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.4 1.095 . . . . 1.04 111.675 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.526 ' CZ ' HG23 ' A' ' 119' ' ' ILE . 2.0 m-85 -83.31 140.6 32.37 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 112.955 -1.93 . . . . 1.03 111.147 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.23 65.2 5.3 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.065 -1.828 . . . . 1.09 106.065 159.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.84 -97.99 1.27 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 118.572 -1.775 . . . . 0.5 110.697 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.87 -25.38 40.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.032 0.753 . . . . 0.83 113.032 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -132.81 129.69 38.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.972 0.891 . . . . 2.01 111.726 -167.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.664 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 3.0 tm? -51.07 120.59 5.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.872 -1.967 . . . . 1.35 109.868 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -106.14 -37.25 6.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.764 -0.653 . . . . 1.08 110.63 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 17.7 p -143.88 164.38 30.73 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.102 -0.499 . . . . 1.12 110.742 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.743 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 21.1 mt -138.93 143.97 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 105.831 -1.914 . . . . 1.48 105.831 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 30.3 t -132.79 135.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.946 0.403 . . . . 1.12 110.472 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.497 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 1.8 m120 -76.24 101.1 5.29 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 107.131 -1.433 . . . . 1.77 107.131 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.574 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 41.1 mtm -67.38 -1.41 4.71 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.34 0.59 . . . . 1.26 111.654 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.497 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 16.9 pt-20 -73.85 -43.96 57.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.193 -0.912 . . . . 1.02 110.988 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -113.26 -25.67 8.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.228 -1.351 . . . . 1.98 109.367 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 75.53 36.47 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.179 -2.282 . . . . 2.0 107.858 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.452 ' HG2' ' HB2' ' A' ' 185' ' ' ASN . 12.2 ptt180 -97.33 170.7 8.9 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 114.167 -1.379 . . . . 2.78 108.819 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -86.05 144.92 27.3 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.433 1.111 . . . . 1.9 113.916 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -116.91 -166.79 1.2 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 105.222 -2.14 . . . . 1.18 105.222 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.833 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 136.19 8.19 1.62 Allowed Glycine 0 N--CA 1.412 -2.934 0 N-CA-C 109.994 -1.242 . . . . 1.89 109.994 -160.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.406 ' HB2' ' NH1' ' A' ' 196' ' ' ARG . 20.7 p90 -152.39 101.95 2.71 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.151 -1.525 . . . . 3.47 110.438 151.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.64 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 3.9 t80 -118.45 99.75 7.03 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.892 -0.781 . . . . 0.89 108.892 168.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 1.4 mpt_? -100.62 123.06 44.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 5.49 111.33 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -93.1 172.57 8.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.336 1.606 . . . . 2.15 115.336 -170.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 164' ' ' SER . 13.9 m-20 -92.71 118.74 68.07 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 112.813 -1.994 . . . . 2.66 110.031 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.701 ' O ' ' HD3' ' A' ' 200' ' ' ARG . 82.5 Cg_exo -45.25 127.74 9.26 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 124.466 3.444 . . . . 2.4 114.924 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.701 ' HD3' ' O ' ' A' ' 199' ' ' PRO . 13.2 mmt180 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.395 -0.812 . . . . 5.84 109.729 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.635 0.255 . . . . 26.61 111.009 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.81 -25.61 7.91 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.972 -0.632 . . . . 24.26 111.664 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 t -88.3 100.3 12.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.752 -0.462 . . . . 23.88 109.752 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.5 t -88.01 -24.61 23.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.038 -0.528 . . . . 23.12 110.637 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.5 m80 65.19 32.64 9.94 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.407 -0.815 . . . . 22.4 110.805 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -109.25 137.23 47.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 22.38 110.726 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 62.16 89.77 0.08 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 124.034 0.834 . . . . 20.96 111.184 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -69.29 122.92 19.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.244 -0.651 . . . . 18.66 109.244 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.463 ' HB3' ' O ' ' A' ' 98' ' ' SER . 2.4 t-160 -65.11 -19.73 66.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.181 -0.463 . . . . 18.21 111.092 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t60 69.35 -85.56 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.51 0.724 . . . . 18.15 112.034 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.0 m -71.97 -43.54 64.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.244 0.545 . . . . 16.83 110.235 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 95' ' ' HIS . 19.4 t -99.91 -175.99 3.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.923 -0.769 . . . . 16.32 108.923 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.27 -132.19 2.53 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.127 -0.789 . . . . 14.64 111.127 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.71 168.75 14.95 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.595 -0.52 . . . . 16.04 109.595 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.538 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 95.4 t -73.26 -53.93 4.51 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 120.91 -0.316 . . . . 12.96 111.786 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 11.2 Cg_exo -70.72 124.31 10.57 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.698 1.599 . . . . 12.74 111.562 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -107.72 114.08 27.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.456 -0.338 . . . . 12.74 110.245 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.84 -170.86 39.03 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.964 -0.636 . . . . 8.95 111.864 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.7 t -68.13 -22.13 64.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.88 0.371 . . . . 8.16 110.43 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -92.48 107.71 19.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.335 -0.393 . . . . 8.44 110.219 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 89.2 mtp -64.57 -36.27 83.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.176 0.512 . . . . 6.56 110.298 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.33 3.37 89.84 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-N 115.322 -0.853 . . . . 1.91 112.743 175.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 22.4 mtt180 -136.62 78.71 1.72 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.361 -1.348 . . . . 5.09 107.361 173.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.676 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.3 tpt -143.58 118.06 9.71 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 114.162 1.171 . . . . 3.06 114.162 -160.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.479 ' CG1' ' HB2' ' A' ' 127' ' ' LEU . 0.8 OUTLIER -104.19 109.29 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 C-N-CA 119.246 -0.982 . . . . 1.41 112.681 179.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -155.03 109.82 3.0 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.146 -1.798 . . . . 1.73 106.146 167.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.671 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.1 mp -98.33 113.69 25.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.596 -0.89 . . . . 2.04 108.596 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.614 ' CB ' ' HE2' ' A' ' 117' ' ' MET . 15.1 tt0 -146.09 108.99 4.3 Favored Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.732 -0.787 . . . . 1.93 109.79 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.475 ' HG3' HG12 ' A' ' 183' ' ' ILE . 33.3 Cg_exo -35.76 130.83 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.407 0 C-N-CA 124.903 3.735 . . . . 0.73 114.473 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 73.71 45.47 0.24 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 122.403 1.097 . . . . 0.72 110.624 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.614 ' HE2' ' CB ' ' A' ' 114' ' ' GLU . 6.1 ptp -121.28 158.57 27.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.286 -1.324 . . . . 2.33 111.416 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 m -102.29 100.14 10.29 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.779 -0.823 . . . . 1.11 108.779 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 12.2 tt -137.93 169.3 18.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.97 -1.013 . . . . 1.14 109.577 -167.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.453 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.5 m -139.88 175.33 9.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.821 0.737 . . . . 0.89 111.45 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.618 ' HA ' HD13 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -20.6 63.02 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.49 -0.929 . . . . 2.86 108.49 167.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.772 ' O ' HG11 ' A' ' 125' ' ' VAL . 6.3 t30 -83.17 -22.64 33.19 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 113.979 -1.464 . . . . 1.68 112.475 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.676 ' HA ' ' H ' ' A' ' 110' ' ' MET . 1.1 mp0 -84.28 -50.01 8.25 Favored 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 120.025 -1.672 . . . . 2.06 107.923 173.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.756 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -61.67 -18.51 59.83 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.511 -1.222 . . . . 3.58 111.268 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.772 HG11 ' O ' ' A' ' 122' ' ' ASN . 11.1 p -47.28 -41.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.114 0.959 . . . . 1.11 110.808 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.521 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.2 mmpt? -69.93 -36.97 75.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.323 -1.308 . . . . 1.32 112.771 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.598 ' HG ' HD12 ' A' ' 197' ' ' LEU . 2.4 tm? -55.42 -33.88 63.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.686 0.755 . . . . 2.45 110.27 167.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' A' ' 124' ' ' MET . 17.4 mt -84.36 -32.6 24.14 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.95 0.881 . . . . 1.13 109.189 -172.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.98 -39.43 89.57 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.901 -1.499 . . . . 1.96 110.219 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 200' ' ' ARG . . . -70.5 -43.19 70.2 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.524 -1.671 . . . . 1.18 112.283 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.49 3.9 54.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 124.538 2.113 . . . . 1.27 106.281 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 130' ' ' ALA . 17.9 mt-30 52.35 49.16 21.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 110.262 -3.154 . . . . 2.22 112.679 168.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.952 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -139.24 175.74 9.3 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.759 -0.776 . . . . 0.9 112.778 -172.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.41 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 79.6 ttt180 -138.69 155.11 48.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.558 -1.275 . . . . 5.25 107.558 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.479 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -49.17 141.36 8.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.427 1.108 . . . . 2.03 113.375 -168.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.569 ' HB ' ' HE1' ' A' ' 133' ' ' TYR . 11.3 p -143.39 135.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.033 -1.894 . . . . 1.73 109.931 -164.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -33.52 70.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.233 1.016 . . . . 1.74 109.475 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -151.8 121.57 7.01 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 113.109 -1.86 . . . . 2.0 109.697 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.543 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -111.09 122.75 48.68 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.188 -1.369 . . . . 1.27 110.855 -177.469 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.503 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.3 OUTLIER -158.94 97.16 1.39 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.824 1.297 . . . . 1.26 109.769 161.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.442 ' HD3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -166.65 165.2 9.95 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.508 -2.133 . . . . 2.11 106.127 161.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.504 ' HB3' ' HA ' ' A' ' 157' ' ' ARG . 27.8 Cg_exo -62.61 116.74 3.72 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 120.973 1.115 . . . . 0.99 109.885 167.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.42 47.25 3.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.834 -1.174 . . . . 0.51 113.424 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.952 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.3 mt-10 -142.41 147.96 37.04 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.769 -0.826 . . . . 2.16 108.769 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.834 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 35.5 p90 -152.59 159.22 43.26 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.432 -0.951 . . . . 0.28 108.432 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.554 HG21 ' CG1' ' A' ' 136' ' ' VAL . 3.6 p -126.95 127.66 45.19 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.92 -0.712 . . . . 1.12 110.954 175.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 135' ' ' GLN . 8.6 p -111.81 110.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.908 0.861 . . . . 1.1 111.322 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -113.65 16.01 18.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.909 -1.041 . . . . 3.64 110.738 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.65 -50.05 0.7 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.81 0.694 . . . . 2.21 111.28 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -81.88 -5.21 58.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.13 0.49 . . . . 1.95 110.175 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -166.39 144.87 5.53 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.444 -0.798 . . . . 0.63 112.073 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 121' ' ' LYS . 37.2 mt -116.1 112.47 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.279 -1.328 . . . . 1.19 107.684 164.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.834 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 65.7 mt-10 -90.82 163.54 14.39 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.373 -2.084 . . . . 1.13 105.373 175.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 24.0 ptm -167.83 154.27 7.76 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.524 0.515 . . . . 2.37 110.514 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 36.2 mt -129.08 115.25 35.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.982 -0.554 . . . . 1.14 110.797 166.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.654 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 74.7 mtp180 -62.28 106.66 0.77 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.646 . . . . 3.61 110.539 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.509 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 73.5 ttt180 -69.88 140.47 88.87 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 106.828 -1.545 . . . . 6.8 106.828 164.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -48.12 125.13 11.3 Favored 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 121.309 1.339 . . . . 2.5 111.432 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 9.3 m-85 -128.63 123.41 33.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.824 -1.534 . . . . 2.1 107.248 176.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.05 74.17 5.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.444 1.116 . . . . 3.66 111.653 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.482 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 99.3 m-85 -122.03 142.89 37.5 Favored Pre-proline 0 C--N 1.306 -1.323 0 CA-C-N 113.904 -1.498 . . . . 3.96 110.076 172.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 37.7 Cg_exo -56.62 -32.45 90.41 Favored 'Trans proline' 0 CA--C 1.499 -1.251 0 C-N-CA 124.837 3.691 . . . . 4.73 113.494 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -81.2 -23.7 37.97 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.041 -0.981 . . . . 5.26 111.333 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 66.6 m -156.32 98.29 1.83 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.625 -0.716 . . . . 3.82 110.105 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -148.63 87.13 1.55 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.003 0.906 . . . . 3.83 110.077 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -134.36 -171.43 2.76 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.065 -1.425 . . . . 3.14 109.009 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.61 174.81 55.1 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 119.774 -1.203 . . . . 1.22 110.974 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 9.5 tt0 -58.25 148.78 26.09 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 114.268 -0.966 . . . . 2.3 111.938 173.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 70.0 t -151.93 128.89 2.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.091 -0.959 . . . . 1.12 109.191 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.7 ' HG2' ' CE ' ' A' ' 186' ' ' MET . 32.6 ttp180 -92.63 102.3 14.72 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.114 -0.948 . . . . 3.33 108.518 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.46 147.9 36.97 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.821 0.82 . . . . 1.02 111.859 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.496 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 10.1 tpt180 -114.36 100.68 8.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.929 -1.487 . . . . 2.43 110.318 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -88.87 96.03 10.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.736 -0.839 . . . . 1.36 108.736 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 117.38 31.67 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.125 0.964 . . . . 1.04 111.316 -171.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -89.88 135.74 33.46 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.225 -1.807 . . . . 1.03 110.487 -179.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -78.95 65.67 4.2 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.362 -1.718 . . . . 1.09 106.362 164.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.3 -99.32 1.18 Allowed Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 118.986 -1.578 . . . . 0.5 110.61 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.46 -24.86 42.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 113.075 0.768 . . . . 0.83 113.075 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -131.27 129.08 41.09 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.299 -0.96 . . . . 2.01 110.934 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.3 tt -53.14 129.32 30.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.457 -1.701 . . . . 1.35 110.049 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.68 -37.75 6.33 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.591 -0.731 . . . . 1.08 110.189 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.7 p -148.12 165.04 32.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.092 -0.504 . . . . 1.12 111.422 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.583 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.7 mm -117.53 149.01 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 105.226 -2.138 . . . . 1.48 105.226 163.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -138.89 128.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.461 0.648 . . . . 1.12 110.065 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.473 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 34.1 t-20 -80.97 102.84 10.4 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.829 -1.174 . . . . 1.77 107.829 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.7 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 38.0 mtm -66.35 -0.73 2.82 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 113.053 0.76 . . . . 1.26 113.053 -166.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 10.7 pt-20 -79.33 -40.95 29.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.127 0.965 . . . . 1.02 111.018 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.486 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 67.6 m-20 -112.27 -26.31 8.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.148 -1.387 . . . . 1.98 109.484 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 185' ' ' ASN . 25.2 t-20 78.2 32.15 0.36 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.611 -2.086 . . . . 2.0 107.872 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 0.1 OUTLIER -91.43 164.55 13.78 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 113.471 -1.695 . . . . 2.78 109.119 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 76.1 mt-30 -85.05 136.02 33.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.491 -0.777 . . . . 1.9 110.132 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.583 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -107.3 90.99 3.47 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 118.86 -0.591 . . . . 1.18 110.177 -175.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.44 -59.2 0.0 OUTLIER Glycine 0 N--CA 1.47 0.91 0 C-N-CA 125.039 1.304 . . . . 1.89 116.268 147.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.442 ' HD2' ' NH1' ' A' ' 196' ' ' ARG . 0.3 OUTLIER -164.86 171.55 14.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.879 -1.661 . . . . 3.47 108.125 174.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.671 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -140.36 130.03 24.31 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.356 0.526 . . . . 0.89 109.66 162.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.666 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -120.43 130.53 54.38 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.667 -0.646 . . . . 5.49 110.659 -170.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.598 HD12 ' HG ' ' A' ' 127' ' ' LEU . 68.1 mt -136.55 171.37 14.59 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.799 1.037 . . . . 2.15 113.799 -166.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -109.51 99.81 38.98 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 114.415 -1.266 . . . . 2.66 110.451 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.68 130.43 39.91 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.483 2.122 . . . . 2.4 112.999 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 130' ' ' ALA . 68.5 mtt85 . . . . . 0 C--O 1.242 0.703 0 CA-C-N 115.388 -0.824 . . . . 5.84 111.436 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.8 ptm . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.236 -0.283 . . . . 26.61 110.236 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.92 159.48 9.4 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.864 -0.684 . . . . 24.26 112.024 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.8 m 55.81 63.94 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 23.88 111.158 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.3 m -63.35 132.41 51.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 23.12 110.259 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -118.86 145.23 45.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.822 0.344 . . . . 22.4 110.587 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -79.11 88.36 4.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.97 -0.559 . . . . 22.38 110.631 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -88.23 37.66 0.82 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.034 -0.53 . . . . 20.96 110.734 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 69.86 90.83 0.09 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.275 -0.875 . . . . 18.66 112.683 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -87.09 -23.44 24.9 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.336 -0.616 . . . . 18.21 109.336 170.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -136.84 178.45 7.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.41 -0.814 . . . . 18.15 109.971 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.1 t -76.46 121.81 23.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.652 -0.499 . . . . 16.83 109.652 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.9 p -69.53 82.2 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.404 0.621 . . . . 16.32 111.162 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.08 -25.54 0.7 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.416 -0.811 . . . . 14.64 111.645 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -97.09 8.86 43.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.676 0.274 . . . . 16.04 110.732 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.88 118.56 53.16 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.85 -0.614 . . . . 12.96 110.375 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.14 161.64 25.81 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.082 2.521 . . . . 12.74 112.195 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -67.39 96.11 0.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 12.74 110.333 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.85 -11.84 70.32 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.486 -0.779 . . . . 8.95 111.675 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.2 m 64.02 -74.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.505 0.722 . . . . 8.16 111.018 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -137.09 87.92 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.949 -0.76 . . . . 8.44 108.949 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.529 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 59.7 mtt -73.39 -79.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.095 0.474 . . . . 6.56 110.825 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.67 -31.32 5.9 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-O 118.774 -1.015 . . . . 1.91 112.989 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.409 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 13.3 mtm180 14.15 80.74 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.922 1.289 . . . . 5.09 112.711 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.563 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 24.9 ttt -141.82 135.54 29.72 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.493 -0.776 . . . . 3.06 111.974 -168.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.0 m -118.18 106.4 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 122.268 1.032 . . . . 1.41 112.953 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -160.1 106.73 1.59 Allowed 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 105.749 -1.945 . . . . 1.73 105.749 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.839 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 3.5 mp -97.13 111.41 23.66 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.474 -0.935 . . . . 2.04 108.474 -173.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 117' ' ' MET . 21.0 tt0 -143.72 107.38 5.05 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-N 114.963 -1.017 . . . . 1.93 110.549 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.489 ' HD3' HD11 ' A' ' 183' ' ' ILE . 29.5 Cg_exo -36.75 129.03 0.49 Allowed 'Trans proline' 0 CA--C 1.515 -0.427 0 C-N-CA 124.476 3.451 . . . . 0.73 113.427 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.9 t70 75.41 50.1 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.685 1.231 . . . . 0.72 109.768 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.584 ' CE ' HD11 ' A' ' 180' ' ' LEU . 13.1 ptt? -122.47 157.24 32.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 113.789 -1.551 . . . . 2.33 110.116 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.3 m -100.01 113.9 26.81 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.299 -1.0 . . . . 1.11 108.299 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.581 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -142.75 159.84 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 116.046 -0.524 . . . . 1.14 111.457 -165.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.504 ' H ' HG13 ' A' ' 119' ' ' ILE . 49.2 m -143.06 179.87 6.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.914 -0.314 . . . . 0.89 110.167 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.566 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 6.9 mtmp? -59.14 -28.12 66.27 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.677 -0.86 . . . . 2.86 108.677 166.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 107' ' ' MET . 4.4 t-20 -85.73 -17.34 36.19 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.996 -1.456 . . . . 1.68 114.446 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.563 ' HG3' ' HB3' ' A' ' 110' ' ' MET . 1.2 tp10 -84.39 -62.28 1.6 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.498 -1.297 . . . . 2.06 107.498 169.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.832 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 14.8 mmt -57.82 -15.81 9.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.627 -2.078 . . . . 3.58 111.765 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 14.6 p -43.19 -41.88 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 122.176 0.989 . . . . 1.11 110.191 175.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.746 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -69.27 -41.58 76.67 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.047 -1.433 . . . . 1.32 113.224 177.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 197' ' ' LEU . 1.1 tt -49.41 -34.3 16.07 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.528 0.68 . . . . 2.45 111.387 167.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.832 ' HG ' ' O ' ' A' ' 124' ' ' MET . 13.9 mt -85.43 -32.53 22.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.158 -0.928 . . . . 1.13 108.824 -171.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.63 -36.53 84.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.11 -1.405 . . . . 1.96 109.814 167.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.7 -42.91 63.7 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.871 -1.513 . . . . 1.18 111.977 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -5.84 56.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 123.648 1.689 . . . . 1.27 106.991 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 58.33 55.51 4.97 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 110.761 -2.927 . . . . 2.22 112.473 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.648 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 3.2 t80 -139.56 176.73 8.48 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 113.126 0.787 . . . . 0.9 113.126 -177.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.457 ' HA ' ' CZ ' ' A' ' 145' ' ' PHE . 14.1 ptm180 -142.19 150.34 40.89 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.091 -1.078 . . . . 5.25 108.091 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 15.0 tm0? -50.37 143.37 8.94 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.802 1.408 . . . . 2.03 114.802 -166.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.603 HG21 ' CB ' ' A' ' 139' ' ' MET . 1.3 m -125.65 159.52 33.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 112.805 -1.998 . . . . 1.73 111.875 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -63.31 -35.79 81.52 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.68 1.229 . . . . 1.74 108.089 169.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 139' ' ' MET . 2.3 ttpt -159.34 132.98 7.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.348 -2.205 . . . . 2.0 109.521 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.603 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -118.6 135.42 54.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.262 -0.881 . . . . 1.27 111.199 176.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.57 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -156.9 97.61 1.7 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.954 1.359 . . . . 1.26 108.892 152.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.57 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -166.12 161.59 12.63 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 112.207 -2.27 . . . . 2.11 106.1 168.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.551 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 62.8 Cg_endo -75.67 128.17 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.209 1.273 . . . . 0.99 111.979 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 99.3 23.29 11.4 Favored Glycine 0 C--N 1.351 1.4 0 C-N-CA 119.975 -1.107 . . . . 0.51 112.35 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.648 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 15.4 mp0 -128.79 172.34 11.37 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.75 -0.463 . . . . 2.16 109.75 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.86 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.9 p90 -163.06 175.11 11.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.237 -1.023 . . . . 0.28 108.237 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.564 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 8.0 p -141.96 126.59 17.93 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 120.11 -0.636 . . . . 1.12 111.598 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.563 HG23 ' HG2' ' A' ' 121' ' ' LYS . 12.4 p -125.56 110.07 23.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.709 0.766 . . . . 1.1 111.849 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -110.03 -58.79 2.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.734 -0.666 . . . . 3.64 110.779 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -163.36 -60.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.922 0.341 . . . . 2.21 111.922 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -92.57 4.36 53.75 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.404 0.52 . . . . 1.95 112.404 -172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.7 p -161.08 155.93 23.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.683 0.754 . . . . 0.63 112.478 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 43.7 mt -115.24 108.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.297 -1.742 . . . . 1.19 106.297 161.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.86 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.6 mp0 -90.59 163.98 14.37 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.521 -2.029 . . . . 1.13 105.521 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 8.7 ptp -165.07 154.31 12.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.83 0.706 . . . . 2.37 111.324 -171.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.643 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 34.6 mt -126.25 110.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.615 0.721 . . . . 1.14 111.141 170.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.811 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 0.2 OUTLIER -68.24 92.97 0.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.957 -1.474 . . . . 3.61 109.838 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.602 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 34.1 ttp180 -68.13 138.53 92.26 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 108.175 -1.046 . . . . 6.8 108.175 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -47.88 123.77 8.99 Favored 'Trans proline' 0 N--CA 1.433 -2.067 0 C-N-CA 120.95 1.1 . . . . 2.5 109.971 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 19.6 m-85 -118.79 129.75 55.41 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.945 -1.48 . . . . 2.1 107.642 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.532 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 6.6 p-10 -86.58 76.69 9.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 122.763 1.268 . . . . 3.66 111.724 -173.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.492 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 92.2 m-85 -114.53 146.87 36.83 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 113.116 -1.856 . . . . 3.96 108.899 171.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.7 Cg_exo -59.76 -33.77 96.18 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 C-N-CA 124.528 3.485 . . . . 4.73 113.348 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -86.4 -18.51 31.6 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.999 -1.0 . . . . 5.26 111.425 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.461 ' HB2' ' OD1' ' A' ' 198' ' ' ASP . 67.3 m -156.07 109.44 2.7 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.839 -0.619 . . . . 3.82 111.216 -173.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.532 ' HD3' ' HA ' ' A' ' 160' ' ' ASP . 23.4 tptp -142.62 97.0 3.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.601 -0.888 . . . . 3.83 108.601 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -138.93 176.62 8.53 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.627 -1.17 . . . . 3.14 112.469 -167.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.94 149.95 31.86 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 113.93 -1.486 . . . . 1.22 112.723 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.811 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.9 tt0 -56.26 153.51 9.36 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 113.419 0.896 . . . . 2.3 113.419 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 41.3 t -152.92 131.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.727 -1.124 . . . . 1.12 109.959 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.625 ' HG3' HG12 ' A' ' 155' ' ' ILE . 5.7 ttm180 -93.39 111.74 23.48 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.82 -0.807 . . . . 3.33 108.82 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.8 141.33 47.44 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.264 -0.974 . . . . 1.02 111.429 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.707 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 5.2 tpt180 -102.45 101.31 11.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.134 -1.394 . . . . 2.43 110.665 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -91.36 96.53 10.58 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.787 -0.365 . . . . 1.36 110.055 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 117.65 31.21 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-O 122.472 1.13 . . . . 1.04 111.494 -173.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.625 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -85.88 131.84 34.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 112.632 -2.076 . . . . 1.03 109.784 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 35.8 t70 -75.91 65.85 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.716 -1.587 . . . . 1.09 106.716 164.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.71 -99.26 1.74 Allowed Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 119.104 -1.522 . . . . 0.5 110.223 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -88.54 -17.62 29.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 113.01 0.744 . . . . 0.83 113.01 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -133.28 126.62 31.86 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 119.163 -1.015 . . . . 2.01 110.693 -168.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.1 tt -52.93 129.47 30.47 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.458 -1.701 . . . . 1.35 110.629 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -38.34 6.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.992 -1.004 . . . . 1.08 109.755 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.1 p -147.72 157.69 43.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.819 -0.628 . . . . 1.12 111.245 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.8 mt -124.86 146.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.707 -1.96 . . . . 1.48 105.707 166.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 43.1 t -136.56 133.58 49.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.448 0.642 . . . . 1.12 109.947 -175.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -79.43 94.0 5.47 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.712 -1.588 . . . . 1.77 106.712 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.562 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 47.6 mtm -66.38 -1.97 4.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.995 0.809 . . . . 1.26 113.095 -162.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.0 pt-20 -81.45 -39.29 25.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.127 0.965 . . . . 1.02 110.682 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 9.1 m120 -108.43 -26.46 10.46 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.779 -1.555 . . . . 1.98 109.117 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.5 t30 75.48 32.02 0.74 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.338 -2.21 . . . . 2.0 108.416 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.9 ptm180 -93.73 155.22 17.36 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.197 -1.365 . . . . 2.78 109.234 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -77.7 131.19 37.59 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.909 -1.041 . . . . 1.9 108.636 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -105.63 89.53 3.12 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.469 -0.892 . . . . 1.18 110.548 -170.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -57.74 0.0 OUTLIER Glycine 0 N--CA 1.467 0.718 0 C-N-CA 125.376 1.465 . . . . 1.89 116.48 146.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.559 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 18.1 p90 -163.88 175.43 10.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.153 -1.523 . . . . 3.47 109.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.839 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.5 t80 -149.08 100.22 3.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.378 0.608 . . . . 0.89 110.445 159.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.559 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 5.2 mmm180 -95.63 141.87 28.61 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 120.628 -1.295 . . . . 5.49 111.666 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.527 HD11 ' HG ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -109.82 173.33 6.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.202 1.556 . . . . 2.15 115.202 -175.381 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.53 ' HB3' ' HD2' ' A' ' 199' ' ' PRO . 5.2 m-20 -98.19 176.75 1.87 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 112.806 -1.997 . . . . 2.66 110.559 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 198' ' ' ASP . 36.9 Cg_exo -44.91 172.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.919 3.079 . . . . 2.4 116.12 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.556 ' OXT' ' HG2' ' A' ' 200' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.884 1.674 . . . . 5.84 112.91 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.723 0.297 . . . . 26.61 110.476 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.18 36.28 1.21 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.587 -0.816 . . . . 24.26 112.481 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.0 p -91.44 -50.51 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.068 0.461 . . . . 23.88 110.012 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.7 m -104.0 73.09 1.13 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.816 -0.629 . . . . 23.12 109.945 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.4 m80 67.2 108.83 0.04 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.284 -0.871 . . . . 22.4 111.296 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -74.07 11.6 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.786 -0.643 . . . . 22.38 111.684 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -84.67 -2.69 57.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.221 -0.659 . . . . 20.96 109.221 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -101.58 54.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 18.66 111.283 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -89.02 -43.73 10.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.333 . . . . 18.21 111.014 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -84.87 98.8 10.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.987 0.422 . . . . 18.15 109.94 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -74.88 134.0 41.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.567 . . . . 16.83 111.388 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.6 m 56.82 50.85 11.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.628 -0.715 . . . . 16.32 111.435 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.22 13.74 0.15 Allowed Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.659 -0.7 . . . . 14.64 112.092 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.4 mt -116.05 -41.51 3.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.103 0.477 . . . . 16.04 110.283 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.473 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 56.9 t -81.34 -50.84 0.92 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.668 -0.696 . . . . 12.96 111.912 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 40.1 Cg_endo -66.74 105.81 1.0 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.035 1.823 . . . . 12.74 112.509 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.46 48.31 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.064 -0.717 . . . . 12.74 109.064 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.88 46.53 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.703 -0.681 . . . . 8.95 111.909 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.4 m -89.69 -9.08 50.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.092 0.472 . . . . 8.16 110.825 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -114.6 20.71 15.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.163 0.506 . . . . 8.44 109.678 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.499 ' HG3' ' OD1' ' A' ' 122' ' ' ASN . 13.2 tpt -102.57 55.87 0.78 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.603 -0.726 . . . . 6.56 110.618 -175.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.12 -34.3 0.3 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.696 -0.684 . . . . 1.91 114.14 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 107' ' ' MET . 0.0 OUTLIER 10.31 80.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.849 1.796 . . . . 5.09 115.849 170.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.59 ' HB3' ' HG2' ' A' ' 123' ' ' GLU . 16.7 tpt -139.35 117.01 11.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.035 -1.066 . . . . 3.06 112.65 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 197' ' ' LEU . 15.9 m -111.5 107.41 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.42 1.105 . . . . 1.41 112.965 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.473 ' C ' HD13 ' A' ' 113' ' ' LEU . 40.3 t30 -160.14 136.16 8.58 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 113.667 -1.606 . . . . 1.73 106.985 168.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 9.0 mp -114.65 100.2 8.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.121 0.486 . . . . 2.04 109.829 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.476 ' N ' ' HE2' ' A' ' 117' ' ' MET . 20.3 tt0 -156.93 97.54 2.08 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-N 115.23 -0.895 . . . . 1.93 109.816 -169.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.818 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 9.6 Cg_exo -34.27 149.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.796 1 C-N-CA 127.396 5.398 . . . . 0.73 115.356 -173.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 29.1 t70 70.55 31.26 2.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.216 -1.356 . . . . 0.72 108.877 -174.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.514 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 8.3 ptp -110.27 154.15 23.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.691 -1.14 . . . . 2.33 109.733 175.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -106.51 76.61 1.14 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.849 -1.167 . . . . 1.11 107.849 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.614 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 1.5 tt -104.15 159.25 5.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.152 -1.386 . . . . 1.14 110.507 -165.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.424 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 37.7 m -141.76 179.91 6.57 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.738 -0.785 . . . . 0.89 110.425 -168.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.608 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 14.5 mttp -64.52 -20.77 66.42 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.025 -1.102 . . . . 2.86 108.025 169.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.839 ' O ' HG13 ' A' ' 125' ' ' VAL . 2.1 t30 -84.46 -25.05 29.22 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.11 -1.405 . . . . 1.68 113.936 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.614 ' OE1' ' HA ' ' A' ' 119' ' ' ILE . 27.5 mt-10 -86.45 -53.9 4.73 Favored 'General case' 0 N--CA 1.412 -2.369 0 O-C-N 120.694 -1.254 . . . . 2.06 108.671 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.814 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.1 mmt -60.62 -18.25 52.08 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.129 -1.85 . . . . 3.58 111.478 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.839 HG13 ' O ' ' A' ' 122' ' ' ASN . 9.2 p -44.75 -44.17 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-O 121.953 0.882 . . . . 1.11 110.534 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.628 ' N ' HG12 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -67.66 -41.98 82.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.297 -1.319 . . . . 1.32 113.082 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 197' ' ' LEU . 2.9 tm? -50.67 -34.67 27.45 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.666 0.604 . . . . 2.45 110.415 169.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.814 ' HG ' ' O ' ' A' ' 124' ' ' MET . 16.3 mt -84.92 -36.74 21.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.659 0.743 . . . . 1.13 109.572 -170.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -64.02 -32.74 74.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.179 -1.373 . . . . 1.96 109.988 168.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.577 ' HB1' ' NH2' ' A' ' 156' ' ' ARG . . . -76.59 -39.85 51.32 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.683 -1.599 . . . . 1.18 111.975 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 159' ' ' PHE . 0.3 OUTLIER -89.71 -5.3 57.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 124.021 1.867 . . . . 1.27 106.397 -178.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 58.35 51.57 8.17 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 110.488 -3.051 . . . . 2.22 112.361 170.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.812 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.6 t80 -135.47 175.4 9.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.278 0.561 . . . . 0.9 112.097 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.85 151.6 48.23 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.204 -1.406 . . . . 5.25 107.204 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.453 ' HB2' HG11 ' A' ' 147' ' ' VAL . 9.7 tm0? -49.67 138.45 14.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.686 1.231 . . . . 2.03 112.704 -170.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 145' ' ' PHE . 15.0 p -134.82 145.72 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 112.597 -2.092 . . . . 1.73 110.613 -162.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.97 -34.62 72.02 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.772 1.272 . . . . 1.74 109.493 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 11.2 ttpt -160.46 129.57 4.92 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 112.31 -2.223 . . . . 2.0 109.015 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.633 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -114.41 121.76 44.55 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.622 -0.717 . . . . 1.27 111.009 -179.412 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 155' ' ' ILE . 1.7 t -158.14 98.39 1.58 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 122.946 1.355 . . . . 1.26 110.062 153.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.549 ' O ' HD11 ' A' ' 155' ' ' ILE . 0.4 OUTLIER -164.42 161.82 15.74 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 112.552 -2.113 . . . . 2.11 106.328 163.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.503 ' HB3' ' NE2' ' A' ' 168' ' ' GLN . 38.4 Cg_exo -60.71 114.55 2.19 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.332 1.355 . . . . 0.99 111.569 173.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 104.6 32.53 4.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 120.396 -0.906 . . . . 0.51 113.625 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.812 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -131.48 169.84 15.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.697 -0.482 . . . . 2.16 109.697 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.841 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.7 p90 -167.35 165.74 14.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.982 -1.118 . . . . 0.28 107.982 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.633 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 17.2 p -134.47 126.86 30.3 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.743 -0.783 . . . . 1.12 111.05 173.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.556 HG22 ' HG2' ' A' ' 121' ' ' LYS . 10.5 p -116.81 112.28 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.591 0.71 . . . . 1.1 111.242 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.74 132.75 3.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.361 -0.836 . . . . 3.64 111.101 -176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 58.56 -88.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.474 0.916 . . . . 2.21 113.474 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -124.57 23.0 8.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.526 0.565 . . . . 1.95 112.526 -170.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.1 p -160.27 149.72 17.63 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.826 1.047 . . . . 0.63 113.826 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.573 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 28.8 mt -113.33 107.57 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 113.392 -1.731 . . . . 1.19 106.56 159.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 4.2 mt-10 -92.73 170.16 9.92 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.871 -1.9 . . . . 1.13 105.871 175.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.549 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 20.7 ptp -167.6 166.32 14.1 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 123.887 0.742 . . . . 2.37 109.708 -171.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 6.4 mt -128.0 92.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.984 0.897 . . . . 1.14 108.733 165.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.667 ' NH1' ' HB3' ' A' ' 198' ' ' ASP . 12.3 tpp180 -128.48 85.18 2.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.738 -1.573 . . . . 3.61 112.28 -168.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.65 ' H ' ' HG3' ' A' ' 168' ' ' GLN . 6.0 mmt180 -136.56 -179.06 0.97 Allowed Pre-proline 0 C--N 1.276 -2.615 0 N-CA-C 106.821 -1.548 . . . . 6.8 106.821 158.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.656 ' CB ' ' HB2' ' A' ' 166' ' ' GLU . 73.9 Cg_exo -39.95 132.63 1.97 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 122.471 2.114 . . . . 2.5 114.519 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 131' ' ' THR . 25.5 m-85 -95.68 167.69 11.13 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.774 -2.466 . . . . 2.1 108.628 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.54 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -74.56 76.47 1.98 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.042 0.925 . . . . 3.66 111.282 174.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 159' ' ' PHE . 59.2 m-85 -90.38 149.0 40.25 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 114.166 -1.379 . . . . 3.96 108.266 169.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 50.3 Cg_exo -53.78 -36.26 81.77 Favored 'Trans proline' 0 CA--C 1.491 -1.674 0 C-N-CA 124.434 3.422 . . . . 4.73 112.736 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -98.71 -11.87 21.54 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 113.9 -1.5 . . . . 5.26 111.1 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 56.7 m -162.7 107.85 1.16 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.565 -0.743 . . . . 3.82 110.386 -173.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 160' ' ' ASP . 13.8 ptpt -134.15 105.53 6.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.796 0.807 . . . . 3.83 110.138 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.656 ' HB2' ' CB ' ' A' ' 158' ' ' PRO . 7.1 mm-40 -129.73 -173.62 3.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.625 -1.171 . . . . 3.14 111.457 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -81.37 127.69 8.05 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-N 114.299 -1.319 . . . . 1.22 113.103 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.65 ' HG3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -80.12 170.44 16.44 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 112.945 0.72 . . . . 2.3 112.945 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 1.9 t -137.05 132.9 47.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 112.966 0.728 . . . . 1.12 112.966 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 154' ' ' MET . 20.9 ttt180 -88.03 110.11 20.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 116.128 -0.487 . . . . 3.33 109.738 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.44 138.67 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.735 0.779 . . . . 1.02 111.661 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.781 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 12.9 tpt180 -103.17 99.57 9.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.181 -1.372 . . . . 2.43 111.088 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.573 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 5.8 mp -91.26 104.5 17.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.388 -0.597 . . . . 1.36 109.388 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.7 114.64 28.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.656 1.217 . . . . 1.04 111.849 -173.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -86.12 131.32 34.28 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 112.516 -2.129 . . . . 1.03 109.45 -178.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.552 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 35.3 t70 -75.61 67.27 2.07 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.634 -1.617 . . . . 1.09 106.634 165.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.37 -98.76 1.27 Allowed Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 119.017 -1.563 . . . . 0.5 110.281 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -82.89 -24.59 33.1 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.852 0.686 . . . . 0.83 112.852 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.552 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 8.0 p-80 -131.74 126.42 34.42 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 119.717 -0.793 . . . . 2.01 111.374 -165.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.35 127.9 26.44 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.661 -1.608 . . . . 1.35 111.058 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -108.14 -38.91 5.64 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.869 -1.059 . . . . 1.08 110.516 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 183' ' ' ILE . 24.0 p -146.03 168.46 20.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.26 -0.427 . . . . 1.12 111.12 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.781 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 2.4 mt -140.82 143.12 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.748 -1.945 . . . . 1.48 105.748 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.7 t -137.06 136.35 47.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.228 0.537 . . . . 1.12 110.154 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.512 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 36.0 t-20 -86.29 100.58 12.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 108.088 -1.079 . . . . 1.77 108.088 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.482 ' HE2' ' HG2' ' A' ' 170' ' ' ARG . 39.1 mtm -64.34 -2.38 2.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 114.021 1.119 . . . . 1.26 114.021 -165.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.512 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.7 pt-20 -80.82 -44.13 18.94 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.861 0.838 . . . . 1.02 110.79 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.497 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 86.5 m-20 -106.45 -25.57 11.81 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.997 -1.456 . . . . 1.98 108.942 -176.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.2 27.8 1.93 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.326 -2.215 . . . . 2.0 107.599 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.414 ' HD2' HD21 ' A' ' 188' ' ' ASN . 0.1 OUTLIER -84.12 166.81 17.33 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.478 -1.692 . . . . 2.78 108.823 178.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -88.25 145.2 26.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.715 1.245 . . . . 1.9 112.67 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.614 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 1.7 m-85 -116.46 -169.34 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.282 -2.235 . . . . 1.18 105.359 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.818 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 134.94 -0.72 3.72 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.256 -1.138 . . . . 1.89 110.256 -163.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -148.65 97.63 2.76 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.138 -1.531 . . . . 3.47 108.369 154.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.597 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.3 t80 -132.15 118.96 20.26 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.004 -0.739 . . . . 0.89 109.004 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.426 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 9.0 mmt180 -105.81 142.49 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.941 -0.392 . . . . 5.49 109.941 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.61 ' CD2' ' HG2' ' A' ' 156' ' ' ARG . 33.7 mt -113.42 154.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.933 -0.576 . . . . 2.15 111.404 -171.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.667 ' HB3' ' NH1' ' A' ' 156' ' ' ARG . 13.4 t70 -94.72 112.11 56.75 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.297 -0.631 . . . . 2.66 109.297 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.41 125.77 19.87 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.893 2.395 . . . . 2.4 113.679 -175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 130' ' ' ALA . 2.0 mpp_? . . . . . 0 C--O 1.248 1.02 0 O-C-N 124.589 1.181 . . . . 5.84 113.081 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.778 0.323 . . . . 26.61 110.783 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.8 -106.81 2.98 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.769 -0.729 . . . . 24.26 112.406 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -84.77 73.34 10.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.296 0.57 . . . . 23.88 110.181 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 t -79.6 104.43 10.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.652 -0.704 . . . . 23.12 109.689 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -83.53 85.17 7.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 22.4 111.198 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -83.27 114.43 21.38 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.558 -0.534 . . . . 22.38 109.558 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -79.61 128.3 33.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.369 -0.378 . . . . 20.96 110.566 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 61.31 43.36 10.8 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.62 0.575 . . . . 18.66 110.267 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -78.08 121.16 23.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.917 -0.583 . . . . 18.21 110.268 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -91.25 103.41 16.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.852 -0.613 . . . . 18.15 109.983 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.1 t -81.23 -26.05 36.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.207 -0.451 . . . . 16.83 110.258 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.1 m 61.36 -171.17 0.15 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.567 -0.742 . . . . 16.32 111.234 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.39 35.61 0.39 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.744 -0.741 . . . . 14.64 112.363 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -118.7 -97.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.605 -0.517 . . . . 16.04 109.605 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.464 ' HB ' ' CD ' ' A' ' 102' ' ' PRO . 94.9 t -83.68 -52.89 0.57 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.57 -0.9 . . . . 12.96 108.57 169.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.464 ' CD ' ' HB ' ' A' ' 101' ' ' VAL . 58.3 Cg_endo -74.05 128.91 12.69 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.486 1.458 . . . . 12.74 110.026 164.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -152.64 36.34 0.5 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.303 0.573 . . . . 12.74 110.153 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.55 -149.92 35.82 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.653 -0.784 . . . . 8.95 111.365 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.4 t 66.3 -78.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.615 0.366 . . . . 8.16 111.045 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -105.83 92.32 4.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.975 0.417 . . . . 8.44 110.028 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.1 mtt -90.71 -177.79 5.09 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.489 -0.56 . . . . 6.56 109.489 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.13 13.17 69.3 Favored Glycine 0 C--O 1.216 -0.982 0 C-N-CA 120.226 -0.988 . . . . 1.91 112.578 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 52.6 mtm180 -131.0 113.74 14.34 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 107.818 -1.179 . . . . 5.09 107.818 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.511 ' O ' ' HB2' ' A' ' 126' ' ' LYS . 12.4 tpt -143.69 159.74 41.95 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.068 -1.053 . . . . 3.06 113.589 -166.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.594 HG11 ' N ' ' A' ' 127' ' ' LEU . 2.6 m -133.33 102.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 122.637 1.208 . . . . 1.41 109.475 159.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -164.22 111.6 1.1 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.691 -1.141 . . . . 1.73 108.194 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 4.4 mt -96.4 103.87 15.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.498 -0.481 . . . . 2.04 110.009 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 117' ' ' MET . 25.3 tt0 -155.88 106.15 2.12 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 119.817 -0.753 . . . . 1.93 110.63 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.561 ' HD3' HD13 ' A' ' 183' ' ' ILE . 18.8 Cg_exo -35.33 144.91 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.78 1 C-N-CA 125.94 4.426 . . . . 0.73 115.721 -175.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 67.74 40.19 2.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.055 -1.43 . . . . 0.72 109.536 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.569 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 10.9 ptt? -113.63 154.05 27.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.438 -1.255 . . . . 2.33 109.416 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -102.9 93.08 4.85 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.98 -1.119 . . . . 1.11 107.98 -173.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.568 HG13 ' CB ' ' A' ' 123' ' ' GLU . 2.2 tt -126.54 162.05 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 114.601 -1.181 . . . . 1.14 110.945 -163.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.457 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.8 m -142.55 179.36 7.01 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.771 -0.826 . . . . 0.89 108.771 -169.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.574 ' HA ' HD13 ' A' ' 152' ' ' ILE . 13.0 mtpp -53.95 -35.24 61.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.06 -0.718 . . . . 2.86 109.06 166.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 0.2 OUTLIER -81.87 -32.52 31.01 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.433 -1.258 . . . . 1.68 112.623 -177.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.568 ' CB ' HG13 ' A' ' 119' ' ' ILE . 19.8 mt-10 -85.5 -20.7 29.29 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 119.653 -1.905 . . . . 2.06 109.167 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.731 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 18.7 mmt -85.4 -18.72 32.86 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.072 -1.422 . . . . 3.58 110.881 166.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 9.6 p -54.12 -36.28 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 CA-C-O 121.749 0.785 . . . . 1.11 111.285 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.576 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.5 mmpt? -71.44 -40.2 70.54 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.787 -1.097 . . . . 1.32 112.0 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.615 ' HB3' ' O ' ' A' ' 124' ' ' MET . 1.5 tm? -49.57 -36.05 22.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.777 0.798 . . . . 2.45 109.163 166.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 124' ' ' MET . 24.4 mt -86.11 -34.35 20.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.394 -0.821 . . . . 1.13 110.08 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.76 -34.89 71.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.184 -1.371 . . . . 1.96 109.216 167.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -73.69 -37.79 65.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.508 -1.678 . . . . 1.18 112.128 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.546 HG23 ' HA ' ' A' ' 128' ' ' LEU . 10.8 t -89.18 -5.26 57.85 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 123.819 1.771 . . . . 1.27 107.079 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 56.82 53.26 8.41 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.048 -2.796 . . . . 2.22 112.71 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.76 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.1 t80 -136.37 176.99 8.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.209 -0.597 . . . . 0.9 112.181 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 41.5 ttt180 -134.37 155.24 50.61 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 5.25 107.603 172.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -50.42 140.24 14.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.623 1.201 . . . . 2.03 112.89 -169.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.593 HG13 HG23 ' A' ' 146' ' ' THR . 12.7 p -141.14 136.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.77 -2.014 . . . . 1.73 109.487 -166.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.5 t -59.43 -30.9 68.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 122.46 1.124 . . . . 1.74 109.578 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -159.22 120.12 3.24 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 112.858 -1.974 . . . . 2.0 108.95 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -111.22 120.63 42.93 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.074 -1.421 . . . . 1.27 110.167 -177.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.28 96.17 2.02 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.275 1.512 . . . . 1.26 109.067 157.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.555 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.2 OUTLIER -166.69 163.04 11.2 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 111.586 -2.552 . . . . 2.11 105.124 165.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.614 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 56.2 Cg_endo -71.6 127.8 13.6 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 CA-C-N 120.63 1.261 . . . . 0.99 111.791 174.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.734 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 97.03 30.12 7.64 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 120.381 -0.914 . . . . 0.51 113.909 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.76 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -128.0 174.46 9.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.295 0.547 . . . . 2.16 110.125 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.883 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 p90 -169.06 163.93 11.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.273 -1.01 . . . . 0.28 108.273 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.593 HG23 HG13 ' A' ' 136' ' ' VAL . 22.3 p -132.86 126.35 32.02 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.176 -0.609 . . . . 1.12 110.956 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 121' ' ' LYS . 6.1 p -112.18 110.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 120.026 -0.669 . . . . 1.1 111.801 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -132.45 43.58 2.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.433 -0.803 . . . . 3.64 111.456 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.54 -54.34 0.67 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.531 0.937 . . . . 2.21 113.531 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -80.98 -15.09 57.19 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.393 0.616 . . . . 1.95 110.288 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.2 p -164.74 154.6 13.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.154 -0.93 . . . . 0.63 111.441 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.635 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 28.4 mt -114.67 110.87 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 113.496 -1.683 . . . . 1.19 106.555 164.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.883 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -88.95 174.87 7.68 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.53 -1.656 . . . . 1.13 106.53 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 28.2 ptm -168.89 159.34 9.45 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 123.501 0.501 . . . . 2.37 110.734 -172.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.4 mt -130.92 110.17 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.098 -0.501 . . . . 1.14 111.321 167.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.755 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 1.4 tpt180 -65.52 91.27 0.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.605 -0.725 . . . . 3.61 110.042 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.734 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 66.9 ttt180 -64.25 133.65 95.71 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 114.978 -1.01 . . . . 6.8 108.525 172.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 166' ' ' GLU . 5.7 Cg_endo -51.78 124.45 14.57 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 120.815 1.01 . . . . 2.5 110.601 170.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.613 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 9.3 m-85 -124.92 126.56 45.71 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.227 -1.768 . . . . 2.1 106.227 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.75 75.88 6.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.893 1.33 . . . . 3.66 111.515 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 65.8 m-85 -119.47 142.89 33.47 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 113.453 -1.703 . . . . 3.96 109.039 171.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.4 Cg_exo -57.58 -30.88 90.1 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 124.648 3.565 . . . . 4.73 113.096 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.27 -14.98 34.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.046 -0.979 . . . . 5.26 111.286 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.429 ' HB3' HH12 ' A' ' 156' ' ' ARG . 58.8 m -161.65 100.56 1.16 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.001 -0.545 . . . . 3.82 111.274 -174.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 86.4 tttt -147.48 97.28 2.82 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.674 0.75 . . . . 3.83 110.014 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 158' ' ' PRO . 28.6 mt-10 -132.81 161.83 33.11 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.557 -1.201 . . . . 3.14 111.43 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.94 151.54 32.02 Favored Glycine 0 CA--C 1.498 -1.017 0 CA-C-N 114.21 -1.359 . . . . 1.22 111.374 172.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.755 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.3 tt0 -44.87 142.1 1.91 Allowed 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 115.203 1.556 . . . . 2.3 115.203 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 51.1 t -153.5 125.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 113.748 -1.569 . . . . 1.12 110.448 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.591 ' HG3' HG12 ' A' ' 155' ' ' ILE . 4.1 ttm180 -84.52 110.63 18.83 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.467 -0.568 . . . . 3.33 109.467 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.422 ' HB1' ' CG ' ' A' ' 154' ' ' MET . . . -116.27 147.71 41.23 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.729 -0.788 . . . . 1.02 111.603 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.787 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.4 tpp180 -109.77 98.97 8.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.552 -1.203 . . . . 2.43 110.84 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.653 HD22 ' CE ' ' A' ' 124' ' ' MET . 1.4 mp -88.7 94.34 9.87 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.438 -0.949 . . . . 1.36 108.438 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.02 120.45 35.24 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 122.443 1.116 . . . . 1.04 111.672 -170.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-30 -90.91 130.07 36.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.746 -2.025 . . . . 1.03 109.962 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.564 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 30.7 t70 -78.68 64.83 3.78 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.224 -1.769 . . . . 1.09 106.224 165.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.99 -99.7 0.96 Allowed Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 119.332 -1.414 . . . . 0.5 110.735 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.65 -25.54 49.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.865 0.691 . . . . 0.83 112.865 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.564 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 6.8 p-80 -133.84 127.18 32.08 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.917 -0.713 . . . . 2.01 110.587 -167.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.0 tt -54.75 130.85 42.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.126 -1.397 . . . . 1.35 110.194 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.15 -39.16 6.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.93 -1.032 . . . . 1.08 109.827 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.8 p -152.56 169.51 22.47 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.029 -0.532 . . . . 1.12 111.244 -173.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.787 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mt -135.81 144.34 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.191 -2.151 . . . . 1.48 105.191 167.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.64 140.17 39.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 117.992 0.36 . . . . 1.12 110.296 -174.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.602 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 37.5 t-20 -81.15 107.91 14.35 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.32 -1.363 . . . . 1.77 107.32 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.411 ' HE2' ' HG2' ' A' ' 170' ' ' ARG . 59.3 mtm -69.16 -1.52 8.04 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 112.586 0.587 . . . . 1.26 112.586 -166.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.602 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 12.1 pt-20 -85.26 -44.54 12.79 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.753 0.787 . . . . 1.02 111.237 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.526 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.7 m-20 -106.37 -26.09 11.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.513 -1.222 . . . . 1.98 109.093 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 185' ' ' ASN . 13.7 t30 77.31 31.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.536 -2.12 . . . . 2.0 107.304 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 ptm180 -89.0 159.24 17.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.736 -1.575 . . . . 2.78 108.889 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.75 149.77 25.53 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.208 1.004 . . . . 1.9 112.732 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.92 -174.04 3.48 Favored 'General case' 0 CA--C 1.472 -2.039 0 CA-C-N 113.246 -1.797 . . . . 1.18 107.754 -173.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.555 ' CA ' ' HD3' ' A' ' 115' ' ' PRO . . . 129.9 24.92 0.94 Allowed Glycine 1 N--CA 1.393 -4.177 0 CA-C-N 114.101 -1.409 . . . . 1.89 112.725 -178.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.36 94.69 2.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.452 -1.874 . . . . 3.47 106.824 145.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.614 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -129.99 101.36 5.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.693 -0.854 . . . . 0.89 108.693 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 3.2 mpt_? -105.35 127.36 52.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.191 0.52 . . . . 5.49 110.888 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.481 HD13 HD21 ' A' ' 127' ' ' LEU . 4.5 mt -104.15 172.55 6.74 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.434 -0.803 . . . . 2.15 111.9 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.25 104.51 9.92 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 114.268 -1.333 . . . . 2.66 108.66 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.96 125.14 17.32 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.042 2.494 . . . . 2.4 113.144 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? . . . . . 0 C--O 1.242 0.691 0 CA-C-N 115.262 -0.881 . . . . 5.84 110.986 -177.641 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.026 -0.361 . . . . 26.61 110.026 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.54 -107.12 2.04 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.918 -0.658 . . . . 24.26 111.486 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.6 m -92.07 162.99 14.13 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.715 -0.476 . . . . 23.88 109.715 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.2 p -62.91 -70.76 0.19 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.588 0.233 . . . . 23.12 110.729 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.8 t60 51.77 67.76 0.91 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.783 -0.644 . . . . 22.4 110.396 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -88.0 133.84 33.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.196 0.522 . . . . 22.38 110.674 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.61 121.74 25.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.549 -0.75 . . . . 20.96 110.861 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -114.79 21.6 14.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.278 0.561 . . . . 18.66 110.405 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 99' ' ' GLY . 55.8 m-70 -133.83 71.54 1.46 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.473 -0.785 . . . . 18.21 109.608 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -72.24 -65.76 0.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.771 -0.65 . . . . 18.15 111.492 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.2 m -92.0 -45.7 8.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.88 0.371 . . . . 16.83 110.747 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.7 m -108.59 135.29 50.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.324 -0.398 . . . . 16.32 110.638 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' HIS . . . 103.51 102.12 2.7 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.832 -0.699 . . . . 14.64 111.55 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.2 tp -86.97 -32.4 20.1 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.948 0.404 . . . . 16.04 110.522 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 m -86.14 133.54 40.66 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.041 -0.527 . . . . 12.96 111.688 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.22 78.91 2.74 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.768 2.312 . . . . 12.74 111.904 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -83.55 158.91 21.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.01 -0.541 . . . . 12.74 110.489 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.63 -156.27 8.27 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.403 -0.679 . . . . 8.95 111.403 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.6 t -82.78 60.27 5.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.388 0.613 . . . . 8.16 110.087 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -130.64 41.9 3.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.725 -0.67 . . . . 8.44 109.401 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.567 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 54.4 ttm 66.45 -86.88 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.195 -0.911 . . . . 6.56 110.876 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.519 ' C ' ' HD3' ' A' ' 109' ' ' ARG . . . 105.42 -29.28 11.77 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-O 118.955 -0.914 . . . . 1.91 113.543 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.519 ' HD3' ' C ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER 14.21 79.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.731 1.382 . . . . 5.09 114.731 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.446 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 34.7 ttp -142.45 124.86 15.63 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.35 -0.94 . . . . 3.06 111.793 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.9 m -110.7 104.91 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-O 122.817 1.294 . . . . 1.41 113.128 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.562 ' O ' ' HE2' ' A' ' 117' ' ' MET . 28.0 t-20 -160.01 109.9 1.83 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 112.587 -2.097 . . . . 1.73 106.054 165.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.3 mp -99.51 123.69 44.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.825 -0.805 . . . . 2.04 108.825 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.601 ' N ' ' HE3' ' A' ' 117' ' ' MET . 1.5 tm-20 -152.22 100.37 2.83 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.499 -0.926 . . . . 1.93 108.499 -172.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 24.5 Cg_exo -35.43 137.66 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.366 1 C-N-CA 125.361 4.041 . . . . 0.73 114.314 -173.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.2 47.57 0.28 Allowed 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.488 1.137 . . . . 0.72 109.795 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.601 ' HE3' ' N ' ' A' ' 114' ' ' GLU . 5.8 ptp -122.36 156.31 34.22 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.537 -1.211 . . . . 2.33 110.867 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.2 m -102.7 77.74 1.63 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.334 1.064 . . . . 1.11 108.471 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.459 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 15.2 tt -106.7 168.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 113.287 -1.779 . . . . 1.14 109.482 -171.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.497 ' O ' ' SD ' ' A' ' 124' ' ' MET . 3.8 m -137.59 162.9 32.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.223 -0.591 . . . . 0.89 109.464 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.529 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -50.34 -26.52 4.97 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 122.009 0.909 . . . . 2.86 108.817 170.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.603 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 4.0 t-20 -82.79 -14.69 53.94 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.826 -1.988 . . . . 1.68 114.535 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.453 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -84.7 -63.63 1.3 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.74 -1.225 . . . . 2.06 109.969 168.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.681 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -64.28 -9.87 20.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.074 -0.966 . . . . 3.58 110.727 174.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 12.4 p -41.7 -41.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.853 0.835 . . . . 1.11 110.62 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.553 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.3 mmpt? -66.13 -37.31 85.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.807 -1.088 . . . . 1.32 113.116 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.646 ' HB3' ' O ' ' A' ' 124' ' ' MET . 2.5 tm? -54.2 -33.58 58.54 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.618 0.723 . . . . 2.45 109.894 167.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.761 ' HB3' ' CE2' ' A' ' 145' ' ' PHE . 15.9 mt -82.44 -34.96 27.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.452 -0.944 . . . . 1.13 108.452 -172.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -60.14 -39.33 85.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.843 -1.526 . . . . 1.96 109.943 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.62 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -70.32 -42.76 71.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.989 -1.459 . . . . 1.18 112.544 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.451 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -88.6 -0.62 57.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 124.284 1.992 . . . . 1.27 105.812 -177.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 130' ' ' ALA . 11.5 mm-40 57.01 49.51 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 110.628 -2.987 . . . . 2.22 111.856 170.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.965 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 1.9 t80 -141.31 174.49 10.49 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 119.484 -0.886 . . . . 0.9 113.198 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 23.4 ptt-85 -137.49 158.15 45.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.142 -1.39 . . . . 5.25 107.585 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.69 140.42 14.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.194 0.997 . . . . 2.03 112.523 -171.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.585 ' HB ' ' CE1' ' A' ' 133' ' ' TYR . 11.9 p -139.85 134.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 113.512 -1.676 . . . . 1.73 110.192 -163.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.02 -33.36 68.89 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.7 1.238 . . . . 1.74 109.602 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.592 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -160.14 131.35 5.82 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 112.308 -2.224 . . . . 2.0 107.801 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.523 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 1.4 ptt? -119.0 137.93 53.18 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 115.023 -0.99 . . . . 1.27 111.127 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -162.31 98.58 1.03 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 122.34 1.067 . . . . 1.26 109.846 152.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -167.62 155.75 8.5 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 113.371 -1.74 . . . . 2.11 106.74 163.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.27 119.62 6.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.051 1.167 . . . . 0.99 110.017 169.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.451 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 93.67 44.17 3.73 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.476 -1.345 . . . . 0.51 112.744 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.965 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.4 mt-10 -145.57 148.85 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.326 -0.99 . . . . 2.16 108.326 172.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.761 ' CE2' ' HB3' ' A' ' 128' ' ' LEU . 40.7 p90 -152.85 156.78 39.65 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.758 -0.83 . . . . 0.28 108.758 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.541 HG22 ' CG1' ' A' ' 136' ' ' VAL . 21.3 p -126.04 126.28 43.99 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.679 -0.692 . . . . 1.12 110.663 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.579 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 9.1 p -125.08 109.88 23.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.966 -1.016 . . . . 1.1 111.511 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -110.27 -66.1 1.1 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.17 -0.468 . . . . 3.64 110.775 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.39 -61.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.076 0.399 . . . . 2.21 112.076 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -93.13 -1.78 56.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.615 0.598 . . . . 1.95 112.615 -171.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.4 p -163.28 152.6 14.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.529 0.937 . . . . 0.63 113.529 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.534 HD13 ' SD ' ' A' ' 124' ' ' MET . 20.7 mt -109.97 110.94 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 113.508 -1.678 . . . . 1.19 107.259 164.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -97.92 107.43 19.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.857 -1.164 . . . . 1.13 107.857 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 7.9 ptm -115.7 139.42 50.15 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.625 0.726 . . . . 2.37 112.124 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.56 HG12 ' CG ' ' A' ' 170' ' ' ARG . 68.4 mt -99.13 108.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.636 -1.165 . . . . 1.14 109.535 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 37.9 ttp180 -68.22 97.14 0.69 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.689 -1.141 . . . . 3.61 109.978 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.462 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 33.0 ttp180 -56.15 142.11 67.4 Favored Pre-proline 0 CA--C 1.514 -0.417 0 N-CA-C 107.264 -1.384 . . . . 6.8 107.264 169.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -46.72 124.92 8.97 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 120.981 1.121 . . . . 2.5 110.459 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.462 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 25.4 m-85 -120.95 131.64 54.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.933 -1.485 . . . . 2.1 108.523 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -89.13 76.6 7.7 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.43 1.109 . . . . 3.66 112.46 -169.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.641 ' HB2' ' O ' ' A' ' 164' ' ' SER . 96.2 m-85 -78.74 142.58 61.36 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 113.952 -1.477 . . . . 3.96 108.07 164.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 34.5 Cg_exo -58.2 -36.39 97.85 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 124.219 3.279 . . . . 4.73 112.37 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -99.84 -10.5 21.7 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.073 -0.967 . . . . 5.26 111.561 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.641 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 20.2 m -150.72 99.82 2.77 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.347 0.499 . . . . 3.82 112.347 -167.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -142.57 105.35 4.52 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.91 -0.774 . . . . 3.83 108.91 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -135.93 -170.67 2.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.67 -1.15 . . . . 3.14 110.649 -167.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.42 179.6 52.89 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.4 -1.273 . . . . 1.22 111.931 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -55.37 158.63 3.1 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 113.464 -1.368 . . . . 2.3 113.386 175.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.451 ' N ' ' HG2' ' A' ' 168' ' ' GLN . 44.0 t -151.21 128.7 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 114.834 -1.075 . . . . 1.12 109.192 173.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.56 ' CG ' HG12 ' A' ' 155' ' ' ILE . 32.6 mtm180 -91.14 109.35 20.6 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 120.941 0.4 . . . . 3.33 110.386 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -114.15 134.14 55.1 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.956 0.884 . . . . 1.02 111.544 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.8 tpp180 -95.0 98.04 10.4 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 113.569 -1.651 . . . . 2.43 110.75 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 151' ' ' SER . 2.8 mp -86.21 93.28 9.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.079 -0.711 . . . . 1.36 109.079 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 114.25 25.92 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 122.012 0.911 . . . . 1.04 111.497 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-85 -87.02 131.48 34.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.446 -1.707 . . . . 1.03 110.197 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.502 ' HB2' ' HB1' ' A' ' 181' ' ' ALA . 38.7 t70 -77.38 65.38 2.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.567 -1.642 . . . . 1.09 106.567 164.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.29 -98.54 1.25 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.911 -1.614 . . . . 0.5 110.379 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.71 -22.93 37.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.906 0.706 . . . . 0.83 112.906 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -133.89 128.42 34.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 119.685 -0.806 . . . . 2.01 111.431 -168.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 5.6 tt -52.77 125.93 18.39 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.899 -1.5 . . . . 1.35 109.648 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 176' ' ' ASP . . . -106.11 -37.74 6.51 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.408 -0.814 . . . . 1.08 109.442 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.4 p -146.13 161.23 40.65 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.533 -0.758 . . . . 1.12 111.001 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.4 mt -128.59 145.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.214 -2.143 . . . . 1.48 105.214 167.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.6 t -142.22 132.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.392 0.615 . . . . 1.12 109.998 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.483 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 32.3 t-20 -79.21 105.26 10.41 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 107.495 -1.298 . . . . 1.77 107.495 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.468 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 38.6 mtm -66.95 -1.48 4.1 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.782 0.676 . . . . 1.26 112.642 -167.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.578 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.9 pt-20 -79.71 -44.14 21.35 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.85 0.833 . . . . 1.02 110.819 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.578 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 70.6 m-20 -107.49 -26.59 10.86 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.293 -1.321 . . . . 1.98 109.454 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 185' ' ' ASN . 53.8 t30 77.02 33.13 0.46 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.534 -2.121 . . . . 2.0 107.586 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.5 ptm180 -91.83 161.47 14.84 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.581 -1.645 . . . . 2.78 109.18 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.62 137.76 32.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.103 -0.953 . . . . 1.9 109.358 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -110.85 89.92 3.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.779 -0.769 . . . . 1.18 110.795 -174.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.54 -58.69 0.0 OUTLIER Glycine 0 N--CA 1.469 0.863 0 C-N-CA 125.173 1.368 . . . . 1.89 116.233 145.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 192' ' ' PHE . 23.6 p90 -164.07 174.4 11.37 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.952 -1.624 . . . . 3.47 107.709 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.756 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.7 t80 -138.31 101.59 4.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.637 0.732 . . . . 0.89 110.626 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -81.92 137.52 35.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.834 -0.621 . . . . 5.49 110.09 -177.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.58 HD12 ' HG ' ' A' ' 127' ' ' LEU . 92.5 mt -134.24 170.48 15.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.493 0.923 . . . . 2.15 113.493 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.423 ' HB2' ' CE2' ' A' ' 161' ' ' PHE . 32.2 t70 -100.57 120.75 55.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.268 -1.333 . . . . 2.66 109.874 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.525 ' HB2' ' NH1' ' A' ' 200' ' ' ARG . 36.7 Cg_endo -68.41 123.0 10.04 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.778 1.652 . . . . 2.4 112.46 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.62 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.286 1.034 . . . . 5.84 112.984 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 121.012 0.434 . . . . 26.61 110.629 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.55 75.72 2.34 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.033 -0.603 . . . . 24.26 112.303 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 92' ' ' HIS . 9.5 t 63.79 48.38 3.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.328 0.585 . . . . 23.88 109.758 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 m -58.96 -63.53 1.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.326 -0.852 . . . . 23.12 110.933 -176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -103.87 42.3 1.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 22.4 110.52 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.405 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 81.1 m-70 -131.3 -78.46 0.52 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.392 -0.367 . . . . 22.38 110.273 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.2 t60 55.5 77.52 0.22 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.513 0.508 . . . . 20.96 110.899 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 49.6 m170 64.15 90.12 0.09 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.785 -0.643 . . . . 18.66 111.24 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -80.71 85.03 6.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.071 0.462 . . . . 18.21 110.245 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -137.73 68.66 1.4 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 18.15 110.015 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.415 ' C ' ' HG ' ' A' ' 98' ' ' SER . 38.1 t -99.19 129.0 45.4 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.271 -0.422 . . . . 16.83 110.271 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.415 ' HG ' ' C ' ' A' ' 97' ' ' SER . 54.5 p 50.12 51.14 17.27 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.305 0.642 . . . . 16.32 111.6 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.08 -25.69 75.22 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.936 -0.574 . . . . 14.64 112.704 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 100' ' ' LEU . 33.5 tp 63.38 29.93 15.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.466 0.65 . . . . 16.04 110.34 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.91 82.67 67.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.881 -0.6 . . . . 12.96 111.53 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.72 -8.22 13.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.567 2.178 . . . . 12.74 112.731 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -99.49 -39.19 8.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.696 -0.229 . . . . 12.74 110.921 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.9 144.02 4.91 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.382 -0.913 . . . . 8.95 112.509 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 106' ' ' HIS . 29.2 p -110.09 10.98 23.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.827 -0.435 . . . . 8.16 109.827 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' A' ' 108' ' ' GLY . 27.4 m-70 72.46 -55.52 0.67 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.349 -0.841 . . . . 8.44 111.957 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.437 ' C ' ' H ' ' A' ' 109' ' ' ARG . 94.5 mmm 73.84 -31.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.599 0.76 . . . . 6.56 110.877 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 106' ' ' HIS . . . 73.48 -32.3 0.83 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-O 119.338 -0.701 . . . . 1.91 114.16 169.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 107' ' ' MET . 0.7 OUTLIER -15.38 82.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.825 1.65 . . . . 5.09 115.084 179.079 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.631 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 57.4 ttm -142.3 110.87 6.13 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.153 -0.619 . . . . 3.06 112.326 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.8 m -107.81 106.66 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-O 122.459 1.123 . . . . 1.41 113.08 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -158.46 108.64 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.185 -1.825 . . . . 1.73 107.008 163.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.761 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.8 mp -95.18 116.85 29.27 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.059 -0.719 . . . . 2.04 109.059 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 117' ' ' MET . 9.3 tt0 -148.3 107.34 3.6 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 119.766 -0.774 . . . . 1.93 110.176 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.508 ' HG3' HG12 ' A' ' 183' ' ' ILE . 37.7 Cg_exo -35.43 130.49 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 124.287 3.325 . . . . 0.73 113.799 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 24.3 t70 68.83 54.33 0.48 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.512 1.149 . . . . 0.72 110.01 -174.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.684 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 14.1 ptt? -121.73 156.18 33.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.972 -1.467 . . . . 2.33 110.364 172.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.51 96.37 6.69 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.496 -0.927 . . . . 1.11 108.496 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.484 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 15.8 tt -136.98 169.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.613 -1.176 . . . . 1.14 109.831 -165.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.581 ' O ' ' HG2' ' A' ' 124' ' ' MET . 20.2 m -139.75 175.94 9.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.809 0.731 . . . . 0.89 111.118 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.575 ' H ' ' HD2' ' A' ' 121' ' ' LYS . 3.2 mptt -62.34 -19.82 63.74 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.123 0.963 . . . . 2.86 108.556 169.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.801 ' O ' HG13 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -81.5 -23.44 37.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.31 -1.768 . . . . 1.68 112.627 177.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.631 ' HA ' ' H ' ' A' ' 110' ' ' MET . 19.6 mt-10 -88.45 -44.01 11.04 Favored 'General case' 0 N--CA 1.408 -2.556 0 O-C-N 120.812 -1.18 . . . . 2.06 108.93 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.717 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 14.1 mmt -63.89 -18.76 64.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.96 -1.473 . . . . 3.58 110.557 169.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -48.96 -41.57 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-O 122.089 0.947 . . . . 1.11 110.287 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.509 ' N ' HG12 ' A' ' 125' ' ' VAL . 8.7 mmpt? -66.67 -38.21 86.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.204 -1.362 . . . . 1.32 113.404 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.639 ' HB3' ' O ' ' A' ' 124' ' ' MET . 13.5 tp -49.85 -40.15 41.46 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.857 0.837 . . . . 2.45 110.114 166.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.2 mt -82.44 -30.84 29.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.016 -0.993 . . . . 1.13 109.259 -167.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.49 -39.3 94.08 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.844 -1.526 . . . . 1.96 110.241 165.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.673 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -72.3 -41.93 66.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.497 -1.683 . . . . 1.18 112.083 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER -97.0 6.79 47.98 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 124.558 2.123 . . . . 1.27 105.784 -177.148 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 46.29 50.67 12.02 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 110.023 -3.262 . . . . 2.22 113.008 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.547 ' HB3' ' CD2' ' A' ' 145' ' ' PHE . 2.8 t80 -136.07 175.03 9.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.879 -0.728 . . . . 0.9 112.437 -173.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 2.2 tmm_? -137.05 147.96 46.49 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.459 -1.682 . . . . 5.25 106.459 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.543 ' N ' ' HD2' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -47.92 140.7 6.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.846 1.308 . . . . 2.03 113.388 -170.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG13 HG21 ' A' ' 146' ' ' THR . 11.8 p -140.88 137.73 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 112.638 -2.074 . . . . 1.73 109.423 -163.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -59.29 -33.22 70.82 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.343 1.068 . . . . 1.74 109.057 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.16 129.01 5.63 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.997 -1.91 . . . . 2.0 109.082 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.528 ' O ' ' HG2' ' A' ' 139' ' ' MET . 0.0 OUTLIER -118.66 129.62 55.4 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.293 -1.321 . . . . 1.27 111.59 -172.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.489 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 1.8 t -160.57 99.33 1.28 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 122.907 1.337 . . . . 1.26 110.867 155.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.421 ' H ' HD13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.14 162.32 14.19 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.737 -2.029 . . . . 2.11 105.985 161.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.499 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 18.2 Cg_endo -60.96 120.47 8.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.102 1.201 . . . . 0.99 110.379 169.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.458 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 91.02 48.56 3.32 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.548 -1.31 . . . . 0.51 112.964 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.541 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 31.7 mt-10 -142.25 167.51 21.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.343 -0.614 . . . . 2.16 109.343 169.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.856 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 46.8 p90 -167.76 163.13 14.18 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.234 -1.024 . . . . 0.28 108.234 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.556 HG21 HG13 ' A' ' 136' ' ' VAL . 25.7 p -130.34 125.89 35.78 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.822 -0.751 . . . . 1.12 111.147 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.511 HG13 ' HB2' ' A' ' 135' ' ' GLN . 7.7 p -115.24 110.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 122.002 0.906 . . . . 1.1 111.133 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -122.73 31.16 6.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.101 -0.954 . . . . 3.64 110.784 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.91 -47.04 0.66 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.485 -0.78 . . . . 2.21 112.211 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -81.67 -16.29 51.79 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.102 0.477 . . . . 1.95 110.569 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.8 p -162.49 154.21 18.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.434 -0.803 . . . . 0.63 112.296 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.559 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 20.2 mt -117.98 107.68 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.696 -1.593 . . . . 1.19 107.346 165.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.856 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.8 mp0 -90.9 168.35 11.76 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.176 -2.157 . . . . 1.13 105.176 174.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.04 157.9 10.01 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.783 0.677 . . . . 2.37 110.291 -169.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 140' ' ' THR . 15.1 mt -127.15 109.99 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 115.425 -0.807 . . . . 1.14 110.347 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.703 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 3.9 tpt180 -70.44 92.35 0.81 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.029 -0.987 . . . . 3.61 109.675 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.581 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 28.1 ttt180 -65.22 139.77 97.67 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.406 -0.816 . . . . 6.8 109.145 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 1.9 Cg_endo -48.8 125.55 13.07 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.409 1.406 . . . . 2.5 110.251 166.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.581 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 19.0 m-85 -121.14 153.15 37.88 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.446 -1.252 . . . . 2.1 108.263 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.73 76.67 2.0 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 122.72 1.248 . . . . 3.66 111.792 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 89.5 m-85 -114.51 143.6 30.21 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 113.885 -1.507 . . . . 3.96 109.194 171.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 37.1 Cg_exo -59.5 -32.73 96.74 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 124.526 3.484 . . . . 4.73 112.623 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -93.62 -16.37 24.41 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.687 -1.142 . . . . 5.26 111.121 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.8 m -148.96 105.39 3.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.853 -0.612 . . . . 3.82 111.885 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -147.51 101.87 3.4 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.772 -0.825 . . . . 3.83 108.772 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -142.87 171.22 14.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.568 -1.197 . . . . 3.14 112.662 -169.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -81.94 151.61 30.56 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 113.503 -1.681 . . . . 1.22 113.047 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.703 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 9.4 tt0 -45.28 147.62 0.74 Allowed 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 115.473 1.657 . . . . 2.3 115.473 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 46.5 t -153.08 131.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 113.998 -1.456 . . . . 1.12 109.856 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 35.9 mtm180 -87.14 116.63 25.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.07 -0.514 . . . . 3.33 110.192 168.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.54 153.1 38.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.613 0.721 . . . . 1.02 111.414 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.693 ' CB ' ' HB ' ' A' ' 184' ' ' VAL . 0.0 OUTLIER -120.57 101.8 8.0 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.264 -1.335 . . . . 2.43 111.147 -172.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.682 HD22 ' SD ' ' A' ' 124' ' ' MET . 1.1 mp -90.72 90.12 7.81 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.443 -0.577 . . . . 1.36 109.443 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.0 125.03 38.39 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.297 1.046 . . . . 1.04 111.139 -175.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 24.4 m-85 -98.45 136.54 38.44 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.158 -1.837 . . . . 1.03 111.354 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -78.28 64.74 3.47 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.813 -1.551 . . . . 1.09 106.813 161.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.24 -99.27 1.17 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 118.71 -1.71 . . . . 0.5 110.599 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.26 -20.49 32.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.913 0.708 . . . . 0.83 112.913 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.16 123.08 27.78 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 119.001 -1.08 . . . . 2.01 110.082 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -56.53 134.48 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.2 -1.818 . . . . 1.35 110.799 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.03 -41.43 5.38 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.509 -1.223 . . . . 1.08 110.517 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.7 p -150.51 158.88 44.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.342 -0.39 . . . . 1.12 111.606 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 1.8 mm -109.98 150.01 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 104.855 -2.276 . . . . 1.48 104.855 163.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.693 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 42.3 t -133.6 131.31 57.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 118.761 0.71 . . . . 1.12 110.255 177.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -80.42 94.34 6.16 Favored 'General case' 0 CA--C 1.476 -1.873 0 N-CA-C 106.8 -1.556 . . . . 1.77 106.8 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.549 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.0 mtm -63.68 -2.53 1.76 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 124.149 0.905 . . . . 1.26 113.39 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.4 pt-20 -83.5 -41.46 17.96 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.784 0.802 . . . . 1.02 110.672 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.441 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.6 m-20 -102.73 -25.93 13.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.262 -1.335 . . . . 1.98 108.549 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.8 t30 73.97 32.82 1.03 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.936 -2.393 . . . . 2.0 107.887 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.8 ptm180 -95.75 162.43 13.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.701 -1.59 . . . . 2.78 109.466 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 77.1 mt-30 -80.83 127.81 32.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.183 -0.917 . . . . 1.9 109.535 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.555 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -100.82 93.01 5.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.747 -0.644 . . . . 1.18 110.303 -171.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 20.87 -58.23 0.0 OUTLIER Glycine 0 N--CA 1.471 0.975 0 N-CA-C 116.542 1.377 . . . . 1.89 116.542 148.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 192' ' ' PHE . 34.0 p90 -162.99 175.14 11.45 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.296 -1.452 . . . . 3.47 108.755 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.761 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -145.06 127.95 16.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.556 -0.535 . . . . 0.89 109.556 156.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.552 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 1.6 mpt_? -112.02 141.56 45.53 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 120.88 -1.138 . . . . 5.49 111.507 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.511 ' HA ' ' NH1' ' A' ' 156' ' ' ARG . 40.6 mt -136.72 163.42 30.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.702 -0.681 . . . . 2.15 112.162 -172.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.57 114.03 50.27 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.866 -1.061 . . . . 2.66 110.214 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.35 128.67 30.45 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.877 2.385 . . . . 2.4 113.892 -175.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.673 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 53.4 mtm180 . . . . . 0 C--O 1.252 1.192 0 CA-C-N 114.775 -1.102 . . . . 5.84 112.316 173.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.265 -0.272 . . . . 26.61 110.265 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.79 -62.62 0.17 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.504 -0.638 . . . . 24.26 111.504 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 p 48.43 80.44 0.06 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.492 0.717 . . . . 23.88 112.094 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.5 t -63.27 -42.14 99.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.003 -0.544 . . . . 23.12 110.744 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -125.63 -19.02 5.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.637 -0.256 . . . . 22.4 110.834 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 69.44 -62.14 0.42 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.653 0.781 . . . . 22.38 111.863 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.96 -67.05 1.02 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.837 0.351 . . . . 20.96 110.367 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -144.77 -175.16 4.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.202 -0.454 . . . . 18.66 110.501 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -57.39 132.6 53.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.017 0.437 . . . . 18.21 110.456 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -70.6 -7.21 42.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.829 -0.623 . . . . 18.15 112.008 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 m -60.32 -31.27 70.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.074 0.464 . . . . 16.83 110.291 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -96.8 82.82 3.33 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.998 -0.547 . . . . 16.32 109.832 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.21 61.31 0.46 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.833 -0.622 . . . . 14.64 112.127 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.5 tp -62.65 -48.4 79.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.908 0.385 . . . . 16.04 110.141 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.4 m -100.7 139.8 20.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.975 -0.557 . . . . 12.96 110.556 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.22 -177.79 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.876 2.384 . . . . 12.74 111.803 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 72.54 -55.99 0.66 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.32 0.648 . . . . 12.74 111.196 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.7 -150.45 12.59 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.493 -0.643 . . . . 8.95 111.493 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.0 t -130.0 -57.91 1.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.984 0.421 . . . . 8.16 109.899 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -120.93 33.67 5.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 8.44 110.003 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 mpt? 67.38 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.623 -0.717 . . . . 6.56 110.999 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.16 16.65 68.93 Favored Glycine 0 C--O 1.224 -0.522 0 C-N-CA 120.544 -0.836 . . . . 1.91 111.994 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.687 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 32.4 mtt180 -139.43 112.08 7.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.404 -0.961 . . . . 5.09 108.404 171.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.3 ttt -142.75 132.24 23.67 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.194 -1.003 . . . . 3.06 113.531 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.489 ' O ' HG22 ' A' ' 111' ' ' VAL . 32.6 m -124.22 101.6 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 123.148 1.452 . . . . 1.41 111.399 164.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.584 ' C ' HD13 ' A' ' 113' ' ' LEU . 43.0 t30 -162.51 119.99 2.06 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 105.007 -2.22 . . . . 1.73 105.007 170.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.639 ' N ' HD13 ' A' ' 113' ' ' LEU . 5.6 mp -109.45 80.21 1.29 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.298 -1.001 . . . . 2.04 108.298 -172.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.526 ' H ' ' HE1' ' A' ' 117' ' ' MET . 27.4 tt0 -123.98 111.02 29.07 Favored Pre-proline 0 C--N 1.29 -2.02 0 C-N-CA 118.946 -1.102 . . . . 1.93 110.295 -169.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.475 ' HG3' HG12 ' A' ' 183' ' ' ILE . 39.2 Cg_exo -35.78 131.98 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 124.886 3.724 . . . . 0.73 114.298 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.7 t70 72.76 50.03 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.552 1.168 . . . . 0.72 110.457 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.526 ' HE1' ' H ' ' A' ' 114' ' ' GLU . 10.6 ptp -122.84 155.57 36.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.166 -1.379 . . . . 2.33 110.924 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -96.67 85.58 3.88 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.933 0.873 . . . . 1.11 108.959 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.602 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -110.18 163.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.397 -1.274 . . . . 1.14 109.924 -172.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.518 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.5 m -140.87 173.92 11.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.673 -0.492 . . . . 0.89 109.673 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.554 ' HG2' ' CG2' ' A' ' 147' ' ' VAL . 44.2 mttp -53.99 -32.74 55.02 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 108.575 -0.898 . . . . 2.86 108.575 164.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.598 ' O ' HG11 ' A' ' 125' ' ' VAL . 41.6 t30 -84.24 -19.19 34.33 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 114.053 -1.43 . . . . 1.68 114.733 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.518 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.3 mp0 -84.9 -63.28 1.36 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 119.755 -1.841 . . . . 2.06 107.183 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.741 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -56.36 -13.47 2.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 112.858 -1.974 . . . . 3.58 111.361 172.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.598 HG11 ' O ' ' A' ' 122' ' ' ASN . 14.5 p -43.19 -43.07 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.2 1.0 . . . . 1.11 110.117 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.687 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.7 -37.54 82.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.115 -1.402 . . . . 1.32 112.774 176.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.645 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -50.94 -33.83 26.11 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.723 0.773 . . . . 2.45 110.873 168.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.741 ' HG ' ' O ' ' A' ' 124' ' ' MET . 16.0 mt -84.55 -32.62 23.75 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.931 -1.032 . . . . 1.13 109.229 -172.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.23 -35.0 77.27 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.352 -1.295 . . . . 1.96 109.644 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.557 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -70.26 -42.04 72.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.252 -1.794 . . . . 1.18 111.904 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.484 HG23 ' HA ' ' A' ' 128' ' ' LEU . 11.6 t -90.33 -2.66 58.01 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 123.384 1.564 . . . . 1.27 107.368 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 55.23 54.85 8.21 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 110.974 -2.83 . . . . 2.22 112.103 172.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.868 ' HH ' ' CG1' ' A' ' 136' ' ' VAL . 3.8 t80 -138.97 177.85 7.59 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 113.095 0.776 . . . . 0.9 113.095 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.41 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -141.31 139.27 33.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.539 -1.282 . . . . 5.25 107.539 177.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.6 OUTLIER -49.06 139.47 10.51 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.35 1.241 . . . . 2.03 114.35 -168.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.868 ' CG1' ' HH ' ' A' ' 133' ' ' TYR . 3.8 m -124.23 156.41 31.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.933 -1.939 . . . . 1.73 111.52 -175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -59.67 -37.48 78.87 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.516 1.15 . . . . 1.74 107.958 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -158.46 134.97 9.45 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 112.611 -2.086 . . . . 2.0 109.397 -177.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.05 136.42 54.58 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.0 -1.0 . . . . 1.27 111.311 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.7 t -159.0 100.59 1.57 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.684 1.231 . . . . 1.26 109.675 151.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.531 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -163.62 170.15 7.56 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.82 -1.991 . . . . 2.11 106.534 165.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.5 117.13 3.66 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.661 1.574 . . . . 0.99 112.604 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.587 ' CA ' ' HB2' ' A' ' 157' ' ' ARG . . . 105.94 36.53 2.73 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.947 -0.644 . . . . 0.51 112.366 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.704 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 12.8 mp0 -130.95 176.82 7.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.171 -0.307 . . . . 2.16 110.171 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.866 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -166.56 175.95 7.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.0 -0.741 . . . . 0.28 109.0 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.593 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 61.7 p -140.98 126.32 18.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.967 -0.56 . . . . 1.12 110.898 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.554 ' CG2' ' HG2' ' A' ' 121' ' ' LYS . 14.4 p -125.41 126.44 70.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.435 0.636 . . . . 1.1 112.241 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -132.36 -74.69 0.51 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.009 -0.541 . . . . 3.64 110.26 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.05 -50.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.893 0.331 . . . . 2.21 111.893 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.88 -11.47 55.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.418 -0.355 . . . . 1.95 111.516 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 10.9 p -165.13 154.72 12.94 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.868 0.842 . . . . 0.63 112.915 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.633 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 63.2 mt -114.61 108.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.597 -1.631 . . . . 1.19 106.597 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.866 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.24 166.61 13.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.703 -1.962 . . . . 1.13 105.703 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.574 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 7.6 ptm -167.53 151.67 6.59 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 124.014 0.821 . . . . 2.37 110.183 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.547 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.3 mt -128.24 113.57 30.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.159 -0.473 . . . . 1.14 110.439 172.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.779 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 13.1 mtp-105 -62.71 107.29 0.93 Allowed 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.347 0.404 . . . . 3.61 110.613 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.587 ' HB2' ' CA ' ' A' ' 143' ' ' GLY . 59.5 ttp180 -65.49 141.82 98.12 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 107.075 -1.454 . . . . 6.8 107.075 165.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -47.28 126.0 11.21 Favored 'Trans proline' 0 N--CA 1.438 -1.737 0 C-N-CA 121.302 1.335 . . . . 2.5 110.767 171.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.488 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 13.5 m-85 -124.22 137.84 54.48 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.016 -1.447 . . . . 2.1 107.658 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -110.72 74.79 0.89 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.687 1.232 . . . . 3.66 111.176 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 88.0 m-85 -120.65 156.93 55.52 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 113.568 -1.651 . . . . 3.96 109.828 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 31.2 Cg_exo -60.8 -31.36 91.7 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 124.386 3.391 . . . . 4.73 113.054 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.56 -15.07 25.81 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.116 -0.947 . . . . 5.26 111.01 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 161' ' ' PHE . 17.2 p -149.34 105.65 3.51 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.734 -0.666 . . . . 3.82 111.046 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -147.27 85.07 1.58 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.27 1.033 . . . . 3.83 109.588 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.526 ' HG3' ' NH1' ' A' ' 156' ' ' ARG . 10.5 pt-20 -165.23 153.33 11.49 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 113.371 -1.741 . . . . 3.14 106.493 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.26 -132.19 0.42 Allowed Glycine 0 C--N 1.303 -1.257 0 CA-C-O 122.817 1.232 . . . . 1.22 113.539 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.779 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 25.4 tt0 -89.57 143.6 26.68 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 112.721 -1.74 . . . . 2.3 113.02 -167.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 61.9 t -154.96 124.43 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.131 -1.395 . . . . 1.12 109.364 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 50.5 mtm180 -81.58 124.74 29.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.548 -0.538 . . . . 3.33 109.548 166.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -129.05 137.18 51.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.654 0.74 . . . . 1.02 110.346 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.1 tpp180 -104.82 106.54 17.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.195 -1.366 . . . . 2.43 110.936 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 5.1 mp -92.31 98.21 11.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.3 -0.63 . . . . 1.36 109.3 174.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.57 120.99 40.86 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.188 0.994 . . . . 1.04 111.499 -171.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -88.57 134.96 33.72 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.953 -1.93 . . . . 1.03 110.229 -177.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 37.4 t70 -77.21 66.15 2.94 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.676 -1.602 . . . . 1.09 106.676 163.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.81 -98.97 1.73 Allowed Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 118.801 -1.666 . . . . 0.5 110.233 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.65 -26.02 30.24 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.878 0.695 . . . . 0.83 112.878 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -128.37 128.81 45.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.442 -0.903 . . . . 2.01 110.865 -166.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.2 tt -52.14 129.13 26.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.433 -1.712 . . . . 1.35 110.546 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.91 -39.32 5.8 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.04 -0.982 . . . . 1.08 110.059 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 167.37 24.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.144 -0.48 . . . . 1.12 111.853 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.55 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 2.0 mm -118.6 147.8 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 105.444 -2.058 . . . . 1.48 105.444 164.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -139.82 128.34 26.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.579 0.704 . . . . 1.12 110.072 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.448 ' CB ' ' HG2' ' A' ' 190' ' ' ARG . 2.4 t-20 -69.4 105.13 2.48 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 107.523 -1.288 . . . . 1.77 107.523 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.607 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 6.7 mtm -65.33 -3.56 4.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.845 0.683 . . . . 1.26 112.845 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.451 ' HG3' ' ND2' ' A' ' 188' ' ' ASN . 11.2 pt-20 -96.12 -37.44 10.59 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.695 0.76 . . . . 1.02 111.303 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.451 ' ND2' ' HG3' ' A' ' 187' ' ' GLU . 48.9 m-80 -104.4 -26.53 12.39 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.541 -1.208 . . . . 1.98 109.893 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 185' ' ' ASN . 25.4 t-20 75.39 31.83 0.76 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.745 -2.025 . . . . 2.0 108.362 -177.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 13.5 ptt180 -92.93 156.46 16.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.454 -1.248 . . . . 2.78 109.503 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -84.69 127.44 34.1 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.87 -1.059 . . . . 1.9 109.692 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.55 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -103.77 92.81 4.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.918 -0.713 . . . . 1.18 110.451 -171.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 18.27 -58.5 0.0 OUTLIER Glycine 0 N--CA 1.468 0.826 0 N-CA-C 115.905 1.122 . . . . 1.89 115.905 145.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -163.32 174.21 12.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.043 -1.578 . . . . 3.47 108.399 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.608 ' HB3' ' CD2' ' A' ' 113' ' ' LEU . 1.9 t80 -142.82 152.71 42.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.086 -1.079 . . . . 0.89 108.086 156.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.542 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.42 147.53 34.75 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 122.058 -0.401 . . . . 5.49 111.422 -172.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.479 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 5.4 mt -132.87 172.43 12.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.636 0.976 . . . . 2.15 113.636 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.91 106.56 31.57 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 113.399 -1.728 . . . . 2.66 108.667 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -50.64 126.18 17.49 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.826 2.351 . . . . 2.4 113.612 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.557 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 79.6 mtp180 . . . . . 0 C--O 1.252 1.196 0 CA-C-N 115.016 -0.993 . . . . 5.84 111.994 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.44 ' SD ' ' HA2' ' A' ' 177' ' ' GLY . 66.2 mtt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.75 0.309 . . . . 26.61 110.249 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.86 63.15 4.12 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.756 -0.735 . . . . 24.26 112.143 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.2 m -87.01 -4.59 59.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.799 0.333 . . . . 23.88 111.206 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.4 t -75.65 -27.91 58.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 23.12 110.322 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.1 t60 74.35 -59.97 0.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.39 0.676 . . . . 22.4 111.215 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -87.89 104.87 17.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.969 0.414 . . . . 22.38 110.056 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -79.47 146.99 32.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.152 -0.684 . . . . 20.96 109.152 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -93.05 -90.04 0.19 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.814 -0.354 . . . . 18.66 111.486 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 26.9 m170 51.01 81.81 0.06 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.208 0.318 . . . . 18.21 110.469 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -59.95 123.39 16.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.027 0.441 . . . . 18.15 111.06 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -90.85 132.38 35.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.803 -0.635 . . . . 16.83 110.053 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 t -77.68 2.22 17.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.876 0.369 . . . . 16.32 110.264 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 103' ' ' ARG . . . -84.42 -13.64 72.98 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 121.004 -0.617 . . . . 14.64 111.982 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp 63.05 -80.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.215 0.606 . . . . 16.04 112.287 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.584 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 84.3 t -125.09 -56.36 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.295 -0.411 . . . . 12.96 111.961 -174.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 101' ' ' VAL . 1.8 Cg_endo -43.35 -42.22 10.41 Favored 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.993 2.462 . . . . 12.74 112.805 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.402 ' HB3' ' HA3' ' A' ' 99' ' ' GLY . 47.4 ttt180 -90.32 97.41 11.17 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.723 -0.473 . . . . 12.74 109.723 174.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.75 58.82 4.89 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.052 -0.594 . . . . 8.95 112.496 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.4 p -80.96 85.45 6.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.047 0.451 . . . . 8.16 110.744 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -101.28 -32.82 10.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.98 -0.554 . . . . 8.44 110.931 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 63.2 mtt 63.64 -153.87 0.32 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.864 -0.607 . . . . 6.56 109.834 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.74 -10.76 73.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.646 -0.787 . . . . 1.91 112.212 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' CB ' ' HG3' ' A' ' 126' ' ' LYS . 3.4 ptm180 -140.49 99.09 3.56 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 122.954 0.501 . . . . 5.09 110.642 168.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.3 ttp -141.14 125.52 17.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 118.306 -1.358 . . . . 3.06 113.732 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.488 ' O ' HG21 ' A' ' 111' ' ' VAL . 26.8 m -114.0 101.53 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 122.763 1.268 . . . . 1.41 110.947 167.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.502 ' C ' HD11 ' A' ' 113' ' ' LEU . 53.0 t30 -163.02 109.75 1.19 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.576 -1.647 . . . . 1.73 106.763 171.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.655 HD11 ' N ' ' A' ' 113' ' ' LEU . 4.9 mp -104.02 77.38 1.43 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.937 -0.764 . . . . 2.04 108.937 -169.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -121.81 107.64 35.7 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 119.342 -0.943 . . . . 1.93 110.311 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.509 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.4 Cg_exo -34.04 130.25 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.542 3.494 . . . . 0.73 114.407 -172.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 23.1 t0 77.72 39.22 0.18 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.456 1.122 . . . . 0.72 110.811 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.621 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -115.05 155.51 26.88 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.867 -1.06 . . . . 2.33 110.577 172.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 m -92.91 86.6 5.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.964 0.887 . . . . 1.11 109.205 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.7 tt -116.46 162.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.076 -1.42 . . . . 1.14 109.718 -171.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.547 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.6 m -142.26 178.03 7.85 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.96 -0.756 . . . . 0.89 108.96 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.606 ' HG2' ' CG2' ' A' ' 147' ' ' VAL . 28.9 mtpt -57.45 -28.58 63.47 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 108.525 -0.917 . . . . 2.86 108.525 163.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.627 ' O ' HG12 ' A' ' 125' ' ' VAL . 32.9 t30 -85.32 -18.44 33.83 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-N 113.851 -1.522 . . . . 1.68 114.774 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.547 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.0 mp0 -86.9 -62.08 1.58 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 119.82 -1.8 . . . . 2.06 108.289 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.811 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.7 tpt -53.58 -17.03 1.8 Allowed 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 112.8 -2.0 . . . . 3.58 110.779 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 122' ' ' ASN . 14.9 p -43.98 -44.92 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.288 1.042 . . . . 1.11 110.447 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.544 ' H ' HG11 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -69.18 -36.29 77.19 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.937 -1.483 . . . . 1.32 112.838 177.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.593 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.7 OUTLIER -51.1 -35.08 33.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 122.028 0.918 . . . . 2.45 110.54 168.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.811 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.2 mt -84.82 -28.6 26.0 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.754 -1.112 . . . . 1.13 109.152 -171.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.69 -20.47 50.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.136 -1.393 . . . . 1.96 110.341 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 200' ' ' ARG . . . -80.62 -43.87 19.82 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.07 -1.423 . . . . 1.18 111.215 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.91 -6.17 54.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 123.653 1.692 . . . . 1.27 107.094 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.12 56.41 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 110.976 -2.829 . . . . 2.22 112.945 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.716 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -135.15 176.72 8.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.615 -0.721 . . . . 0.9 111.817 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -136.98 149.95 47.84 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.126 -1.435 . . . . 5.25 107.126 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -48.88 137.0 13.24 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.737 1.256 . . . . 2.03 112.836 -170.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.69 ' CG2' ' HH ' ' A' ' 133' ' ' TYR . 11.6 p -137.6 140.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 112.349 -2.205 . . . . 1.73 109.677 -164.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 m -63.5 -31.72 72.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.096 0.951 . . . . 1.74 109.3 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -152.6 117.72 5.19 Favored 'General case' 0 CA--C 1.485 -1.539 0 CA-C-N 113.352 -1.749 . . . . 2.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.579 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -109.59 117.88 35.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 113.81 -1.541 . . . . 1.27 110.12 179.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.416 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -151.12 95.59 2.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.24 1.495 . . . . 1.26 108.399 156.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.522 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -168.31 155.87 7.63 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 111.546 -2.57 . . . . 2.11 105.029 168.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.465 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 14.6 Cg_exo -71.17 123.6 9.77 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.526 1.484 . . . . 0.99 112.18 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.681 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 106.15 20.14 9.48 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 120.579 -0.82 . . . . 0.51 111.781 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.716 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.8 mp0 -125.99 173.82 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.807 -0.442 . . . . 2.16 109.807 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.858 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 47.6 p90 -168.42 168.17 11.38 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.506 -1.294 . . . . 0.28 107.506 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.583 HG23 HG11 ' A' ' 136' ' ' VAL . 34.9 p -133.19 127.27 33.43 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.713 -0.795 . . . . 1.12 110.499 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.606 ' CG2' ' HG2' ' A' ' 121' ' ' LYS . 10.7 p -122.93 121.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.715 -0.794 . . . . 1.1 112.861 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -111.02 -77.47 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.973 . . . . 3.64 109.74 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -176.73 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.261 -0.881 . . . . 2.21 109.092 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.45 -19.32 39.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.97 -1.014 . . . . 1.95 110.128 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 21.0 p -160.6 155.03 23.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.149 -0.932 . . . . 0.63 111.751 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.545 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 53.4 mt -121.11 113.82 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.487 -1.671 . . . . 1.19 106.487 163.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.858 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -89.82 169.99 10.79 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.374 -1.713 . . . . 1.13 106.374 175.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.23 150.54 5.36 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 123.802 0.689 . . . . 2.37 110.672 -174.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.587 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.3 mt -128.71 119.47 49.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.763 -0.653 . . . . 1.14 109.938 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 82.6 mtp180 -67.21 112.9 4.74 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.458 0.474 . . . . 3.61 110.719 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.562 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 14.8 tpt180 -72.22 133.83 83.18 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 107.616 -1.253 . . . . 6.8 107.616 166.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.411 ' HD2' ' HD2' ' A' ' 157' ' ' ARG . 1.8 Cg_endo -46.89 126.01 10.54 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 121.205 1.27 . . . . 2.5 110.642 167.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.562 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 17.3 m-85 -121.17 145.51 47.75 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.236 -1.347 . . . . 2.1 107.716 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.36 73.78 1.23 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.616 1.198 . . . . 3.66 111.13 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 97.0 m-85 -120.99 149.92 52.1 Favored Pre-proline 0 C--N 1.306 -1.286 0 CA-C-N 113.766 -1.561 . . . . 3.96 109.902 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.2 Cg_exo -62.12 -30.38 82.31 Favored 'Trans proline' 0 CA--C 1.503 -1.053 0 C-N-CA 124.532 3.488 . . . . 4.73 112.783 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.24 -11.72 22.37 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.691 -1.14 . . . . 5.26 110.967 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.8 m -145.37 99.66 3.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.861 -0.609 . . . . 3.82 111.348 -173.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 166' ' ' GLU . 5.6 tppp? -149.17 99.77 2.97 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.41 -0.589 . . . . 3.83 109.41 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 165' ' ' LYS . 7.0 mt-10 -149.76 174.6 12.43 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.214 -0.903 . . . . 3.14 109.611 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.63 175.91 54.77 Favored Glycine 0 C--N 1.298 -1.543 0 CA-C-N 114.388 -1.278 . . . . 1.22 111.21 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.706 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 5.3 tt0 -58.26 152.13 17.97 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.133 -1.034 . . . . 2.3 112.064 172.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 53.7 t -153.69 130.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.712 -1.131 . . . . 1.12 108.711 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.636 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 51.4 mtm180 -87.25 122.82 31.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.225 0.536 . . . . 3.33 110.152 169.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -130.25 128.45 41.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.091 0.948 . . . . 1.02 110.791 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.512 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 9.0 tpp180 -96.26 120.88 37.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.496 -1.683 . . . . 2.43 110.251 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.566 HD21 ' CG ' ' A' ' 113' ' ' LEU . 7.4 mp -111.54 103.99 12.36 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.422 0.63 . . . . 1.36 111.045 174.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.75 124.87 47.01 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.777 -1.101 . . . . 1.04 111.284 -174.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -97.9 139.6 33.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.137 -1.847 . . . . 1.03 110.683 -175.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.1 64.06 4.81 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 106.754 -1.573 . . . . 1.09 106.754 160.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.44 ' HA2' ' SD ' ' A' ' 87' ' ' MET . . . 69.84 -98.82 0.64 Allowed Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 118.78 -1.676 . . . . 0.5 110.926 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.41 -25.47 59.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.939 0.718 . . . . 0.83 112.939 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -136.28 133.89 37.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.768 -0.773 . . . . 2.01 109.824 -169.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -60.1 138.79 57.81 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.115 -1.402 . . . . 1.35 110.0 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.34 -45.21 4.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.043 -0.98 . . . . 1.08 110.513 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.8 p -148.66 158.8 44.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 111.698 0.259 . . . . 1.12 111.698 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.549 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.2 mm -107.42 148.32 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 104.966 -2.235 . . . . 1.48 104.966 165.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.5 t -140.05 126.88 23.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.532 0.682 . . . . 1.12 110.077 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -69.72 107.48 3.49 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.356 -1.349 . . . . 1.77 107.356 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.651 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 20.3 mtm -64.66 -8.33 14.01 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 112.862 0.69 . . . . 1.26 112.862 -165.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -91.66 -41.83 10.51 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.768 0.794 . . . . 1.02 111.45 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -98.24 -25.47 14.86 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.391 -1.277 . . . . 1.98 109.381 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.1 t30 70.09 35.47 2.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.912 -2.404 . . . . 2.0 108.015 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.675 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.5 ptm180 -96.42 157.78 15.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.604 -1.634 . . . . 2.78 108.833 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 87.8 mt-30 -85.94 129.43 34.84 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.336 -0.847 . . . . 1.9 109.221 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.549 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -104.1 91.91 4.15 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.259 -0.576 . . . . 1.18 110.547 -170.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.33 -59.09 0.0 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 116.26 1.264 . . . . 1.89 116.26 147.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 192' ' ' PHE . 26.2 p90 -164.75 171.08 14.74 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.639 -1.281 . . . . 3.47 109.137 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -139.19 151.87 46.92 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.842 -1.17 . . . . 0.89 107.842 159.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.697 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.23 148.46 36.48 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.906 -0.496 . . . . 5.49 110.465 -175.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.588 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 3.5 mt -130.15 172.07 12.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.282 1.039 . . . . 2.15 113.728 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -97.74 114.13 64.55 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 113.207 -1.815 . . . . 2.66 108.249 170.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.07 124.51 16.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.176 2.584 . . . . 2.4 114.087 -169.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.859 0 O-C-N 124.395 1.06 . . . . 5.84 112.506 177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 120.62 0.248 . . . . 26.61 110.475 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.97 71.95 2.33 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.884 -0.674 . . . . 24.26 111.625 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.5 t -142.5 119.06 11.0 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.05 -0.352 . . . . 23.88 110.05 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.7 t -84.0 93.03 7.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.125 -0.489 . . . . 23.12 110.171 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -74.91 106.92 6.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.295 -0.632 . . . . 22.4 109.295 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -82.01 39.31 0.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 22.38 111.904 -171.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -151.43 150.19 30.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.45 -0.574 . . . . 20.96 109.45 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -83.6 62.71 6.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.45 -0.341 . . . . 18.66 110.199 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 52.46 65.06 1.62 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.716 -0.675 . . . . 18.21 110.564 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -110.2 56.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.452 0.644 . . . . 18.15 109.327 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.4 m -124.37 70.48 1.11 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.57 -0.741 . . . . 16.83 111.12 -173.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 m -67.71 147.54 52.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.144 -0.48 . . . . 16.32 110.412 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.15 -42.9 1.79 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 14.64 112.114 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.68 41.91 1.17 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.415 0.626 . . . . 16.04 110.146 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -164.69 119.06 1.0 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.251 -0.886 . . . . 12.96 110.233 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.6 168.43 24.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.578 2.185 . . . . 12.74 111.691 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 62.26 61.22 1.33 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.522 0.677 . . . . 12.74 109.98 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.28 -142.77 46.39 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.518 -0.765 . . . . 8.95 112.147 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.1 m -120.05 41.91 3.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.147 0.498 . . . . 8.16 109.806 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -57.17 134.55 55.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.416 -0.811 . . . . 8.44 110.417 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.426 ' C ' ' H ' ' A' ' 109' ' ' ARG . 22.9 mmt -81.26 -39.17 25.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.716 -0.675 . . . . 6.56 110.698 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.693 ' O ' ' HA ' ' A' ' 123' ' ' GLU . . . 78.92 -31.74 1.99 Allowed Glycine 0 C--O 1.217 -0.968 0 CA-C-N 115.383 -0.826 . . . . 1.91 111.884 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.432 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -73.17 99.55 2.85 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.327 1.051 . . . . 5.09 109.114 174.434 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.568 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 26.2 ttt -144.23 136.92 26.93 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.423 -0.511 . . . . 3.06 111.882 -170.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 126' ' ' LYS . 2.0 m -119.8 104.4 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 122.569 1.175 . . . . 1.41 113.41 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -159.74 108.23 1.76 Allowed 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.939 -1.937 . . . . 1.73 106.895 163.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.815 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.2 mp -98.17 113.21 25.05 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.517 0.675 . . . . 2.04 109.295 -173.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -139.97 100.77 7.17 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.76 -1.109 . . . . 1.93 109.031 -173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.44 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 23.5 Cg_exo -35.12 133.68 0.19 Allowed 'Trans proline' 0 CA--C 1.515 -0.46 0 C-N-CA 124.452 3.435 . . . . 0.73 113.997 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 31.4 t70 74.74 47.06 0.12 Allowed 'General case' 0 CA--C 1.529 0.135 0 O-C-N 124.583 1.177 . . . . 0.72 109.91 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.561 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 12.4 ptt? -121.12 155.79 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.266 -1.333 . . . . 2.33 110.339 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 179' ' ' HIS . 56.5 m -101.59 102.75 13.52 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.532 -0.914 . . . . 1.11 108.532 -176.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.505 ' CG2' ' HE2' ' A' ' 124' ' ' MET . 16.6 tt -138.93 167.76 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.212 -0.904 . . . . 1.14 110.64 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.6 m -140.84 174.33 10.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.765 0.711 . . . . 0.89 110.785 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.481 ' HA ' HD12 ' A' ' 152' ' ' ILE . 11.9 mttp -57.49 -26.19 60.91 Favored 'General case' 0 C--O 1.211 -0.944 0 N-CA-C 109.089 -0.708 . . . . 2.86 109.089 165.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.623 ' O ' HG11 ' A' ' 125' ' ' VAL . 40.6 t30 -84.44 -17.1 40.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.316 -1.311 . . . . 1.68 114.052 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 1.8 tt0 -87.18 -60.25 2.03 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.658 -1.238 . . . . 2.06 107.658 168.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.825 ' SD ' HD11 ' A' ' 152' ' ' ILE . 61.2 mtt -54.86 -15.91 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.832 -1.985 . . . . 3.58 111.906 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.623 HG11 ' O ' ' A' ' 122' ' ' ASN . 12.9 p -44.16 -40.63 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 122.141 0.972 . . . . 1.11 109.967 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.67 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.77 -40.7 84.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.066 -1.425 . . . . 1.32 112.743 176.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.58 ' HA ' HD12 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -49.74 -33.71 16.97 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.686 0.755 . . . . 2.45 111.041 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.6 mt -85.96 -34.27 20.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.856 -1.065 . . . . 1.13 109.607 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.59 -34.6 76.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.448 -1.251 . . . . 1.96 109.854 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.89 67.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.512 -1.676 . . . . 1.18 111.451 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.402 ' O ' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -89.64 -0.42 57.51 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 123.976 1.846 . . . . 1.27 106.969 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 55.75 54.6 8.03 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 111.079 -2.782 . . . . 2.22 112.693 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.562 ' CE1' ' HB ' ' A' ' 136' ' ' VAL . 2.7 t80 -141.38 174.93 10.08 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.022 -0.535 . . . . 0.9 111.864 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -137.1 156.46 48.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.949 -1.13 . . . . 5.25 107.949 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.414 ' HB2' HG13 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.86 139.73 16.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.31 1.052 . . . . 2.03 112.172 -170.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 145' ' ' PHE . 14.0 p -138.61 142.5 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 112.998 -1.91 . . . . 1.73 110.205 -164.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.12 -33.41 69.11 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.519 1.152 . . . . 1.74 109.616 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 1.4 ttpt -160.54 129.19 4.73 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 112.521 -2.127 . . . . 2.0 108.262 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.573 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -116.32 128.86 55.91 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.919 -0.582 . . . . 1.27 111.541 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.0 OUTLIER -161.68 98.56 1.11 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.551 1.167 . . . . 1.26 110.279 157.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.2 OUTLIER -166.66 167.07 8.39 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 112.891 -1.959 . . . . 2.11 105.833 161.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.486 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 24.4 Cg_exo -62.59 127.76 21.63 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 120.866 1.044 . . . . 0.99 110.416 170.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.704 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 86.25 42.69 6.52 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.428 -1.367 . . . . 0.51 112.96 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 28.2 mt-10 -140.76 166.15 25.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.843 -0.428 . . . . 2.16 109.843 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.757 ' O ' HG13 ' A' ' 136' ' ' VAL . 46.2 p90 -167.85 161.46 13.1 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.825 -0.806 . . . . 0.28 108.825 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.547 HG22 ' SD ' ' A' ' 139' ' ' MET . 71.4 p -123.35 130.73 53.13 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.284 0.564 . . . . 1.12 110.461 171.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 135' ' ' GLN . 9.8 p -120.54 108.53 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.984 0.897 . . . . 1.1 110.374 172.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -109.62 -68.2 0.94 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 3.64 110.296 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.6 -53.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.933 0.346 . . . . 2.21 111.933 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -102.17 1.83 36.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.545 0.572 . . . . 1.95 112.545 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 2.8 p -163.93 153.16 14.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.554 0.693 . . . . 0.63 112.807 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.825 HD11 ' SD ' ' A' ' 124' ' ' MET . 52.6 mt -112.11 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.287 -1.324 . . . . 1.19 107.683 165.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 2.4 mt-10 -95.65 103.22 15.09 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.371 -0.831 . . . . 1.13 109.325 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -113.62 166.65 11.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.396 -0.82 . . . . 2.37 111.848 -169.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.581 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 14.7 mt -127.63 106.64 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 114.616 -1.175 . . . . 1.14 110.297 173.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.702 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 53.4 ttt180 -68.05 91.02 0.33 Allowed 'General case' 0 C--N 1.32 -0.702 0 O-C-N 124.025 0.828 . . . . 3.61 110.08 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.704 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 64.0 ttt180 -58.75 139.15 86.48 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.471 -0.786 . . . . 6.8 109.911 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 142' ' ' PRO . 4.8 Cg_endo -50.73 125.04 14.75 Favored 'Trans proline' 0 N--CA 1.437 -1.835 0 C-N-CA 121.155 1.236 . . . . 2.5 110.228 167.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.593 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 25.9 m-85 -117.46 121.42 40.98 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.231 -1.35 . . . . 2.1 107.976 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 11.8 p-10 -81.26 77.29 8.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.815 1.293 . . . . 3.66 111.511 -173.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 83.3 m-85 -115.9 145.21 34.27 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 113.165 -1.834 . . . . 3.96 108.983 171.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.4 Cg_exo -59.19 -31.63 95.65 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 124.683 3.588 . . . . 4.73 113.47 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.27 -17.93 31.38 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.894 -1.048 . . . . 5.26 111.404 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 72.2 m -157.69 112.25 2.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.824 -0.625 . . . . 3.82 111.469 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 160' ' ' ASP . 23.6 tptp -142.08 97.82 3.21 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.913 0.863 . . . . 3.83 108.995 172.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -126.94 175.3 8.17 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.344 -1.298 . . . . 3.14 112.401 -168.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.09 147.08 28.55 Favored Glycine 0 C--N 1.312 -0.781 0 CA-C-N 113.82 -1.536 . . . . 1.22 111.632 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.702 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.9 OUTLIER -58.41 158.32 7.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.306 0.574 . . . . 2.3 112.413 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 59.6 t -151.45 127.43 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.049 -0.978 . . . . 1.12 110.154 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.57 ' HG3' HG12 ' A' ' 155' ' ' ILE . 8.6 mtt180 -82.8 110.74 18.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.059 -0.519 . . . . 3.33 109.901 169.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.97 137.63 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.992 0.901 . . . . 1.02 111.693 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.683 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 3.7 tpp180 -101.83 101.35 11.79 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.74 -1.573 . . . . 2.43 110.798 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.581 HD23 ' SD ' ' A' ' 124' ' ' MET . 2.9 mp -88.97 92.24 9.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.425 -0.583 . . . . 1.36 109.425 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.02 39.6 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.532 1.158 . . . . 1.04 111.902 -171.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-85 -88.81 137.58 32.19 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.647 -2.069 . . . . 1.03 110.89 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.541 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 30.9 t70 -81.93 65.1 6.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.987 -1.857 . . . . 1.09 105.987 160.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 73.59 -99.43 1.01 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 118.66 -1.733 . . . . 0.5 110.743 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -75.96 -26.99 57.34 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 112.773 0.657 . . . . 0.83 112.773 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.401 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 13.1 p-80 -133.12 129.74 38.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.862 -0.735 . . . . 2.01 111.181 -168.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.9 tt -52.6 126.52 19.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.286 -1.325 . . . . 1.35 109.756 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -103.0 -38.7 7.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.432 -0.803 . . . . 1.08 109.453 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.2 p -147.16 161.5 40.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.284 -0.871 . . . . 1.12 110.463 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.683 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 24.9 mt -126.17 147.66 30.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 104.212 -2.514 . . . . 1.48 104.212 167.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 3.8 t -136.71 134.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.855 -0.738 . . . . 1.12 111.692 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.54 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 12.1 m120 -72.53 97.74 2.17 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.424 -1.695 . . . . 1.77 106.424 174.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.474 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 46.1 mtm -65.95 -2.91 4.39 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.277 0.561 . . . . 1.26 112.345 -168.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.54 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 14.1 pt-20 -74.38 -42.85 58.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.046 0.927 . . . . 1.02 110.829 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -105.41 -25.52 12.33 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.277 -1.329 . . . . 1.98 108.814 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 185' ' ' ASN . 5.7 t30 73.47 36.47 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 111.834 -2.439 . . . . 2.0 108.063 -174.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 11.5 ptt180 -100.1 161.14 13.8 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.466 -1.243 . . . . 2.78 110.337 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -76.93 134.42 38.93 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.082 -0.963 . . . . 1.9 110.666 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.77 91.14 3.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.888 -0.577 . . . . 1.18 110.206 -174.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.46 -57.47 0.0 OUTLIER Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.68 1.432 . . . . 1.89 116.68 144.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -162.52 176.26 10.61 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.297 -1.451 . . . . 3.47 109.129 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.815 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 10.9 t80 -149.34 100.43 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.445 0.64 . . . . 0.89 110.197 156.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -98.86 139.18 34.92 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.546 -0.721 . . . . 5.49 111.128 -175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.58 HD12 ' HA ' ' A' ' 127' ' ' LEU . 2.0 mt -109.81 172.44 6.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 113.639 0.977 . . . . 2.15 113.639 -175.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.404 ' HA ' ' HD2' ' A' ' 199' ' ' PRO . 35.9 m-20 -122.22 99.69 43.05 Favored Pre-proline 0 N--CA 1.443 -0.815 0 CA-C-N 113.382 -1.736 . . . . 2.66 109.276 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 198' ' ' ASP . 17.7 Cg_endo -59.04 156.31 34.72 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.705 2.27 . . . . 2.4 112.878 -176.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.637 ' HD3' ' OXT' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.185 -0.912 . . . . 5.84 110.804 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.07 -0.345 . . . . 26.61 110.07 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.55 85.14 0.23 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.936 -0.649 . . . . 24.26 112.062 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.5 p -74.6 149.44 40.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.718 0.294 . . . . 23.88 110.511 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.7 t -78.45 89.34 4.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.186 0.517 . . . . 23.12 110.136 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -139.24 151.93 46.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.768 -0.651 . . . . 22.4 110.27 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -94.05 117.4 30.05 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.446 -0.575 . . . . 22.38 109.446 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -83.43 -53.28 5.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.264 -0.425 . . . . 20.96 111.391 -175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -135.09 112.24 10.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.518 -0.31 . . . . 18.66 110.479 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -160.33 -173.01 3.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.152 -0.685 . . . . 18.21 109.152 178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 65.85 40.01 4.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.339 0.59 . . . . 18.15 109.962 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.5 p -129.51 164.02 24.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.233 -0.894 . . . . 16.83 110.378 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.6 m -96.12 75.28 3.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.19 0.519 . . . . 16.32 110.631 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.38 69.04 0.92 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.915 -0.66 . . . . 14.64 113.023 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 65.99 102.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.417 0.627 . . . . 16.04 111.209 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.1 t -111.06 107.2 57.66 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.705 -0.679 . . . . 12.96 109.87 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.79 130.47 26.27 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.844 2.362 . . . . 12.74 112.17 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -146.87 44.67 1.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.536 0.684 . . . . 12.74 109.45 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.86 32.1 81.73 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 110.814 -0.914 . . . . 8.95 110.814 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -89.2 123.96 33.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.273 -0.464 . . . . 8.16 111.154 -172.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -79.51 -24.64 42.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.323 0.582 . . . . 8.44 109.432 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.0 mmt -133.23 -74.22 0.49 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.283 -0.871 . . . . 6.56 109.098 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.11 22.15 79.23 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 119.48 -1.343 . . . . 1.91 112.454 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.548 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 21.3 mtm180 -140.28 79.73 1.72 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 122.942 0.497 . . . . 5.09 110.112 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.546 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 34.8 tpp -141.57 133.04 26.8 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.703 -1.599 . . . . 3.06 115.209 -169.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.423 HG13 ' HE3' ' A' ' 124' ' ' MET . 17.3 m -121.11 107.84 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.111 0.958 . . . . 1.41 113.126 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -158.64 109.7 2.12 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.262 -1.384 . . . . 1.73 107.262 167.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.668 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 5.8 mp -95.34 101.16 12.87 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.205 0.526 . . . . 2.04 110.315 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -145.56 95.74 4.92 Favored Pre-proline 0 N--CA 1.429 -1.502 0 C-N-CA 119.781 -0.768 . . . . 1.93 109.455 -174.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -33.53 142.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.589 1 C-N-CA 126.356 4.704 . . . . 0.73 115.422 -174.331 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.1 40.06 0.74 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.698 -1.592 . . . . 0.72 109.197 -170.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.566 ' CE ' HD13 ' A' ' 180' ' ' LEU . 9.6 ptt? -118.09 154.84 31.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 113.993 -1.458 . . . . 2.33 109.734 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.5 m -101.46 81.04 2.14 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.298 1.047 . . . . 1.11 108.593 -175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.615 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -104.88 161.94 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.464 -1.698 . . . . 1.14 109.871 -169.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.505 ' H ' HG13 ' A' ' 119' ' ' ILE . 23.1 m -143.34 179.3 7.17 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 119.634 -0.826 . . . . 0.89 110.583 -173.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 1.2 mttm -61.62 -24.77 66.92 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.79 -1.189 . . . . 2.86 107.79 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.672 ' O ' HG13 ' A' ' 125' ' ' VAL . 4.3 t30 -83.77 -24.19 31.2 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 114.102 -1.408 . . . . 1.68 113.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 110' ' ' MET . 0.9 OUTLIER -80.48 -60.63 2.24 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.153 -2.217 . . . . 2.06 106.769 175.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.812 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.4 mmt -57.86 -17.26 15.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.767 -2.015 . . . . 3.58 111.943 173.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 122' ' ' ASN . 9.4 p -43.5 -42.16 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 122.0 0.905 . . . . 1.11 110.518 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.548 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.93 -37.66 81.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.366 -1.288 . . . . 1.32 113.806 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.561 ' CG ' HD12 ' A' ' 197' ' ' LEU . 2.9 tm? -56.34 -34.15 66.32 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.455 0.645 . . . . 2.45 109.943 167.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.812 ' HG ' ' O ' ' A' ' 124' ' ' MET . 11.8 mt -84.06 -31.38 25.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.948 0.88 . . . . 1.13 108.932 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.5 -31.25 68.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.796 -1.547 . . . . 1.96 110.043 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.609 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -72.75 -44.56 61.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.956 -1.474 . . . . 1.18 111.387 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.427 ' HA ' ' HZ ' ' A' ' 159' ' ' PHE . 0.6 OUTLIER -92.94 -1.43 56.71 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.294 -1.743 . . . . 1.27 106.294 -177.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.94 50.8 15.97 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.696 -2.502 . . . . 2.22 111.826 169.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.822 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.8 t80 -129.92 175.22 9.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.506 0.67 . . . . 0.9 112.125 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -141.1 149.54 41.72 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.305 -1.739 . . . . 5.25 106.305 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.768 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 20.7 tm0? -51.26 140.97 15.75 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.952 1.358 . . . . 2.03 113.765 -167.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.741 HG13 ' O ' ' A' ' 145' ' ' PHE . 14.6 p -136.93 144.91 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 112.27 -2.241 . . . . 1.73 110.51 -161.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -59.07 -34.2 71.7 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 122.684 1.231 . . . . 1.74 109.095 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.407 ' HG2' ' N ' ' A' ' 139' ' ' MET . 2.3 ttpt -159.55 128.61 5.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.57 -2.105 . . . . 2.0 109.104 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.601 ' SD ' ' HA ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -116.14 124.31 50.02 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.47 -0.786 . . . . 1.27 111.165 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.8 t -158.13 97.92 1.55 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.678 1.228 . . . . 1.26 109.68 153.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.59 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -166.23 161.05 12.59 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 112.699 -2.046 . . . . 2.11 106.469 164.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.418 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 23.9 Cg_exo -65.36 116.79 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 121.404 1.403 . . . . 0.99 111.259 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.597 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 108.32 21.44 7.65 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 119.804 -1.189 . . . . 0.51 113.087 -173.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.822 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 11.5 mp0 -134.48 159.44 41.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.256 0.528 . . . . 2.16 111.647 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.78 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.0 p90 -163.57 167.86 20.78 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.999 -1.111 . . . . 0.28 107.999 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.579 HG22 ' CG1' ' A' ' 136' ' ' VAL . 6.0 p -133.34 126.93 32.43 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.768 -0.773 . . . . 1.12 111.56 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.768 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.8 p -125.56 127.45 71.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.401 0.619 . . . . 1.1 112.142 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -133.71 -77.06 0.48 Allowed 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.008 -0.433 . . . . 3.64 110.088 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.44 -57.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.376 -0.375 . . . . 2.21 111.31 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -90.74 3.9 53.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.618 0.599 . . . . 1.95 112.618 -173.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.0 p -167.93 152.01 6.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.017 0.913 . . . . 0.63 113.292 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 42.0 mt -114.5 109.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 113.608 -1.633 . . . . 1.19 106.694 161.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.78 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.5 mp0 -91.91 159.54 15.71 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 105.427 -2.064 . . . . 1.13 105.427 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.653 ' HE1' ' SD ' ' A' ' 124' ' ' MET . 17.8 ptp -164.16 162.43 22.77 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.828 0.705 . . . . 2.37 110.785 -172.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.47 HG12 ' HG3' ' A' ' 170' ' ' ARG . 11.9 mt -111.35 108.27 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.008 -0.997 . . . . 1.14 110.531 163.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 195' ' ' PHE . 12.7 tpt180 -45.17 112.19 0.41 Allowed 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 113.511 -1.677 . . . . 3.61 110.076 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.981 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -43.78 98.41 0.18 Allowed Pre-proline 0 C--N 1.318 -0.768 0 O-C-N 125.7 1.875 . . . . 6.8 114.791 -163.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' A' ' 168' ' ' GLN . 9.0 Cg_endo -94.64 123.17 0.37 Allowed 'Trans proline' 0 N--CA 1.435 -1.923 0 C-N-CA 122.984 2.456 . . . . 2.5 110.312 164.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.981 ' CE2' ' HB2' ' A' ' 157' ' ' ARG . 12.3 m-85 -148.34 151.53 35.5 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.28 -1.378 . . . . 2.1 107.28 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -92.3 78.16 5.12 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.647 1.213 . . . . 3.66 111.307 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 58.3 m-85 -115.9 144.33 32.51 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 113.817 -1.538 . . . . 3.96 109.036 173.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.8 Cg_exo -59.05 -31.08 94.95 Favored 'Trans proline' 0 CA--C 1.501 -1.173 0 C-N-CA 124.619 3.546 . . . . 4.73 112.908 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -95.67 -11.65 26.81 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.82 -1.082 . . . . 5.26 111.416 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.2 m -161.2 103.99 1.28 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.385 -0.37 . . . . 3.82 111.539 -174.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -147.35 90.39 1.87 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.973 0.892 . . . . 3.83 110.035 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -110.06 172.82 6.64 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.096 -1.411 . . . . 3.14 111.729 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.62 138.53 19.71 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 114.561 -1.199 . . . . 1.22 113.079 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.531 ' HA ' ' HG3' ' A' ' 158' ' ' PRO . 7.0 tt0 -62.78 148.95 45.3 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.478 -0.861 . . . . 2.3 113.292 177.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 156' ' ' ARG . 53.9 t -154.4 120.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.053 -1.43 . . . . 1.12 109.212 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 154' ' ' MET . 0.0 OUTLIER -76.84 114.23 15.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.55 -0.537 . . . . 3.33 109.55 170.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.05 131.86 54.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.883 -1.127 . . . . 1.02 110.761 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.754 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.1 tpp180 -93.32 97.66 10.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.174 -1.375 . . . . 2.43 110.45 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -87.28 91.46 8.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.853 -0.425 . . . . 1.36 109.853 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.4 114.67 27.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.551 1.167 . . . . 1.04 111.936 -173.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -82.75 134.32 35.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.556 -2.111 . . . . 1.03 110.11 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.514 ' HB2' ' HB1' ' A' ' 181' ' ' ALA . 34.0 t70 -77.14 66.16 2.89 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.649 -1.611 . . . . 1.09 106.649 163.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.5 -98.09 1.63 Allowed Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 118.678 -1.725 . . . . 0.5 110.158 -174.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -92.23 -13.43 30.49 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.384 0.883 . . . . 0.83 113.384 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -136.09 125.07 24.23 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 119.109 -1.036 . . . . 2.01 110.899 -171.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.4 tt -53.61 127.67 26.31 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.217 -1.811 . . . . 1.35 111.047 -176.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 176' ' ' ASP . . . -106.45 -38.32 6.22 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.079 -0.964 . . . . 1.08 110.283 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -147.26 166.96 25.46 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.918 -0.583 . . . . 1.12 110.734 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 32.6 mt -137.12 145.17 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 106.348 -1.723 . . . . 1.48 106.348 168.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 47.5 t -139.11 134.49 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 109.533 -0.543 . . . . 1.12 109.533 -174.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.666 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 42.2 t-20 -81.12 103.81 11.18 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.439 -1.319 . . . . 1.77 107.439 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.493 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 33.5 mtm -67.04 -2.51 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.875 0.695 . . . . 1.26 112.875 -165.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.666 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.7 pt-20 -83.55 -41.93 17.37 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 122.055 0.931 . . . . 1.02 111.06 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.52 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 0.9 OUTLIER -108.26 -25.36 11.08 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.255 -1.339 . . . . 1.98 109.313 -177.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 185' ' ' ASN . 20.5 t-20 75.56 32.59 0.7 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 112.365 -2.198 . . . . 2.0 107.69 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.8 ptm180 -88.86 162.28 16.24 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 113.673 -1.603 . . . . 2.78 109.633 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -88.98 139.67 30.22 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.609 -1.178 . . . . 1.9 113.128 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.638 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 5.3 m-85 -105.74 -166.45 1.21 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.889 -1.959 . . . . 1.18 107.691 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.567 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 138.22 -9.17 3.54 Favored Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 107.791 -2.123 . . . . 1.89 107.791 -147.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.9 109.32 2.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.045 -1.077 . . . . 3.47 111.071 155.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.8 t80 -125.12 137.75 54.17 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.228 -0.92 . . . . 0.89 109.342 163.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.664 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.2 mpt_? -123.07 146.4 47.73 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.069 -0.394 . . . . 5.49 110.52 -176.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.561 HD12 ' CG ' ' A' ' 127' ' ' LEU . 38.2 mt -137.48 171.1 14.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.869 0.366 . . . . 2.15 111.757 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.419 ' CB ' ' HE ' ' A' ' 157' ' ' ARG . 12.5 t70 -113.86 111.13 48.53 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.609 -0.723 . . . . 2.66 109.62 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.04 126.26 20.53 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.414 2.076 . . . . 2.4 113.099 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.609 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.252 0 CA-C-N 115.047 -0.979 . . . . 5.84 111.62 -176.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.724 -0.472 . . . . 26.61 109.724 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.85 -83.62 1.26 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.658 -0.782 . . . . 24.26 111.659 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.3 m 54.03 50.89 15.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.156 0.503 . . . . 23.88 111.414 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -65.81 -38.58 89.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.921 -0.581 . . . . 23.12 110.718 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -114.0 23.75 12.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.244 0.545 . . . . 22.4 110.853 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -118.73 132.97 56.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.616 -0.72 . . . . 22.38 109.209 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 39.8 m80 63.99 30.89 14.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.53 0.681 . . . . 20.96 109.659 -172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -121.4 111.94 17.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.196 -0.911 . . . . 18.66 109.472 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -79.68 146.15 32.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.4 -0.364 . . . . 18.21 110.894 -176.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -83.49 163.52 20.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.136 -0.69 . . . . 18.15 109.136 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.1 m 63.86 94.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.657 0.598 . . . . 16.83 110.989 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 27.1 t -65.21 120.91 13.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.12 -0.491 . . . . 16.32 110.068 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.465 ' HA3' ' SD ' ' A' ' 107' ' ' MET . . . 92.36 -78.71 1.2 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.087 -0.578 . . . . 14.64 112.534 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.2 tp 74.7 -54.65 0.67 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.651 0.781 . . . . 16.04 110.905 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 35.4 m -83.5 150.16 59.36 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.168 -0.469 . . . . 12.96 110.287 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 101' ' ' VAL . 5.7 Cg_exo -78.45 48.92 2.88 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.872 2.381 . . . . 12.74 112.481 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -87.97 70.29 9.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.257 0.551 . . . . 12.74 110.223 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.91 141.48 7.39 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.851 -0.69 . . . . 8.95 112.065 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 122' ' ' ASN . 8.7 t -83.97 76.31 10.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.039 0.447 . . . . 8.16 110.031 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -136.63 7.33 3.02 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.023 0.379 . . . . 8.44 112.023 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.465 ' SD ' ' HA3' ' A' ' 99' ' ' GLY . 3.8 ptt? -140.92 147.16 38.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.732 0.301 . . . . 6.56 111.041 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.1 -10.57 37.06 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.033 -0.603 . . . . 1.91 112.049 -171.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.43 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -26.97 106.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.852 1.261 . . . . 5.09 112.026 167.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 54.2 ttm -143.04 138.33 29.89 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.847 0.684 . . . . 3.06 112.847 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.12 102.12 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 122.524 1.154 . . . . 1.41 112.819 166.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -163.08 109.06 1.14 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.95 -1.87 . . . . 1.73 105.95 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.631 ' CD1' ' HB3' ' A' ' 195' ' ' PHE . 40.3 mt -93.16 113.58 25.85 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.425 -0.51 . . . . 2.04 110.022 -169.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 117' ' ' MET . 38.5 tt0 -138.78 104.77 7.5 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.512 -0.475 . . . . 1.93 110.773 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 31.5 Cg_exo -36.59 128.88 0.46 Allowed 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 124.032 3.155 . . . . 0.73 113.317 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.8 t70 71.94 50.84 0.23 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 122.6 1.19 . . . . 0.72 110.026 -173.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.544 ' HE1' HD11 ' A' ' 180' ' ' LEU . 14.0 ptt? -121.45 155.75 34.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.232 -1.349 . . . . 2.33 110.51 174.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.93 85.93 3.89 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.814 0.816 . . . . 1.11 109.682 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -111.23 161.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.598 -1.183 . . . . 1.14 110.083 -173.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.599 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.9 m -141.44 176.6 8.74 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.125 -0.695 . . . . 0.89 109.125 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.563 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 7.3 mtpp -55.8 -30.55 61.53 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.439 -0.578 . . . . 2.86 109.439 166.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.597 ' O ' HG11 ' A' ' 125' ' ' VAL . 57.5 t30 -86.02 -17.49 35.11 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.979 1.474 . . . . 1.68 114.979 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.599 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.7 mp0 -85.4 -62.63 1.49 Allowed 'General case' 0 N--CA 1.425 -1.703 0 O-C-N 120.581 -1.325 . . . . 2.06 107.749 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.767 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 3.6 ttm -59.9 -13.26 10.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.03 -1.895 . . . . 3.58 111.23 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 122' ' ' ASN . 14.8 p -42.81 -41.82 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 122.075 0.941 . . . . 1.11 110.306 171.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.627 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -68.87 -39.32 79.9 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.391 -1.277 . . . . 1.32 112.549 177.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.646 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -49.07 -34.0 12.79 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.639 0.733 . . . . 2.45 110.968 168.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.767 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.6 mt -84.91 -30.34 24.43 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.934 -1.03 . . . . 1.13 109.529 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.9 -19.23 52.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.046 -1.434 . . . . 1.96 110.502 170.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.38 -40.91 25.64 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.981 -1.463 . . . . 1.18 110.788 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.539 HG21 ' HA ' ' A' ' 128' ' ' LEU . 15.0 t -91.53 2.69 56.26 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.25 1.5 . . . . 1.27 107.407 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 43.99 54.41 5.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 111.438 -2.619 . . . . 2.22 112.948 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.724 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.6 t80 -134.27 177.45 7.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.813 -0.63 . . . . 0.9 111.087 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -136.29 148.63 48.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.777 -1.194 . . . . 5.25 107.777 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.38 135.2 17.91 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.745 1.26 . . . . 2.03 111.374 -172.153 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 145' ' ' PHE . 12.3 p -128.3 133.11 67.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 112.58 -2.1 . . . . 1.73 109.006 -165.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -58.97 -31.85 69.12 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.736 1.255 . . . . 1.74 109.496 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 4.1 tmmm? -160.33 132.66 6.26 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 112.297 -2.229 . . . . 2.0 107.498 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.635 ' HB2' ' CD ' ' A' ' 144' ' ' GLU . 8.6 ptt? -115.35 133.04 56.4 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.868 -1.06 . . . . 1.27 112.993 -168.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.492 ' HA ' ' OE1' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -162.51 100.36 1.04 Allowed 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.992 0.901 . . . . 1.26 108.668 152.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.459 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.61 150.01 7.56 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.825 -1.534 . . . . 2.11 108.83 169.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.54 134.57 41.85 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.197 1.265 . . . . 0.99 110.036 170.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.65 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 76.43 54.21 5.19 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.898 -1.144 . . . . 0.51 111.873 -173.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.724 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -144.73 178.15 8.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.691 -0.195 . . . . 2.16 110.636 177.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.829 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 53.0 p90 -168.84 170.64 9.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.222 -1.029 . . . . 0.28 108.222 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 136' ' ' VAL . 19.0 p -132.98 126.74 32.64 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.148 -0.621 . . . . 1.12 110.864 171.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.477 ' CG2' ' HG2' ' A' ' 121' ' ' LYS . 8.7 p -124.64 112.76 33.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.693 0.758 . . . . 1.1 112.004 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -116.7 -66.02 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.772 -0.649 . . . . 3.64 110.596 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.65 -69.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.276 . . . . 2.21 111.634 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -83.07 10.9 7.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 112.439 0.533 . . . . 1.95 112.439 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -170.42 151.14 3.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.925 0.869 . . . . 0.63 112.792 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.657 ' HB ' ' SD ' ' A' ' 124' ' ' MET . 59.7 mt -120.28 115.74 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.707 -1.588 . . . . 1.19 106.961 165.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.829 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 6.9 mp0 -89.64 176.01 7.04 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.558 -1.275 . . . . 1.13 107.558 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 12.8 ptm -169.23 160.82 9.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.76 0.663 . . . . 2.37 111.208 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 29.3 mt -127.78 115.06 38.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 122.76 0.424 . . . . 1.14 110.81 165.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.789 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 77.6 mtp180 -71.51 91.83 1.08 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.399 -0.364 . . . . 3.61 110.52 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.65 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 36.9 ttp180 -59.87 136.36 90.26 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 107.086 -1.45 . . . . 6.8 107.086 168.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -47.58 125.11 10.49 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.348 1.365 . . . . 2.5 111.15 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 165' ' ' LYS . 11.7 m-85 -123.15 122.84 39.42 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.892 -1.503 . . . . 2.1 107.177 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -97.15 76.75 2.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.798 1.285 . . . . 3.66 110.997 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.489 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 97.3 m-85 -116.66 149.48 43.96 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 113.548 -1.66 . . . . 3.96 110.009 175.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 52.8 Cg_exo -56.72 -33.71 94.49 Favored 'Trans proline' 0 CA--C 1.495 -1.464 0 C-N-CA 124.919 3.746 . . . . 4.73 112.912 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.436 ' C ' ' HG ' ' A' ' 164' ' ' SER . 3.0 m-20 -98.19 -9.52 25.56 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.095 -1.411 . . . . 5.26 111.208 -175.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.436 ' HG ' ' C ' ' A' ' 163' ' ' ASP . 48.7 m -162.03 104.03 1.15 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.83 -0.623 . . . . 3.82 110.865 -174.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 86.7 tttt -147.61 102.33 3.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.495 0.664 . . . . 3.83 109.985 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -147.16 159.77 43.23 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.82 -1.082 . . . . 3.14 111.514 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.34 152.77 34.61 Favored Glycine 0 CA--C 1.496 -1.113 0 CA-C-N 113.41 -1.723 . . . . 1.22 112.324 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.789 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.8 tt0 -45.03 141.48 2.25 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 115.342 1.608 . . . . 2.3 115.342 -177.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 78.9 t -154.58 129.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 113.067 -1.878 . . . . 1.12 109.229 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.632 ' HG2' ' CE ' ' A' ' 186' ' ' MET . 16.0 ttm180 -91.86 102.33 14.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.908 -0.775 . . . . 3.33 108.908 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.407 ' C ' ' HE3' ' A' ' 186' ' ' MET . . . -105.34 143.74 33.1 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.244 -0.983 . . . . 1.02 112.054 -173.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.655 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 11.7 tpp180 -99.95 113.62 26.31 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.947 -1.479 . . . . 2.43 110.206 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.707 HD22 ' SD ' ' A' ' 124' ' ' MET . 7.2 mp -107.7 102.14 11.39 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.039 -0.664 . . . . 1.36 110.578 175.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.65 125.33 47.06 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 114.938 -1.028 . . . . 1.04 111.721 -170.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-30 -89.51 133.26 34.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.855 -1.975 . . . . 1.03 110.212 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.2 t70 -74.25 65.78 1.22 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.609 -1.626 . . . . 1.09 106.609 161.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.07 -98.27 1.59 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.673 -1.727 . . . . 0.5 110.368 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -86.92 -20.31 27.55 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.094 0.775 . . . . 0.83 113.094 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -133.15 130.67 39.5 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.742 -0.783 . . . . 2.01 110.727 -169.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.597 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 4.4 tt -52.64 129.35 29.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.933 -1.485 . . . . 1.35 110.803 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.61 -38.24 6.2 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.873 -1.058 . . . . 1.08 109.816 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.3 p -148.34 158.29 44.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.841 -0.618 . . . . 1.12 111.502 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.655 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 17.1 mt -125.02 146.58 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 105.827 -1.916 . . . . 1.48 105.827 167.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.5 t -142.09 135.44 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.665 0.745 . . . . 1.12 110.743 -171.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.24 95.95 7.1 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.497 -1.297 . . . . 1.77 107.497 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.632 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 28.3 mtm -62.35 -2.94 1.15 Allowed 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 114.028 1.122 . . . . 1.26 114.028 -164.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 9.6 pt-20 -81.53 -43.33 18.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.822 0.82 . . . . 1.02 110.705 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.534 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.3 m-20 -105.7 -25.7 12.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.314 -1.312 . . . . 1.98 109.034 -177.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 75.72 31.77 0.71 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.316 -2.22 . . . . 2.0 108.318 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 4.0 ptm180 -91.01 156.12 18.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.147 -1.388 . . . . 2.78 109.778 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.99 132.82 35.4 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.729 -1.123 . . . . 1.9 109.72 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -107.45 91.29 3.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.796 -0.762 . . . . 1.18 111.35 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -58.1 0.0 OUTLIER Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.506 1.362 . . . . 1.89 116.506 145.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 192' ' ' PHE . 99.7 m-85 -160.34 175.52 12.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.916 -1.642 . . . . 3.47 107.435 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.635 ' C ' ' HD3' ' A' ' 196' ' ' ARG . 2.1 t80 -142.77 145.41 33.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.244 -1.021 . . . . 0.89 108.244 153.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.635 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -130.52 138.57 50.28 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.15 -0.969 . . . . 5.49 110.798 -171.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 196' ' ' ARG . 2.3 mt -125.52 171.29 10.64 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 113.533 0.938 . . . . 2.15 113.533 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.45 125.41 86.22 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 113.205 -1.816 . . . . 2.66 110.057 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.634 ' O ' ' HD3' ' A' ' 200' ' ' ARG . 1.6 Cg_endo -47.73 126.07 12.13 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.155 3.236 . . . . 2.4 114.746 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 199' ' ' PRO . 6.7 mmt180 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.533 -0.746 . . . . 5.84 109.801 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.6 tmm? . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.679 -0.489 . . . . 26.61 109.679 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.39 130.27 9.86 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.714 -0.755 . . . . 24.26 111.9 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.1 p -74.93 -31.61 61.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.885 0.374 . . . . 23.88 111.201 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 m -77.71 73.93 4.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.221 0.534 . . . . 23.12 111.075 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -73.56 -18.23 61.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.841 -0.618 . . . . 22.4 110.421 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -75.17 84.67 2.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 22.38 110.534 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -138.56 135.08 34.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.158 -0.473 . . . . 20.96 110.437 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -87.26 102.53 14.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.899 -0.592 . . . . 18.66 110.531 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -112.27 85.13 2.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.122 0.487 . . . . 18.21 110.193 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -89.58 -32.06 17.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.857 -0.61 . . . . 18.15 110.348 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.1 m -71.89 88.92 1.05 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.96 -0.564 . . . . 16.83 110.553 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.0 t -137.16 27.19 2.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.835 -0.621 . . . . 16.32 110.004 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.22 -156.27 18.54 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.694 -0.765 . . . . 14.64 111.844 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 58.66 32.42 22.15 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.282 0.563 . . . . 16.04 110.528 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.41 97.21 35.09 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.612 -0.722 . . . . 12.96 110.76 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -89.97 -2.44 5.57 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.723 2.282 . . . . 12.74 112.438 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -111.54 126.65 55.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.057 -0.519 . . . . 12.74 110.781 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.77 -60.73 4.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.853 -0.689 . . . . 8.95 112.251 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.31 137.17 58.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 8.16 111.382 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -69.42 -29.42 67.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 8.44 109.882 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 49.2 ttm -80.7 143.86 32.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.918 -0.583 . . . . 6.56 109.456 173.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.24 17.32 16.08 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 120.485 -0.864 . . . . 1.91 111.518 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 2.0 mtt180 -137.31 90.79 2.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.241 -0.651 . . . . 5.09 109.241 170.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.6 mtt -138.82 127.28 23.07 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.498 -0.881 . . . . 3.06 112.687 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.4 m -121.32 103.22 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 122.496 1.141 . . . . 1.41 112.139 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -161.1 108.35 1.48 Allowed 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.402 -1.726 . . . . 1.73 106.77 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 mp -97.07 78.94 2.81 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.493 -0.929 . . . . 2.04 108.493 -174.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -113.66 95.58 37.39 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.429 -0.805 . . . . 1.93 110.279 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.547 ' HG3' HG12 ' A' ' 183' ' ' ILE . 25.3 Cg_exo -33.68 125.87 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.523 3.482 . . . . 0.73 114.147 -171.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.1 t70 77.62 48.62 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 124.813 1.321 . . . . 0.72 110.125 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.71 154.95 36.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.832 -1.076 . . . . 2.33 110.42 171.173 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -94.6 93.77 7.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.477 -0.783 . . . . 1.11 109.037 -170.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.52 HG21 ' HE3' ' A' ' 117' ' ' MET . 19.7 tt -139.74 169.97 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 114.68 -1.146 . . . . 1.14 110.729 -166.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.544 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 m -137.98 174.25 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.947 -0.761 . . . . 0.89 108.947 -177.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.476 ' HB2' HD13 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -66.67 -19.31 65.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.179 -1.045 . . . . 2.86 108.179 169.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.586 ' O ' HG13 ' A' ' 125' ' ' VAL . 1.8 t30 -83.68 -18.06 39.29 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-N 114.401 -1.272 . . . . 1.68 113.596 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.6 mp0 -86.25 -54.94 4.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 120.483 -1.385 . . . . 2.06 107.32 167.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.702 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.2 mmt -53.8 -13.56 0.74 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.974 -1.921 . . . . 3.58 111.771 168.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 122' ' ' ASN . 14.9 p -43.36 -42.78 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 122.31 1.052 . . . . 1.11 109.58 171.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -65.37 -39.66 92.58 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.715 -1.584 . . . . 1.32 112.939 176.152 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.59 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.6 OUTLIER -51.25 -32.49 24.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.731 0.777 . . . . 2.45 110.94 170.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 124' ' ' MET . 16.7 mt -85.83 -33.42 21.32 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.005 -0.998 . . . . 1.13 109.568 -172.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' A' ' 126' ' ' LYS . 2.8 mt-10 -72.26 -23.71 61.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.982 -1.463 . . . . 1.96 110.011 169.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.457 ' HA ' ' HG3' ' A' ' 200' ' ' ARG . . . -76.94 -44.3 32.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.679 -1.6 . . . . 1.18 111.598 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -86.28 -6.57 58.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.538 1.637 . . . . 1.27 107.538 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 58.59 53.46 6.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 111.156 -2.747 . . . . 2.22 112.348 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.708 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.9 t80 -136.3 176.35 8.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.882 -0.599 . . . . 0.9 111.769 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -135.59 152.14 50.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.043 -1.466 . . . . 5.25 107.043 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.478 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.68 137.65 15.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.579 1.18 . . . . 2.03 112.512 -170.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.735 HG11 ' O ' ' A' ' 145' ' ' PHE . 14.7 p -135.35 142.0 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.519 -2.128 . . . . 1.73 109.751 -166.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.71 -34.12 70.96 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.684 1.23 . . . . 1.74 109.129 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 5.5 ttpt -159.86 126.14 4.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.424 -2.171 . . . . 2.0 108.385 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.614 ' SD ' HG21 ' A' ' 146' ' ' THR . 0.0 OUTLIER -112.68 130.14 56.15 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.606 -0.725 . . . . 1.27 110.536 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.476 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 0.9 OUTLIER -158.4 98.15 1.53 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.836 1.303 . . . . 1.26 109.431 152.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -164.93 167.2 10.12 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 112.23 -2.259 . . . . 2.11 106.048 167.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.471 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 59.5 Cg_endo -72.26 126.18 11.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.426 1.417 . . . . 0.99 112.102 174.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.592 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 95.72 26.04 12.42 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 120.438 -0.887 . . . . 0.51 113.415 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.708 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 6.1 mp0 -126.82 171.42 11.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.1 0.45 . . . . 2.16 110.439 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.735 ' O ' HG11 ' A' ' 136' ' ' VAL . 43.1 p90 -168.4 165.09 12.82 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.481 -0.933 . . . . 0.28 108.481 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.614 HG21 ' SD ' ' A' ' 139' ' ' MET . 53.9 p -126.29 128.95 47.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.029 -0.532 . . . . 1.12 110.659 171.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.478 ' CG1' ' HG3' ' A' ' 135' ' ' GLN . 8.5 p -112.76 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.513 0.673 . . . . 1.1 111.093 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -122.95 36.96 4.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.523 -0.762 . . . . 3.64 110.484 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.38 -54.51 0.67 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.446 -0.797 . . . . 2.21 112.687 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -87.26 -10.43 52.43 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.895 0.379 . . . . 1.95 111.517 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -161.61 141.99 10.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.904 0.859 . . . . 0.63 112.716 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 146' ' ' THR . 35.4 mt -112.56 109.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.576 -1.647 . . . . 1.19 108.033 169.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 23.6 mt-10 -101.74 103.07 13.81 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.765 -0.828 . . . . 1.13 108.765 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.537 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 23.4 ptm -106.66 163.87 12.55 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.301 -0.863 . . . . 2.37 111.764 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.629 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 47.2 mt -130.08 112.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.166 -0.924 . . . . 1.14 110.817 168.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.665 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 56.6 mtm180 -64.34 113.16 3.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.291 -0.413 . . . . 3.61 110.357 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.592 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 79.6 ttt180 -73.72 135.82 77.71 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 107.051 -1.462 . . . . 6.8 107.051 166.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -49.5 125.3 13.63 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 120.873 1.049 . . . . 2.5 110.146 170.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 24.9 m-85 -117.19 145.77 43.66 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.283 -1.326 . . . . 2.1 108.556 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -97.4 76.31 2.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.544 1.164 . . . . 3.66 111.666 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.511 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 77.0 m-85 -115.98 142.5 29.26 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 113.663 -1.608 . . . . 3.96 108.965 171.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 37.4 Cg_exo -58.73 -28.92 88.12 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 124.769 3.646 . . . . 4.73 113.11 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.45 -10.26 25.72 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.936 -1.029 . . . . 5.26 111.421 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.425 ' HB2' ' OD1' ' A' ' 198' ' ' ASP . 48.9 m -158.22 106.4 1.97 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.2 0.524 . . . . 3.82 111.435 -175.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -147.53 82.66 1.53 Allowed 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.874 0.845 . . . . 3.83 108.807 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -118.63 -177.06 3.22 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.251 -1.34 . . . . 3.14 111.829 -169.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.44 154.89 37.07 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 114.521 -1.218 . . . . 1.22 111.789 173.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.7 OUTLIER -54.25 153.88 4.91 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.415 -0.892 . . . . 2.3 112.48 176.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 55.5 t -153.09 129.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.128 -0.942 . . . . 1.12 109.663 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.523 ' HG2' ' CE ' ' A' ' 186' ' ' MET . 9.3 ttt180 -88.6 107.55 18.97 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 109.202 -0.666 . . . . 3.33 109.202 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.53 137.14 53.42 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 119.275 -0.97 . . . . 1.02 111.986 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 15.5 tpp85 -99.09 107.37 19.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.762 -1.563 . . . . 2.43 111.455 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 151' ' ' SER . 4.7 mp -94.25 96.27 9.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.055 -0.52 . . . . 1.36 109.912 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.08 118.15 34.04 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.539 1.161 . . . . 1.04 110.9 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 41.9 m-85 -92.31 127.04 37.65 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 112.847 -1.979 . . . . 1.03 110.038 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.477 ' HB2' ' HB1' ' A' ' 181' ' ' ALA . 17.3 t70 -75.73 65.59 1.91 Allowed 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.643 -1.614 . . . . 1.09 106.643 167.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.32 -100.18 0.78 Allowed Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.404 -1.379 . . . . 0.5 110.897 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.44 -21.63 48.88 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.24 0.829 . . . . 0.83 113.24 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 16.3 p-80 -135.82 128.65 31.12 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 119.822 -0.751 . . . . 2.01 110.287 -170.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.9 tt -60.26 130.03 44.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.294 -1.321 . . . . 1.35 109.664 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 176' ' ' ASP . . . -103.02 -40.93 6.28 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.675 -0.693 . . . . 1.08 110.74 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 158.49 43.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.167 0.432 . . . . 1.12 112.167 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 3.1 mm -115.28 148.28 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 105.139 -2.171 . . . . 1.48 105.139 164.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.711 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.1 t -139.05 126.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.41 0.624 . . . . 1.12 110.33 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.593 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.6 t-20 -78.1 99.05 5.99 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.488 -1.301 . . . . 1.77 107.488 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.523 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 32.8 mtm -64.36 -2.17 2.08 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.816 1.043 . . . . 1.26 113.816 -166.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.593 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.9 pt-20 -80.36 -43.05 21.77 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.039 0.923 . . . . 1.02 110.645 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.52 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 7.8 m120 -109.03 -25.63 10.6 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.995 -1.457 . . . . 1.98 109.579 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 77.56 27.35 0.62 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.689 -2.05 . . . . 2.0 108.044 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.711 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 33.9 mtp180 -74.04 160.67 30.96 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.76 -1.564 . . . . 2.78 109.68 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 96.4 mt-30 -95.38 118.07 31.46 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.484 -1.234 . . . . 1.9 108.462 175.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.604 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -93.63 91.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.748 -0.781 . . . . 1.18 110.552 -166.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.98 -57.39 0.0 OUTLIER Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.277 1.418 . . . . 1.89 116.407 145.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 192' ' ' PHE . 48.3 p90 -163.73 174.73 11.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.701 -1.75 . . . . 3.47 107.584 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.722 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.0 t80 -151.41 98.69 2.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.28 0.562 . . . . 0.89 109.595 158.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.479 ' O ' ' HD2' ' A' ' 196' ' ' ARG . 2.8 ppt_? -90.29 145.57 24.88 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.412 -0.805 . . . . 5.49 111.222 -176.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 127' ' ' LEU . 1.8 mt -119.0 171.82 7.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.027 0.917 . . . . 2.15 113.291 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 164' ' ' SER . 8.8 m-20 -76.6 134.98 68.79 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 113.439 -1.709 . . . . 2.66 110.165 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.628 ' O ' ' HD3' ' A' ' 200' ' ' ARG . 3.6 Cg_endo -50.33 126.41 17.5 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 124.21 3.273 . . . . 2.4 114.802 -172.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.628 ' HD3' ' O ' ' A' ' 199' ' ' PRO . 23.9 mmt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-N 115.556 -0.747 . . . . 5.84 109.606 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.842 0.353 . . . . 26.61 110.737 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.96 -58.17 4.01 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.819 -0.705 . . . . 24.26 112.881 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.5 m -95.27 2.67 54.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.173 0.511 . . . . 23.88 110.766 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -70.98 133.94 46.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.748 . . . . 23.12 110.611 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.549 ' HA ' ' O ' ' A' ' 97' ' ' SER . 36.1 m80 -105.14 -0.66 26.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.246 0.546 . . . . 22.4 110.487 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -134.87 60.51 1.7 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.629 -0.714 . . . . 22.38 109.523 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -99.18 -44.91 6.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.766 -0.652 . . . . 20.96 109.314 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -163.52 110.43 1.15 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.495 -0.928 . . . . 18.66 108.495 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.1 m170 63.74 -152.72 0.32 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.374 -0.602 . . . . 18.21 109.374 -170.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -82.19 91.36 6.7 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.803 -0.443 . . . . 18.15 109.803 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 91' ' ' HIS . 16.3 m -75.57 91.28 2.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.79 -0.641 . . . . 16.83 110.86 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 p -97.49 16.22 20.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.977 -0.556 . . . . 16.32 110.925 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.09 -85.77 0.17 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.413 -0.675 . . . . 14.64 111.413 -176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 50.35 57.28 6.76 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.989 0.424 . . . . 16.04 111.116 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.2 m -71.64 128.73 89.39 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.046 -0.524 . . . . 12.96 111.11 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.32 108.89 1.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.621 2.214 . . . . 12.74 112.186 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.4 ttp-105 -69.32 -26.35 64.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.654 -0.703 . . . . 12.74 109.742 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.56 146.45 12.53 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.145 -0.934 . . . . 8.95 111.454 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.1 p -77.55 68.87 3.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.449 0.643 . . . . 8.16 110.13 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.555 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 89.2 m-70 -120.35 -80.52 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.805 -0.634 . . . . 8.44 111.327 -176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 106' ' ' HIS . 4.2 mpp? -134.95 -174.15 3.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.326 -0.397 . . . . 6.56 110.953 -175.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.9 17.09 11.39 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 118.383 -1.232 . . . . 1.91 114.537 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.72 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 13.8 mmt180 14.18 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.842 1.257 . . . . 5.09 112.816 175.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.674 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.5 tpt -139.94 124.63 18.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.392 0.886 . . . . 3.06 113.392 -165.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.659 HG12 ' N ' ' A' ' 127' ' ' LEU . 0.6 OUTLIER -126.66 107.65 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 114.21 1.189 . . . . 1.41 114.21 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -157.86 107.03 2.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.158 -1.793 . . . . 1.73 106.158 163.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.797 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.2 mp -85.68 112.66 21.23 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.728 -0.669 . . . . 2.04 110.781 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 33.2 tt0 -156.43 102.07 2.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 114.957 -1.019 . . . . 1.93 109.911 -176.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.678 ' HD3' ' CD1' ' A' ' 183' ' ' ILE . 9.7 Cg_exo -30.48 138.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 125.654 4.236 . . . . 0.73 114.593 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.6 t70 76.05 40.98 0.24 Allowed 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.778 1.299 . . . . 0.72 109.331 -171.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.522 ' CE ' HD12 ' A' ' 180' ' ' LEU . 11.9 ptt? -121.63 154.94 36.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.401 -1.272 . . . . 2.33 109.623 174.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.61 87.36 2.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.836 -1.172 . . . . 1.11 107.836 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.586 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 tt -111.08 157.18 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.084 -1.416 . . . . 1.14 110.316 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.701 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.9 m -141.24 176.76 8.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.12 -0.696 . . . . 0.89 109.12 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.829 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 5.8 mtpm? -56.27 -28.26 58.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.266 0.555 . . . . 2.86 109.511 165.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.72 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.6 t30 -84.26 -19.04 34.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.062 1.134 . . . . 1.68 114.062 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.701 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -88.22 -62.01 1.59 Allowed 'General case' 0 N--CA 1.415 -2.197 0 O-C-N 120.769 -1.207 . . . . 2.06 108.931 176.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.829 ' SD ' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -58.11 -16.69 14.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 112.994 -1.912 . . . . 3.58 110.382 172.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 122' ' ' ASN . 11.3 p -42.63 -43.33 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.288 1.042 . . . . 1.11 110.712 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.504 ' N ' HG12 ' A' ' 125' ' ' VAL . 10.1 mmpt? -69.65 -35.92 75.61 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.22 -1.354 . . . . 1.32 113.132 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.659 ' N ' HG12 ' A' ' 111' ' ' VAL . 9.0 tt -52.92 -34.04 53.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.571 0.7 . . . . 2.45 110.085 168.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.696 ' HB3' ' CE2' ' A' ' 145' ' ' PHE . 6.3 mt -83.86 -34.31 24.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.471 -0.937 . . . . 1.13 108.471 -171.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.97 -33.23 75.55 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.919 -1.491 . . . . 1.96 109.728 169.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 200' ' ' ARG . . . -72.75 -45.95 56.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.967 -1.47 . . . . 1.18 111.766 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.87 -1.73 58.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 123.747 1.737 . . . . 1.27 107.741 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 55.5 54.46 8.45 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 110.817 -2.902 . . . . 2.22 112.666 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.576 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 3.2 t80 -137.84 175.67 9.38 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.9 112.455 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 30.1 tpt180 -139.17 151.95 47.02 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.57 -1.27 . . . . 5.25 107.57 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 1.5 tm0? -49.22 142.4 7.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.335 1.064 . . . . 2.03 113.05 -168.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.6 p -141.6 139.98 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 113.215 -1.811 . . . . 1.73 110.169 -163.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -59.8 -32.31 70.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.511 1.148 . . . . 1.74 109.791 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -159.35 127.78 5.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.754 -2.021 . . . . 2.0 108.825 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.567 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -117.49 124.02 47.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.728 -1.124 . . . . 1.27 111.098 -177.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.704 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.3 t -158.7 95.23 1.3 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 123.236 1.493 . . . . 1.26 110.473 154.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.704 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.39 155.39 16.99 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 111.71 -2.495 . . . . 2.11 105.706 163.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.515 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 27.8 Cg_exo -61.13 126.05 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.15 1.233 . . . . 0.99 110.807 173.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.485 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 92.8 45.04 3.74 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 119.878 -1.153 . . . . 0.51 112.995 -172.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 37.0 mt-10 -141.88 174.45 10.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.903 0.351 . . . . 2.16 110.534 173.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.854 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -170.47 164.7 8.6 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.66 -1.237 . . . . 0.28 107.66 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.567 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 1.1 p -134.41 129.17 34.92 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 119.328 -0.949 . . . . 1.12 110.757 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.504 HG21 ' HG2' ' A' ' 121' ' ' LYS . 10.6 p -122.58 109.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.878 0.846 . . . . 1.1 111.832 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -106.89 -72.33 0.72 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.299 -0.864 . . . . 3.64 110.031 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.61 -53.97 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.72 0.295 . . . . 2.21 111.75 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -82.68 -12.63 57.46 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.491 -0.322 . . . . 1.95 111.721 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 15.9 p -160.33 153.26 21.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.13 0.967 . . . . 0.63 112.397 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.774 HD12 ' SD ' ' A' ' 124' ' ' MET . 74.6 mt -110.99 114.24 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.33 -1.759 . . . . 1.19 107.002 165.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.854 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.2 mp0 -90.59 165.85 13.52 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.978 -1.86 . . . . 1.13 105.978 174.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.591 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -167.64 156.76 9.87 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 124.123 0.89 . . . . 2.37 109.818 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.577 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 13.5 mt -127.28 105.44 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.054 -0.521 . . . . 1.14 110.19 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.771 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.2 ttt-85 -73.53 88.35 1.64 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.159 -0.928 . . . . 3.61 109.919 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.515 ' HB2' ' C ' ' A' ' 142' ' ' PRO . 53.4 ttt180 -60.55 144.11 89.28 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.064 -0.971 . . . . 6.8 109.854 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 1.4 Cg_endo -48.28 126.36 13.6 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 121.757 1.638 . . . . 2.5 110.938 166.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 165' ' ' LYS . 13.0 m-85 -125.78 136.57 53.29 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.927 -1.509 . . . . 2.1 106.927 175.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.27 74.34 3.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.645 1.212 . . . . 3.66 111.449 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 72.6 m-85 -120.69 148.9 49.28 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 113.524 -1.671 . . . . 3.96 110.023 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.7 Cg_exo -59.44 -31.84 95.43 Favored 'Trans proline' 0 CA--C 1.502 -1.087 0 C-N-CA 124.749 3.633 . . . . 4.73 113.513 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -88.47 -22.96 23.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.065 -0.971 . . . . 5.26 111.42 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.5 m -154.36 102.04 2.41 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.345 -0.843 . . . . 3.82 111.252 -170.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 64.7 tttm -147.83 98.02 2.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.701 -0.681 . . . . 3.83 109.337 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -144.87 179.36 7.38 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.702 -1.136 . . . . 3.14 111.636 -170.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.35 154.04 38.09 Favored Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 114.32 -1.309 . . . . 1.22 111.623 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.771 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.3 tt0 -59.63 153.46 19.95 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.393 0.616 . . . . 2.3 112.399 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 45.6 t -153.23 129.55 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.074 . . . . 1.12 109.519 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.583 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 27.5 mtm180 -82.82 118.32 23.33 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.049 -0.523 . . . . 3.33 109.847 168.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.3 131.05 56.35 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.654 0.74 . . . . 1.02 111.27 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.747 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 8.8 tpp180 -98.21 100.71 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.376 -1.283 . . . . 2.43 111.104 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.8 mp -87.0 92.38 9.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.175 -0.305 . . . . 1.36 110.175 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.83 120.83 35.7 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 122.626 1.203 . . . . 1.04 111.635 -175.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-30 -86.93 136.21 33.02 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.792 -2.004 . . . . 1.03 111.049 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 39.9 t0 -78.82 65.19 3.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.076 -1.824 . . . . 1.09 106.076 161.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.93 1.52 Allowed Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 118.944 -1.598 . . . . 0.5 110.497 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -82.42 -27.47 31.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.723 0.638 . . . . 0.83 112.723 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -129.85 129.54 44.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.77 0.795 . . . . 2.01 110.615 -167.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.9 tt -53.38 128.9 30.18 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.449 -1.705 . . . . 1.35 111.235 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.12 -38.35 6.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.83 -1.077 . . . . 1.08 110.047 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.7 p -146.15 162.58 37.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.655 -0.702 . . . . 1.12 110.648 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.747 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 26.8 mt -134.31 145.2 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 105.735 -1.95 . . . . 1.48 105.735 167.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 43.1 t -136.98 135.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 109.683 -0.488 . . . . 1.12 109.683 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.617 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 47.2 t-20 -76.94 108.08 9.73 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 106.809 -1.552 . . . . 1.77 106.809 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.583 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 36.3 mtm -67.94 -2.41 7.44 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.545 -0.462 . . . . 1.26 111.976 -169.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.617 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.0 pt-20 -85.65 -45.98 11.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.482 0.658 . . . . 1.02 111.321 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.583 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -102.16 -26.24 13.42 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 114.802 -1.09 . . . . 1.98 109.36 -176.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 185' ' ' ASN . 52.7 t30 76.48 27.16 0.83 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 112.446 -2.161 . . . . 2.0 107.559 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 17.6 ptt180 -84.56 162.85 19.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.14 -1.391 . . . . 2.78 109.249 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -91.98 139.14 30.94 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.562 1.172 . . . . 1.9 112.734 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.65 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 2.6 m-85 -100.75 -165.73 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.908 -1.951 . . . . 1.18 108.324 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.592 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.14 -5.64 3.61 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.644 -2.183 . . . . 1.89 107.644 -148.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -153.79 119.43 5.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.928 -1.136 . . . . 3.47 111.333 157.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.797 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 5.1 t80 -140.77 100.58 3.88 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.17 -0.678 . . . . 0.89 109.17 161.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -102.13 110.47 22.44 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.466 -0.771 . . . . 5.49 111.203 -170.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.96 168.2 17.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.548 0.69 . . . . 2.15 112.45 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -103.89 96.18 8.87 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.439 -1.255 . . . . 2.66 108.074 172.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.07 125.21 12.84 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.131 2.554 . . . . 2.4 113.828 -170.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.726 0 CA-C-N 114.64 -1.164 . . . . 5.84 111.602 -177.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.749 0.309 . . . . 26.61 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.93 -80.11 1.59 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.676 -0.774 . . . . 24.26 112.329 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.7 t -152.93 37.57 0.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.388 0.614 . . . . 23.88 109.988 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 m -89.48 97.35 11.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.912 -0.585 . . . . 23.12 110.743 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -124.48 73.69 1.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.365 -0.38 . . . . 22.4 110.679 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -130.34 -33.84 1.66 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.58 -0.282 . . . . 22.38 111.114 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -149.12 136.98 20.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.069 -0.345 . . . . 20.96 110.069 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -152.13 112.53 4.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.225 0.536 . . . . 18.66 110.252 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -126.9 12.84 7.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.758 -0.656 . . . . 18.21 109.493 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -129.67 19.35 5.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.842 -0.617 . . . . 18.15 110.323 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.7 p -96.98 71.18 2.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.908 -0.587 . . . . 16.83 111.11 -176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.1 p -90.44 -8.09 51.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.88 -0.6 . . . . 16.32 110.552 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.65 -127.1 8.86 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.94 -0.647 . . . . 14.64 111.99 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.41 -17.4 54.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.072 0.463 . . . . 16.04 110.728 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.2 t -67.3 125.37 90.96 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.97 -0.559 . . . . 12.96 110.114 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.79 156.75 31.24 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.001 2.467 . . . . 12.74 111.818 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' A' ' 103' ' ' ARG . 1.5 mpt_? -110.75 -40.19 4.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.443 -0.344 . . . . 12.74 111.061 -175.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.75 36.22 4.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.604 -0.807 . . . . 8.95 112.774 -176.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.447 ' C ' ' H ' ' A' ' 107' ' ' MET . 4.3 p -81.01 -33.96 33.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.646 0.26 . . . . 8.16 111.503 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 68.6 -18.0 0.18 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.112 0.782 . . . . 8.44 113.112 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.447 ' H ' ' C ' ' A' ' 105' ' ' SER . 54.9 ttm -67.57 100.24 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.869 0.366 . . . . 6.56 110.259 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.45 14.02 62.46 Favored Glycine 0 C--O 1.215 -1.072 0 CA-C-N 115.826 -0.624 . . . . 1.91 111.869 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -138.91 102.66 4.61 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.887 0.875 . . . . 5.09 108.73 175.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.433 ' HB2' ' HG3' ' A' ' 123' ' ' GLU . 21.9 mmt -140.85 135.82 31.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 113.787 1.032 . . . . 3.06 113.787 -166.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.57 105.68 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.447 1.118 . . . . 1.41 113.876 172.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -160.01 107.75 1.67 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.955 -1.93 . . . . 1.73 105.809 161.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.9 mp -87.67 108.7 19.22 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.987 -0.746 . . . . 2.04 108.987 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.2 tt0 -142.78 112.33 5.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.309 -0.956 . . . . 1.93 111.123 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.486 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.1 Cg_exo -35.9 127.79 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.012 3.141 . . . . 0.73 113.016 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.3 t70 75.74 43.83 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 O-C-N 124.476 1.11 . . . . 0.72 110.536 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.571 ' HE1' HD11 ' A' ' 180' ' ' LEU . 16.7 ptt? -114.06 154.99 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.818 -1.083 . . . . 2.33 110.14 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -102.77 98.56 8.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.15 -1.056 . . . . 1.11 108.15 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.592 HG13 ' CB ' ' A' ' 123' ' ' GLU . 1.5 tt -134.34 168.68 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 114.821 -1.081 . . . . 1.14 110.573 -164.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.527 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.3 m -141.36 175.55 9.57 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.207 -0.664 . . . . 0.89 109.207 -174.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.46 ' HA ' HD11 ' A' ' 152' ' ' ILE . 19.1 mttp -57.62 -32.72 67.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.304 -0.998 . . . . 2.86 108.304 164.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.576 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 34.6 t30 -83.02 -19.35 37.11 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 113.78 -1.555 . . . . 1.68 114.2 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.592 ' CB ' HG13 ' A' ' 119' ' ' ILE . 2.1 mp0 -82.49 -57.83 3.18 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.542 -1.974 . . . . 2.06 106.74 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.662 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 2.3 tpp -54.99 -13.76 1.24 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.381 -1.736 . . . . 3.58 111.969 170.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.576 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 13.1 p -45.24 -39.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 122.246 1.022 . . . . 1.11 110.09 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.7 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -66.76 -40.12 88.14 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.93 -1.487 . . . . 1.32 112.685 176.041 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.657 ' HA ' ' CD1' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -49.63 -33.34 15.12 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.378 0.608 . . . . 2.45 111.172 167.239 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 124' ' ' MET . 7.1 mt -83.97 -37.75 21.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.246 -0.888 . . . . 1.13 109.187 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.2 -43.26 92.26 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.288 -1.324 . . . . 1.96 110.221 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.44 -45.09 80.99 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.29 -1.777 . . . . 1.18 112.056 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.3 t -86.4 -2.63 58.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 123.664 1.697 . . . . 1.27 107.155 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 53.44 51.02 16.12 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.13 -2.759 . . . . 2.22 112.584 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.766 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -136.97 176.5 8.65 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.093 0.473 . . . . 0.9 111.782 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.8 153.84 49.62 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.758 -1.201 . . . . 5.25 107.758 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 19.3 tm0? -51.03 139.05 18.39 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.539 1.161 . . . . 2.03 112.341 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.666 HG11 ' O ' ' A' ' 145' ' ' PHE . 14.8 p -136.67 140.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 112.718 -2.037 . . . . 1.73 109.781 -164.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -58.95 -32.22 69.42 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.347 1.07 . . . . 1.74 109.439 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 27.3 ttpt -160.88 121.29 2.8 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.962 -1.927 . . . . 2.0 109.109 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.585 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -109.88 118.64 37.01 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.996 -1.002 . . . . 1.27 110.894 -177.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.08 96.52 2.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.948 1.356 . . . . 1.26 108.993 157.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.513 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -166.39 169.52 6.38 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.04 -2.345 . . . . 2.11 105.548 167.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.516 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 3.3 Cg_exo -77.87 125.12 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.486 1.457 . . . . 0.99 112.471 175.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.644 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 94.54 38.18 5.08 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 120.654 -0.784 . . . . 0.51 113.311 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.766 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 9.4 mp0 -131.69 173.44 11.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 122.604 -0.351 . . . . 2.16 110.079 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.854 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.9 p90 -169.0 166.65 11.01 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.601 -1.259 . . . . 0.28 107.601 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.585 ' CG2' ' HB3' ' A' ' 139' ' ' MET . 11.9 p -134.52 126.49 29.47 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.739 -0.784 . . . . 1.12 110.751 173.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 152' ' ' ILE . 11.1 p -117.68 110.29 30.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.827 0.823 . . . . 1.1 111.121 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -106.25 -75.82 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 3.64 110.204 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.68 -58.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.469 . . . . 2.21 110.545 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -92.24 7.49 42.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.122 -0.49 . . . . 1.95 111.924 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -161.25 152.14 18.33 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.938 0.875 . . . . 0.63 112.612 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.641 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 67.6 mt -120.32 109.9 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.371 -1.741 . . . . 1.19 106.742 163.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.854 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.11 170.96 9.88 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.292 -1.744 . . . . 1.13 106.292 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.62 ' SD ' HD11 ' A' ' 127' ' ' LEU . 10.6 ptm -167.29 158.18 11.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.679 0.612 . . . . 2.37 110.869 -173.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.56 HG12 ' HG3' ' A' ' 170' ' ' ARG . 13.0 mt -129.27 112.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.466 -0.788 . . . . 1.14 110.501 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.79 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 34.6 mtp180 -71.95 99.72 2.3 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.033 -0.667 . . . . 3.61 109.748 177.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.644 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 61.8 ttt180 -65.64 137.59 96.4 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 107.33 -1.359 . . . . 6.8 107.33 171.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -47.1 123.9 8.18 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 120.61 0.873 . . . . 2.5 110.009 169.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 22.7 m-85 -120.26 155.47 33.18 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.865 -1.516 . . . . 2.1 108.613 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -108.33 73.49 0.88 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.768 1.271 . . . . 3.66 111.049 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 92.8 m-85 -121.49 147.08 46.76 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 113.69 -1.596 . . . . 3.96 110.376 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 31.2 Cg_exo -59.08 -30.03 92.17 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 124.556 3.504 . . . . 4.73 112.847 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -98.18 -7.03 30.17 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.975 -1.011 . . . . 5.26 111.336 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 57.5 m -161.19 99.63 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.167 -0.469 . . . . 3.82 111.621 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 64.1 tttm -148.41 91.95 1.96 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.608 0.718 . . . . 3.83 109.78 174.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -155.26 -177.75 6.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.859 -1.064 . . . . 3.14 112.122 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.59 156.42 38.78 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.36 -0.837 . . . . 1.22 113.502 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.79 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 51.7 tt0 -49.82 147.63 3.63 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.215 -1.493 . . . . 2.3 114.692 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 66.2 t -153.06 131.38 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.377 -1.283 . . . . 1.12 109.884 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.56 ' HG3' HG12 ' A' ' 155' ' ' ILE . 17.3 mtm180 -91.38 111.56 23.11 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.097 -0.502 . . . . 3.33 110.395 169.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.75 146.99 41.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.026 0.917 . . . . 1.02 111.619 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.472 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 7.3 tpt180 -111.77 103.79 12.08 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.586 -1.643 . . . . 2.43 110.323 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.65 HD23 ' SD ' ' A' ' 124' ' ' MET . 5.5 mp -92.77 94.33 8.92 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.755 -0.461 . . . . 1.36 109.755 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.68 127.85 40.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.582 1.182 . . . . 1.04 111.83 -173.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.672 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-85 -94.16 135.46 35.51 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 112.653 -2.067 . . . . 1.03 110.801 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.524 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 18.7 t70 -80.99 64.39 5.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.925 -1.88 . . . . 1.09 105.925 162.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.72 -99.51 1.13 Allowed Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.219 -1.467 . . . . 0.5 111.004 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.66 -24.69 41.66 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.721 0.637 . . . . 0.83 112.721 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -132.34 128.64 38.13 Favored 'General case' 0 N--CA 1.426 -1.666 0 C-N-CA 119.577 -0.849 . . . . 2.01 110.645 -170.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.8 tt -53.92 130.72 38.38 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.585 -1.643 . . . . 1.35 110.26 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.93 -38.48 6.04 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.443 -0.799 . . . . 1.08 110.499 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -146.03 164.31 32.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.189 -0.46 . . . . 1.12 111.785 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.529 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.6 mm -116.45 148.93 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 105.114 -2.18 . . . . 1.48 105.114 164.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.1 t -139.78 128.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.416 0.627 . . . . 1.12 109.844 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.568 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 46.6 t-20 -75.94 111.55 11.44 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 107.123 -1.436 . . . . 1.77 107.123 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.504 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.2 mtm -70.22 -1.22 9.64 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.478 -0.489 . . . . 1.26 112.101 -169.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.568 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 7.4 pt-20 -83.18 -45.8 13.48 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.614 0.721 . . . . 1.02 111.265 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.522 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -103.67 -25.81 13.01 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.948 -1.023 . . . . 1.98 109.236 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 185' ' ' ASN . 47.6 t-20 74.28 36.17 0.68 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 112.278 -2.237 . . . . 2.0 107.127 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 7.2 ptm180 -93.27 161.53 14.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.422 -1.717 . . . . 2.78 109.387 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 78.4 mt-30 -88.17 125.23 34.51 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.99 -1.004 . . . . 1.9 109.46 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.529 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.7 92.28 4.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.884 -0.579 . . . . 1.18 110.446 -170.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.82 -58.03 0.0 OUTLIER Glycine 0 N--CA 1.469 0.881 0 C-N-CA 125.066 1.317 . . . . 1.89 116.334 146.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' PHE . 38.4 p90 -163.62 175.38 10.68 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.347 -1.426 . . . . 3.47 108.685 175.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.579 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.5 t80 -140.79 154.56 46.31 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.911 -1.144 . . . . 0.89 107.911 157.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.627 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -136.04 139.74 43.31 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.636 -0.665 . . . . 5.49 109.992 -170.667 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.657 ' CD1' ' HA ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -114.41 172.49 6.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 114.967 1.469 . . . . 2.15 114.967 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.428 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 9.9 p-10 -98.93 172.4 4.77 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 111.902 -2.408 . . . . 2.66 108.723 176.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 198' ' ' ASP . 81.3 Cg_exo -46.43 144.51 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.579 2.186 . . . . 2.4 113.548 172.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.352 0 CA-C-O 118.325 -0.845 . . . . 5.84 109.879 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.009 -0.367 . . . . 26.61 110.009 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.66 39.43 86.32 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.745 -0.942 . . . . 24.26 110.745 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -79.65 54.31 1.77 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.224 0.535 . . . . 23.88 111.615 -173.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 p -77.34 -47.71 19.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.832 -0.622 . . . . 23.12 109.5 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -169.8 -78.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.465 -0.789 . . . . 22.4 109.346 174.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 36.6 m80 53.04 -164.08 0.09 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.433 0.458 . . . . 22.38 111.641 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -68.7 -43.92 75.04 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.044 -0.354 . . . . 20.96 110.044 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 74.5 t60 65.8 -82.69 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.601 -0.727 . . . . 18.66 112.024 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 94' ' ' HIS . 59.0 m-70 69.78 131.44 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.447 0.699 . . . . 18.21 111.606 -174.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -83.38 83.4 7.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.782 -0.644 . . . . 18.15 109.546 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.1 p -69.99 -69.22 0.36 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.555 -0.748 . . . . 16.83 111.499 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 m 57.42 57.42 4.4 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.178 0.513 . . . . 16.32 110.902 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.86 -95.75 0.11 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.965 -0.636 . . . . 14.64 112.154 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.21 -61.88 1.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.528 0.204 . . . . 16.04 110.912 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.7 m -95.95 109.03 44.51 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.049 0.452 . . . . 12.96 111.424 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.91 -4.28 14.73 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.579 2.186 . . . . 12.74 112.885 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -95.87 -36.77 10.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.803 0.335 . . . . 12.74 111.143 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.85 -135.58 37.94 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.005 -0.616 . . . . 8.95 112.379 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.6 m 61.41 -80.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.337 0.655 . . . . 8.16 111.957 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -93.54 67.12 3.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.318 0.58 . . . . 8.44 110.607 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.8 mtm -71.4 126.26 29.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.765 -0.652 . . . . 6.56 111.437 -174.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.02 -30.9 9.47 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 115.787 -0.642 . . . . 1.91 112.343 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.836 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 72.6 mtt180 -87.31 91.84 8.86 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.529 -0.915 . . . . 5.09 108.529 177.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.602 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 27.0 ttt -143.89 131.1 20.72 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.96 -1.018 . . . . 3.06 113.203 -163.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.7 m -116.58 105.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 122.301 1.048 . . . . 1.41 112.883 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -159.92 106.22 1.61 Allowed 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.292 -1.776 . . . . 1.73 106.247 165.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.826 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.7 mp -97.3 111.52 23.73 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 119.958 -0.697 . . . . 2.04 109.528 -172.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -140.0 104.84 6.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.223 -0.899 . . . . 1.93 109.856 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.513 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 13.1 Cg_exo -33.63 129.74 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 125.157 3.905 . . . . 0.73 114.21 -172.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.6 t70 79.61 44.01 0.06 Allowed 'General case' 0 C--N 1.341 0.214 0 O-C-N 124.967 1.417 . . . . 0.72 110.529 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.658 ' SD ' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.35 155.65 34.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.876 -1.056 . . . . 2.33 110.774 173.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 29.2 m -93.36 77.87 4.47 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 122.282 1.039 . . . . 1.11 109.547 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.687 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -96.17 161.09 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.496 -1.684 . . . . 1.14 109.296 -174.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.578 ' H ' HG13 ' A' ' 119' ' ' ILE . 7.6 m -141.78 177.09 8.41 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 118.612 0.642 . . . . 0.89 109.925 -173.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.634 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 34.3 mttp -53.42 -33.66 54.8 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.149 -1.056 . . . . 2.86 108.149 163.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.836 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 41.1 t30 -81.88 -18.85 42.36 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 114.311 -1.313 . . . . 1.68 114.177 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.602 ' HA ' ' H ' ' A' ' 110' ' ' MET . 3.4 tt0 -85.64 -62.18 1.59 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.151 -1.593 . . . . 2.06 107.918 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.744 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -58.74 -16.78 18.24 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.455 -1.702 . . . . 3.58 111.143 172.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' ' 122' ' ' ASN . 9.6 p -42.81 -42.73 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.99 0.9 . . . . 1.11 111.071 176.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.55 ' CE ' HG12 ' A' ' 125' ' ' VAL . 10.5 mmpt? -67.7 -41.15 84.03 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.44 -1.254 . . . . 1.32 112.154 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.554 ' CG ' HD11 ' A' ' 197' ' ' LEU . 2.5 tm? -53.12 -32.44 47.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.396 0.617 . . . . 2.45 110.392 167.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.764 HD23 ' CD2' ' A' ' 145' ' ' PHE . 26.2 mt -82.16 -34.0 29.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.756 0.789 . . . . 1.13 109.066 -171.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.18 -37.25 85.17 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.235 -1.348 . . . . 1.96 110.164 167.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 127' ' ' LEU . . . -68.6 -41.94 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.675 -1.602 . . . . 1.18 112.512 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.408 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.13 -1.52 57.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 124.176 1.941 . . . . 1.27 106.107 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 56.13 55.19 7.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 110.714 -2.948 . . . . 2.22 111.927 170.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.536 ' CE1' ' HB ' ' A' ' 136' ' ' VAL . 2.5 t80 -138.3 174.94 10.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.479 0.657 . . . . 0.9 112.407 -176.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.1 ptt85 -141.86 147.61 37.44 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.948 -1.501 . . . . 5.25 106.948 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.83 135.05 20.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.763 1.268 . . . . 2.03 112.455 -171.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 145' ' ' PHE . 12.5 p -134.37 141.04 44.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.386 -2.188 . . . . 1.73 110.14 -162.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -58.74 -34.28 71.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.493 1.139 . . . . 1.74 109.61 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -160.12 128.5 4.81 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.782 -2.008 . . . . 2.0 109.101 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.563 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -118.43 133.79 55.59 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.838 -1.074 . . . . 1.27 111.612 -173.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.552 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.8 t -162.92 100.21 0.99 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.491 1.138 . . . . 1.26 110.957 153.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.3 OUTLIER -164.51 160.67 15.86 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 113.161 -1.836 . . . . 2.11 106.211 161.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.518 ' CB ' ' HA ' ' A' ' 157' ' ' ARG . 23.3 Cg_exo -62.94 120.92 8.61 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 121.055 1.17 . . . . 0.99 109.839 170.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 95.54 38.37 4.75 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 119.716 -1.231 . . . . 0.51 113.102 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 42.1 mt-10 -140.94 167.55 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.889 -0.411 . . . . 2.16 109.889 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.764 ' CD2' HD23 ' A' ' 128' ' ' LEU . 51.3 p90 -167.67 163.43 14.41 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.395 -0.965 . . . . 0.28 108.395 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.576 HG21 HG12 ' A' ' 136' ' ' VAL . 53.6 p -128.87 127.34 41.65 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.061 0.457 . . . . 1.12 110.703 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.484 HG23 ' HG2' ' A' ' 121' ' ' LYS . 11.8 p -121.51 116.65 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.555 0.693 . . . . 1.1 111.813 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.498 ' HG3' ' H ' ' A' ' 149' ' ' ALA . 11.0 pt20 -117.43 -62.34 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.863 -0.608 . . . . 3.64 111.247 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.498 ' H ' ' HG3' ' A' ' 148' ' ' GLN . . . -168.97 -63.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 2.21 110.791 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -83.0 4.65 25.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.365 -0.379 . . . . 1.95 111.798 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.687 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 16.4 p -165.47 150.0 8.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.978 0.894 . . . . 0.63 112.992 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.461 HG12 ' CG2' ' A' ' 147' ' ' VAL . 65.6 mt -116.5 107.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.333 -1.758 . . . . 1.19 106.326 160.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.535 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 5.5 mt-10 -99.42 102.2 13.7 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.57 -0.9 . . . . 1.13 108.57 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 8.6 ptm -109.38 156.94 19.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.157 -0.929 . . . . 2.37 112.149 -170.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.614 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.8 mt -123.5 119.07 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.322 -1.308 . . . . 1.14 109.991 172.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.7 mtm180 -65.57 119.58 11.36 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.437 0.461 . . . . 3.61 110.444 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.518 ' HA ' ' CB ' ' A' ' 142' ' ' PRO . 56.6 ttp180 -68.58 145.22 96.96 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 105.273 -2.121 . . . . 6.8 105.273 162.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -45.84 124.0 6.63 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 CA-C-N 120.782 1.315 . . . . 2.5 111.211 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.465 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 18.3 m-85 -129.59 151.02 50.66 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.617 -1.629 . . . . 2.1 107.41 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -107.95 81.34 1.48 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.246 1.022 . . . . 3.66 112.347 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 198' ' ' ASP . 36.8 m-85 -87.98 145.37 36.3 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 114.326 -1.306 . . . . 3.96 108.721 170.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.1 Cg_exo -60.23 -29.36 88.84 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 124.328 3.352 . . . . 4.73 112.432 175.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.5 -10.28 22.33 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.538 -1.21 . . . . 5.26 111.44 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.4 t -160.57 101.47 1.34 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.227 0.537 . . . . 3.82 110.559 -173.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -134.53 86.75 2.29 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.327 1.061 . . . . 3.83 109.377 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -144.51 -170.62 3.42 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 113.666 -1.607 . . . . 3.14 108.471 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.36 -129.17 0.65 Allowed Glycine 0 N--CA 1.434 -1.471 0 CA-C-O 123.186 1.437 . . . . 1.22 113.36 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.614 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 6.6 tt0 -83.97 152.79 24.26 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 111.812 -2.194 . . . . 2.3 113.276 -167.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 43.1 t -153.23 128.53 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.979 -1.01 . . . . 1.12 109.542 174.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.548 ' HB3' ' CE ' ' A' ' 186' ' ' MET . 15.0 mtt180 -89.86 114.09 25.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 120.9 0.381 . . . . 3.33 110.469 170.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.79 129.86 56.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.342 1.067 . . . . 1.02 111.278 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.5 tpt180 -96.09 100.28 11.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.219 -1.809 . . . . 2.43 110.925 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 151' ' ' SER . 10.7 mp -85.08 93.96 8.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.737 -0.468 . . . . 1.36 109.737 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.527 HG21 ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -94.59 113.44 25.26 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.504 1.145 . . . . 1.04 111.687 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -82.77 135.43 34.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.679 -2.055 . . . . 1.03 110.347 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 36.9 t70 -76.59 65.85 2.47 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.345 -1.724 . . . . 1.09 106.345 161.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 -98.37 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 118.877 -1.63 . . . . 0.5 110.78 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.79 -17.56 37.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.505 0.928 . . . . 0.83 113.505 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -139.45 130.27 26.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.506 -0.877 . . . . 2.01 110.628 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.687 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 4.8 tt -53.66 128.51 29.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.122 -1.399 . . . . 1.35 110.568 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -100.89 -39.02 7.98 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.717 -1.129 . . . . 1.08 108.994 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 26.2 p -150.8 158.96 44.78 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.475 -0.784 . . . . 1.12 110.592 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 16.1 mt -120.29 146.67 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 105.063 -2.199 . . . . 1.48 105.063 168.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 22.6 t -138.77 129.73 34.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.36 0.6 . . . . 1.12 110.152 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.591 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.3 t-20 -75.15 101.94 4.77 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 106.817 -1.549 . . . . 1.77 106.817 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.548 ' CE ' ' HB3' ' A' ' 170' ' ' ARG . 36.2 mtm -65.51 -3.09 3.95 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.653 0.595 . . . . 1.26 112.516 -167.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.591 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 8.5 pt-20 -80.1 -43.62 21.4 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.756 0.789 . . . . 1.02 110.813 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.582 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 8.9 m120 -104.91 -25.72 12.48 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 114.464 -1.244 . . . . 1.98 109.367 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 185' ' ' ASN . 58.0 t30 76.19 33.29 0.57 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 112.59 -2.096 . . . . 2.0 107.873 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.3 ptm180 -96.14 157.6 15.82 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 2.78 109.846 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.6 126.53 31.84 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.814 -1.084 . . . . 1.9 109.308 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.23 90.5 3.94 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.321 -0.552 . . . . 1.18 110.875 -168.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.27 -57.75 0.0 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 116.635 1.414 . . . . 1.89 116.635 145.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.476 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 3.4 p90 -164.08 175.58 10.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.525 -1.337 . . . . 3.47 109.671 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.826 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.3 t80 -148.34 103.42 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.206 0.526 . . . . 0.89 110.899 159.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 1.6 mmm180 -95.45 133.65 39.18 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.441 -0.787 . . . . 5.49 110.465 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.554 HD11 ' CG ' ' A' ' 127' ' ' LEU . 69.0 mt -122.89 171.44 9.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 114.388 1.255 . . . . 2.15 114.388 -166.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.453 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 19.0 t70 -101.32 111.28 63.44 Favored Pre-proline 0 C--O 1.22 -0.476 0 CA-C-N 113.935 -1.484 . . . . 2.66 110.554 -176.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.44 139.31 17.32 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.602 2.201 . . . . 2.4 113.224 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.578 ' HD3' ' O ' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.5 -0.773 . . . . 5.84 111.157 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 110.053 -0.351 . . . . 26.61 110.053 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 144.24 -85.8 0.18 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.633 -0.794 . . . . 24.26 112.28 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.9 m 69.23 -72.26 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.272 0.629 . . . . 23.88 111.044 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m -86.01 137.88 32.38 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.987 -0.375 . . . . 23.12 109.987 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -68.8 102.83 1.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.356 -0.384 . . . . 22.4 110.543 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -81.58 123.57 28.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 22.38 110.026 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -72.46 -25.59 61.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.132 0.492 . . . . 20.96 110.161 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -115.61 119.22 35.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.725 -0.843 . . . . 18.66 108.725 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -92.69 172.17 8.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.018 0.437 . . . . 18.21 111.398 -174.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -133.85 122.19 22.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.569 -0.742 . . . . 18.15 109.872 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.9 t -71.71 -53.26 14.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.912 -0.586 . . . . 16.83 110.013 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.8 p 45.34 51.66 9.32 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.175 0.59 . . . . 16.32 111.999 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.17 -148.31 21.33 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.653 -0.784 . . . . 14.64 111.998 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.29 -18.66 45.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.013 0.435 . . . . 16.04 109.899 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -110.91 100.01 44.76 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.492 0.663 . . . . 12.96 110.468 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -88.25 61.39 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.828 2.352 . . . . 12.74 112.242 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -101.31 126.63 48.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.228 -0.442 . . . . 12.74 110.895 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.32 80.88 0.34 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.138 -0.785 . . . . 8.95 111.138 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.8 t -98.5 172.62 7.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 8.16 110.37 -175.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -135.23 -50.39 0.75 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.699 -0.682 . . . . 8.44 109.979 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.3 mmt -79.4 -52.23 8.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.728 -0.669 . . . . 6.56 110.662 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 123' ' ' GLU . . . 75.58 -31.86 1.21 Allowed Glycine 0 C--O 1.226 -0.378 0 CA-C-N 115.652 -0.703 . . . . 1.91 114.066 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.732 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -35.51 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.58 1.152 . . . . 5.09 113.36 177.411 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 15.6 tpt -142.44 129.92 21.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.61 -1.177 . . . . 3.06 111.786 -175.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 111' ' ' VAL . 20.9 m -118.56 102.63 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.731 1.253 . . . . 1.41 111.904 168.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -162.44 109.59 1.3 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.111 -1.859 . . . . 1.73 106.244 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 52.2 mt -96.38 108.04 20.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.418 -0.586 . . . . 2.04 109.418 -175.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 117' ' ' MET . 2.6 tm-20 -142.88 110.14 5.58 Favored Pre-proline 0 C--N 1.309 -1.192 0 C-N-CA 119.298 -0.961 . . . . 1.93 110.442 -175.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 27.9 Cg_exo -35.11 126.61 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 124.25 3.3 . . . . 0.73 113.777 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 22.3 t0 75.9 49.61 0.07 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.762 1.267 . . . . 0.72 110.37 -174.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.569 ' HE3' HD13 ' A' ' 180' ' ' LEU . 13.5 ptt? -119.27 155.71 31.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.983 -1.462 . . . . 2.33 109.529 172.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.0 m -101.76 83.88 2.47 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.365 -0.976 . . . . 1.11 108.365 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.57 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -109.0 161.41 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.821 -1.536 . . . . 1.14 110.071 -170.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.615 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.4 m -142.79 174.17 10.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.623 -0.881 . . . . 0.89 108.623 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.966 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 19.4 mtpp -54.93 -28.37 50.52 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.671 0.748 . . . . 2.86 109.723 163.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.554 ' O ' HG13 ' A' ' 125' ' ' VAL . 32.4 t30 -85.93 -18.68 32.01 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 114.692 1.367 . . . . 1.68 114.692 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.615 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.0 OUTLIER -86.09 -62.91 1.41 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.565 1.174 . . . . 2.06 108.134 171.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.966 ' SD ' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -58.12 -14.04 6.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 112.347 -2.206 . . . . 3.58 110.871 173.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 122' ' ' ASN . 12.1 p -41.89 -42.32 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.91 0.862 . . . . 1.11 109.637 170.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.732 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -68.37 -39.96 81.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.579 -1.191 . . . . 1.32 113.834 174.456 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.552 ' HB3' ' O ' ' A' ' 124' ' ' MET . 0.7 OUTLIER -49.9 -32.2 14.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.446 0.641 . . . . 2.45 111.0 170.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 124' ' ' MET . 8.6 mt -85.67 -37.68 19.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 1.13 108.984 -172.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.61 -36.19 77.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.94 -1.482 . . . . 1.96 109.672 168.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.417 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -72.66 -41.27 65.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.879 -1.509 . . . . 1.18 112.208 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.5 t -89.04 -0.77 57.71 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 123.255 1.502 . . . . 1.27 107.641 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 52.16 52.21 14.79 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.173 -2.739 . . . . 2.22 112.337 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.753 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.3 t80 -138.99 176.19 8.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.9 112.022 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -139.18 153.0 47.84 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.682 -1.229 . . . . 5.25 107.682 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 17.8 tm0? -50.84 138.95 17.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.535 1.16 . . . . 2.03 112.591 -169.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.5 p -136.22 140.94 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.802 -1.999 . . . . 1.73 109.972 -163.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -58.35 -32.77 68.85 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.714 1.245 . . . . 1.74 109.478 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 7.0 ttpt -160.22 127.12 4.36 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 112.417 -2.174 . . . . 2.0 108.663 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -112.91 124.02 51.65 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.227 -0.897 . . . . 1.27 110.767 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.16 97.88 1.82 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.99 1.376 . . . . 1.26 109.105 154.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.575 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -165.64 169.51 6.94 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 112.251 -2.249 . . . . 2.11 105.662 166.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.552 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 60.5 Cg_endo -75.88 123.9 7.71 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 120.777 1.313 . . . . 0.99 112.311 173.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.524 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 98.25 39.76 3.66 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 120.678 -0.772 . . . . 0.51 113.279 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.753 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 12.4 mp0 -135.48 173.78 11.33 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 122.829 0.452 . . . . 2.16 110.585 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.85 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.3 p90 -169.19 168.62 9.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.245 -1.02 . . . . 0.28 108.245 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 40.5 p -135.27 126.46 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.357 -0.537 . . . . 1.12 111.955 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.628 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.8 p -125.37 129.05 73.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.956 -0.565 . . . . 1.1 111.804 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.488 ' HA ' ' OE1' ' A' ' 148' ' ' GLN . 6.1 tp60 -144.2 -70.18 0.3 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.326 -0.55 . . . . 3.64 111.534 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.28 -67.46 0.54 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 2.21 112.633 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -87.27 -11.76 48.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.807 0.669 . . . . 1.95 112.807 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 20.6 p -165.05 157.77 16.15 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.873 0.844 . . . . 0.63 112.933 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.662 HD13 ' SD ' ' A' ' 124' ' ' MET . 50.2 mt -114.61 115.76 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.079 -1.419 . . . . 1.19 107.613 167.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.85 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.3 mp0 -89.33 171.39 9.79 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 106.51 -1.663 . . . . 1.13 106.51 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.598 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 26.7 ptm -167.96 154.16 7.49 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.739 0.649 . . . . 2.37 110.348 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.552 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.5 mt -128.75 114.32 32.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.33 -0.395 . . . . 1.14 110.826 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.722 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 10.0 mtp-105 -72.11 95.76 1.68 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.664 -0.414 . . . . 3.61 111.209 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.552 ' HB2' ' C ' ' A' ' 142' ' ' PRO . 35.9 ttm180 -59.24 131.29 87.47 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.488 -1.671 . . . . 6.8 106.488 163.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -49.95 123.72 11.32 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 CA-C-N 119.844 0.98 . . . . 2.5 110.962 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 6.4 m-85 -124.77 130.89 53.29 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.215 -1.811 . . . . 2.1 106.744 174.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.97 86.76 4.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.531 1.158 . . . . 3.66 111.642 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 72.3 m-85 -116.52 150.97 46.46 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 113.803 -1.544 . . . . 3.96 109.757 172.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.2 Cg_exo -60.16 -30.04 90.44 Favored 'Trans proline' 0 CA--C 1.502 -1.117 0 C-N-CA 124.781 3.654 . . . . 4.73 113.174 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.08 -7.94 28.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.954 -1.021 . . . . 5.26 111.312 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.4 m -158.48 109.01 2.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.033 0.444 . . . . 3.82 110.999 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -148.02 100.74 3.22 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.613 0.721 . . . . 3.83 109.411 174.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -148.65 164.26 34.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.535 -1.211 . . . . 3.14 110.793 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.58 160.19 45.18 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 113.798 -1.547 . . . . 1.22 111.947 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.722 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.2 tt0 -47.06 140.65 4.8 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 114.412 1.264 . . . . 2.3 114.412 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 44.2 t -154.5 130.29 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.707 -1.588 . . . . 1.12 109.99 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.601 ' HB3' ' HE2' ' A' ' 186' ' ' MET . 35.7 mtm180 -86.9 114.77 23.81 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 116.189 -0.46 . . . . 3.33 110.325 168.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -117.0 132.43 56.71 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.844 0.83 . . . . 1.02 111.289 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.513 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 11.5 tpp180 -99.28 109.08 21.76 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.039 -1.437 . . . . 2.43 111.034 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 5.4 mp -91.59 91.48 8.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.12 -0.491 . . . . 1.36 109.968 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.7 125.59 37.39 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.283 1.04 . . . . 1.04 111.844 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.666 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 2.0 m-85 -89.59 138.15 31.72 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.953 -1.93 . . . . 1.03 111.579 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.514 ' HB2' ' HB1' ' A' ' 181' ' ' ALA . 30.3 t70 -81.96 64.99 6.89 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 105.833 -1.914 . . . . 1.09 105.833 159.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.16 -98.75 1.02 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 118.892 -1.623 . . . . 0.5 111.144 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.34 -25.57 46.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.521 0.563 . . . . 0.83 112.521 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -135.46 132.88 37.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.369 0.604 . . . . 2.01 110.132 -168.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -54.59 134.02 46.62 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.1 -1.409 . . . . 1.35 110.617 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 176' ' ' ASP . . . -106.78 -41.54 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.925 -1.034 . . . . 1.08 110.081 -176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 p -147.21 163.8 35.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.027 -0.533 . . . . 1.12 111.705 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.509 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.6 mm -111.14 148.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.144 -2.169 . . . . 1.48 105.144 165.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.8 t -141.51 131.79 25.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.407 0.622 . . . . 1.12 109.947 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.566 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 40.7 t-20 -79.44 110.11 14.43 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.124 -1.065 . . . . 1.77 108.124 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.601 ' HE2' ' HB3' ' A' ' 170' ' ' ARG . 16.3 mtp -65.91 -2.46 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.036 0.754 . . . . 1.26 113.036 -171.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.566 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 8.3 pt-20 -81.18 -42.53 20.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.817 0.818 . . . . 1.02 111.153 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.482 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 6.1 m-20 -111.24 -26.55 9.11 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.391 -1.277 . . . . 1.98 109.738 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 185' ' ' ASN . 9.2 t30 76.28 34.47 0.5 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.519 -2.128 . . . . 2.0 107.642 -177.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 5.2 ptm180 -90.31 162.92 14.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.427 -1.715 . . . . 2.78 108.641 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -88.02 140.17 29.77 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.727 -0.67 . . . . 1.9 110.001 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.509 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -114.08 92.31 3.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.701 -0.666 . . . . 1.18 110.523 -176.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.08 -58.63 0.0 OUTLIER Glycine 0 N--CA 1.469 0.839 0 N-CA-C 116.15 1.22 . . . . 1.89 116.15 146.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 192' ' ' PHE . 35.0 p90 -163.42 174.23 12.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.702 -1.249 . . . . 3.47 109.25 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.509 ' HB3' ' CD1' ' A' ' 113' ' ' LEU . 1.4 t80 -140.31 154.45 46.8 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.201 -0.666 . . . . 0.89 109.201 159.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.599 ' H ' ' HD2' ' A' ' 196' ' ' ARG . 0.1 OUTLIER -138.53 153.97 48.76 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.806 -0.559 . . . . 5.49 111.933 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 127' ' ' LEU . 5.1 mt -129.55 172.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.425 1.268 . . . . 2.15 114.425 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.454 ' OD2' ' HD2' ' A' ' 159' ' ' PHE . 3.2 m-20 -85.7 137.93 35.85 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 112.38 -2.191 . . . . 2.66 111.03 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.738 ' O ' ' HD2' ' A' ' 200' ' ' ARG . 8.1 Cg_endo -54.83 136.61 72.64 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.13 3.22 . . . . 2.4 114.481 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.738 ' HD2' ' O ' ' A' ' 199' ' ' PRO . 14.2 mmm180 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.883 -0.579 . . . . 5.84 109.83 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 121.017 0.437 . . . . 26.61 110.238 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.25 -111.96 0.5 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.576 -0.61 . . . . 24.26 111.576 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' HD2' ' A' ' 91' ' ' HIS . 24.0 t 58.29 40.05 24.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.953 0.406 . . . . 23.88 110.932 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.8 m 70.43 12.58 7.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.571 -0.74 . . . . 23.12 112.147 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.415 ' HD2' ' O ' ' A' ' 89' ' ' SER . 10.5 p80 -152.32 59.9 0.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.54 0.686 . . . . 22.4 110.603 175.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -59.2 -27.82 66.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.73 -0.668 . . . . 22.38 110.571 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -154.45 156.35 36.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.01 -0.541 . . . . 20.96 109.76 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -85.34 151.29 24.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.754 -0.461 . . . . 18.66 109.754 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -58.54 -74.92 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.568 0.581 . . . . 18.21 112.568 -167.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -85.88 -1.11 56.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 18.15 111.144 -174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 m -80.64 -17.85 49.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.167 0.508 . . . . 16.83 109.893 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.8 m -94.94 79.69 3.64 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.957 -0.565 . . . . 16.32 110.427 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.95 -164.0 18.44 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.665 -0.698 . . . . 14.64 111.595 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.9 mt -92.53 122.26 34.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.272 -0.269 . . . . 16.04 110.272 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 p 37.4 88.7 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 O-C-N 124.515 1.134 . . . . 12.96 113.324 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.79 66.22 6.7 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.841 2.361 . . . . 12.74 112.446 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -68.09 -63.32 1.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.205 -0.452 . . . . 12.74 111.488 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.18 59.67 4.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 8.95 112.666 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.477 ' HA ' ' CD ' ' A' ' 109' ' ' ARG . 50.6 m -96.53 80.97 3.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.091 0.472 . . . . 8.16 111.354 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -95.74 49.3 1.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.079 -0.509 . . . . 8.44 109.766 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 53.6 tpp 65.46 98.08 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.225 0.824 . . . . 6.56 113.225 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.36 -28.87 12.14 Favored Glycine 0 C--O 1.224 -0.502 0 CA-C-O 118.565 -1.13 . . . . 1.91 114.87 168.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.477 ' CD ' ' HA ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -20.32 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.68 0.993 . . . . 5.09 113.68 175.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.2 tpt -141.37 132.57 26.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.332 -0.547 . . . . 3.06 112.015 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 13.3 m -121.88 104.29 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 122.814 1.292 . . . . 1.41 113.037 171.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.643 ' O ' ' HE1' ' A' ' 117' ' ' MET . 63.1 t30 -161.01 110.72 1.67 Allowed 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 105.011 -2.218 . . . . 1.73 105.011 166.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 59.1 mt -97.16 115.22 27.16 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.967 -0.693 . . . . 2.04 110.963 -174.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.419 ' N ' ' HE2' ' A' ' 117' ' ' MET . 21.9 tt0 -155.34 91.26 2.86 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 121.649 0.738 . . . . 1.93 109.279 -173.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.643 ' HA ' ' CD2' ' A' ' 180' ' ' LEU . 0.3 OUTLIER -31.49 144.22 0.03 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.76 1 C-N-CA 126.671 4.914 . . . . 0.73 115.536 -175.946 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.3 t70 78.05 36.61 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 113.757 -1.565 . . . . 0.72 109.057 -170.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.643 ' HE1' ' O ' ' A' ' 112' ' ' ASN . 7.2 ptp -121.09 155.43 34.46 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.768 -1.106 . . . . 2.33 111.09 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.7 m -101.37 84.47 2.62 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.224 -1.028 . . . . 1.11 108.224 -175.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.615 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -110.03 163.91 6.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.055 -1.43 . . . . 1.14 109.854 -168.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.532 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.8 m -140.87 177.41 8.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.064 -0.655 . . . . 0.89 109.913 -172.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.605 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -60.97 -27.07 68.01 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 108.145 -1.057 . . . . 2.86 108.145 165.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.508 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER -84.54 -17.73 37.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.996 -1.456 . . . . 1.68 114.416 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.532 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.9 mp0 -85.48 -62.39 1.54 Allowed 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 120.56 -1.337 . . . . 2.06 108.421 170.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.766 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 mmt -57.02 -16.52 7.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.166 -1.834 . . . . 3.58 111.901 173.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 14.9 p -42.34 -42.82 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.219 1.009 . . . . 1.11 110.797 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.68 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -67.83 -41.24 83.3 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.947 -1.478 . . . . 1.32 113.087 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.489 ' HB3' ' O ' ' A' ' 124' ' ' MET . 2.9 tm? -52.61 -32.73 43.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.29 0.567 . . . . 2.45 110.273 167.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.8 mt -82.34 -35.92 27.4 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.442 0.639 . . . . 1.13 109.541 -172.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 200' ' ' ARG . 0.5 OUTLIER -57.77 -44.7 86.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.664 -1.153 . . . . 1.96 109.944 164.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 127' ' ' LEU . . . -65.09 -39.64 93.46 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.209 -1.814 . . . . 1.18 112.636 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 128' ' ' LEU . 2.8 t -93.19 3.92 54.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.191 -1.781 . . . . 1.27 106.191 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.84 52.24 9.88 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 110.84 -2.891 . . . . 2.22 111.88 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.579 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 2.6 t80 -136.7 175.17 9.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 119.901 -0.72 . . . . 0.9 112.725 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -139.67 149.9 44.26 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.664 -1.606 . . . . 5.25 106.664 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.505 ' HB2' HG11 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -49.92 141.52 10.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.534 1.159 . . . . 2.03 113.136 -169.028 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.571 HG12 HG22 ' A' ' 146' ' ' THR . 14.1 p -139.91 141.46 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.957 -1.929 . . . . 1.73 110.07 -162.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m -58.85 -34.59 71.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 122.607 1.194 . . . . 1.74 109.232 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 4.9 tmmm? -160.81 130.29 4.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.491 -2.141 . . . . 2.0 109.259 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 139' ' ' MET . 0.0 OUTLIER -119.08 125.82 50.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.624 -1.171 . . . . 1.27 112.117 -172.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.475 ' HA ' HD13 ' A' ' 155' ' ' ILE . 1.7 t -160.64 99.79 1.28 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.931 1.348 . . . . 1.26 110.865 156.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -165.73 157.89 12.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 105.501 -2.037 . . . . 2.11 105.501 163.379 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -61.13 113.68 1.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.088 1.424 . . . . 0.99 109.727 171.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.422 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 105.45 47.71 1.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.214 -0.993 . . . . 0.51 113.272 -175.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.579 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 44.3 mt-10 -145.73 170.7 15.97 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 122.532 0.333 . . . . 2.16 110.264 172.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.845 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 49.8 p90 -167.8 165.31 14.09 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.918 -1.141 . . . . 0.28 107.918 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.611 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 35.9 p -132.17 126.11 32.83 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.862 -0.735 . . . . 1.12 110.843 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 135' ' ' GLN . 8.6 p -125.18 169.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.798 -0.637 . . . . 1.1 111.413 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? 78.05 75.56 0.06 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.637 0.775 . . . . 3.64 110.215 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -177.85 -94.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.373 -1.285 . . . . 2.21 109.167 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -135.68 11.89 3.43 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.13 0.491 . . . . 1.95 110.443 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 3.3 p -165.8 158.06 14.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.63 112.265 -171.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.641 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 38.5 mt -107.69 106.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 106.458 -1.682 . . . . 1.19 106.458 159.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.845 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.7 mt-10 -91.07 164.18 14.04 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 104.779 -2.304 . . . . 1.13 104.779 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 19.2 ptp -166.06 164.0 18.16 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.871 0.732 . . . . 2.37 110.221 -170.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.801 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.2 mt -127.95 94.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.854 0.835 . . . . 1.14 110.698 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.701 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 1.3 tmt_? -127.94 97.59 4.86 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.496 -1.229 . . . . 3.61 111.857 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.537 ' HB3' ' HA ' ' A' ' 168' ' ' GLN . 9.0 tpt180 -128.65 163.89 41.98 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 104.852 -2.277 . . . . 6.8 104.852 153.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.462 ' HD2' ' HG3' ' A' ' 157' ' ' ARG . 19.2 Cg_exo -43.02 126.0 4.37 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 CA-C-N 120.611 1.254 . . . . 2.5 111.068 165.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.562 ' HB2' ' CE2' ' A' ' 161' ' ' PHE . 85.9 m-85 -79.54 169.46 17.99 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.772 -2.013 . . . . 2.1 109.829 -175.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.1 77.9 0.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.458 1.123 . . . . 3.66 112.014 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 159' ' ' PHE . 31.2 m-85 -114.08 153.05 46.31 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 113.619 -1.628 . . . . 3.96 109.229 172.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 38.4 Cg_exo -60.63 -34.29 92.42 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 124.284 3.323 . . . . 4.73 113.124 176.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -92.12 -11.28 36.1 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.073 -0.967 . . . . 5.26 111.759 -176.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 58.4 m -161.27 111.79 1.7 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.128 -1.064 . . . . 3.82 108.128 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -137.96 103.58 5.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.683 0.754 . . . . 3.83 110.207 -174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -134.61 162.92 30.94 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.411 -1.268 . . . . 3.14 111.611 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' ARG . . . -81.21 127.31 7.84 Favored Glycine 0 CA--C 1.494 -1.232 0 CA-C-N 114.048 -1.433 . . . . 1.22 111.089 172.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 2.6 pm0 -53.16 -176.19 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 114.821 1.415 . . . . 2.3 114.821 -173.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.801 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 4.0 t -155.5 127.69 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 113.706 -1.588 . . . . 1.12 110.334 -169.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 154' ' ' MET . 22.2 mtm180 -93.63 115.24 27.7 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.583 0.23 . . . . 3.33 110.551 171.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -112.9 130.2 56.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.93 0.872 . . . . 1.02 110.904 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.754 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.8 tpt180 -96.09 98.48 10.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.762 -1.563 . . . . 2.43 110.901 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.641 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 7.0 mp -88.49 97.8 11.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 110.169 -0.308 . . . . 1.36 110.169 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.19 117.11 30.67 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.576 1.179 . . . . 1.04 111.672 -173.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -85.45 131.92 34.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.689 -2.05 . . . . 1.03 110.03 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 38.2 t70 -76.9 65.3 2.56 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.199 -1.778 . . . . 1.09 106.199 164.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.96 -98.55 0.88 Allowed Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 119.138 -1.506 . . . . 0.5 110.526 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.71 -26.34 54.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.88 0.696 . . . . 0.83 112.88 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.468 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 5.7 p-80 -137.34 130.02 30.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.636 0.732 . . . . 2.01 111.187 -167.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 5.3 tt -53.13 127.75 25.31 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.93 -1.487 . . . . 1.35 110.87 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -39.39 5.88 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.253 -0.885 . . . . 1.08 110.186 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.8 p -145.96 166.66 25.38 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.965 -0.562 . . . . 1.12 110.885 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 38.5 mt -136.59 145.48 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 106.025 -1.843 . . . . 1.48 106.025 169.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 38.8 t -139.16 132.94 39.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.295 0.569 . . . . 1.12 109.996 -173.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.431 ' CB ' ' HG2' ' A' ' 190' ' ' ARG . 0.2 OUTLIER -80.55 103.34 10.33 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.577 -1.268 . . . . 1.77 107.577 -176.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.566 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 29.5 mtm -65.92 -1.59 3.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 123.861 0.726 . . . . 1.26 112.722 -166.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 188' ' ' ASN . 11.7 pt-20 -77.13 -45.62 26.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.015 0.912 . . . . 1.02 110.696 174.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 190' ' ' ARG . 27.0 t-20 -108.65 -26.31 10.43 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.125 -1.398 . . . . 1.98 109.249 -174.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.3 t30 78.09 26.93 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.654 -2.066 . . . . 2.0 107.109 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 16.7 ptt180 -85.0 160.64 20.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.841 -1.527 . . . . 2.78 109.651 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.66 141.41 28.54 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.457 -1.247 . . . . 1.9 113.518 -172.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.669 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 5.8 m-85 -106.85 -166.56 1.18 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 112.635 -2.075 . . . . 1.18 107.092 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.528 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.55 -10.72 3.75 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.591 -2.203 . . . . 1.89 107.591 -149.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 196' ' ' ARG . 27.4 p90 -155.76 105.39 2.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.196 -1.002 . . . . 3.47 111.267 156.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.586 ' C ' ' HD2' ' A' ' 196' ' ' ARG . 4.0 t80 -119.57 132.75 55.8 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.13 -0.981 . . . . 0.89 109.325 166.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.586 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.1 mpt_? -115.92 146.35 42.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.867 -0.42 . . . . 5.49 109.867 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 33.0 mt -127.73 162.78 25.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.431 -0.35 . . . . 2.15 111.577 -171.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -94.27 163.21 23.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 2.66 110.61 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -45.26 148.01 2.11 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.151 2.567 . . . . 2.4 113.23 173.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.488 ' O ' ' HD2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.855 -0.611 . . . . 5.84 110.731 -174.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.1 ttm . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.945 -0.391 . . . . 26.61 109.945 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.08 24.39 57.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.893 -0.67 . . . . 24.26 111.86 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 4.9 m -84.25 157.72 21.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.755 0.312 . . . . 23.88 110.819 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.1 m -85.27 102.57 13.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.719 -0.475 . . . . 23.12 109.719 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 49.7 t60 62.13 71.99 0.52 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.381 0.61 . . . . 22.4 109.841 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 89' ' ' SER . 33.9 t60 -76.53 82.7 3.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.511 -0.768 . . . . 22.38 110.239 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 -155.87 0.63 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.494 -0.776 . . . . 20.96 109.759 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 71.54 -77.95 0.05 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.319 0.648 . . . . 18.66 109.62 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -147.29 -74.33 0.2 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.435 -0.95 . . . . 18.21 108.435 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -135.76 -58.86 0.77 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.045 -0.724 . . . . 18.15 109.045 172.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 m 57.21 68.29 0.87 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.504 -0.771 . . . . 16.83 112.19 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 p -94.18 -12.29 28.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.966 -0.561 . . . . 16.32 110.516 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.61 70.44 0.8 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.888 -0.672 . . . . 14.64 112.244 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.5 tp -70.08 120.21 15.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.762 0.315 . . . . 16.04 110.593 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.14 97.37 38.64 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 121.082 0.468 . . . . 12.96 110.702 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.79 -178.49 3.13 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.709 2.273 . . . . 12.74 111.98 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -64.21 -64.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.404 -0.591 . . . . 12.74 109.404 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.02 159.54 19.04 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.886 -0.673 . . . . 8.95 112.996 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 p -127.68 138.85 52.94 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.146 -0.316 . . . . 8.16 110.146 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.414 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 32.6 m80 64.35 78.17 0.29 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.539 0.524 . . . . 8.44 110.378 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.483 ' HA ' ' HE3' ' A' ' 107' ' ' MET . 27.1 mmt -62.19 117.97 6.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.979 -0.555 . . . . 6.56 111.053 -176.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.93 -8.61 59.58 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.999 -0.619 . . . . 1.91 112.402 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -140.59 75.12 1.49 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.447 0.699 . . . . 5.09 109.985 173.354 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.613 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 9.2 ttt -137.65 97.64 3.49 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 118.098 -1.441 . . . . 3.06 113.748 -163.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.6 m -101.42 107.79 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 113.548 0.944 . . . . 1.41 113.548 -178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.466 ' O ' ' HE1' ' A' ' 117' ' ' MET . 7.4 p30 -159.2 110.88 2.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.922 -1.881 . . . . 1.73 105.922 166.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.795 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.4 mp -100.72 116.15 31.94 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.461 -0.496 . . . . 2.04 110.406 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 0.3 OUTLIER -154.01 90.24 3.3 Favored Pre-proline 0 N--CA 1.432 -1.371 0 N-CA-C 109.089 -0.708 . . . . 1.93 109.089 -177.187 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.68 ' HD3' ' CD1' ' A' ' 183' ' ' ILE . 1.3 Cg_exo -29.04 144.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 1 C-N-CA 126.755 4.97 . . . . 0.73 116.467 -175.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.9 t70 74.68 37.66 0.52 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.791 -1.55 . . . . 0.72 108.781 -172.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.466 ' HE1' ' O ' ' A' ' 112' ' ' ASN . 5.8 ptp -120.9 155.88 33.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.199 -1.364 . . . . 2.33 110.893 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.1 m -101.33 82.25 2.3 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 122.42 1.105 . . . . 1.11 108.33 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.521 HG12 ' SD ' ' A' ' 124' ' ' MET . 17.8 tt -121.54 165.11 17.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.349 -1.75 . . . . 1.14 108.668 -169.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.492 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 4.2 m -140.1 175.66 9.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.713 -0.795 . . . . 0.89 111.405 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 121' ' ' LYS . 1.8 mptt -59.95 -20.14 55.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.044 -0.98 . . . . 2.86 108.91 169.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.6 ' O ' HG13 ' A' ' 125' ' ' VAL . 9.2 t30 -83.03 -21.87 33.71 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 114.062 -1.426 . . . . 1.68 112.757 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.613 ' HG3' ' HB3' ' A' ' 110' ' ' MET . 1.2 mp0 -85.94 -48.46 8.68 Favored 'General case' 0 N--CA 1.408 -2.533 0 O-C-N 120.01 -1.681 . . . . 2.06 107.825 173.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.735 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -62.59 -18.03 61.32 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 113.762 -1.563 . . . . 3.58 111.264 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -47.34 -40.74 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 122.324 1.059 . . . . 1.11 110.569 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.606 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -66.94 -41.04 87.63 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.872 -1.513 . . . . 1.32 113.351 177.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.534 ' CG ' HD13 ' A' ' 197' ' ' LEU . 2.9 tm? -52.11 -34.93 46.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.532 0.682 . . . . 2.45 110.156 168.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 124' ' ' MET . 18.0 mt -83.23 -36.24 24.76 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.783 0.801 . . . . 1.13 109.054 -170.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HB3' ' HA ' ' A' ' 200' ' ' ARG . 2.0 tp10 -61.82 -39.64 92.49 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.114 -1.403 . . . . 1.96 109.468 167.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.34 -43.29 81.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.306 -1.315 . . . . 1.18 112.252 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.46 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.52 2.98 56.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 124.373 2.035 . . . . 1.27 106.336 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 56.09 46.37 21.76 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 110.341 -3.118 . . . . 2.22 112.409 169.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.893 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -136.77 174.88 10.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.84 -0.744 . . . . 0.9 112.753 -173.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.426 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 31.8 ttm180 -142.97 154.72 44.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.016 -1.476 . . . . 5.25 107.016 177.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 13.6 tm0? -49.43 142.88 7.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.593 1.187 . . . . 2.03 113.714 -167.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.719 HG11 ' O ' ' A' ' 145' ' ' PHE . 13.3 p -142.97 142.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 112.752 -2.022 . . . . 1.73 110.304 -163.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 -34.05 70.01 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.718 1.247 . . . . 1.74 109.17 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -158.86 123.05 3.98 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.508 -2.133 . . . . 2.0 108.653 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.641 ' SD ' HG21 ' A' ' 146' ' ' THR . 0.0 OUTLIER -111.2 128.55 55.95 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.095 -0.957 . . . . 1.27 110.209 -178.545 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.592 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -160.89 99.15 1.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.756 1.265 . . . . 1.26 109.97 158.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -165.18 168.52 8.38 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 112.595 -2.093 . . . . 2.11 105.618 162.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.511 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 14.9 Cg_exo -66.02 119.25 6.25 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 N-CA-C 109.192 -1.118 . . . . 0.99 109.192 167.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 90.94 47.96 3.5 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.513 -1.327 . . . . 0.51 113.161 -171.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.893 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.1 mt-10 -150.62 147.17 27.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.845 -0.798 . . . . 2.16 108.845 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.719 ' O ' HG11 ' A' ' 136' ' ' VAL . 38.4 p90 -154.19 160.64 41.96 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.729 -0.841 . . . . 0.28 108.729 -177.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.641 HG21 ' SD ' ' A' ' 139' ' ' MET . 39.1 p -125.24 127.64 47.06 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.496 0.665 . . . . 1.12 110.606 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 12.8 p -121.43 113.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.187 -0.915 . . . . 1.1 110.911 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -111.53 -80.78 0.58 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.62 -0.718 . . . . 3.64 110.321 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.09 -54.84 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.72 -0.673 . . . . 2.21 110.049 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -96.47 8.24 44.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 1.95 112.264 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.697 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 23.1 p -164.13 147.01 9.34 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.947 1.092 . . . . 0.63 113.947 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 146' ' ' THR . 54.9 mt -115.03 107.8 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 112.907 -1.951 . . . . 1.19 106.852 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.543 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 6.4 mt-10 -102.29 103.68 14.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.466 -0.939 . . . . 1.13 108.466 -176.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.459 ' SD ' ' HE1' ' A' ' 195' ' ' PHE . 6.0 ptm -117.04 155.19 29.64 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.928 -1.033 . . . . 2.37 112.465 -167.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 38.4 mt -118.79 124.41 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 114.482 -1.235 . . . . 1.14 110.307 170.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.697 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 58.6 mtm180 -75.35 117.27 16.97 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.67 -0.493 . . . . 3.61 109.67 173.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.558 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 19.3 ttm180 -79.37 138.8 55.52 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 107.081 -1.452 . . . . 6.8 107.081 167.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -49.15 124.66 11.98 Favored 'Trans proline' 0 N--CA 1.438 -1.736 0 C-N-CA 121.019 1.146 . . . . 2.5 110.987 171.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 14.1 m-85 -124.45 124.13 41.65 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.759 -1.564 . . . . 2.1 107.426 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.98 75.34 4.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.646 1.213 . . . . 3.66 111.253 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 69.5 m-85 -118.27 145.61 37.51 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 113.717 -1.583 . . . . 3.96 110.153 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 33.3 Cg_exo -60.28 -26.76 83.41 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 124.824 3.682 . . . . 4.73 113.355 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -94.08 -17.99 22.26 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.768 -1.106 . . . . 5.26 111.252 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.503 ' CB ' ' HB2' ' A' ' 198' ' ' ASP . 69.9 m -159.92 105.25 1.56 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.558 -0.746 . . . . 3.82 110.593 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 60.5 tttm -147.05 102.98 3.56 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.498 0.666 . . . . 3.83 109.964 176.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -146.46 169.76 18.25 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 122.177 0.989 . . . . 3.14 112.046 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -81.35 158.38 39.72 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 112.868 -1.969 . . . . 1.22 111.985 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.697 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 49.3 tt0 -44.89 145.24 0.99 Allowed 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.541 -1.329 . . . . 2.3 114.46 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 31.0 t -153.59 133.81 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.884 -1.507 . . . . 1.12 110.081 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.505 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 18.5 mtm180 -94.8 115.67 27.78 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.962 -0.563 . . . . 3.33 110.397 168.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.33 134.17 55.13 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.075 0.94 . . . . 1.02 112.161 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.765 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 16.2 tpt180 -96.25 95.74 8.31 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.22 -1.809 . . . . 2.43 110.255 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.697 ' O ' ' HA ' ' A' ' 151' ' ' SER . 3.9 mp -87.31 95.88 10.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.171 -0.677 . . . . 1.36 109.171 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.44 111.01 22.98 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.377 1.084 . . . . 1.04 111.556 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 52.7 m-85 -87.28 129.71 34.88 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.992 -1.913 . . . . 1.03 110.438 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 35.5 t70 -78.85 66.12 4.24 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 106.539 -1.652 . . . . 1.09 106.539 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.27 -99.32 1.18 Allowed Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 119.227 -1.463 . . . . 0.5 110.329 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.71 -24.82 33.43 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.937 0.717 . . . . 0.83 112.937 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.5 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 9.5 p-80 -130.49 123.03 28.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.636 0.731 . . . . 2.01 110.763 -166.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.9 tt -54.11 128.52 31.11 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.772 -1.558 . . . . 1.35 110.883 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 176' ' ' ASP . . . -106.39 -39.06 6.01 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.105 -0.952 . . . . 1.08 110.33 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.469 ' HA ' ' HB3' ' A' ' 115' ' ' PRO . 19.3 p -149.4 163.31 38.1 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.214 -0.448 . . . . 1.12 111.092 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.765 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 44.5 mt -136.43 145.44 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 105.889 -1.893 . . . . 1.48 105.889 168.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 49.1 t -138.86 136.77 43.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.821 -0.437 . . . . 1.12 109.821 -174.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.538 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.0 t-20 -85.31 97.66 10.08 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.511 -1.292 . . . . 1.77 107.511 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.543 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 57.6 mtm -64.61 -3.1 2.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 124.182 0.926 . . . . 1.26 113.239 -162.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.0 pt-20 -80.53 -40.6 25.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.855 0.836 . . . . 1.02 110.802 177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.498 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 77.0 m-20 -113.58 -25.29 8.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.287 -1.324 . . . . 1.98 109.335 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 80.72 28.57 0.22 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.733 -2.031 . . . . 2.0 108.283 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.538 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 0.6 OUTLIER -83.28 155.57 23.56 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.656 -1.611 . . . . 2.78 110.637 176.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -84.74 140.97 30.88 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.641 -1.163 . . . . 1.9 112.917 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.642 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 3.9 m-85 -103.27 -166.67 1.29 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.942 -1.936 . . . . 1.18 107.97 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.526 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 136.09 -2.38 3.58 Favored Glycine 0 CA--C 1.482 -1.986 0 N-CA-C 107.736 -2.146 . . . . 1.89 107.736 -151.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.48 ' O ' ' HD2' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -156.81 100.06 1.88 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 113.698 -1.251 . . . . 3.47 111.903 151.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.795 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 t80 -116.68 100.78 8.06 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.87 -1.132 . . . . 0.89 109.952 168.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -96.88 138.49 34.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.295 -0.412 . . . . 5.49 110.579 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.534 HD13 ' CG ' ' A' ' 127' ' ' LEU . 45.8 mt -132.42 160.68 35.68 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.255 0.55 . . . . 2.15 112.189 -170.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 164' ' ' SER . 20.3 t70 -96.8 115.7 65.8 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.229 -0.896 . . . . 2.66 109.375 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -62.84 126.4 18.05 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.703 1.602 . . . . 2.4 113.536 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.449 ' OXT' ' HG2' ' A' ' 200' ' ' ARG . 28.7 ttt180 . . . . . 0 C--O 1.25 1.122 0 O-C-N 124.71 1.256 . . . . 5.84 113.722 165.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 7.1 ptm180 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 114.638 1.347 . . . . 4.32 114.638 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.414 ' HB3' ' HG2' ' A' ' 123' ' ' GLU . 60.9 ttp -140.44 121.74 14.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.557 -0.457 . . . . 2.59 111.515 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 105.7 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 122.246 1.022 . . . . 0.74 113.566 173.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -159.79 106.2 1.63 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.248 -2.13 . . . . 1.38 105.248 159.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.708 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 11.5 mt -82.8 103.64 12.44 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.425 -0.51 . . . . 1.33 110.169 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -145.08 99.46 4.62 Favored Pre-proline 0 N--CA 1.429 -1.492 0 C-N-CA 119.37 -0.932 . . . . 1.93 110.431 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.797 ' HD3' HD12 ' A' ' 183' ' ' ILE . 0.5 OUTLIER -34.14 139.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.644 1 C-N-CA 125.668 4.245 . . . . 0.65 115.011 -178.84 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.4 t70 77.22 35.56 0.34 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.834 -1.53 . . . . 0.72 109.408 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.505 ' HE3' HD13 ' A' ' 180' ' ' LEU . 10.8 ptt? -114.56 155.13 27.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.401 -1.272 . . . . 1.67 109.879 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 179' ' ' HIS . 21.4 m -101.71 103.74 14.52 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.079 -1.082 . . . . 0.58 108.079 -175.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.605 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.4 tt -136.56 166.66 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.277 -0.874 . . . . 0.65 110.566 -165.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.618 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.6 m -141.42 176.24 9.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.738 -0.838 . . . . 0.44 108.738 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.542 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -28.0 68.85 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.53 -0.915 . . . . 2.33 108.53 166.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.606 ' O ' HG12 ' A' ' 125' ' ' VAL . 0.3 OUTLIER -84.23 -19.14 34.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.127 -1.397 . . . . 1.32 113.485 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.618 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.5 mt-10 -87.6 -54.22 4.38 Favored 'General case' 0 N--CA 1.422 -1.839 0 O-C-N 120.444 -1.41 . . . . 2.06 108.994 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.762 ' SD ' HD23 ' A' ' 173' ' ' LEU . 2.1 tpp -59.76 -16.36 27.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.767 -1.56 . . . . 3.13 111.147 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 122' ' ' ASN . 15.0 p -43.81 -41.24 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 122.185 0.993 . . . . 0.37 110.228 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.535 ' HG2' ' HA ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -65.3 -42.54 92.96 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.927 -1.488 . . . . 0.63 113.031 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.643 HD23 HD23 ' A' ' 128' ' ' LEU . 0.8 OUTLIER -50.82 -33.88 25.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.814 0.816 . . . . 1.79 110.595 169.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 124' ' ' MET . 20.2 mt -84.6 -35.87 22.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.553 -1.203 . . . . 0.38 109.654 -171.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.36 -24.95 63.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.483 -1.235 . . . . 1.96 110.31 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -76.41 -42.13 45.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.504 -1.225 . . . . 0.64 110.924 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.697 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.4 t -87.11 1.31 53.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 123.531 1.634 . . . . 0.59 107.32 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 46.39 51.98 11.11 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 110.924 -2.853 . . . . 1.8 112.249 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.632 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.9 t80 -135.31 176.5 8.62 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.478 0.548 . . . . 0.52 112.478 -172.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.542 ' HD3' ' N ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -140.21 142.06 35.88 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.947 -1.501 . . . . 4.54 106.947 177.069 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.597 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 14.6 tm0? -48.98 142.16 6.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.26 1.208 . . . . 1.28 114.26 -168.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.725 HG23 HG22 ' A' ' 146' ' ' THR . 3.1 m -125.5 155.62 34.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.779 -2.01 . . . . 1.05 110.953 -176.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -61.36 -35.74 78.29 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.737 1.256 . . . . 1.38 108.446 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 5.6 tmmm? -159.87 133.18 6.94 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.65 -2.068 . . . . 1.44 109.816 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.565 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.34 135.86 54.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.577 -1.192 . . . . 0.9 111.31 -177.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.719 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -161.57 97.89 1.1 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.668 1.223 . . . . 0.61 110.718 149.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.719 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.07 161.73 20.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 112.7 -2.045 . . . . 1.77 106.313 164.197 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.38 130.94 28.3 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.299 1.332 . . . . 0.62 111.4 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.88 49.3 3.38 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.306 -0.95 . . . . 0.51 112.948 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.632 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 48.7 mt-10 -141.09 178.1 7.61 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.907 0.384 . . . . 2.16 111.357 175.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.868 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 50.2 p90 -165.73 175.59 8.68 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.063 -1.088 . . . . 0.28 108.063 169.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.725 HG22 HG23 ' A' ' 136' ' ' VAL . 25.6 p -142.3 126.13 17.1 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.471 0.653 . . . . 0.42 111.169 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.597 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.7 p -125.37 109.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.235 -0.893 . . . . 0.34 109.886 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -142.61 -60.8 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.65 -0.42 . . . . 3.11 111.607 -171.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.92 -92.43 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.49 0.552 . . . . 1.65 112.49 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -104.83 -0.11 27.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.11 0.481 . . . . 1.68 111.173 -171.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 174' ' ' THR . 5.2 p -146.82 160.05 42.76 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.314 0.857 . . . . 0.37 113.314 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.617 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 60.5 mt -110.53 109.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 106.816 -1.55 . . . . 0.53 106.816 162.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.8 mp0 -89.38 175.91 7.13 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.015 -1.476 . . . . 1.13 107.015 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.636 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 25.6 ptm -168.67 154.66 6.76 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 123.496 0.498 . . . . 1.8 111.108 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.585 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 21.7 mt -127.62 110.16 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.753 -0.658 . . . . 0.43 110.309 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.815 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 28.2 mtp180 . . . . . 0 C--N 1.316 -0.867 0 CA-C-N 116.186 -0.461 . . . . 3.13 110.759 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.815 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.6 tt0 . . . . . 0 N--CA 1.425 -1.707 0 N-CA-C 113.502 0.927 . . . . 1.86 113.502 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 50.1 t -154.37 133.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.689 -1.141 . . . . 0.41 109.519 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 154' ' ' MET . 8.5 mtm180 -91.12 115.16 27.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.814 0.34 . . . . 2.8 110.399 169.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.04 145.39 43.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.812 0.815 . . . . 0.29 111.353 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.761 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.2 tpt180 -111.49 98.66 7.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.838 -1.528 . . . . 1.71 110.501 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.762 HD23 ' SD ' ' A' ' 124' ' ' MET . 4.5 mp -91.76 94.48 9.37 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.247 -0.279 . . . . 0.69 110.247 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -98.1 126.26 43.47 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.438 1.114 . . . . 0.26 111.653 -171.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.2 m-85 -89.82 138.34 31.57 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 112.859 -1.973 . . . . 0.72 111.07 -177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.9 t70 -79.39 64.49 4.29 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.027 -1.842 . . . . 1.09 106.027 160.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.7 -98.37 1.05 Allowed Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 118.879 -1.629 . . . . 0.47 110.713 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -79.14 -24.8 43.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.023 0.749 . . . . 0.83 113.023 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 118' ' ' THR . 1.9 p80 -134.68 129.99 35.63 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.951 -0.7 . . . . 1.21 110.844 -169.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.27 128.15 27.13 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.743 -1.572 . . . . 0.64 110.546 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.23 -41.48 5.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.492 -0.776 . . . . 0.29 110.486 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.1 p -145.49 166.86 24.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.226 -0.443 . . . . 0.33 110.921 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 115' ' ' PRO . 39.5 mt -136.18 145.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.108 -1.812 . . . . 0.76 106.108 169.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 45.0 t -137.26 140.17 42.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.277 0.56 . . . . 0.35 110.186 -174.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.485 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.1 t-20 -81.13 100.97 9.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.733 -1.21 . . . . 1.77 107.733 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.551 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 49.3 mtm -64.27 -2.76 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.403 0.89 . . . . 0.55 113.403 -164.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.461 ' HG3' ' OD1' ' A' ' 188' ' ' ASN . 10.9 pt-20 -91.92 -40.06 11.36 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.812 0.815 . . . . 1.02 111.225 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 187' ' ' GLU . 5.8 m-20 -105.78 -25.36 12.22 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.449 -1.251 . . . . 1.4 109.495 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 73.86 33.91 0.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 112.429 -2.169 . . . . 1.33 108.041 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 3.9 ptm180 -93.33 161.88 14.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.03 -1.441 . . . . 2.28 110.082 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.3 140.84 29.13 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.542 -1.208 . . . . 1.36 113.518 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.624 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 8.8 m-85 -106.44 -166.02 1.14 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.834 -1.984 . . . . 1.18 107.286 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.568 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.99 -6.73 3.46 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 107.83 -2.108 . . . . 1.28 107.83 -149.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -154.71 112.61 3.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.878 -1.161 . . . . 2.8 111.507 157.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.708 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t80 -129.18 101.6 6.09 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.702 -0.799 . . . . 0.6 109.965 162.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -100.06 128.75 46.1 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.03 -1.044 . . . . 4.77 111.948 -171.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.436 ' CD1' HD12 ' A' ' 127' ' ' LEU . 8.9 mt -107.76 171.27 7.49 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.174 -0.466 . . . . 1.61 111.129 173.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 108.727 -0.842 . . . . 2.66 108.727 175.408 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.55 ' NH1' HG21 ' A' ' 125' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.717 0.294 . . . . 4.32 111.263 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.649 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 48.2 tpp -143.63 138.78 29.24 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.361 -0.536 . . . . 2.59 110.961 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -126.77 104.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.374 1.083 . . . . 0.74 113.059 177.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -158.85 107.76 1.92 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 112.962 -1.926 . . . . 1.38 106.177 167.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 6.6 mt -91.3 100.62 13.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.5 -0.48 . . . . 1.33 110.111 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -150.34 109.44 3.19 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.377 0.608 . . . . 1.93 109.677 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.858 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 10.6 Cg_exo -34.77 146.3 0.05 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.849 1 C-N-CA 126.876 5.05 . . . . 0.65 115.43 -173.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.57 39.61 2.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.089 -1.414 . . . . 0.72 109.019 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.59 ' HE1' HD22 ' A' ' 113' ' ' LEU . 10.5 ptt? -117.57 154.37 31.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.655 -1.157 . . . . 1.67 109.485 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.1 m -101.81 79.33 1.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.152 0.977 . . . . 0.58 108.599 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.755 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -97.1 156.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 113.936 -1.484 . . . . 0.65 109.384 -171.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 124' ' ' MET . 10.8 m -141.95 174.15 10.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.156 -0.683 . . . . 0.44 109.156 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.641 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 35.2 mtpt -49.43 -33.49 14.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.38 0.609 . . . . 2.33 110.175 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.603 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 63.0 t30 -84.49 -16.18 43.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.335 1.235 . . . . 1.32 114.335 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.649 ' CG ' ' HB3' ' A' ' 110' ' ' MET . 6.2 tt0 -86.31 -60.53 1.97 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.374 -1.453 . . . . 2.06 107.894 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.79 ' SD ' HD21 ' A' ' 128' ' ' LEU . 0.5 OUTLIER -54.7 -17.59 3.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.457 -1.701 . . . . 3.13 111.105 173.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 13.7 p -42.35 -40.57 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-O 122.018 0.914 . . . . 0.37 110.34 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.636 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.7 -42.72 81.55 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.129 -1.396 . . . . 0.63 113.699 177.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.67 HD12 HD23 ' A' ' 128' ' ' LEU . 2.8 tm? -50.86 -34.78 29.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.568 0.699 . . . . 1.79 110.359 168.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 ' SD ' ' A' ' 124' ' ' MET . 7.3 mt -85.36 -34.86 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.568 -0.742 . . . . 0.38 110.143 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.29 -25.77 66.21 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.154 -1.385 . . . . 1.96 110.778 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -77.38 -45.39 26.11 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.978 -1.464 . . . . 0.64 111.272 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.97 -5.99 46.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 123.637 1.684 . . . . 0.59 107.471 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.54 55.34 5.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 110.983 -2.826 . . . . 1.8 112.464 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.724 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.5 t80 -132.15 176.38 8.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.853 0.686 . . . . 0.52 112.853 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.415 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 58.2 ttt180 -142.86 141.57 31.6 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.949 -1.5 . . . . 4.54 106.949 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -49.04 144.79 4.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 115.627 1.714 . . . . 1.28 115.627 -165.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 146' ' ' THR . 3.1 m -129.51 162.67 36.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 112.223 -2.262 . . . . 1.05 110.862 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -73.0 -35.55 66.84 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.591 -1.263 . . . . 1.38 107.591 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -145.46 124.84 13.06 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 112.795 -2.002 . . . . 1.44 110.513 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.581 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -117.93 128.87 55.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.093 -1.412 . . . . 0.9 110.047 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 96.03 1.68 Allowed 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.044 1.402 . . . . 0.61 109.364 155.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.586 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -167.61 161.26 10.16 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 111.979 -2.373 . . . . 1.77 105.771 167.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.19 126.32 9.77 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.675 1.583 . . . . 0.62 111.865 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 103.43 19.41 12.41 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 119.904 -1.141 . . . . 0.51 112.328 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.724 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 13.4 mp0 -128.33 173.19 10.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.661 0.267 . . . . 2.16 110.682 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.841 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 54.9 p90 -165.9 175.85 8.31 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.707 -1.22 . . . . 0.28 107.707 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.867 HG22 HG23 ' A' ' 136' ' ' VAL . 3.5 p -138.1 132.59 32.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 120.227 -0.589 . . . . 0.42 110.823 170.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 135' ' ' GLN . 14.6 p -124.14 109.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 122.347 1.07 . . . . 0.34 111.813 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -99.18 -74.99 0.57 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.523 -1.217 . . . . 3.11 109.313 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.62 -46.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.016 -0.993 . . . . 1.65 109.328 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.36 -11.42 57.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.408 -0.814 . . . . 1.68 111.236 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 14.6 p -158.89 152.28 22.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.125 0.964 . . . . 0.37 112.829 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.611 HG21 ' SD ' ' A' ' 124' ' ' MET . 68.5 mt -116.59 113.72 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 112.977 -1.92 . . . . 0.53 107.554 164.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -92.88 165.56 12.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.565 -1.643 . . . . 1.13 106.565 173.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.626 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 14.5 ptp -166.37 151.43 8.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 123.835 0.71 . . . . 1.8 110.764 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.688 HG12 ' HG3' ' A' ' 170' ' ' ARG . 7.5 mt -129.63 110.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.65 -0.705 . . . . 0.43 110.265 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 33.7 mtp180 . . . . . 0 C--N 1.317 -0.837 0 C-N-CA 120.483 -0.487 . . . . 3.13 110.354 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.569 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.94 0 N-CA-C 112.715 0.635 . . . . 1.86 112.715 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 95.4 t -151.86 127.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.179 -0.918 . . . . 0.41 110.089 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.688 ' HG3' HG12 ' A' ' 155' ' ' ILE . 3.7 mtm180 -85.77 115.46 23.43 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.468 -0.787 . . . . 2.8 110.262 169.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 153' ' ' GLU . . . -116.44 139.8 50.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.313 -0.955 . . . . 0.29 111.591 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.751 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 13.2 tpt180 -104.48 98.57 8.32 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.982 -1.463 . . . . 1.71 110.781 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 151' ' ' SER . 8.3 mp -88.16 103.25 15.58 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.237 -0.283 . . . . 0.69 110.237 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.21 119.57 39.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.4 1.095 . . . . 0.26 111.675 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.548 ' CZ ' HG23 ' A' ' 119' ' ' ILE . 2.0 m-85 -83.31 140.6 32.37 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 112.955 -1.93 . . . . 0.72 111.147 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.7 t70 -80.23 65.2 5.3 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.065 -1.828 . . . . 1.09 106.065 159.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.84 -97.99 1.27 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 118.572 -1.775 . . . . 0.47 110.697 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.87 -25.38 40.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.032 0.753 . . . . 0.83 113.032 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -132.81 129.69 38.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.972 0.891 . . . . 1.21 111.726 -167.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.755 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.0 tm? -51.07 120.59 5.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.872 -1.967 . . . . 0.64 109.868 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -106.14 -37.25 6.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.764 -0.653 . . . . 0.29 110.63 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.411 ' C ' HG13 ' A' ' 183' ' ' ILE . 17.7 p -143.88 164.38 30.73 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.102 -0.499 . . . . 0.33 110.742 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.751 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 21.1 mt -138.93 143.97 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 105.831 -1.914 . . . . 0.76 105.831 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 30.3 t -132.79 135.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.946 0.403 . . . . 0.35 110.472 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.535 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 1.8 m120 -76.24 101.1 5.29 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 107.131 -1.433 . . . . 1.77 107.131 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.628 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 41.1 mtm -67.38 -1.41 4.71 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.34 0.59 . . . . 0.55 111.654 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 16.9 pt-20 -73.85 -43.96 57.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.193 -0.912 . . . . 1.02 110.988 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -113.26 -25.67 8.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.228 -1.351 . . . . 1.4 109.367 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 75.53 36.47 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.179 -2.282 . . . . 1.33 107.858 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 185' ' ' ASN . 12.2 ptt180 -97.33 170.7 8.9 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 114.167 -1.379 . . . . 2.28 108.819 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -86.05 144.92 27.3 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.433 1.111 . . . . 1.36 113.916 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.572 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -116.91 -166.79 1.2 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 105.222 -2.14 . . . . 1.18 105.222 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.858 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 136.19 8.19 1.62 Allowed Glycine 0 N--CA 1.412 -2.934 0 N-CA-C 109.994 -1.242 . . . . 1.28 109.994 -160.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.433 ' HB2' ' NH1' ' A' ' 196' ' ' ARG . 20.7 p90 -152.39 101.95 2.71 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.151 -1.525 . . . . 2.8 110.438 151.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.725 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 3.9 t80 -118.45 99.75 7.03 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.892 -0.781 . . . . 0.6 108.892 168.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.433 ' NH1' ' HB2' ' A' ' 194' ' ' PHE . 1.4 mpt_? -100.62 123.06 44.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 4.77 111.33 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -93.1 172.57 8.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.336 1.606 . . . . 1.61 115.336 -170.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 . . . . . 0 N--CA 1.445 -0.696 0 CA-C-N 112.813 -1.994 . . . . 2.66 110.031 177.786 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 22.4 mtt180 . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 107.361 -1.348 . . . . 4.32 107.361 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.804 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.3 tpt -143.58 118.06 9.71 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 114.162 1.171 . . . . 2.59 114.162 -160.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 127' ' ' LEU . 0.8 OUTLIER -104.19 109.29 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 C-N-CA 119.246 -0.982 . . . . 0.74 112.681 179.164 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -155.03 109.82 3.0 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.146 -1.798 . . . . 1.38 106.146 167.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.1 mp -98.33 113.69 25.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.596 -0.89 . . . . 1.33 108.596 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 15.1 tt0 -146.09 108.99 4.3 Favored Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.732 -0.787 . . . . 1.93 109.79 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HG3' HG12 ' A' ' 183' ' ' ILE . 33.3 Cg_exo -35.76 130.83 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.407 0 C-N-CA 124.903 3.735 . . . . 0.65 114.473 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 73.71 45.47 0.24 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 122.403 1.097 . . . . 0.72 110.624 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.484 ' HE3' ' HB3' ' A' ' 114' ' ' GLU . 6.1 ptp -121.28 158.57 27.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.286 -1.324 . . . . 1.67 111.416 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 m -102.29 100.14 10.29 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.779 -0.823 . . . . 0.58 108.779 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.596 HG21 ' HE1' ' A' ' 124' ' ' MET . 12.2 tt -137.93 169.3 18.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.97 -1.013 . . . . 0.65 109.577 -167.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.533 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.5 m -139.88 175.33 9.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.821 0.737 . . . . 0.44 111.45 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.679 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -20.6 63.02 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.49 -0.929 . . . . 2.33 108.49 167.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.759 ' O ' HG12 ' A' ' 125' ' ' VAL . 6.3 t30 -83.17 -22.64 33.19 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 113.979 -1.464 . . . . 1.32 112.475 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.804 ' HA ' ' H ' ' A' ' 110' ' ' MET . 1.1 mp0 -84.28 -50.01 8.25 Favored 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 120.025 -1.672 . . . . 2.06 107.923 173.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.764 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -61.67 -18.51 59.83 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.511 -1.222 . . . . 3.13 111.268 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.1 p -47.28 -41.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.114 0.959 . . . . 0.37 110.808 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.536 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.2 mmpt? -69.93 -36.97 75.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.323 -1.308 . . . . 0.63 112.771 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.732 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.4 tm? -55.42 -33.88 63.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.686 0.755 . . . . 1.79 110.27 167.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.764 ' HG ' ' O ' ' A' ' 124' ' ' MET . 17.4 mt -84.36 -32.6 24.14 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.95 0.881 . . . . 0.38 109.189 -172.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.98 -39.43 89.57 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.901 -1.499 . . . . 1.96 110.219 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -70.5 -43.19 70.2 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.524 -1.671 . . . . 0.64 112.283 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.49 3.9 54.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 124.538 2.113 . . . . 0.59 106.281 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 130' ' ' ALA . 17.9 mt-30 52.35 49.16 21.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 110.262 -3.154 . . . . 1.8 112.679 168.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.981 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -139.24 175.74 9.3 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.759 -0.776 . . . . 0.52 112.778 -172.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.41 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 79.6 ttt180 -138.69 155.11 48.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.558 -1.275 . . . . 4.54 107.558 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.492 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.17 141.36 8.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.427 1.108 . . . . 1.28 113.375 -168.178 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.834 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.3 p -143.39 135.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.033 -1.894 . . . . 1.05 109.931 -164.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -33.52 70.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.233 1.016 . . . . 1.38 109.475 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -151.8 121.57 7.01 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 113.109 -1.86 . . . . 1.44 109.697 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.594 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -111.09 122.75 48.68 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.188 -1.369 . . . . 0.9 110.855 -177.469 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.3 OUTLIER -158.94 97.16 1.39 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.824 1.297 . . . . 0.61 109.769 161.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.446 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -166.65 165.2 9.95 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.508 -2.133 . . . . 1.77 106.127 161.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.61 116.74 3.72 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 120.973 1.115 . . . . 0.62 109.885 167.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.42 47.25 3.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.834 -1.174 . . . . 0.51 113.424 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.981 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.3 mt-10 -142.41 147.96 37.04 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.769 -0.826 . . . . 2.16 108.769 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.855 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 35.5 p90 -152.59 159.22 43.26 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.432 -0.951 . . . . 0.28 108.432 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.704 HG22 HG13 ' A' ' 136' ' ' VAL . 3.6 p -126.95 127.66 45.19 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.92 -0.712 . . . . 0.42 110.954 175.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.629 HG23 HG12 ' A' ' 152' ' ' ILE . 8.6 p -111.81 110.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.908 0.861 . . . . 0.34 111.322 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -113.65 16.01 18.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.909 -1.041 . . . . 3.11 110.738 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.65 -50.05 0.7 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.81 0.694 . . . . 1.65 111.28 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -81.88 -5.21 58.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.13 0.49 . . . . 1.68 110.175 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -166.39 144.87 5.53 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.444 -0.798 . . . . 0.37 112.073 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.679 HD11 ' HA ' ' A' ' 121' ' ' LYS . 37.2 mt -116.1 112.47 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.279 -1.328 . . . . 0.53 107.684 164.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.855 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 65.7 mt-10 -90.82 163.54 14.39 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.373 -2.084 . . . . 1.13 105.373 175.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.506 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 24.0 ptm -167.83 154.27 7.76 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.524 0.515 . . . . 1.8 110.514 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.586 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 36.2 mt -129.08 115.25 35.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.982 -0.554 . . . . 0.43 110.797 166.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.652 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 74.7 mtp180 . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.646 . . . . 3.13 110.539 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 9.5 tt0 . . . . . 0 N--CA 1.416 -2.151 0 CA-C-O 121.165 0.507 . . . . 1.86 111.938 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 70.0 t -151.93 128.89 2.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.091 -0.959 . . . . 0.41 109.191 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.746 ' HG2' ' CE ' ' A' ' 186' ' ' MET . 32.6 ttp180 -92.63 102.3 14.72 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.114 -0.948 . . . . 2.8 108.518 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.46 147.9 36.97 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.821 0.82 . . . . 0.29 111.859 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.536 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 10.1 tpt180 -114.36 100.68 8.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.929 -1.487 . . . . 1.71 110.318 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.666 HD21 HD21 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -88.87 96.03 10.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.736 -0.839 . . . . 0.69 108.736 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 117.38 31.67 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.125 0.964 . . . . 0.26 111.316 -171.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.724 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -89.88 135.74 33.46 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.225 -1.807 . . . . 0.72 110.487 -179.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -78.95 65.67 4.2 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.362 -1.718 . . . . 1.09 106.362 164.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.3 -99.32 1.18 Allowed Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 118.986 -1.578 . . . . 0.47 110.61 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.46 -24.86 42.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 113.075 0.768 . . . . 0.83 113.075 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -131.27 129.08 41.09 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.299 -0.96 . . . . 1.21 110.934 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.724 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.3 tt -53.14 129.32 30.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.457 -1.701 . . . . 0.64 110.049 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.68 -37.75 6.33 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.591 -0.731 . . . . 0.29 110.189 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.7 p -148.12 165.04 32.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.092 -0.504 . . . . 0.33 111.422 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.591 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.7 mm -117.53 149.01 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 105.226 -2.138 . . . . 0.76 105.226 163.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -138.89 128.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.461 0.648 . . . . 0.35 110.065 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.475 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 34.1 t-20 -80.97 102.84 10.4 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.829 -1.174 . . . . 1.77 107.829 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.746 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 38.0 mtm -66.35 -0.73 2.82 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 113.053 0.76 . . . . 0.55 113.053 -166.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 10.7 pt-20 -79.33 -40.95 29.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.127 0.965 . . . . 1.02 111.018 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.493 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 67.6 m-20 -112.27 -26.31 8.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.148 -1.387 . . . . 1.4 109.484 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 78.2 32.15 0.36 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.611 -2.086 . . . . 1.33 107.872 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 0.1 OUTLIER -91.43 164.55 13.78 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 113.471 -1.695 . . . . 2.28 109.119 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 76.1 mt-30 -85.05 136.02 33.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.491 -0.777 . . . . 1.36 110.132 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.591 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -107.3 90.99 3.47 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 118.86 -0.591 . . . . 1.18 110.177 -175.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.44 -59.2 0.0 OUTLIER Glycine 0 N--CA 1.47 0.91 0 C-N-CA 125.039 1.304 . . . . 1.28 116.268 147.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.445 ' HD2' ' NH1' ' A' ' 196' ' ' ARG . 0.3 OUTLIER -164.86 171.55 14.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.879 -1.661 . . . . 2.8 108.125 174.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -140.36 130.03 24.31 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.356 0.526 . . . . 0.6 109.66 162.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.645 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -120.43 130.53 54.38 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.667 -0.646 . . . . 4.77 110.659 -170.19 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.732 HD13 ' HG ' ' A' ' 127' ' ' LEU . 68.1 mt -136.55 171.37 14.59 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.799 1.037 . . . . 1.61 113.799 -166.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 114.415 -1.266 . . . . 2.66 110.451 -176.05 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 13.3 mtm180 . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.711 0.634 . . . . 4.32 112.711 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.594 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 24.9 ttt -141.82 135.54 29.72 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.493 -0.776 . . . . 2.59 111.974 -168.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 ' HE1' ' A' ' 124' ' ' MET . 2.0 m -118.18 106.4 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 122.268 1.032 . . . . 0.74 112.953 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -160.1 106.73 1.59 Allowed 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 105.749 -1.945 . . . . 1.38 105.749 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.837 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 3.5 mp -97.13 111.41 23.66 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.474 -0.935 . . . . 1.33 108.474 -173.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 117' ' ' MET . 21.0 tt0 -143.72 107.38 5.05 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-N 114.963 -1.017 . . . . 1.93 110.549 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.509 ' HD3' HD12 ' A' ' 183' ' ' ILE . 29.5 Cg_exo -36.75 129.03 0.49 Allowed 'Trans proline' 0 CA--C 1.515 -0.427 0 C-N-CA 124.476 3.451 . . . . 0.65 113.427 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.9 t70 75.41 50.1 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.685 1.231 . . . . 0.72 109.768 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.649 ' HE3' HD13 ' A' ' 180' ' ' LEU . 13.1 ptt? -122.47 157.24 32.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 113.789 -1.551 . . . . 1.67 110.116 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.3 m -100.01 113.9 26.81 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.299 -1.0 . . . . 0.58 108.299 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -142.75 159.84 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 116.046 -0.524 . . . . 0.65 111.457 -165.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.483 ' H ' HG13 ' A' ' 119' ' ' ILE . 49.2 m -143.06 179.87 6.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.914 -0.314 . . . . 0.44 110.167 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.862 ' HG2' HG21 ' A' ' 147' ' ' VAL . 6.9 mtmp? -59.14 -28.12 66.27 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.677 -0.86 . . . . 2.33 108.677 166.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.608 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 4.4 t-20 -85.73 -17.34 36.19 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.996 -1.456 . . . . 1.32 114.446 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.594 ' HG3' ' HB3' ' A' ' 110' ' ' MET . 1.2 tp10 -84.39 -62.28 1.6 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.498 -1.297 . . . . 2.06 107.498 169.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.843 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 14.8 mmt -57.82 -15.81 9.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.627 -2.078 . . . . 3.13 111.765 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 14.6 p -43.19 -41.88 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 122.176 0.989 . . . . 0.37 110.191 175.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.737 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -69.27 -41.58 76.67 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.047 -1.433 . . . . 0.63 113.224 177.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.778 HD23 HD23 ' A' ' 128' ' ' LEU . 1.1 tt -49.41 -34.3 16.07 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.528 0.68 . . . . 1.79 111.387 167.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.843 ' HG ' ' O ' ' A' ' 124' ' ' MET . 13.9 mt -85.43 -32.53 22.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.158 -0.928 . . . . 0.38 108.824 -171.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.63 -36.53 84.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.11 -1.405 . . . . 1.96 109.814 167.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.7 -42.91 63.7 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.871 -1.513 . . . . 0.64 111.977 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -5.84 56.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 123.648 1.689 . . . . 0.59 106.991 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 58.33 55.51 4.97 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 110.761 -2.927 . . . . 1.8 112.473 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.665 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 3.2 t80 -139.56 176.73 8.48 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 113.126 0.787 . . . . 0.52 113.126 -177.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 145' ' ' PHE . 14.1 ptm180 -142.19 150.34 40.89 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.091 -1.078 . . . . 4.54 108.091 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 15.0 tm0? -50.37 143.37 8.94 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.802 1.408 . . . . 1.28 114.802 -166.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.835 HG23 HG22 ' A' ' 146' ' ' THR . 1.3 m -125.65 159.52 33.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 112.805 -1.998 . . . . 1.05 111.875 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -63.31 -35.79 81.52 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.68 1.229 . . . . 1.38 108.089 169.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 139' ' ' MET . 2.3 ttpt -159.34 132.98 7.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.348 -2.205 . . . . 1.44 109.521 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.589 ' HB2' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -118.6 135.42 54.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.262 -0.881 . . . . 0.9 111.199 176.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.569 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -156.9 97.61 1.7 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.954 1.359 . . . . 0.61 108.892 152.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.569 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -166.12 161.59 12.63 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 112.207 -2.27 . . . . 1.77 106.1 168.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.478 ' HA ' HG22 ' A' ' 155' ' ' ILE . 62.8 Cg_endo -75.67 128.17 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.209 1.273 . . . . 0.62 111.979 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.626 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 99.3 23.29 11.4 Favored Glycine 0 C--N 1.351 1.4 0 C-N-CA 119.975 -1.107 . . . . 0.51 112.35 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.665 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 15.4 mp0 -128.79 172.34 11.37 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.75 -0.463 . . . . 2.16 109.75 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.882 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.9 p90 -163.06 175.11 11.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.237 -1.023 . . . . 0.28 108.237 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.835 HG22 HG23 ' A' ' 136' ' ' VAL . 8.0 p -141.96 126.59 17.93 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 120.11 -0.636 . . . . 0.42 111.598 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.862 HG21 ' HG2' ' A' ' 121' ' ' LYS . 12.4 p -125.56 110.07 23.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.709 0.766 . . . . 0.34 111.849 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -110.03 -58.79 2.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.734 -0.666 . . . . 3.11 110.779 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -163.36 -60.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.922 0.341 . . . . 1.65 111.922 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -92.57 4.36 53.75 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.404 0.52 . . . . 1.68 112.404 -172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.7 p -161.08 155.93 23.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.683 0.754 . . . . 0.37 112.478 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 43.7 mt -115.24 108.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.297 -1.742 . . . . 0.53 106.297 161.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.882 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.6 mp0 -90.59 163.98 14.37 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.521 -2.029 . . . . 1.13 105.521 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 8.7 ptp -165.07 154.31 12.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.83 0.706 . . . . 1.8 111.324 -171.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.675 HG12 ' HG3' ' A' ' 170' ' ' ARG . 34.6 mt -126.25 110.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.615 0.721 . . . . 0.43 111.141 170.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 113.957 -1.474 . . . . 3.13 109.838 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.822 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.9 tt0 . . . . . 0 N--CA 1.436 -1.15 0 N-CA-C 113.419 0.896 . . . . 1.86 113.419 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 41.3 t -152.92 131.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.727 -1.124 . . . . 0.41 109.959 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.675 ' HG3' HG12 ' A' ' 155' ' ' ILE . 5.7 ttm180 -93.39 111.74 23.48 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.82 -0.807 . . . . 2.8 108.82 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.8 141.33 47.44 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.264 -0.974 . . . . 0.29 111.429 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 5.2 tpt180 -102.45 101.31 11.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.134 -1.394 . . . . 1.71 110.665 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -91.36 96.53 10.58 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.787 -0.365 . . . . 0.69 110.055 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 117.65 31.21 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-O 122.472 1.13 . . . . 0.26 111.494 -173.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -85.88 131.84 34.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 112.632 -2.076 . . . . 0.72 109.784 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 35.8 t70 -75.91 65.85 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.716 -1.587 . . . . 1.09 106.716 164.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.71 -99.26 1.74 Allowed Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 119.104 -1.522 . . . . 0.47 110.223 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -88.54 -17.62 29.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 113.01 0.744 . . . . 0.83 113.01 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -133.28 126.62 31.86 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 119.163 -1.015 . . . . 1.21 110.693 -168.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.688 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.1 tt -52.93 129.47 30.47 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.458 -1.701 . . . . 0.64 110.629 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -38.34 6.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.992 -1.004 . . . . 0.29 109.755 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.1 p -147.72 157.69 43.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.819 -0.628 . . . . 0.33 111.245 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.8 mt -124.86 146.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.707 -1.96 . . . . 0.76 105.707 166.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 43.1 t -136.56 133.58 49.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.448 0.642 . . . . 0.35 109.947 -175.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 1.9 t-20 -79.43 94.0 5.47 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.712 -1.588 . . . . 1.77 106.712 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.572 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 47.6 mtm -66.38 -1.97 4.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.995 0.809 . . . . 0.55 113.095 -162.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.0 pt-20 -81.45 -39.29 25.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.127 0.965 . . . . 1.02 110.682 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.48 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 86.7 m-20 -108.43 -26.46 10.46 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.779 -1.555 . . . . 1.4 109.117 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.5 t30 75.48 32.02 0.74 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.338 -2.21 . . . . 1.33 108.416 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.9 ptm180 -93.73 155.22 17.36 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.197 -1.365 . . . . 2.28 109.234 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -77.7 131.19 37.59 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.909 -1.041 . . . . 1.36 108.636 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -105.63 89.53 3.12 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.469 -0.892 . . . . 1.18 110.548 -170.157 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -57.74 0.0 OUTLIER Glycine 0 N--CA 1.467 0.718 0 C-N-CA 125.376 1.465 . . . . 1.28 116.48 146.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.609 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 18.1 p90 -163.88 175.43 10.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.153 -1.523 . . . . 2.8 109.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.837 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.5 t80 -149.08 100.22 3.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.378 0.608 . . . . 0.6 110.445 159.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.609 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 5.2 mmm180 -95.63 141.87 28.61 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 120.628 -1.295 . . . . 4.77 111.666 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.535 ' HG ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -109.82 173.33 6.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.202 1.556 . . . . 1.61 115.202 -175.381 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 CA--C 1.535 0.387 0 CA-C-N 112.806 -1.997 . . . . 2.66 110.559 178.513 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 115.849 1.796 . . . . 4.32 115.849 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.673 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 16.7 tpt -139.35 117.01 11.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.035 -1.066 . . . . 2.59 112.65 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.634 ' HB ' HD12 ' A' ' 197' ' ' LEU . 15.9 m -111.5 107.41 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.42 1.105 . . . . 0.74 112.965 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.436 ' C ' HD12 ' A' ' 113' ' ' LEU . 40.3 t30 -160.14 136.16 8.58 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 113.667 -1.606 . . . . 1.38 106.985 168.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 9.0 mp -114.65 100.2 8.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.121 0.486 . . . . 1.33 109.829 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -156.93 97.54 2.08 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-N 115.23 -0.895 . . . . 1.93 109.816 -169.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.849 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 9.6 Cg_exo -34.27 149.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.796 1 C-N-CA 127.396 5.398 . . . . 0.65 115.356 -173.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 29.1 t70 70.55 31.26 2.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.216 -1.356 . . . . 0.72 108.877 -174.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.6 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 8.3 ptp -110.27 154.15 23.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.691 -1.14 . . . . 1.67 109.733 175.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -106.51 76.61 1.14 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.849 -1.167 . . . . 0.58 107.849 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.627 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 1.5 tt -104.15 159.25 5.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.152 -1.386 . . . . 0.65 110.507 -165.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.488 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 37.7 m -141.76 179.91 6.57 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.738 -0.785 . . . . 0.44 110.425 -168.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.953 ' HG2' HG21 ' A' ' 147' ' ' VAL . 14.5 mttp -64.52 -20.77 66.42 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.025 -1.102 . . . . 2.33 108.025 169.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.672 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t30 -84.46 -25.05 29.22 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.11 -1.405 . . . . 1.32 113.936 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.673 ' HA ' ' H ' ' A' ' 110' ' ' MET . 27.5 mt-10 -86.45 -53.9 4.73 Favored 'General case' 0 N--CA 1.412 -2.369 0 O-C-N 120.694 -1.254 . . . . 2.06 108.671 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.826 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.1 mmt -60.62 -18.25 52.08 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.129 -1.85 . . . . 3.13 111.478 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.677 HG13 ' HE3' ' A' ' 126' ' ' LYS . 9.2 p -44.75 -44.17 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-O 121.953 0.882 . . . . 0.37 110.534 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.677 ' HE3' HG13 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -67.66 -41.98 82.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.297 -1.319 . . . . 0.63 113.082 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.564 HD23 ' HB3' ' A' ' 197' ' ' LEU . 2.9 tm? -50.67 -34.67 27.45 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.666 0.604 . . . . 1.79 110.415 169.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.826 ' HG ' ' O ' ' A' ' 124' ' ' MET . 16.3 mt -84.92 -36.74 21.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.659 0.743 . . . . 0.38 109.572 -170.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -64.02 -32.74 74.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.179 -1.373 . . . . 1.96 109.988 168.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.59 -39.85 51.32 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.683 -1.599 . . . . 0.64 111.975 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 127' ' ' LEU . 0.3 OUTLIER -89.71 -5.3 57.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 124.021 1.867 . . . . 0.59 106.397 -178.169 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 58.35 51.57 8.17 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 110.488 -3.051 . . . . 1.8 112.361 170.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.826 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.6 t80 -135.47 175.4 9.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.278 0.561 . . . . 0.52 112.097 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.85 151.6 48.23 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.204 -1.406 . . . . 4.54 107.204 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.461 ' HB2' HG12 ' A' ' 147' ' ' VAL . 9.7 tm0? -49.67 138.45 14.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.686 1.231 . . . . 1.28 112.704 -170.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.66 ' CG1' HG22 ' A' ' 146' ' ' THR . 15.0 p -134.82 145.72 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 112.597 -2.092 . . . . 1.05 110.613 -162.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.97 -34.62 72.02 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.772 1.272 . . . . 1.38 109.493 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 11.2 ttpt -160.46 129.57 4.92 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 112.31 -2.223 . . . . 1.44 109.015 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.651 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -114.41 121.76 44.55 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.622 -0.717 . . . . 0.9 111.009 -179.412 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.429 ' HA ' HD11 ' A' ' 155' ' ' ILE . 1.7 t -158.14 98.39 1.58 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 122.946 1.355 . . . . 0.61 110.062 153.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.553 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.4 OUTLIER -164.42 161.82 15.74 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 112.552 -2.113 . . . . 1.77 106.328 163.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.71 114.55 2.19 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.332 1.355 . . . . 0.62 111.569 173.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 104.6 32.53 4.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 120.396 -0.906 . . . . 0.51 113.625 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.826 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -131.48 169.84 15.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.697 -0.482 . . . . 2.16 109.697 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.851 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.7 p90 -167.35 165.74 14.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.982 -1.118 . . . . 0.28 107.982 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.66 HG22 ' CG1' ' A' ' 136' ' ' VAL . 17.2 p -134.47 126.86 30.3 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.743 -0.783 . . . . 0.42 111.05 173.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.953 HG21 ' HG2' ' A' ' 121' ' ' LYS . 10.5 p -116.81 112.28 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.591 0.71 . . . . 0.34 111.242 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.74 132.75 3.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.361 -0.836 . . . . 3.11 111.101 -176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 58.56 -88.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.474 0.916 . . . . 1.65 113.474 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -124.57 23.0 8.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.526 0.565 . . . . 1.68 112.526 -170.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.1 p -160.27 149.72 17.63 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.826 1.047 . . . . 0.37 113.826 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 147' ' ' VAL . 28.8 mt -113.33 107.57 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 113.392 -1.731 . . . . 0.53 106.56 159.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.851 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 4.2 mt-10 -92.73 170.16 9.92 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.871 -1.9 . . . . 1.13 105.871 175.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 20.7 ptp -167.6 166.32 14.1 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 123.887 0.742 . . . . 1.8 109.708 -171.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.805 HG22 ' HG2' ' A' ' 168' ' ' GLN . 6.4 mt -128.0 92.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.984 0.897 . . . . 0.43 108.733 165.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.901 ' HG2' HD22 ' A' ' 197' ' ' LEU . 12.3 tpp180 . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 113.738 -1.573 . . . . 3.13 112.28 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.805 ' HG2' HG22 ' A' ' 155' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.424 -1.74 0 N-CA-C 112.945 0.72 . . . . 1.86 112.945 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 1.9 t -137.05 132.9 47.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 112.966 0.728 . . . . 0.41 112.966 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 154' ' ' MET . 20.9 ttt180 -88.03 110.11 20.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 116.128 -0.487 . . . . 2.8 109.738 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.44 138.67 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.735 0.779 . . . . 0.29 111.661 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.772 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 12.9 tpt180 -103.17 99.57 9.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.181 -1.372 . . . . 1.71 111.088 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 5.8 mp -91.26 104.5 17.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.388 -0.597 . . . . 0.69 109.388 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.7 114.64 28.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.656 1.217 . . . . 0.26 111.849 -173.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -86.12 131.32 34.28 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 112.516 -2.129 . . . . 0.72 109.45 -178.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.557 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 35.3 t70 -75.61 67.27 2.07 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.634 -1.617 . . . . 1.09 106.634 165.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.37 -98.76 1.27 Allowed Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 119.017 -1.563 . . . . 0.47 110.281 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -82.89 -24.59 33.1 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.852 0.686 . . . . 0.83 112.852 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.557 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 8.0 p-80 -131.74 126.42 34.42 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 119.717 -0.793 . . . . 1.21 111.374 -165.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.35 127.9 26.44 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.661 -1.608 . . . . 0.64 111.058 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -108.14 -38.91 5.64 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.869 -1.059 . . . . 0.29 110.516 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.439 ' O ' HG13 ' A' ' 183' ' ' ILE . 24.0 p -146.03 168.46 20.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.26 -0.427 . . . . 0.33 111.12 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.772 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 2.4 mt -140.82 143.12 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.748 -1.945 . . . . 0.76 105.748 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.7 t -137.06 136.35 47.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.228 0.537 . . . . 0.35 110.154 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.526 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 36.0 t-20 -86.29 100.58 12.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 108.088 -1.079 . . . . 1.77 108.088 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.463 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 39.1 mtm -64.34 -2.38 2.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 114.021 1.119 . . . . 0.55 114.021 -165.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.526 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.7 pt-20 -80.82 -44.13 18.94 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.861 0.838 . . . . 1.02 110.79 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.505 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 8.7 m120 -106.45 -25.57 11.81 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.997 -1.456 . . . . 1.4 108.942 -176.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.2 27.8 1.93 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.326 -2.215 . . . . 1.33 107.599 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -84.12 166.81 17.33 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.478 -1.692 . . . . 2.28 108.823 178.004 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -88.25 145.2 26.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.715 1.245 . . . . 1.36 112.67 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.626 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 1.7 m-85 -116.46 -169.34 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.282 -2.235 . . . . 1.18 105.359 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.849 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 134.94 -0.72 3.72 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.256 -1.138 . . . . 1.28 110.256 -163.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -148.65 97.63 2.76 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.138 -1.531 . . . . 2.8 108.369 154.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.3 t80 -132.15 118.96 20.26 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.004 -0.739 . . . . 0.6 109.004 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.422 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 9.0 mmt180 -105.81 142.49 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.941 -0.392 . . . . 4.77 109.941 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.901 HD22 ' HG2' ' A' ' 156' ' ' ARG . 33.7 mt -113.42 154.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.933 -0.576 . . . . 1.61 111.404 -171.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.675 ' HB3' ' NH1' ' A' ' 156' ' ' ARG . 13.4 t70 . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 109.297 -0.631 . . . . 2.66 109.297 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 52.6 mtm180 . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 107.818 -1.179 . . . . 4.32 107.818 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.52 ' O ' ' HB2' ' A' ' 126' ' ' LYS . 12.4 tpt -143.69 159.74 41.95 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.068 -1.053 . . . . 2.59 113.589 -166.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 127' ' ' LEU . 2.6 m -133.33 102.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 122.637 1.208 . . . . 0.74 109.475 159.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -164.22 111.6 1.1 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.691 -1.141 . . . . 1.38 108.194 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.682 ' HB3' HD13 ' A' ' 183' ' ' ILE . 4.4 mt -96.4 103.87 15.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.498 -0.481 . . . . 1.33 110.009 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.62 ' H ' ' HE2' ' A' ' 117' ' ' MET . 25.3 tt0 -155.88 106.15 2.12 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 119.817 -0.753 . . . . 1.93 110.63 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.586 ' HD3' ' CA ' ' A' ' 193' ' ' GLY . 18.8 Cg_exo -35.33 144.91 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.78 1 C-N-CA 125.94 4.426 . . . . 0.65 115.721 -175.048 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 67.74 40.19 2.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.055 -1.43 . . . . 0.72 109.536 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.633 ' HE3' HD13 ' A' ' 180' ' ' LEU . 10.9 ptt? -113.63 154.05 27.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.438 -1.255 . . . . 1.67 109.416 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -102.9 93.08 4.85 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.98 -1.119 . . . . 0.58 107.98 -173.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.656 HD13 ' HE2' ' A' ' 124' ' ' MET . 2.2 tt -126.54 162.05 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 114.601 -1.181 . . . . 0.65 110.945 -163.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.587 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.8 m -142.55 179.36 7.01 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.771 -0.826 . . . . 0.44 108.771 -169.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.855 ' HG2' HG21 ' A' ' 147' ' ' VAL . 13.0 mtpp -53.95 -35.24 61.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.06 -0.718 . . . . 2.33 109.06 166.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.937 ' O ' HG12 ' A' ' 125' ' ' VAL . 6.2 t-20 -81.87 -32.52 31.01 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.433 -1.258 . . . . 1.32 112.623 -177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.592 ' CB ' HG13 ' A' ' 119' ' ' ILE . 19.8 mt-10 -85.5 -20.7 29.29 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 119.653 -1.905 . . . . 2.06 109.167 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.764 ' HG3' HD12 ' A' ' 152' ' ' ILE . 18.7 mmt -85.4 -18.72 32.86 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.072 -1.422 . . . . 3.13 110.881 166.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.937 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.6 p -54.12 -36.28 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 CA-C-O 121.749 0.785 . . . . 0.37 111.285 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.921 ' HE3' HG13 ' A' ' 125' ' ' VAL . 1.5 mmpt? -71.44 -40.2 70.54 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.787 -1.097 . . . . 0.63 112.0 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.749 ' N ' HG12 ' A' ' 111' ' ' VAL . 1.5 tm? -49.57 -36.05 22.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.777 0.798 . . . . 1.79 109.163 166.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' A' ' 124' ' ' MET . 24.4 mt -86.11 -34.35 20.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.394 -0.821 . . . . 0.38 110.08 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 126' ' ' LYS . 2.9 tp10 -58.76 -34.89 71.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.184 -1.371 . . . . 1.96 109.216 167.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -73.69 -37.79 65.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.508 -1.678 . . . . 0.64 112.128 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 128' ' ' LEU . 10.8 t -89.18 -5.26 57.85 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 123.819 1.771 . . . . 0.59 107.079 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 56.82 53.26 8.41 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.048 -2.796 . . . . 1.8 112.71 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.777 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.1 t80 -136.37 176.99 8.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.209 -0.597 . . . . 0.52 112.181 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 41.5 ttt180 -134.37 155.24 50.61 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 4.54 107.603 172.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.431 ' HB2' HG12 ' A' ' 147' ' ' VAL . 11.3 tm0? -50.42 140.24 14.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.623 1.201 . . . . 1.28 112.89 -169.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.7 p -141.14 136.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.77 -2.014 . . . . 1.05 109.487 -166.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.5 t -59.43 -30.9 68.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 122.46 1.124 . . . . 1.38 109.578 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -159.22 120.12 3.24 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 112.858 -1.974 . . . . 1.44 108.95 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.657 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -111.22 120.63 42.93 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.074 -1.421 . . . . 0.9 110.167 -177.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.28 96.17 2.02 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.275 1.512 . . . . 0.61 109.067 157.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.566 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.2 OUTLIER -166.69 163.04 11.2 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 111.586 -2.552 . . . . 1.77 105.124 165.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.6 127.8 13.6 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 CA-C-N 120.63 1.261 . . . . 0.62 111.791 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 97.03 30.12 7.64 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 120.381 -0.914 . . . . 0.51 113.909 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.777 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -128.0 174.46 9.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.295 0.547 . . . . 2.16 110.125 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.897 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 p90 -169.06 163.93 11.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.273 -1.01 . . . . 0.28 108.273 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.736 HG22 HG13 ' A' ' 136' ' ' VAL . 22.3 p -132.86 126.35 32.02 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.176 -0.609 . . . . 0.42 110.956 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.855 HG21 ' HG2' ' A' ' 121' ' ' LYS . 6.1 p -112.18 110.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 120.026 -0.669 . . . . 0.34 111.801 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -132.45 43.58 2.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.433 -0.803 . . . . 3.11 111.456 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.54 -54.34 0.67 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.531 0.937 . . . . 1.65 113.531 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -80.98 -15.09 57.19 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.393 0.616 . . . . 1.68 110.288 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.2 p -164.74 154.6 13.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.154 -0.93 . . . . 0.37 111.441 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.764 HD12 ' HG3' ' A' ' 124' ' ' MET . 28.4 mt -114.67 110.87 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 113.496 -1.683 . . . . 0.53 106.555 164.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.897 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -88.95 174.87 7.68 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.53 -1.656 . . . . 1.13 106.53 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 28.2 ptm -168.89 159.34 9.45 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 123.501 0.501 . . . . 1.8 110.734 -172.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.4 mt -130.92 110.17 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.098 -0.501 . . . . 0.43 111.321 167.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.763 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 1.4 tpt180 . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.605 -0.725 . . . . 3.13 110.042 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.763 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 48.1 tt0 . . . . . 0 N--CA 1.426 -1.645 0 N-CA-C 115.203 1.556 . . . . 1.86 115.203 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 51.1 t -153.5 125.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 113.748 -1.569 . . . . 0.41 110.448 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HG3' HG12 ' A' ' 155' ' ' ILE . 4.1 ttm180 -84.52 110.63 18.83 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.467 -0.568 . . . . 2.8 109.467 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HB3' ' CG ' ' A' ' 154' ' ' MET . . . -116.27 147.71 41.23 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.729 -0.788 . . . . 0.29 111.603 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.785 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.4 tpp180 -109.77 98.97 8.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.552 -1.203 . . . . 1.71 110.84 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CE ' ' A' ' 124' ' ' MET . 1.4 mp -88.7 94.34 9.87 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.438 -0.949 . . . . 0.69 108.438 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.02 120.45 35.24 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 122.443 1.116 . . . . 0.26 111.672 -170.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-30 -90.91 130.07 36.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.746 -2.025 . . . . 0.72 109.962 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.57 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 30.7 t70 -78.68 64.83 3.78 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.224 -1.769 . . . . 1.09 106.224 165.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.99 -99.7 0.96 Allowed Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 119.332 -1.414 . . . . 0.47 110.735 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.65 -25.54 49.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.865 0.691 . . . . 0.83 112.865 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 6.8 p-80 -133.84 127.18 32.08 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.917 -0.713 . . . . 1.21 110.587 -167.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.0 tt -54.75 130.85 42.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.126 -1.397 . . . . 0.64 110.194 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.15 -39.16 6.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.93 -1.032 . . . . 0.29 109.827 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.8 p -152.56 169.51 22.47 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.029 -0.532 . . . . 0.33 111.244 -173.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.785 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mt -135.81 144.34 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.191 -2.151 . . . . 0.76 105.191 167.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 47.5 t -138.64 140.17 39.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 117.992 0.36 . . . . 0.35 110.296 -174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.606 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 37.5 t-20 -81.15 107.91 14.35 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.32 -1.363 . . . . 1.77 107.32 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.431 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 59.3 mtm -69.16 -1.52 8.04 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 112.586 0.587 . . . . 0.55 112.586 -166.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.606 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 12.1 pt-20 -85.26 -44.54 12.79 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.753 0.787 . . . . 1.02 111.237 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.533 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.7 m-20 -106.37 -26.09 11.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.513 -1.222 . . . . 1.4 109.093 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 188' ' ' ASN . 13.7 t30 77.31 31.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.536 -2.12 . . . . 1.33 107.304 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.458 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 ptm180 -89.0 159.24 17.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.736 -1.575 . . . . 2.28 108.889 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.75 149.77 25.53 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.208 1.004 . . . . 1.36 112.732 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.92 -174.04 3.48 Favored 'General case' 0 CA--C 1.472 -2.039 0 CA-C-N 113.246 -1.797 . . . . 1.18 107.754 -173.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.618 ' HA2' HD12 ' A' ' 183' ' ' ILE . . . 129.9 24.92 0.94 Allowed Glycine 1 N--CA 1.393 -4.177 0 CA-C-N 114.101 -1.409 . . . . 1.28 112.725 -178.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.36 94.69 2.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.452 -1.874 . . . . 2.8 106.824 145.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.679 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -129.99 101.36 5.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.693 -0.854 . . . . 0.6 108.693 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 3.2 mpt_? -105.35 127.36 52.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.191 0.52 . . . . 4.77 110.888 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.595 HD12 HD22 ' A' ' 127' ' ' LEU . 4.5 mt -104.15 172.55 6.74 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.434 -0.803 . . . . 1.61 111.9 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.445 -0.718 0 CA-C-N 114.268 -1.333 . . . . 2.66 108.66 173.427 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HB3' ' HE3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 114.731 1.382 . . . . 4.32 114.731 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.509 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 34.7 ttp -142.45 124.86 15.63 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.35 -0.94 . . . . 2.59 111.793 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.9 m -110.7 104.91 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-O 122.817 1.294 . . . . 0.74 113.128 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -160.01 109.9 1.83 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 112.587 -2.097 . . . . 1.38 106.054 165.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.808 HD21 HD21 ' A' ' 173' ' ' LEU . 4.3 mp -99.51 123.69 44.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.825 -0.805 . . . . 1.33 108.825 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -152.22 100.37 2.83 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.499 -0.926 . . . . 1.93 108.499 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.489 ' HD3' HD12 ' A' ' 183' ' ' ILE . 24.5 Cg_exo -35.43 137.66 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.366 1 C-N-CA 125.361 4.041 . . . . 0.65 114.314 -173.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.2 47.57 0.28 Allowed 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.488 1.137 . . . . 0.72 109.795 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.504 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 5.8 ptp -122.36 156.31 34.22 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.537 -1.211 . . . . 1.67 110.867 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.2 m -102.7 77.74 1.63 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.334 1.064 . . . . 0.58 108.471 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.509 HG22 ' HB2' ' A' ' 180' ' ' LEU . 15.2 tt -106.7 168.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 113.287 -1.779 . . . . 0.65 109.482 -171.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.513 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.8 m -137.59 162.9 32.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.223 -0.591 . . . . 0.44 109.464 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.649 ' HG2' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.34 -26.52 4.97 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 122.009 0.909 . . . . 2.33 108.817 170.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.695 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 4.0 t-20 -82.79 -14.69 53.94 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.826 -1.988 . . . . 1.32 114.535 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.513 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -84.7 -63.63 1.3 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.74 -1.225 . . . . 2.06 109.969 168.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.706 ' CE ' HD23 ' A' ' 173' ' ' LEU . 0.0 OUTLIER -64.28 -9.87 20.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.074 -0.966 . . . . 3.13 110.727 174.127 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.695 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 12.4 p -41.7 -41.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.853 0.835 . . . . 0.37 110.62 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.503 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.3 mmpt? -66.13 -37.31 85.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.807 -1.088 . . . . 0.63 113.116 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.808 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.5 tm? -54.2 -33.58 58.54 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.618 0.723 . . . . 1.79 109.894 167.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.763 ' HB3' ' CE2' ' A' ' 145' ' ' PHE . 15.9 mt -82.44 -34.96 27.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.452 -0.944 . . . . 0.38 108.452 -172.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -60.14 -39.33 85.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.843 -1.526 . . . . 1.96 109.943 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 132' ' ' GLN . . . -70.32 -42.76 71.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.989 -1.459 . . . . 0.64 112.544 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.446 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -88.6 -0.62 57.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 124.284 1.992 . . . . 0.59 105.812 -177.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 130' ' ' ALA . 11.5 mm-40 57.01 49.51 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 110.628 -2.987 . . . . 1.8 111.856 170.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.993 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 1.9 t80 -141.31 174.49 10.49 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 119.484 -0.886 . . . . 0.52 113.198 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 23.4 ptt-85 -137.49 158.15 45.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.142 -1.39 . . . . 4.54 107.585 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.69 140.42 14.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.194 0.997 . . . . 1.28 112.523 -171.027 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.805 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.9 p -139.85 134.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 113.512 -1.676 . . . . 1.05 110.192 -163.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.02 -33.36 68.89 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.7 1.238 . . . . 1.38 109.602 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.589 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -160.14 131.35 5.82 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 112.308 -2.224 . . . . 1.44 107.801 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.541 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 1.4 ptt? -119.0 137.93 53.18 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 115.023 -0.99 . . . . 0.9 111.127 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.49 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -162.31 98.58 1.03 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 122.34 1.067 . . . . 0.61 109.846 152.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.423 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -167.62 155.75 8.5 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 113.371 -1.74 . . . . 1.77 106.74 163.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.522 ' HA ' HG22 ' A' ' 155' ' ' ILE . 19.0 Cg_endo -61.27 119.62 6.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.051 1.167 . . . . 0.62 110.017 169.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.446 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 93.67 44.17 3.73 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.476 -1.345 . . . . 0.51 112.744 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.993 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.4 mt-10 -145.57 148.85 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.326 -0.99 . . . . 2.16 108.326 172.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.805 ' O ' HG12 ' A' ' 136' ' ' VAL . 40.7 p90 -152.85 156.78 39.65 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.758 -0.83 . . . . 0.28 108.758 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.75 HG22 HG13 ' A' ' 136' ' ' VAL . 21.3 p -126.04 126.28 43.99 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.679 -0.692 . . . . 0.42 110.663 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.649 HG21 ' HG2' ' A' ' 121' ' ' LYS . 9.1 p -125.08 109.88 23.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.966 -1.016 . . . . 0.34 111.511 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -110.27 -66.1 1.1 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.17 -0.468 . . . . 3.11 110.775 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.39 -61.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.076 0.399 . . . . 1.65 112.076 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -93.13 -1.78 56.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.615 0.598 . . . . 1.68 112.615 -171.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.4 p -163.28 152.6 14.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.529 0.937 . . . . 0.37 113.529 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.533 HD12 ' CG ' ' A' ' 124' ' ' MET . 20.7 mt -109.97 110.94 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 113.508 -1.678 . . . . 0.53 107.259 164.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -97.92 107.43 19.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.857 -1.164 . . . . 1.13 107.857 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 7.9 ptm -115.7 139.42 50.15 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.625 0.726 . . . . 1.8 112.124 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.64 HG23 ' HG3' ' A' ' 168' ' ' GLN . 68.4 mt -99.13 108.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.636 -1.165 . . . . 0.43 109.535 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.72 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 37.9 ttp180 . . . . . 0 C--N 1.31 -1.11 0 CA-C-N 114.689 -1.141 . . . . 3.13 109.978 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.72 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 113.386 0.884 . . . . 1.86 113.386 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.455 ' N ' ' HG2' ' A' ' 168' ' ' GLN . 44.0 t -151.21 128.7 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 114.834 -1.075 . . . . 0.41 109.192 173.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HG3' HG12 ' A' ' 155' ' ' ILE . 32.6 mtm180 -91.14 109.35 20.6 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 120.941 0.4 . . . . 2.8 110.386 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -114.15 134.14 55.1 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.956 0.884 . . . . 0.29 111.544 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.8 tpp180 -95.0 98.04 10.4 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 113.569 -1.651 . . . . 1.71 110.75 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.808 HD21 HD21 ' A' ' 113' ' ' LEU . 2.8 mp -86.21 93.28 9.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.079 -0.711 . . . . 0.69 109.079 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 114.25 25.92 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 122.012 0.911 . . . . 0.26 111.497 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-85 -87.02 131.48 34.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.446 -1.707 . . . . 0.72 110.197 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.7 t70 -77.38 65.38 2.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.567 -1.642 . . . . 1.09 106.567 164.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.29 -98.54 1.25 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.911 -1.614 . . . . 0.47 110.379 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.71 -22.93 37.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.906 0.706 . . . . 0.83 112.906 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -133.89 128.42 34.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 119.685 -0.806 . . . . 1.21 111.431 -168.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 5.6 tt -52.77 125.93 18.39 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.899 -1.5 . . . . 0.64 109.648 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.11 -37.74 6.51 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.408 -0.814 . . . . 0.29 109.442 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.4 p -146.13 161.23 40.65 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.533 -0.758 . . . . 0.33 111.001 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.4 mt -128.59 145.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.214 -2.143 . . . . 0.76 105.214 167.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.6 t -142.22 132.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.392 0.615 . . . . 0.35 109.998 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 32.3 t-20 -79.21 105.26 10.41 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 107.495 -1.298 . . . . 1.77 107.495 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.514 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 38.6 mtm -66.95 -1.48 4.1 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.782 0.676 . . . . 0.55 112.642 -167.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.59 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.9 pt-20 -79.71 -44.14 21.35 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.85 0.833 . . . . 1.02 110.819 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.59 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 70.6 m-20 -107.49 -26.59 10.86 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.293 -1.321 . . . . 1.4 109.454 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 188' ' ' ASN . 53.8 t30 77.02 33.13 0.46 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.534 -2.121 . . . . 1.33 107.586 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.5 ptm180 -91.83 161.47 14.84 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.581 -1.645 . . . . 2.28 109.18 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.62 137.76 32.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.103 -0.953 . . . . 1.36 109.358 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -110.85 89.92 3.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.779 -0.769 . . . . 1.18 110.795 -174.262 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.54 -58.69 0.0 OUTLIER Glycine 0 N--CA 1.469 0.863 0 C-N-CA 125.173 1.368 . . . . 1.28 116.233 145.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 23.6 p90 -164.07 174.4 11.37 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.952 -1.624 . . . . 2.8 107.709 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.762 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.7 t80 -138.31 101.59 4.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.637 0.732 . . . . 0.6 110.626 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -81.92 137.52 35.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.834 -0.621 . . . . 4.77 110.09 -177.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.808 HD13 ' HG ' ' A' ' 127' ' ' LEU . 92.5 mt -134.24 170.48 15.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.493 0.923 . . . . 1.61 113.493 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 114.268 -1.333 . . . . 2.66 109.874 -178.707 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 115.084 1.513 . . . . 4.32 115.084 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.774 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 57.4 ttm -142.3 110.87 6.13 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.153 -0.619 . . . . 2.59 112.326 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.8 m -107.81 106.66 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-O 122.459 1.123 . . . . 0.74 113.08 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -158.46 108.64 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.185 -1.825 . . . . 1.38 107.008 163.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.761 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.8 mp -95.18 116.85 29.27 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.059 -0.719 . . . . 1.33 109.059 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -148.3 107.34 3.6 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 119.766 -0.774 . . . . 1.93 110.176 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.535 ' HG3' HG12 ' A' ' 183' ' ' ILE . 37.7 Cg_exo -35.43 130.49 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 124.287 3.325 . . . . 0.65 113.799 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 24.3 t70 68.83 54.33 0.48 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.512 1.149 . . . . 0.72 110.01 -174.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.702 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 14.1 ptt? -121.73 156.18 33.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.972 -1.467 . . . . 1.67 110.364 172.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.51 96.37 6.69 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.496 -0.927 . . . . 0.58 108.496 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.83 HD13 ' HE2' ' A' ' 124' ' ' MET . 15.8 tt -136.98 169.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.613 -1.176 . . . . 0.65 109.831 -165.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 124' ' ' MET . 20.2 m -139.75 175.94 9.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.809 0.731 . . . . 0.44 111.118 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.638 ' H ' ' HD2' ' A' ' 121' ' ' LYS . 3.2 mptt -62.34 -19.82 63.74 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.123 0.963 . . . . 2.33 108.556 169.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.71 ' O ' HG12 ' A' ' 125' ' ' VAL . 5.2 t30 -81.5 -23.44 37.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.31 -1.768 . . . . 1.32 112.627 177.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.774 ' HA ' ' H ' ' A' ' 110' ' ' MET . 19.6 mt-10 -88.45 -44.01 11.04 Favored 'General case' 0 N--CA 1.408 -2.556 0 O-C-N 120.812 -1.18 . . . . 2.06 108.93 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.83 ' HE2' HD13 ' A' ' 119' ' ' ILE . 14.1 mmt -63.89 -18.76 64.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.96 -1.473 . . . . 3.13 110.557 169.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -48.96 -41.57 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-O 122.089 0.947 . . . . 0.37 110.287 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.524 ' CE ' HG13 ' A' ' 125' ' ' VAL . 8.7 mmpt? -66.67 -38.21 86.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.204 -1.362 . . . . 0.63 113.404 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.888 HD13 HD13 ' A' ' 197' ' ' LEU . 13.5 tp -49.85 -40.15 41.46 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.857 0.837 . . . . 1.79 110.114 166.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.2 mt -82.44 -30.84 29.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.016 -0.993 . . . . 0.38 109.259 -167.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.49 -39.3 94.08 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.844 -1.526 . . . . 1.96 110.241 165.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -72.3 -41.93 66.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.497 -1.683 . . . . 0.64 112.083 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER -97.0 6.79 47.98 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 124.558 2.123 . . . . 0.59 105.784 -177.148 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 46.29 50.67 12.02 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 110.023 -3.262 . . . . 1.8 113.008 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.559 ' HB3' ' CD2' ' A' ' 145' ' ' PHE . 2.8 t80 -136.07 175.03 9.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.879 -0.728 . . . . 0.52 112.437 -173.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 2.2 tmm_? -137.05 147.96 46.49 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.459 -1.682 . . . . 4.54 106.459 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.537 ' N ' ' HD2' ' A' ' 134' ' ' ARG . 9.7 tm0? -47.92 140.7 6.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.846 1.308 . . . . 1.28 113.388 -170.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.8 p -140.88 137.73 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 112.638 -2.074 . . . . 1.05 109.423 -163.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -59.29 -33.22 70.82 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.343 1.068 . . . . 1.38 109.057 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.16 129.01 5.63 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.997 -1.91 . . . . 1.44 109.082 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.656 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -118.66 129.62 55.4 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.293 -1.321 . . . . 0.9 111.59 -172.35 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 1.8 t -160.57 99.33 1.28 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 122.907 1.337 . . . . 0.61 110.867 155.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.496 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.14 162.32 14.19 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.737 -2.029 . . . . 1.77 105.985 161.261 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.96 120.47 8.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.102 1.201 . . . . 0.62 110.379 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.02 48.56 3.32 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.548 -1.31 . . . . 0.51 112.964 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.55 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 31.7 mt-10 -142.25 167.51 21.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.343 -0.614 . . . . 2.16 109.343 169.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.871 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 46.8 p90 -167.76 163.13 14.18 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.234 -1.024 . . . . 0.28 108.234 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.737 HG22 HG13 ' A' ' 136' ' ' VAL . 25.7 p -130.34 125.89 35.78 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.822 -0.751 . . . . 0.42 111.147 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.651 HG23 HG12 ' A' ' 152' ' ' ILE . 7.7 p -115.24 110.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 122.002 0.906 . . . . 0.34 111.133 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -122.73 31.16 6.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.101 -0.954 . . . . 3.11 110.784 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.91 -47.04 0.66 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.485 -0.78 . . . . 1.65 112.211 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -81.67 -16.29 51.79 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.102 0.477 . . . . 1.68 110.569 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.44 ' HB3' HG23 ' A' ' 174' ' ' THR . 1.8 p -162.49 154.21 18.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.434 -0.803 . . . . 0.37 112.296 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.675 HD12 ' HG3' ' A' ' 124' ' ' MET . 20.2 mt -117.98 107.68 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.696 -1.593 . . . . 0.53 107.346 165.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.871 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.8 mp0 -90.9 168.35 11.76 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.176 -2.157 . . . . 1.13 105.176 174.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.04 157.9 10.01 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.783 0.677 . . . . 1.8 110.291 -169.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 140' ' ' THR . 15.1 mt -127.15 109.99 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 115.425 -0.807 . . . . 0.43 110.347 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.725 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 3.9 tpt180 . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 115.029 -0.987 . . . . 3.13 109.675 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.725 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 51.9 tt0 . . . . . 0 N--CA 1.425 -1.722 0 N-CA-C 115.473 1.657 . . . . 1.86 115.473 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 46.5 t -153.08 131.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 113.998 -1.456 . . . . 0.41 109.856 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.616 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 35.9 mtm180 -87.14 116.63 25.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.07 -0.514 . . . . 2.8 110.192 168.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.54 153.1 38.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.613 0.721 . . . . 0.29 111.414 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.723 ' CB ' ' HB ' ' A' ' 184' ' ' VAL . 0.0 OUTLIER -120.57 101.8 8.0 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.264 -1.335 . . . . 1.71 111.147 -172.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.601 HD21 HD21 ' A' ' 113' ' ' LEU . 1.1 mp -90.72 90.12 7.81 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.443 -0.577 . . . . 0.69 109.443 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -94.0 125.03 38.39 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.297 1.046 . . . . 0.26 111.139 -175.092 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 24.4 m-85 -98.45 136.54 38.44 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.158 -1.837 . . . . 0.72 111.354 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 181' ' ' ALA . 47.5 m-20 -78.28 64.74 3.47 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.813 -1.551 . . . . 1.09 106.813 161.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.24 -99.27 1.17 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 118.71 -1.71 . . . . 0.47 110.599 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.26 -20.49 32.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.913 0.708 . . . . 0.83 112.913 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.16 123.08 27.78 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 119.001 -1.08 . . . . 1.21 110.082 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -56.53 134.48 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.2 -1.818 . . . . 0.64 110.799 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.415 ' HB2' ' OD2' ' A' ' 176' ' ' ASP . . . -106.03 -41.43 5.38 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.509 -1.223 . . . . 0.29 110.517 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.7 p -150.51 158.88 44.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.342 -0.39 . . . . 0.33 111.606 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.564 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.8 mm -109.98 150.01 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 104.855 -2.276 . . . . 0.76 104.855 163.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.723 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 42.3 t -133.6 131.31 57.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 118.761 0.71 . . . . 0.35 110.255 177.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.43 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.0 t-20 -80.42 94.34 6.16 Favored 'General case' 0 CA--C 1.476 -1.873 0 N-CA-C 106.8 -1.556 . . . . 1.77 106.8 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.616 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.0 mtm -63.68 -2.53 1.76 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 124.149 0.905 . . . . 0.55 113.39 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.4 pt-20 -83.5 -41.46 17.96 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.784 0.802 . . . . 1.02 110.672 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.451 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.6 m-20 -102.73 -25.93 13.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.262 -1.335 . . . . 1.4 108.549 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.8 t30 73.97 32.82 1.03 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.936 -2.393 . . . . 1.33 107.887 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.8 ptm180 -95.75 162.43 13.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.701 -1.59 . . . . 2.28 109.466 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 77.1 mt-30 -80.83 127.81 32.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.183 -0.917 . . . . 1.36 109.535 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.564 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -100.82 93.01 5.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.747 -0.644 . . . . 1.18 110.303 -171.255 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 20.87 -58.23 0.0 OUTLIER Glycine 0 N--CA 1.471 0.975 0 N-CA-C 116.542 1.377 . . . . 1.28 116.542 148.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 192' ' ' PHE . 34.0 p90 -162.99 175.14 11.45 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.296 -1.452 . . . . 2.8 108.755 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.761 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -145.06 127.95 16.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.556 -0.535 . . . . 0.6 109.556 156.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.548 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 1.6 mpt_? -112.02 141.56 45.53 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 120.88 -1.138 . . . . 4.77 111.507 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.888 HD13 HD13 ' A' ' 127' ' ' LEU . 40.6 mt -136.72 163.42 30.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.702 -0.681 . . . . 1.61 112.162 -172.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 114.866 -1.061 . . . . 2.66 110.214 -177.494 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.697 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 32.4 mtt180 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.404 -0.961 . . . . 4.32 108.404 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.3 ttt -142.75 132.24 23.67 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.194 -1.003 . . . . 2.59 113.531 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' VAL . 32.6 m -124.22 101.6 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 123.148 1.452 . . . . 0.74 111.399 164.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.509 ' C ' HD12 ' A' ' 113' ' ' LEU . 43.0 t30 -162.51 119.99 2.06 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 105.007 -2.22 . . . . 1.38 105.007 170.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.754 HD23 HD11 ' A' ' 173' ' ' LEU . 5.6 mp -109.45 80.21 1.29 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.298 -1.001 . . . . 1.33 108.298 -172.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.552 ' H ' ' CE ' ' A' ' 117' ' ' MET . 27.4 tt0 -123.98 111.02 29.07 Favored Pre-proline 0 C--N 1.29 -2.02 0 C-N-CA 118.946 -1.102 . . . . 1.93 110.295 -169.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.504 ' HG3' HG12 ' A' ' 183' ' ' ILE . 39.2 Cg_exo -35.78 131.98 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 124.886 3.724 . . . . 0.65 114.298 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 28.7 t70 72.76 50.03 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.552 1.168 . . . . 0.72 110.457 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.552 ' CE ' ' H ' ' A' ' 114' ' ' GLU . 10.6 ptp -122.84 155.57 36.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.166 -1.379 . . . . 1.67 110.924 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -96.67 85.58 3.88 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.933 0.873 . . . . 0.58 108.959 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -110.18 163.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.397 -1.274 . . . . 0.65 109.924 -172.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.636 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.5 m -140.87 173.92 11.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.673 -0.492 . . . . 0.44 109.673 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.822 ' HG2' HG21 ' A' ' 147' ' ' VAL . 44.2 mttp -53.99 -32.74 55.02 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 108.575 -0.898 . . . . 2.33 108.575 164.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.627 ' O ' HG12 ' A' ' 125' ' ' VAL . 41.6 t30 -84.24 -19.19 34.33 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 114.053 -1.43 . . . . 1.32 114.733 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.636 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.3 mp0 -84.9 -63.28 1.36 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 119.755 -1.841 . . . . 2.06 107.183 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.751 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -56.36 -13.47 2.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 112.858 -1.974 . . . . 3.13 111.361 172.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 122' ' ' ASN . 14.5 p -43.19 -43.07 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.2 1.0 . . . . 0.37 110.117 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.697 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.7 -37.54 82.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.115 -1.402 . . . . 0.63 112.774 176.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -50.94 -33.83 26.11 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.723 0.773 . . . . 1.79 110.873 168.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 127' ' ' LEU . 16.0 mt -84.55 -32.62 23.75 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.931 -1.032 . . . . 0.38 109.229 -172.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.23 -35.0 77.27 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.352 -1.295 . . . . 1.96 109.644 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.26 -42.04 72.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.252 -1.794 . . . . 0.64 111.904 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.571 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.6 t -90.33 -2.66 58.01 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 123.384 1.564 . . . . 0.59 107.368 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 55.23 54.85 8.21 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 110.974 -2.83 . . . . 1.8 112.103 172.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.732 ' CZ ' ' HG3' ' A' ' 144' ' ' GLU . 3.8 t80 -138.97 177.85 7.59 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 113.095 0.776 . . . . 0.52 113.095 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.426 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -141.31 139.27 33.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.539 -1.282 . . . . 4.54 107.539 177.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 16.0 tm0? -49.06 139.47 10.51 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.35 1.241 . . . . 1.28 114.35 -168.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.781 HG23 HG22 ' A' ' 146' ' ' THR . 3.8 m -124.23 156.41 31.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.933 -1.939 . . . . 1.05 111.52 -175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -59.67 -37.48 78.87 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.516 1.15 . . . . 1.38 107.958 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -158.46 134.97 9.45 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 112.611 -2.086 . . . . 1.44 109.397 -177.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.562 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.05 136.42 54.58 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.0 -1.0 . . . . 0.9 111.311 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.7 t -159.0 100.59 1.57 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.684 1.231 . . . . 0.61 109.675 151.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.54 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -163.62 170.15 7.56 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.82 -1.991 . . . . 1.77 106.534 165.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.5 117.13 3.66 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.661 1.574 . . . . 0.62 112.604 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 105.94 36.53 2.73 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.947 -0.644 . . . . 0.51 112.366 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.732 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 12.8 mp0 -130.95 176.82 7.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.171 -0.307 . . . . 2.16 110.171 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.885 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -166.56 175.95 7.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.0 -0.741 . . . . 0.28 109.0 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.781 HG22 HG23 ' A' ' 136' ' ' VAL . 61.7 p -140.98 126.32 18.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.967 -0.56 . . . . 0.42 110.898 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.822 HG21 ' HG2' ' A' ' 121' ' ' LYS . 14.4 p -125.41 126.44 70.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.435 0.636 . . . . 0.34 112.241 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -132.36 -74.69 0.51 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.009 -0.541 . . . . 3.11 110.26 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.05 -50.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.893 0.331 . . . . 1.65 111.893 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.88 -11.47 55.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.418 -0.355 . . . . 1.68 111.516 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 10.9 p -165.13 154.72 12.94 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.868 0.842 . . . . 0.37 112.915 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.763 HG12 HG23 ' A' ' 147' ' ' VAL . 63.2 mt -114.61 108.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.597 -1.631 . . . . 0.53 106.597 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.885 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.24 166.61 13.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.703 -1.962 . . . . 1.13 105.703 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 7.6 ptm -167.53 151.67 6.59 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 124.014 0.821 . . . . 1.8 110.183 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.549 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.3 mt -128.24 113.57 30.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.159 -0.473 . . . . 0.43 110.439 172.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.773 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 13.1 mtp-105 . . . . . 0 C--N 1.316 -0.881 0 O-C-N 123.347 0.404 . . . . 3.13 110.613 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.773 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 25.4 tt0 . . . . . 0 N--CA 1.413 -2.279 0 N-CA-C 113.02 0.748 . . . . 1.86 113.02 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 61.9 t -154.96 124.43 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.131 -1.395 . . . . 0.41 109.364 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 50.5 mtm180 -81.58 124.74 29.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.548 -0.538 . . . . 2.8 109.548 166.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -129.05 137.18 51.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.654 0.74 . . . . 0.29 110.346 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.552 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 7.1 tpp180 -104.82 106.54 17.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.195 -1.366 . . . . 1.71 110.936 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.754 HD11 HD23 ' A' ' 113' ' ' LEU . 5.1 mp -92.31 98.21 11.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.3 -0.63 . . . . 0.69 109.3 174.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.57 120.99 40.86 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.188 0.994 . . . . 0.26 111.499 -171.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -88.57 134.96 33.72 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.953 -1.93 . . . . 0.72 110.229 -177.381 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 37.4 t70 -77.21 66.15 2.94 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.676 -1.602 . . . . 1.09 106.676 163.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.81 -98.97 1.73 Allowed Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 118.801 -1.666 . . . . 0.47 110.233 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.65 -26.02 30.24 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.878 0.695 . . . . 0.83 112.878 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -128.37 128.81 45.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.442 -0.903 . . . . 1.21 110.865 -166.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.741 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.2 tt -52.14 129.13 26.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.433 -1.712 . . . . 0.64 110.546 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.91 -39.32 5.8 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.04 -0.982 . . . . 0.29 110.059 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 167.37 24.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.144 -0.48 . . . . 0.33 111.853 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' A' ' 195' ' ' PHE . 2.0 mm -118.6 147.8 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 105.444 -2.058 . . . . 0.76 105.444 164.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -139.82 128.34 26.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.579 0.704 . . . . 0.35 110.072 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.459 ' CB ' ' HG2' ' A' ' 190' ' ' ARG . 2.4 t-20 -69.4 105.13 2.48 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 107.523 -1.288 . . . . 1.77 107.523 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.686 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 6.7 mtm -65.33 -3.56 4.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.845 0.683 . . . . 0.55 112.845 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.49 ' HG3' ' ND2' ' A' ' 188' ' ' ASN . 11.2 pt-20 -96.12 -37.44 10.59 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.695 0.76 . . . . 1.02 111.303 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 187' ' ' GLU . 48.9 m-80 -104.4 -26.53 12.39 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.541 -1.208 . . . . 1.4 109.893 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 75.39 31.83 0.76 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.745 -2.025 . . . . 1.33 108.362 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 13.5 ptt180 -92.93 156.46 16.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.454 -1.248 . . . . 2.28 109.503 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -84.69 127.44 34.1 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.87 -1.059 . . . . 1.36 109.692 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.556 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -103.77 92.81 4.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.918 -0.713 . . . . 1.18 110.451 -171.522 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 18.27 -58.5 0.0 OUTLIER Glycine 0 N--CA 1.468 0.826 0 N-CA-C 115.905 1.122 . . . . 1.28 115.905 145.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -163.32 174.21 12.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.043 -1.578 . . . . 2.8 108.399 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.688 ' HB3' HD22 ' A' ' 113' ' ' LEU . 1.9 t80 -142.82 152.71 42.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.086 -1.079 . . . . 0.6 108.086 156.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.42 147.53 34.75 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 122.058 -0.401 . . . . 4.77 111.422 -172.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.479 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 5.4 mt -132.87 172.43 12.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.636 0.976 . . . . 1.61 113.636 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-N 113.399 -1.728 . . . . 2.66 108.667 169.993 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HB2' ' HG3' ' A' ' 126' ' ' LYS . 3.4 ptm180 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 119.209 -0.424 . . . . 4.32 110.642 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.425 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 52.3 ttp -141.14 125.52 17.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 118.306 -1.358 . . . . 2.59 113.732 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 111' ' ' VAL . 26.8 m -114.0 101.53 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 122.763 1.268 . . . . 0.74 110.947 167.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.435 ' C ' HD12 ' A' ' 113' ' ' LEU . 53.0 t30 -163.02 109.75 1.19 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.576 -1.647 . . . . 1.38 106.763 171.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.603 ' CG ' HD21 ' A' ' 173' ' ' LEU . 4.9 mp -104.02 77.38 1.43 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.937 -0.764 . . . . 1.33 108.937 -169.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -121.81 107.64 35.7 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 119.342 -0.943 . . . . 1.93 110.311 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.532 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.4 Cg_exo -34.04 130.25 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.542 3.494 . . . . 0.65 114.407 -172.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 23.1 t0 77.72 39.22 0.18 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.456 1.122 . . . . 0.72 110.811 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.635 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -115.05 155.51 26.88 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.867 -1.06 . . . . 1.67 110.577 172.13 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 m -92.91 86.6 5.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.964 0.887 . . . . 0.58 109.205 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.63 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.7 tt -116.46 162.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.076 -1.42 . . . . 0.65 109.718 -171.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.682 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.6 m -142.26 178.03 7.85 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.96 -0.756 . . . . 0.44 108.96 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.817 ' HG2' HG21 ' A' ' 147' ' ' VAL . 28.9 mtpt -57.45 -28.58 63.47 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 108.525 -0.917 . . . . 2.33 108.525 163.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.583 ' O ' HG12 ' A' ' 125' ' ' VAL . 32.9 t30 -85.32 -18.44 33.83 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-N 113.851 -1.522 . . . . 1.32 114.774 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.682 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.0 mp0 -86.9 -62.08 1.58 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 119.82 -1.8 . . . . 2.06 108.289 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.822 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.7 tpt -53.58 -17.03 1.8 Allowed 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 112.8 -2.0 . . . . 3.13 110.779 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.593 HG13 ' HE3' ' A' ' 126' ' ' LYS . 14.9 p -43.98 -44.92 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.288 1.042 . . . . 0.37 110.447 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HE3' HG13 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -69.18 -36.29 77.19 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.937 -1.483 . . . . 0.63 112.838 177.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.76 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -51.1 -35.08 33.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 122.028 0.918 . . . . 1.79 110.54 168.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.822 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.2 mt -84.82 -28.6 26.0 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.754 -1.112 . . . . 0.38 109.152 -171.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.69 -20.47 50.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.136 -1.393 . . . . 1.96 110.341 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -80.62 -43.87 19.82 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.07 -1.423 . . . . 0.64 111.215 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.91 -6.17 54.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 123.653 1.692 . . . . 0.59 107.094 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.12 56.41 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 110.976 -2.829 . . . . 1.8 112.945 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.732 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -135.15 176.72 8.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.615 -0.721 . . . . 0.52 111.817 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 65.7 ttt180 -136.98 149.95 47.84 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.126 -1.435 . . . . 4.54 107.126 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -48.88 137.0 13.24 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.737 1.256 . . . . 1.28 112.836 -170.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.6 p -137.6 140.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 112.349 -2.205 . . . . 1.05 109.677 -164.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 m -63.5 -31.72 72.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.096 0.951 . . . . 1.38 109.3 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -152.6 117.72 5.19 Favored 'General case' 0 CA--C 1.485 -1.539 0 CA-C-N 113.352 -1.749 . . . . 1.44 110.661 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.664 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -109.59 117.88 35.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 113.81 -1.541 . . . . 0.9 110.12 179.351 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -151.12 95.59 2.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.24 1.495 . . . . 0.61 108.399 156.415 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.53 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -168.31 155.87 7.63 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 111.546 -2.57 . . . . 1.77 105.029 168.401 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.476 ' HA ' HG22 ' A' ' 155' ' ' ILE . 14.6 Cg_exo -71.17 123.6 9.77 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.526 1.484 . . . . 0.62 112.18 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.688 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 106.15 20.14 9.48 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 120.579 -0.82 . . . . 0.51 111.781 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.732 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.8 mp0 -125.99 173.82 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.807 -0.442 . . . . 2.16 109.807 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.885 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 47.6 p90 -168.42 168.17 11.38 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.506 -1.294 . . . . 0.28 107.506 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.683 HG22 HG13 ' A' ' 136' ' ' VAL . 34.9 p -133.19 127.27 33.43 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.713 -0.795 . . . . 0.42 110.499 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.879 HG23 HG12 ' A' ' 152' ' ' ILE . 10.7 p -122.93 121.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.715 -0.794 . . . . 0.34 112.861 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -111.02 -77.47 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.973 . . . . 3.11 109.74 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -176.73 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.261 -0.881 . . . . 1.65 109.092 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.45 -19.32 39.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.97 -1.014 . . . . 1.68 110.128 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 21.0 p -160.6 155.03 23.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.149 -0.932 . . . . 0.37 111.751 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.879 HG12 HG23 ' A' ' 147' ' ' VAL . 53.4 mt -121.11 113.82 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.487 -1.671 . . . . 0.53 106.487 163.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.885 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -89.82 169.99 10.79 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.374 -1.713 . . . . 1.13 106.374 175.437 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.23 150.54 5.36 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 123.802 0.689 . . . . 1.8 110.672 -174.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.6 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.3 mt -128.71 119.47 49.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.763 -0.653 . . . . 0.43 109.938 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.71 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 82.6 mtp180 . . . . . 0 C--N 1.32 -0.695 0 O-C-N 123.458 0.474 . . . . 3.13 110.719 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.71 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 5.3 tt0 . . . . . 0 N--CA 1.425 -1.685 0 CA-C-O 121.301 0.572 . . . . 1.86 112.064 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 53.7 t -153.69 130.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.712 -1.131 . . . . 0.41 108.711 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.703 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 51.4 mtm180 -87.25 122.82 31.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.225 0.536 . . . . 2.8 110.152 169.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -130.25 128.45 41.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.091 0.948 . . . . 0.29 110.791 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.543 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 9.0 tpp180 -96.26 120.88 37.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.496 -1.683 . . . . 1.71 110.251 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.603 HD21 ' CG ' ' A' ' 113' ' ' LEU . 7.4 mp -111.54 103.99 12.36 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.422 0.63 . . . . 0.69 111.045 174.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.75 124.87 47.01 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.777 -1.101 . . . . 0.26 111.284 -174.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -97.9 139.6 33.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.137 -1.847 . . . . 0.72 110.683 -175.088 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.1 64.06 4.81 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 106.754 -1.573 . . . . 1.09 106.754 160.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.84 -98.82 0.64 Allowed Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 118.78 -1.676 . . . . 0.47 110.926 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.41 -25.47 59.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.939 0.718 . . . . 0.83 112.939 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -136.28 133.89 37.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.768 -0.773 . . . . 1.21 109.824 -169.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -60.1 138.79 57.81 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.115 -1.402 . . . . 0.64 110.0 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.34 -45.21 4.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.043 -0.98 . . . . 0.29 110.513 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.8 p -148.66 158.8 44.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 111.698 0.259 . . . . 0.33 111.698 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.555 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.2 mm -107.42 148.32 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 104.966 -2.235 . . . . 0.76 104.966 165.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.5 t -140.05 126.88 23.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.532 0.682 . . . . 0.35 110.077 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -69.72 107.48 3.49 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.356 -1.349 . . . . 1.77 107.356 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.703 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 20.3 mtm -64.66 -8.33 14.01 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 112.862 0.69 . . . . 0.55 112.862 -165.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -91.66 -41.83 10.51 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.768 0.794 . . . . 1.02 111.45 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -98.24 -25.47 14.86 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.391 -1.277 . . . . 1.4 109.381 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.1 t30 70.09 35.47 2.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.912 -2.404 . . . . 1.33 108.015 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.5 ptm180 -96.42 157.78 15.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.604 -1.634 . . . . 2.28 108.833 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 87.8 mt-30 -85.94 129.43 34.84 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.336 -0.847 . . . . 1.36 109.221 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.555 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -104.1 91.91 4.15 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.259 -0.576 . . . . 1.18 110.547 -170.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.33 -59.09 0.0 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 116.26 1.264 . . . . 1.28 116.26 147.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 192' ' ' PHE . 26.2 p90 -164.75 171.08 14.74 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.639 -1.281 . . . . 2.8 109.137 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.575 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -139.19 151.87 46.92 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.842 -1.17 . . . . 0.6 107.842 159.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.697 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.23 148.46 36.48 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.906 -0.496 . . . . 4.77 110.465 -175.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.599 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 3.5 mt -130.15 172.07 12.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.282 1.039 . . . . 1.61 113.728 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-N 113.207 -1.815 . . . . 2.66 108.249 170.546 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.114 -0.699 . . . . 4.32 109.114 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.581 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 26.2 ttt -144.23 136.92 26.93 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.423 -0.511 . . . . 2.59 111.882 -170.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 126' ' ' LYS . 2.0 m -119.8 104.4 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 122.569 1.175 . . . . 0.74 113.41 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -159.74 108.23 1.76 Allowed 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.939 -1.937 . . . . 1.38 106.895 163.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.823 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.2 mp -98.17 113.21 25.05 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.517 0.675 . . . . 1.33 109.295 -173.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -139.97 100.77 7.17 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.76 -1.109 . . . . 1.93 109.031 -173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.48 ' HD3' HD12 ' A' ' 183' ' ' ILE . 23.5 Cg_exo -35.12 133.68 0.19 Allowed 'Trans proline' 0 CA--C 1.515 -0.46 0 C-N-CA 124.452 3.435 . . . . 0.65 113.997 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 31.4 t70 74.74 47.06 0.12 Allowed 'General case' 0 CA--C 1.529 0.135 0 O-C-N 124.583 1.177 . . . . 0.72 109.91 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.589 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 12.4 ptt? -121.12 155.79 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.266 -1.333 . . . . 1.67 110.339 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 179' ' ' HIS . 56.5 m -101.59 102.75 13.52 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.532 -0.914 . . . . 0.58 108.532 -176.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.71 HD13 ' HE3' ' A' ' 124' ' ' MET . 16.6 tt -138.93 167.76 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.212 -0.904 . . . . 0.65 110.64 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.6 m -140.84 174.33 10.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.765 0.711 . . . . 0.44 110.785 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.514 ' HA ' HD11 ' A' ' 152' ' ' ILE . 11.9 mttp -57.49 -26.19 60.91 Favored 'General case' 0 C--O 1.211 -0.944 0 N-CA-C 109.089 -0.708 . . . . 2.33 109.089 165.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 40.6 t30 -84.44 -17.1 40.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.316 -1.311 . . . . 1.32 114.052 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.581 ' CG ' ' HB3' ' A' ' 110' ' ' MET . 1.8 tt0 -87.18 -60.25 2.03 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.658 -1.238 . . . . 2.06 107.658 168.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.848 ' SD ' HD12 ' A' ' 152' ' ' ILE . 61.2 mtt -54.86 -15.91 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.832 -1.985 . . . . 3.13 111.906 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.576 HG13 ' HE3' ' A' ' 126' ' ' LYS . 12.9 p -44.16 -40.63 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 122.141 0.972 . . . . 0.37 109.967 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.659 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.77 -40.7 84.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.066 -1.425 . . . . 0.63 112.743 176.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -49.74 -33.71 16.97 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.686 0.755 . . . . 1.79 111.041 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 127' ' ' LEU . 14.6 mt -85.96 -34.27 20.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.856 -1.065 . . . . 0.38 109.607 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.59 -34.6 76.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.448 -1.251 . . . . 1.96 109.854 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.89 67.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.512 -1.676 . . . . 0.64 111.451 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.415 ' O ' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -89.64 -0.42 57.51 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 123.976 1.846 . . . . 0.59 106.969 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 55.75 54.6 8.03 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 111.079 -2.782 . . . . 1.8 112.693 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 2.7 t80 -141.38 174.93 10.08 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.022 -0.535 . . . . 0.52 111.864 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -137.1 156.46 48.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.949 -1.13 . . . . 4.54 107.949 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.415 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.86 139.73 16.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.31 1.052 . . . . 1.28 112.172 -170.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.0 p -138.61 142.5 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 112.998 -1.91 . . . . 1.05 110.205 -164.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.12 -33.41 69.11 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.519 1.152 . . . . 1.38 109.616 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 1.4 ttpt -160.54 129.19 4.73 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 112.521 -2.127 . . . . 1.44 108.262 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.62 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -116.32 128.86 55.91 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.919 -0.582 . . . . 0.9 111.541 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.426 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.0 OUTLIER -161.68 98.56 1.11 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.551 1.167 . . . . 0.61 110.279 157.311 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.452 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -166.66 167.07 8.39 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 112.891 -1.959 . . . . 1.77 105.833 161.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.59 127.76 21.63 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 120.866 1.044 . . . . 0.62 110.416 170.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 131' ' ' THR . . . 86.25 42.69 6.52 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.428 -1.367 . . . . 0.51 112.96 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 28.2 mt-10 -140.76 166.15 25.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.843 -0.428 . . . . 2.16 109.843 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.721 ' O ' HG12 ' A' ' 136' ' ' VAL . 46.2 p90 -167.85 161.46 13.1 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.825 -0.806 . . . . 0.28 108.825 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.601 HG23 ' SD ' ' A' ' 139' ' ' MET . 71.4 p -123.35 130.73 53.13 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.284 0.564 . . . . 0.42 110.461 171.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 152' ' ' ILE . 9.8 p -120.54 108.53 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.984 0.897 . . . . 0.34 110.374 172.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -109.62 -68.2 0.94 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 3.11 110.296 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.6 -53.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.933 0.346 . . . . 1.65 111.933 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -102.17 1.83 36.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.545 0.572 . . . . 1.68 112.545 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 2.8 p -163.93 153.16 14.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.554 0.693 . . . . 0.37 112.807 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.848 HD12 ' SD ' ' A' ' 124' ' ' MET . 52.6 mt -112.11 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.287 -1.324 . . . . 0.53 107.683 165.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 2.4 mt-10 -95.65 103.22 15.09 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.371 -0.831 . . . . 1.13 109.325 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -113.62 166.65 11.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.396 -0.82 . . . . 1.8 111.848 -169.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.61 HG12 ' HG3' ' A' ' 170' ' ' ARG . 14.7 mt -127.63 106.64 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 114.616 -1.175 . . . . 0.43 110.297 173.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.721 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 53.4 ttt180 . . . . . 0 C--N 1.32 -0.702 0 O-C-N 124.025 0.828 . . . . 3.13 110.08 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.721 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 121.306 0.574 . . . . 1.86 112.413 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 59.6 t -151.45 127.43 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.049 -0.978 . . . . 0.41 110.154 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.61 ' HG3' HG12 ' A' ' 155' ' ' ILE . 8.6 mtt180 -82.8 110.74 18.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.059 -0.519 . . . . 2.8 109.901 169.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.97 137.63 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.992 0.901 . . . . 0.29 111.693 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 3.7 tpp180 -101.83 101.35 11.79 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.74 -1.573 . . . . 1.71 110.798 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.685 HD23 ' SD ' ' A' ' 124' ' ' MET . 2.9 mp -88.97 92.24 9.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.425 -0.583 . . . . 0.69 109.425 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.02 39.6 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.532 1.158 . . . . 0.26 111.902 -171.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-85 -88.81 137.58 32.19 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.647 -2.069 . . . . 0.72 110.89 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.9 t70 -81.93 65.1 6.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.987 -1.857 . . . . 1.09 105.987 160.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 73.59 -99.43 1.01 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 118.66 -1.733 . . . . 0.47 110.743 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -75.96 -26.99 57.34 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 112.773 0.657 . . . . 0.83 112.773 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.429 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 13.1 p-80 -133.12 129.74 38.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.862 -0.735 . . . . 1.21 111.181 -168.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.9 tt -52.6 126.52 19.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.286 -1.325 . . . . 0.64 109.756 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -103.0 -38.7 7.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.432 -0.803 . . . . 0.29 109.453 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.2 p -147.16 161.5 40.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.284 -0.871 . . . . 0.33 110.463 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 24.9 mt -126.17 147.66 30.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 104.212 -2.514 . . . . 0.76 104.212 167.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 3.8 t -136.71 134.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.855 -0.738 . . . . 0.35 111.692 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.596 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 12.1 m120 -72.53 97.74 2.17 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.424 -1.695 . . . . 1.77 106.424 174.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.522 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 46.1 mtm -65.95 -2.91 4.39 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.277 0.561 . . . . 0.55 112.345 -168.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.596 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 14.1 pt-20 -74.38 -42.85 58.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.046 0.927 . . . . 1.02 110.829 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -105.41 -25.52 12.33 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.277 -1.329 . . . . 1.4 108.814 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.7 t30 73.47 36.47 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 111.834 -2.439 . . . . 1.33 108.063 -174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 11.5 ptt180 -100.1 161.14 13.8 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.466 -1.243 . . . . 2.28 110.337 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -76.93 134.42 38.93 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.082 -0.963 . . . . 1.36 110.666 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -105.77 91.14 3.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.888 -0.577 . . . . 1.18 110.206 -174.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.46 -57.47 0.0 OUTLIER Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.68 1.432 . . . . 1.28 116.68 144.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -162.52 176.26 10.61 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.297 -1.451 . . . . 2.8 109.129 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.823 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 10.9 t80 -149.34 100.43 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.445 0.64 . . . . 0.6 110.197 156.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -98.86 139.18 34.92 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.546 -0.721 . . . . 4.77 111.128 -175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 127' ' ' LEU . 2.0 mt -109.81 172.44 6.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 113.639 0.977 . . . . 1.61 113.639 -175.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 N--CA 1.443 -0.815 0 CA-C-N 113.382 -1.736 . . . . 2.66 109.276 -179.851 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.561 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 21.3 mtm180 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 119.285 -0.388 . . . . 4.32 110.112 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.577 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 34.8 tpp -141.57 133.04 26.8 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.703 -1.599 . . . . 2.59 115.209 -169.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.594 HG12 ' HE1' ' A' ' 124' ' ' MET . 17.3 m -121.11 107.84 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.111 0.958 . . . . 0.74 113.126 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -158.64 109.7 2.12 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.262 -1.384 . . . . 1.38 107.262 167.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.668 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 5.8 mp -95.34 101.16 12.87 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.205 0.526 . . . . 1.33 110.315 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -145.56 95.74 4.92 Favored Pre-proline 0 N--CA 1.429 -1.502 0 C-N-CA 119.781 -0.768 . . . . 1.93 109.455 -174.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.667 ' HD3' HD12 ' A' ' 183' ' ' ILE . 1.0 OUTLIER -33.53 142.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.589 1 C-N-CA 126.356 4.704 . . . . 0.65 115.422 -174.331 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.1 40.06 0.74 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.698 -1.592 . . . . 0.72 109.197 -170.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.592 ' HE3' HD13 ' A' ' 180' ' ' LEU . 9.6 ptt? -118.09 154.84 31.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 113.993 -1.458 . . . . 1.67 109.734 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.5 m -101.46 81.04 2.14 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.298 1.047 . . . . 0.58 108.593 -175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.669 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -104.88 161.94 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.464 -1.698 . . . . 0.65 109.871 -169.367 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.56 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 23.1 m -143.34 179.3 7.17 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 119.634 -0.826 . . . . 0.44 110.583 -173.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.627 ' HG2' HG21 ' A' ' 147' ' ' VAL . 1.2 mttm -61.62 -24.77 66.92 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.79 -1.189 . . . . 2.33 107.79 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.746 ' O ' HG12 ' A' ' 125' ' ' VAL . 4.3 t30 -83.77 -24.19 31.2 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 114.102 -1.408 . . . . 1.32 113.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.577 ' HA ' ' H ' ' A' ' 110' ' ' MET . 0.9 OUTLIER -80.48 -60.63 2.24 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.153 -2.217 . . . . 2.06 106.769 175.502 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.822 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.4 mmt -57.86 -17.26 15.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.767 -2.015 . . . . 3.13 111.943 173.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.4 p -43.5 -42.16 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 122.0 0.905 . . . . 0.37 110.518 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.561 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.93 -37.66 81.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.366 -1.288 . . . . 0.63 113.806 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.74 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.9 tm? -56.34 -34.15 66.32 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.455 0.645 . . . . 1.79 109.943 167.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.822 ' HG ' ' O ' ' A' ' 124' ' ' MET . 11.8 mt -84.06 -31.38 25.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.948 0.88 . . . . 0.38 108.932 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.5 -31.25 68.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.796 -1.547 . . . . 1.96 110.043 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -72.75 -44.56 61.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.956 -1.474 . . . . 0.64 111.387 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.412 ' O ' ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -92.94 -1.43 56.71 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.294 -1.743 . . . . 0.59 106.294 -177.547 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 53.94 50.8 15.97 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.696 -2.502 . . . . 1.8 111.826 169.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.838 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.8 t80 -129.92 175.22 9.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.506 0.67 . . . . 0.52 112.125 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -141.1 149.54 41.72 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.305 -1.739 . . . . 4.54 106.305 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.783 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 20.7 tm0? -51.26 140.97 15.75 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.952 1.358 . . . . 1.28 113.765 -167.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.6 p -136.93 144.91 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 112.27 -2.241 . . . . 1.05 110.51 -161.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -59.07 -34.2 71.7 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 122.684 1.231 . . . . 1.38 109.095 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 2.3 ttpt -159.55 128.61 5.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.57 -2.105 . . . . 1.44 109.104 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.612 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.14 124.31 50.02 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.47 -0.786 . . . . 0.9 111.165 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.8 t -158.13 97.92 1.55 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.678 1.228 . . . . 0.61 109.68 153.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.604 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -166.23 161.05 12.59 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 112.699 -2.046 . . . . 1.77 106.469 164.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.36 116.79 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 121.404 1.403 . . . . 0.62 111.259 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.598 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 108.32 21.44 7.65 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 119.804 -1.189 . . . . 0.51 113.087 -173.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.838 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 11.5 mp0 -134.48 159.44 41.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.256 0.528 . . . . 2.16 111.647 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.79 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.0 p90 -163.57 167.86 20.78 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.999 -1.111 . . . . 0.28 107.999 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.636 HG22 HG13 ' A' ' 136' ' ' VAL . 6.0 p -133.34 126.93 32.43 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.768 -0.773 . . . . 0.42 111.56 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.783 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.8 p -125.56 127.45 71.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.401 0.619 . . . . 0.34 112.142 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -133.71 -77.06 0.48 Allowed 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.008 -0.433 . . . . 3.11 110.088 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.44 -57.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.376 -0.375 . . . . 1.65 111.31 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -90.74 3.9 53.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.618 0.599 . . . . 1.68 112.618 -173.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.0 p -167.93 152.01 6.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.017 0.913 . . . . 0.37 113.292 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.641 HG12 HG23 ' A' ' 147' ' ' VAL . 42.0 mt -114.5 109.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 113.608 -1.633 . . . . 0.53 106.694 161.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.79 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.5 mp0 -91.91 159.54 15.71 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 105.427 -2.064 . . . . 1.13 105.427 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.665 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 17.8 ptp -164.16 162.43 22.77 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.828 0.705 . . . . 1.8 110.785 -172.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.777 HG23 ' HG3' ' A' ' 168' ' ' GLN . 11.9 mt -111.35 108.27 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.008 -0.997 . . . . 0.43 110.531 163.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 195' ' ' PHE . 12.7 tpt180 . . . . . 0 CA--C 1.506 -0.741 0 CA-C-N 113.511 -1.677 . . . . 3.13 110.076 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.777 ' HG3' HG23 ' A' ' 155' ' ' ILE . 7.0 tt0 . . . . . 0 N--CA 1.437 -1.091 0 N-CA-C 113.292 0.849 . . . . 1.86 113.292 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 156' ' ' ARG . 53.9 t -154.4 120.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.053 -1.43 . . . . 0.41 109.212 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 154' ' ' MET . 0.0 OUTLIER -76.84 114.23 15.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.55 -0.537 . . . . 2.8 109.55 170.085 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.05 131.86 54.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.883 -1.127 . . . . 0.29 110.761 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.77 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.1 tpp180 -93.32 97.66 10.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.174 -1.375 . . . . 1.71 110.45 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -87.28 91.46 8.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.853 -0.425 . . . . 0.69 109.853 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.4 114.67 27.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.551 1.167 . . . . 0.26 111.936 -173.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.751 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -82.75 134.32 35.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.556 -2.111 . . . . 0.72 110.11 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 34.0 t70 -77.14 66.16 2.89 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.649 -1.611 . . . . 1.09 106.649 163.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.5 -98.09 1.63 Allowed Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 118.678 -1.725 . . . . 0.47 110.158 -174.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -92.23 -13.43 30.49 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.384 0.883 . . . . 0.83 113.384 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -136.09 125.07 24.23 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 119.109 -1.036 . . . . 1.21 110.899 -171.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.751 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.4 tt -53.61 127.67 26.31 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.217 -1.811 . . . . 0.64 111.047 -176.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.45 -38.32 6.22 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.079 -0.964 . . . . 0.29 110.283 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -147.26 166.96 25.46 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.918 -0.583 . . . . 0.33 110.734 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.77 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 32.6 mt -137.12 145.17 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 106.348 -1.723 . . . . 0.76 106.348 168.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 47.5 t -139.11 134.49 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 109.533 -0.543 . . . . 0.35 109.533 -174.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.671 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 42.2 t-20 -81.12 103.81 11.18 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.439 -1.319 . . . . 1.77 107.439 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.525 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 33.5 mtm -67.04 -2.51 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.875 0.695 . . . . 0.55 112.875 -165.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.671 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.7 pt-20 -83.55 -41.93 17.37 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 122.055 0.931 . . . . 1.02 111.06 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.527 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 6.3 m-20 -108.26 -25.36 11.08 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.255 -1.339 . . . . 1.4 109.313 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 75.56 32.59 0.7 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 112.365 -2.198 . . . . 1.33 107.69 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.8 ptm180 -88.86 162.28 16.24 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 113.673 -1.603 . . . . 2.28 109.633 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -88.98 139.67 30.22 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.609 -1.178 . . . . 1.36 113.128 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 5.3 m-85 -105.74 -166.45 1.21 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.889 -1.959 . . . . 1.18 107.691 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.592 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 138.22 -9.17 3.54 Favored Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 107.791 -2.123 . . . . 1.28 107.791 -147.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.9 109.32 2.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.045 -1.077 . . . . 2.8 111.071 155.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.8 t80 -125.12 137.75 54.17 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.228 -0.92 . . . . 0.6 109.342 163.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.662 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.2 mpt_? -123.07 146.4 47.73 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.069 -0.394 . . . . 4.77 110.52 -176.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.74 HD13 ' HG ' ' A' ' 127' ' ' LEU . 38.2 mt -137.48 171.1 14.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.869 0.366 . . . . 1.61 111.757 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.609 -0.723 . . . . 2.66 109.62 -178.605 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 112.026 0.38 . . . . 4.32 112.026 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 54.2 ttm -143.04 138.33 29.89 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.847 0.684 . . . . 2.59 112.847 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.12 102.12 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 122.524 1.154 . . . . 0.74 112.819 166.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -163.08 109.06 1.14 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.95 -1.87 . . . . 1.38 105.95 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.948 HD13 HD21 ' A' ' 173' ' ' LEU . 40.3 mt -93.16 113.58 25.85 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.425 -0.51 . . . . 1.33 110.022 -169.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 117' ' ' MET . 38.5 tt0 -138.78 104.77 7.5 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.512 -0.475 . . . . 1.93 110.773 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.495 ' HD3' HD12 ' A' ' 183' ' ' ILE . 31.5 Cg_exo -36.59 128.88 0.46 Allowed 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 124.032 3.155 . . . . 0.65 113.317 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.8 t70 71.94 50.84 0.23 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 122.6 1.19 . . . . 0.72 110.026 -173.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.583 ' HE3' HD13 ' A' ' 180' ' ' LEU . 14.0 ptt? -121.45 155.75 34.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.232 -1.349 . . . . 1.67 110.51 174.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.93 85.93 3.89 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.814 0.816 . . . . 0.58 109.682 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.694 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -111.23 161.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.598 -1.183 . . . . 0.65 110.083 -173.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.733 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.9 m -141.44 176.6 8.74 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.125 -0.695 . . . . 0.44 109.125 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.65 ' HG2' HG21 ' A' ' 147' ' ' VAL . 7.3 mtpp -55.8 -30.55 61.53 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.439 -0.578 . . . . 2.33 109.439 166.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.613 ' O ' HG12 ' A' ' 125' ' ' VAL . 57.5 t30 -86.02 -17.49 35.11 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.979 1.474 . . . . 1.32 114.979 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.733 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.7 mp0 -85.4 -62.63 1.49 Allowed 'General case' 0 N--CA 1.425 -1.703 0 O-C-N 120.581 -1.325 . . . . 2.06 107.749 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.778 ' SD ' HD22 ' A' ' 173' ' ' LEU . 3.6 ttm -59.9 -13.26 10.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.03 -1.895 . . . . 3.13 111.23 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 122' ' ' ASN . 14.8 p -42.81 -41.82 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 122.075 0.941 . . . . 0.37 110.306 171.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.618 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -68.87 -39.32 79.9 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.391 -1.277 . . . . 0.63 112.549 177.093 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.775 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -49.07 -34.0 12.79 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.639 0.733 . . . . 1.79 110.968 168.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.6 mt -84.91 -30.34 24.43 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.934 -1.03 . . . . 0.38 109.529 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.9 -19.23 52.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.046 -1.434 . . . . 1.96 110.502 170.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.38 -40.91 25.64 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.981 -1.463 . . . . 0.64 110.788 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 128' ' ' LEU . 15.0 t -91.53 2.69 56.26 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.25 1.5 . . . . 0.59 107.407 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 43.99 54.41 5.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 111.438 -2.619 . . . . 1.8 112.948 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.741 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.6 t80 -134.27 177.45 7.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.813 -0.63 . . . . 0.52 111.087 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -136.29 148.63 48.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.777 -1.194 . . . . 4.54 107.777 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 1.6 tt0 -49.38 135.2 17.91 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.745 1.26 . . . . 1.28 111.374 -172.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.3 p -128.3 133.11 67.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 112.58 -2.1 . . . . 1.05 109.006 -165.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -58.97 -31.85 69.12 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.736 1.255 . . . . 1.38 109.496 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 136' ' ' VAL . 4.1 tmmm? -160.33 132.66 6.26 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 112.297 -2.229 . . . . 1.44 107.498 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.657 ' HB2' ' CD ' ' A' ' 144' ' ' GLU . 8.6 ptt? -115.35 133.04 56.4 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.868 -1.06 . . . . 0.9 112.993 -168.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.46 ' HA ' ' OE1' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -162.51 100.36 1.04 Allowed 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.992 0.901 . . . . 0.61 108.668 152.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.61 150.01 7.56 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.825 -1.534 . . . . 1.77 108.83 169.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.54 134.57 41.85 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.197 1.265 . . . . 0.62 110.036 170.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.43 54.21 5.19 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.898 -1.144 . . . . 0.51 111.873 -173.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.741 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -144.73 178.15 8.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.691 -0.195 . . . . 2.16 110.636 177.587 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.852 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 53.0 p90 -168.84 170.64 9.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.222 -1.029 . . . . 0.28 108.222 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 139' ' ' MET . 19.0 p -132.98 126.74 32.64 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.148 -0.621 . . . . 0.42 110.864 171.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.747 HG23 HG12 ' A' ' 152' ' ' ILE . 8.7 p -124.64 112.76 33.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.693 0.758 . . . . 0.34 112.004 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -116.7 -66.02 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.772 -0.649 . . . . 3.11 110.596 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.65 -69.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.276 . . . . 1.65 111.634 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -83.07 10.9 7.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 112.439 0.533 . . . . 1.68 112.439 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -170.42 151.14 3.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.925 0.869 . . . . 0.37 112.792 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.747 HG12 HG23 ' A' ' 147' ' ' VAL . 59.7 mt -120.28 115.74 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.707 -1.588 . . . . 0.53 106.961 165.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.852 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 6.9 mp0 -89.64 176.01 7.04 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.558 -1.275 . . . . 1.13 107.558 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 12.8 ptm -169.23 160.82 9.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.76 0.663 . . . . 1.8 111.208 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' A' ' 170' ' ' ARG . 29.3 mt -127.78 115.06 38.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 122.76 0.424 . . . . 0.43 110.81 165.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.781 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 77.6 mtp180 . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 116.399 -0.364 . . . . 3.13 110.52 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.781 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 49.2 tt0 . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 115.342 1.608 . . . . 1.86 115.342 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 78.9 t -154.58 129.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 113.067 -1.878 . . . . 0.41 109.229 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.875 ' HG2' ' HE3' ' A' ' 186' ' ' MET . 16.0 ttm180 -91.86 102.33 14.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.908 -0.775 . . . . 2.8 108.908 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -105.34 143.74 33.1 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.244 -0.983 . . . . 0.29 112.054 -173.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 11.7 tpp180 -99.95 113.62 26.31 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.947 -1.479 . . . . 1.71 110.206 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.948 HD21 HD13 ' A' ' 113' ' ' LEU . 7.2 mp -107.7 102.14 11.39 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.039 -0.664 . . . . 0.69 110.578 175.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.65 125.33 47.06 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 114.938 -1.028 . . . . 0.26 111.721 -170.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-30 -89.51 133.26 34.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.855 -1.975 . . . . 0.72 110.212 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.2 t70 -74.25 65.78 1.22 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.609 -1.626 . . . . 1.09 106.609 161.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.07 -98.27 1.59 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.673 -1.727 . . . . 0.47 110.368 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -86.92 -20.31 27.55 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.094 0.775 . . . . 0.83 113.094 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -133.15 130.67 39.5 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.742 -0.783 . . . . 1.21 110.727 -169.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.694 ' HB2' HG22 ' A' ' 119' ' ' ILE . 4.4 tt -52.64 129.35 29.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.933 -1.485 . . . . 0.64 110.803 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.61 -38.24 6.2 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.873 -1.058 . . . . 0.29 109.816 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.3 p -148.34 158.29 44.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.841 -0.618 . . . . 0.33 111.502 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.648 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 17.1 mt -125.02 146.58 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 105.827 -1.916 . . . . 0.76 105.827 167.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.5 t -142.09 135.44 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.665 0.745 . . . . 0.35 110.743 -171.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.402 ' ND2' ' HG2' ' A' ' 187' ' ' GLU . 62.9 t30 -81.24 95.95 7.1 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.497 -1.297 . . . . 1.77 107.497 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.875 ' HE3' ' HG2' ' A' ' 170' ' ' ARG . 28.3 mtm -62.35 -2.94 1.15 Allowed 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 114.028 1.122 . . . . 0.55 114.028 -164.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 9.6 pt-20 -81.53 -43.33 18.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.822 0.82 . . . . 1.02 110.705 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.546 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.3 m-20 -105.7 -25.7 12.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.314 -1.312 . . . . 1.4 109.034 -177.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 75.72 31.77 0.71 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.316 -2.22 . . . . 1.33 108.318 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 4.0 ptm180 -91.01 156.12 18.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.147 -1.388 . . . . 2.28 109.778 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.99 132.82 35.4 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.729 -1.123 . . . . 1.36 109.72 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -107.45 91.29 3.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.796 -0.762 . . . . 1.18 111.35 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -58.1 0.0 OUTLIER Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.506 1.362 . . . . 1.28 116.506 145.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 192' ' ' PHE . 99.7 m-85 -160.34 175.52 12.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.916 -1.642 . . . . 2.8 107.435 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.892 ' HB3' HD12 ' A' ' 113' ' ' LEU . 2.1 t80 -142.77 145.41 33.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.244 -1.021 . . . . 0.6 108.244 153.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.632 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -130.52 138.57 50.28 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.15 -0.969 . . . . 4.77 110.798 -171.366 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 196' ' ' ARG . 2.3 mt -125.52 171.29 10.64 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 113.533 0.938 . . . . 1.61 113.533 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.446 -0.635 0 CA-C-N 113.205 -1.816 . . . . 2.66 110.057 176.555 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.513 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 2.0 mtt180 . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 109.241 -0.651 . . . . 4.32 109.241 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.6 mtt -138.82 127.28 23.07 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.498 -0.881 . . . . 2.59 112.687 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.4 m -121.32 103.22 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 122.496 1.141 . . . . 0.74 112.139 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -161.1 108.35 1.48 Allowed 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.402 -1.726 . . . . 1.38 106.77 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 mp -97.07 78.94 2.81 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.493 -0.929 . . . . 1.33 108.493 -174.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -113.66 95.58 37.39 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.429 -0.805 . . . . 1.93 110.279 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.576 ' HG3' HG12 ' A' ' 183' ' ' ILE . 25.3 Cg_exo -33.68 125.87 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.523 3.482 . . . . 0.65 114.147 -171.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.1 t70 77.62 48.62 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 124.813 1.321 . . . . 0.72 110.125 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.71 154.95 36.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.832 -1.076 . . . . 1.67 110.42 171.173 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -94.6 93.77 7.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.477 -0.783 . . . . 0.58 109.037 -170.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.495 HG21 ' HE2' ' A' ' 117' ' ' MET . 19.7 tt -139.74 169.97 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 114.68 -1.146 . . . . 0.65 110.729 -166.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.625 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 m -137.98 174.25 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.947 -0.761 . . . . 0.44 108.947 -177.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.611 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -66.67 -19.31 65.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.179 -1.045 . . . . 2.33 108.179 169.351 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.555 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 1.8 t30 -83.68 -18.06 39.29 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-N 114.401 -1.272 . . . . 1.32 113.596 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.6 mp0 -86.25 -54.94 4.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 120.483 -1.385 . . . . 2.06 107.32 167.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.713 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.2 mmt -53.8 -13.56 0.74 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.974 -1.921 . . . . 3.13 111.771 168.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 14.9 p -43.36 -42.78 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 122.31 1.052 . . . . 0.37 109.58 171.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -65.37 -39.66 92.58 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.715 -1.584 . . . . 0.63 112.939 176.152 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -51.25 -32.49 24.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.731 0.777 . . . . 1.79 110.94 170.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 127' ' ' LEU . 16.7 mt -85.83 -33.42 21.32 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.005 -0.998 . . . . 0.38 109.568 -172.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.43 ' OE2' ' HE2' ' A' ' 126' ' ' LYS . 2.8 mt-10 -72.26 -23.71 61.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.982 -1.463 . . . . 1.96 110.011 169.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -76.94 -44.3 32.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.679 -1.6 . . . . 0.64 111.598 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -86.28 -6.57 58.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.538 1.637 . . . . 0.59 107.538 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 58.59 53.46 6.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 111.156 -2.747 . . . . 1.8 112.348 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.727 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.9 t80 -136.3 176.35 8.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.882 -0.599 . . . . 0.52 111.769 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 22.9 tpt180 -135.59 152.14 50.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.043 -1.466 . . . . 4.54 107.043 175.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 2.5 tt0 -49.68 137.65 15.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.579 1.18 . . . . 1.28 112.512 -170.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.7 p -135.35 142.0 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.519 -2.128 . . . . 1.05 109.751 -166.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.71 -34.12 70.96 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.684 1.23 . . . . 1.38 109.129 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 5.5 ttpt -159.86 126.14 4.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.424 -2.171 . . . . 1.44 108.385 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.65 ' SD ' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -112.68 130.14 56.15 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.606 -0.725 . . . . 0.9 110.536 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.9 OUTLIER -158.4 98.15 1.53 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.836 1.303 . . . . 0.61 109.431 152.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -164.93 167.2 10.12 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 112.23 -2.259 . . . . 1.77 106.048 167.357 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.26 126.18 11.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.426 1.417 . . . . 0.62 112.102 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 95.72 26.04 12.42 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 120.438 -0.887 . . . . 0.51 113.415 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.727 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 6.1 mp0 -126.82 171.42 11.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.1 0.45 . . . . 2.16 110.439 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.681 ' O ' HG12 ' A' ' 136' ' ' VAL . 43.1 p90 -168.4 165.09 12.82 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.481 -0.933 . . . . 0.28 108.481 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.65 HG23 ' SD ' ' A' ' 139' ' ' MET . 53.9 p -126.29 128.95 47.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.029 -0.532 . . . . 0.42 110.659 171.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.482 ' CG1' ' HG3' ' A' ' 135' ' ' GLN . 8.5 p -112.76 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.513 0.673 . . . . 0.34 111.093 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -122.95 36.96 4.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.523 -0.762 . . . . 3.11 110.484 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.38 -54.51 0.67 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.446 -0.797 . . . . 1.65 112.687 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -87.26 -10.43 52.43 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.895 0.379 . . . . 1.68 111.517 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -161.61 141.99 10.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.904 0.859 . . . . 0.37 112.716 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.611 HD11 ' HA ' ' A' ' 121' ' ' LYS . 35.4 mt -112.56 109.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.576 -1.647 . . . . 0.53 108.033 169.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 23.6 mt-10 -101.74 103.07 13.81 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.765 -0.828 . . . . 1.13 108.765 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 23.4 ptm -106.66 163.87 12.55 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.301 -0.863 . . . . 1.8 111.764 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.647 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 47.2 mt -130.08 112.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.166 -0.924 . . . . 0.43 110.817 168.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.671 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 56.6 mtm180 . . . . . 0 C--N 1.318 -0.77 0 CA-C-N 116.291 -0.413 . . . . 3.13 110.357 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.431 -1.408 0 CA-C-O 121.255 0.55 . . . . 1.86 112.48 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 55.5 t -153.09 129.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.128 -0.942 . . . . 0.41 109.663 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.974 ' HG2' ' HE3' ' A' ' 186' ' ' MET . 9.3 ttt180 -88.6 107.55 18.97 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 109.202 -0.666 . . . . 2.8 109.202 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.53 137.14 53.42 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 119.275 -0.97 . . . . 0.29 111.986 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 15.5 tpp85 -99.09 107.37 19.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.762 -1.563 . . . . 1.71 111.455 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 151' ' ' SER . 4.7 mp -94.25 96.27 9.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.055 -0.52 . . . . 0.69 109.912 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -98.08 118.15 34.04 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.539 1.161 . . . . 0.26 110.9 -178.485 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 41.9 m-85 -92.31 127.04 37.65 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 112.847 -1.979 . . . . 0.72 110.038 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 17.3 t70 -75.73 65.59 1.91 Allowed 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.643 -1.614 . . . . 1.09 106.643 167.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.32 -100.18 0.78 Allowed Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.404 -1.379 . . . . 0.47 110.897 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.44 -21.63 48.88 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.24 0.829 . . . . 0.83 113.24 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.445 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 16.3 p-80 -135.82 128.65 31.12 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 119.822 -0.751 . . . . 1.21 110.287 -170.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.9 tt -60.26 130.03 44.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.294 -1.321 . . . . 0.64 109.664 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -103.02 -40.93 6.28 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.675 -0.693 . . . . 0.29 110.74 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 158.49 43.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.167 0.432 . . . . 0.33 112.167 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.615 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 3.1 mm -115.28 148.28 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 105.139 -2.171 . . . . 0.76 105.139 164.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.1 t -139.05 126.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.41 0.624 . . . . 0.35 110.33 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.595 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.6 t-20 -78.1 99.05 5.99 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.488 -1.301 . . . . 1.77 107.488 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.974 ' HE3' ' HG2' ' A' ' 170' ' ' ARG . 32.8 mtm -64.36 -2.17 2.08 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.816 1.043 . . . . 0.55 113.816 -166.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.595 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.9 pt-20 -80.36 -43.05 21.77 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.039 0.923 . . . . 1.02 110.645 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.524 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 7.8 m120 -109.03 -25.63 10.6 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.995 -1.457 . . . . 1.4 109.579 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 77.56 27.35 0.62 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.689 -2.05 . . . . 1.33 108.044 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.72 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 33.9 mtp180 -74.04 160.67 30.96 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.76 -1.564 . . . . 2.28 109.68 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 96.4 mt-30 -95.38 118.07 31.46 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.484 -1.234 . . . . 1.36 108.462 175.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.615 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -93.63 91.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.748 -0.781 . . . . 1.18 110.552 -166.641 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.98 -57.39 0.0 OUTLIER Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.277 1.418 . . . . 1.28 116.407 145.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 192' ' ' PHE . 48.3 p90 -163.73 174.73 11.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.701 -1.75 . . . . 2.8 107.584 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.722 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.0 t80 -151.41 98.69 2.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.28 0.562 . . . . 0.6 109.595 158.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.497 ' O ' ' HD2' ' A' ' 196' ' ' ARG . 2.8 ppt_? -90.29 145.57 24.88 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.412 -0.805 . . . . 4.77 111.222 -176.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 127' ' ' LEU . 1.8 mt -119.0 171.82 7.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.027 0.917 . . . . 1.61 113.291 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 113.439 -1.709 . . . . 2.66 110.165 176.186 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 13.8 mmt180 . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.816 0.673 . . . . 4.32 112.816 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.772 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.5 tpt -139.94 124.63 18.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.392 0.886 . . . . 2.59 113.392 -165.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.65 HG11 ' N ' ' A' ' 127' ' ' LEU . 0.6 OUTLIER -126.66 107.65 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 114.21 1.189 . . . . 0.74 114.21 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -157.86 107.03 2.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.158 -1.793 . . . . 1.38 106.158 163.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.8 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.2 mp -85.68 112.66 21.23 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.728 -0.669 . . . . 1.33 110.781 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 33.2 tt0 -156.43 102.07 2.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 114.957 -1.019 . . . . 1.93 109.911 -176.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.696 ' HD3' ' CD1' ' A' ' 183' ' ' ILE . 9.7 Cg_exo -30.48 138.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 125.654 4.236 . . . . 0.65 114.593 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.6 t70 76.05 40.98 0.24 Allowed 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.778 1.299 . . . . 0.72 109.331 -171.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.545 ' HE3' HD13 ' A' ' 180' ' ' LEU . 11.9 ptt? -121.63 154.94 36.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.401 -1.272 . . . . 1.67 109.623 174.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.61 87.36 2.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.836 -1.172 . . . . 0.58 107.836 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.689 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.2 tt -111.08 157.18 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.084 -1.416 . . . . 0.65 110.316 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.79 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.9 m -141.24 176.76 8.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.12 -0.696 . . . . 0.44 109.12 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.831 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 5.8 mtpm? -56.27 -28.26 58.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.266 0.555 . . . . 2.33 109.511 165.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.6 t30 -84.26 -19.04 34.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.062 1.134 . . . . 1.32 114.062 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.79 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -88.22 -62.01 1.59 Allowed 'General case' 0 N--CA 1.415 -2.197 0 O-C-N 120.769 -1.207 . . . . 2.06 108.931 176.226 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.966 ' HG3' HG21 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -58.11 -16.69 14.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 112.994 -1.912 . . . . 3.13 110.382 172.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 11.3 p -42.63 -43.33 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.288 1.042 . . . . 0.37 110.712 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.529 ' CE ' HG13 ' A' ' 125' ' ' VAL . 10.1 mmpt? -69.65 -35.92 75.61 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.22 -1.354 . . . . 0.63 113.132 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.65 ' N ' HG11 ' A' ' 111' ' ' VAL . 9.0 tt -52.92 -34.04 53.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.571 0.7 . . . . 1.79 110.085 168.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 124' ' ' MET . 6.3 mt -83.86 -34.31 24.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.471 -0.937 . . . . 0.38 108.471 -171.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.97 -33.23 75.55 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.919 -1.491 . . . . 1.96 109.728 169.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -72.75 -45.95 56.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.967 -1.47 . . . . 0.64 111.766 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.87 -1.73 58.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 123.747 1.737 . . . . 0.59 107.741 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 55.5 54.46 8.45 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 110.817 -2.902 . . . . 1.8 112.666 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 3.2 t80 -137.84 175.67 9.38 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.52 112.455 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 30.1 tpt180 -139.17 151.95 47.02 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.57 -1.27 . . . . 4.54 107.57 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 1.5 tm0? -49.22 142.4 7.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.335 1.064 . . . . 1.28 113.05 -168.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.6 p -141.6 139.98 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 113.215 -1.811 . . . . 1.05 110.169 -163.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -59.8 -32.31 70.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.511 1.148 . . . . 1.38 109.791 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -159.35 127.78 5.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.754 -2.021 . . . . 1.44 108.825 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.684 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -117.49 124.02 47.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.728 -1.124 . . . . 0.9 111.098 -177.461 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.715 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.3 t -158.7 95.23 1.3 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 123.236 1.493 . . . . 0.61 110.473 154.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.715 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.39 155.39 16.99 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 111.71 -2.495 . . . . 1.77 105.706 163.036 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.13 126.05 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.15 1.233 . . . . 0.62 110.807 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.8 45.04 3.74 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 119.878 -1.153 . . . . 0.51 112.995 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.572 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 37.0 mt-10 -141.88 174.45 10.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.903 0.351 . . . . 2.16 110.534 173.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.868 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -170.47 164.7 8.6 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.66 -1.237 . . . . 0.28 107.66 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.676 HG22 ' CG1' ' A' ' 136' ' ' VAL . 1.1 p -134.41 129.17 34.92 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 119.328 -0.949 . . . . 0.42 110.757 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' A' ' 121' ' ' LYS . 10.6 p -122.58 109.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.878 0.846 . . . . 0.34 111.832 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -106.89 -72.33 0.72 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.299 -0.864 . . . . 3.11 110.031 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.61 -53.97 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.72 0.295 . . . . 1.65 111.75 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -82.68 -12.63 57.46 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.491 -0.322 . . . . 1.68 111.721 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 15.9 p -160.33 153.26 21.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.13 0.967 . . . . 0.37 112.397 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.966 HG21 ' HG3' ' A' ' 124' ' ' MET . 74.6 mt -110.99 114.24 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.33 -1.759 . . . . 0.53 107.002 165.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.2 mp0 -90.59 165.85 13.52 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.978 -1.86 . . . . 1.13 105.978 174.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.639 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -167.64 156.76 9.87 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 124.123 0.89 . . . . 1.8 109.818 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.594 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 13.5 mt -127.28 105.44 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.054 -0.521 . . . . 0.43 110.19 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.804 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.2 ttt-85 . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 115.159 -0.928 . . . . 3.13 109.919 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.804 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.3 tt0 . . . . . 0 N--CA 1.433 -1.294 0 CA-C-O 121.393 0.616 . . . . 1.86 112.399 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 45.6 t -153.23 129.55 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.074 . . . . 0.41 109.519 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.634 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 27.5 mtm180 -82.82 118.32 23.33 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.049 -0.523 . . . . 2.8 109.847 168.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.3 131.05 56.35 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.654 0.74 . . . . 0.29 111.27 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.766 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 8.8 tpp180 -98.21 100.71 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.376 -1.283 . . . . 1.71 111.104 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.8 mp -87.0 92.38 9.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.175 -0.305 . . . . 0.69 110.175 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.83 120.83 35.7 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 122.626 1.203 . . . . 0.26 111.635 -175.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-30 -86.93 136.21 33.02 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.792 -2.004 . . . . 0.72 111.049 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.677 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 39.9 t0 -78.82 65.19 3.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.076 -1.824 . . . . 1.09 106.076 161.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.93 1.52 Allowed Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 118.944 -1.598 . . . . 0.47 110.497 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -82.42 -27.47 31.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.723 0.638 . . . . 0.83 112.723 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -129.85 129.54 44.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.77 0.795 . . . . 1.21 110.615 -167.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.689 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.9 tt -53.38 128.9 30.18 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.449 -1.705 . . . . 0.64 111.235 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.12 -38.35 6.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.83 -1.077 . . . . 0.29 110.047 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.7 p -146.15 162.58 37.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.655 -0.702 . . . . 0.33 110.648 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.766 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 26.8 mt -134.31 145.2 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 105.735 -1.95 . . . . 0.76 105.735 167.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 43.1 t -136.98 135.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 109.683 -0.488 . . . . 0.35 109.683 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.626 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 47.2 t-20 -76.94 108.08 9.73 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 106.809 -1.552 . . . . 1.77 106.809 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.634 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 36.3 mtm -67.94 -2.41 7.44 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.545 -0.462 . . . . 0.55 111.976 -169.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.626 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.0 pt-20 -85.65 -45.98 11.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.482 0.658 . . . . 1.02 111.321 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.592 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -102.16 -26.24 13.42 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 114.802 -1.09 . . . . 1.4 109.36 -176.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 185' ' ' ASN . 52.7 t30 76.48 27.16 0.83 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 112.446 -2.161 . . . . 1.33 107.559 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 17.6 ptt180 -84.56 162.85 19.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.14 -1.391 . . . . 2.28 109.249 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -91.98 139.14 30.94 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.562 1.172 . . . . 1.36 112.734 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 2.6 m-85 -100.75 -165.73 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.908 -1.951 . . . . 1.18 108.324 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.629 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.14 -5.64 3.61 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.644 -2.183 . . . . 1.28 107.644 -148.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -153.79 119.43 5.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.928 -1.136 . . . . 2.8 111.333 157.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.8 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 5.1 t80 -140.77 100.58 3.88 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.17 -0.678 . . . . 0.6 109.17 161.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -102.13 110.47 22.44 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.466 -0.771 . . . . 4.77 111.203 -170.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.45 HD23 HD13 ' A' ' 113' ' ' LEU . 4.1 mm? -82.96 168.2 17.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.548 0.69 . . . . 1.61 112.45 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 114.439 -1.255 . . . . 2.66 108.074 172.05 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.41 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 44.1 mtt180 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.73 -0.841 . . . . 4.32 108.73 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.45 ' HB2' ' HG3' ' A' ' 123' ' ' GLU . 21.9 mmt -140.85 135.82 31.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 113.787 1.032 . . . . 2.59 113.787 -166.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.401 HG11 HD12 ' A' ' 197' ' ' LEU . 0.3 OUTLIER -135.57 105.68 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.447 1.118 . . . . 0.74 113.876 172.043 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -160.01 107.75 1.67 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.955 -1.93 . . . . 1.38 105.809 161.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.9 mp -87.67 108.7 19.22 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.987 -0.746 . . . . 1.33 108.987 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.2 tt0 -142.78 112.33 5.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.309 -0.956 . . . . 1.93 111.123 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.1 Cg_exo -35.9 127.79 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.012 3.141 . . . . 0.65 113.016 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.3 t70 75.74 43.83 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 O-C-N 124.476 1.11 . . . . 0.72 110.536 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.646 ' HE3' HD13 ' A' ' 180' ' ' LEU . 16.7 ptt? -114.06 154.99 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.818 -1.083 . . . . 1.67 110.14 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -102.77 98.56 8.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.15 -1.056 . . . . 0.58 108.15 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.624 HG13 ' CB ' ' A' ' 123' ' ' GLU . 1.5 tt -134.34 168.68 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 114.821 -1.081 . . . . 0.65 110.573 -164.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.665 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.3 m -141.36 175.55 9.57 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 -174.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.576 ' HA ' HD11 ' A' ' 152' ' ' ILE . 19.1 mttp -57.62 -32.72 67.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.304 -0.998 . . . . 2.33 108.304 164.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.713 ' O ' HG12 ' A' ' 125' ' ' VAL . 34.6 t30 -83.02 -19.35 37.11 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 113.78 -1.555 . . . . 1.32 114.2 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.665 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.1 mp0 -82.49 -57.83 3.18 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.542 -1.974 . . . . 2.06 106.74 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.669 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 2.3 tpp -54.99 -13.76 1.24 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.381 -1.736 . . . . 3.13 111.969 170.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 122' ' ' ASN . 13.1 p -45.24 -39.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 122.246 1.022 . . . . 0.37 110.09 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.685 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -66.76 -40.12 88.14 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.93 -1.487 . . . . 0.63 112.685 176.041 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -49.63 -33.34 15.12 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.378 0.608 . . . . 1.79 111.172 167.239 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 127' ' ' LEU . 7.1 mt -83.97 -37.75 21.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.246 -0.888 . . . . 0.38 109.187 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.2 -43.26 92.26 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.288 -1.324 . . . . 1.96 110.221 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.44 -45.09 80.99 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.29 -1.777 . . . . 0.64 112.056 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.3 t -86.4 -2.63 58.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 123.664 1.697 . . . . 0.59 107.155 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 53.44 51.02 16.12 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.13 -2.759 . . . . 1.8 112.584 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.779 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -136.97 176.5 8.65 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.093 0.473 . . . . 0.52 111.782 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.8 153.84 49.62 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.758 -1.201 . . . . 4.54 107.758 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 19.3 tm0? -51.03 139.05 18.39 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.539 1.161 . . . . 1.28 112.341 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.8 p -136.67 140.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 112.718 -2.037 . . . . 1.05 109.781 -164.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -58.95 -32.22 69.42 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.347 1.07 . . . . 1.38 109.439 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 27.3 ttpt -160.88 121.29 2.8 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.962 -1.927 . . . . 1.44 109.109 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.653 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -109.88 118.64 37.01 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.996 -1.002 . . . . 0.9 110.894 -177.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.08 96.52 2.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.948 1.356 . . . . 0.61 108.993 157.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.522 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -166.39 169.52 6.38 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.04 -2.345 . . . . 1.77 105.548 167.704 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.87 125.12 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.486 1.457 . . . . 0.62 112.471 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 94.54 38.18 5.08 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 120.654 -0.784 . . . . 0.51 113.311 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.779 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 9.4 mp0 -131.69 173.44 11.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 122.604 -0.351 . . . . 2.16 110.079 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.869 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.9 p90 -169.0 166.65 11.01 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.601 -1.259 . . . . 0.28 107.601 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.699 HG22 HG13 ' A' ' 136' ' ' VAL . 11.9 p -134.52 126.49 29.47 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.739 -0.784 . . . . 0.42 110.751 173.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.774 HG23 HG12 ' A' ' 152' ' ' ILE . 11.1 p -117.68 110.29 30.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.827 0.823 . . . . 0.34 111.121 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -106.25 -75.82 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 3.11 110.204 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.68 -58.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.469 . . . . 1.65 110.545 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -92.24 7.49 42.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.122 -0.49 . . . . 1.68 111.924 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -161.25 152.14 18.33 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.938 0.875 . . . . 0.37 112.612 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.774 HG12 HG23 ' A' ' 147' ' ' VAL . 67.6 mt -120.32 109.9 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.371 -1.741 . . . . 0.53 106.742 163.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.11 170.96 9.88 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.292 -1.744 . . . . 1.13 106.292 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.648 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 10.6 ptm -167.29 158.18 11.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.679 0.612 . . . . 1.8 110.869 -173.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.593 HG12 ' HG3' ' A' ' 170' ' ' ARG . 13.0 mt -129.27 112.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.466 -0.788 . . . . 0.43 110.501 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.803 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 34.6 mtp180 . . . . . 0 CA--C 1.502 -0.889 0 C-N-CA 120.033 -0.667 . . . . 3.13 109.748 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.803 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 51.7 tt0 . . . . . 0 N--CA 1.42 -1.945 0 N-CA-C 114.692 1.367 . . . . 1.86 114.692 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 66.2 t -153.06 131.38 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.377 -1.283 . . . . 0.41 109.884 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.593 ' HG3' HG12 ' A' ' 155' ' ' ILE . 17.3 mtm180 -91.38 111.56 23.11 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.097 -0.502 . . . . 2.8 110.395 169.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.75 146.99 41.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.026 0.917 . . . . 0.29 111.619 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.501 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 7.3 tpt180 -111.77 103.79 12.08 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.586 -1.643 . . . . 1.71 110.323 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.653 HD23 ' SD ' ' A' ' 124' ' ' MET . 5.5 mp -92.77 94.33 8.92 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.755 -0.461 . . . . 0.69 109.755 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.68 127.85 40.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.582 1.182 . . . . 0.26 111.83 -173.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.728 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-85 -94.16 135.46 35.51 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 112.653 -2.067 . . . . 0.72 110.801 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 18.7 t70 -80.99 64.39 5.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.925 -1.88 . . . . 1.09 105.925 162.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.72 -99.51 1.13 Allowed Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.219 -1.467 . . . . 0.47 111.004 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.66 -24.69 41.66 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.721 0.637 . . . . 0.83 112.721 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -132.34 128.64 38.13 Favored 'General case' 0 N--CA 1.426 -1.666 0 C-N-CA 119.577 -0.849 . . . . 1.21 110.645 -170.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.8 tt -53.92 130.72 38.38 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.585 -1.643 . . . . 0.64 110.26 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.609 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.93 -38.48 6.04 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.443 -0.799 . . . . 0.29 110.499 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -146.03 164.31 32.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.189 -0.46 . . . . 0.33 111.785 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.535 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.6 mm -116.45 148.93 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 105.114 -2.18 . . . . 0.76 105.114 164.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.7 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.1 t -139.78 128.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.416 0.627 . . . . 0.35 109.844 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.587 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 46.6 t-20 -75.94 111.55 11.44 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 107.123 -1.436 . . . . 1.77 107.123 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.54 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.2 mtm -70.22 -1.22 9.64 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.478 -0.489 . . . . 0.55 112.101 -169.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.587 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 7.4 pt-20 -83.18 -45.8 13.48 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.614 0.721 . . . . 1.02 111.265 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.527 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -103.67 -25.81 13.01 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.948 -1.023 . . . . 1.4 109.236 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 185' ' ' ASN . 47.6 t-20 74.28 36.17 0.68 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 112.278 -2.237 . . . . 1.33 107.127 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.7 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 7.2 ptm180 -93.27 161.53 14.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.422 -1.717 . . . . 2.28 109.387 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 78.4 mt-30 -88.17 125.23 34.51 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.99 -1.004 . . . . 1.36 109.46 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.535 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.7 92.28 4.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.884 -0.579 . . . . 1.18 110.446 -170.576 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.82 -58.03 0.0 OUTLIER Glycine 0 N--CA 1.469 0.881 0 C-N-CA 125.066 1.317 . . . . 1.28 116.334 146.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' PHE . 38.4 p90 -163.62 175.38 10.68 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.347 -1.426 . . . . 2.8 108.685 175.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.5 t80 -140.79 154.56 46.31 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.911 -1.144 . . . . 0.6 107.911 157.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.719 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -136.04 139.74 43.31 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.636 -0.665 . . . . 4.77 109.992 -170.667 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -114.41 172.49 6.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 114.967 1.469 . . . . 1.61 114.967 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.444 -0.755 0 CA-C-N 111.902 -2.408 . . . . 2.66 108.723 176.792 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.856 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 72.6 mtt180 . . . . . 0 CA--C 1.497 -1.093 0 N-CA-C 108.529 -0.915 . . . . 4.32 108.529 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.683 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 27.0 ttt -143.89 131.1 20.72 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.96 -1.018 . . . . 2.59 113.203 -163.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.7 m -116.58 105.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 122.301 1.048 . . . . 0.74 112.883 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -159.92 106.22 1.61 Allowed 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.292 -1.776 . . . . 1.38 106.247 165.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.829 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.7 mp -97.3 111.52 23.73 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 119.958 -0.697 . . . . 1.33 109.528 -172.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -140.0 104.84 6.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.223 -0.899 . . . . 1.93 109.856 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.516 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 13.1 Cg_exo -33.63 129.74 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 125.157 3.905 . . . . 0.65 114.21 -172.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.6 t70 79.61 44.01 0.06 Allowed 'General case' 0 C--N 1.341 0.214 0 O-C-N 124.967 1.417 . . . . 0.72 110.529 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.652 ' SD ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.35 155.65 34.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.876 -1.056 . . . . 1.67 110.774 173.486 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 29.2 m -93.36 77.87 4.47 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 122.282 1.039 . . . . 0.58 109.547 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.712 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -96.17 161.09 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.496 -1.684 . . . . 0.65 109.296 -174.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.54 ' H ' HG13 ' A' ' 119' ' ' ILE . 7.6 m -141.78 177.09 8.41 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 118.612 0.642 . . . . 0.44 109.925 -173.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.8 ' HG2' HG21 ' A' ' 147' ' ' VAL . 34.3 mttp -53.42 -33.66 54.8 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.149 -1.056 . . . . 2.33 108.149 163.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.856 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 41.1 t30 -81.88 -18.85 42.36 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 114.311 -1.313 . . . . 1.32 114.177 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.683 ' HA ' ' H ' ' A' ' 110' ' ' MET . 3.4 tt0 -85.64 -62.18 1.59 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.151 -1.593 . . . . 2.06 107.918 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.755 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -58.74 -16.78 18.24 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.455 -1.702 . . . . 3.13 111.143 172.2 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.6 p -42.81 -42.73 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.99 0.9 . . . . 0.37 111.071 176.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.593 ' CE ' HG13 ' A' ' 125' ' ' VAL . 10.5 mmpt? -67.7 -41.15 84.03 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.44 -1.254 . . . . 0.63 112.154 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.5 tm? -53.12 -32.44 47.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.396 0.617 . . . . 1.79 110.392 167.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' A' ' 124' ' ' MET . 26.2 mt -82.16 -34.0 29.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.756 0.789 . . . . 0.38 109.066 -171.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.18 -37.25 85.17 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.235 -1.348 . . . . 1.96 110.164 167.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -68.6 -41.94 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.675 -1.602 . . . . 0.64 112.512 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.4 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.13 -1.52 57.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 124.176 1.941 . . . . 0.59 106.107 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 56.13 55.19 7.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 110.714 -2.948 . . . . 1.8 111.927 170.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 2.5 t80 -138.3 174.94 10.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.479 0.657 . . . . 0.52 112.407 -176.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 134' ' ' ARG . 20.1 ptt85 -141.86 147.61 37.44 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.948 -1.501 . . . . 4.54 106.948 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.83 135.05 20.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.763 1.268 . . . . 1.28 112.455 -171.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.5 p -134.37 141.04 44.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.386 -2.188 . . . . 1.05 110.14 -162.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -58.74 -34.28 71.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.493 1.139 . . . . 1.38 109.61 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -160.12 128.5 4.81 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.782 -2.008 . . . . 1.44 109.101 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.602 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -118.43 133.79 55.59 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.838 -1.074 . . . . 0.9 111.612 -173.632 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.552 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.8 t -162.92 100.21 0.99 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.491 1.138 . . . . 0.61 110.957 153.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.3 OUTLIER -164.51 160.67 15.86 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 113.161 -1.836 . . . . 1.77 106.211 161.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.441 ' HA ' HG22 ' A' ' 155' ' ' ILE . 23.3 Cg_exo -62.94 120.92 8.61 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 121.055 1.17 . . . . 0.62 109.839 170.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.4 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 95.54 38.37 4.75 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 119.716 -1.231 . . . . 0.51 113.102 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 42.1 mt-10 -140.94 167.55 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.889 -0.411 . . . . 2.16 109.889 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.74 ' CD2' HD22 ' A' ' 128' ' ' LEU . 51.3 p90 -167.67 163.43 14.41 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.395 -0.965 . . . . 0.28 108.395 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.513 HG22 HG13 ' A' ' 136' ' ' VAL . 53.6 p -128.87 127.34 41.65 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.061 0.457 . . . . 0.42 110.703 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 121' ' ' LYS . 11.8 p -121.51 116.65 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.555 0.693 . . . . 0.34 111.813 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.519 ' HG3' ' H ' ' A' ' 149' ' ' ALA . 11.0 pt20 -117.43 -62.34 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.863 -0.608 . . . . 3.11 111.247 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.519 ' H ' ' HG3' ' A' ' 148' ' ' GLN . . . -168.97 -63.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 1.65 110.791 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -83.0 4.65 25.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.365 -0.379 . . . . 1.68 111.798 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 16.4 p -165.47 150.0 8.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.978 0.894 . . . . 0.37 112.992 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.734 HG12 HG23 ' A' ' 147' ' ' VAL . 65.6 mt -116.5 107.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.333 -1.758 . . . . 0.53 106.326 160.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.537 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 5.5 mt-10 -99.42 102.2 13.7 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.57 -0.9 . . . . 1.13 108.57 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 8.6 ptm -109.38 156.94 19.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.157 -0.929 . . . . 1.8 112.149 -170.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.63 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.8 mt -123.5 119.07 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.322 -1.308 . . . . 0.43 109.991 172.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.7 mtm180 . . . . . 0 C--N 1.32 -0.681 0 O-C-N 123.437 0.461 . . . . 3.13 110.444 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.63 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 6.6 tt0 . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 113.276 0.843 . . . . 1.86 113.276 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 43.1 t -153.23 128.53 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.979 -1.01 . . . . 0.41 109.542 174.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.584 ' HB3' ' HE2' ' A' ' 186' ' ' MET . 15.0 mtt180 -89.86 114.09 25.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 120.9 0.381 . . . . 2.8 110.469 170.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.79 129.86 56.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.342 1.067 . . . . 0.29 111.278 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.5 tpt180 -96.09 100.28 11.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.219 -1.809 . . . . 1.71 110.925 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 151' ' ' SER . 10.7 mp -85.08 93.96 8.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.737 -0.468 . . . . 0.69 109.737 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.573 HG23 ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -94.59 113.44 25.26 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.504 1.145 . . . . 0.26 111.687 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -82.77 135.43 34.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.679 -2.055 . . . . 0.72 110.347 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 36.9 t70 -76.59 65.85 2.47 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.345 -1.724 . . . . 1.09 106.345 161.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 -98.37 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 118.877 -1.63 . . . . 0.47 110.78 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.79 -17.56 37.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.505 0.928 . . . . 0.83 113.505 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -139.45 130.27 26.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.506 -0.877 . . . . 1.21 110.628 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.712 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 4.8 tt -53.66 128.51 29.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.122 -1.399 . . . . 0.64 110.568 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -100.89 -39.02 7.98 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.717 -1.129 . . . . 0.29 108.994 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 26.2 p -150.8 158.96 44.78 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.475 -0.784 . . . . 0.33 110.592 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 16.1 mt -120.29 146.67 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 105.063 -2.199 . . . . 0.76 105.063 168.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 22.6 t -138.77 129.73 34.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.36 0.6 . . . . 0.35 110.152 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.593 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.3 t-20 -75.15 101.94 4.77 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 106.817 -1.549 . . . . 1.77 106.817 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.584 ' HE2' ' HB3' ' A' ' 170' ' ' ARG . 36.2 mtm -65.51 -3.09 3.95 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.653 0.595 . . . . 0.55 112.516 -167.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.593 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 8.5 pt-20 -80.1 -43.62 21.4 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.756 0.789 . . . . 1.02 110.813 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.588 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 8.9 m120 -104.91 -25.72 12.48 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 114.464 -1.244 . . . . 1.4 109.367 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 58.0 t30 76.19 33.29 0.57 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 112.59 -2.096 . . . . 1.33 107.873 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.641 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.3 ptm180 -96.14 157.6 15.82 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 2.28 109.846 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.6 126.53 31.84 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.814 -1.084 . . . . 1.36 109.308 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.23 90.5 3.94 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.321 -0.552 . . . . 1.18 110.875 -168.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.27 -57.75 0.0 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 116.635 1.414 . . . . 1.28 116.635 145.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.519 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 3.4 p90 -164.08 175.58 10.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.525 -1.337 . . . . 2.8 109.671 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.829 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.3 t80 -148.34 103.42 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.206 0.526 . . . . 0.6 110.899 159.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.519 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 1.6 mmm180 -95.45 133.65 39.18 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.441 -0.787 . . . . 4.77 110.465 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 127' ' ' LEU . 69.0 mt -122.89 171.44 9.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 114.388 1.255 . . . . 1.61 114.388 -166.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.22 -0.476 0 CA-C-N 113.935 -1.484 . . . . 2.66 110.554 -176.161 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.745 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 122.218 1.008 . . . . 4.32 113.36 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 15.6 tpt -142.44 129.92 21.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.61 -1.177 . . . . 2.59 111.786 -175.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.56 102.63 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.731 1.253 . . . . 0.74 111.904 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -162.44 109.59 1.3 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.111 -1.859 . . . . 1.38 106.244 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.789 HD12 ' HB3' ' A' ' 195' ' ' PHE . 52.2 mt -96.38 108.04 20.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.418 -0.586 . . . . 1.33 109.418 -175.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 2.6 tm-20 -142.88 110.14 5.58 Favored Pre-proline 0 C--N 1.309 -1.192 0 C-N-CA 119.298 -0.961 . . . . 1.93 110.442 -175.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.492 ' HG3' HG12 ' A' ' 183' ' ' ILE . 27.9 Cg_exo -35.11 126.61 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 124.25 3.3 . . . . 0.65 113.777 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 22.3 t0 75.9 49.61 0.07 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.762 1.267 . . . . 0.72 110.37 -174.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.656 ' HE3' HD13 ' A' ' 180' ' ' LEU . 13.5 ptt? -119.27 155.71 31.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.983 -1.462 . . . . 1.67 109.529 172.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 179' ' ' HIS . 8.0 m -101.76 83.88 2.47 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.365 -0.976 . . . . 0.58 108.365 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -109.0 161.41 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.821 -1.536 . . . . 0.65 110.071 -170.27 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.742 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.4 m -142.79 174.17 10.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.623 -0.881 . . . . 0.44 108.623 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.975 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 19.4 mtpp -54.93 -28.37 50.52 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.671 0.748 . . . . 2.33 109.723 163.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.581 ' O ' HG12 ' A' ' 125' ' ' VAL . 32.4 t30 -85.93 -18.68 32.01 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 114.692 1.367 . . . . 1.32 114.692 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.742 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.0 OUTLIER -86.09 -62.91 1.41 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.565 1.174 . . . . 2.06 108.134 171.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.975 ' SD ' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -58.12 -14.04 6.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 112.347 -2.206 . . . . 3.13 110.871 173.119 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 122' ' ' ASN . 12.1 p -41.89 -42.32 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.91 0.862 . . . . 0.37 109.637 170.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.745 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -68.37 -39.96 81.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.579 -1.191 . . . . 0.63 113.834 174.456 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.572 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -49.9 -32.2 14.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.446 0.641 . . . . 1.79 111.0 170.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 124' ' ' MET . 8.6 mt -85.67 -37.68 19.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 0.38 108.984 -172.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.61 -36.19 77.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.94 -1.482 . . . . 1.96 109.672 168.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.66 -41.27 65.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.879 -1.509 . . . . 0.64 112.208 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.703 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.5 t -89.04 -0.77 57.71 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 123.255 1.502 . . . . 0.59 107.641 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 52.16 52.21 14.79 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.173 -2.739 . . . . 1.8 112.337 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.765 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.3 t80 -138.99 176.19 8.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.52 112.022 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -139.18 153.0 47.84 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.682 -1.229 . . . . 4.54 107.682 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.641 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 17.8 tm0? -50.84 138.95 17.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.535 1.16 . . . . 1.28 112.591 -169.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.5 p -136.22 140.94 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.802 -1.999 . . . . 1.05 109.972 -163.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -58.35 -32.77 68.85 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.714 1.245 . . . . 1.38 109.478 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 7.0 ttpt -160.22 127.12 4.36 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 112.417 -2.174 . . . . 1.44 108.663 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -112.91 124.02 51.65 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.227 -0.897 . . . . 0.9 110.767 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.16 97.88 1.82 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.99 1.376 . . . . 0.61 109.105 154.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.584 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -165.64 169.51 6.94 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 112.251 -2.249 . . . . 1.77 105.662 166.528 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.88 123.9 7.71 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 120.777 1.313 . . . . 0.62 112.311 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 98.25 39.76 3.66 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 120.678 -0.772 . . . . 0.51 113.279 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.765 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 12.4 mp0 -135.48 173.78 11.33 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 122.829 0.452 . . . . 2.16 110.585 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.882 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.3 p90 -169.19 168.62 9.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.245 -1.02 . . . . 0.28 108.245 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.587 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 40.5 p -135.27 126.46 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.357 -0.537 . . . . 0.42 111.955 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 152' ' ' ILE . 14.8 p -125.37 129.05 73.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.956 -0.565 . . . . 0.34 111.804 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.493 ' HA ' ' OE1' ' A' ' 148' ' ' GLN . 6.1 tp60 -144.2 -70.18 0.3 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.326 -0.55 . . . . 3.11 111.534 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.28 -67.46 0.54 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 1.65 112.633 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -87.27 -11.76 48.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.807 0.669 . . . . 1.68 112.807 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 20.6 p -165.05 157.77 16.15 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.873 0.844 . . . . 0.37 112.933 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 147' ' ' VAL . 50.2 mt -114.61 115.76 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.079 -1.419 . . . . 0.53 107.613 167.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.882 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.3 mp0 -89.33 171.39 9.79 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 106.51 -1.663 . . . . 1.13 106.51 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.623 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 26.7 ptm -167.96 154.16 7.49 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.739 0.649 . . . . 1.8 110.348 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.568 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.5 mt -128.75 114.32 32.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.33 -0.395 . . . . 0.43 110.826 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.709 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 10.0 mtp-105 . . . . . 0 C--N 1.316 -0.863 0 C-N-CA 120.664 -0.414 . . . . 3.13 111.209 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.709 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 49.5 tt0 . . . . . 0 N--CA 1.42 -1.961 0 N-CA-C 114.412 1.264 . . . . 1.86 114.412 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 44.2 t -154.5 130.29 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.707 -1.588 . . . . 0.41 109.99 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.649 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 35.7 mtm180 -86.9 114.77 23.81 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 116.189 -0.46 . . . . 2.8 110.325 168.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -117.0 132.43 56.71 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.844 0.83 . . . . 0.29 111.289 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.556 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 11.5 tpp180 -99.28 109.08 21.76 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.039 -1.437 . . . . 1.71 111.034 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 113' ' ' LEU . 5.4 mp -91.59 91.48 8.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.12 -0.491 . . . . 0.69 109.968 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.7 125.59 37.39 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.283 1.04 . . . . 0.26 111.844 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 2.0 m-85 -89.59 138.15 31.72 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.953 -1.93 . . . . 0.72 111.579 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.3 t70 -81.96 64.99 6.89 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 105.833 -1.914 . . . . 1.09 105.833 159.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.16 -98.75 1.02 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 118.892 -1.623 . . . . 0.47 111.144 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.34 -25.57 46.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.521 0.563 . . . . 0.83 112.521 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 118' ' ' THR . 7.1 p80 -135.46 132.88 37.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.369 0.604 . . . . 1.21 110.132 -168.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.713 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -54.59 134.02 46.62 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.1 -1.409 . . . . 0.64 110.617 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.605 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.78 -41.54 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.925 -1.034 . . . . 0.29 110.081 -176.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 p -147.21 163.8 35.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.027 -0.533 . . . . 0.33 111.705 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 195' ' ' PHE . 1.6 mm -111.14 148.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.144 -2.169 . . . . 0.76 105.144 165.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.8 t -141.51 131.79 25.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.407 0.622 . . . . 0.35 109.947 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.583 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 40.7 t-20 -79.44 110.11 14.43 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.124 -1.065 . . . . 1.77 108.124 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.649 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 16.3 mtp -65.91 -2.46 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.036 0.754 . . . . 0.55 113.036 -171.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.583 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 8.3 pt-20 -81.18 -42.53 20.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.817 0.818 . . . . 1.02 111.153 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.49 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 6.1 m-20 -111.24 -26.55 9.11 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.391 -1.277 . . . . 1.4 109.738 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.2 t30 76.28 34.47 0.5 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.519 -2.128 . . . . 1.33 107.642 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 5.2 ptm180 -90.31 162.92 14.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.427 -1.715 . . . . 2.28 108.641 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -88.02 140.17 29.77 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.727 -0.67 . . . . 1.36 110.001 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.519 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -114.08 92.31 3.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.701 -0.666 . . . . 1.18 110.523 -176.54 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.08 -58.63 0.0 OUTLIER Glycine 0 N--CA 1.469 0.839 0 N-CA-C 116.15 1.22 . . . . 1.28 116.15 146.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 192' ' ' PHE . 35.0 p90 -163.42 174.23 12.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.702 -1.249 . . . . 2.8 109.25 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.789 ' HB3' HD12 ' A' ' 113' ' ' LEU . 1.4 t80 -140.31 154.45 46.8 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.201 -0.666 . . . . 0.6 109.201 159.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.666 ' H ' ' HD2' ' A' ' 196' ' ' ARG . 0.1 OUTLIER -138.53 153.97 48.76 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.806 -0.559 . . . . 4.77 111.933 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.585 HD21 ' HE1' ' A' ' 154' ' ' MET . 5.1 mt -129.55 172.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.425 1.268 . . . . 1.61 114.425 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.443 -0.814 0 CA-C-N 112.38 -2.191 . . . . 2.66 111.03 -175.715 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 113.68 0.993 . . . . 4.32 113.68 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.423 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 16.2 tpt -141.37 132.57 26.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.332 -0.547 . . . . 2.59 112.015 -173.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 13.3 m -121.88 104.29 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 122.814 1.292 . . . . 0.74 113.037 171.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.407 ' O ' ' HE1' ' A' ' 117' ' ' MET . 63.1 t30 -161.01 110.72 1.67 Allowed 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 105.011 -2.218 . . . . 1.38 105.011 166.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.597 HD21 ' SD ' ' A' ' 124' ' ' MET . 59.1 mt -97.16 115.22 27.16 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.967 -0.693 . . . . 1.33 110.963 -174.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.478 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 21.9 tt0 -155.34 91.26 2.86 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 121.649 0.738 . . . . 1.93 109.279 -173.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.759 ' HD3' HD12 ' A' ' 183' ' ' ILE . 0.3 OUTLIER -31.49 144.22 0.03 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.76 1 C-N-CA 126.671 4.914 . . . . 0.65 115.536 -175.946 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.3 t70 78.05 36.61 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 113.757 -1.565 . . . . 0.72 109.057 -170.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.433 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 7.2 ptp -121.09 155.43 34.46 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.768 -1.106 . . . . 1.67 111.09 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.7 m -101.37 84.47 2.62 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.224 -1.028 . . . . 0.58 108.224 -175.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.721 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -110.03 163.91 6.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.055 -1.43 . . . . 0.65 109.854 -168.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.647 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.8 m -140.87 177.41 8.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.064 -0.655 . . . . 0.44 109.913 -172.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.621 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -60.97 -27.07 68.01 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 108.145 -1.057 . . . . 2.33 108.145 165.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.591 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER -84.54 -17.73 37.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.996 -1.456 . . . . 1.32 114.416 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.647 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.9 mp0 -85.48 -62.39 1.54 Allowed 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 120.56 -1.337 . . . . 2.06 108.421 170.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.779 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 mmt -57.02 -16.52 7.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.166 -1.834 . . . . 3.13 111.901 173.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.621 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 14.9 p -42.34 -42.82 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.219 1.009 . . . . 0.37 110.797 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.674 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -67.83 -41.24 83.3 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.947 -1.478 . . . . 0.63 113.087 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.507 HD23 ' HB3' ' A' ' 197' ' ' LEU . 2.9 tm? -52.61 -32.73 43.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.29 0.567 . . . . 1.79 110.273 167.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.8 mt -82.34 -35.92 27.4 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.442 0.639 . . . . 0.38 109.541 -172.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -44.7 86.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.664 -1.153 . . . . 1.96 109.944 164.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -65.09 -39.64 93.46 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.209 -1.814 . . . . 0.64 112.636 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 128' ' ' LEU . 2.8 t -93.19 3.92 54.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.191 -1.781 . . . . 0.59 106.191 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 45.84 52.24 9.88 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 110.84 -2.891 . . . . 1.8 111.88 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 2.6 t80 -136.7 175.17 9.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 119.901 -0.72 . . . . 0.52 112.725 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -139.67 149.9 44.26 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.664 -1.606 . . . . 4.54 106.664 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' HB2' HG12 ' A' ' 147' ' ' VAL . 19.5 tm0? -49.92 141.52 10.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.534 1.159 . . . . 1.28 113.136 -169.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.1 p -139.91 141.46 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.957 -1.929 . . . . 1.05 110.07 -162.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m -58.85 -34.59 71.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 122.607 1.194 . . . . 1.38 109.232 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -160.81 130.29 4.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.491 -2.141 . . . . 1.44 109.259 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.672 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -119.08 125.82 50.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.624 -1.171 . . . . 0.9 112.117 -172.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.491 ' HA ' HD11 ' A' ' 155' ' ' ILE . 1.7 t -160.64 99.79 1.28 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.931 1.348 . . . . 0.61 110.865 156.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.504 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -165.73 157.89 12.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 105.501 -2.037 . . . . 1.77 105.501 163.379 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -61.13 113.68 1.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.088 1.424 . . . . 0.62 109.727 171.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.416 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 105.45 47.71 1.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.214 -0.993 . . . . 0.51 113.272 -175.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.582 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 44.3 mt-10 -145.73 170.7 15.97 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 122.532 0.333 . . . . 2.16 110.264 172.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.863 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 49.8 p90 -167.8 165.31 14.09 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.918 -1.141 . . . . 0.28 107.918 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.667 HG22 HG13 ' A' ' 136' ' ' VAL . 35.9 p -132.17 126.11 32.83 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.862 -0.735 . . . . 0.42 110.843 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.747 HG23 HG12 ' A' ' 152' ' ' ILE . 8.6 p -125.18 169.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.798 -0.637 . . . . 0.34 111.413 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 18.7 tm0? 78.05 75.56 0.06 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.637 0.775 . . . . 3.11 110.215 176.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -177.85 -94.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.373 -1.285 . . . . 1.65 109.167 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -135.68 11.89 3.43 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.13 0.491 . . . . 1.68 110.443 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 3.3 p -165.8 158.06 14.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.37 112.265 -171.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.747 HG12 HG23 ' A' ' 147' ' ' VAL . 38.5 mt -107.69 106.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 106.458 -1.682 . . . . 0.53 106.458 159.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.863 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.7 mt-10 -91.07 164.18 14.04 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 104.779 -2.304 . . . . 1.13 104.779 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 19.2 ptp -166.06 164.0 18.16 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.871 0.732 . . . . 1.8 110.221 -170.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.823 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.2 mt -127.95 94.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.854 0.835 . . . . 0.43 110.698 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.713 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 1.3 tmt_? . . . . . 0 N--CA 1.438 -1.072 0 CA-C-N 114.496 -1.229 . . . . 3.13 111.857 -173.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.503 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 2.6 pm0 . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 114.821 1.415 . . . . 1.86 114.821 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 4.0 t -155.5 127.69 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 113.706 -1.588 . . . . 0.41 110.334 -169.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 154' ' ' MET . 22.2 mtm180 -93.63 115.24 27.7 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.583 0.23 . . . . 2.8 110.551 171.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -112.9 130.2 56.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.93 0.872 . . . . 0.29 110.904 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.75 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.8 tpt180 -96.09 98.48 10.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.762 -1.563 . . . . 1.71 110.901 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 7.0 mp -88.49 97.8 11.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 110.169 -0.308 . . . . 0.69 110.169 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.427 HG23 ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -97.19 117.11 30.67 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.576 1.179 . . . . 0.26 111.672 -173.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -85.45 131.92 34.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.689 -2.05 . . . . 0.72 110.03 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.2 t70 -76.9 65.3 2.56 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.199 -1.778 . . . . 1.09 106.199 164.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.96 -98.55 0.88 Allowed Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 119.138 -1.506 . . . . 0.47 110.526 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.71 -26.34 54.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.88 0.696 . . . . 0.83 112.88 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.476 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 5.7 p-80 -137.34 130.02 30.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.636 0.732 . . . . 1.21 111.187 -167.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.721 ' HB2' HG22 ' A' ' 119' ' ' ILE . 5.3 tt -53.13 127.75 25.31 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.93 -1.487 . . . . 0.64 110.87 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -39.39 5.88 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.253 -0.885 . . . . 0.29 110.186 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.8 p -145.96 166.66 25.38 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.965 -0.562 . . . . 0.33 110.885 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.759 HD12 ' HD3' ' A' ' 115' ' ' PRO . 38.5 mt -136.59 145.48 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 106.025 -1.843 . . . . 0.76 106.025 169.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 38.8 t -139.16 132.94 39.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.295 0.569 . . . . 0.35 109.996 -173.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.471 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 0.2 OUTLIER -80.55 103.34 10.33 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.577 -1.268 . . . . 1.77 107.577 -176.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 29.5 mtm -65.92 -1.59 3.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 123.861 0.726 . . . . 0.55 112.722 -166.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 11.7 pt-20 -77.13 -45.62 26.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.015 0.912 . . . . 1.02 110.696 174.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 190' ' ' ARG . 27.0 t-20 -108.65 -26.31 10.43 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.125 -1.398 . . . . 1.4 109.249 -174.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.3 t30 78.09 26.93 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.654 -2.066 . . . . 1.33 107.109 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.471 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 16.7 ptt180 -85.0 160.64 20.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.841 -1.527 . . . . 2.28 109.651 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.66 141.41 28.54 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.457 -1.247 . . . . 1.36 113.518 -172.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.695 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 5.8 m-85 -106.85 -166.56 1.18 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 112.635 -2.075 . . . . 1.18 107.092 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.549 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.55 -10.72 3.75 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.591 -2.203 . . . . 1.28 107.591 -149.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 196' ' ' ARG . 27.4 p90 -155.76 105.39 2.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.196 -1.002 . . . . 2.8 111.267 156.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.0 t80 -119.57 132.75 55.8 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.13 -0.981 . . . . 0.6 109.325 166.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.583 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.1 mpt_? -115.92 146.35 42.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.867 -0.42 . . . . 4.77 109.867 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 33.0 mt -127.73 162.78 25.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.431 -0.35 . . . . 1.61 111.577 -171.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 2.66 110.61 -177.466 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.985 -0.376 . . . . 4.32 109.985 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.72 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 9.2 ttt -137.65 97.64 3.49 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 118.098 -1.441 . . . . 2.59 113.748 -163.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 127' ' ' LEU . 1.6 m -101.42 107.79 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 113.548 0.944 . . . . 0.74 113.548 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -159.2 110.88 2.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.922 -1.881 . . . . 1.38 105.922 166.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.804 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.4 mp -100.72 116.15 31.94 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.461 -0.496 . . . . 1.33 110.406 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 0.3 OUTLIER -154.01 90.24 3.3 Favored Pre-proline 0 N--CA 1.432 -1.371 0 N-CA-C 109.089 -0.708 . . . . 1.93 109.089 -177.187 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.729 ' HD3' HD12 ' A' ' 183' ' ' ILE . 1.3 Cg_exo -29.04 144.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 1 C-N-CA 126.755 4.97 . . . . 0.65 116.467 -175.704 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.9 t70 74.68 37.66 0.52 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.791 -1.55 . . . . 0.72 108.781 -172.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.443 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 5.8 ptp -120.9 155.88 33.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.199 -1.364 . . . . 1.67 110.893 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.1 m -101.33 82.25 2.3 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 122.42 1.105 . . . . 0.58 108.33 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.532 HG13 ' CB ' ' A' ' 123' ' ' GLU . 17.8 tt -121.54 165.11 17.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.349 -1.75 . . . . 0.65 108.668 -169.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.526 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 4.2 m -140.1 175.66 9.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.713 -0.795 . . . . 0.44 111.405 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.653 ' HG2' HG21 ' A' ' 147' ' ' VAL . 1.8 mptt -59.95 -20.14 55.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.044 -0.98 . . . . 2.33 108.91 169.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.705 ' O ' HG12 ' A' ' 125' ' ' VAL . 9.2 t30 -83.03 -21.87 33.71 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 114.062 -1.426 . . . . 1.32 112.757 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.72 ' HA ' ' H ' ' A' ' 110' ' ' MET . 1.2 mp0 -85.94 -48.46 8.68 Favored 'General case' 0 N--CA 1.408 -2.533 0 O-C-N 120.01 -1.681 . . . . 2.06 107.825 173.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.745 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -62.59 -18.03 61.32 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 113.762 -1.563 . . . . 3.13 111.264 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -47.34 -40.74 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 122.324 1.059 . . . . 0.37 110.569 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.598 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -66.94 -41.04 87.63 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.872 -1.513 . . . . 0.63 113.351 177.46 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.723 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.9 tm? -52.11 -34.93 46.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.532 0.682 . . . . 1.79 110.156 168.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 124' ' ' MET . 18.0 mt -83.23 -36.24 24.76 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.783 0.801 . . . . 0.38 109.054 -170.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.82 -39.64 92.49 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.114 -1.403 . . . . 1.96 109.468 167.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -67.34 -43.29 81.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.306 -1.315 . . . . 0.64 112.252 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.458 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.52 2.98 56.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 124.373 2.035 . . . . 0.59 106.336 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 56.09 46.37 21.76 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 110.341 -3.118 . . . . 1.8 112.409 169.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.922 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -136.77 174.88 10.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.84 -0.744 . . . . 0.52 112.753 -173.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.426 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 31.8 ttm180 -142.97 154.72 44.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.016 -1.476 . . . . 4.54 107.016 177.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 13.6 tm0? -49.43 142.88 7.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.593 1.187 . . . . 1.28 113.714 -167.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 145' ' ' PHE . 13.3 p -142.97 142.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 112.752 -2.022 . . . . 1.05 110.304 -163.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 -34.05 70.01 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.718 1.247 . . . . 1.38 109.17 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -158.86 123.05 3.98 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.508 -2.133 . . . . 1.44 108.653 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.682 ' SD ' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -111.2 128.55 55.95 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.095 -0.957 . . . . 0.9 110.209 -178.545 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.596 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -160.89 99.15 1.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.756 1.265 . . . . 0.61 109.97 158.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.596 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -165.18 168.52 8.38 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 112.595 -2.093 . . . . 1.77 105.618 162.507 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.462 ' HG3' ' OE1' ' A' ' 168' ' ' GLN . 14.9 Cg_exo -66.02 119.25 6.25 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 N-CA-C 109.192 -1.118 . . . . 0.62 109.192 167.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.458 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 90.94 47.96 3.5 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.513 -1.327 . . . . 0.51 113.161 -171.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.922 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.1 mt-10 -150.62 147.17 27.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.845 -0.798 . . . . 2.16 108.845 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.733 ' O ' HG12 ' A' ' 136' ' ' VAL . 38.4 p90 -154.19 160.64 41.96 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.729 -0.841 . . . . 0.28 108.729 -177.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.682 HG23 ' SD ' ' A' ' 139' ' ' MET . 39.1 p -125.24 127.64 47.06 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.496 0.665 . . . . 0.42 110.606 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.653 HG21 ' HG2' ' A' ' 121' ' ' LYS . 12.8 p -121.43 113.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.187 -0.915 . . . . 0.34 110.911 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -111.53 -80.78 0.58 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.62 -0.718 . . . . 3.11 110.321 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.09 -54.84 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.72 -0.673 . . . . 1.65 110.049 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -96.47 8.24 44.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 1.68 112.264 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.688 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 23.1 p -164.13 147.01 9.34 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.947 1.092 . . . . 0.37 113.947 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 147' ' ' VAL . 54.9 mt -115.03 107.8 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 112.907 -1.951 . . . . 0.53 106.852 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.544 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 6.4 mt-10 -102.29 103.68 14.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.466 -0.939 . . . . 1.13 108.466 -176.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.454 ' SD ' ' HE1' ' A' ' 195' ' ' PHE . 6.0 ptm -117.04 155.19 29.64 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.928 -1.033 . . . . 1.8 112.465 -167.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.632 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 38.4 mt -118.79 124.41 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 114.482 -1.235 . . . . 0.43 110.307 170.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 58.6 mtm180 . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 109.67 -0.493 . . . . 3.13 109.67 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.669 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 49.3 tt0 . . . . . 0 N--CA 1.423 -1.812 0 N-CA-C 114.46 1.282 . . . . 1.86 114.46 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 31.0 t -153.59 133.81 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.884 -1.507 . . . . 0.41 110.081 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 18.5 mtm180 -94.8 115.67 27.78 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.962 -0.563 . . . . 2.8 110.397 168.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.33 134.17 55.13 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.075 0.94 . . . . 0.29 112.161 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.761 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 16.2 tpt180 -96.25 95.74 8.31 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.22 -1.809 . . . . 1.71 110.255 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.755 HD21 HD21 ' A' ' 113' ' ' LEU . 3.9 mp -87.31 95.88 10.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.171 -0.677 . . . . 0.69 109.171 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.44 111.01 22.98 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.377 1.084 . . . . 0.26 111.556 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.753 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 52.7 m-85 -87.28 129.71 34.88 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.992 -1.913 . . . . 0.72 110.438 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 35.5 t70 -78.85 66.12 4.24 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 106.539 -1.652 . . . . 1.09 106.539 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.27 -99.32 1.18 Allowed Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 119.227 -1.463 . . . . 0.47 110.329 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.71 -24.82 33.43 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.937 0.717 . . . . 0.83 112.937 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.506 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 9.5 p-80 -130.49 123.03 28.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.636 0.731 . . . . 1.21 110.763 -166.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.753 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.9 tt -54.11 128.52 31.11 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.772 -1.558 . . . . 0.64 110.883 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.39 -39.06 6.01 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.105 -0.952 . . . . 0.29 110.33 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 115' ' ' PRO . 19.3 p -149.4 163.31 38.1 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.214 -0.448 . . . . 0.33 111.092 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.761 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 44.5 mt -136.43 145.44 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 105.889 -1.893 . . . . 0.76 105.889 168.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 49.1 t -138.86 136.77 43.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.821 -0.437 . . . . 0.35 109.821 -174.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.603 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 64.2 t30 -85.31 97.66 10.08 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.511 -1.292 . . . . 1.77 107.511 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.544 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 57.6 mtm -64.61 -3.1 2.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 124.182 0.926 . . . . 0.55 113.239 -162.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.0 pt-20 -80.53 -40.6 25.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.855 0.836 . . . . 1.02 110.802 177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.506 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 77.0 m-20 -113.58 -25.29 8.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.287 -1.324 . . . . 1.4 109.335 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 80.72 28.57 0.22 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.733 -2.031 . . . . 1.33 108.283 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.603 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 0.6 OUTLIER -83.28 155.57 23.56 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.656 -1.611 . . . . 2.28 110.637 176.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -84.74 140.97 30.88 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.641 -1.163 . . . . 1.36 112.917 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.668 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 3.9 m-85 -103.27 -166.67 1.29 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.942 -1.936 . . . . 1.18 107.97 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 136.09 -2.38 3.58 Favored Glycine 0 CA--C 1.482 -1.986 0 N-CA-C 107.736 -2.146 . . . . 1.28 107.736 -151.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.47 ' O ' ' HD2' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -156.81 100.06 1.88 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 113.698 -1.251 . . . . 2.8 111.903 151.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.804 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 t80 -116.68 100.78 8.06 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.87 -1.132 . . . . 0.6 109.952 168.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -96.88 138.49 34.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.295 -0.412 . . . . 4.77 110.579 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.723 HD13 ' HG ' ' A' ' 127' ' ' LEU . 45.8 mt -132.42 160.68 35.68 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.255 0.55 . . . . 1.61 112.189 -170.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.229 -0.896 . . . . 2.66 109.375 175.86 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 69.3 mtm . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.851 0.358 . . . . 26.27 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.07 129.72 3.48 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.841 -0.695 . . . . 24.15 111.62 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 t 57.99 57.13 4.25 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.518 0.675 . . . . 23.64 110.013 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 m -87.79 96.03 10.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.644 -0.707 . . . . 22.83 110.612 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -88.69 112.98 23.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.754 -0.657 . . . . 22.11 109.433 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -91.0 -158.12 0.54 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.419 -0.355 . . . . 22.07 111.093 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.4 m80 65.86 51.64 1.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.198 0.523 . . . . 20.59 110.603 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -91.02 76.6 6.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.052 -0.522 . . . . 18.44 110.885 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -81.96 102.03 10.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.025 -0.534 . . . . 17.98 109.838 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -69.97 136.51 50.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.254 -0.43 . . . . 17.87 110.399 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 p -82.77 84.1 7.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.044 -0.526 . . . . 16.77 110.487 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 m -68.07 97.74 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 16.32 110.121 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.57 54.14 1.59 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.637 -0.792 . . . . 14.63 111.357 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.7 tp -75.06 75.05 2.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.278 0.561 . . . . 15.68 110.609 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.44 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 59.0 t -87.49 -53.25 0.39 Allowed Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.67 -0.695 . . . . 12.69 110.737 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.44 ' HD2' ' H ' ' A' ' 101' ' ' VAL . 60.9 Cg_endo -71.56 175.81 8.98 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.753 1.636 . . . . 12.08 111.867 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 74.42 -32.1 0.23 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.58 0.752 . . . . 12.18 111.667 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.57 -173.83 22.28 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.179 -0.534 . . . . 8.55 112.211 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.5 t -80.64 130.62 35.21 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.277 -0.638 . . . . 8.07 109.277 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -135.58 62.85 1.62 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.079 0.466 . . . . 7.76 110.965 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 63.0 mtt -100.15 -52.89 3.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.198 -0.667 . . . . 6.12 109.198 173.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.82 -31.76 2.75 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-O 118.816 -0.991 . . . . 1.91 114.722 169.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 7.1 ptm180 -17.26 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.638 1.347 . . . . 4.32 114.638 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.414 ' HB3' ' HG2' ' A' ' 123' ' ' GLU . 60.9 ttp -140.44 121.74 14.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.557 -0.457 . . . . 2.59 111.515 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 105.7 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 122.246 1.022 . . . . 0.74 113.566 173.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -159.79 106.2 1.63 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.248 -2.13 . . . . 1.38 105.248 159.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.708 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 11.5 mt -82.8 103.64 12.44 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.425 -0.51 . . . . 1.33 110.169 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -145.08 99.46 4.62 Favored Pre-proline 0 N--CA 1.429 -1.492 0 C-N-CA 119.37 -0.932 . . . . 1.93 110.431 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.797 ' HD3' HD12 ' A' ' 183' ' ' ILE . 0.5 OUTLIER -34.14 139.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.644 1 C-N-CA 125.668 4.245 . . . . 0.65 115.011 -178.84 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.4 t70 77.22 35.56 0.34 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.834 -1.53 . . . . 0.72 109.408 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.505 ' HE3' HD13 ' A' ' 180' ' ' LEU . 10.8 ptt? -114.56 155.13 27.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.401 -1.272 . . . . 1.67 109.879 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 179' ' ' HIS . 21.4 m -101.71 103.74 14.52 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.079 -1.082 . . . . 0.58 108.079 -175.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.605 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.4 tt -136.56 166.66 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.277 -0.874 . . . . 0.65 110.566 -165.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.618 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.6 m -141.42 176.24 9.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.738 -0.838 . . . . 0.44 108.738 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.542 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -28.0 68.85 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.53 -0.915 . . . . 2.33 108.53 166.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.606 ' O ' HG12 ' A' ' 125' ' ' VAL . 0.3 OUTLIER -84.23 -19.14 34.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.127 -1.397 . . . . 1.32 113.485 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.618 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.5 mt-10 -87.6 -54.22 4.38 Favored 'General case' 0 N--CA 1.422 -1.839 0 O-C-N 120.444 -1.41 . . . . 2.06 108.994 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.762 ' SD ' HD23 ' A' ' 173' ' ' LEU . 2.1 tpp -59.76 -16.36 27.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.767 -1.56 . . . . 3.13 111.147 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 122' ' ' ASN . 15.0 p -43.81 -41.24 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 122.185 0.993 . . . . 0.37 110.228 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.535 ' HG2' ' HA ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -65.3 -42.54 92.96 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.927 -1.488 . . . . 0.63 113.031 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.643 HD23 HD23 ' A' ' 128' ' ' LEU . 0.8 OUTLIER -50.82 -33.88 25.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.814 0.816 . . . . 1.79 110.595 169.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 124' ' ' MET . 20.2 mt -84.6 -35.87 22.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.553 -1.203 . . . . 0.38 109.654 -171.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.36 -24.95 63.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.483 -1.235 . . . . 1.96 110.31 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -76.41 -42.13 45.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.504 -1.225 . . . . 0.64 110.924 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.697 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.4 t -87.11 1.31 53.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 123.531 1.634 . . . . 0.59 107.32 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 46.39 51.98 11.11 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 110.924 -2.853 . . . . 1.8 112.249 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.632 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.9 t80 -135.31 176.5 8.62 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.478 0.548 . . . . 0.52 112.478 -172.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.542 ' HD3' ' N ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -140.21 142.06 35.88 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.947 -1.501 . . . . 4.54 106.947 177.069 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.597 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 14.6 tm0? -48.98 142.16 6.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.26 1.208 . . . . 1.28 114.26 -168.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.725 HG23 HG22 ' A' ' 146' ' ' THR . 3.1 m -125.5 155.62 34.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.779 -2.01 . . . . 1.05 110.953 -176.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -61.36 -35.74 78.29 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.737 1.256 . . . . 1.38 108.446 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 5.6 tmmm? -159.87 133.18 6.94 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.65 -2.068 . . . . 1.44 109.816 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.565 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.34 135.86 54.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.577 -1.192 . . . . 0.9 111.31 -177.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.719 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -161.57 97.89 1.1 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.668 1.223 . . . . 0.61 110.718 149.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.719 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.07 161.73 20.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 112.7 -2.045 . . . . 1.77 106.313 164.197 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.38 130.94 28.3 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.299 1.332 . . . . 0.62 111.4 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.612 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 89.88 49.3 3.38 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.306 -0.95 . . . . 0.51 112.948 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.632 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 48.7 mt-10 -141.09 178.1 7.61 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.907 0.384 . . . . 2.16 111.357 175.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.868 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 50.2 p90 -165.73 175.59 8.68 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.063 -1.088 . . . . 0.28 108.063 169.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.725 HG22 HG23 ' A' ' 136' ' ' VAL . 25.6 p -142.3 126.13 17.1 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.471 0.653 . . . . 0.42 111.169 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.597 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.7 p -125.37 109.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.235 -0.893 . . . . 0.34 109.886 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -142.61 -60.8 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.65 -0.42 . . . . 3.11 111.607 -171.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.92 -92.43 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.49 0.552 . . . . 1.65 112.49 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -104.83 -0.11 27.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.11 0.481 . . . . 1.68 111.173 -171.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 174' ' ' THR . 5.2 p -146.82 160.05 42.76 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.314 0.857 . . . . 0.37 113.314 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.617 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 60.5 mt -110.53 109.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 106.816 -1.55 . . . . 0.53 106.816 162.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.8 mp0 -89.38 175.91 7.13 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.015 -1.476 . . . . 1.13 107.015 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.636 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 25.6 ptm -168.67 154.66 6.76 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 123.496 0.498 . . . . 1.8 111.108 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.585 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 21.7 mt -127.62 110.16 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.753 -0.658 . . . . 0.43 110.309 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.815 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 28.2 mtp180 -63.87 106.39 1.0 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.186 -0.461 . . . . 3.13 110.759 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.612 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 63.6 ttt180 -71.15 147.56 93.54 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 107.617 -1.253 . . . . 6.16 107.617 170.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -47.2 125.97 11.02 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 121.235 1.29 . . . . 2.1 110.602 168.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.544 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 22.4 m-85 -128.35 132.98 48.58 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.302 -1.317 . . . . 1.83 108.448 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -95.66 76.72 3.26 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.744 1.259 . . . . 3.66 111.116 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.484 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 18.1 m-85 -115.82 139.52 25.01 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 113.614 -1.63 . . . . 3.54 108.957 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.0 Cg_exo -57.71 -31.24 91.57 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 124.472 3.448 . . . . 4.48 112.632 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -98.49 -7.83 27.74 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.786 -1.097 . . . . 5.26 111.108 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.1 m -159.88 98.72 1.35 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.446 -0.343 . . . . 3.43 111.404 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.66 97.58 2.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.597 0.713 . . . . 3.34 109.717 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -146.42 -175.29 4.72 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.873 -1.058 . . . . 3.14 110.894 -173.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.37 173.49 54.87 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 114.264 -1.335 . . . . 1.11 112.14 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.815 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.6 tt0 -62.49 152.73 33.75 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.41 -1.395 . . . . 1.86 113.502 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 50.1 t -154.37 133.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.689 -1.141 . . . . 0.41 109.519 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 154' ' ' MET . 8.5 mtm180 -91.12 115.16 27.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.814 0.34 . . . . 2.8 110.399 169.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.04 145.39 43.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.812 0.815 . . . . 0.29 111.353 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.761 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.2 tpt180 -111.49 98.66 7.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.838 -1.528 . . . . 1.71 110.501 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.762 HD23 ' SD ' ' A' ' 124' ' ' MET . 4.5 mp -91.76 94.48 9.37 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.247 -0.279 . . . . 0.69 110.247 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -98.1 126.26 43.47 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.438 1.114 . . . . 0.26 111.653 -171.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.2 m-85 -89.82 138.34 31.57 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 112.859 -1.973 . . . . 0.72 111.07 -177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.9 t70 -79.39 64.49 4.29 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.027 -1.842 . . . . 1.09 106.027 160.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.7 -98.37 1.05 Allowed Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 118.879 -1.629 . . . . 0.47 110.713 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -79.14 -24.8 43.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.023 0.749 . . . . 0.83 113.023 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 118' ' ' THR . 1.9 p80 -134.68 129.99 35.63 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.951 -0.7 . . . . 1.21 110.844 -169.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.27 128.15 27.13 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.743 -1.572 . . . . 0.64 110.546 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.23 -41.48 5.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.492 -0.776 . . . . 0.29 110.486 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.1 p -145.49 166.86 24.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.226 -0.443 . . . . 0.33 110.921 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 115' ' ' PRO . 39.5 mt -136.18 145.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.108 -1.812 . . . . 0.76 106.108 169.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 45.0 t -137.26 140.17 42.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.277 0.56 . . . . 0.35 110.186 -174.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.485 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.1 t-20 -81.13 100.97 9.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.733 -1.21 . . . . 1.77 107.733 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.551 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 49.3 mtm -64.27 -2.76 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.403 0.89 . . . . 0.55 113.403 -164.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.461 ' HG3' ' OD1' ' A' ' 188' ' ' ASN . 10.9 pt-20 -91.92 -40.06 11.36 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.812 0.815 . . . . 1.02 111.225 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 187' ' ' GLU . 5.8 m-20 -105.78 -25.36 12.22 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.449 -1.251 . . . . 1.4 109.495 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 73.86 33.91 0.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 112.429 -2.169 . . . . 1.33 108.041 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 3.9 ptm180 -93.33 161.88 14.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.03 -1.441 . . . . 2.28 110.082 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.3 140.84 29.13 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.542 -1.208 . . . . 1.36 113.518 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.624 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 8.8 m-85 -106.44 -166.02 1.14 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.834 -1.984 . . . . 1.18 107.286 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.568 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.99 -6.73 3.46 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 107.83 -2.108 . . . . 1.28 107.83 -149.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -154.71 112.61 3.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.878 -1.161 . . . . 2.8 111.507 157.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.708 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t80 -129.18 101.6 6.09 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.702 -0.799 . . . . 0.6 109.965 162.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -100.06 128.75 46.1 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.03 -1.044 . . . . 4.77 111.948 -171.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.436 ' CD1' HD12 ' A' ' 127' ' ' LEU . 8.9 mt -107.76 171.27 7.49 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.174 -0.466 . . . . 1.61 111.129 173.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -116.28 97.68 50.13 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.727 -0.842 . . . . 2.66 108.727 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -46.49 118.52 2.6 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.503 2.802 . . . . 2.01 115.253 -168.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 125.35 1.46 . . . . 5.19 110.166 170.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.658 ' N ' ' HG ' ' A' ' 90' ' ' SER . 23.1 ptt? . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 111.382 0.141 . . . . 26.27 111.382 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.06 -93.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 24.15 111.966 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.6 t -82.62 63.8 6.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.385 0.612 . . . . 23.64 109.674 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.658 ' HG ' ' N ' ' A' ' 87' ' ' MET . 17.1 m -112.28 20.0 17.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.997 -0.547 . . . . 22.83 111.478 -175.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -107.75 96.03 6.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.078 0.466 . . . . 22.11 110.252 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -81.85 135.05 35.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.571 -0.529 . . . . 22.07 109.571 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -75.55 105.89 6.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.37 -0.377 . . . . 20.59 110.161 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -138.23 38.4 2.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.005 0.431 . . . . 18.44 111.139 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -142.33 152.59 43.09 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.756 -0.461 . . . . 17.98 109.756 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -55.41 107.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.528 0.518 . . . . 17.87 110.163 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.2 m -97.84 126.31 43.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.817 -0.629 . . . . 16.77 111.213 -174.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.8 m -143.52 158.66 43.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.532 -0.758 . . . . 16.32 109.28 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' HA3' ' HG2' ' A' ' 102' ' ' PRO . . . -158.23 152.83 24.02 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.159 -1.02 . . . . 14.63 112.736 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.0 tp -79.47 -46.0 18.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.086 0.47 . . . . 15.68 110.023 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.505 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 51.3 t -90.36 -53.15 0.31 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.711 -0.677 . . . . 12.69 111.035 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 61.9 Cg_endo -75.28 55.76 4.2 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.908 1.739 . . . . 12.08 111.685 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -83.71 91.98 7.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.641 -0.709 . . . . 12.18 110.371 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -173.77 -146.7 5.66 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.383 -0.687 . . . . 8.55 111.383 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.2 m 72.89 -44.19 0.59 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.627 0.771 . . . . 8.07 111.606 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -83.28 43.1 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.989 0.423 . . . . 7.76 111.121 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 93.0 mmm -117.87 138.06 52.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.043 -0.526 . . . . 6.12 110.139 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 123' ' ' GLU . . . 86.29 -32.53 3.83 Favored Glycine 0 C--O 1.22 -0.748 0 CA-C-N 116.039 -0.528 . . . . 1.91 113.122 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.55 ' NH1' HG21 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -53.08 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.824 0.85 . . . . 4.32 111.263 175.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.649 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 48.2 tpp -143.63 138.78 29.24 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.361 -0.536 . . . . 2.59 110.961 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -126.77 104.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.374 1.083 . . . . 0.74 113.059 177.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -158.85 107.76 1.92 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 112.962 -1.926 . . . . 1.38 106.177 167.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 6.6 mt -91.3 100.62 13.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.5 -0.48 . . . . 1.33 110.111 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -150.34 109.44 3.19 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.377 0.608 . . . . 1.93 109.677 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.858 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 10.6 Cg_exo -34.77 146.3 0.05 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.849 1 C-N-CA 126.876 5.05 . . . . 0.65 115.43 -173.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.57 39.61 2.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.089 -1.414 . . . . 0.72 109.019 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.59 ' HE1' HD22 ' A' ' 113' ' ' LEU . 10.5 ptt? -117.57 154.37 31.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.655 -1.157 . . . . 1.67 109.485 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.1 m -101.81 79.33 1.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.152 0.977 . . . . 0.58 108.599 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.755 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -97.1 156.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 113.936 -1.484 . . . . 0.65 109.384 -171.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 124' ' ' MET . 10.8 m -141.95 174.15 10.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.156 -0.683 . . . . 0.44 109.156 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.641 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 35.2 mtpt -49.43 -33.49 14.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.38 0.609 . . . . 2.33 110.175 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.603 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 63.0 t30 -84.49 -16.18 43.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.335 1.235 . . . . 1.32 114.335 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.649 ' CG ' ' HB3' ' A' ' 110' ' ' MET . 6.2 tt0 -86.31 -60.53 1.97 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.374 -1.453 . . . . 2.06 107.894 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.79 ' SD ' HD21 ' A' ' 128' ' ' LEU . 0.5 OUTLIER -54.7 -17.59 3.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.457 -1.701 . . . . 3.13 111.105 173.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 13.7 p -42.35 -40.57 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-O 122.018 0.914 . . . . 0.37 110.34 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.636 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.7 -42.72 81.55 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.129 -1.396 . . . . 0.63 113.699 177.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.67 HD12 HD23 ' A' ' 128' ' ' LEU . 2.8 tm? -50.86 -34.78 29.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.568 0.699 . . . . 1.79 110.359 168.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 ' SD ' ' A' ' 124' ' ' MET . 7.3 mt -85.36 -34.86 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.568 -0.742 . . . . 0.38 110.143 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.29 -25.77 66.21 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.154 -1.385 . . . . 1.96 110.778 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -77.38 -45.39 26.11 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.978 -1.464 . . . . 0.64 111.272 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.97 -5.99 46.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 123.637 1.684 . . . . 0.59 107.471 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.54 55.34 5.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 110.983 -2.826 . . . . 1.8 112.464 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.724 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.5 t80 -132.15 176.38 8.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.853 0.686 . . . . 0.52 112.853 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.415 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 58.2 ttt180 -142.86 141.57 31.6 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.949 -1.5 . . . . 4.54 106.949 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -49.04 144.79 4.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 115.627 1.714 . . . . 1.28 115.627 -165.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 146' ' ' THR . 3.1 m -129.51 162.67 36.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 112.223 -2.262 . . . . 1.05 110.862 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -73.0 -35.55 66.84 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.591 -1.263 . . . . 1.38 107.591 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -145.46 124.84 13.06 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 112.795 -2.002 . . . . 1.44 110.513 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.581 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -117.93 128.87 55.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.093 -1.412 . . . . 0.9 110.047 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 96.03 1.68 Allowed 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.044 1.402 . . . . 0.61 109.364 155.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.586 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -167.61 161.26 10.16 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 111.979 -2.373 . . . . 1.77 105.771 167.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.19 126.32 9.77 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.675 1.583 . . . . 0.62 111.865 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 103.43 19.41 12.41 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 119.904 -1.141 . . . . 0.51 112.328 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.724 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 13.4 mp0 -128.33 173.19 10.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.661 0.267 . . . . 2.16 110.682 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.841 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 54.9 p90 -165.9 175.85 8.31 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.707 -1.22 . . . . 0.28 107.707 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.867 HG22 HG23 ' A' ' 136' ' ' VAL . 3.5 p -138.1 132.59 32.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 120.227 -0.589 . . . . 0.42 110.823 170.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 135' ' ' GLN . 14.6 p -124.14 109.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 122.347 1.07 . . . . 0.34 111.813 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -99.18 -74.99 0.57 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.523 -1.217 . . . . 3.11 109.313 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.62 -46.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.016 -0.993 . . . . 1.65 109.328 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.36 -11.42 57.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.408 -0.814 . . . . 1.68 111.236 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 14.6 p -158.89 152.28 22.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.125 0.964 . . . . 0.37 112.829 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.611 HG21 ' SD ' ' A' ' 124' ' ' MET . 68.5 mt -116.59 113.72 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 112.977 -1.92 . . . . 0.53 107.554 164.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -92.88 165.56 12.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.565 -1.643 . . . . 1.13 106.565 173.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.626 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 14.5 ptp -166.37 151.43 8.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 123.835 0.71 . . . . 1.8 110.764 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.688 HG12 ' HG3' ' A' ' 170' ' ' ARG . 7.5 mt -129.63 110.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.65 -0.705 . . . . 0.43 110.265 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 33.7 mtp180 -68.2 101.26 1.14 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.483 -0.487 . . . . 3.13 110.354 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.571 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 50.1 ttt180 -54.44 146.56 32.68 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 107.052 -1.462 . . . . 6.16 107.052 166.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -70.89 124.75 10.9 Favored 'Trans proline' 0 N--CA 1.432 -2.146 0 CA-C-N 120.316 1.148 . . . . 2.1 109.23 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 17.5 m-85 -118.19 163.1 17.15 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.126 -1.397 . . . . 1.83 108.396 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -110.9 76.93 1.0 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.27 1.033 . . . . 3.66 111.239 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 34.2 m-85 -116.5 147.85 40.56 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 114.153 -1.385 . . . . 3.54 110.354 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 31.8 Cg_exo -59.04 -31.95 96.57 Favored 'Trans proline' 0 CA--C 1.501 -1.146 0 C-N-CA 125.009 3.806 . . . . 4.48 113.651 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -95.44 -13.53 24.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.23 -0.896 . . . . 5.26 111.008 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.439 ' HB2' ' OD1' ' A' ' 198' ' ' ASP . 21.5 m -157.67 103.09 1.9 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.989 -0.55 . . . . 3.43 111.574 -172.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -147.11 86.38 1.63 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.894 0.854 . . . . 3.34 109.022 173.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.08 -170.3 3.59 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.208 -1.36 . . . . 3.14 111.11 -173.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -70.72 155.36 52.86 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.879 -0.601 . . . . 1.11 112.624 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.569 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -60.63 164.4 4.63 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.632 -0.784 . . . . 1.86 112.715 -178.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 95.4 t -151.86 127.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.179 -0.918 . . . . 0.41 110.089 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.688 ' HG3' HG12 ' A' ' 155' ' ' ILE . 3.7 mtm180 -85.77 115.46 23.43 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.468 -0.787 . . . . 2.8 110.262 169.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 153' ' ' GLU . . . -116.44 139.8 50.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.313 -0.955 . . . . 0.29 111.591 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.751 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 13.2 tpt180 -104.48 98.57 8.32 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.982 -1.463 . . . . 1.71 110.781 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 151' ' ' SER . 8.3 mp -88.16 103.25 15.58 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.237 -0.283 . . . . 0.69 110.237 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.21 119.57 39.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.4 1.095 . . . . 0.26 111.675 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.548 ' CZ ' HG23 ' A' ' 119' ' ' ILE . 2.0 m-85 -83.31 140.6 32.37 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 112.955 -1.93 . . . . 0.72 111.147 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.7 t70 -80.23 65.2 5.3 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.065 -1.828 . . . . 1.09 106.065 159.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.84 -97.99 1.27 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 118.572 -1.775 . . . . 0.47 110.697 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.87 -25.38 40.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.032 0.753 . . . . 0.83 113.032 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -132.81 129.69 38.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.972 0.891 . . . . 1.21 111.726 -167.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.755 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.0 tm? -51.07 120.59 5.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.872 -1.967 . . . . 0.64 109.868 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -106.14 -37.25 6.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.764 -0.653 . . . . 0.29 110.63 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.411 ' C ' HG13 ' A' ' 183' ' ' ILE . 17.7 p -143.88 164.38 30.73 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.102 -0.499 . . . . 0.33 110.742 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.751 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 21.1 mt -138.93 143.97 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 105.831 -1.914 . . . . 0.76 105.831 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 30.3 t -132.79 135.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.946 0.403 . . . . 0.35 110.472 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.535 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 1.8 m120 -76.24 101.1 5.29 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 107.131 -1.433 . . . . 1.77 107.131 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.628 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 41.1 mtm -67.38 -1.41 4.71 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.34 0.59 . . . . 0.55 111.654 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 16.9 pt-20 -73.85 -43.96 57.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.193 -0.912 . . . . 1.02 110.988 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -113.26 -25.67 8.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.228 -1.351 . . . . 1.4 109.367 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 75.53 36.47 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.179 -2.282 . . . . 1.33 107.858 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 185' ' ' ASN . 12.2 ptt180 -97.33 170.7 8.9 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 114.167 -1.379 . . . . 2.28 108.819 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -86.05 144.92 27.3 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.433 1.111 . . . . 1.36 113.916 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.572 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -116.91 -166.79 1.2 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 105.222 -2.14 . . . . 1.18 105.222 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.858 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 136.19 8.19 1.62 Allowed Glycine 0 N--CA 1.412 -2.934 0 N-CA-C 109.994 -1.242 . . . . 1.28 109.994 -160.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.433 ' HB2' ' NH1' ' A' ' 196' ' ' ARG . 20.7 p90 -152.39 101.95 2.71 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.151 -1.525 . . . . 2.8 110.438 151.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.725 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 3.9 t80 -118.45 99.75 7.03 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.892 -0.781 . . . . 0.6 108.892 168.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.433 ' NH1' ' HB2' ' A' ' 194' ' ' PHE . 1.4 mpt_? -100.62 123.06 44.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 4.77 111.33 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -93.1 172.57 8.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.336 1.606 . . . . 1.61 115.336 -170.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 164' ' ' SER . 13.9 m-20 -92.71 118.74 68.07 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 112.813 -1.994 . . . . 2.66 110.031 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.693 ' O ' ' HD3' ' A' ' 200' ' ' ARG . 82.5 Cg_exo -45.25 127.74 9.26 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 124.466 3.444 . . . . 2.01 114.924 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.693 ' HD3' ' O ' ' A' ' 199' ' ' PRO . 13.2 mmt180 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.395 -0.812 . . . . 5.19 109.729 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.635 0.255 . . . . 26.27 111.009 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.81 -25.61 7.91 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.972 -0.632 . . . . 24.15 111.664 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 t -88.3 100.3 12.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.752 -0.462 . . . . 23.64 109.752 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.5 t -88.01 -24.61 23.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.038 -0.528 . . . . 22.83 110.637 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.5 m80 65.19 32.64 9.94 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.407 -0.815 . . . . 22.11 110.805 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -109.25 137.23 47.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 22.07 110.726 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 62.16 89.77 0.08 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 124.034 0.834 . . . . 20.59 111.184 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -69.29 122.92 19.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.244 -0.651 . . . . 18.44 109.244 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 98' ' ' SER . 2.4 t-160 -65.11 -19.73 66.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.181 -0.463 . . . . 17.98 111.092 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t60 69.35 -85.56 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.51 0.724 . . . . 17.87 112.034 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.0 m -71.97 -43.54 64.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.244 0.545 . . . . 16.77 110.235 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 95' ' ' HIS . 19.4 t -99.91 -175.99 3.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.923 -0.769 . . . . 16.32 108.923 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.27 -132.19 2.53 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.127 -0.789 . . . . 14.63 111.127 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.71 168.75 14.95 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.595 -0.52 . . . . 15.68 109.595 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.565 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 95.4 t -73.26 -53.93 4.51 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 120.91 -0.316 . . . . 12.69 111.786 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 11.2 Cg_exo -70.72 124.31 10.57 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.698 1.599 . . . . 12.08 111.562 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -107.72 114.08 27.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.456 -0.338 . . . . 12.18 110.245 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.84 -170.86 39.03 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.964 -0.636 . . . . 8.55 111.864 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.7 t -68.13 -22.13 64.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.88 0.371 . . . . 8.07 110.43 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -92.48 107.71 19.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.335 -0.393 . . . . 7.76 110.219 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 89.2 mtp -64.57 -36.27 83.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.176 0.512 . . . . 6.12 110.298 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.33 3.37 89.84 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-N 115.322 -0.853 . . . . 1.91 112.743 175.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 22.4 mtt180 -136.62 78.71 1.72 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.361 -1.348 . . . . 4.32 107.361 173.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.804 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.3 tpt -143.58 118.06 9.71 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 114.162 1.171 . . . . 2.59 114.162 -160.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 127' ' ' LEU . 0.8 OUTLIER -104.19 109.29 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 C-N-CA 119.246 -0.982 . . . . 0.74 112.681 179.164 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -155.03 109.82 3.0 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.146 -1.798 . . . . 1.38 106.146 167.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.1 mp -98.33 113.69 25.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.596 -0.89 . . . . 1.33 108.596 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 15.1 tt0 -146.09 108.99 4.3 Favored Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.732 -0.787 . . . . 1.93 109.79 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HG3' HG12 ' A' ' 183' ' ' ILE . 33.3 Cg_exo -35.76 130.83 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.407 0 C-N-CA 124.903 3.735 . . . . 0.65 114.473 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 73.71 45.47 0.24 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 122.403 1.097 . . . . 0.72 110.624 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.484 ' HE3' ' HB3' ' A' ' 114' ' ' GLU . 6.1 ptp -121.28 158.57 27.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.286 -1.324 . . . . 1.67 111.416 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 m -102.29 100.14 10.29 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.779 -0.823 . . . . 0.58 108.779 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.596 HG21 ' HE1' ' A' ' 124' ' ' MET . 12.2 tt -137.93 169.3 18.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.97 -1.013 . . . . 0.65 109.577 -167.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.533 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.5 m -139.88 175.33 9.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.821 0.737 . . . . 0.44 111.45 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.679 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -20.6 63.02 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.49 -0.929 . . . . 2.33 108.49 167.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.759 ' O ' HG12 ' A' ' 125' ' ' VAL . 6.3 t30 -83.17 -22.64 33.19 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 113.979 -1.464 . . . . 1.32 112.475 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.804 ' HA ' ' H ' ' A' ' 110' ' ' MET . 1.1 mp0 -84.28 -50.01 8.25 Favored 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 120.025 -1.672 . . . . 2.06 107.923 173.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.764 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -61.67 -18.51 59.83 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.511 -1.222 . . . . 3.13 111.268 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.1 p -47.28 -41.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.114 0.959 . . . . 0.37 110.808 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.536 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.2 mmpt? -69.93 -36.97 75.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.323 -1.308 . . . . 0.63 112.771 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.732 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.4 tm? -55.42 -33.88 63.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.686 0.755 . . . . 1.79 110.27 167.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.764 ' HG ' ' O ' ' A' ' 124' ' ' MET . 17.4 mt -84.36 -32.6 24.14 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.95 0.881 . . . . 0.38 109.189 -172.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.98 -39.43 89.57 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.901 -1.499 . . . . 1.96 110.219 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 200' ' ' ARG . . . -70.5 -43.19 70.2 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.524 -1.671 . . . . 0.64 112.283 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.49 3.9 54.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 124.538 2.113 . . . . 0.59 106.281 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 130' ' ' ALA . 17.9 mt-30 52.35 49.16 21.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 110.262 -3.154 . . . . 1.8 112.679 168.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.981 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -139.24 175.74 9.3 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.759 -0.776 . . . . 0.52 112.778 -172.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.41 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 79.6 ttt180 -138.69 155.11 48.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.558 -1.275 . . . . 4.54 107.558 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.492 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.17 141.36 8.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.427 1.108 . . . . 1.28 113.375 -168.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.834 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.3 p -143.39 135.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.033 -1.894 . . . . 1.05 109.931 -164.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -33.52 70.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.233 1.016 . . . . 1.38 109.475 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -151.8 121.57 7.01 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 113.109 -1.86 . . . . 1.44 109.697 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.594 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -111.09 122.75 48.68 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.188 -1.369 . . . . 0.9 110.855 -177.469 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.3 OUTLIER -158.94 97.16 1.39 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.824 1.297 . . . . 0.61 109.769 161.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.446 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -166.65 165.2 9.95 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.508 -2.133 . . . . 1.77 106.127 161.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 157' ' ' ARG . 27.8 Cg_exo -62.61 116.74 3.72 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 120.973 1.115 . . . . 0.62 109.885 167.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.42 47.25 3.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.834 -1.174 . . . . 0.51 113.424 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.981 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.3 mt-10 -142.41 147.96 37.04 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.769 -0.826 . . . . 2.16 108.769 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.855 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 35.5 p90 -152.59 159.22 43.26 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.432 -0.951 . . . . 0.28 108.432 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.704 HG22 HG13 ' A' ' 136' ' ' VAL . 3.6 p -126.95 127.66 45.19 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.92 -0.712 . . . . 0.42 110.954 175.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.629 HG23 HG12 ' A' ' 152' ' ' ILE . 8.6 p -111.81 110.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.908 0.861 . . . . 0.34 111.322 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -113.65 16.01 18.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.909 -1.041 . . . . 3.11 110.738 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.65 -50.05 0.7 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.81 0.694 . . . . 1.65 111.28 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -81.88 -5.21 58.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.13 0.49 . . . . 1.68 110.175 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -166.39 144.87 5.53 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.444 -0.798 . . . . 0.37 112.073 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.679 HD11 ' HA ' ' A' ' 121' ' ' LYS . 37.2 mt -116.1 112.47 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.279 -1.328 . . . . 0.53 107.684 164.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.855 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 65.7 mt-10 -90.82 163.54 14.39 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.373 -2.084 . . . . 1.13 105.373 175.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.506 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 24.0 ptm -167.83 154.27 7.76 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.524 0.515 . . . . 1.8 110.514 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.586 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 36.2 mt -129.08 115.25 35.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.982 -0.554 . . . . 0.43 110.797 166.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.652 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 74.7 mtp180 -62.28 106.66 0.77 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.646 . . . . 3.13 110.539 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.548 ' HA ' ' HB3' ' A' ' 142' ' ' PRO . 73.5 ttt180 -69.88 140.47 88.87 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 106.828 -1.545 . . . . 6.16 106.828 164.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -48.12 125.13 11.3 Favored 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 121.309 1.339 . . . . 2.1 111.432 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 9.3 m-85 -128.63 123.41 33.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.824 -1.534 . . . . 1.83 107.248 176.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.05 74.17 5.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.444 1.116 . . . . 3.66 111.653 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.495 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 99.3 m-85 -122.03 142.89 37.5 Favored Pre-proline 0 C--N 1.306 -1.323 0 CA-C-N 113.904 -1.498 . . . . 3.54 110.076 172.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 37.7 Cg_exo -56.62 -32.45 90.41 Favored 'Trans proline' 0 CA--C 1.499 -1.251 0 C-N-CA 124.837 3.691 . . . . 4.48 113.494 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -81.2 -23.7 37.97 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.041 -0.981 . . . . 5.26 111.333 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 66.6 m -156.32 98.29 1.83 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.625 -0.716 . . . . 3.43 110.105 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -148.63 87.13 1.55 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.003 0.906 . . . . 3.34 110.077 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -134.36 -171.43 2.76 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.065 -1.425 . . . . 3.14 109.009 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.61 174.81 55.1 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 119.774 -1.203 . . . . 1.11 110.974 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 9.5 tt0 -58.25 148.78 26.09 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 114.268 -0.966 . . . . 1.86 111.938 173.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 70.0 t -151.93 128.89 2.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.091 -0.959 . . . . 0.41 109.191 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.746 ' HG2' ' CE ' ' A' ' 186' ' ' MET . 32.6 ttp180 -92.63 102.3 14.72 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.114 -0.948 . . . . 2.8 108.518 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.46 147.9 36.97 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.821 0.82 . . . . 0.29 111.859 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.536 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 10.1 tpt180 -114.36 100.68 8.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.929 -1.487 . . . . 1.71 110.318 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.666 HD21 HD21 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -88.87 96.03 10.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.736 -0.839 . . . . 0.69 108.736 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 117.38 31.67 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.125 0.964 . . . . 0.26 111.316 -171.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.724 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -89.88 135.74 33.46 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.225 -1.807 . . . . 0.72 110.487 -179.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -78.95 65.67 4.2 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.362 -1.718 . . . . 1.09 106.362 164.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.3 -99.32 1.18 Allowed Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 118.986 -1.578 . . . . 0.47 110.61 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.46 -24.86 42.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 113.075 0.768 . . . . 0.83 113.075 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -131.27 129.08 41.09 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.299 -0.96 . . . . 1.21 110.934 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.724 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.3 tt -53.14 129.32 30.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.457 -1.701 . . . . 0.64 110.049 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.68 -37.75 6.33 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.591 -0.731 . . . . 0.29 110.189 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.7 p -148.12 165.04 32.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.092 -0.504 . . . . 0.33 111.422 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.591 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.7 mm -117.53 149.01 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 105.226 -2.138 . . . . 0.76 105.226 163.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -138.89 128.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.461 0.648 . . . . 0.35 110.065 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.475 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 34.1 t-20 -80.97 102.84 10.4 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.829 -1.174 . . . . 1.77 107.829 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.746 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 38.0 mtm -66.35 -0.73 2.82 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 113.053 0.76 . . . . 0.55 113.053 -166.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 10.7 pt-20 -79.33 -40.95 29.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.127 0.965 . . . . 1.02 111.018 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.493 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 67.6 m-20 -112.27 -26.31 8.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.148 -1.387 . . . . 1.4 109.484 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 78.2 32.15 0.36 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.611 -2.086 . . . . 1.33 107.872 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 0.1 OUTLIER -91.43 164.55 13.78 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 113.471 -1.695 . . . . 2.28 109.119 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 76.1 mt-30 -85.05 136.02 33.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.491 -0.777 . . . . 1.36 110.132 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.591 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -107.3 90.99 3.47 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 118.86 -0.591 . . . . 1.18 110.177 -175.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.44 -59.2 0.0 OUTLIER Glycine 0 N--CA 1.47 0.91 0 C-N-CA 125.039 1.304 . . . . 1.28 116.268 147.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.445 ' HD2' ' NH1' ' A' ' 196' ' ' ARG . 0.3 OUTLIER -164.86 171.55 14.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.879 -1.661 . . . . 2.8 108.125 174.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -140.36 130.03 24.31 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.356 0.526 . . . . 0.6 109.66 162.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.645 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -120.43 130.53 54.38 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.667 -0.646 . . . . 4.77 110.659 -170.19 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.732 HD13 ' HG ' ' A' ' 127' ' ' LEU . 68.1 mt -136.55 171.37 14.59 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.799 1.037 . . . . 1.61 113.799 -166.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 199' ' ' PRO . 33.8 t70 -109.51 99.81 38.98 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 114.415 -1.266 . . . . 2.66 110.451 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 198' ' ' ASP . 10.5 Cg_endo -56.68 130.43 39.91 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.483 2.122 . . . . 2.01 112.999 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 130' ' ' ALA . 68.5 mtt85 . . . . . 0 C--O 1.242 0.703 0 CA-C-N 115.388 -0.824 . . . . 5.19 111.436 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.8 ptm . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.236 -0.283 . . . . 26.27 110.236 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.92 159.48 9.4 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.864 -0.684 . . . . 24.15 112.024 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.8 m 55.81 63.94 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 23.64 111.158 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.3 m -63.35 132.41 51.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 22.83 110.259 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -118.86 145.23 45.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.822 0.344 . . . . 22.11 110.587 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -79.11 88.36 4.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.97 -0.559 . . . . 22.07 110.631 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -88.23 37.66 0.82 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.034 -0.53 . . . . 20.59 110.734 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 69.2 m80 69.86 90.83 0.09 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.275 -0.875 . . . . 18.44 112.683 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -87.09 -23.44 24.9 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.336 -0.616 . . . . 17.98 109.336 170.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -136.84 178.45 7.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.41 -0.814 . . . . 17.87 109.971 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.1 t -76.46 121.81 23.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.652 -0.499 . . . . 16.77 109.652 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.9 p -69.53 82.2 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.404 0.621 . . . . 16.32 111.162 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.08 -25.54 0.7 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.416 -0.811 . . . . 14.63 111.645 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -97.09 8.86 43.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.676 0.274 . . . . 15.68 110.732 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 58.0 t -65.88 118.56 53.16 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.85 -0.614 . . . . 12.69 110.375 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 101' ' ' VAL . 26.1 Cg_exo -62.14 161.64 25.81 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.082 2.521 . . . . 12.08 112.195 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -67.39 96.11 0.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 12.18 110.333 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.85 -11.84 70.32 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.486 -0.779 . . . . 8.55 111.675 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.2 m 64.02 -74.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.505 0.722 . . . . 8.07 111.018 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -137.09 87.92 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.949 -0.76 . . . . 7.76 108.949 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.402 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 59.7 mtt -73.39 -79.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.095 0.474 . . . . 6.12 110.825 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.67 -31.32 5.9 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-O 118.774 -1.015 . . . . 1.91 112.989 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 13.3 mtm180 14.15 80.74 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.922 1.289 . . . . 4.32 112.711 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.594 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 24.9 ttt -141.82 135.54 29.72 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.493 -0.776 . . . . 2.59 111.974 -168.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 ' HE1' ' A' ' 124' ' ' MET . 2.0 m -118.18 106.4 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 122.268 1.032 . . . . 0.74 112.953 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -160.1 106.73 1.59 Allowed 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 105.749 -1.945 . . . . 1.38 105.749 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.837 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 3.5 mp -97.13 111.41 23.66 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.474 -0.935 . . . . 1.33 108.474 -173.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 117' ' ' MET . 21.0 tt0 -143.72 107.38 5.05 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-N 114.963 -1.017 . . . . 1.93 110.549 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.509 ' HD3' HD12 ' A' ' 183' ' ' ILE . 29.5 Cg_exo -36.75 129.03 0.49 Allowed 'Trans proline' 0 CA--C 1.515 -0.427 0 C-N-CA 124.476 3.451 . . . . 0.65 113.427 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.9 t70 75.41 50.1 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.685 1.231 . . . . 0.72 109.768 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.649 ' HE3' HD13 ' A' ' 180' ' ' LEU . 13.1 ptt? -122.47 157.24 32.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 113.789 -1.551 . . . . 1.67 110.116 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.3 m -100.01 113.9 26.81 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.299 -1.0 . . . . 0.58 108.299 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -142.75 159.84 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 116.046 -0.524 . . . . 0.65 111.457 -165.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.483 ' H ' HG13 ' A' ' 119' ' ' ILE . 49.2 m -143.06 179.87 6.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.914 -0.314 . . . . 0.44 110.167 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.862 ' HG2' HG21 ' A' ' 147' ' ' VAL . 6.9 mtmp? -59.14 -28.12 66.27 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.677 -0.86 . . . . 2.33 108.677 166.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.608 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 0.2 OUTLIER -85.73 -17.34 36.19 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.996 -1.456 . . . . 1.32 114.446 -178.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.594 ' HG3' ' HB3' ' A' ' 110' ' ' MET . 1.2 tp10 -84.39 -62.28 1.6 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.498 -1.297 . . . . 2.06 107.498 169.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.843 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 14.8 mmt -57.82 -15.81 9.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.627 -2.078 . . . . 3.13 111.765 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 14.6 p -43.19 -41.88 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 122.176 0.989 . . . . 0.37 110.191 175.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.737 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -69.27 -41.58 76.67 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.047 -1.433 . . . . 0.63 113.224 177.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.778 HD23 HD23 ' A' ' 128' ' ' LEU . 1.1 tt -49.41 -34.3 16.07 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.528 0.68 . . . . 1.79 111.387 167.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.843 ' HG ' ' O ' ' A' ' 124' ' ' MET . 13.9 mt -85.43 -32.53 22.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.158 -0.928 . . . . 0.38 108.824 -171.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.63 -36.53 84.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.11 -1.405 . . . . 1.96 109.814 167.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.7 -42.91 63.7 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.871 -1.513 . . . . 0.64 111.977 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -5.84 56.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 123.648 1.689 . . . . 0.59 106.991 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 58.33 55.51 4.97 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 110.761 -2.927 . . . . 1.8 112.473 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.665 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 3.2 t80 -139.56 176.73 8.48 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 113.126 0.787 . . . . 0.52 113.126 -177.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 145' ' ' PHE . 14.1 ptm180 -142.19 150.34 40.89 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.091 -1.078 . . . . 4.54 108.091 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 15.0 tm0? -50.37 143.37 8.94 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.802 1.408 . . . . 1.28 114.802 -166.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.835 HG23 HG22 ' A' ' 146' ' ' THR . 1.3 m -125.65 159.52 33.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 112.805 -1.998 . . . . 1.05 111.875 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -63.31 -35.79 81.52 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.68 1.229 . . . . 1.38 108.089 169.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 139' ' ' MET . 2.3 ttpt -159.34 132.98 7.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.348 -2.205 . . . . 1.44 109.521 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.589 ' HB2' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -118.6 135.42 54.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.262 -0.881 . . . . 0.9 111.199 176.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.569 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -156.9 97.61 1.7 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.954 1.359 . . . . 0.61 108.892 152.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.569 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -166.12 161.59 12.63 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 112.207 -2.27 . . . . 1.77 106.1 168.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.559 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 62.8 Cg_endo -75.67 128.17 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.209 1.273 . . . . 0.62 111.979 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.626 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 99.3 23.29 11.4 Favored Glycine 0 C--N 1.351 1.4 0 C-N-CA 119.975 -1.107 . . . . 0.51 112.35 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.665 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 15.4 mp0 -128.79 172.34 11.37 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.75 -0.463 . . . . 2.16 109.75 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.882 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.9 p90 -163.06 175.11 11.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.237 -1.023 . . . . 0.28 108.237 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.835 HG22 HG23 ' A' ' 136' ' ' VAL . 8.0 p -141.96 126.59 17.93 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 120.11 -0.636 . . . . 0.42 111.598 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.862 HG21 ' HG2' ' A' ' 121' ' ' LYS . 12.4 p -125.56 110.07 23.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.709 0.766 . . . . 0.34 111.849 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -110.03 -58.79 2.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.734 -0.666 . . . . 3.11 110.779 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -163.36 -60.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.922 0.341 . . . . 1.65 111.922 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -92.57 4.36 53.75 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.404 0.52 . . . . 1.68 112.404 -172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.7 p -161.08 155.93 23.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.683 0.754 . . . . 0.37 112.478 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 43.7 mt -115.24 108.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.297 -1.742 . . . . 0.53 106.297 161.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.882 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.6 mp0 -90.59 163.98 14.37 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.521 -2.029 . . . . 1.13 105.521 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 8.7 ptp -165.07 154.31 12.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.83 0.706 . . . . 1.8 111.324 -171.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.675 HG12 ' HG3' ' A' ' 170' ' ' ARG . 34.6 mt -126.25 110.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.615 0.721 . . . . 0.43 111.141 170.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 0.2 OUTLIER -68.24 92.97 0.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.957 -1.474 . . . . 3.13 109.838 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.62 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 34.1 ttp180 -68.13 138.53 92.26 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 108.175 -1.046 . . . . 6.16 108.175 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -47.88 123.77 8.99 Favored 'Trans proline' 0 N--CA 1.433 -2.067 0 C-N-CA 120.95 1.1 . . . . 2.1 109.971 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 19.6 m-85 -118.79 129.75 55.41 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.945 -1.48 . . . . 1.83 107.642 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 6.6 p-10 -86.58 76.69 9.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 122.763 1.268 . . . . 3.66 111.724 -173.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 92.2 m-85 -114.53 146.87 36.83 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 113.116 -1.856 . . . . 3.54 108.899 171.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.7 Cg_exo -59.76 -33.77 96.18 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 C-N-CA 124.528 3.485 . . . . 4.48 113.348 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -86.4 -18.51 31.6 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.999 -1.0 . . . . 5.26 111.425 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.465 ' HB2' ' OD1' ' A' ' 198' ' ' ASP . 67.3 m -156.07 109.44 2.7 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.839 -0.619 . . . . 3.43 111.216 -173.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 160' ' ' ASP . 23.4 tptp -142.62 97.0 3.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.601 -0.888 . . . . 3.34 108.601 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -138.93 176.62 8.53 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.627 -1.17 . . . . 3.14 112.469 -167.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.94 149.95 31.86 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 113.93 -1.486 . . . . 1.11 112.723 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.822 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.9 tt0 -56.26 153.51 9.36 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 113.419 0.896 . . . . 1.86 113.419 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 41.3 t -152.92 131.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.727 -1.124 . . . . 0.41 109.959 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.675 ' HG3' HG12 ' A' ' 155' ' ' ILE . 5.7 ttm180 -93.39 111.74 23.48 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.82 -0.807 . . . . 2.8 108.82 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.8 141.33 47.44 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.264 -0.974 . . . . 0.29 111.429 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 5.2 tpt180 -102.45 101.31 11.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.134 -1.394 . . . . 1.71 110.665 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -91.36 96.53 10.58 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.787 -0.365 . . . . 0.69 110.055 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 117.65 31.21 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-O 122.472 1.13 . . . . 0.26 111.494 -173.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -85.88 131.84 34.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 112.632 -2.076 . . . . 0.72 109.784 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 35.8 t70 -75.91 65.85 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.716 -1.587 . . . . 1.09 106.716 164.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.71 -99.26 1.74 Allowed Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 119.104 -1.522 . . . . 0.47 110.223 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -88.54 -17.62 29.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 113.01 0.744 . . . . 0.83 113.01 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -133.28 126.62 31.86 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 119.163 -1.015 . . . . 1.21 110.693 -168.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.688 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.1 tt -52.93 129.47 30.47 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.458 -1.701 . . . . 0.64 110.629 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -38.34 6.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.992 -1.004 . . . . 0.29 109.755 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.1 p -147.72 157.69 43.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.819 -0.628 . . . . 0.33 111.245 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.8 mt -124.86 146.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.707 -1.96 . . . . 0.76 105.707 166.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 43.1 t -136.56 133.58 49.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.448 0.642 . . . . 0.35 109.947 -175.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 1.9 t-20 -79.43 94.0 5.47 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.712 -1.588 . . . . 1.77 106.712 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.572 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 47.6 mtm -66.38 -1.97 4.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.995 0.809 . . . . 0.55 113.095 -162.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.0 pt-20 -81.45 -39.29 25.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.127 0.965 . . . . 1.02 110.682 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.48 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 86.7 m-20 -108.43 -26.46 10.46 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.779 -1.555 . . . . 1.4 109.117 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.5 t30 75.48 32.02 0.74 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.338 -2.21 . . . . 1.33 108.416 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.9 ptm180 -93.73 155.22 17.36 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.197 -1.365 . . . . 2.28 109.234 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -77.7 131.19 37.59 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.909 -1.041 . . . . 1.36 108.636 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -105.63 89.53 3.12 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.469 -0.892 . . . . 1.18 110.548 -170.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -57.74 0.0 OUTLIER Glycine 0 N--CA 1.467 0.718 0 C-N-CA 125.376 1.465 . . . . 1.28 116.48 146.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.609 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 18.1 p90 -163.88 175.43 10.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.153 -1.523 . . . . 2.8 109.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.837 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.5 t80 -149.08 100.22 3.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.378 0.608 . . . . 0.6 110.445 159.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.609 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 5.2 mmm180 -95.63 141.87 28.61 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 120.628 -1.295 . . . . 4.77 111.666 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.535 ' HG ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -109.82 173.33 6.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.202 1.556 . . . . 1.61 115.202 -175.381 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.554 ' HB3' ' HD2' ' A' ' 199' ' ' PRO . 5.2 m-20 -98.19 176.75 1.87 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 112.806 -1.997 . . . . 2.66 110.559 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 198' ' ' ASP . 36.9 Cg_exo -44.91 172.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.919 3.079 . . . . 2.01 116.12 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.565 ' OXT' ' HG2' ' A' ' 200' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.884 1.674 . . . . 5.19 112.91 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.723 0.297 . . . . 26.27 110.476 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.18 36.28 1.21 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.587 -0.816 . . . . 24.15 112.481 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.0 p -91.44 -50.51 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.068 0.461 . . . . 23.64 110.012 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.7 m -104.0 73.09 1.13 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.816 -0.629 . . . . 22.83 109.945 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.4 m80 67.2 108.83 0.04 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.284 -0.871 . . . . 22.11 111.296 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -74.07 11.6 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.786 -0.643 . . . . 22.07 111.684 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -84.67 -2.69 57.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.221 -0.659 . . . . 20.59 109.221 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -101.58 54.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 18.44 111.283 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -89.02 -43.73 10.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.333 . . . . 17.98 111.014 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -84.87 98.8 10.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.987 0.422 . . . . 17.87 109.94 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -74.88 134.0 41.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.567 . . . . 16.77 111.388 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.6 m 56.82 50.85 11.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.628 -0.715 . . . . 16.32 111.435 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.22 13.74 0.15 Allowed Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.659 -0.7 . . . . 14.63 112.092 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.4 mt -116.05 -41.51 3.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.103 0.477 . . . . 15.68 110.283 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.482 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 56.9 t -81.34 -50.84 0.92 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.668 -0.696 . . . . 12.69 111.912 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 40.1 Cg_endo -66.74 105.81 1.0 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.035 1.823 . . . . 12.08 112.509 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.46 48.31 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.064 -0.717 . . . . 12.18 109.064 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.88 46.53 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.703 -0.681 . . . . 8.55 111.909 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.4 m -89.69 -9.08 50.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.092 0.472 . . . . 8.07 110.825 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -114.6 20.71 15.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.163 0.506 . . . . 7.76 109.678 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.51 ' HG3' ' OD1' ' A' ' 122' ' ' ASN . 13.2 tpt -102.57 55.87 0.78 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.603 -0.726 . . . . 6.12 110.618 -175.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.12 -34.3 0.3 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.696 -0.684 . . . . 1.91 114.14 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 107' ' ' MET . 0.0 OUTLIER 10.31 80.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.849 1.796 . . . . 4.32 115.849 170.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.673 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 16.7 tpt -139.35 117.01 11.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.035 -1.066 . . . . 2.59 112.65 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.634 ' HB ' HD12 ' A' ' 197' ' ' LEU . 15.9 m -111.5 107.41 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.42 1.105 . . . . 0.74 112.965 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.436 ' C ' HD12 ' A' ' 113' ' ' LEU . 40.3 t30 -160.14 136.16 8.58 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 113.667 -1.606 . . . . 1.38 106.985 168.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 9.0 mp -114.65 100.2 8.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.121 0.486 . . . . 1.33 109.829 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -156.93 97.54 2.08 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-N 115.23 -0.895 . . . . 1.93 109.816 -169.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.849 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 9.6 Cg_exo -34.27 149.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.796 1 C-N-CA 127.396 5.398 . . . . 0.65 115.356 -173.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 29.1 t70 70.55 31.26 2.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.216 -1.356 . . . . 0.72 108.877 -174.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.6 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 8.3 ptp -110.27 154.15 23.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.691 -1.14 . . . . 1.67 109.733 175.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -106.51 76.61 1.14 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.849 -1.167 . . . . 0.58 107.849 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.627 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 1.5 tt -104.15 159.25 5.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.152 -1.386 . . . . 0.65 110.507 -165.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.488 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 37.7 m -141.76 179.91 6.57 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.738 -0.785 . . . . 0.44 110.425 -168.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.953 ' HG2' HG21 ' A' ' 147' ' ' VAL . 14.5 mttp -64.52 -20.77 66.42 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.025 -1.102 . . . . 2.33 108.025 169.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.672 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t30 -84.46 -25.05 29.22 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.11 -1.405 . . . . 1.32 113.936 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.673 ' HA ' ' H ' ' A' ' 110' ' ' MET . 27.5 mt-10 -86.45 -53.9 4.73 Favored 'General case' 0 N--CA 1.412 -2.369 0 O-C-N 120.694 -1.254 . . . . 2.06 108.671 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.826 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.1 mmt -60.62 -18.25 52.08 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.129 -1.85 . . . . 3.13 111.478 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.677 HG13 ' HE3' ' A' ' 126' ' ' LYS . 9.2 p -44.75 -44.17 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-O 121.953 0.882 . . . . 0.37 110.534 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.677 ' HE3' HG13 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -67.66 -41.98 82.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.297 -1.319 . . . . 0.63 113.082 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.564 HD23 ' HB3' ' A' ' 197' ' ' LEU . 2.9 tm? -50.67 -34.67 27.45 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.666 0.604 . . . . 1.79 110.415 169.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.826 ' HG ' ' O ' ' A' ' 124' ' ' MET . 16.3 mt -84.92 -36.74 21.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.659 0.743 . . . . 0.38 109.572 -170.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -64.02 -32.74 74.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.179 -1.373 . . . . 1.96 109.988 168.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 200' ' ' ARG . . . -76.59 -39.85 51.32 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.683 -1.599 . . . . 0.64 111.975 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.644 ' HA ' ' CZ ' ' A' ' 159' ' ' PHE . 0.3 OUTLIER -89.71 -5.3 57.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 124.021 1.867 . . . . 0.59 106.397 -178.169 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 58.35 51.57 8.17 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 110.488 -3.051 . . . . 1.8 112.361 170.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.826 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.6 t80 -135.47 175.4 9.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.278 0.561 . . . . 0.52 112.097 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.85 151.6 48.23 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.204 -1.406 . . . . 4.54 107.204 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.461 ' HB2' HG12 ' A' ' 147' ' ' VAL . 9.7 tm0? -49.67 138.45 14.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.686 1.231 . . . . 1.28 112.704 -170.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.66 ' CG1' HG22 ' A' ' 146' ' ' THR . 15.0 p -134.82 145.72 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 112.597 -2.092 . . . . 1.05 110.613 -162.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.97 -34.62 72.02 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.772 1.272 . . . . 1.38 109.493 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 11.2 ttpt -160.46 129.57 4.92 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 112.31 -2.223 . . . . 1.44 109.015 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.651 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -114.41 121.76 44.55 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.622 -0.717 . . . . 0.9 111.009 -179.412 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.429 ' HA ' HD11 ' A' ' 155' ' ' ILE . 1.7 t -158.14 98.39 1.58 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 122.946 1.355 . . . . 0.61 110.062 153.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.553 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.4 OUTLIER -164.42 161.82 15.74 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 112.552 -2.113 . . . . 1.77 106.328 163.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.71 114.55 2.19 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.332 1.355 . . . . 0.62 111.569 173.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 104.6 32.53 4.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 120.396 -0.906 . . . . 0.51 113.625 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.826 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -131.48 169.84 15.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.697 -0.482 . . . . 2.16 109.697 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.851 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.7 p90 -167.35 165.74 14.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.982 -1.118 . . . . 0.28 107.982 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.66 HG22 ' CG1' ' A' ' 136' ' ' VAL . 17.2 p -134.47 126.86 30.3 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.743 -0.783 . . . . 0.42 111.05 173.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.953 HG21 ' HG2' ' A' ' 121' ' ' LYS . 10.5 p -116.81 112.28 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.591 0.71 . . . . 0.34 111.242 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.74 132.75 3.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.361 -0.836 . . . . 3.11 111.101 -176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 58.56 -88.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.474 0.916 . . . . 1.65 113.474 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -124.57 23.0 8.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.526 0.565 . . . . 1.68 112.526 -170.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.1 p -160.27 149.72 17.63 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.826 1.047 . . . . 0.37 113.826 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 147' ' ' VAL . 28.8 mt -113.33 107.57 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 113.392 -1.731 . . . . 0.53 106.56 159.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.851 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 4.2 mt-10 -92.73 170.16 9.92 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.871 -1.9 . . . . 1.13 105.871 175.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 20.7 ptp -167.6 166.32 14.1 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 123.887 0.742 . . . . 1.8 109.708 -171.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.805 HG22 ' HG2' ' A' ' 168' ' ' GLN . 6.4 mt -128.0 92.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.984 0.897 . . . . 0.43 108.733 165.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.901 ' HG2' HD22 ' A' ' 197' ' ' LEU . 12.3 tpp180 -128.48 85.18 2.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.738 -1.573 . . . . 3.13 112.28 -168.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.816 ' H ' ' HG3' ' A' ' 168' ' ' GLN . 6.0 mmt180 -136.56 -179.06 0.97 Allowed Pre-proline 0 C--N 1.276 -2.615 0 N-CA-C 106.821 -1.548 . . . . 6.16 106.821 158.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.67 ' CB ' ' HB2' ' A' ' 166' ' ' GLU . 73.9 Cg_exo -39.95 132.63 1.97 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 122.471 2.114 . . . . 2.1 114.519 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.644 ' CZ ' ' HA ' ' A' ' 131' ' ' THR . 25.5 m-85 -95.68 167.69 11.13 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.774 -2.466 . . . . 1.83 108.628 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -74.56 76.47 1.98 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.042 0.925 . . . . 3.66 111.282 174.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 159' ' ' PHE . 59.2 m-85 -90.38 149.0 40.25 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 114.166 -1.379 . . . . 3.54 108.266 169.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.78 -36.26 81.77 Favored 'Trans proline' 0 CA--C 1.491 -1.674 0 C-N-CA 124.434 3.422 . . . . 4.48 112.736 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -98.71 -11.87 21.54 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 113.9 -1.5 . . . . 5.26 111.1 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 56.7 m -162.7 107.85 1.16 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.565 -0.743 . . . . 3.43 110.386 -173.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.571 ' HB3' ' HA ' ' A' ' 160' ' ' ASP . 13.8 ptpt -134.15 105.53 6.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.796 0.807 . . . . 3.34 110.138 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.67 ' HB2' ' CB ' ' A' ' 158' ' ' PRO . 7.1 mm-40 -129.73 -173.62 3.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.625 -1.171 . . . . 3.14 111.457 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -81.37 127.69 8.05 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-N 114.299 -1.319 . . . . 1.11 113.103 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.816 ' HG3' ' H ' ' A' ' 157' ' ' ARG . 0.5 OUTLIER -80.12 170.44 16.44 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 112.945 0.72 . . . . 1.86 112.945 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 1.9 t -137.05 132.9 47.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 112.966 0.728 . . . . 0.41 112.966 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 154' ' ' MET . 20.9 ttt180 -88.03 110.11 20.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 116.128 -0.487 . . . . 2.8 109.738 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.44 138.67 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.735 0.779 . . . . 0.29 111.661 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.772 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 12.9 tpt180 -103.17 99.57 9.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.181 -1.372 . . . . 1.71 111.088 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 5.8 mp -91.26 104.5 17.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.388 -0.597 . . . . 0.69 109.388 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.7 114.64 28.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.656 1.217 . . . . 0.26 111.849 -173.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -86.12 131.32 34.28 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 112.516 -2.129 . . . . 0.72 109.45 -178.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.557 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 35.3 t70 -75.61 67.27 2.07 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.634 -1.617 . . . . 1.09 106.634 165.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.37 -98.76 1.27 Allowed Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 119.017 -1.563 . . . . 0.47 110.281 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -82.89 -24.59 33.1 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.852 0.686 . . . . 0.83 112.852 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.557 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 8.0 p-80 -131.74 126.42 34.42 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 119.717 -0.793 . . . . 1.21 111.374 -165.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.35 127.9 26.44 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.661 -1.608 . . . . 0.64 111.058 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -108.14 -38.91 5.64 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.869 -1.059 . . . . 0.29 110.516 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.439 ' O ' HG13 ' A' ' 183' ' ' ILE . 24.0 p -146.03 168.46 20.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.26 -0.427 . . . . 0.33 111.12 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.772 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 2.4 mt -140.82 143.12 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.748 -1.945 . . . . 0.76 105.748 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.7 t -137.06 136.35 47.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.228 0.537 . . . . 0.35 110.154 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.526 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 36.0 t-20 -86.29 100.58 12.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 108.088 -1.079 . . . . 1.77 108.088 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.463 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 39.1 mtm -64.34 -2.38 2.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 114.021 1.119 . . . . 0.55 114.021 -165.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.526 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.7 pt-20 -80.82 -44.13 18.94 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.861 0.838 . . . . 1.02 110.79 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.505 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 8.7 m120 -106.45 -25.57 11.81 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.997 -1.456 . . . . 1.4 108.942 -176.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.2 27.8 1.93 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.326 -2.215 . . . . 1.33 107.599 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -84.12 166.81 17.33 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.478 -1.692 . . . . 2.28 108.823 178.004 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -88.25 145.2 26.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.715 1.245 . . . . 1.36 112.67 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.626 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 1.7 m-85 -116.46 -169.34 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.282 -2.235 . . . . 1.18 105.359 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.849 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 134.94 -0.72 3.72 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.256 -1.138 . . . . 1.28 110.256 -163.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -148.65 97.63 2.76 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.138 -1.531 . . . . 2.8 108.369 154.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.3 t80 -132.15 118.96 20.26 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.004 -0.739 . . . . 0.6 109.004 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.422 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 9.0 mmt180 -105.81 142.49 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.941 -0.392 . . . . 4.77 109.941 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.901 HD22 ' HG2' ' A' ' 156' ' ' ARG . 33.7 mt -113.42 154.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.933 -0.576 . . . . 1.61 111.404 -171.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.675 ' HB3' ' NH1' ' A' ' 156' ' ' ARG . 13.4 t70 -94.72 112.11 56.75 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.297 -0.631 . . . . 2.66 109.297 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 198' ' ' ASP . 11.9 Cg_endo -57.41 125.77 19.87 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.893 2.395 . . . . 2.01 113.679 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 130' ' ' ALA . 2.0 mpp_? . . . . . 0 C--O 1.248 1.02 0 O-C-N 124.589 1.181 . . . . 5.19 113.081 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.778 0.323 . . . . 26.27 110.783 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.8 -106.81 2.98 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.769 -0.729 . . . . 24.15 112.406 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -84.77 73.34 10.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.296 0.57 . . . . 23.64 110.181 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 t -79.6 104.43 10.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.652 -0.704 . . . . 22.83 109.689 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -83.53 85.17 7.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 22.11 111.198 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -83.27 114.43 21.38 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.558 -0.534 . . . . 22.07 109.558 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -79.61 128.3 33.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.369 -0.378 . . . . 20.59 110.566 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 61.31 43.36 10.8 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.62 0.575 . . . . 18.44 110.267 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -78.08 121.16 23.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.917 -0.583 . . . . 17.98 110.268 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -91.25 103.41 16.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.852 -0.613 . . . . 17.87 109.983 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.1 t -81.23 -26.05 36.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.207 -0.451 . . . . 16.77 110.258 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.1 m 61.36 -171.17 0.15 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.567 -0.742 . . . . 16.32 111.234 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.423 ' H ' HD12 ' A' ' 100' ' ' LEU . . . -161.39 35.61 0.39 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.744 -0.741 . . . . 14.63 112.363 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD12 ' H ' ' A' ' 99' ' ' GLY . 5.1 mp -118.7 -97.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.605 -0.517 . . . . 15.68 109.605 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.476 ' HB ' ' CD ' ' A' ' 102' ' ' PRO . 94.9 t -83.68 -52.89 0.57 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.57 -0.9 . . . . 12.69 108.57 169.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 101' ' ' VAL . 58.3 Cg_endo -74.05 128.91 12.69 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.486 1.458 . . . . 12.08 110.026 164.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -152.64 36.34 0.5 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.303 0.573 . . . . 12.18 110.153 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.55 -149.92 35.82 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.653 -0.784 . . . . 8.55 111.365 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.4 t 66.3 -78.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.615 0.366 . . . . 8.07 111.045 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -105.83 92.32 4.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.975 0.417 . . . . 7.76 110.028 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.1 mtt -90.71 -177.79 5.09 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.489 -0.56 . . . . 6.12 109.489 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.13 13.17 69.3 Favored Glycine 0 C--O 1.216 -0.982 0 C-N-CA 120.226 -0.988 . . . . 1.91 112.578 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 52.6 mtm180 -131.0 113.74 14.34 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 107.818 -1.179 . . . . 4.32 107.818 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.52 ' O ' ' HB2' ' A' ' 126' ' ' LYS . 12.4 tpt -143.69 159.74 41.95 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.068 -1.053 . . . . 2.59 113.589 -166.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 127' ' ' LEU . 2.6 m -133.33 102.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 122.637 1.208 . . . . 0.74 109.475 159.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -164.22 111.6 1.1 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.691 -1.141 . . . . 1.38 108.194 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.682 ' HB3' HD13 ' A' ' 183' ' ' ILE . 4.4 mt -96.4 103.87 15.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.498 -0.481 . . . . 1.33 110.009 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.62 ' H ' ' HE2' ' A' ' 117' ' ' MET . 25.3 tt0 -155.88 106.15 2.12 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 119.817 -0.753 . . . . 1.93 110.63 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.586 ' HD3' ' CA ' ' A' ' 193' ' ' GLY . 18.8 Cg_exo -35.33 144.91 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.78 1 C-N-CA 125.94 4.426 . . . . 0.65 115.721 -175.048 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 67.74 40.19 2.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.055 -1.43 . . . . 0.72 109.536 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.633 ' HE3' HD13 ' A' ' 180' ' ' LEU . 10.9 ptt? -113.63 154.05 27.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.438 -1.255 . . . . 1.67 109.416 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -102.9 93.08 4.85 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.98 -1.119 . . . . 0.58 107.98 -173.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.656 HD13 ' HE2' ' A' ' 124' ' ' MET . 2.2 tt -126.54 162.05 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 114.601 -1.181 . . . . 0.65 110.945 -163.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.587 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.8 m -142.55 179.36 7.01 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.771 -0.826 . . . . 0.44 108.771 -169.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.855 ' HG2' HG21 ' A' ' 147' ' ' VAL . 13.0 mtpp -53.95 -35.24 61.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.06 -0.718 . . . . 2.33 109.06 166.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.937 ' O ' HG12 ' A' ' 125' ' ' VAL . 6.2 t-20 -81.87 -32.52 31.01 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.433 -1.258 . . . . 1.32 112.623 -177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.592 ' CB ' HG13 ' A' ' 119' ' ' ILE . 19.8 mt-10 -85.5 -20.7 29.29 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 119.653 -1.905 . . . . 2.06 109.167 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.764 ' HG3' HD12 ' A' ' 152' ' ' ILE . 18.7 mmt -85.4 -18.72 32.86 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.072 -1.422 . . . . 3.13 110.881 166.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.937 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.6 p -54.12 -36.28 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 CA-C-O 121.749 0.785 . . . . 0.37 111.285 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.921 ' HE3' HG13 ' A' ' 125' ' ' VAL . 1.5 mmpt? -71.44 -40.2 70.54 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.787 -1.097 . . . . 0.63 112.0 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.749 ' N ' HG12 ' A' ' 111' ' ' VAL . 1.5 tm? -49.57 -36.05 22.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.777 0.798 . . . . 1.79 109.163 166.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' A' ' 124' ' ' MET . 24.4 mt -86.11 -34.35 20.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.394 -0.821 . . . . 0.38 110.08 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 126' ' ' LYS . 2.9 tp10 -58.76 -34.89 71.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.184 -1.371 . . . . 1.96 109.216 167.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -73.69 -37.79 65.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.508 -1.678 . . . . 0.64 112.128 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 128' ' ' LEU . 10.8 t -89.18 -5.26 57.85 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 123.819 1.771 . . . . 0.59 107.079 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 56.82 53.26 8.41 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.048 -2.796 . . . . 1.8 112.71 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.777 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.1 t80 -136.37 176.99 8.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.209 -0.597 . . . . 0.52 112.181 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 41.5 ttt180 -134.37 155.24 50.61 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 4.54 107.603 172.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.431 ' HB2' HG12 ' A' ' 147' ' ' VAL . 11.3 tm0? -50.42 140.24 14.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.623 1.201 . . . . 1.28 112.89 -169.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.7 p -141.14 136.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.77 -2.014 . . . . 1.05 109.487 -166.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.5 t -59.43 -30.9 68.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 122.46 1.124 . . . . 1.38 109.578 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -159.22 120.12 3.24 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 112.858 -1.974 . . . . 1.44 108.95 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.657 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -111.22 120.63 42.93 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.074 -1.421 . . . . 0.9 110.167 -177.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.28 96.17 2.02 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.275 1.512 . . . . 0.61 109.067 157.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.566 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.2 OUTLIER -166.69 163.04 11.2 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 111.586 -2.552 . . . . 1.77 105.124 165.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.622 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 56.2 Cg_endo -71.6 127.8 13.6 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 CA-C-N 120.63 1.261 . . . . 0.62 111.791 174.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.75 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 97.03 30.12 7.64 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 120.381 -0.914 . . . . 0.51 113.909 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.777 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -128.0 174.46 9.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.295 0.547 . . . . 2.16 110.125 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.897 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 p90 -169.06 163.93 11.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.273 -1.01 . . . . 0.28 108.273 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.736 HG22 HG13 ' A' ' 136' ' ' VAL . 22.3 p -132.86 126.35 32.02 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.176 -0.609 . . . . 0.42 110.956 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.855 HG21 ' HG2' ' A' ' 121' ' ' LYS . 6.1 p -112.18 110.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 120.026 -0.669 . . . . 0.34 111.801 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -132.45 43.58 2.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.433 -0.803 . . . . 3.11 111.456 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.54 -54.34 0.67 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.531 0.937 . . . . 1.65 113.531 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -80.98 -15.09 57.19 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.393 0.616 . . . . 1.68 110.288 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.2 p -164.74 154.6 13.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.154 -0.93 . . . . 0.37 111.441 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.764 HD12 ' HG3' ' A' ' 124' ' ' MET . 28.4 mt -114.67 110.87 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 113.496 -1.683 . . . . 0.53 106.555 164.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.897 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -88.95 174.87 7.68 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.53 -1.656 . . . . 1.13 106.53 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 28.2 ptm -168.89 159.34 9.45 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 123.501 0.501 . . . . 1.8 110.734 -172.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.4 mt -130.92 110.17 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.098 -0.501 . . . . 0.43 111.321 167.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.763 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 1.4 tpt180 -65.52 91.27 0.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.605 -0.725 . . . . 3.13 110.042 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.75 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 66.9 ttt180 -64.25 133.65 95.71 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 114.978 -1.01 . . . . 6.16 108.525 172.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.78 124.45 14.57 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 120.815 1.01 . . . . 2.1 110.601 170.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.614 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 9.3 m-85 -124.92 126.56 45.71 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.227 -1.768 . . . . 1.83 106.227 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.75 75.88 6.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.893 1.33 . . . . 3.66 111.515 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.483 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 65.8 m-85 -119.47 142.89 33.47 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 113.453 -1.703 . . . . 3.54 109.039 171.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.4 Cg_exo -57.58 -30.88 90.1 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 124.648 3.565 . . . . 4.48 113.096 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.27 -14.98 34.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.046 -0.979 . . . . 5.26 111.286 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.451 ' HB3' HH12 ' A' ' 156' ' ' ARG . 58.8 m -161.65 100.56 1.16 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.001 -0.545 . . . . 3.43 111.274 -174.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 86.4 tttt -147.48 97.28 2.82 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.674 0.75 . . . . 3.34 110.014 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -132.81 161.83 33.11 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.557 -1.201 . . . . 3.14 111.43 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.94 151.54 32.02 Favored Glycine 0 CA--C 1.498 -1.017 0 CA-C-N 114.21 -1.359 . . . . 1.11 111.374 172.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.763 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 48.1 tt0 -44.87 142.1 1.91 Allowed 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 115.203 1.556 . . . . 1.86 115.203 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 51.1 t -153.5 125.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 113.748 -1.569 . . . . 0.41 110.448 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HG3' HG12 ' A' ' 155' ' ' ILE . 4.1 ttm180 -84.52 110.63 18.83 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.467 -0.568 . . . . 2.8 109.467 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HB3' ' CG ' ' A' ' 154' ' ' MET . . . -116.27 147.71 41.23 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.729 -0.788 . . . . 0.29 111.603 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.785 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.4 tpp180 -109.77 98.97 8.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.552 -1.203 . . . . 1.71 110.84 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CE ' ' A' ' 124' ' ' MET . 1.4 mp -88.7 94.34 9.87 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.438 -0.949 . . . . 0.69 108.438 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.02 120.45 35.24 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 122.443 1.116 . . . . 0.26 111.672 -170.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-30 -90.91 130.07 36.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.746 -2.025 . . . . 0.72 109.962 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.57 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 30.7 t70 -78.68 64.83 3.78 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.224 -1.769 . . . . 1.09 106.224 165.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.99 -99.7 0.96 Allowed Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 119.332 -1.414 . . . . 0.47 110.735 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.65 -25.54 49.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.865 0.691 . . . . 0.83 112.865 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 6.8 p-80 -133.84 127.18 32.08 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.917 -0.713 . . . . 1.21 110.587 -167.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.0 tt -54.75 130.85 42.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.126 -1.397 . . . . 0.64 110.194 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.15 -39.16 6.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.93 -1.032 . . . . 0.29 109.827 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.8 p -152.56 169.51 22.47 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.029 -0.532 . . . . 0.33 111.244 -173.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.785 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mt -135.81 144.34 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.191 -2.151 . . . . 0.76 105.191 167.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 47.5 t -138.64 140.17 39.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 117.992 0.36 . . . . 0.35 110.296 -174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.606 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 37.5 t-20 -81.15 107.91 14.35 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.32 -1.363 . . . . 1.77 107.32 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.431 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 59.3 mtm -69.16 -1.52 8.04 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 112.586 0.587 . . . . 0.55 112.586 -166.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.606 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 12.1 pt-20 -85.26 -44.54 12.79 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.753 0.787 . . . . 1.02 111.237 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.533 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.7 m-20 -106.37 -26.09 11.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.513 -1.222 . . . . 1.4 109.093 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 188' ' ' ASN . 13.7 t30 77.31 31.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.536 -2.12 . . . . 1.33 107.304 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.458 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 ptm180 -89.0 159.24 17.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.736 -1.575 . . . . 2.28 108.889 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.75 149.77 25.53 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.208 1.004 . . . . 1.36 112.732 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.92 -174.04 3.48 Favored 'General case' 0 CA--C 1.472 -2.039 0 CA-C-N 113.246 -1.797 . . . . 1.18 107.754 -173.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.618 ' HA2' HD12 ' A' ' 183' ' ' ILE . . . 129.9 24.92 0.94 Allowed Glycine 1 N--CA 1.393 -4.177 0 CA-C-N 114.101 -1.409 . . . . 1.28 112.725 -178.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.36 94.69 2.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.452 -1.874 . . . . 2.8 106.824 145.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.679 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -129.99 101.36 5.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.693 -0.854 . . . . 0.6 108.693 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 3.2 mpt_? -105.35 127.36 52.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.191 0.52 . . . . 4.77 110.888 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.595 HD12 HD22 ' A' ' 127' ' ' LEU . 4.5 mt -104.15 172.55 6.74 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.434 -0.803 . . . . 1.61 111.9 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.25 104.51 9.92 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 114.268 -1.333 . . . . 2.66 108.66 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.96 125.14 17.32 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.042 2.494 . . . . 2.01 113.144 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.409 ' NE ' ' HD3' ' A' ' 126' ' ' LYS . 6.5 mpt_? . . . . . 0 C--O 1.242 0.691 0 CA-C-N 115.262 -0.881 . . . . 5.19 110.986 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.026 -0.361 . . . . 26.27 110.026 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.54 -107.12 2.04 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.918 -0.658 . . . . 24.15 111.486 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.6 m -92.07 162.99 14.13 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.715 -0.476 . . . . 23.64 109.715 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.2 p -62.91 -70.76 0.19 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.588 0.233 . . . . 22.83 110.729 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.8 t60 51.77 67.76 0.91 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.783 -0.644 . . . . 22.11 110.396 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -88.0 133.84 33.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.196 0.522 . . . . 22.07 110.674 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.61 121.74 25.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.549 -0.75 . . . . 20.59 110.861 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -114.79 21.6 14.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.278 0.561 . . . . 18.44 110.405 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 99' ' ' GLY . 55.8 m-70 -133.83 71.54 1.46 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.473 -0.785 . . . . 17.98 109.608 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -72.24 -65.76 0.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.771 -0.65 . . . . 17.87 111.492 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.2 m -92.0 -45.7 8.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.88 0.371 . . . . 16.77 110.747 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.7 m -108.59 135.29 50.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.324 -0.398 . . . . 16.32 110.638 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 95' ' ' HIS . . . 103.51 102.12 2.7 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.832 -0.699 . . . . 14.63 111.55 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.2 tp -86.97 -32.4 20.1 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.948 0.404 . . . . 15.68 110.522 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 m -86.14 133.54 40.66 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.041 -0.527 . . . . 12.69 111.688 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.22 78.91 2.74 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.768 2.312 . . . . 12.08 111.904 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -83.55 158.91 21.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.01 -0.541 . . . . 12.18 110.489 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.63 -156.27 8.27 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.403 -0.679 . . . . 8.55 111.403 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.6 t -82.78 60.27 5.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.388 0.613 . . . . 8.07 110.087 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -130.64 41.9 3.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.725 -0.67 . . . . 7.76 109.401 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.577 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 54.4 ttm 66.45 -86.88 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.195 -0.911 . . . . 6.12 110.876 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.52 ' C ' ' HD3' ' A' ' 109' ' ' ARG . . . 105.42 -29.28 11.77 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-O 118.955 -0.914 . . . . 1.91 113.543 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.52 ' HD3' ' C ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER 14.21 79.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.731 1.382 . . . . 4.32 114.731 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.509 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 34.7 ttp -142.45 124.86 15.63 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.35 -0.94 . . . . 2.59 111.793 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.9 m -110.7 104.91 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-O 122.817 1.294 . . . . 0.74 113.128 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -160.01 109.9 1.83 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 112.587 -2.097 . . . . 1.38 106.054 165.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.808 HD21 HD21 ' A' ' 173' ' ' LEU . 4.3 mp -99.51 123.69 44.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.825 -0.805 . . . . 1.33 108.825 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -152.22 100.37 2.83 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.499 -0.926 . . . . 1.93 108.499 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.489 ' HD3' HD12 ' A' ' 183' ' ' ILE . 24.5 Cg_exo -35.43 137.66 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.366 1 C-N-CA 125.361 4.041 . . . . 0.65 114.314 -173.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.2 47.57 0.28 Allowed 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.488 1.137 . . . . 0.72 109.795 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.504 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 5.8 ptp -122.36 156.31 34.22 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.537 -1.211 . . . . 1.67 110.867 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.2 m -102.7 77.74 1.63 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.334 1.064 . . . . 0.58 108.471 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.509 HG22 ' HB2' ' A' ' 180' ' ' LEU . 15.2 tt -106.7 168.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 113.287 -1.779 . . . . 0.65 109.482 -171.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.513 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.8 m -137.59 162.9 32.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.223 -0.591 . . . . 0.44 109.464 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.649 ' HG2' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.34 -26.52 4.97 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 122.009 0.909 . . . . 2.33 108.817 170.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.695 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 4.0 t-20 -82.79 -14.69 53.94 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.826 -1.988 . . . . 1.32 114.535 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.513 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -84.7 -63.63 1.3 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.74 -1.225 . . . . 2.06 109.969 168.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.706 ' CE ' HD23 ' A' ' 173' ' ' LEU . 0.0 OUTLIER -64.28 -9.87 20.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.074 -0.966 . . . . 3.13 110.727 174.127 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.695 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 12.4 p -41.7 -41.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.853 0.835 . . . . 0.37 110.62 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.503 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.3 mmpt? -66.13 -37.31 85.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.807 -1.088 . . . . 0.63 113.116 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.808 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.5 tm? -54.2 -33.58 58.54 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.618 0.723 . . . . 1.79 109.894 167.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.763 ' HB3' ' CE2' ' A' ' 145' ' ' PHE . 15.9 mt -82.44 -34.96 27.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.452 -0.944 . . . . 0.38 108.452 -172.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -60.14 -39.33 85.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.843 -1.526 . . . . 1.96 109.943 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.612 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -70.32 -42.76 71.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.989 -1.459 . . . . 0.64 112.544 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.446 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -88.6 -0.62 57.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 124.284 1.992 . . . . 0.59 105.812 -177.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 130' ' ' ALA . 11.5 mm-40 57.01 49.51 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 110.628 -2.987 . . . . 1.8 111.856 170.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.993 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 1.9 t80 -141.31 174.49 10.49 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 119.484 -0.886 . . . . 0.52 113.198 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 23.4 ptt-85 -137.49 158.15 45.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.142 -1.39 . . . . 4.54 107.585 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.69 140.42 14.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.194 0.997 . . . . 1.28 112.523 -171.027 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.805 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.9 p -139.85 134.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 113.512 -1.676 . . . . 1.05 110.192 -163.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.02 -33.36 68.89 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.7 1.238 . . . . 1.38 109.602 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.589 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -160.14 131.35 5.82 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 112.308 -2.224 . . . . 1.44 107.801 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.541 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 1.4 ptt? -119.0 137.93 53.18 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 115.023 -0.99 . . . . 0.9 111.127 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.49 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -162.31 98.58 1.03 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 122.34 1.067 . . . . 0.61 109.846 152.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.423 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -167.62 155.75 8.5 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 113.371 -1.74 . . . . 1.77 106.74 163.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.522 ' HA ' HG22 ' A' ' 155' ' ' ILE . 19.0 Cg_endo -61.27 119.62 6.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.051 1.167 . . . . 0.62 110.017 169.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.45 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 93.67 44.17 3.73 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.476 -1.345 . . . . 0.51 112.744 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.993 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.4 mt-10 -145.57 148.85 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.326 -0.99 . . . . 2.16 108.326 172.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.805 ' O ' HG12 ' A' ' 136' ' ' VAL . 40.7 p90 -152.85 156.78 39.65 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.758 -0.83 . . . . 0.28 108.758 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.75 HG22 HG13 ' A' ' 136' ' ' VAL . 21.3 p -126.04 126.28 43.99 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.679 -0.692 . . . . 0.42 110.663 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.649 HG21 ' HG2' ' A' ' 121' ' ' LYS . 9.1 p -125.08 109.88 23.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.966 -1.016 . . . . 0.34 111.511 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -110.27 -66.1 1.1 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.17 -0.468 . . . . 3.11 110.775 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.39 -61.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.076 0.399 . . . . 1.65 112.076 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -93.13 -1.78 56.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.615 0.598 . . . . 1.68 112.615 -171.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.4 p -163.28 152.6 14.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.529 0.937 . . . . 0.37 113.529 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.533 HD12 ' CG ' ' A' ' 124' ' ' MET . 20.7 mt -109.97 110.94 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 113.508 -1.678 . . . . 0.53 107.259 164.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -97.92 107.43 19.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.857 -1.164 . . . . 1.13 107.857 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 7.9 ptm -115.7 139.42 50.15 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.625 0.726 . . . . 1.8 112.124 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.64 HG23 ' HG3' ' A' ' 168' ' ' GLN . 68.4 mt -99.13 108.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.636 -1.165 . . . . 0.43 109.535 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.72 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 37.9 ttp180 -68.22 97.14 0.69 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.689 -1.141 . . . . 3.13 109.978 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.466 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 33.0 ttp180 -56.15 142.11 67.4 Favored Pre-proline 0 CA--C 1.514 -0.417 0 N-CA-C 107.264 -1.384 . . . . 6.16 107.264 169.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -46.72 124.92 8.97 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 120.981 1.121 . . . . 2.1 110.459 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 25.4 m-85 -120.95 131.64 54.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.933 -1.485 . . . . 1.83 108.523 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -89.13 76.6 7.7 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.43 1.109 . . . . 3.66 112.46 -169.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.65 ' HB2' ' O ' ' A' ' 164' ' ' SER . 96.2 m-85 -78.74 142.58 61.36 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 113.952 -1.477 . . . . 3.54 108.07 164.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 34.5 Cg_exo -58.2 -36.39 97.85 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 124.219 3.279 . . . . 4.48 112.37 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -99.84 -10.5 21.7 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.073 -0.967 . . . . 5.26 111.561 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.65 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 20.2 m -150.72 99.82 2.77 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.347 0.499 . . . . 3.43 112.347 -167.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -142.57 105.35 4.52 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.91 -0.774 . . . . 3.34 108.91 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -135.93 -170.67 2.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.67 -1.15 . . . . 3.14 110.649 -167.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.42 179.6 52.89 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.4 -1.273 . . . . 1.11 111.931 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.72 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -55.37 158.63 3.1 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 113.464 -1.368 . . . . 1.86 113.386 175.027 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.455 ' N ' ' HG2' ' A' ' 168' ' ' GLN . 44.0 t -151.21 128.7 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 114.834 -1.075 . . . . 0.41 109.192 173.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HG3' HG12 ' A' ' 155' ' ' ILE . 32.6 mtm180 -91.14 109.35 20.6 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 120.941 0.4 . . . . 2.8 110.386 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -114.15 134.14 55.1 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.956 0.884 . . . . 0.29 111.544 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.8 tpp180 -95.0 98.04 10.4 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 113.569 -1.651 . . . . 1.71 110.75 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.808 HD21 HD21 ' A' ' 113' ' ' LEU . 2.8 mp -86.21 93.28 9.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.079 -0.711 . . . . 0.69 109.079 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 114.25 25.92 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 122.012 0.911 . . . . 0.26 111.497 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-85 -87.02 131.48 34.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.446 -1.707 . . . . 0.72 110.197 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.7 t70 -77.38 65.38 2.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.567 -1.642 . . . . 1.09 106.567 164.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.29 -98.54 1.25 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.911 -1.614 . . . . 0.47 110.379 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.71 -22.93 37.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.906 0.706 . . . . 0.83 112.906 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -133.89 128.42 34.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 119.685 -0.806 . . . . 1.21 111.431 -168.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 5.6 tt -52.77 125.93 18.39 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.899 -1.5 . . . . 0.64 109.648 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.11 -37.74 6.51 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.408 -0.814 . . . . 0.29 109.442 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.4 p -146.13 161.23 40.65 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.533 -0.758 . . . . 0.33 111.001 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.4 mt -128.59 145.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.214 -2.143 . . . . 0.76 105.214 167.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.6 t -142.22 132.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.392 0.615 . . . . 0.35 109.998 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 32.3 t-20 -79.21 105.26 10.41 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 107.495 -1.298 . . . . 1.77 107.495 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.514 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 38.6 mtm -66.95 -1.48 4.1 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.782 0.676 . . . . 0.55 112.642 -167.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.59 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.9 pt-20 -79.71 -44.14 21.35 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.85 0.833 . . . . 1.02 110.819 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.59 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 70.6 m-20 -107.49 -26.59 10.86 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.293 -1.321 . . . . 1.4 109.454 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 188' ' ' ASN . 53.8 t30 77.02 33.13 0.46 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.534 -2.121 . . . . 1.33 107.586 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.5 ptm180 -91.83 161.47 14.84 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.581 -1.645 . . . . 2.28 109.18 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.62 137.76 32.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.103 -0.953 . . . . 1.36 109.358 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -110.85 89.92 3.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.779 -0.769 . . . . 1.18 110.795 -174.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.54 -58.69 0.0 OUTLIER Glycine 0 N--CA 1.469 0.863 0 C-N-CA 125.173 1.368 . . . . 1.28 116.233 145.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 23.6 p90 -164.07 174.4 11.37 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.952 -1.624 . . . . 2.8 107.709 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.762 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.7 t80 -138.31 101.59 4.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.637 0.732 . . . . 0.6 110.626 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -81.92 137.52 35.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.834 -0.621 . . . . 4.77 110.09 -177.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.808 HD13 ' HG ' ' A' ' 127' ' ' LEU . 92.5 mt -134.24 170.48 15.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.493 0.923 . . . . 1.61 113.493 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 161' ' ' PHE . 32.2 t70 -100.57 120.75 55.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.268 -1.333 . . . . 2.66 109.874 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.549 ' HB2' ' NH1' ' A' ' 200' ' ' ARG . 36.7 Cg_endo -68.41 123.0 10.04 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.778 1.652 . . . . 2.01 112.46 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.612 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.286 1.034 . . . . 5.19 112.984 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 121.012 0.434 . . . . 26.27 110.629 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.55 75.72 2.34 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.033 -0.603 . . . . 24.15 112.303 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 92' ' ' HIS . 9.5 t 63.79 48.38 3.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.328 0.585 . . . . 23.64 109.758 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 m -58.96 -63.53 1.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.326 -0.852 . . . . 22.83 110.933 -176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -103.87 42.3 1.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 22.11 110.52 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.422 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 81.1 m-70 -131.3 -78.46 0.52 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.392 -0.367 . . . . 22.07 110.273 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.2 t60 55.5 77.52 0.22 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.513 0.508 . . . . 20.59 110.899 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 49.6 m170 64.15 90.12 0.09 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.785 -0.643 . . . . 18.44 111.24 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -80.71 85.03 6.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.071 0.462 . . . . 17.98 110.245 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -137.73 68.66 1.4 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 17.87 110.015 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.1 t -99.19 129.0 45.4 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.271 -0.422 . . . . 16.77 110.271 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.5 p 50.12 51.14 17.27 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.305 0.642 . . . . 16.32 111.6 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.08 -25.69 75.22 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.936 -0.574 . . . . 14.63 112.704 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 100' ' ' LEU . 33.5 tp 63.38 29.93 15.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.466 0.65 . . . . 15.68 110.34 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.91 82.67 67.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.881 -0.6 . . . . 12.69 111.53 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.72 -8.22 13.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.567 2.178 . . . . 12.08 112.731 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -99.49 -39.19 8.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.696 -0.229 . . . . 12.18 110.921 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.9 144.02 4.91 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.382 -0.913 . . . . 8.55 112.509 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 106' ' ' HIS . 29.2 p -110.09 10.98 23.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.827 -0.435 . . . . 8.07 109.827 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 105' ' ' SER . 27.4 m-70 72.46 -55.52 0.67 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.349 -0.841 . . . . 7.76 111.957 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.408 ' C ' ' H ' ' A' ' 109' ' ' ARG . 94.5 mmm 73.84 -31.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.599 0.76 . . . . 6.12 110.877 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 106' ' ' HIS . . . 73.48 -32.3 0.83 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-O 119.338 -0.701 . . . . 1.91 114.16 169.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.408 ' H ' ' C ' ' A' ' 107' ' ' MET . 0.7 OUTLIER -15.38 82.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.825 1.65 . . . . 4.32 115.084 179.079 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.774 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 57.4 ttm -142.3 110.87 6.13 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.153 -0.619 . . . . 2.59 112.326 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.8 m -107.81 106.66 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-O 122.459 1.123 . . . . 0.74 113.08 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -158.46 108.64 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.185 -1.825 . . . . 1.38 107.008 163.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.761 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.8 mp -95.18 116.85 29.27 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.059 -0.719 . . . . 1.33 109.059 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -148.3 107.34 3.6 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 119.766 -0.774 . . . . 1.93 110.176 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.535 ' HG3' HG12 ' A' ' 183' ' ' ILE . 37.7 Cg_exo -35.43 130.49 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 124.287 3.325 . . . . 0.65 113.799 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 24.3 t70 68.83 54.33 0.48 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.512 1.149 . . . . 0.72 110.01 -174.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.702 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 14.1 ptt? -121.73 156.18 33.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.972 -1.467 . . . . 1.67 110.364 172.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.51 96.37 6.69 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.496 -0.927 . . . . 0.58 108.496 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.83 HD13 ' HE2' ' A' ' 124' ' ' MET . 15.8 tt -136.98 169.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.613 -1.176 . . . . 0.65 109.831 -165.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 124' ' ' MET . 20.2 m -139.75 175.94 9.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.809 0.731 . . . . 0.44 111.118 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.638 ' H ' ' HD2' ' A' ' 121' ' ' LYS . 3.2 mptt -62.34 -19.82 63.74 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.123 0.963 . . . . 2.33 108.556 169.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.71 ' O ' HG12 ' A' ' 125' ' ' VAL . 5.2 t30 -81.5 -23.44 37.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.31 -1.768 . . . . 1.32 112.627 177.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.774 ' HA ' ' H ' ' A' ' 110' ' ' MET . 19.6 mt-10 -88.45 -44.01 11.04 Favored 'General case' 0 N--CA 1.408 -2.556 0 O-C-N 120.812 -1.18 . . . . 2.06 108.93 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.83 ' HE2' HD13 ' A' ' 119' ' ' ILE . 14.1 mmt -63.89 -18.76 64.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.96 -1.473 . . . . 3.13 110.557 169.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -48.96 -41.57 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-O 122.089 0.947 . . . . 0.37 110.287 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.524 ' CE ' HG13 ' A' ' 125' ' ' VAL . 8.7 mmpt? -66.67 -38.21 86.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.204 -1.362 . . . . 0.63 113.404 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.888 HD13 HD13 ' A' ' 197' ' ' LEU . 13.5 tp -49.85 -40.15 41.46 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.857 0.837 . . . . 1.79 110.114 166.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.2 mt -82.44 -30.84 29.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.016 -0.993 . . . . 0.38 109.259 -167.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.49 -39.3 94.08 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.844 -1.526 . . . . 1.96 110.241 165.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.679 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -72.3 -41.93 66.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.497 -1.683 . . . . 0.64 112.083 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER -97.0 6.79 47.98 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 124.558 2.123 . . . . 0.59 105.784 -177.148 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 46.29 50.67 12.02 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 110.023 -3.262 . . . . 1.8 113.008 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.559 ' HB3' ' CD2' ' A' ' 145' ' ' PHE . 2.8 t80 -136.07 175.03 9.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.879 -0.728 . . . . 0.52 112.437 -173.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 2.2 tmm_? -137.05 147.96 46.49 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.459 -1.682 . . . . 4.54 106.459 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.537 ' N ' ' HD2' ' A' ' 134' ' ' ARG . 9.7 tm0? -47.92 140.7 6.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.846 1.308 . . . . 1.28 113.388 -170.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.8 p -140.88 137.73 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 112.638 -2.074 . . . . 1.05 109.423 -163.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -59.29 -33.22 70.82 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.343 1.068 . . . . 1.38 109.057 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.16 129.01 5.63 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.997 -1.91 . . . . 1.44 109.082 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.656 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -118.66 129.62 55.4 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.293 -1.321 . . . . 0.9 111.59 -172.35 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 1.8 t -160.57 99.33 1.28 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 122.907 1.337 . . . . 0.61 110.867 155.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.496 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.14 162.32 14.19 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.737 -2.029 . . . . 1.77 105.985 161.261 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.508 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 18.2 Cg_endo -60.96 120.47 8.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.102 1.201 . . . . 0.62 110.379 169.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.476 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 91.02 48.56 3.32 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.548 -1.31 . . . . 0.51 112.964 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.55 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 31.7 mt-10 -142.25 167.51 21.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.343 -0.614 . . . . 2.16 109.343 169.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.871 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 46.8 p90 -167.76 163.13 14.18 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.234 -1.024 . . . . 0.28 108.234 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.737 HG22 HG13 ' A' ' 136' ' ' VAL . 25.7 p -130.34 125.89 35.78 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.822 -0.751 . . . . 0.42 111.147 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.651 HG23 HG12 ' A' ' 152' ' ' ILE . 7.7 p -115.24 110.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 122.002 0.906 . . . . 0.34 111.133 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -122.73 31.16 6.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.101 -0.954 . . . . 3.11 110.784 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.91 -47.04 0.66 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.485 -0.78 . . . . 1.65 112.211 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -81.67 -16.29 51.79 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.102 0.477 . . . . 1.68 110.569 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.44 ' HB3' HG23 ' A' ' 174' ' ' THR . 1.8 p -162.49 154.21 18.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.434 -0.803 . . . . 0.37 112.296 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.675 HD12 ' HG3' ' A' ' 124' ' ' MET . 20.2 mt -117.98 107.68 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.696 -1.593 . . . . 0.53 107.346 165.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.871 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.8 mp0 -90.9 168.35 11.76 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.176 -2.157 . . . . 1.13 105.176 174.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.04 157.9 10.01 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.783 0.677 . . . . 1.8 110.291 -169.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 140' ' ' THR . 15.1 mt -127.15 109.99 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 115.425 -0.807 . . . . 0.43 110.347 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.725 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 3.9 tpt180 -70.44 92.35 0.81 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.029 -0.987 . . . . 3.13 109.675 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.581 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 28.1 ttt180 -65.22 139.77 97.67 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.406 -0.816 . . . . 6.16 109.145 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.483 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 1.9 Cg_endo -48.8 125.55 13.07 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.409 1.406 . . . . 2.1 110.251 166.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.581 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 19.0 m-85 -121.14 153.15 37.88 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.446 -1.252 . . . . 1.83 108.263 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.73 76.67 2.0 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 122.72 1.248 . . . . 3.66 111.792 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 89.5 m-85 -114.51 143.6 30.21 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 113.885 -1.507 . . . . 3.54 109.194 171.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 37.1 Cg_exo -59.5 -32.73 96.74 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 124.526 3.484 . . . . 4.48 112.623 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -93.62 -16.37 24.41 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.687 -1.142 . . . . 5.26 111.121 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.8 m -148.96 105.39 3.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.853 -0.612 . . . . 3.43 111.885 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -147.51 101.87 3.4 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.772 -0.825 . . . . 3.34 108.772 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -142.87 171.22 14.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.568 -1.197 . . . . 3.14 112.662 -169.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -81.94 151.61 30.56 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 113.503 -1.681 . . . . 1.11 113.047 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.725 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 51.9 tt0 -45.28 147.62 0.74 Allowed 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 115.473 1.657 . . . . 1.86 115.473 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 46.5 t -153.08 131.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 113.998 -1.456 . . . . 0.41 109.856 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.616 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 35.9 mtm180 -87.14 116.63 25.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.07 -0.514 . . . . 2.8 110.192 168.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.54 153.1 38.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.613 0.721 . . . . 0.29 111.414 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.723 ' CB ' ' HB ' ' A' ' 184' ' ' VAL . 0.0 OUTLIER -120.57 101.8 8.0 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.264 -1.335 . . . . 1.71 111.147 -172.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.601 HD21 HD21 ' A' ' 113' ' ' LEU . 1.1 mp -90.72 90.12 7.81 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.443 -0.577 . . . . 0.69 109.443 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -94.0 125.03 38.39 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.297 1.046 . . . . 0.26 111.139 -175.092 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 24.4 m-85 -98.45 136.54 38.44 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.158 -1.837 . . . . 0.72 111.354 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 181' ' ' ALA . 47.5 m-20 -78.28 64.74 3.47 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.813 -1.551 . . . . 1.09 106.813 161.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.24 -99.27 1.17 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 118.71 -1.71 . . . . 0.47 110.599 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.26 -20.49 32.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.913 0.708 . . . . 0.83 112.913 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.16 123.08 27.78 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 119.001 -1.08 . . . . 1.21 110.082 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -56.53 134.48 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.2 -1.818 . . . . 0.64 110.799 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.415 ' HB2' ' OD2' ' A' ' 176' ' ' ASP . . . -106.03 -41.43 5.38 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.509 -1.223 . . . . 0.29 110.517 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.7 p -150.51 158.88 44.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.342 -0.39 . . . . 0.33 111.606 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.564 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.8 mm -109.98 150.01 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 104.855 -2.276 . . . . 0.76 104.855 163.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.723 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 42.3 t -133.6 131.31 57.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 118.761 0.71 . . . . 0.35 110.255 177.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.43 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.0 t-20 -80.42 94.34 6.16 Favored 'General case' 0 CA--C 1.476 -1.873 0 N-CA-C 106.8 -1.556 . . . . 1.77 106.8 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.616 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.0 mtm -63.68 -2.53 1.76 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 124.149 0.905 . . . . 0.55 113.39 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.4 pt-20 -83.5 -41.46 17.96 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.784 0.802 . . . . 1.02 110.672 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.451 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.6 m-20 -102.73 -25.93 13.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.262 -1.335 . . . . 1.4 108.549 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.8 t30 73.97 32.82 1.03 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.936 -2.393 . . . . 1.33 107.887 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.8 ptm180 -95.75 162.43 13.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.701 -1.59 . . . . 2.28 109.466 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 77.1 mt-30 -80.83 127.81 32.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.183 -0.917 . . . . 1.36 109.535 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.564 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -100.82 93.01 5.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.747 -0.644 . . . . 1.18 110.303 -171.255 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 20.87 -58.23 0.0 OUTLIER Glycine 0 N--CA 1.471 0.975 0 N-CA-C 116.542 1.377 . . . . 1.28 116.542 148.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 192' ' ' PHE . 34.0 p90 -162.99 175.14 11.45 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.296 -1.452 . . . . 2.8 108.755 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.761 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -145.06 127.95 16.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.556 -0.535 . . . . 0.6 109.556 156.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.548 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 1.6 mpt_? -112.02 141.56 45.53 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 120.88 -1.138 . . . . 4.77 111.507 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.888 HD13 HD13 ' A' ' 127' ' ' LEU . 40.6 mt -136.72 163.42 30.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.702 -0.681 . . . . 1.61 112.162 -172.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 199' ' ' PRO . 1.9 m-20 -112.57 114.03 50.27 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.866 -1.061 . . . . 2.66 110.214 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 198' ' ' ASP . 12.1 Cg_endo -57.35 128.67 30.45 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.877 2.385 . . . . 2.01 113.892 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.679 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 53.4 mtm180 . . . . . 0 C--O 1.252 1.192 0 CA-C-N 114.775 -1.102 . . . . 5.19 112.316 173.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.265 -0.272 . . . . 26.27 110.265 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.79 -62.62 0.17 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.504 -0.638 . . . . 24.15 111.504 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 p 48.43 80.44 0.06 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.492 0.717 . . . . 23.64 112.094 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.5 t -63.27 -42.14 99.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.003 -0.544 . . . . 22.83 110.744 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -125.63 -19.02 5.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.637 -0.256 . . . . 22.11 110.834 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 69.44 -62.14 0.42 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.653 0.781 . . . . 22.07 111.863 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.96 -67.05 1.02 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.837 0.351 . . . . 20.59 110.367 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -144.77 -175.16 4.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.202 -0.454 . . . . 18.44 110.501 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -57.39 132.6 53.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.017 0.437 . . . . 17.98 110.456 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -70.6 -7.21 42.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.829 -0.623 . . . . 17.87 112.008 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 m -60.32 -31.27 70.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.074 0.464 . . . . 16.77 110.291 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -96.8 82.82 3.33 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.998 -0.547 . . . . 16.32 109.832 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.21 61.31 0.46 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.833 -0.622 . . . . 14.63 112.127 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.5 tp -62.65 -48.4 79.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.908 0.385 . . . . 15.68 110.141 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.4 m -100.7 139.8 20.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.975 -0.557 . . . . 12.69 110.556 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.22 -177.79 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.876 2.384 . . . . 12.08 111.803 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 72.54 -55.99 0.66 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.32 0.648 . . . . 12.18 111.196 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.7 -150.45 12.59 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.493 -0.643 . . . . 8.55 111.493 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.0 t -130.0 -57.91 1.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.984 0.421 . . . . 8.07 109.899 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -120.93 33.67 5.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 7.76 110.003 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 mpt? 67.38 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.623 -0.717 . . . . 6.12 110.999 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.16 16.65 68.93 Favored Glycine 0 C--O 1.224 -0.522 0 C-N-CA 120.544 -0.836 . . . . 1.91 111.994 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.697 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 32.4 mtt180 -139.43 112.08 7.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.404 -0.961 . . . . 4.32 108.404 171.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.3 ttt -142.75 132.24 23.67 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.194 -1.003 . . . . 2.59 113.531 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' VAL . 32.6 m -124.22 101.6 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 123.148 1.452 . . . . 0.74 111.399 164.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.509 ' C ' HD12 ' A' ' 113' ' ' LEU . 43.0 t30 -162.51 119.99 2.06 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 105.007 -2.22 . . . . 1.38 105.007 170.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.754 HD23 HD11 ' A' ' 173' ' ' LEU . 5.6 mp -109.45 80.21 1.29 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.298 -1.001 . . . . 1.33 108.298 -172.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.552 ' H ' ' CE ' ' A' ' 117' ' ' MET . 27.4 tt0 -123.98 111.02 29.07 Favored Pre-proline 0 C--N 1.29 -2.02 0 C-N-CA 118.946 -1.102 . . . . 1.93 110.295 -169.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' HG3' HG12 ' A' ' 183' ' ' ILE . 39.2 Cg_exo -35.78 131.98 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 124.886 3.724 . . . . 0.65 114.298 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 28.7 t70 72.76 50.03 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.552 1.168 . . . . 0.72 110.457 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.552 ' CE ' ' H ' ' A' ' 114' ' ' GLU . 10.6 ptp -122.84 155.57 36.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.166 -1.379 . . . . 1.67 110.924 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -96.67 85.58 3.88 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.933 0.873 . . . . 0.58 108.959 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -110.18 163.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.397 -1.274 . . . . 0.65 109.924 -172.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.636 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.5 m -140.87 173.92 11.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.673 -0.492 . . . . 0.44 109.673 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.822 ' HG2' HG21 ' A' ' 147' ' ' VAL . 44.2 mttp -53.99 -32.74 55.02 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 108.575 -0.898 . . . . 2.33 108.575 164.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.627 ' O ' HG12 ' A' ' 125' ' ' VAL . 41.6 t30 -84.24 -19.19 34.33 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 114.053 -1.43 . . . . 1.32 114.733 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.636 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.3 mp0 -84.9 -63.28 1.36 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 119.755 -1.841 . . . . 2.06 107.183 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.751 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -56.36 -13.47 2.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 112.858 -1.974 . . . . 3.13 111.361 172.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 122' ' ' ASN . 14.5 p -43.19 -43.07 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.2 1.0 . . . . 0.37 110.117 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.697 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.7 -37.54 82.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.115 -1.402 . . . . 0.63 112.774 176.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -50.94 -33.83 26.11 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.723 0.773 . . . . 1.79 110.873 168.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 127' ' ' LEU . 16.0 mt -84.55 -32.62 23.75 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.931 -1.032 . . . . 0.38 109.229 -172.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.23 -35.0 77.27 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.352 -1.295 . . . . 1.96 109.644 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.572 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -70.26 -42.04 72.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.252 -1.794 . . . . 0.64 111.904 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.571 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.6 t -90.33 -2.66 58.01 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 123.384 1.564 . . . . 0.59 107.368 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 55.23 54.85 8.21 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 110.974 -2.83 . . . . 1.8 112.103 172.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.732 ' CZ ' ' HG3' ' A' ' 144' ' ' GLU . 3.8 t80 -138.97 177.85 7.59 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 113.095 0.776 . . . . 0.52 113.095 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.426 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -141.31 139.27 33.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.539 -1.282 . . . . 4.54 107.539 177.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 16.0 tm0? -49.06 139.47 10.51 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.35 1.241 . . . . 1.28 114.35 -168.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.781 HG23 HG22 ' A' ' 146' ' ' THR . 3.8 m -124.23 156.41 31.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.933 -1.939 . . . . 1.05 111.52 -175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -59.67 -37.48 78.87 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.516 1.15 . . . . 1.38 107.958 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -158.46 134.97 9.45 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 112.611 -2.086 . . . . 1.44 109.397 -177.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.562 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.05 136.42 54.58 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.0 -1.0 . . . . 0.9 111.311 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.7 t -159.0 100.59 1.57 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.684 1.231 . . . . 0.61 109.675 151.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.54 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -163.62 170.15 7.56 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.82 -1.991 . . . . 1.77 106.534 165.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.5 117.13 3.66 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.661 1.574 . . . . 0.62 112.604 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.601 ' CA ' ' HB2' ' A' ' 157' ' ' ARG . . . 105.94 36.53 2.73 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.947 -0.644 . . . . 0.51 112.366 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.732 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 12.8 mp0 -130.95 176.82 7.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.171 -0.307 . . . . 2.16 110.171 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.885 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -166.56 175.95 7.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.0 -0.741 . . . . 0.28 109.0 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.781 HG22 HG23 ' A' ' 136' ' ' VAL . 61.7 p -140.98 126.32 18.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.967 -0.56 . . . . 0.42 110.898 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.822 HG21 ' HG2' ' A' ' 121' ' ' LYS . 14.4 p -125.41 126.44 70.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.435 0.636 . . . . 0.34 112.241 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -132.36 -74.69 0.51 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.009 -0.541 . . . . 3.11 110.26 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.05 -50.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.893 0.331 . . . . 1.65 111.893 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.88 -11.47 55.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.418 -0.355 . . . . 1.68 111.516 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 10.9 p -165.13 154.72 12.94 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.868 0.842 . . . . 0.37 112.915 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.763 HG12 HG23 ' A' ' 147' ' ' VAL . 63.2 mt -114.61 108.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.597 -1.631 . . . . 0.53 106.597 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.885 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.24 166.61 13.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.703 -1.962 . . . . 1.13 105.703 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 7.6 ptm -167.53 151.67 6.59 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 124.014 0.821 . . . . 1.8 110.183 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.549 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.3 mt -128.24 113.57 30.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.159 -0.473 . . . . 0.43 110.439 172.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.773 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 13.1 mtp-105 -62.71 107.29 0.93 Allowed 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.347 0.404 . . . . 3.13 110.613 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.601 ' HB2' ' CA ' ' A' ' 143' ' ' GLY . 59.5 ttp180 -65.49 141.82 98.12 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 107.075 -1.454 . . . . 6.16 107.075 165.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -47.28 126.0 11.21 Favored 'Trans proline' 0 N--CA 1.438 -1.737 0 C-N-CA 121.302 1.335 . . . . 2.1 110.767 171.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 13.5 m-85 -124.22 137.84 54.48 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.016 -1.447 . . . . 1.83 107.658 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -110.72 74.79 0.89 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.687 1.232 . . . . 3.66 111.176 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 88.0 m-85 -120.65 156.93 55.52 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 113.568 -1.651 . . . . 3.54 109.828 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 31.2 Cg_exo -60.8 -31.36 91.7 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 124.386 3.391 . . . . 4.48 113.054 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.56 -15.07 25.81 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.116 -0.947 . . . . 5.26 111.01 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 161' ' ' PHE . 17.2 p -149.34 105.65 3.51 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.734 -0.666 . . . . 3.43 111.046 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -147.27 85.07 1.58 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.27 1.033 . . . . 3.34 109.588 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.557 ' HG3' ' NH1' ' A' ' 156' ' ' ARG . 10.5 pt-20 -165.23 153.33 11.49 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 113.371 -1.741 . . . . 3.14 106.493 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.26 -132.19 0.42 Allowed Glycine 0 C--N 1.303 -1.257 0 CA-C-O 122.817 1.232 . . . . 1.11 113.539 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.773 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 25.4 tt0 -89.57 143.6 26.68 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 112.721 -1.74 . . . . 1.86 113.02 -167.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 61.9 t -154.96 124.43 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.131 -1.395 . . . . 0.41 109.364 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 50.5 mtm180 -81.58 124.74 29.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.548 -0.538 . . . . 2.8 109.548 166.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -129.05 137.18 51.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.654 0.74 . . . . 0.29 110.346 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.552 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 7.1 tpp180 -104.82 106.54 17.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.195 -1.366 . . . . 1.71 110.936 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.754 HD11 HD23 ' A' ' 113' ' ' LEU . 5.1 mp -92.31 98.21 11.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.3 -0.63 . . . . 0.69 109.3 174.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.57 120.99 40.86 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.188 0.994 . . . . 0.26 111.499 -171.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -88.57 134.96 33.72 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.953 -1.93 . . . . 0.72 110.229 -177.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 37.4 t70 -77.21 66.15 2.94 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.676 -1.602 . . . . 1.09 106.676 163.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.81 -98.97 1.73 Allowed Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 118.801 -1.666 . . . . 0.47 110.233 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.65 -26.02 30.24 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.878 0.695 . . . . 0.83 112.878 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -128.37 128.81 45.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.442 -0.903 . . . . 1.21 110.865 -166.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.741 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.2 tt -52.14 129.13 26.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.433 -1.712 . . . . 0.64 110.546 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.91 -39.32 5.8 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.04 -0.982 . . . . 0.29 110.059 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 167.37 24.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.144 -0.48 . . . . 0.33 111.853 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' A' ' 195' ' ' PHE . 2.0 mm -118.6 147.8 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 105.444 -2.058 . . . . 0.76 105.444 164.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -139.82 128.34 26.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.579 0.704 . . . . 0.35 110.072 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.459 ' CB ' ' HG2' ' A' ' 190' ' ' ARG . 2.4 t-20 -69.4 105.13 2.48 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 107.523 -1.288 . . . . 1.77 107.523 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.686 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 6.7 mtm -65.33 -3.56 4.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.845 0.683 . . . . 0.55 112.845 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.49 ' HG3' ' ND2' ' A' ' 188' ' ' ASN . 11.2 pt-20 -96.12 -37.44 10.59 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.695 0.76 . . . . 1.02 111.303 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 187' ' ' GLU . 48.9 m-80 -104.4 -26.53 12.39 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.541 -1.208 . . . . 1.4 109.893 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 75.39 31.83 0.76 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.745 -2.025 . . . . 1.33 108.362 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 13.5 ptt180 -92.93 156.46 16.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.454 -1.248 . . . . 2.28 109.503 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -84.69 127.44 34.1 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.87 -1.059 . . . . 1.36 109.692 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.556 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -103.77 92.81 4.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.918 -0.713 . . . . 1.18 110.451 -171.522 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 18.27 -58.5 0.0 OUTLIER Glycine 0 N--CA 1.468 0.826 0 N-CA-C 115.905 1.122 . . . . 1.28 115.905 145.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -163.32 174.21 12.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.043 -1.578 . . . . 2.8 108.399 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.688 ' HB3' HD22 ' A' ' 113' ' ' LEU . 1.9 t80 -142.82 152.71 42.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.086 -1.079 . . . . 0.6 108.086 156.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.42 147.53 34.75 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 122.058 -0.401 . . . . 4.77 111.422 -172.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.479 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 5.4 mt -132.87 172.43 12.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.636 0.976 . . . . 1.61 113.636 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.91 106.56 31.57 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 113.399 -1.728 . . . . 2.66 108.667 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -50.64 126.18 17.49 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.826 2.351 . . . . 2.01 113.612 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.572 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 79.6 mtp180 . . . . . 0 C--O 1.252 1.196 0 CA-C-N 115.016 -0.993 . . . . 5.19 111.994 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.46 ' SD ' ' HA2' ' A' ' 177' ' ' GLY . 66.2 mtt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.75 0.309 . . . . 26.27 110.249 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.86 63.15 4.12 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.756 -0.735 . . . . 24.15 112.143 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.2 m -87.01 -4.59 59.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.799 0.333 . . . . 23.64 111.206 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.4 t -75.65 -27.91 58.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 22.83 110.322 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.1 t60 74.35 -59.97 0.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.39 0.676 . . . . 22.11 111.215 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -87.89 104.87 17.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.969 0.414 . . . . 22.07 110.056 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -79.47 146.99 32.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.152 -0.684 . . . . 20.59 109.152 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -93.05 -90.04 0.19 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.814 -0.354 . . . . 18.44 111.486 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 26.9 m170 51.01 81.81 0.06 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.208 0.318 . . . . 17.98 110.469 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -59.95 123.39 16.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.027 0.441 . . . . 17.87 111.06 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -90.85 132.38 35.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.803 -0.635 . . . . 16.77 110.053 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 t -77.68 2.22 17.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.876 0.369 . . . . 16.32 110.264 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 103' ' ' ARG . . . -84.42 -13.64 72.98 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 121.004 -0.617 . . . . 14.63 111.982 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp 63.05 -80.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.215 0.606 . . . . 15.68 112.287 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.681 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 84.3 t -125.09 -56.36 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.295 -0.411 . . . . 12.69 111.961 -174.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.681 ' HD2' ' H ' ' A' ' 101' ' ' VAL . 1.8 Cg_endo -43.35 -42.22 10.41 Favored 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.993 2.462 . . . . 12.08 112.805 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.434 ' HB3' ' HA3' ' A' ' 99' ' ' GLY . 47.4 ttt180 -90.32 97.41 11.17 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.723 -0.473 . . . . 12.18 109.723 174.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.75 58.82 4.89 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.052 -0.594 . . . . 8.55 112.496 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.4 p -80.96 85.45 6.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.047 0.451 . . . . 8.07 110.744 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -101.28 -32.82 10.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.98 -0.554 . . . . 7.76 110.931 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 63.2 mtt 63.64 -153.87 0.32 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.864 -0.607 . . . . 6.12 109.834 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.74 -10.76 73.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.646 -0.787 . . . . 1.91 112.212 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HB2' ' HG3' ' A' ' 126' ' ' LYS . 3.4 ptm180 -140.49 99.09 3.56 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 122.954 0.501 . . . . 4.32 110.642 168.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.425 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 52.3 ttp -141.14 125.52 17.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 118.306 -1.358 . . . . 2.59 113.732 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 111' ' ' VAL . 26.8 m -114.0 101.53 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 122.763 1.268 . . . . 0.74 110.947 167.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.435 ' C ' HD12 ' A' ' 113' ' ' LEU . 53.0 t30 -163.02 109.75 1.19 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.576 -1.647 . . . . 1.38 106.763 171.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.603 ' CG ' HD21 ' A' ' 173' ' ' LEU . 4.9 mp -104.02 77.38 1.43 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.937 -0.764 . . . . 1.33 108.937 -169.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -121.81 107.64 35.7 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 119.342 -0.943 . . . . 1.93 110.311 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.532 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.4 Cg_exo -34.04 130.25 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.542 3.494 . . . . 0.65 114.407 -172.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 23.1 t0 77.72 39.22 0.18 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.456 1.122 . . . . 0.72 110.811 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.635 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -115.05 155.51 26.88 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.867 -1.06 . . . . 1.67 110.577 172.13 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 m -92.91 86.6 5.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.964 0.887 . . . . 0.58 109.205 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.63 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.7 tt -116.46 162.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.076 -1.42 . . . . 0.65 109.718 -171.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.682 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.6 m -142.26 178.03 7.85 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.96 -0.756 . . . . 0.44 108.96 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.817 ' HG2' HG21 ' A' ' 147' ' ' VAL . 28.9 mtpt -57.45 -28.58 63.47 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 108.525 -0.917 . . . . 2.33 108.525 163.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.583 ' O ' HG12 ' A' ' 125' ' ' VAL . 32.9 t30 -85.32 -18.44 33.83 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-N 113.851 -1.522 . . . . 1.32 114.774 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.682 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.0 mp0 -86.9 -62.08 1.58 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 119.82 -1.8 . . . . 2.06 108.289 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.822 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.7 tpt -53.58 -17.03 1.8 Allowed 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 112.8 -2.0 . . . . 3.13 110.779 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.593 HG13 ' HE3' ' A' ' 126' ' ' LYS . 14.9 p -43.98 -44.92 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.288 1.042 . . . . 0.37 110.447 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HE3' HG13 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -69.18 -36.29 77.19 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.937 -1.483 . . . . 0.63 112.838 177.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.76 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -51.1 -35.08 33.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 122.028 0.918 . . . . 1.79 110.54 168.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.822 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.2 mt -84.82 -28.6 26.0 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.754 -1.112 . . . . 0.38 109.152 -171.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.69 -20.47 50.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.136 -1.393 . . . . 1.96 110.341 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 200' ' ' ARG . . . -80.62 -43.87 19.82 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.07 -1.423 . . . . 0.64 111.215 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.91 -6.17 54.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 123.653 1.692 . . . . 0.59 107.094 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.12 56.41 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 110.976 -2.829 . . . . 1.8 112.945 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.732 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -135.15 176.72 8.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.615 -0.721 . . . . 0.52 111.817 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 65.7 ttt180 -136.98 149.95 47.84 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.126 -1.435 . . . . 4.54 107.126 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -48.88 137.0 13.24 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.737 1.256 . . . . 1.28 112.836 -170.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.6 p -137.6 140.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 112.349 -2.205 . . . . 1.05 109.677 -164.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 m -63.5 -31.72 72.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.096 0.951 . . . . 1.38 109.3 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -152.6 117.72 5.19 Favored 'General case' 0 CA--C 1.485 -1.539 0 CA-C-N 113.352 -1.749 . . . . 1.44 110.661 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.664 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -109.59 117.88 35.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 113.81 -1.541 . . . . 0.9 110.12 179.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -151.12 95.59 2.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.24 1.495 . . . . 0.61 108.399 156.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.53 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -168.31 155.87 7.63 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 111.546 -2.57 . . . . 1.77 105.029 168.401 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.479 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 14.6 Cg_exo -71.17 123.6 9.77 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.526 1.484 . . . . 0.62 112.18 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.688 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 106.15 20.14 9.48 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 120.579 -0.82 . . . . 0.51 111.781 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.732 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.8 mp0 -125.99 173.82 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.807 -0.442 . . . . 2.16 109.807 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.885 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 47.6 p90 -168.42 168.17 11.38 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.506 -1.294 . . . . 0.28 107.506 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.683 HG22 HG13 ' A' ' 136' ' ' VAL . 34.9 p -133.19 127.27 33.43 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.713 -0.795 . . . . 0.42 110.499 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.879 HG23 HG12 ' A' ' 152' ' ' ILE . 10.7 p -122.93 121.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.715 -0.794 . . . . 0.34 112.861 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -111.02 -77.47 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.973 . . . . 3.11 109.74 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -176.73 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.261 -0.881 . . . . 1.65 109.092 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.45 -19.32 39.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.97 -1.014 . . . . 1.68 110.128 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 21.0 p -160.6 155.03 23.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.149 -0.932 . . . . 0.37 111.751 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.879 HG12 HG23 ' A' ' 147' ' ' VAL . 53.4 mt -121.11 113.82 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.487 -1.671 . . . . 0.53 106.487 163.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.885 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -89.82 169.99 10.79 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.374 -1.713 . . . . 1.13 106.374 175.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.23 150.54 5.36 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 123.802 0.689 . . . . 1.8 110.672 -174.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.6 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.3 mt -128.71 119.47 49.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.763 -0.653 . . . . 0.43 109.938 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.71 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 82.6 mtp180 -67.21 112.9 4.74 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.458 0.474 . . . . 3.13 110.719 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.568 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 14.8 tpt180 -72.22 133.83 83.18 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 107.616 -1.253 . . . . 6.16 107.616 166.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.419 ' HD2' ' HD2' ' A' ' 157' ' ' ARG . 1.8 Cg_endo -46.89 126.01 10.54 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 121.205 1.27 . . . . 2.1 110.642 167.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 17.3 m-85 -121.17 145.51 47.75 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.236 -1.347 . . . . 1.83 107.716 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.36 73.78 1.23 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.616 1.198 . . . . 3.66 111.13 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.508 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 97.0 m-85 -120.99 149.92 52.1 Favored Pre-proline 0 C--N 1.306 -1.286 0 CA-C-N 113.766 -1.561 . . . . 3.54 109.902 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.2 Cg_exo -62.12 -30.38 82.31 Favored 'Trans proline' 0 CA--C 1.503 -1.053 0 C-N-CA 124.532 3.488 . . . . 4.48 112.783 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.24 -11.72 22.37 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.691 -1.14 . . . . 5.26 110.967 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.8 m -145.37 99.66 3.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.861 -0.609 . . . . 3.43 111.348 -173.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 166' ' ' GLU . 5.6 tppp? -149.17 99.77 2.97 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.41 -0.589 . . . . 3.34 109.41 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 165' ' ' LYS . 7.0 mt-10 -149.76 174.6 12.43 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.214 -0.903 . . . . 3.14 109.611 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.63 175.91 54.77 Favored Glycine 0 C--N 1.298 -1.543 0 CA-C-N 114.388 -1.278 . . . . 1.11 111.21 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.71 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 5.3 tt0 -58.26 152.13 17.97 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.133 -1.034 . . . . 1.86 112.064 172.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 53.7 t -153.69 130.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.712 -1.131 . . . . 0.41 108.711 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.703 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 51.4 mtm180 -87.25 122.82 31.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.225 0.536 . . . . 2.8 110.152 169.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -130.25 128.45 41.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.091 0.948 . . . . 0.29 110.791 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.543 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 9.0 tpp180 -96.26 120.88 37.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.496 -1.683 . . . . 1.71 110.251 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.603 HD21 ' CG ' ' A' ' 113' ' ' LEU . 7.4 mp -111.54 103.99 12.36 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.422 0.63 . . . . 0.69 111.045 174.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.75 124.87 47.01 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.777 -1.101 . . . . 0.26 111.284 -174.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -97.9 139.6 33.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.137 -1.847 . . . . 0.72 110.683 -175.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.1 64.06 4.81 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 106.754 -1.573 . . . . 1.09 106.754 160.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.46 ' HA2' ' SD ' ' A' ' 87' ' ' MET . . . 69.84 -98.82 0.64 Allowed Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 118.78 -1.676 . . . . 0.47 110.926 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.41 -25.47 59.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.939 0.718 . . . . 0.83 112.939 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -136.28 133.89 37.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.768 -0.773 . . . . 1.21 109.824 -169.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -60.1 138.79 57.81 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.115 -1.402 . . . . 0.64 110.0 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.34 -45.21 4.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.043 -0.98 . . . . 0.29 110.513 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.8 p -148.66 158.8 44.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 111.698 0.259 . . . . 0.33 111.698 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.555 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.2 mm -107.42 148.32 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 104.966 -2.235 . . . . 0.76 104.966 165.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.5 t -140.05 126.88 23.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.532 0.682 . . . . 0.35 110.077 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -69.72 107.48 3.49 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.356 -1.349 . . . . 1.77 107.356 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.703 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 20.3 mtm -64.66 -8.33 14.01 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 112.862 0.69 . . . . 0.55 112.862 -165.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -91.66 -41.83 10.51 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.768 0.794 . . . . 1.02 111.45 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -98.24 -25.47 14.86 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.391 -1.277 . . . . 1.4 109.381 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.1 t30 70.09 35.47 2.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.912 -2.404 . . . . 1.33 108.015 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.5 ptm180 -96.42 157.78 15.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.604 -1.634 . . . . 2.28 108.833 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 87.8 mt-30 -85.94 129.43 34.84 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.336 -0.847 . . . . 1.36 109.221 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.555 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -104.1 91.91 4.15 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.259 -0.576 . . . . 1.18 110.547 -170.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.33 -59.09 0.0 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 116.26 1.264 . . . . 1.28 116.26 147.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 192' ' ' PHE . 26.2 p90 -164.75 171.08 14.74 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.639 -1.281 . . . . 2.8 109.137 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.575 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -139.19 151.87 46.92 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.842 -1.17 . . . . 0.6 107.842 159.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.697 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.23 148.46 36.48 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.906 -0.496 . . . . 4.77 110.465 -175.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.599 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 3.5 mt -130.15 172.07 12.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.282 1.039 . . . . 1.61 113.728 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -97.74 114.13 64.55 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 113.207 -1.815 . . . . 2.66 108.249 170.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.07 124.51 16.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.176 2.584 . . . . 2.01 114.087 -169.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.859 0 O-C-N 124.395 1.06 . . . . 5.19 112.506 177.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 120.62 0.248 . . . . 26.27 110.475 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.97 71.95 2.33 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.884 -0.674 . . . . 24.15 111.625 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.5 t -142.5 119.06 11.0 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.05 -0.352 . . . . 23.64 110.05 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.7 t -84.0 93.03 7.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.125 -0.489 . . . . 22.83 110.171 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -74.91 106.92 6.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.295 -0.632 . . . . 22.11 109.295 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -82.01 39.31 0.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 22.07 111.904 -171.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -151.43 150.19 30.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.45 -0.574 . . . . 20.59 109.45 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -83.6 62.71 6.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.45 -0.341 . . . . 18.44 110.199 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 52.46 65.06 1.62 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.716 -0.675 . . . . 17.98 110.564 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -110.2 56.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.452 0.644 . . . . 17.87 109.327 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.403 ' HB3' HD21 ' A' ' 100' ' ' LEU . 19.4 m -124.37 70.48 1.11 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.57 -0.741 . . . . 16.77 111.12 -173.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 m -67.71 147.54 52.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.144 -0.48 . . . . 16.32 110.412 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.15 -42.9 1.79 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 14.63 112.114 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.43 ' H ' HD23 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -101.68 41.91 1.17 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.415 0.626 . . . . 15.68 110.146 178.209 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -164.69 119.06 1.0 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.251 -0.886 . . . . 12.69 110.233 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.6 168.43 24.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.578 2.185 . . . . 12.08 111.691 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 62.26 61.22 1.33 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.522 0.677 . . . . 12.18 109.98 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.28 -142.77 46.39 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.518 -0.765 . . . . 8.55 112.147 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.1 m -120.05 41.91 3.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.147 0.498 . . . . 8.07 109.806 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -57.17 134.55 55.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.416 -0.811 . . . . 7.76 110.417 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 109' ' ' ARG . 22.9 mmt -81.26 -39.17 25.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.716 -0.675 . . . . 6.12 110.698 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 123' ' ' GLU . . . 78.92 -31.74 1.99 Allowed Glycine 0 C--O 1.217 -0.968 0 CA-C-N 115.383 -0.826 . . . . 1.91 111.884 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -73.17 99.55 2.85 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.327 1.051 . . . . 4.32 109.114 174.434 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.581 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 26.2 ttt -144.23 136.92 26.93 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.423 -0.511 . . . . 2.59 111.882 -170.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 126' ' ' LYS . 2.0 m -119.8 104.4 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 122.569 1.175 . . . . 0.74 113.41 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -159.74 108.23 1.76 Allowed 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.939 -1.937 . . . . 1.38 106.895 163.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.823 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.2 mp -98.17 113.21 25.05 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.517 0.675 . . . . 1.33 109.295 -173.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -139.97 100.77 7.17 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.76 -1.109 . . . . 1.93 109.031 -173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' HD3' HD12 ' A' ' 183' ' ' ILE . 23.5 Cg_exo -35.12 133.68 0.19 Allowed 'Trans proline' 0 CA--C 1.515 -0.46 0 C-N-CA 124.452 3.435 . . . . 0.65 113.997 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 31.4 t70 74.74 47.06 0.12 Allowed 'General case' 0 CA--C 1.529 0.135 0 O-C-N 124.583 1.177 . . . . 0.72 109.91 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.589 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 12.4 ptt? -121.12 155.79 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.266 -1.333 . . . . 1.67 110.339 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 179' ' ' HIS . 56.5 m -101.59 102.75 13.52 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.532 -0.914 . . . . 0.58 108.532 -176.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.71 HD13 ' HE3' ' A' ' 124' ' ' MET . 16.6 tt -138.93 167.76 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.212 -0.904 . . . . 0.65 110.64 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.6 m -140.84 174.33 10.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.765 0.711 . . . . 0.44 110.785 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.514 ' HA ' HD11 ' A' ' 152' ' ' ILE . 11.9 mttp -57.49 -26.19 60.91 Favored 'General case' 0 C--O 1.211 -0.944 0 N-CA-C 109.089 -0.708 . . . . 2.33 109.089 165.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 40.6 t30 -84.44 -17.1 40.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.316 -1.311 . . . . 1.32 114.052 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.7 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 1.8 tt0 -87.18 -60.25 2.03 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.658 -1.238 . . . . 2.06 107.658 168.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.848 ' SD ' HD12 ' A' ' 152' ' ' ILE . 61.2 mtt -54.86 -15.91 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.832 -1.985 . . . . 3.13 111.906 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.576 HG13 ' HE3' ' A' ' 126' ' ' LYS . 12.9 p -44.16 -40.63 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 122.141 0.972 . . . . 0.37 109.967 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.659 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.77 -40.7 84.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.066 -1.425 . . . . 0.63 112.743 176.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -49.74 -33.71 16.97 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.686 0.755 . . . . 1.79 111.041 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 127' ' ' LEU . 14.6 mt -85.96 -34.27 20.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.856 -1.065 . . . . 0.38 109.607 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.59 -34.6 76.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.448 -1.251 . . . . 1.96 109.854 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.89 67.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.512 -1.676 . . . . 0.64 111.451 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.421 ' HA ' ' HZ ' ' A' ' 159' ' ' PHE . 0.5 OUTLIER -89.64 -0.42 57.51 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 123.976 1.846 . . . . 0.59 106.969 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 55.75 54.6 8.03 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 111.079 -2.782 . . . . 1.8 112.693 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 2.7 t80 -141.38 174.93 10.08 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.022 -0.535 . . . . 0.52 111.864 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -137.1 156.46 48.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.949 -1.13 . . . . 4.54 107.949 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.415 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.86 139.73 16.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.31 1.052 . . . . 1.28 112.172 -170.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.0 p -138.61 142.5 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 112.998 -1.91 . . . . 1.05 110.205 -164.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.12 -33.41 69.11 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.519 1.152 . . . . 1.38 109.616 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 1.4 ttpt -160.54 129.19 4.73 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 112.521 -2.127 . . . . 1.44 108.262 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.62 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -116.32 128.86 55.91 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.919 -0.582 . . . . 0.9 111.541 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.426 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.0 OUTLIER -161.68 98.56 1.11 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.551 1.167 . . . . 0.61 110.279 157.311 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.452 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -166.66 167.07 8.39 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 112.891 -1.959 . . . . 1.77 105.833 161.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.494 ' HB3' ' HD2' ' A' ' 158' ' ' PRO . 24.4 Cg_exo -62.59 127.76 21.63 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 120.866 1.044 . . . . 0.62 110.416 170.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.721 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 86.25 42.69 6.52 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.428 -1.367 . . . . 0.51 112.96 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 28.2 mt-10 -140.76 166.15 25.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.843 -0.428 . . . . 2.16 109.843 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.721 ' O ' HG12 ' A' ' 136' ' ' VAL . 46.2 p90 -167.85 161.46 13.1 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.825 -0.806 . . . . 0.28 108.825 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.601 HG23 ' SD ' ' A' ' 139' ' ' MET . 71.4 p -123.35 130.73 53.13 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.284 0.564 . . . . 0.42 110.461 171.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 152' ' ' ILE . 9.8 p -120.54 108.53 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.984 0.897 . . . . 0.34 110.374 172.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -109.62 -68.2 0.94 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 3.11 110.296 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.6 -53.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.933 0.346 . . . . 1.65 111.933 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -102.17 1.83 36.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.545 0.572 . . . . 1.68 112.545 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 2.8 p -163.93 153.16 14.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.554 0.693 . . . . 0.37 112.807 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.848 HD12 ' SD ' ' A' ' 124' ' ' MET . 52.6 mt -112.11 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.287 -1.324 . . . . 0.53 107.683 165.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 2.4 mt-10 -95.65 103.22 15.09 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.371 -0.831 . . . . 1.13 109.325 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -113.62 166.65 11.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.396 -0.82 . . . . 1.8 111.848 -169.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.61 HG12 ' HG3' ' A' ' 170' ' ' ARG . 14.7 mt -127.63 106.64 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 114.616 -1.175 . . . . 0.43 110.297 173.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.721 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 53.4 ttt180 -68.05 91.02 0.33 Allowed 'General case' 0 C--N 1.32 -0.702 0 O-C-N 124.025 0.828 . . . . 3.13 110.08 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.721 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 64.0 ttt180 -58.75 139.15 86.48 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.471 -0.786 . . . . 6.16 109.911 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 142' ' ' PRO . 4.8 Cg_endo -50.73 125.04 14.75 Favored 'Trans proline' 0 N--CA 1.437 -1.835 0 C-N-CA 121.155 1.236 . . . . 2.1 110.228 167.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.595 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 25.9 m-85 -117.46 121.42 40.98 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.231 -1.35 . . . . 1.83 107.976 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 11.8 p-10 -81.26 77.29 8.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.815 1.293 . . . . 3.66 111.511 -173.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 83.3 m-85 -115.9 145.21 34.27 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 113.165 -1.834 . . . . 3.54 108.983 171.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.4 Cg_exo -59.19 -31.63 95.65 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 124.683 3.588 . . . . 4.48 113.47 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.27 -17.93 31.38 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.894 -1.048 . . . . 5.26 111.404 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 72.2 m -157.69 112.25 2.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.824 -0.625 . . . . 3.43 111.469 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 160' ' ' ASP . 23.6 tptp -142.08 97.82 3.21 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.913 0.863 . . . . 3.34 108.995 172.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -126.94 175.3 8.17 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.344 -1.298 . . . . 3.14 112.401 -168.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.09 147.08 28.55 Favored Glycine 0 C--N 1.312 -0.781 0 CA-C-N 113.82 -1.536 . . . . 1.11 111.632 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.721 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.9 OUTLIER -58.41 158.32 7.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.306 0.574 . . . . 1.86 112.413 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 59.6 t -151.45 127.43 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.049 -0.978 . . . . 0.41 110.154 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.61 ' HG3' HG12 ' A' ' 155' ' ' ILE . 8.6 mtt180 -82.8 110.74 18.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.059 -0.519 . . . . 2.8 109.901 169.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.97 137.63 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.992 0.901 . . . . 0.29 111.693 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 3.7 tpp180 -101.83 101.35 11.79 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.74 -1.573 . . . . 1.71 110.798 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.685 HD23 ' SD ' ' A' ' 124' ' ' MET . 2.9 mp -88.97 92.24 9.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.425 -0.583 . . . . 0.69 109.425 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.02 39.6 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.532 1.158 . . . . 0.26 111.902 -171.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-85 -88.81 137.58 32.19 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.647 -2.069 . . . . 0.72 110.89 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.9 t70 -81.93 65.1 6.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.987 -1.857 . . . . 1.09 105.987 160.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 73.59 -99.43 1.01 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 118.66 -1.733 . . . . 0.47 110.743 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -75.96 -26.99 57.34 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 112.773 0.657 . . . . 0.83 112.773 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.429 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 13.1 p-80 -133.12 129.74 38.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.862 -0.735 . . . . 1.21 111.181 -168.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.9 tt -52.6 126.52 19.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.286 -1.325 . . . . 0.64 109.756 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -103.0 -38.7 7.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.432 -0.803 . . . . 0.29 109.453 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.2 p -147.16 161.5 40.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.284 -0.871 . . . . 0.33 110.463 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 24.9 mt -126.17 147.66 30.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 104.212 -2.514 . . . . 0.76 104.212 167.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 3.8 t -136.71 134.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.855 -0.738 . . . . 0.35 111.692 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.596 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 12.1 m120 -72.53 97.74 2.17 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.424 -1.695 . . . . 1.77 106.424 174.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.522 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 46.1 mtm -65.95 -2.91 4.39 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.277 0.561 . . . . 0.55 112.345 -168.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.596 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 14.1 pt-20 -74.38 -42.85 58.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.046 0.927 . . . . 1.02 110.829 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -105.41 -25.52 12.33 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.277 -1.329 . . . . 1.4 108.814 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.7 t30 73.47 36.47 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 111.834 -2.439 . . . . 1.33 108.063 -174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 11.5 ptt180 -100.1 161.14 13.8 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.466 -1.243 . . . . 2.28 110.337 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -76.93 134.42 38.93 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.082 -0.963 . . . . 1.36 110.666 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -105.77 91.14 3.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.888 -0.577 . . . . 1.18 110.206 -174.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.46 -57.47 0.0 OUTLIER Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.68 1.432 . . . . 1.28 116.68 144.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -162.52 176.26 10.61 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.297 -1.451 . . . . 2.8 109.129 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.823 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 10.9 t80 -149.34 100.43 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.445 0.64 . . . . 0.6 110.197 156.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -98.86 139.18 34.92 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.546 -0.721 . . . . 4.77 111.128 -175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 127' ' ' LEU . 2.0 mt -109.81 172.44 6.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 113.639 0.977 . . . . 1.61 113.639 -175.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.425 ' HA ' ' HD2' ' A' ' 199' ' ' PRO . 35.9 m-20 -122.22 99.69 43.05 Favored Pre-proline 0 N--CA 1.443 -0.815 0 CA-C-N 113.382 -1.736 . . . . 2.66 109.276 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 198' ' ' ASP . 17.7 Cg_endo -59.04 156.31 34.72 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.705 2.27 . . . . 2.01 112.878 -176.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.631 ' HD3' ' OXT' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.185 -0.912 . . . . 5.19 110.804 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.07 -0.345 . . . . 26.27 110.07 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.55 85.14 0.23 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.936 -0.649 . . . . 24.15 112.062 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.5 p -74.6 149.44 40.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.718 0.294 . . . . 23.64 110.511 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.7 t -78.45 89.34 4.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.186 0.517 . . . . 22.83 110.136 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -139.24 151.93 46.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.768 -0.651 . . . . 22.11 110.27 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -94.05 117.4 30.05 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.446 -0.575 . . . . 22.07 109.446 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -83.43 -53.28 5.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.264 -0.425 . . . . 20.59 111.391 -175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -135.09 112.24 10.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.518 -0.31 . . . . 18.44 110.479 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -160.33 -173.01 3.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.152 -0.685 . . . . 17.98 109.152 178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 65.85 40.01 4.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.339 0.59 . . . . 17.87 109.962 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.5 p -129.51 164.02 24.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.233 -0.894 . . . . 16.77 110.378 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.6 m -96.12 75.28 3.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.19 0.519 . . . . 16.32 110.631 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.38 69.04 0.92 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.915 -0.66 . . . . 14.63 113.023 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 65.99 102.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.417 0.627 . . . . 15.68 111.209 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.1 t -111.06 107.2 57.66 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.705 -0.679 . . . . 12.69 109.87 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.79 130.47 26.27 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.844 2.362 . . . . 12.08 112.17 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -146.87 44.67 1.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.536 0.684 . . . . 12.18 109.45 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.86 32.1 81.73 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 110.814 -0.914 . . . . 8.55 110.814 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -89.2 123.96 33.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.273 -0.464 . . . . 8.07 111.154 -172.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -79.51 -24.64 42.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.323 0.582 . . . . 7.76 109.432 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.0 mmt -133.23 -74.22 0.49 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.283 -0.871 . . . . 6.12 109.098 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.11 22.15 79.23 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 119.48 -1.343 . . . . 1.91 112.454 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.561 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 21.3 mtm180 -140.28 79.73 1.72 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 122.942 0.497 . . . . 4.32 110.112 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.577 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 34.8 tpp -141.57 133.04 26.8 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.703 -1.599 . . . . 2.59 115.209 -169.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.594 HG12 ' HE1' ' A' ' 124' ' ' MET . 17.3 m -121.11 107.84 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.111 0.958 . . . . 0.74 113.126 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -158.64 109.7 2.12 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.262 -1.384 . . . . 1.38 107.262 167.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.668 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 5.8 mp -95.34 101.16 12.87 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.205 0.526 . . . . 1.33 110.315 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -145.56 95.74 4.92 Favored Pre-proline 0 N--CA 1.429 -1.502 0 C-N-CA 119.781 -0.768 . . . . 1.93 109.455 -174.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.667 ' HD3' HD12 ' A' ' 183' ' ' ILE . 1.0 OUTLIER -33.53 142.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.589 1 C-N-CA 126.356 4.704 . . . . 0.65 115.422 -174.331 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.1 40.06 0.74 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.698 -1.592 . . . . 0.72 109.197 -170.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.592 ' HE3' HD13 ' A' ' 180' ' ' LEU . 9.6 ptt? -118.09 154.84 31.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 113.993 -1.458 . . . . 1.67 109.734 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.5 m -101.46 81.04 2.14 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.298 1.047 . . . . 0.58 108.593 -175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.669 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -104.88 161.94 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.464 -1.698 . . . . 0.65 109.871 -169.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.56 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 23.1 m -143.34 179.3 7.17 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 119.634 -0.826 . . . . 0.44 110.583 -173.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.627 ' HG2' HG21 ' A' ' 147' ' ' VAL . 1.2 mttm -61.62 -24.77 66.92 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.79 -1.189 . . . . 2.33 107.79 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.746 ' O ' HG12 ' A' ' 125' ' ' VAL . 4.3 t30 -83.77 -24.19 31.2 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 114.102 -1.408 . . . . 1.32 113.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.577 ' HA ' ' H ' ' A' ' 110' ' ' MET . 0.9 OUTLIER -80.48 -60.63 2.24 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.153 -2.217 . . . . 2.06 106.769 175.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.822 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.4 mmt -57.86 -17.26 15.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.767 -2.015 . . . . 3.13 111.943 173.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.4 p -43.5 -42.16 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 122.0 0.905 . . . . 0.37 110.518 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.561 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.93 -37.66 81.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.366 -1.288 . . . . 0.63 113.806 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.74 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.9 tm? -56.34 -34.15 66.32 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.455 0.645 . . . . 1.79 109.943 167.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.822 ' HG ' ' O ' ' A' ' 124' ' ' MET . 11.8 mt -84.06 -31.38 25.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.948 0.88 . . . . 0.38 108.932 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.5 -31.25 68.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.796 -1.547 . . . . 1.96 110.043 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.595 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -72.75 -44.56 61.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.956 -1.474 . . . . 0.64 111.387 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.45 ' HA ' ' HZ ' ' A' ' 159' ' ' PHE . 0.6 OUTLIER -92.94 -1.43 56.71 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.294 -1.743 . . . . 0.59 106.294 -177.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 53.94 50.8 15.97 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.696 -2.502 . . . . 1.8 111.826 169.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.838 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.8 t80 -129.92 175.22 9.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.506 0.67 . . . . 0.52 112.125 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -141.1 149.54 41.72 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.305 -1.739 . . . . 4.54 106.305 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.783 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 20.7 tm0? -51.26 140.97 15.75 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.952 1.358 . . . . 1.28 113.765 -167.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.6 p -136.93 144.91 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 112.27 -2.241 . . . . 1.05 110.51 -161.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -59.07 -34.2 71.7 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 122.684 1.231 . . . . 1.38 109.095 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 2.3 ttpt -159.55 128.61 5.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.57 -2.105 . . . . 1.44 109.104 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.612 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.14 124.31 50.02 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.47 -0.786 . . . . 0.9 111.165 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.8 t -158.13 97.92 1.55 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.678 1.228 . . . . 0.61 109.68 153.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.604 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -166.23 161.05 12.59 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 112.699 -2.046 . . . . 1.77 106.469 164.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.401 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 23.9 Cg_exo -65.36 116.79 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 121.404 1.403 . . . . 0.62 111.259 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.598 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 108.32 21.44 7.65 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 119.804 -1.189 . . . . 0.51 113.087 -173.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.838 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 11.5 mp0 -134.48 159.44 41.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.256 0.528 . . . . 2.16 111.647 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.79 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.0 p90 -163.57 167.86 20.78 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.999 -1.111 . . . . 0.28 107.999 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.636 HG22 HG13 ' A' ' 136' ' ' VAL . 6.0 p -133.34 126.93 32.43 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.768 -0.773 . . . . 0.42 111.56 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.783 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.8 p -125.56 127.45 71.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.401 0.619 . . . . 0.34 112.142 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -133.71 -77.06 0.48 Allowed 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.008 -0.433 . . . . 3.11 110.088 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.44 -57.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.376 -0.375 . . . . 1.65 111.31 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -90.74 3.9 53.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.618 0.599 . . . . 1.68 112.618 -173.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.0 p -167.93 152.01 6.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.017 0.913 . . . . 0.37 113.292 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.641 HG12 HG23 ' A' ' 147' ' ' VAL . 42.0 mt -114.5 109.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 113.608 -1.633 . . . . 0.53 106.694 161.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.79 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.5 mp0 -91.91 159.54 15.71 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 105.427 -2.064 . . . . 1.13 105.427 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.665 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 17.8 ptp -164.16 162.43 22.77 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.828 0.705 . . . . 1.8 110.785 -172.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.777 HG23 ' HG3' ' A' ' 168' ' ' GLN . 11.9 mt -111.35 108.27 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.008 -0.997 . . . . 0.43 110.531 163.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 195' ' ' PHE . 12.7 tpt180 -45.17 112.19 0.41 Allowed 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 113.511 -1.677 . . . . 3.13 110.076 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.996 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -43.78 98.41 0.18 Allowed Pre-proline 0 C--N 1.318 -0.768 0 O-C-N 125.7 1.875 . . . . 6.16 114.791 -163.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.499 ' HG3' ' HA ' ' A' ' 168' ' ' GLN . 9.0 Cg_endo -94.64 123.17 0.37 Allowed 'Trans proline' 0 N--CA 1.435 -1.923 0 C-N-CA 122.984 2.456 . . . . 2.1 110.312 164.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.996 ' CE2' ' HB2' ' A' ' 157' ' ' ARG . 12.3 m-85 -148.34 151.53 35.5 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.28 -1.378 . . . . 1.83 107.28 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -92.3 78.16 5.12 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.647 1.213 . . . . 3.66 111.307 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 58.3 m-85 -115.9 144.33 32.51 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 113.817 -1.538 . . . . 3.54 109.036 173.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.8 Cg_exo -59.05 -31.08 94.95 Favored 'Trans proline' 0 CA--C 1.501 -1.173 0 C-N-CA 124.619 3.546 . . . . 4.48 112.908 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -95.67 -11.65 26.81 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.82 -1.082 . . . . 5.26 111.416 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.2 m -161.2 103.99 1.28 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.385 -0.37 . . . . 3.43 111.539 -174.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -147.35 90.39 1.87 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.973 0.892 . . . . 3.34 110.035 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -110.06 172.82 6.64 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.096 -1.411 . . . . 3.14 111.729 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.62 138.53 19.71 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 114.561 -1.199 . . . . 1.11 113.079 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.777 ' HG3' HG23 ' A' ' 155' ' ' ILE . 7.0 tt0 -62.78 148.95 45.3 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.478 -0.861 . . . . 1.86 113.292 177.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 156' ' ' ARG . 53.9 t -154.4 120.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.053 -1.43 . . . . 0.41 109.212 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 154' ' ' MET . 0.0 OUTLIER -76.84 114.23 15.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.55 -0.537 . . . . 2.8 109.55 170.085 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.05 131.86 54.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.883 -1.127 . . . . 0.29 110.761 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.77 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.1 tpp180 -93.32 97.66 10.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.174 -1.375 . . . . 1.71 110.45 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -87.28 91.46 8.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.853 -0.425 . . . . 0.69 109.853 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.4 114.67 27.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.551 1.167 . . . . 0.26 111.936 -173.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.751 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -82.75 134.32 35.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.556 -2.111 . . . . 0.72 110.11 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 34.0 t70 -77.14 66.16 2.89 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.649 -1.611 . . . . 1.09 106.649 163.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.5 -98.09 1.63 Allowed Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 118.678 -1.725 . . . . 0.47 110.158 -174.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -92.23 -13.43 30.49 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.384 0.883 . . . . 0.83 113.384 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -136.09 125.07 24.23 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 119.109 -1.036 . . . . 1.21 110.899 -171.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.751 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.4 tt -53.61 127.67 26.31 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.217 -1.811 . . . . 0.64 111.047 -176.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.45 -38.32 6.22 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.079 -0.964 . . . . 0.29 110.283 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -147.26 166.96 25.46 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.918 -0.583 . . . . 0.33 110.734 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.77 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 32.6 mt -137.12 145.17 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 106.348 -1.723 . . . . 0.76 106.348 168.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 47.5 t -139.11 134.49 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 109.533 -0.543 . . . . 0.35 109.533 -174.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.671 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 42.2 t-20 -81.12 103.81 11.18 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.439 -1.319 . . . . 1.77 107.439 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.525 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 33.5 mtm -67.04 -2.51 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.875 0.695 . . . . 0.55 112.875 -165.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.671 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.7 pt-20 -83.55 -41.93 17.37 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 122.055 0.931 . . . . 1.02 111.06 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.527 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 6.3 m-20 -108.26 -25.36 11.08 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.255 -1.339 . . . . 1.4 109.313 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 75.56 32.59 0.7 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 112.365 -2.198 . . . . 1.33 107.69 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.8 ptm180 -88.86 162.28 16.24 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 113.673 -1.603 . . . . 2.28 109.633 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -88.98 139.67 30.22 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.609 -1.178 . . . . 1.36 113.128 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 5.3 m-85 -105.74 -166.45 1.21 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.889 -1.959 . . . . 1.18 107.691 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.592 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 138.22 -9.17 3.54 Favored Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 107.791 -2.123 . . . . 1.28 107.791 -147.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.9 109.32 2.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.045 -1.077 . . . . 2.8 111.071 155.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.8 t80 -125.12 137.75 54.17 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.228 -0.92 . . . . 0.6 109.342 163.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.662 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.2 mpt_? -123.07 146.4 47.73 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.069 -0.394 . . . . 4.77 110.52 -176.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.74 HD13 ' HG ' ' A' ' 127' ' ' LEU . 38.2 mt -137.48 171.1 14.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.869 0.366 . . . . 1.61 111.757 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.453 ' CB ' ' HE ' ' A' ' 157' ' ' ARG . 12.5 t70 -113.86 111.13 48.53 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.609 -0.723 . . . . 2.66 109.62 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.04 126.26 20.53 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.414 2.076 . . . . 2.01 113.099 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.595 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.252 0 CA-C-N 115.047 -0.979 . . . . 5.19 111.62 -176.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.724 -0.472 . . . . 26.27 109.724 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.85 -83.62 1.26 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.658 -0.782 . . . . 24.15 111.659 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.3 m 54.03 50.89 15.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.156 0.503 . . . . 23.64 111.414 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -65.81 -38.58 89.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.921 -0.581 . . . . 22.83 110.718 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -114.0 23.75 12.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.244 0.545 . . . . 22.11 110.853 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -118.73 132.97 56.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.616 -0.72 . . . . 22.07 109.209 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 39.8 m80 63.99 30.89 14.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.53 0.681 . . . . 20.59 109.659 -172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -121.4 111.94 17.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.196 -0.911 . . . . 18.44 109.472 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -79.68 146.15 32.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.4 -0.364 . . . . 17.98 110.894 -176.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -83.49 163.52 20.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.136 -0.69 . . . . 17.87 109.136 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.1 m 63.86 94.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.657 0.598 . . . . 16.77 110.989 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 27.1 t -65.21 120.91 13.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.12 -0.491 . . . . 16.32 110.068 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.485 ' HA3' ' SD ' ' A' ' 107' ' ' MET . . . 92.36 -78.71 1.2 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.087 -0.578 . . . . 14.63 112.534 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 99' ' ' GLY . 50.2 tp 74.7 -54.65 0.67 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.651 0.781 . . . . 15.68 110.905 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 35.4 m -83.5 150.16 59.36 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.168 -0.469 . . . . 12.69 110.287 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 101' ' ' VAL . 5.7 Cg_exo -78.45 48.92 2.88 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.872 2.381 . . . . 12.08 112.481 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -87.97 70.29 9.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.257 0.551 . . . . 12.18 110.223 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.91 141.48 7.39 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.851 -0.69 . . . . 8.55 112.065 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 122' ' ' ASN . 8.7 t -83.97 76.31 10.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.039 0.447 . . . . 8.07 110.031 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -136.63 7.33 3.02 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.023 0.379 . . . . 7.76 112.023 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.489 ' H ' HD21 ' A' ' 122' ' ' ASN . 3.8 ptt? -140.92 147.16 38.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.732 0.301 . . . . 6.12 111.041 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.1 -10.57 37.06 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.033 -0.603 . . . . 1.91 112.049 -171.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -26.97 106.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.852 1.261 . . . . 4.32 112.026 167.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 54.2 ttm -143.04 138.33 29.89 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.847 0.684 . . . . 2.59 112.847 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.12 102.12 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 122.524 1.154 . . . . 0.74 112.819 166.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -163.08 109.06 1.14 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.95 -1.87 . . . . 1.38 105.95 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.948 HD13 HD21 ' A' ' 173' ' ' LEU . 40.3 mt -93.16 113.58 25.85 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.425 -0.51 . . . . 1.33 110.022 -169.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 117' ' ' MET . 38.5 tt0 -138.78 104.77 7.5 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.512 -0.475 . . . . 1.93 110.773 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.495 ' HD3' HD12 ' A' ' 183' ' ' ILE . 31.5 Cg_exo -36.59 128.88 0.46 Allowed 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 124.032 3.155 . . . . 0.65 113.317 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.8 t70 71.94 50.84 0.23 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 122.6 1.19 . . . . 0.72 110.026 -173.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.583 ' HE3' HD13 ' A' ' 180' ' ' LEU . 14.0 ptt? -121.45 155.75 34.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.232 -1.349 . . . . 1.67 110.51 174.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.93 85.93 3.89 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.814 0.816 . . . . 0.58 109.682 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.694 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -111.23 161.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.598 -1.183 . . . . 0.65 110.083 -173.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.733 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.9 m -141.44 176.6 8.74 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.125 -0.695 . . . . 0.44 109.125 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.65 ' HG2' HG21 ' A' ' 147' ' ' VAL . 7.3 mtpp -55.8 -30.55 61.53 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.439 -0.578 . . . . 2.33 109.439 166.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.613 ' O ' HG12 ' A' ' 125' ' ' VAL . 57.5 t30 -86.02 -17.49 35.11 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.979 1.474 . . . . 1.32 114.979 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.733 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.7 mp0 -85.4 -62.63 1.49 Allowed 'General case' 0 N--CA 1.425 -1.703 0 O-C-N 120.581 -1.325 . . . . 2.06 107.749 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.778 ' SD ' HD22 ' A' ' 173' ' ' LEU . 3.6 ttm -59.9 -13.26 10.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.03 -1.895 . . . . 3.13 111.23 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 122' ' ' ASN . 14.8 p -42.81 -41.82 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 122.075 0.941 . . . . 0.37 110.306 171.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.618 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -68.87 -39.32 79.9 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.391 -1.277 . . . . 0.63 112.549 177.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.775 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -49.07 -34.0 12.79 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.639 0.733 . . . . 1.79 110.968 168.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.6 mt -84.91 -30.34 24.43 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.934 -1.03 . . . . 0.38 109.529 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.9 -19.23 52.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.046 -1.434 . . . . 1.96 110.502 170.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.38 -40.91 25.64 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.981 -1.463 . . . . 0.64 110.788 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 128' ' ' LEU . 15.0 t -91.53 2.69 56.26 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.25 1.5 . . . . 0.59 107.407 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 43.99 54.41 5.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 111.438 -2.619 . . . . 1.8 112.948 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.741 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.6 t80 -134.27 177.45 7.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.813 -0.63 . . . . 0.52 111.087 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -136.29 148.63 48.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.777 -1.194 . . . . 4.54 107.777 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 1.6 tt0 -49.38 135.2 17.91 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.745 1.26 . . . . 1.28 111.374 -172.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.3 p -128.3 133.11 67.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 112.58 -2.1 . . . . 1.05 109.006 -165.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -58.97 -31.85 69.12 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.736 1.255 . . . . 1.38 109.496 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 136' ' ' VAL . 4.1 tmmm? -160.33 132.66 6.26 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 112.297 -2.229 . . . . 1.44 107.498 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.657 ' HB2' ' CD ' ' A' ' 144' ' ' GLU . 8.6 ptt? -115.35 133.04 56.4 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.868 -1.06 . . . . 0.9 112.993 -168.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.46 ' HA ' ' OE1' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -162.51 100.36 1.04 Allowed 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.992 0.901 . . . . 0.61 108.668 152.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.61 150.01 7.56 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.825 -1.534 . . . . 1.77 108.83 169.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.54 134.57 41.85 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.197 1.265 . . . . 0.62 110.036 170.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.668 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 76.43 54.21 5.19 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.898 -1.144 . . . . 0.51 111.873 -173.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.741 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -144.73 178.15 8.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.691 -0.195 . . . . 2.16 110.636 177.587 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.852 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 53.0 p90 -168.84 170.64 9.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.222 -1.029 . . . . 0.28 108.222 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 139' ' ' MET . 19.0 p -132.98 126.74 32.64 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.148 -0.621 . . . . 0.42 110.864 171.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.747 HG23 HG12 ' A' ' 152' ' ' ILE . 8.7 p -124.64 112.76 33.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.693 0.758 . . . . 0.34 112.004 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -116.7 -66.02 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.772 -0.649 . . . . 3.11 110.596 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.65 -69.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.276 . . . . 1.65 111.634 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -83.07 10.9 7.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 112.439 0.533 . . . . 1.68 112.439 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -170.42 151.14 3.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.925 0.869 . . . . 0.37 112.792 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.747 HG12 HG23 ' A' ' 147' ' ' VAL . 59.7 mt -120.28 115.74 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.707 -1.588 . . . . 0.53 106.961 165.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.852 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 6.9 mp0 -89.64 176.01 7.04 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.558 -1.275 . . . . 1.13 107.558 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 12.8 ptm -169.23 160.82 9.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.76 0.663 . . . . 1.8 111.208 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' A' ' 170' ' ' ARG . 29.3 mt -127.78 115.06 38.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 122.76 0.424 . . . . 0.43 110.81 165.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.781 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 77.6 mtp180 -71.51 91.83 1.08 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.399 -0.364 . . . . 3.13 110.52 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.668 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 36.9 ttp180 -59.87 136.36 90.26 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 107.086 -1.45 . . . . 6.16 107.086 168.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -47.58 125.11 10.49 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.348 1.365 . . . . 2.1 111.15 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 165' ' ' LYS . 11.7 m-85 -123.15 122.84 39.42 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.892 -1.503 . . . . 1.83 107.177 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -97.15 76.75 2.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.798 1.285 . . . . 3.66 110.997 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 97.3 m-85 -116.66 149.48 43.96 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 113.548 -1.66 . . . . 3.54 110.009 175.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 52.8 Cg_exo -56.72 -33.71 94.49 Favored 'Trans proline' 0 CA--C 1.495 -1.464 0 C-N-CA 124.919 3.746 . . . . 4.48 112.912 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.19 -9.52 25.56 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.095 -1.411 . . . . 5.26 111.208 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 48.7 m -162.03 104.03 1.15 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.83 -0.623 . . . . 3.43 110.865 -174.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 86.7 tttt -147.61 102.33 3.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.495 0.664 . . . . 3.34 109.985 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -147.16 159.77 43.23 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.82 -1.082 . . . . 3.14 111.514 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.34 152.77 34.61 Favored Glycine 0 CA--C 1.496 -1.113 0 CA-C-N 113.41 -1.723 . . . . 1.11 112.324 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.781 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 49.2 tt0 -45.03 141.48 2.25 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 115.342 1.608 . . . . 1.86 115.342 -177.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 78.9 t -154.58 129.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 113.067 -1.878 . . . . 0.41 109.229 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 1.029 ' HG2' ' HE3' ' A' ' 186' ' ' MET . 16.0 ttm180 -91.86 102.33 14.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.908 -0.775 . . . . 2.8 108.908 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -105.34 143.74 33.1 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.244 -0.983 . . . . 0.29 112.054 -173.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 11.7 tpp180 -99.95 113.62 26.31 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.947 -1.479 . . . . 1.71 110.206 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.948 HD21 HD13 ' A' ' 113' ' ' LEU . 7.2 mp -107.7 102.14 11.39 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.039 -0.664 . . . . 0.69 110.578 175.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.65 125.33 47.06 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 114.938 -1.028 . . . . 0.26 111.721 -170.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-30 -89.51 133.26 34.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.855 -1.975 . . . . 0.72 110.212 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.2 t70 -74.25 65.78 1.22 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.609 -1.626 . . . . 1.09 106.609 161.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.07 -98.27 1.59 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.673 -1.727 . . . . 0.47 110.368 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -86.92 -20.31 27.55 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.094 0.775 . . . . 0.83 113.094 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -133.15 130.67 39.5 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.742 -0.783 . . . . 1.21 110.727 -169.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.694 ' HB2' HG22 ' A' ' 119' ' ' ILE . 4.4 tt -52.64 129.35 29.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.933 -1.485 . . . . 0.64 110.803 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.61 -38.24 6.2 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.873 -1.058 . . . . 0.29 109.816 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.3 p -148.34 158.29 44.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.841 -0.618 . . . . 0.33 111.502 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.648 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 17.1 mt -125.02 146.58 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 105.827 -1.916 . . . . 0.76 105.827 167.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.5 t -142.09 135.44 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.665 0.745 . . . . 0.35 110.743 -171.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.402 ' ND2' ' HG2' ' A' ' 187' ' ' GLU . 62.9 t30 -81.24 95.95 7.1 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.497 -1.297 . . . . 1.77 107.497 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' MET . . . . . 1.029 ' HE3' ' HG2' ' A' ' 170' ' ' ARG . 28.3 mtm -62.35 -2.94 1.15 Allowed 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 114.028 1.122 . . . . 0.55 114.028 -164.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 9.6 pt-20 -81.53 -43.33 18.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.822 0.82 . . . . 1.02 110.705 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.546 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.3 m-20 -105.7 -25.7 12.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.314 -1.312 . . . . 1.4 109.034 -177.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 75.72 31.77 0.71 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.316 -2.22 . . . . 1.33 108.318 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 4.0 ptm180 -91.01 156.12 18.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.147 -1.388 . . . . 2.28 109.778 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.99 132.82 35.4 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.729 -1.123 . . . . 1.36 109.72 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -107.45 91.29 3.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.796 -0.762 . . . . 1.18 111.35 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -58.1 0.0 OUTLIER Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.506 1.362 . . . . 1.28 116.506 145.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 192' ' ' PHE . 99.7 m-85 -160.34 175.52 12.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.916 -1.642 . . . . 2.8 107.435 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.892 ' HB3' HD12 ' A' ' 113' ' ' LEU . 2.1 t80 -142.77 145.41 33.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.244 -1.021 . . . . 0.6 108.244 153.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.632 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -130.52 138.57 50.28 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.15 -0.969 . . . . 4.77 110.798 -171.366 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 196' ' ' ARG . 2.3 mt -125.52 171.29 10.64 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 113.533 0.938 . . . . 1.61 113.533 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.429 ' HA ' ' HD2' ' A' ' 199' ' ' PRO . 18.2 t70 -77.45 125.41 86.22 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 113.205 -1.816 . . . . 2.66 110.057 176.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.605 ' O ' ' HD3' ' A' ' 200' ' ' ARG . 1.6 Cg_endo -47.73 126.07 12.13 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.155 3.236 . . . . 2.01 114.746 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.605 ' HD3' ' O ' ' A' ' 199' ' ' PRO . 6.7 mmt180 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.533 -0.746 . . . . 5.19 109.801 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.6 tmm? . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.679 -0.489 . . . . 26.27 109.679 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.39 130.27 9.86 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.714 -0.755 . . . . 24.15 111.9 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.1 p -74.93 -31.61 61.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.885 0.374 . . . . 23.64 111.201 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 m -77.71 73.93 4.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.221 0.534 . . . . 22.83 111.075 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -73.56 -18.23 61.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.841 -0.618 . . . . 22.11 110.421 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -75.17 84.67 2.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 22.07 110.534 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -138.56 135.08 34.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.158 -0.473 . . . . 20.59 110.437 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -87.26 102.53 14.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.899 -0.592 . . . . 18.44 110.531 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -112.27 85.13 2.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.122 0.487 . . . . 17.98 110.193 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -89.58 -32.06 17.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.857 -0.61 . . . . 17.87 110.348 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.1 m -71.89 88.92 1.05 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.96 -0.564 . . . . 16.77 110.553 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.0 t -137.16 27.19 2.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.835 -0.621 . . . . 16.32 110.004 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.22 -156.27 18.54 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.694 -0.765 . . . . 14.63 111.844 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 58.66 32.42 22.15 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.282 0.563 . . . . 15.68 110.528 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.41 97.21 35.09 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.612 -0.722 . . . . 12.69 110.76 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -89.97 -2.44 5.57 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.723 2.282 . . . . 12.08 112.438 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -111.54 126.65 55.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.057 -0.519 . . . . 12.18 110.781 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.77 -60.73 4.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.853 -0.689 . . . . 8.55 112.251 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.31 137.17 58.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 8.07 111.382 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -69.42 -29.42 67.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 7.76 109.882 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 49.2 ttm -80.7 143.86 32.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.918 -0.583 . . . . 6.12 109.456 173.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.24 17.32 16.08 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 120.485 -0.864 . . . . 1.91 111.518 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.513 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 2.0 mtt180 -137.31 90.79 2.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.241 -0.651 . . . . 4.32 109.241 170.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.6 mtt -138.82 127.28 23.07 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.498 -0.881 . . . . 2.59 112.687 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.4 m -121.32 103.22 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 122.496 1.141 . . . . 0.74 112.139 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -161.1 108.35 1.48 Allowed 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.402 -1.726 . . . . 1.38 106.77 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 mp -97.07 78.94 2.81 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.493 -0.929 . . . . 1.33 108.493 -174.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -113.66 95.58 37.39 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.429 -0.805 . . . . 1.93 110.279 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.576 ' HG3' HG12 ' A' ' 183' ' ' ILE . 25.3 Cg_exo -33.68 125.87 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.523 3.482 . . . . 0.65 114.147 -171.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.1 t70 77.62 48.62 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 124.813 1.321 . . . . 0.72 110.125 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.71 154.95 36.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.832 -1.076 . . . . 1.67 110.42 171.173 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -94.6 93.77 7.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.477 -0.783 . . . . 0.58 109.037 -170.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.495 HG21 ' HE2' ' A' ' 117' ' ' MET . 19.7 tt -139.74 169.97 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 114.68 -1.146 . . . . 0.65 110.729 -166.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.625 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 m -137.98 174.25 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.947 -0.761 . . . . 0.44 108.947 -177.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.611 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -66.67 -19.31 65.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.179 -1.045 . . . . 2.33 108.179 169.351 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.555 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 1.8 t30 -83.68 -18.06 39.29 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-N 114.401 -1.272 . . . . 1.32 113.596 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.6 mp0 -86.25 -54.94 4.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 120.483 -1.385 . . . . 2.06 107.32 167.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.713 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.2 mmt -53.8 -13.56 0.74 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.974 -1.921 . . . . 3.13 111.771 168.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 14.9 p -43.36 -42.78 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 122.31 1.052 . . . . 0.37 109.58 171.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -65.37 -39.66 92.58 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.715 -1.584 . . . . 0.63 112.939 176.152 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -51.25 -32.49 24.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.731 0.777 . . . . 1.79 110.94 170.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 127' ' ' LEU . 16.7 mt -85.83 -33.42 21.32 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.005 -0.998 . . . . 0.38 109.568 -172.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.43 ' OE2' ' HE2' ' A' ' 126' ' ' LYS . 2.8 mt-10 -72.26 -23.71 61.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.982 -1.463 . . . . 1.96 110.011 169.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.466 ' HA ' ' HG3' ' A' ' 200' ' ' ARG . . . -76.94 -44.3 32.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.679 -1.6 . . . . 0.64 111.598 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -86.28 -6.57 58.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.538 1.637 . . . . 0.59 107.538 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 58.59 53.46 6.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 111.156 -2.747 . . . . 1.8 112.348 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.727 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.9 t80 -136.3 176.35 8.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.882 -0.599 . . . . 0.52 111.769 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 22.9 tpt180 -135.59 152.14 50.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.043 -1.466 . . . . 4.54 107.043 175.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 2.5 tt0 -49.68 137.65 15.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.579 1.18 . . . . 1.28 112.512 -170.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.7 p -135.35 142.0 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.519 -2.128 . . . . 1.05 109.751 -166.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.71 -34.12 70.96 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.684 1.23 . . . . 1.38 109.129 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 5.5 ttpt -159.86 126.14 4.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.424 -2.171 . . . . 1.44 108.385 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.65 ' SD ' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -112.68 130.14 56.15 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.606 -0.725 . . . . 0.9 110.536 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.9 OUTLIER -158.4 98.15 1.53 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.836 1.303 . . . . 0.61 109.431 152.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -164.93 167.2 10.12 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 112.23 -2.259 . . . . 1.77 106.048 167.357 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.476 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 59.5 Cg_endo -72.26 126.18 11.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.426 1.417 . . . . 0.62 112.102 174.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.605 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 95.72 26.04 12.42 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 120.438 -0.887 . . . . 0.51 113.415 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.727 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 6.1 mp0 -126.82 171.42 11.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.1 0.45 . . . . 2.16 110.439 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.681 ' O ' HG12 ' A' ' 136' ' ' VAL . 43.1 p90 -168.4 165.09 12.82 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.481 -0.933 . . . . 0.28 108.481 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.65 HG23 ' SD ' ' A' ' 139' ' ' MET . 53.9 p -126.29 128.95 47.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.029 -0.532 . . . . 0.42 110.659 171.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.482 ' CG1' ' HG3' ' A' ' 135' ' ' GLN . 8.5 p -112.76 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.513 0.673 . . . . 0.34 111.093 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -122.95 36.96 4.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.523 -0.762 . . . . 3.11 110.484 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.38 -54.51 0.67 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.446 -0.797 . . . . 1.65 112.687 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -87.26 -10.43 52.43 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.895 0.379 . . . . 1.68 111.517 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -161.61 141.99 10.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.904 0.859 . . . . 0.37 112.716 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.611 HD11 ' HA ' ' A' ' 121' ' ' LYS . 35.4 mt -112.56 109.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.576 -1.647 . . . . 0.53 108.033 169.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 23.6 mt-10 -101.74 103.07 13.81 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.765 -0.828 . . . . 1.13 108.765 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 23.4 ptm -106.66 163.87 12.55 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.301 -0.863 . . . . 1.8 111.764 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.647 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 47.2 mt -130.08 112.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.166 -0.924 . . . . 0.43 110.817 168.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.671 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 56.6 mtm180 -64.34 113.16 3.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.291 -0.413 . . . . 3.13 110.357 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.605 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 79.6 ttt180 -73.72 135.82 77.71 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 107.051 -1.462 . . . . 6.16 107.051 166.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -49.5 125.3 13.63 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 120.873 1.049 . . . . 2.1 110.146 170.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 24.9 m-85 -117.19 145.77 43.66 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.283 -1.326 . . . . 1.83 108.556 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -97.4 76.31 2.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.544 1.164 . . . . 3.66 111.666 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.512 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 77.0 m-85 -115.98 142.5 29.26 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 113.663 -1.608 . . . . 3.54 108.965 171.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 37.4 Cg_exo -58.73 -28.92 88.12 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 124.769 3.646 . . . . 4.48 113.11 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.45 -10.26 25.72 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.936 -1.029 . . . . 5.26 111.421 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.441 ' HB2' ' OD1' ' A' ' 198' ' ' ASP . 48.9 m -158.22 106.4 1.97 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.2 0.524 . . . . 3.43 111.435 -175.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -147.53 82.66 1.53 Allowed 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.874 0.845 . . . . 3.34 108.807 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -118.63 -177.06 3.22 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.251 -1.34 . . . . 3.14 111.829 -169.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.44 154.89 37.07 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 114.521 -1.218 . . . . 1.11 111.789 173.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.7 OUTLIER -54.25 153.88 4.91 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.415 -0.892 . . . . 1.86 112.48 176.261 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 55.5 t -153.09 129.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.128 -0.942 . . . . 0.41 109.663 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.974 ' HG2' ' HE3' ' A' ' 186' ' ' MET . 9.3 ttt180 -88.6 107.55 18.97 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 109.202 -0.666 . . . . 2.8 109.202 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.53 137.14 53.42 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 119.275 -0.97 . . . . 0.29 111.986 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 15.5 tpp85 -99.09 107.37 19.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.762 -1.563 . . . . 1.71 111.455 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 151' ' ' SER . 4.7 mp -94.25 96.27 9.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.055 -0.52 . . . . 0.69 109.912 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -98.08 118.15 34.04 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.539 1.161 . . . . 0.26 110.9 -178.485 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 41.9 m-85 -92.31 127.04 37.65 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 112.847 -1.979 . . . . 0.72 110.038 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 17.3 t70 -75.73 65.59 1.91 Allowed 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.643 -1.614 . . . . 1.09 106.643 167.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.32 -100.18 0.78 Allowed Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.404 -1.379 . . . . 0.47 110.897 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.44 -21.63 48.88 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.24 0.829 . . . . 0.83 113.24 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.445 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 16.3 p-80 -135.82 128.65 31.12 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 119.822 -0.751 . . . . 1.21 110.287 -170.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.9 tt -60.26 130.03 44.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.294 -1.321 . . . . 0.64 109.664 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -103.02 -40.93 6.28 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.675 -0.693 . . . . 0.29 110.74 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 158.49 43.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.167 0.432 . . . . 0.33 112.167 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.615 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 3.1 mm -115.28 148.28 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 105.139 -2.171 . . . . 0.76 105.139 164.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.1 t -139.05 126.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.41 0.624 . . . . 0.35 110.33 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.595 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.6 t-20 -78.1 99.05 5.99 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.488 -1.301 . . . . 1.77 107.488 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.974 ' HE3' ' HG2' ' A' ' 170' ' ' ARG . 32.8 mtm -64.36 -2.17 2.08 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.816 1.043 . . . . 0.55 113.816 -166.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.595 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.9 pt-20 -80.36 -43.05 21.77 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.039 0.923 . . . . 1.02 110.645 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.524 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 7.8 m120 -109.03 -25.63 10.6 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.995 -1.457 . . . . 1.4 109.579 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 77.56 27.35 0.62 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.689 -2.05 . . . . 1.33 108.044 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.72 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 33.9 mtp180 -74.04 160.67 30.96 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.76 -1.564 . . . . 2.28 109.68 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 96.4 mt-30 -95.38 118.07 31.46 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.484 -1.234 . . . . 1.36 108.462 175.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.615 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -93.63 91.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.748 -0.781 . . . . 1.18 110.552 -166.641 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.98 -57.39 0.0 OUTLIER Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.277 1.418 . . . . 1.28 116.407 145.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 192' ' ' PHE . 48.3 p90 -163.73 174.73 11.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.701 -1.75 . . . . 2.8 107.584 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.722 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.0 t80 -151.41 98.69 2.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.28 0.562 . . . . 0.6 109.595 158.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.497 ' O ' ' HD2' ' A' ' 196' ' ' ARG . 2.8 ppt_? -90.29 145.57 24.88 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.412 -0.805 . . . . 4.77 111.222 -176.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 127' ' ' LEU . 1.8 mt -119.0 171.82 7.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.027 0.917 . . . . 1.61 113.291 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.441 ' OD1' ' HB2' ' A' ' 164' ' ' SER . 8.8 m-20 -76.6 134.98 68.79 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 113.439 -1.709 . . . . 2.66 110.165 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.608 ' O ' ' HD3' ' A' ' 200' ' ' ARG . 3.6 Cg_endo -50.33 126.41 17.5 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 124.21 3.273 . . . . 2.01 114.802 -172.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 199' ' ' PRO . 23.9 mmt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-N 115.556 -0.747 . . . . 5.19 109.606 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.711 ' N ' ' HG ' ' A' ' 90' ' ' SER . 69.9 mtm . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.842 0.353 . . . . 26.27 110.737 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.96 -58.17 4.01 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.819 -0.705 . . . . 24.15 112.881 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.5 m -95.27 2.67 54.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.173 0.511 . . . . 23.64 110.766 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.711 ' HG ' ' N ' ' A' ' 87' ' ' MET . 2.3 p -70.98 133.94 46.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.748 . . . . 22.83 110.611 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.564 ' HA ' ' O ' ' A' ' 97' ' ' SER . 36.1 m80 -105.14 -0.66 26.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.246 0.546 . . . . 22.11 110.487 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -134.87 60.51 1.7 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.629 -0.714 . . . . 22.07 109.523 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -99.18 -44.91 6.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.766 -0.652 . . . . 20.59 109.314 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -163.52 110.43 1.15 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.495 -0.928 . . . . 18.44 108.495 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.43 ' HB3' ' H ' ' A' ' 96' ' ' HIS . 32.1 m170 63.74 -152.72 0.32 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.374 -0.602 . . . . 17.98 109.374 -170.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.43 ' H ' ' HB3' ' A' ' 95' ' ' HIS . 84.8 t60 -82.19 91.36 6.7 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.803 -0.443 . . . . 17.87 109.803 175.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 91' ' ' HIS . 16.3 m -75.57 91.28 2.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.79 -0.641 . . . . 16.77 110.86 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 p -97.49 16.22 20.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.977 -0.556 . . . . 16.32 110.925 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.09 -85.77 0.17 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.413 -0.675 . . . . 14.63 111.413 -176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 50.35 57.28 6.76 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.989 0.424 . . . . 15.68 111.116 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.2 m -71.64 128.73 89.39 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.046 -0.524 . . . . 12.69 111.11 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.32 108.89 1.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.621 2.214 . . . . 12.08 112.186 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.4 ttp-105 -69.32 -26.35 64.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.654 -0.703 . . . . 12.18 109.742 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.56 146.45 12.53 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.145 -0.934 . . . . 8.55 111.454 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.1 p -77.55 68.87 3.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.449 0.643 . . . . 8.07 110.13 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.569 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 89.2 m-70 -120.35 -80.52 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.805 -0.634 . . . . 7.76 111.327 -176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 106' ' ' HIS . 4.2 mpp? -134.95 -174.15 3.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.326 -0.397 . . . . 6.12 110.953 -175.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.9 17.09 11.39 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 118.383 -1.232 . . . . 1.91 114.537 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 13.8 mmt180 14.18 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.842 1.257 . . . . 4.32 112.816 175.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.772 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.5 tpt -139.94 124.63 18.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.392 0.886 . . . . 2.59 113.392 -165.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.65 HG11 ' N ' ' A' ' 127' ' ' LEU . 0.6 OUTLIER -126.66 107.65 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 114.21 1.189 . . . . 0.74 114.21 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -157.86 107.03 2.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.158 -1.793 . . . . 1.38 106.158 163.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.8 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.2 mp -85.68 112.66 21.23 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.728 -0.669 . . . . 1.33 110.781 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 33.2 tt0 -156.43 102.07 2.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 114.957 -1.019 . . . . 1.93 109.911 -176.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.696 ' HD3' ' CD1' ' A' ' 183' ' ' ILE . 9.7 Cg_exo -30.48 138.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 125.654 4.236 . . . . 0.65 114.593 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.6 t70 76.05 40.98 0.24 Allowed 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.778 1.299 . . . . 0.72 109.331 -171.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.545 ' HE3' HD13 ' A' ' 180' ' ' LEU . 11.9 ptt? -121.63 154.94 36.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.401 -1.272 . . . . 1.67 109.623 174.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.61 87.36 2.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.836 -1.172 . . . . 0.58 107.836 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.689 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.2 tt -111.08 157.18 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.084 -1.416 . . . . 0.65 110.316 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.79 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.9 m -141.24 176.76 8.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.12 -0.696 . . . . 0.44 109.12 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.831 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 5.8 mtpm? -56.27 -28.26 58.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.266 0.555 . . . . 2.33 109.511 165.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.7 t-20 -84.26 -19.04 34.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.062 1.134 . . . . 1.32 114.062 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.79 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -88.22 -62.01 1.59 Allowed 'General case' 0 N--CA 1.415 -2.197 0 O-C-N 120.769 -1.207 . . . . 2.06 108.931 176.226 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.966 ' HG3' HG21 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -58.11 -16.69 14.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 112.994 -1.912 . . . . 3.13 110.382 172.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 11.3 p -42.63 -43.33 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.288 1.042 . . . . 0.37 110.712 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.529 ' CE ' HG13 ' A' ' 125' ' ' VAL . 10.1 mmpt? -69.65 -35.92 75.61 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.22 -1.354 . . . . 0.63 113.132 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.65 ' N ' HG11 ' A' ' 111' ' ' VAL . 9.0 tt -52.92 -34.04 53.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.571 0.7 . . . . 1.79 110.085 168.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 124' ' ' MET . 6.3 mt -83.86 -34.31 24.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.471 -0.937 . . . . 0.38 108.471 -171.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.97 -33.23 75.55 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.919 -1.491 . . . . 1.96 109.728 169.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 200' ' ' ARG . . . -72.75 -45.95 56.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.967 -1.47 . . . . 0.64 111.766 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.41 ' HA ' ' HZ ' ' A' ' 159' ' ' PHE . 0.4 OUTLIER -89.87 -1.73 58.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 123.747 1.737 . . . . 0.59 107.741 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 55.5 54.46 8.45 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 110.817 -2.902 . . . . 1.8 112.666 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 3.2 t80 -137.84 175.67 9.38 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.52 112.455 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 30.1 tpt180 -139.17 151.95 47.02 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.57 -1.27 . . . . 4.54 107.57 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 1.5 tm0? -49.22 142.4 7.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.335 1.064 . . . . 1.28 113.05 -168.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.6 p -141.6 139.98 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 113.215 -1.811 . . . . 1.05 110.169 -163.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -59.8 -32.31 70.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.511 1.148 . . . . 1.38 109.791 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -159.35 127.78 5.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.754 -2.021 . . . . 1.44 108.825 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.684 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -117.49 124.02 47.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.728 -1.124 . . . . 0.9 111.098 -177.461 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.715 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.3 t -158.7 95.23 1.3 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 123.236 1.493 . . . . 0.61 110.473 154.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.715 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.39 155.39 16.99 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 111.71 -2.495 . . . . 1.77 105.706 163.036 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.524 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 27.8 Cg_exo -61.13 126.05 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.15 1.233 . . . . 0.62 110.807 173.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.504 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 92.8 45.04 3.74 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 119.878 -1.153 . . . . 0.51 112.995 -172.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.572 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 37.0 mt-10 -141.88 174.45 10.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.903 0.351 . . . . 2.16 110.534 173.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.868 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -170.47 164.7 8.6 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.66 -1.237 . . . . 0.28 107.66 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.676 HG22 ' CG1' ' A' ' 136' ' ' VAL . 1.1 p -134.41 129.17 34.92 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 119.328 -0.949 . . . . 0.42 110.757 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' A' ' 121' ' ' LYS . 10.6 p -122.58 109.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.878 0.846 . . . . 0.34 111.832 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -106.89 -72.33 0.72 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.299 -0.864 . . . . 3.11 110.031 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.61 -53.97 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.72 0.295 . . . . 1.65 111.75 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -82.68 -12.63 57.46 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.491 -0.322 . . . . 1.68 111.721 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 15.9 p -160.33 153.26 21.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.13 0.967 . . . . 0.37 112.397 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.966 HG21 ' HG3' ' A' ' 124' ' ' MET . 74.6 mt -110.99 114.24 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.33 -1.759 . . . . 0.53 107.002 165.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.2 mp0 -90.59 165.85 13.52 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.978 -1.86 . . . . 1.13 105.978 174.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.639 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -167.64 156.76 9.87 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 124.123 0.89 . . . . 1.8 109.818 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.594 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 13.5 mt -127.28 105.44 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.054 -0.521 . . . . 0.43 110.19 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.804 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.2 ttt-85 -73.53 88.35 1.64 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.159 -0.928 . . . . 3.13 109.919 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.524 ' HB2' ' C ' ' A' ' 142' ' ' PRO . 53.4 ttt180 -60.55 144.11 89.28 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.064 -0.971 . . . . 6.16 109.854 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 1.4 Cg_endo -48.28 126.36 13.6 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 121.757 1.638 . . . . 2.1 110.938 166.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 165' ' ' LYS . 13.0 m-85 -125.78 136.57 53.29 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.927 -1.509 . . . . 1.83 106.927 175.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.27 74.34 3.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.645 1.212 . . . . 3.66 111.449 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.499 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 72.6 m-85 -120.69 148.9 49.28 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 113.524 -1.671 . . . . 3.54 110.023 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.7 Cg_exo -59.44 -31.84 95.43 Favored 'Trans proline' 0 CA--C 1.502 -1.087 0 C-N-CA 124.749 3.633 . . . . 4.48 113.513 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -88.47 -22.96 23.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.065 -0.971 . . . . 5.26 111.42 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.5 m -154.36 102.04 2.41 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.345 -0.843 . . . . 3.43 111.252 -170.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 64.7 tttm -147.83 98.02 2.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.701 -0.681 . . . . 3.34 109.337 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -144.87 179.36 7.38 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.702 -1.136 . . . . 3.14 111.636 -170.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.35 154.04 38.09 Favored Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 114.32 -1.309 . . . . 1.11 111.623 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.804 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.3 tt0 -59.63 153.46 19.95 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.393 0.616 . . . . 1.86 112.399 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 45.6 t -153.23 129.55 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.074 . . . . 0.41 109.519 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.634 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 27.5 mtm180 -82.82 118.32 23.33 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.049 -0.523 . . . . 2.8 109.847 168.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.3 131.05 56.35 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.654 0.74 . . . . 0.29 111.27 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.766 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 8.8 tpp180 -98.21 100.71 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.376 -1.283 . . . . 1.71 111.104 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.8 mp -87.0 92.38 9.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.175 -0.305 . . . . 0.69 110.175 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.83 120.83 35.7 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 122.626 1.203 . . . . 0.26 111.635 -175.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-30 -86.93 136.21 33.02 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.792 -2.004 . . . . 0.72 111.049 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.677 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 39.9 t0 -78.82 65.19 3.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.076 -1.824 . . . . 1.09 106.076 161.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.93 1.52 Allowed Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 118.944 -1.598 . . . . 0.47 110.497 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -82.42 -27.47 31.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.723 0.638 . . . . 0.83 112.723 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -129.85 129.54 44.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.77 0.795 . . . . 1.21 110.615 -167.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.689 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.9 tt -53.38 128.9 30.18 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.449 -1.705 . . . . 0.64 111.235 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.12 -38.35 6.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.83 -1.077 . . . . 0.29 110.047 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.7 p -146.15 162.58 37.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.655 -0.702 . . . . 0.33 110.648 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.766 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 26.8 mt -134.31 145.2 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 105.735 -1.95 . . . . 0.76 105.735 167.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 43.1 t -136.98 135.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 109.683 -0.488 . . . . 0.35 109.683 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.626 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 47.2 t-20 -76.94 108.08 9.73 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 106.809 -1.552 . . . . 1.77 106.809 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.634 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 36.3 mtm -67.94 -2.41 7.44 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.545 -0.462 . . . . 0.55 111.976 -169.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.626 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.0 pt-20 -85.65 -45.98 11.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.482 0.658 . . . . 1.02 111.321 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.592 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -102.16 -26.24 13.42 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 114.802 -1.09 . . . . 1.4 109.36 -176.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 185' ' ' ASN . 52.7 t30 76.48 27.16 0.83 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 112.446 -2.161 . . . . 1.33 107.559 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 17.6 ptt180 -84.56 162.85 19.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.14 -1.391 . . . . 2.28 109.249 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -91.98 139.14 30.94 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.562 1.172 . . . . 1.36 112.734 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 2.6 m-85 -100.75 -165.73 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.908 -1.951 . . . . 1.18 108.324 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.629 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.14 -5.64 3.61 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.644 -2.183 . . . . 1.28 107.644 -148.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -153.79 119.43 5.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.928 -1.136 . . . . 2.8 111.333 157.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.8 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 5.1 t80 -140.77 100.58 3.88 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.17 -0.678 . . . . 0.6 109.17 161.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -102.13 110.47 22.44 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.466 -0.771 . . . . 4.77 111.203 -170.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.45 HD23 HD13 ' A' ' 113' ' ' LEU . 4.1 mm? -82.96 168.2 17.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.548 0.69 . . . . 1.61 112.45 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -103.89 96.18 8.87 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.439 -1.255 . . . . 2.66 108.074 172.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.07 125.21 12.84 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.131 2.554 . . . . 2.01 113.828 -170.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.726 0 CA-C-N 114.64 -1.164 . . . . 5.19 111.602 -177.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.749 0.309 . . . . 26.27 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.93 -80.11 1.59 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.676 -0.774 . . . . 24.15 112.329 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.7 t -152.93 37.57 0.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.388 0.614 . . . . 23.64 109.988 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 m -89.48 97.35 11.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.912 -0.585 . . . . 22.83 110.743 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -124.48 73.69 1.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.365 -0.38 . . . . 22.11 110.679 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -130.34 -33.84 1.66 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.58 -0.282 . . . . 22.07 111.114 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -149.12 136.98 20.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.069 -0.345 . . . . 20.59 110.069 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -152.13 112.53 4.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.225 0.536 . . . . 18.44 110.252 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -126.9 12.84 7.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.758 -0.656 . . . . 17.98 109.493 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -129.67 19.35 5.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.842 -0.617 . . . . 17.87 110.323 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.7 p -96.98 71.18 2.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.908 -0.587 . . . . 16.77 111.11 -176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.1 p -90.44 -8.09 51.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.88 -0.6 . . . . 16.32 110.552 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.65 -127.1 8.86 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.94 -0.647 . . . . 14.63 111.99 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.41 -17.4 54.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.072 0.463 . . . . 15.68 110.728 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.2 t -67.3 125.37 90.96 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.97 -0.559 . . . . 12.69 110.114 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.79 156.75 31.24 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.001 2.467 . . . . 12.08 111.818 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 103' ' ' ARG . 1.5 mpt_? -110.75 -40.19 4.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.443 -0.344 . . . . 12.18 111.061 -175.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.75 36.22 4.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.604 -0.807 . . . . 8.55 112.774 -176.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 107' ' ' MET . 4.3 p -81.01 -33.96 33.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.646 0.26 . . . . 8.07 111.503 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 68.6 -18.0 0.18 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.112 0.782 . . . . 7.76 113.112 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 105' ' ' SER . 54.9 ttm -67.57 100.24 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.869 0.366 . . . . 6.12 110.259 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.45 14.02 62.46 Favored Glycine 0 C--O 1.215 -1.072 0 CA-C-N 115.826 -0.624 . . . . 1.91 111.869 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.41 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 44.1 mtt180 -138.91 102.66 4.61 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.887 0.875 . . . . 4.32 108.73 175.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.45 ' HB2' ' HG3' ' A' ' 123' ' ' GLU . 21.9 mmt -140.85 135.82 31.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 113.787 1.032 . . . . 2.59 113.787 -166.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.401 HG11 HD12 ' A' ' 197' ' ' LEU . 0.3 OUTLIER -135.57 105.68 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.447 1.118 . . . . 0.74 113.876 172.043 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -160.01 107.75 1.67 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.955 -1.93 . . . . 1.38 105.809 161.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.9 mp -87.67 108.7 19.22 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.987 -0.746 . . . . 1.33 108.987 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.2 tt0 -142.78 112.33 5.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.309 -0.956 . . . . 1.93 111.123 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.1 Cg_exo -35.9 127.79 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.012 3.141 . . . . 0.65 113.016 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.3 t70 75.74 43.83 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 O-C-N 124.476 1.11 . . . . 0.72 110.536 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.646 ' HE3' HD13 ' A' ' 180' ' ' LEU . 16.7 ptt? -114.06 154.99 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.818 -1.083 . . . . 1.67 110.14 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -102.77 98.56 8.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.15 -1.056 . . . . 0.58 108.15 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.624 HG13 ' CB ' ' A' ' 123' ' ' GLU . 1.5 tt -134.34 168.68 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 114.821 -1.081 . . . . 0.65 110.573 -164.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.665 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.3 m -141.36 175.55 9.57 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 -174.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.576 ' HA ' HD11 ' A' ' 152' ' ' ILE . 19.1 mttp -57.62 -32.72 67.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.304 -0.998 . . . . 2.33 108.304 164.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.713 ' O ' HG12 ' A' ' 125' ' ' VAL . 34.6 t30 -83.02 -19.35 37.11 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 113.78 -1.555 . . . . 1.32 114.2 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.665 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.1 mp0 -82.49 -57.83 3.18 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.542 -1.974 . . . . 2.06 106.74 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.669 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 2.3 tpp -54.99 -13.76 1.24 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.381 -1.736 . . . . 3.13 111.969 170.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 122' ' ' ASN . 13.1 p -45.24 -39.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 122.246 1.022 . . . . 0.37 110.09 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.685 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -66.76 -40.12 88.14 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.93 -1.487 . . . . 0.63 112.685 176.041 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -49.63 -33.34 15.12 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.378 0.608 . . . . 1.79 111.172 167.239 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 127' ' ' LEU . 7.1 mt -83.97 -37.75 21.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.246 -0.888 . . . . 0.38 109.187 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.2 -43.26 92.26 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.288 -1.324 . . . . 1.96 110.221 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.44 -45.09 80.99 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.29 -1.777 . . . . 0.64 112.056 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.3 t -86.4 -2.63 58.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 123.664 1.697 . . . . 0.59 107.155 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 53.44 51.02 16.12 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.13 -2.759 . . . . 1.8 112.584 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.779 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -136.97 176.5 8.65 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.093 0.473 . . . . 0.52 111.782 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.8 153.84 49.62 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.758 -1.201 . . . . 4.54 107.758 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 19.3 tm0? -51.03 139.05 18.39 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.539 1.161 . . . . 1.28 112.341 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.8 p -136.67 140.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 112.718 -2.037 . . . . 1.05 109.781 -164.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -58.95 -32.22 69.42 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.347 1.07 . . . . 1.38 109.439 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 27.3 ttpt -160.88 121.29 2.8 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.962 -1.927 . . . . 1.44 109.109 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.653 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -109.88 118.64 37.01 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.996 -1.002 . . . . 0.9 110.894 -177.263 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.08 96.52 2.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.948 1.356 . . . . 0.61 108.993 157.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.522 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -166.39 169.52 6.38 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.04 -2.345 . . . . 1.77 105.548 167.704 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.522 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 3.3 Cg_exo -77.87 125.12 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.486 1.457 . . . . 0.62 112.471 175.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.662 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 94.54 38.18 5.08 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 120.654 -0.784 . . . . 0.51 113.311 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.779 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 9.4 mp0 -131.69 173.44 11.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 122.604 -0.351 . . . . 2.16 110.079 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.869 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.9 p90 -169.0 166.65 11.01 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.601 -1.259 . . . . 0.28 107.601 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.699 HG22 HG13 ' A' ' 136' ' ' VAL . 11.9 p -134.52 126.49 29.47 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.739 -0.784 . . . . 0.42 110.751 173.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.774 HG23 HG12 ' A' ' 152' ' ' ILE . 11.1 p -117.68 110.29 30.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.827 0.823 . . . . 0.34 111.121 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -106.25 -75.82 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 3.11 110.204 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.68 -58.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.469 . . . . 1.65 110.545 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -92.24 7.49 42.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.122 -0.49 . . . . 1.68 111.924 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -161.25 152.14 18.33 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.938 0.875 . . . . 0.37 112.612 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.774 HG12 HG23 ' A' ' 147' ' ' VAL . 67.6 mt -120.32 109.9 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.371 -1.741 . . . . 0.53 106.742 163.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.11 170.96 9.88 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.292 -1.744 . . . . 1.13 106.292 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.648 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 10.6 ptm -167.29 158.18 11.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.679 0.612 . . . . 1.8 110.869 -173.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.593 HG12 ' HG3' ' A' ' 170' ' ' ARG . 13.0 mt -129.27 112.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.466 -0.788 . . . . 0.43 110.501 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.803 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 34.6 mtp180 -71.95 99.72 2.3 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.033 -0.667 . . . . 3.13 109.748 177.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.662 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 61.8 ttt180 -65.64 137.59 96.4 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 107.33 -1.359 . . . . 6.16 107.33 171.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -47.1 123.9 8.18 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 120.61 0.873 . . . . 2.1 110.009 169.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 22.7 m-85 -120.26 155.47 33.18 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.865 -1.516 . . . . 1.83 108.613 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -108.33 73.49 0.88 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.768 1.271 . . . . 3.66 111.049 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.482 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 92.8 m-85 -121.49 147.08 46.76 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 113.69 -1.596 . . . . 3.54 110.376 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 31.2 Cg_exo -59.08 -30.03 92.17 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 124.556 3.504 . . . . 4.48 112.847 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -98.18 -7.03 30.17 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.975 -1.011 . . . . 5.26 111.336 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 57.5 m -161.19 99.63 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.167 -0.469 . . . . 3.43 111.621 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 64.1 tttm -148.41 91.95 1.96 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.608 0.718 . . . . 3.34 109.78 174.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -155.26 -177.75 6.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.859 -1.064 . . . . 3.14 112.122 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.59 156.42 38.78 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.36 -0.837 . . . . 1.11 113.502 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.803 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 51.7 tt0 -49.82 147.63 3.63 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.215 -1.493 . . . . 1.86 114.692 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 66.2 t -153.06 131.38 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.377 -1.283 . . . . 0.41 109.884 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.593 ' HG3' HG12 ' A' ' 155' ' ' ILE . 17.3 mtm180 -91.38 111.56 23.11 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.097 -0.502 . . . . 2.8 110.395 169.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.75 146.99 41.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.026 0.917 . . . . 0.29 111.619 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.501 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 7.3 tpt180 -111.77 103.79 12.08 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.586 -1.643 . . . . 1.71 110.323 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.653 HD23 ' SD ' ' A' ' 124' ' ' MET . 5.5 mp -92.77 94.33 8.92 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.755 -0.461 . . . . 0.69 109.755 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.68 127.85 40.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.582 1.182 . . . . 0.26 111.83 -173.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.728 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-85 -94.16 135.46 35.51 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 112.653 -2.067 . . . . 0.72 110.801 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 18.7 t70 -80.99 64.39 5.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.925 -1.88 . . . . 1.09 105.925 162.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.72 -99.51 1.13 Allowed Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.219 -1.467 . . . . 0.47 111.004 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.66 -24.69 41.66 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.721 0.637 . . . . 0.83 112.721 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -132.34 128.64 38.13 Favored 'General case' 0 N--CA 1.426 -1.666 0 C-N-CA 119.577 -0.849 . . . . 1.21 110.645 -170.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.8 tt -53.92 130.72 38.38 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.585 -1.643 . . . . 0.64 110.26 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.609 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.93 -38.48 6.04 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.443 -0.799 . . . . 0.29 110.499 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -146.03 164.31 32.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.189 -0.46 . . . . 0.33 111.785 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.535 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.6 mm -116.45 148.93 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 105.114 -2.18 . . . . 0.76 105.114 164.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.7 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.1 t -139.78 128.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.416 0.627 . . . . 0.35 109.844 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.587 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 46.6 t-20 -75.94 111.55 11.44 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 107.123 -1.436 . . . . 1.77 107.123 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.54 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.2 mtm -70.22 -1.22 9.64 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.478 -0.489 . . . . 0.55 112.101 -169.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.587 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 7.4 pt-20 -83.18 -45.8 13.48 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.614 0.721 . . . . 1.02 111.265 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.527 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -103.67 -25.81 13.01 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.948 -1.023 . . . . 1.4 109.236 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 185' ' ' ASN . 47.6 t-20 74.28 36.17 0.68 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 112.278 -2.237 . . . . 1.33 107.127 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.7 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 7.2 ptm180 -93.27 161.53 14.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.422 -1.717 . . . . 2.28 109.387 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 78.4 mt-30 -88.17 125.23 34.51 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.99 -1.004 . . . . 1.36 109.46 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.535 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.7 92.28 4.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.884 -0.579 . . . . 1.18 110.446 -170.576 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.82 -58.03 0.0 OUTLIER Glycine 0 N--CA 1.469 0.881 0 C-N-CA 125.066 1.317 . . . . 1.28 116.334 146.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' PHE . 38.4 p90 -163.62 175.38 10.68 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.347 -1.426 . . . . 2.8 108.685 175.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.5 t80 -140.79 154.56 46.31 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.911 -1.144 . . . . 0.6 107.911 157.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.719 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -136.04 139.74 43.31 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.636 -0.665 . . . . 4.77 109.992 -170.667 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -114.41 172.49 6.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 114.967 1.469 . . . . 1.61 114.967 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.453 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 9.9 p-10 -98.93 172.4 4.77 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 111.902 -2.408 . . . . 2.66 108.723 176.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 198' ' ' ASP . 81.3 Cg_exo -46.43 144.51 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.579 2.186 . . . . 2.01 113.548 172.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.352 0 CA-C-O 118.325 -0.845 . . . . 5.19 109.879 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.009 -0.367 . . . . 26.27 110.009 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.66 39.43 86.32 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.745 -0.942 . . . . 24.15 110.745 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -79.65 54.31 1.77 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.224 0.535 . . . . 23.64 111.615 -173.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 p -77.34 -47.71 19.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.832 -0.622 . . . . 22.83 109.5 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -169.8 -78.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.465 -0.789 . . . . 22.11 109.346 174.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 36.6 m80 53.04 -164.08 0.09 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.433 0.458 . . . . 22.07 111.641 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -68.7 -43.92 75.04 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.044 -0.354 . . . . 20.59 110.044 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 74.5 t60 65.8 -82.69 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.601 -0.727 . . . . 18.44 112.024 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 94' ' ' HIS . 59.0 m-70 69.78 131.44 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.447 0.699 . . . . 17.98 111.606 -174.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -83.38 83.4 7.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.782 -0.644 . . . . 17.87 109.546 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.1 p -69.99 -69.22 0.36 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.555 -0.748 . . . . 16.77 111.499 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 m 57.42 57.42 4.4 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.178 0.513 . . . . 16.32 110.902 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.86 -95.75 0.11 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.965 -0.636 . . . . 14.63 112.154 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.21 -61.88 1.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.528 0.204 . . . . 15.68 110.912 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.7 m -95.95 109.03 44.51 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.049 0.452 . . . . 12.69 111.424 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.91 -4.28 14.73 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.579 2.186 . . . . 12.08 112.885 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -95.87 -36.77 10.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.803 0.335 . . . . 12.18 111.143 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.85 -135.58 37.94 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.005 -0.616 . . . . 8.55 112.379 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.6 m 61.41 -80.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.337 0.655 . . . . 8.07 111.957 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -93.54 67.12 3.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.318 0.58 . . . . 7.76 110.607 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.8 mtm -71.4 126.26 29.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.765 -0.652 . . . . 6.12 111.437 -174.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.02 -30.9 9.47 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 115.787 -0.642 . . . . 1.91 112.343 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.856 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 72.6 mtt180 -87.31 91.84 8.86 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.529 -0.915 . . . . 4.32 108.529 177.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.683 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 27.0 ttt -143.89 131.1 20.72 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.96 -1.018 . . . . 2.59 113.203 -163.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.7 m -116.58 105.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 122.301 1.048 . . . . 0.74 112.883 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -159.92 106.22 1.61 Allowed 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.292 -1.776 . . . . 1.38 106.247 165.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.829 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.7 mp -97.3 111.52 23.73 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 119.958 -0.697 . . . . 1.33 109.528 -172.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -140.0 104.84 6.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.223 -0.899 . . . . 1.93 109.856 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.516 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 13.1 Cg_exo -33.63 129.74 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 125.157 3.905 . . . . 0.65 114.21 -172.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.6 t70 79.61 44.01 0.06 Allowed 'General case' 0 C--N 1.341 0.214 0 O-C-N 124.967 1.417 . . . . 0.72 110.529 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.652 ' SD ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.35 155.65 34.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.876 -1.056 . . . . 1.67 110.774 173.486 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 29.2 m -93.36 77.87 4.47 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 122.282 1.039 . . . . 0.58 109.547 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.712 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -96.17 161.09 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.496 -1.684 . . . . 0.65 109.296 -174.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.54 ' H ' HG13 ' A' ' 119' ' ' ILE . 7.6 m -141.78 177.09 8.41 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 118.612 0.642 . . . . 0.44 109.925 -173.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.8 ' HG2' HG21 ' A' ' 147' ' ' VAL . 34.3 mttp -53.42 -33.66 54.8 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.149 -1.056 . . . . 2.33 108.149 163.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.856 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 41.1 t30 -81.88 -18.85 42.36 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 114.311 -1.313 . . . . 1.32 114.177 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.683 ' HA ' ' H ' ' A' ' 110' ' ' MET . 3.4 tt0 -85.64 -62.18 1.59 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.151 -1.593 . . . . 2.06 107.918 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.755 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -58.74 -16.78 18.24 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.455 -1.702 . . . . 3.13 111.143 172.2 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.6 p -42.81 -42.73 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.99 0.9 . . . . 0.37 111.071 176.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.593 ' CE ' HG13 ' A' ' 125' ' ' VAL . 10.5 mmpt? -67.7 -41.15 84.03 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.44 -1.254 . . . . 0.63 112.154 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.5 tm? -53.12 -32.44 47.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.396 0.617 . . . . 1.79 110.392 167.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' A' ' 124' ' ' MET . 26.2 mt -82.16 -34.0 29.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.756 0.789 . . . . 0.38 109.066 -171.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.18 -37.25 85.17 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.235 -1.348 . . . . 1.96 110.164 167.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -68.6 -41.94 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.675 -1.602 . . . . 0.64 112.512 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.4 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.13 -1.52 57.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 124.176 1.941 . . . . 0.59 106.107 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 56.13 55.19 7.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 110.714 -2.948 . . . . 1.8 111.927 170.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 2.5 t80 -138.3 174.94 10.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.479 0.657 . . . . 0.52 112.407 -176.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 134' ' ' ARG . 20.1 ptt85 -141.86 147.61 37.44 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.948 -1.501 . . . . 4.54 106.948 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.83 135.05 20.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.763 1.268 . . . . 1.28 112.455 -171.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.5 p -134.37 141.04 44.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.386 -2.188 . . . . 1.05 110.14 -162.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -58.74 -34.28 71.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.493 1.139 . . . . 1.38 109.61 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -160.12 128.5 4.81 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.782 -2.008 . . . . 1.44 109.101 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.602 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -118.43 133.79 55.59 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.838 -1.074 . . . . 0.9 111.612 -173.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.552 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.8 t -162.92 100.21 0.99 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.491 1.138 . . . . 0.61 110.957 153.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.3 OUTLIER -164.51 160.67 15.86 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 113.161 -1.836 . . . . 1.77 106.211 161.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.527 ' CB ' ' HA ' ' A' ' 157' ' ' ARG . 23.3 Cg_exo -62.94 120.92 8.61 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 121.055 1.17 . . . . 0.62 109.839 170.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.4 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 95.54 38.37 4.75 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 119.716 -1.231 . . . . 0.51 113.102 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 42.1 mt-10 -140.94 167.55 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.889 -0.411 . . . . 2.16 109.889 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.74 ' CD2' HD22 ' A' ' 128' ' ' LEU . 51.3 p90 -167.67 163.43 14.41 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.395 -0.965 . . . . 0.28 108.395 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.513 HG22 HG13 ' A' ' 136' ' ' VAL . 53.6 p -128.87 127.34 41.65 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.061 0.457 . . . . 0.42 110.703 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 121' ' ' LYS . 11.8 p -121.51 116.65 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.555 0.693 . . . . 0.34 111.813 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.519 ' HG3' ' H ' ' A' ' 149' ' ' ALA . 11.0 pt20 -117.43 -62.34 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.863 -0.608 . . . . 3.11 111.247 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.519 ' H ' ' HG3' ' A' ' 148' ' ' GLN . . . -168.97 -63.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 1.65 110.791 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -83.0 4.65 25.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.365 -0.379 . . . . 1.68 111.798 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 16.4 p -165.47 150.0 8.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.978 0.894 . . . . 0.37 112.992 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.734 HG12 HG23 ' A' ' 147' ' ' VAL . 65.6 mt -116.5 107.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.333 -1.758 . . . . 0.53 106.326 160.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.537 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 5.5 mt-10 -99.42 102.2 13.7 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.57 -0.9 . . . . 1.13 108.57 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 8.6 ptm -109.38 156.94 19.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.157 -0.929 . . . . 1.8 112.149 -170.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.63 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.8 mt -123.5 119.07 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.322 -1.308 . . . . 0.43 109.991 172.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.7 mtm180 -65.57 119.58 11.36 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.437 0.461 . . . . 3.13 110.444 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 142' ' ' PRO . 56.6 ttp180 -68.58 145.22 96.96 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 105.273 -2.121 . . . . 6.16 105.273 162.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -45.84 124.0 6.63 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 CA-C-N 120.782 1.315 . . . . 2.1 111.211 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 18.3 m-85 -129.59 151.02 50.66 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.617 -1.629 . . . . 1.83 107.41 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -107.95 81.34 1.48 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.246 1.022 . . . . 3.66 112.347 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 198' ' ' ASP . 36.8 m-85 -87.98 145.37 36.3 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 114.326 -1.306 . . . . 3.54 108.721 170.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.1 Cg_exo -60.23 -29.36 88.84 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 124.328 3.352 . . . . 4.48 112.432 175.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.5 -10.28 22.33 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.538 -1.21 . . . . 5.26 111.44 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.4 t -160.57 101.47 1.34 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.227 0.537 . . . . 3.43 110.559 -173.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -134.53 86.75 2.29 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.327 1.061 . . . . 3.34 109.377 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -144.51 -170.62 3.42 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 113.666 -1.607 . . . . 3.14 108.471 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.36 -129.17 0.65 Allowed Glycine 0 N--CA 1.434 -1.471 0 CA-C-O 123.186 1.437 . . . . 1.11 113.36 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.63 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 6.6 tt0 -83.97 152.79 24.26 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 111.812 -2.194 . . . . 1.86 113.276 -167.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 43.1 t -153.23 128.53 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.979 -1.01 . . . . 0.41 109.542 174.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.546 ' HB3' ' CE ' ' A' ' 186' ' ' MET . 15.0 mtt180 -89.86 114.09 25.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 120.9 0.381 . . . . 2.8 110.469 170.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.79 129.86 56.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.342 1.067 . . . . 0.29 111.278 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.5 tpt180 -96.09 100.28 11.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.219 -1.809 . . . . 1.71 110.925 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 151' ' ' SER . 10.7 mp -85.08 93.96 8.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.737 -0.468 . . . . 0.69 109.737 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.573 HG23 ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -94.59 113.44 25.26 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.504 1.145 . . . . 0.26 111.687 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -82.77 135.43 34.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.679 -2.055 . . . . 0.72 110.347 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 36.9 t70 -76.59 65.85 2.47 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.345 -1.724 . . . . 1.09 106.345 161.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 -98.37 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 118.877 -1.63 . . . . 0.47 110.78 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.79 -17.56 37.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.505 0.928 . . . . 0.83 113.505 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -139.45 130.27 26.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.506 -0.877 . . . . 1.21 110.628 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.712 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 4.8 tt -53.66 128.51 29.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.122 -1.399 . . . . 0.64 110.568 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -100.89 -39.02 7.98 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.717 -1.129 . . . . 0.29 108.994 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 26.2 p -150.8 158.96 44.78 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.475 -0.784 . . . . 0.33 110.592 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 16.1 mt -120.29 146.67 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 105.063 -2.199 . . . . 0.76 105.063 168.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 22.6 t -138.77 129.73 34.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.36 0.6 . . . . 0.35 110.152 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.593 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.3 t-20 -75.15 101.94 4.77 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 106.817 -1.549 . . . . 1.77 106.817 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.546 ' CE ' ' HB3' ' A' ' 170' ' ' ARG . 36.2 mtm -65.51 -3.09 3.95 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.653 0.595 . . . . 0.55 112.516 -167.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.593 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 8.5 pt-20 -80.1 -43.62 21.4 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.756 0.789 . . . . 1.02 110.813 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.588 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 8.9 m120 -104.91 -25.72 12.48 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 114.464 -1.244 . . . . 1.4 109.367 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 58.0 t30 76.19 33.29 0.57 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 112.59 -2.096 . . . . 1.33 107.873 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.641 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.3 ptm180 -96.14 157.6 15.82 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 2.28 109.846 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.6 126.53 31.84 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.814 -1.084 . . . . 1.36 109.308 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.23 90.5 3.94 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.321 -0.552 . . . . 1.18 110.875 -168.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.27 -57.75 0.0 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 116.635 1.414 . . . . 1.28 116.635 145.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.519 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 3.4 p90 -164.08 175.58 10.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.525 -1.337 . . . . 2.8 109.671 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.829 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.3 t80 -148.34 103.42 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.206 0.526 . . . . 0.6 110.899 159.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.519 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 1.6 mmm180 -95.45 133.65 39.18 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.441 -0.787 . . . . 4.77 110.465 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 127' ' ' LEU . 69.0 mt -122.89 171.44 9.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 114.388 1.255 . . . . 1.61 114.388 -166.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.459 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 19.0 t70 -101.32 111.28 63.44 Favored Pre-proline 0 C--O 1.22 -0.476 0 CA-C-N 113.935 -1.484 . . . . 2.66 110.554 -176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.44 139.31 17.32 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.602 2.201 . . . . 2.01 113.224 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.576 ' HD3' ' O ' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.5 -0.773 . . . . 5.19 111.157 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 110.053 -0.351 . . . . 26.27 110.053 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 144.24 -85.8 0.18 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.633 -0.794 . . . . 24.15 112.28 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.9 m 69.23 -72.26 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.272 0.629 . . . . 23.64 111.044 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m -86.01 137.88 32.38 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.987 -0.375 . . . . 22.83 109.987 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -68.8 102.83 1.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.356 -0.384 . . . . 22.11 110.543 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -81.58 123.57 28.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 22.07 110.026 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -72.46 -25.59 61.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.132 0.492 . . . . 20.59 110.161 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -115.61 119.22 35.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.725 -0.843 . . . . 18.44 108.725 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -92.69 172.17 8.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.018 0.437 . . . . 17.98 111.398 -174.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -133.85 122.19 22.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.569 -0.742 . . . . 17.87 109.872 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.9 t -71.71 -53.26 14.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.912 -0.586 . . . . 16.77 110.013 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.8 p 45.34 51.66 9.32 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.175 0.59 . . . . 16.32 111.999 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.17 -148.31 21.33 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.653 -0.784 . . . . 14.63 111.998 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.29 -18.66 45.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.013 0.435 . . . . 15.68 109.899 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -110.91 100.01 44.76 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.492 0.663 . . . . 12.69 110.468 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -88.25 61.39 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.828 2.352 . . . . 12.08 112.242 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.404 HH12 ' CD ' ' A' ' 123' ' ' GLU . 40.7 ttt180 -101.31 126.63 48.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.228 -0.442 . . . . 12.18 110.895 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.32 80.88 0.34 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.138 -0.785 . . . . 8.55 111.138 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.8 t -98.5 172.62 7.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 8.07 110.37 -175.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -135.23 -50.39 0.75 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.699 -0.682 . . . . 7.76 109.979 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.3 mmt -79.4 -52.23 8.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.728 -0.669 . . . . 6.12 110.662 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 123' ' ' GLU . . . 75.58 -31.86 1.21 Allowed Glycine 0 C--O 1.226 -0.378 0 CA-C-N 115.652 -0.703 . . . . 1.91 114.066 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.745 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -35.51 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.58 1.152 . . . . 4.32 113.36 177.411 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 15.6 tpt -142.44 129.92 21.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.61 -1.177 . . . . 2.59 111.786 -175.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.56 102.63 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.731 1.253 . . . . 0.74 111.904 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -162.44 109.59 1.3 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.111 -1.859 . . . . 1.38 106.244 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.789 HD12 ' HB3' ' A' ' 195' ' ' PHE . 52.2 mt -96.38 108.04 20.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.418 -0.586 . . . . 1.33 109.418 -175.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 2.6 tm-20 -142.88 110.14 5.58 Favored Pre-proline 0 C--N 1.309 -1.192 0 C-N-CA 119.298 -0.961 . . . . 1.93 110.442 -175.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.492 ' HG3' HG12 ' A' ' 183' ' ' ILE . 27.9 Cg_exo -35.11 126.61 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 124.25 3.3 . . . . 0.65 113.777 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 22.3 t0 75.9 49.61 0.07 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.762 1.267 . . . . 0.72 110.37 -174.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.656 ' HE3' HD13 ' A' ' 180' ' ' LEU . 13.5 ptt? -119.27 155.71 31.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.983 -1.462 . . . . 1.67 109.529 172.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 179' ' ' HIS . 8.0 m -101.76 83.88 2.47 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.365 -0.976 . . . . 0.58 108.365 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -109.0 161.41 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.821 -1.536 . . . . 0.65 110.071 -170.27 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.742 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.4 m -142.79 174.17 10.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.623 -0.881 . . . . 0.44 108.623 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.975 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 19.4 mtpp -54.93 -28.37 50.52 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.671 0.748 . . . . 2.33 109.723 163.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.581 ' O ' HG12 ' A' ' 125' ' ' VAL . 32.4 t30 -85.93 -18.68 32.01 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 114.692 1.367 . . . . 1.32 114.692 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.742 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.0 OUTLIER -86.09 -62.91 1.41 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.565 1.174 . . . . 2.06 108.134 171.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.975 ' SD ' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -58.12 -14.04 6.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 112.347 -2.206 . . . . 3.13 110.871 173.119 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 122' ' ' ASN . 12.1 p -41.89 -42.32 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.91 0.862 . . . . 0.37 109.637 170.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.745 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -68.37 -39.96 81.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.579 -1.191 . . . . 0.63 113.834 174.456 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.572 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -49.9 -32.2 14.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.446 0.641 . . . . 1.79 111.0 170.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 124' ' ' MET . 8.6 mt -85.67 -37.68 19.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 0.38 108.984 -172.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.61 -36.19 77.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.94 -1.482 . . . . 1.96 109.672 168.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.66 -41.27 65.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.879 -1.509 . . . . 0.64 112.208 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.703 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.5 t -89.04 -0.77 57.71 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 123.255 1.502 . . . . 0.59 107.641 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 52.16 52.21 14.79 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.173 -2.739 . . . . 1.8 112.337 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.765 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.3 t80 -138.99 176.19 8.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.52 112.022 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -139.18 153.0 47.84 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.682 -1.229 . . . . 4.54 107.682 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.641 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 17.8 tm0? -50.84 138.95 17.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.535 1.16 . . . . 1.28 112.591 -169.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.5 p -136.22 140.94 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.802 -1.999 . . . . 1.05 109.972 -163.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -58.35 -32.77 68.85 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.714 1.245 . . . . 1.38 109.478 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 7.0 ttpt -160.22 127.12 4.36 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 112.417 -2.174 . . . . 1.44 108.663 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -112.91 124.02 51.65 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.227 -0.897 . . . . 0.9 110.767 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.16 97.88 1.82 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.99 1.376 . . . . 0.61 109.105 154.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.584 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -165.64 169.51 6.94 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 112.251 -2.249 . . . . 1.77 105.662 166.528 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.561 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 60.5 Cg_endo -75.88 123.9 7.71 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 120.777 1.313 . . . . 0.62 112.311 173.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.538 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 98.25 39.76 3.66 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 120.678 -0.772 . . . . 0.51 113.279 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.765 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 12.4 mp0 -135.48 173.78 11.33 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 122.829 0.452 . . . . 2.16 110.585 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.882 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.3 p90 -169.19 168.62 9.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.245 -1.02 . . . . 0.28 108.245 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.587 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 40.5 p -135.27 126.46 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.357 -0.537 . . . . 0.42 111.955 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 152' ' ' ILE . 14.8 p -125.37 129.05 73.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.956 -0.565 . . . . 0.34 111.804 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.493 ' HA ' ' OE1' ' A' ' 148' ' ' GLN . 6.1 tp60 -144.2 -70.18 0.3 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.326 -0.55 . . . . 3.11 111.534 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.28 -67.46 0.54 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 1.65 112.633 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -87.27 -11.76 48.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.807 0.669 . . . . 1.68 112.807 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 20.6 p -165.05 157.77 16.15 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.873 0.844 . . . . 0.37 112.933 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 147' ' ' VAL . 50.2 mt -114.61 115.76 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.079 -1.419 . . . . 0.53 107.613 167.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.882 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.3 mp0 -89.33 171.39 9.79 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 106.51 -1.663 . . . . 1.13 106.51 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.623 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 26.7 ptm -167.96 154.16 7.49 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.739 0.649 . . . . 1.8 110.348 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.568 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.5 mt -128.75 114.32 32.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.33 -0.395 . . . . 0.43 110.826 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.709 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 10.0 mtp-105 -72.11 95.76 1.68 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.664 -0.414 . . . . 3.13 111.209 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.561 ' HB2' ' C ' ' A' ' 142' ' ' PRO . 35.9 ttm180 -59.24 131.29 87.47 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.488 -1.671 . . . . 6.16 106.488 163.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -49.95 123.72 11.32 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 CA-C-N 119.844 0.98 . . . . 2.1 110.962 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 6.4 m-85 -124.77 130.89 53.29 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.215 -1.811 . . . . 1.83 106.744 174.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.97 86.76 4.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.531 1.158 . . . . 3.66 111.642 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 72.3 m-85 -116.52 150.97 46.46 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 113.803 -1.544 . . . . 3.54 109.757 172.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.2 Cg_exo -60.16 -30.04 90.44 Favored 'Trans proline' 0 CA--C 1.502 -1.117 0 C-N-CA 124.781 3.654 . . . . 4.48 113.174 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.08 -7.94 28.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.954 -1.021 . . . . 5.26 111.312 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.4 m -158.48 109.01 2.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.033 0.444 . . . . 3.43 110.999 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -148.02 100.74 3.22 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.613 0.721 . . . . 3.34 109.411 174.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -148.65 164.26 34.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.535 -1.211 . . . . 3.14 110.793 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.58 160.19 45.18 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 113.798 -1.547 . . . . 1.11 111.947 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.709 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 49.5 tt0 -47.06 140.65 4.8 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 114.412 1.264 . . . . 1.86 114.412 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 44.2 t -154.5 130.29 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.707 -1.588 . . . . 0.41 109.99 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.649 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 35.7 mtm180 -86.9 114.77 23.81 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 116.189 -0.46 . . . . 2.8 110.325 168.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -117.0 132.43 56.71 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.844 0.83 . . . . 0.29 111.289 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.556 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 11.5 tpp180 -99.28 109.08 21.76 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.039 -1.437 . . . . 1.71 111.034 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 113' ' ' LEU . 5.4 mp -91.59 91.48 8.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.12 -0.491 . . . . 0.69 109.968 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.7 125.59 37.39 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.283 1.04 . . . . 0.26 111.844 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 2.0 m-85 -89.59 138.15 31.72 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.953 -1.93 . . . . 0.72 111.579 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.3 t70 -81.96 64.99 6.89 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 105.833 -1.914 . . . . 1.09 105.833 159.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.16 -98.75 1.02 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 118.892 -1.623 . . . . 0.47 111.144 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.34 -25.57 46.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.521 0.563 . . . . 0.83 112.521 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 118' ' ' THR . 7.1 p80 -135.46 132.88 37.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.369 0.604 . . . . 1.21 110.132 -168.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.713 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -54.59 134.02 46.62 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.1 -1.409 . . . . 0.64 110.617 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.605 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.78 -41.54 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.925 -1.034 . . . . 0.29 110.081 -176.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 p -147.21 163.8 35.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.027 -0.533 . . . . 0.33 111.705 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 195' ' ' PHE . 1.6 mm -111.14 148.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.144 -2.169 . . . . 0.76 105.144 165.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.8 t -141.51 131.79 25.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.407 0.622 . . . . 0.35 109.947 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.583 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 40.7 t-20 -79.44 110.11 14.43 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.124 -1.065 . . . . 1.77 108.124 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.649 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 16.3 mtp -65.91 -2.46 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.036 0.754 . . . . 0.55 113.036 -171.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.583 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 8.3 pt-20 -81.18 -42.53 20.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.817 0.818 . . . . 1.02 111.153 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.49 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 6.1 m-20 -111.24 -26.55 9.11 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.391 -1.277 . . . . 1.4 109.738 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.2 t30 76.28 34.47 0.5 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.519 -2.128 . . . . 1.33 107.642 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 5.2 ptm180 -90.31 162.92 14.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.427 -1.715 . . . . 2.28 108.641 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -88.02 140.17 29.77 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.727 -0.67 . . . . 1.36 110.001 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.519 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -114.08 92.31 3.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.701 -0.666 . . . . 1.18 110.523 -176.54 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.08 -58.63 0.0 OUTLIER Glycine 0 N--CA 1.469 0.839 0 N-CA-C 116.15 1.22 . . . . 1.28 116.15 146.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 192' ' ' PHE . 35.0 p90 -163.42 174.23 12.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.702 -1.249 . . . . 2.8 109.25 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.789 ' HB3' HD12 ' A' ' 113' ' ' LEU . 1.4 t80 -140.31 154.45 46.8 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.201 -0.666 . . . . 0.6 109.201 159.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.666 ' H ' ' HD2' ' A' ' 196' ' ' ARG . 0.1 OUTLIER -138.53 153.97 48.76 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.806 -0.559 . . . . 4.77 111.933 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.585 HD21 ' HE1' ' A' ' 154' ' ' MET . 5.1 mt -129.55 172.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.425 1.268 . . . . 1.61 114.425 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.453 ' OD2' ' HD2' ' A' ' 159' ' ' PHE . 3.2 m-20 -85.7 137.93 35.85 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 112.38 -2.191 . . . . 2.66 111.03 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.74 ' O ' ' HD2' ' A' ' 200' ' ' ARG . 8.1 Cg_endo -54.83 136.61 72.64 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.13 3.22 . . . . 2.01 114.481 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.74 ' HD2' ' O ' ' A' ' 199' ' ' PRO . 14.2 mmm180 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.883 -0.579 . . . . 5.19 109.83 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 121.017 0.437 . . . . 26.27 110.238 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.25 -111.96 0.5 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.576 -0.61 . . . . 24.15 111.576 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.0 t 58.29 40.05 24.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.953 0.406 . . . . 23.64 110.932 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.8 m 70.43 12.58 7.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.571 -0.74 . . . . 22.83 112.147 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -152.32 59.9 0.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.54 0.686 . . . . 22.11 110.603 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -59.2 -27.82 66.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.73 -0.668 . . . . 22.07 110.571 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -154.45 156.35 36.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.01 -0.541 . . . . 20.59 109.76 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -85.34 151.29 24.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.754 -0.461 . . . . 18.44 109.754 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -58.54 -74.92 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.568 0.581 . . . . 17.98 112.568 -167.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -85.88 -1.11 56.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 17.87 111.144 -174.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 m -80.64 -17.85 49.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.167 0.508 . . . . 16.77 109.893 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.8 m -94.94 79.69 3.64 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.957 -0.565 . . . . 16.32 110.427 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.95 -164.0 18.44 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.665 -0.698 . . . . 14.63 111.595 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.9 mt -92.53 122.26 34.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.272 -0.269 . . . . 15.68 110.272 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 p 37.4 88.7 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 O-C-N 124.515 1.134 . . . . 12.69 113.324 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.79 66.22 6.7 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.841 2.361 . . . . 12.08 112.446 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -68.09 -63.32 1.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.205 -0.452 . . . . 12.18 111.488 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.18 59.67 4.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 8.55 112.666 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.481 ' HA ' ' CD ' ' A' ' 109' ' ' ARG . 50.6 m -96.53 80.97 3.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.091 0.472 . . . . 8.07 111.354 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -95.74 49.3 1.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.079 -0.509 . . . . 7.76 109.766 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 53.6 tpp 65.46 98.08 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.225 0.824 . . . . 6.12 113.225 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.36 -28.87 12.14 Favored Glycine 0 C--O 1.224 -0.502 0 CA-C-O 118.565 -1.13 . . . . 1.91 114.87 168.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.481 ' CD ' ' HA ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -20.32 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.68 0.993 . . . . 4.32 113.68 175.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.423 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 16.2 tpt -141.37 132.57 26.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.332 -0.547 . . . . 2.59 112.015 -173.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 13.3 m -121.88 104.29 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 122.814 1.292 . . . . 0.74 113.037 171.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.407 ' O ' ' HE1' ' A' ' 117' ' ' MET . 63.1 t30 -161.01 110.72 1.67 Allowed 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 105.011 -2.218 . . . . 1.38 105.011 166.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.597 HD21 ' SD ' ' A' ' 124' ' ' MET . 59.1 mt -97.16 115.22 27.16 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.967 -0.693 . . . . 1.33 110.963 -174.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.478 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 21.9 tt0 -155.34 91.26 2.86 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 121.649 0.738 . . . . 1.93 109.279 -173.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.759 ' HD3' HD12 ' A' ' 183' ' ' ILE . 0.3 OUTLIER -31.49 144.22 0.03 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.76 1 C-N-CA 126.671 4.914 . . . . 0.65 115.536 -175.946 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.3 t70 78.05 36.61 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 113.757 -1.565 . . . . 0.72 109.057 -170.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.433 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 7.2 ptp -121.09 155.43 34.46 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.768 -1.106 . . . . 1.67 111.09 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.7 m -101.37 84.47 2.62 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.224 -1.028 . . . . 0.58 108.224 -175.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.721 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -110.03 163.91 6.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.055 -1.43 . . . . 0.65 109.854 -168.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.647 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.8 m -140.87 177.41 8.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.064 -0.655 . . . . 0.44 109.913 -172.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.621 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -60.97 -27.07 68.01 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 108.145 -1.057 . . . . 2.33 108.145 165.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.591 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER -84.54 -17.73 37.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.996 -1.456 . . . . 1.32 114.416 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.647 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.9 mp0 -85.48 -62.39 1.54 Allowed 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 120.56 -1.337 . . . . 2.06 108.421 170.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.779 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 mmt -57.02 -16.52 7.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.166 -1.834 . . . . 3.13 111.901 173.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.621 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 14.9 p -42.34 -42.82 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.219 1.009 . . . . 0.37 110.797 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.674 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -67.83 -41.24 83.3 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.947 -1.478 . . . . 0.63 113.087 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.507 HD23 ' HB3' ' A' ' 197' ' ' LEU . 2.9 tm? -52.61 -32.73 43.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.29 0.567 . . . . 1.79 110.273 167.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.8 mt -82.34 -35.92 27.4 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.442 0.639 . . . . 0.38 109.541 -172.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 200' ' ' ARG . 0.5 OUTLIER -57.77 -44.7 86.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.664 -1.153 . . . . 1.96 109.944 164.317 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -65.09 -39.64 93.46 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.209 -1.814 . . . . 0.64 112.636 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 128' ' ' LEU . 2.8 t -93.19 3.92 54.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.191 -1.781 . . . . 0.59 106.191 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 45.84 52.24 9.88 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 110.84 -2.891 . . . . 1.8 111.88 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 2.6 t80 -136.7 175.17 9.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 119.901 -0.72 . . . . 0.52 112.725 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -139.67 149.9 44.26 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.664 -1.606 . . . . 4.54 106.664 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' HB2' HG12 ' A' ' 147' ' ' VAL . 19.5 tm0? -49.92 141.52 10.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.534 1.159 . . . . 1.28 113.136 -169.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.1 p -139.91 141.46 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.957 -1.929 . . . . 1.05 110.07 -162.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m -58.85 -34.59 71.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 122.607 1.194 . . . . 1.38 109.232 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -160.81 130.29 4.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.491 -2.141 . . . . 1.44 109.259 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.672 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -119.08 125.82 50.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.624 -1.171 . . . . 0.9 112.117 -172.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.491 ' HA ' HD11 ' A' ' 155' ' ' ILE . 1.7 t -160.64 99.79 1.28 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.931 1.348 . . . . 0.61 110.865 156.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.504 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -165.73 157.89 12.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 105.501 -2.037 . . . . 1.77 105.501 163.379 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -61.13 113.68 1.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.088 1.424 . . . . 0.62 109.727 171.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.416 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 105.45 47.71 1.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.214 -0.993 . . . . 0.51 113.272 -175.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.582 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 44.3 mt-10 -145.73 170.7 15.97 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 122.532 0.333 . . . . 2.16 110.264 172.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.863 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 49.8 p90 -167.8 165.31 14.09 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.918 -1.141 . . . . 0.28 107.918 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.667 HG22 HG13 ' A' ' 136' ' ' VAL . 35.9 p -132.17 126.11 32.83 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.862 -0.735 . . . . 0.42 110.843 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.747 HG23 HG12 ' A' ' 152' ' ' ILE . 8.6 p -125.18 169.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.798 -0.637 . . . . 0.34 111.413 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 18.7 tm0? 78.05 75.56 0.06 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.637 0.775 . . . . 3.11 110.215 176.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -177.85 -94.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.373 -1.285 . . . . 1.65 109.167 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -135.68 11.89 3.43 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.13 0.491 . . . . 1.68 110.443 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 3.3 p -165.8 158.06 14.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.37 112.265 -171.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.747 HG12 HG23 ' A' ' 147' ' ' VAL . 38.5 mt -107.69 106.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 106.458 -1.682 . . . . 0.53 106.458 159.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.863 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.7 mt-10 -91.07 164.18 14.04 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 104.779 -2.304 . . . . 1.13 104.779 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 19.2 ptp -166.06 164.0 18.16 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.871 0.732 . . . . 1.8 110.221 -170.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.823 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.2 mt -127.95 94.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.854 0.835 . . . . 0.43 110.698 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.713 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 1.3 tmt_? -127.94 97.59 4.86 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.496 -1.229 . . . . 3.13 111.857 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.619 ' HB3' ' HA ' ' A' ' 168' ' ' GLN . 9.0 tpt180 -128.65 163.89 41.98 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 104.852 -2.277 . . . . 6.16 104.852 153.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.447 ' HD2' ' HG3' ' A' ' 157' ' ' ARG . 19.2 Cg_exo -43.02 126.0 4.37 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 CA-C-N 120.611 1.254 . . . . 2.1 111.068 165.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.573 ' HB2' ' CE2' ' A' ' 161' ' ' PHE . 85.9 m-85 -79.54 169.46 17.99 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.772 -2.013 . . . . 1.83 109.829 -175.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 6.4 p-10 -69.1 77.9 0.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.458 1.123 . . . . 3.66 112.014 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 159' ' ' PHE . 31.2 m-85 -114.08 153.05 46.31 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 113.619 -1.628 . . . . 3.54 109.229 172.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 38.4 Cg_exo -60.63 -34.29 92.42 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 124.284 3.323 . . . . 4.48 113.124 176.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -92.12 -11.28 36.1 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.073 -0.967 . . . . 5.26 111.759 -176.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 58.4 m -161.27 111.79 1.7 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.128 -1.064 . . . . 3.43 108.128 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 160' ' ' ASP . 25.8 tptp -137.96 103.58 5.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.683 0.754 . . . . 3.34 110.207 -174.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -134.61 162.92 30.94 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.411 -1.268 . . . . 3.14 111.611 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 157' ' ' ARG . . . -81.21 127.31 7.84 Favored Glycine 0 CA--C 1.494 -1.232 0 CA-C-N 114.048 -1.433 . . . . 1.11 111.089 172.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.619 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 2.6 pm0 -53.16 -176.19 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 114.821 1.415 . . . . 1.86 114.821 -173.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 4.0 t -155.5 127.69 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 113.706 -1.588 . . . . 0.41 110.334 -169.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 154' ' ' MET . 22.2 mtm180 -93.63 115.24 27.7 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.583 0.23 . . . . 2.8 110.551 171.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -112.9 130.2 56.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.93 0.872 . . . . 0.29 110.904 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.75 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.8 tpt180 -96.09 98.48 10.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.762 -1.563 . . . . 1.71 110.901 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 7.0 mp -88.49 97.8 11.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 110.169 -0.308 . . . . 0.69 110.169 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.427 HG23 ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -97.19 117.11 30.67 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.576 1.179 . . . . 0.26 111.672 -173.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -85.45 131.92 34.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.689 -2.05 . . . . 0.72 110.03 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.2 t70 -76.9 65.3 2.56 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.199 -1.778 . . . . 1.09 106.199 164.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.96 -98.55 0.88 Allowed Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 119.138 -1.506 . . . . 0.47 110.526 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.71 -26.34 54.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.88 0.696 . . . . 0.83 112.88 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.476 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 5.7 p-80 -137.34 130.02 30.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.636 0.732 . . . . 1.21 111.187 -167.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.721 ' HB2' HG22 ' A' ' 119' ' ' ILE . 5.3 tt -53.13 127.75 25.31 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.93 -1.487 . . . . 0.64 110.87 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -39.39 5.88 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.253 -0.885 . . . . 0.29 110.186 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.8 p -145.96 166.66 25.38 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.965 -0.562 . . . . 0.33 110.885 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.759 HD12 ' HD3' ' A' ' 115' ' ' PRO . 38.5 mt -136.59 145.48 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 106.025 -1.843 . . . . 0.76 106.025 169.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 38.8 t -139.16 132.94 39.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.295 0.569 . . . . 0.35 109.996 -173.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.471 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 0.2 OUTLIER -80.55 103.34 10.33 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.577 -1.268 . . . . 1.77 107.577 -176.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 29.5 mtm -65.92 -1.59 3.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 123.861 0.726 . . . . 0.55 112.722 -166.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 11.7 pt-20 -77.13 -45.62 26.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.015 0.912 . . . . 1.02 110.696 174.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 190' ' ' ARG . 27.0 t-20 -108.65 -26.31 10.43 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.125 -1.398 . . . . 1.4 109.249 -174.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.3 t30 78.09 26.93 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.654 -2.066 . . . . 1.33 107.109 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.471 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 16.7 ptt180 -85.0 160.64 20.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.841 -1.527 . . . . 2.28 109.651 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.66 141.41 28.54 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.457 -1.247 . . . . 1.36 113.518 -172.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.695 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 5.8 m-85 -106.85 -166.56 1.18 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 112.635 -2.075 . . . . 1.18 107.092 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.549 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.55 -10.72 3.75 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.591 -2.203 . . . . 1.28 107.591 -149.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 196' ' ' ARG . 27.4 p90 -155.76 105.39 2.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.196 -1.002 . . . . 2.8 111.267 156.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.0 t80 -119.57 132.75 55.8 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.13 -0.981 . . . . 0.6 109.325 166.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.583 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.1 mpt_? -115.92 146.35 42.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.867 -0.42 . . . . 4.77 109.867 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 33.0 mt -127.73 162.78 25.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.431 -0.35 . . . . 1.61 111.577 -171.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -94.27 163.21 23.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 2.66 110.61 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -45.26 148.01 2.11 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.151 2.567 . . . . 2.01 113.23 173.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.486 ' O ' ' HD2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.855 -0.611 . . . . 5.19 110.731 -174.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.1 ttm . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.945 -0.391 . . . . 26.27 109.945 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.08 24.39 57.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.893 -0.67 . . . . 24.15 111.86 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 4.9 m -84.25 157.72 21.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.755 0.312 . . . . 23.64 110.819 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.1 m -85.27 102.57 13.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.719 -0.475 . . . . 22.83 109.719 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 49.7 t60 62.13 71.99 0.52 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.381 0.61 . . . . 22.11 109.841 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 89' ' ' SER . 33.9 t60 -76.53 82.7 3.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.511 -0.768 . . . . 22.07 110.239 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 -155.87 0.63 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.494 -0.776 . . . . 20.59 109.759 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 71.54 -77.95 0.05 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.319 0.648 . . . . 18.44 109.62 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -147.29 -74.33 0.2 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.435 -0.95 . . . . 17.98 108.435 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -135.76 -58.86 0.77 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.045 -0.724 . . . . 17.87 109.045 172.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 m 57.21 68.29 0.87 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.504 -0.771 . . . . 16.77 112.19 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 p -94.18 -12.29 28.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.966 -0.561 . . . . 16.32 110.516 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.61 70.44 0.8 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.888 -0.672 . . . . 14.63 112.244 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.5 tp -70.08 120.21 15.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.762 0.315 . . . . 15.68 110.593 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.14 97.37 38.64 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 121.082 0.468 . . . . 12.69 110.702 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.79 -178.49 3.13 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.709 2.273 . . . . 12.08 111.98 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -64.21 -64.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.404 -0.591 . . . . 12.18 109.404 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.02 159.54 19.04 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.886 -0.673 . . . . 8.55 112.996 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 p -127.68 138.85 52.94 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.146 -0.316 . . . . 8.07 110.146 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.468 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 32.6 m80 64.35 78.17 0.29 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.539 0.524 . . . . 7.76 110.378 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.1 mmt -62.19 117.97 6.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.979 -0.555 . . . . 6.12 111.053 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.93 -8.61 59.58 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.999 -0.619 . . . . 1.91 112.402 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -140.59 75.12 1.49 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.447 0.699 . . . . 4.32 109.985 173.354 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.72 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 9.2 ttt -137.65 97.64 3.49 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 118.098 -1.441 . . . . 2.59 113.748 -163.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 127' ' ' LEU . 1.6 m -101.42 107.79 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 113.548 0.944 . . . . 0.74 113.548 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -159.2 110.88 2.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.922 -1.881 . . . . 1.38 105.922 166.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.804 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.4 mp -100.72 116.15 31.94 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.461 -0.496 . . . . 1.33 110.406 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 0.3 OUTLIER -154.01 90.24 3.3 Favored Pre-proline 0 N--CA 1.432 -1.371 0 N-CA-C 109.089 -0.708 . . . . 1.93 109.089 -177.187 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.729 ' HD3' HD12 ' A' ' 183' ' ' ILE . 1.3 Cg_exo -29.04 144.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 1 C-N-CA 126.755 4.97 . . . . 0.65 116.467 -175.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.9 t70 74.68 37.66 0.52 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.791 -1.55 . . . . 0.72 108.781 -172.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.443 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 5.8 ptp -120.9 155.88 33.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.199 -1.364 . . . . 1.67 110.893 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.1 m -101.33 82.25 2.3 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 122.42 1.105 . . . . 0.58 108.33 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.532 HG13 ' CB ' ' A' ' 123' ' ' GLU . 17.8 tt -121.54 165.11 17.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.349 -1.75 . . . . 0.65 108.668 -169.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.526 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 4.2 m -140.1 175.66 9.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.713 -0.795 . . . . 0.44 111.405 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.653 ' HG2' HG21 ' A' ' 147' ' ' VAL . 1.8 mptt -59.95 -20.14 55.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.044 -0.98 . . . . 2.33 108.91 169.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.705 ' O ' HG12 ' A' ' 125' ' ' VAL . 9.2 t30 -83.03 -21.87 33.71 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 114.062 -1.426 . . . . 1.32 112.757 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.72 ' HA ' ' H ' ' A' ' 110' ' ' MET . 1.2 mp0 -85.94 -48.46 8.68 Favored 'General case' 0 N--CA 1.408 -2.533 0 O-C-N 120.01 -1.681 . . . . 2.06 107.825 173.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.745 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -62.59 -18.03 61.32 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 113.762 -1.563 . . . . 3.13 111.264 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -47.34 -40.74 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 122.324 1.059 . . . . 0.37 110.569 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.598 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -66.94 -41.04 87.63 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.872 -1.513 . . . . 0.63 113.351 177.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.723 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.9 tm? -52.11 -34.93 46.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.532 0.682 . . . . 1.79 110.156 168.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 124' ' ' MET . 18.0 mt -83.23 -36.24 24.76 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.783 0.801 . . . . 0.38 109.054 -170.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.82 -39.64 92.49 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.114 -1.403 . . . . 1.96 109.468 167.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -67.34 -43.29 81.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.306 -1.315 . . . . 0.64 112.252 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.458 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.52 2.98 56.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 124.373 2.035 . . . . 0.59 106.336 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 56.09 46.37 21.76 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 110.341 -3.118 . . . . 1.8 112.409 169.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.922 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -136.77 174.88 10.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.84 -0.744 . . . . 0.52 112.753 -173.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.426 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 31.8 ttm180 -142.97 154.72 44.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.016 -1.476 . . . . 4.54 107.016 177.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 13.6 tm0? -49.43 142.88 7.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.593 1.187 . . . . 1.28 113.714 -167.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 145' ' ' PHE . 13.3 p -142.97 142.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 112.752 -2.022 . . . . 1.05 110.304 -163.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 -34.05 70.01 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.718 1.247 . . . . 1.38 109.17 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -158.86 123.05 3.98 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.508 -2.133 . . . . 1.44 108.653 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.682 ' SD ' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -111.2 128.55 55.95 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.095 -0.957 . . . . 0.9 110.209 -178.545 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.596 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -160.89 99.15 1.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.756 1.265 . . . . 0.61 109.97 158.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.596 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -165.18 168.52 8.38 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 112.595 -2.093 . . . . 1.77 105.618 162.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.516 ' HB3' ' HA ' ' A' ' 157' ' ' ARG . 14.9 Cg_exo -66.02 119.25 6.25 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 N-CA-C 109.192 -1.118 . . . . 0.62 109.192 167.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.458 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 90.94 47.96 3.5 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.513 -1.327 . . . . 0.51 113.161 -171.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.922 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.1 mt-10 -150.62 147.17 27.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.845 -0.798 . . . . 2.16 108.845 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.733 ' O ' HG12 ' A' ' 136' ' ' VAL . 38.4 p90 -154.19 160.64 41.96 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.729 -0.841 . . . . 0.28 108.729 -177.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.682 HG23 ' SD ' ' A' ' 139' ' ' MET . 39.1 p -125.24 127.64 47.06 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.496 0.665 . . . . 0.42 110.606 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.653 HG21 ' HG2' ' A' ' 121' ' ' LYS . 12.8 p -121.43 113.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.187 -0.915 . . . . 0.34 110.911 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -111.53 -80.78 0.58 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.62 -0.718 . . . . 3.11 110.321 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.09 -54.84 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.72 -0.673 . . . . 1.65 110.049 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -96.47 8.24 44.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 1.68 112.264 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.688 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 23.1 p -164.13 147.01 9.34 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.947 1.092 . . . . 0.37 113.947 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 147' ' ' VAL . 54.9 mt -115.03 107.8 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 112.907 -1.951 . . . . 0.53 106.852 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.544 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 6.4 mt-10 -102.29 103.68 14.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.466 -0.939 . . . . 1.13 108.466 -176.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.454 ' SD ' ' HE1' ' A' ' 195' ' ' PHE . 6.0 ptm -117.04 155.19 29.64 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.928 -1.033 . . . . 1.8 112.465 -167.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.632 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 38.4 mt -118.79 124.41 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 114.482 -1.235 . . . . 0.43 110.307 170.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 58.6 mtm180 -75.35 117.27 16.97 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.67 -0.493 . . . . 3.13 109.67 173.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.558 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 19.3 ttm180 -79.37 138.8 55.52 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 107.081 -1.452 . . . . 6.16 107.081 167.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -49.15 124.66 11.98 Favored 'Trans proline' 0 N--CA 1.438 -1.736 0 C-N-CA 121.019 1.146 . . . . 2.1 110.987 171.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 14.1 m-85 -124.45 124.13 41.65 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.759 -1.564 . . . . 1.83 107.426 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.98 75.34 4.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.646 1.213 . . . . 3.66 111.253 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 69.5 m-85 -118.27 145.61 37.51 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 113.717 -1.583 . . . . 3.54 110.153 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 33.3 Cg_exo -60.28 -26.76 83.41 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 124.824 3.682 . . . . 4.48 113.355 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -94.08 -17.99 22.26 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.768 -1.106 . . . . 5.26 111.252 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.504 ' CB ' ' HB2' ' A' ' 198' ' ' ASP . 69.9 m -159.92 105.25 1.56 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.558 -0.746 . . . . 3.43 110.593 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 60.5 tttm -147.05 102.98 3.56 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.498 0.666 . . . . 3.34 109.964 176.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -146.46 169.76 18.25 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 122.177 0.989 . . . . 3.14 112.046 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -81.35 158.38 39.72 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 112.868 -1.969 . . . . 1.11 111.985 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.669 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 49.3 tt0 -44.89 145.24 0.99 Allowed 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.541 -1.329 . . . . 1.86 114.46 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 31.0 t -153.59 133.81 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.884 -1.507 . . . . 0.41 110.081 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 18.5 mtm180 -94.8 115.67 27.78 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.962 -0.563 . . . . 2.8 110.397 168.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.33 134.17 55.13 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.075 0.94 . . . . 0.29 112.161 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.761 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 16.2 tpt180 -96.25 95.74 8.31 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.22 -1.809 . . . . 1.71 110.255 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.755 HD21 HD21 ' A' ' 113' ' ' LEU . 3.9 mp -87.31 95.88 10.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.171 -0.677 . . . . 0.69 109.171 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.44 111.01 22.98 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.377 1.084 . . . . 0.26 111.556 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.753 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 52.7 m-85 -87.28 129.71 34.88 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.992 -1.913 . . . . 0.72 110.438 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 35.5 t70 -78.85 66.12 4.24 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 106.539 -1.652 . . . . 1.09 106.539 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.27 -99.32 1.18 Allowed Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 119.227 -1.463 . . . . 0.47 110.329 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.71 -24.82 33.43 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.937 0.717 . . . . 0.83 112.937 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.506 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 9.5 p-80 -130.49 123.03 28.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.636 0.731 . . . . 1.21 110.763 -166.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.753 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.9 tt -54.11 128.52 31.11 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.772 -1.558 . . . . 0.64 110.883 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.39 -39.06 6.01 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.105 -0.952 . . . . 0.29 110.33 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 115' ' ' PRO . 19.3 p -149.4 163.31 38.1 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.214 -0.448 . . . . 0.33 111.092 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.761 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 44.5 mt -136.43 145.44 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 105.889 -1.893 . . . . 0.76 105.889 168.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 49.1 t -138.86 136.77 43.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.821 -0.437 . . . . 0.35 109.821 -174.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.603 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 64.2 t30 -85.31 97.66 10.08 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.511 -1.292 . . . . 1.77 107.511 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.544 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 57.6 mtm -64.61 -3.1 2.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 124.182 0.926 . . . . 0.55 113.239 -162.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.0 pt-20 -80.53 -40.6 25.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.855 0.836 . . . . 1.02 110.802 177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.506 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 77.0 m-20 -113.58 -25.29 8.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.287 -1.324 . . . . 1.4 109.335 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 80.72 28.57 0.22 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.733 -2.031 . . . . 1.33 108.283 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.603 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 0.6 OUTLIER -83.28 155.57 23.56 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.656 -1.611 . . . . 2.28 110.637 176.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -84.74 140.97 30.88 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.641 -1.163 . . . . 1.36 112.917 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.668 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 3.9 m-85 -103.27 -166.67 1.29 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.942 -1.936 . . . . 1.18 107.97 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 136.09 -2.38 3.58 Favored Glycine 0 CA--C 1.482 -1.986 0 N-CA-C 107.736 -2.146 . . . . 1.28 107.736 -151.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.47 ' O ' ' HD2' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -156.81 100.06 1.88 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 113.698 -1.251 . . . . 2.8 111.903 151.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.804 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 t80 -116.68 100.78 8.06 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.87 -1.132 . . . . 0.6 109.952 168.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -96.88 138.49 34.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.295 -0.412 . . . . 4.77 110.579 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.723 HD13 ' HG ' ' A' ' 127' ' ' LEU . 45.8 mt -132.42 160.68 35.68 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.255 0.55 . . . . 1.61 112.189 -170.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 164' ' ' SER . 20.3 t70 -96.8 115.7 65.8 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.229 -0.896 . . . . 2.66 109.375 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -62.84 126.4 18.05 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.703 1.602 . . . . 2.01 113.536 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.409 ' OXT' ' HG2' ' A' ' 200' ' ' ARG . 28.7 ttt180 . . . . . 0 C--O 1.25 1.122 0 O-C-N 124.71 1.256 . . . . 5.19 113.722 165.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 7.1 ptm180 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 114.638 1.347 . . . . 4.32 114.638 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.414 ' HB3' ' HG2' ' A' ' 123' ' ' GLU . 60.9 ttp -140.44 121.74 14.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.557 -0.457 . . . . 2.59 111.515 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 105.7 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 122.246 1.022 . . . . 0.74 113.566 173.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -159.79 106.2 1.63 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.248 -2.13 . . . . 1.38 105.248 159.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.708 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 11.5 mt -82.8 103.64 12.44 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.425 -0.51 . . . . 1.33 110.169 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -145.08 99.46 4.62 Favored Pre-proline 0 N--CA 1.429 -1.492 0 C-N-CA 119.37 -0.932 . . . . 1.93 110.431 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.797 ' HD3' HD12 ' A' ' 183' ' ' ILE . 0.5 OUTLIER -34.14 139.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.644 1 C-N-CA 125.668 4.245 . . . . 0.65 115.011 -178.84 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.4 t70 77.22 35.56 0.34 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.834 -1.53 . . . . 0.72 109.408 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.505 ' HE3' HD13 ' A' ' 180' ' ' LEU . 10.8 ptt? -114.56 155.13 27.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.401 -1.272 . . . . 1.67 109.879 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 179' ' ' HIS . 21.4 m -101.71 103.74 14.52 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.079 -1.082 . . . . 0.58 108.079 -175.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.605 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.4 tt -136.56 166.66 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.277 -0.874 . . . . 0.65 110.566 -165.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.618 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.6 m -141.42 176.24 9.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.738 -0.838 . . . . 0.44 108.738 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.542 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -28.0 68.85 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.53 -0.915 . . . . 2.33 108.53 166.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.606 ' O ' HG12 ' A' ' 125' ' ' VAL . 0.3 OUTLIER -84.23 -19.14 34.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.127 -1.397 . . . . 1.32 113.485 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.618 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.5 mt-10 -87.6 -54.22 4.38 Favored 'General case' 0 N--CA 1.422 -1.839 0 O-C-N 120.444 -1.41 . . . . 2.06 108.994 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.762 ' SD ' HD23 ' A' ' 173' ' ' LEU . 2.1 tpp -59.76 -16.36 27.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.767 -1.56 . . . . 3.13 111.147 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 122' ' ' ASN . 15.0 p -43.81 -41.24 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 122.185 0.993 . . . . 0.37 110.228 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.535 ' HG2' ' HA ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -65.3 -42.54 92.96 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.927 -1.488 . . . . 0.63 113.031 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.643 HD23 HD23 ' A' ' 128' ' ' LEU . 0.8 OUTLIER -50.82 -33.88 25.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.814 0.816 . . . . 1.79 110.595 169.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 124' ' ' MET . 20.2 mt -84.6 -35.87 22.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.553 -1.203 . . . . 0.38 109.654 -171.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.36 -24.95 63.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.483 -1.235 . . . . 1.96 110.31 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -76.41 -42.13 45.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.504 -1.225 . . . . 0.64 110.924 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.697 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.4 t -87.11 1.31 53.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 123.531 1.634 . . . . 0.59 107.32 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 46.39 51.98 11.11 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 110.924 -2.853 . . . . 1.8 112.249 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.632 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.9 t80 -135.31 176.5 8.62 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.478 0.548 . . . . 0.52 112.478 -172.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.542 ' HD3' ' N ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -140.21 142.06 35.88 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.947 -1.501 . . . . 4.54 106.947 177.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.597 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 14.6 tm0? -48.98 142.16 6.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.26 1.208 . . . . 1.28 114.26 -168.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.725 HG23 HG22 ' A' ' 146' ' ' THR . 3.1 m -125.5 155.62 34.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.779 -2.01 . . . . 1.05 110.953 -176.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -61.36 -35.74 78.29 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.737 1.256 . . . . 1.38 108.446 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 5.6 tmmm? -159.87 133.18 6.94 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.65 -2.068 . . . . 1.44 109.816 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.565 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.34 135.86 54.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.577 -1.192 . . . . 0.9 111.31 -177.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.719 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -161.57 97.89 1.1 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.668 1.223 . . . . 0.61 110.718 149.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.719 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.07 161.73 20.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 112.7 -2.045 . . . . 1.77 106.313 164.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.38 130.94 28.3 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.299 1.332 . . . . 0.62 111.4 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.88 49.3 3.38 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.306 -0.95 . . . . 0.51 112.948 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.632 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 48.7 mt-10 -141.09 178.1 7.61 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.907 0.384 . . . . 2.16 111.357 175.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.868 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 50.2 p90 -165.73 175.59 8.68 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.063 -1.088 . . . . 0.28 108.063 169.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.725 HG22 HG23 ' A' ' 136' ' ' VAL . 25.6 p -142.3 126.13 17.1 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.471 0.653 . . . . 0.42 111.169 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.597 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.7 p -125.37 109.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.235 -0.893 . . . . 0.34 109.886 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -142.61 -60.8 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.65 -0.42 . . . . 3.11 111.607 -171.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.92 -92.43 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.49 0.552 . . . . 1.65 112.49 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -104.83 -0.11 27.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.11 0.481 . . . . 1.68 111.173 -171.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 174' ' ' THR . 5.2 p -146.82 160.05 42.76 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.314 0.857 . . . . 0.37 113.314 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.617 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 60.5 mt -110.53 109.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 106.816 -1.55 . . . . 0.53 106.816 162.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.8 mp0 -89.38 175.91 7.13 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.015 -1.476 . . . . 1.13 107.015 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.636 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 25.6 ptm -168.67 154.66 6.76 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 123.496 0.498 . . . . 1.8 111.108 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.585 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 21.7 mt -127.62 110.16 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.753 -0.658 . . . . 0.43 110.309 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.815 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 28.2 mtp180 . . . . . 0 C--N 1.316 -0.867 0 CA-C-N 116.186 -0.461 . . . . 3.13 110.759 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.815 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.6 tt0 . . . . . 0 N--CA 1.425 -1.707 0 N-CA-C 113.502 0.927 . . . . 1.86 113.502 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 50.1 t -154.37 133.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.689 -1.141 . . . . 0.41 109.519 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 154' ' ' MET . 8.5 mtm180 -91.12 115.16 27.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.814 0.34 . . . . 2.8 110.399 169.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.04 145.39 43.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.812 0.815 . . . . 0.29 111.353 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.761 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.2 tpt180 -111.49 98.66 7.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.838 -1.528 . . . . 1.71 110.501 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.762 HD23 ' SD ' ' A' ' 124' ' ' MET . 4.5 mp -91.76 94.48 9.37 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.247 -0.279 . . . . 0.69 110.247 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -98.1 126.26 43.47 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.438 1.114 . . . . 0.26 111.653 -171.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.2 m-85 -89.82 138.34 31.57 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 112.859 -1.973 . . . . 0.72 111.07 -177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.9 t70 -79.39 64.49 4.29 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.027 -1.842 . . . . 1.09 106.027 160.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.7 -98.37 1.05 Allowed Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 118.879 -1.629 . . . . 0.47 110.713 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -79.14 -24.8 43.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.023 0.749 . . . . 0.83 113.023 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 118' ' ' THR . 1.9 p80 -134.68 129.99 35.63 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.951 -0.7 . . . . 1.21 110.844 -169.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.27 128.15 27.13 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.743 -1.572 . . . . 0.64 110.546 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.23 -41.48 5.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.492 -0.776 . . . . 0.29 110.486 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.1 p -145.49 166.86 24.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.226 -0.443 . . . . 0.33 110.921 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 115' ' ' PRO . 39.5 mt -136.18 145.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.108 -1.812 . . . . 0.76 106.108 169.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 45.0 t -137.26 140.17 42.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.277 0.56 . . . . 0.35 110.186 -174.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.485 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.1 t-20 -81.13 100.97 9.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.733 -1.21 . . . . 1.77 107.733 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.551 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 49.3 mtm -64.27 -2.76 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.403 0.89 . . . . 0.55 113.403 -164.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.461 ' HG3' ' OD1' ' A' ' 188' ' ' ASN . 10.9 pt-20 -91.92 -40.06 11.36 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.812 0.815 . . . . 1.02 111.225 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 187' ' ' GLU . 5.8 m-20 -105.78 -25.36 12.22 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.449 -1.251 . . . . 1.4 109.495 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 73.86 33.91 0.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 112.429 -2.169 . . . . 1.33 108.041 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 3.9 ptm180 -93.33 161.88 14.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.03 -1.441 . . . . 2.28 110.082 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.3 140.84 29.13 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.542 -1.208 . . . . 1.36 113.518 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.624 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 8.8 m-85 -106.44 -166.02 1.14 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.834 -1.984 . . . . 1.18 107.286 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.568 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.99 -6.73 3.46 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 107.83 -2.108 . . . . 1.28 107.83 -149.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -154.71 112.61 3.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.878 -1.161 . . . . 2.8 111.507 157.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.708 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t80 -129.18 101.6 6.09 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.702 -0.799 . . . . 0.6 109.965 162.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -100.06 128.75 46.1 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.03 -1.044 . . . . 4.77 111.948 -171.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.436 ' CD1' HD12 ' A' ' 127' ' ' LEU . 8.9 mt -107.76 171.27 7.49 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.174 -0.466 . . . . 1.61 111.129 173.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 108.727 -0.842 . . . . 2.66 108.727 175.408 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.55 ' NH1' HG21 ' A' ' 125' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.717 0.294 . . . . 4.32 111.263 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.649 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 48.2 tpp -143.63 138.78 29.24 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.361 -0.536 . . . . 2.59 110.961 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -126.77 104.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.374 1.083 . . . . 0.74 113.059 177.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -158.85 107.76 1.92 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 112.962 -1.926 . . . . 1.38 106.177 167.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 6.6 mt -91.3 100.62 13.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.5 -0.48 . . . . 1.33 110.111 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -150.34 109.44 3.19 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.377 0.608 . . . . 1.93 109.677 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.858 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 10.6 Cg_exo -34.77 146.3 0.05 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.849 1 C-N-CA 126.876 5.05 . . . . 0.65 115.43 -173.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.57 39.61 2.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.089 -1.414 . . . . 0.72 109.019 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.59 ' HE1' HD22 ' A' ' 113' ' ' LEU . 10.5 ptt? -117.57 154.37 31.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.655 -1.157 . . . . 1.67 109.485 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.1 m -101.81 79.33 1.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.152 0.977 . . . . 0.58 108.599 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.755 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -97.1 156.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 113.936 -1.484 . . . . 0.65 109.384 -171.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 124' ' ' MET . 10.8 m -141.95 174.15 10.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.156 -0.683 . . . . 0.44 109.156 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.641 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 35.2 mtpt -49.43 -33.49 14.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.38 0.609 . . . . 2.33 110.175 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.603 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 63.0 t30 -84.49 -16.18 43.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.335 1.235 . . . . 1.32 114.335 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.649 ' CG ' ' HB3' ' A' ' 110' ' ' MET . 6.2 tt0 -86.31 -60.53 1.97 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.374 -1.453 . . . . 2.06 107.894 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.79 ' SD ' HD21 ' A' ' 128' ' ' LEU . 0.5 OUTLIER -54.7 -17.59 3.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.457 -1.701 . . . . 3.13 111.105 173.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 13.7 p -42.35 -40.57 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-O 122.018 0.914 . . . . 0.37 110.34 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.636 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.7 -42.72 81.55 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.129 -1.396 . . . . 0.63 113.699 177.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.67 HD12 HD23 ' A' ' 128' ' ' LEU . 2.8 tm? -50.86 -34.78 29.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.568 0.699 . . . . 1.79 110.359 168.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 ' SD ' ' A' ' 124' ' ' MET . 7.3 mt -85.36 -34.86 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.568 -0.742 . . . . 0.38 110.143 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.29 -25.77 66.21 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.154 -1.385 . . . . 1.96 110.778 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -77.38 -45.39 26.11 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.978 -1.464 . . . . 0.64 111.272 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.97 -5.99 46.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 123.637 1.684 . . . . 0.59 107.471 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.54 55.34 5.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 110.983 -2.826 . . . . 1.8 112.464 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.724 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.5 t80 -132.15 176.38 8.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.853 0.686 . . . . 0.52 112.853 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.415 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 58.2 ttt180 -142.86 141.57 31.6 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.949 -1.5 . . . . 4.54 106.949 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -49.04 144.79 4.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 115.627 1.714 . . . . 1.28 115.627 -165.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 146' ' ' THR . 3.1 m -129.51 162.67 36.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 112.223 -2.262 . . . . 1.05 110.862 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -73.0 -35.55 66.84 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.591 -1.263 . . . . 1.38 107.591 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -145.46 124.84 13.06 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 112.795 -2.002 . . . . 1.44 110.513 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.581 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -117.93 128.87 55.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.093 -1.412 . . . . 0.9 110.047 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 96.03 1.68 Allowed 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.044 1.402 . . . . 0.61 109.364 155.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.586 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -167.61 161.26 10.16 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 111.979 -2.373 . . . . 1.77 105.771 167.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.19 126.32 9.77 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.675 1.583 . . . . 0.62 111.865 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 103.43 19.41 12.41 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 119.904 -1.141 . . . . 0.51 112.328 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.724 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 13.4 mp0 -128.33 173.19 10.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.661 0.267 . . . . 2.16 110.682 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.841 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 54.9 p90 -165.9 175.85 8.31 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.707 -1.22 . . . . 0.28 107.707 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.867 HG22 HG23 ' A' ' 136' ' ' VAL . 3.5 p -138.1 132.59 32.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 120.227 -0.589 . . . . 0.42 110.823 170.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 135' ' ' GLN . 14.6 p -124.14 109.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 122.347 1.07 . . . . 0.34 111.813 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -99.18 -74.99 0.57 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.523 -1.217 . . . . 3.11 109.313 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.62 -46.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.016 -0.993 . . . . 1.65 109.328 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.36 -11.42 57.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.408 -0.814 . . . . 1.68 111.236 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 14.6 p -158.89 152.28 22.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.125 0.964 . . . . 0.37 112.829 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.611 HG21 ' SD ' ' A' ' 124' ' ' MET . 68.5 mt -116.59 113.72 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 112.977 -1.92 . . . . 0.53 107.554 164.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -92.88 165.56 12.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.565 -1.643 . . . . 1.13 106.565 173.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.626 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 14.5 ptp -166.37 151.43 8.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 123.835 0.71 . . . . 1.8 110.764 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.688 HG12 ' HG3' ' A' ' 170' ' ' ARG . 7.5 mt -129.63 110.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.65 -0.705 . . . . 0.43 110.265 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 33.7 mtp180 . . . . . 0 C--N 1.317 -0.837 0 C-N-CA 120.483 -0.487 . . . . 3.13 110.354 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.569 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.94 0 N-CA-C 112.715 0.635 . . . . 1.86 112.715 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 95.4 t -151.86 127.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.179 -0.918 . . . . 0.41 110.089 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.688 ' HG3' HG12 ' A' ' 155' ' ' ILE . 3.7 mtm180 -85.77 115.46 23.43 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.468 -0.787 . . . . 2.8 110.262 169.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 153' ' ' GLU . . . -116.44 139.8 50.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.313 -0.955 . . . . 0.29 111.591 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.751 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 13.2 tpt180 -104.48 98.57 8.32 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.982 -1.463 . . . . 1.71 110.781 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 151' ' ' SER . 8.3 mp -88.16 103.25 15.58 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.237 -0.283 . . . . 0.69 110.237 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.21 119.57 39.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.4 1.095 . . . . 0.26 111.675 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.548 ' CZ ' HG23 ' A' ' 119' ' ' ILE . 2.0 m-85 -83.31 140.6 32.37 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 112.955 -1.93 . . . . 0.72 111.147 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.7 t70 -80.23 65.2 5.3 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.065 -1.828 . . . . 1.09 106.065 159.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.84 -97.99 1.27 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 118.572 -1.775 . . . . 0.47 110.697 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.87 -25.38 40.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.032 0.753 . . . . 0.83 113.032 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -132.81 129.69 38.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.972 0.891 . . . . 1.21 111.726 -167.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.755 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.0 tm? -51.07 120.59 5.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.872 -1.967 . . . . 0.64 109.868 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -106.14 -37.25 6.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.764 -0.653 . . . . 0.29 110.63 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.411 ' C ' HG13 ' A' ' 183' ' ' ILE . 17.7 p -143.88 164.38 30.73 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.102 -0.499 . . . . 0.33 110.742 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.751 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 21.1 mt -138.93 143.97 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 105.831 -1.914 . . . . 0.76 105.831 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 30.3 t -132.79 135.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.946 0.403 . . . . 0.35 110.472 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.535 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 1.8 m120 -76.24 101.1 5.29 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 107.131 -1.433 . . . . 1.77 107.131 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.628 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 41.1 mtm -67.38 -1.41 4.71 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.34 0.59 . . . . 0.55 111.654 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 16.9 pt-20 -73.85 -43.96 57.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.193 -0.912 . . . . 1.02 110.988 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -113.26 -25.67 8.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.228 -1.351 . . . . 1.4 109.367 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 75.53 36.47 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.179 -2.282 . . . . 1.33 107.858 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 185' ' ' ASN . 12.2 ptt180 -97.33 170.7 8.9 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 114.167 -1.379 . . . . 2.28 108.819 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -86.05 144.92 27.3 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.433 1.111 . . . . 1.36 113.916 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.572 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -116.91 -166.79 1.2 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 105.222 -2.14 . . . . 1.18 105.222 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.858 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 136.19 8.19 1.62 Allowed Glycine 0 N--CA 1.412 -2.934 0 N-CA-C 109.994 -1.242 . . . . 1.28 109.994 -160.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.433 ' HB2' ' NH1' ' A' ' 196' ' ' ARG . 20.7 p90 -152.39 101.95 2.71 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.151 -1.525 . . . . 2.8 110.438 151.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.725 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 3.9 t80 -118.45 99.75 7.03 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.892 -0.781 . . . . 0.6 108.892 168.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.433 ' NH1' ' HB2' ' A' ' 194' ' ' PHE . 1.4 mpt_? -100.62 123.06 44.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 4.77 111.33 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -93.1 172.57 8.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.336 1.606 . . . . 1.61 115.336 -170.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 . . . . . 0 N--CA 1.445 -0.696 0 CA-C-N 112.813 -1.994 . . . . 2.66 110.031 177.786 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 22.4 mtt180 . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 107.361 -1.348 . . . . 4.32 107.361 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.804 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.3 tpt -143.58 118.06 9.71 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 114.162 1.171 . . . . 2.59 114.162 -160.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 127' ' ' LEU . 0.8 OUTLIER -104.19 109.29 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 C-N-CA 119.246 -0.982 . . . . 0.74 112.681 179.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -155.03 109.82 3.0 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.146 -1.798 . . . . 1.38 106.146 167.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.1 mp -98.33 113.69 25.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.596 -0.89 . . . . 1.33 108.596 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 15.1 tt0 -146.09 108.99 4.3 Favored Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.732 -0.787 . . . . 1.93 109.79 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HG3' HG12 ' A' ' 183' ' ' ILE . 33.3 Cg_exo -35.76 130.83 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.407 0 C-N-CA 124.903 3.735 . . . . 0.65 114.473 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 73.71 45.47 0.24 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 122.403 1.097 . . . . 0.72 110.624 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.484 ' HE3' ' HB3' ' A' ' 114' ' ' GLU . 6.1 ptp -121.28 158.57 27.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.286 -1.324 . . . . 1.67 111.416 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 m -102.29 100.14 10.29 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.779 -0.823 . . . . 0.58 108.779 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.596 HG21 ' HE1' ' A' ' 124' ' ' MET . 12.2 tt -137.93 169.3 18.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.97 -1.013 . . . . 0.65 109.577 -167.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.533 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.5 m -139.88 175.33 9.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.821 0.737 . . . . 0.44 111.45 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.679 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -20.6 63.02 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.49 -0.929 . . . . 2.33 108.49 167.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.759 ' O ' HG12 ' A' ' 125' ' ' VAL . 6.3 t30 -83.17 -22.64 33.19 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 113.979 -1.464 . . . . 1.32 112.475 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.804 ' HA ' ' H ' ' A' ' 110' ' ' MET . 1.1 mp0 -84.28 -50.01 8.25 Favored 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 120.025 -1.672 . . . . 2.06 107.923 173.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.764 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -61.67 -18.51 59.83 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.511 -1.222 . . . . 3.13 111.268 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.1 p -47.28 -41.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.114 0.959 . . . . 0.37 110.808 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.536 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.2 mmpt? -69.93 -36.97 75.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.323 -1.308 . . . . 0.63 112.771 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.732 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.4 tm? -55.42 -33.88 63.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.686 0.755 . . . . 1.79 110.27 167.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.764 ' HG ' ' O ' ' A' ' 124' ' ' MET . 17.4 mt -84.36 -32.6 24.14 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.95 0.881 . . . . 0.38 109.189 -172.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.98 -39.43 89.57 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.901 -1.499 . . . . 1.96 110.219 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -70.5 -43.19 70.2 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.524 -1.671 . . . . 0.64 112.283 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.49 3.9 54.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 124.538 2.113 . . . . 0.59 106.281 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 130' ' ' ALA . 17.9 mt-30 52.35 49.16 21.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 110.262 -3.154 . . . . 1.8 112.679 168.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.981 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -139.24 175.74 9.3 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.759 -0.776 . . . . 0.52 112.778 -172.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.41 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 79.6 ttt180 -138.69 155.11 48.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.558 -1.275 . . . . 4.54 107.558 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.492 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -49.17 141.36 8.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.427 1.108 . . . . 1.28 113.375 -168.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.834 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.3 p -143.39 135.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.033 -1.894 . . . . 1.05 109.931 -164.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -33.52 70.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.233 1.016 . . . . 1.38 109.475 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -151.8 121.57 7.01 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 113.109 -1.86 . . . . 1.44 109.697 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.594 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -111.09 122.75 48.68 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.188 -1.369 . . . . 0.9 110.855 -177.469 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.3 OUTLIER -158.94 97.16 1.39 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.824 1.297 . . . . 0.61 109.769 161.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.446 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -166.65 165.2 9.95 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.508 -2.133 . . . . 1.77 106.127 161.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.61 116.74 3.72 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 120.973 1.115 . . . . 0.62 109.885 167.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.42 47.25 3.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.834 -1.174 . . . . 0.51 113.424 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.981 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.3 mt-10 -142.41 147.96 37.04 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.769 -0.826 . . . . 2.16 108.769 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.855 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 35.5 p90 -152.59 159.22 43.26 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.432 -0.951 . . . . 0.28 108.432 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.704 HG22 HG13 ' A' ' 136' ' ' VAL . 3.6 p -126.95 127.66 45.19 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.92 -0.712 . . . . 0.42 110.954 175.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.629 HG23 HG12 ' A' ' 152' ' ' ILE . 8.6 p -111.81 110.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.908 0.861 . . . . 0.34 111.322 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -113.65 16.01 18.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.909 -1.041 . . . . 3.11 110.738 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.65 -50.05 0.7 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.81 0.694 . . . . 1.65 111.28 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -81.88 -5.21 58.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.13 0.49 . . . . 1.68 110.175 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -166.39 144.87 5.53 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.444 -0.798 . . . . 0.37 112.073 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.679 HD11 ' HA ' ' A' ' 121' ' ' LYS . 37.2 mt -116.1 112.47 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.279 -1.328 . . . . 0.53 107.684 164.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.855 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 65.7 mt-10 -90.82 163.54 14.39 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.373 -2.084 . . . . 1.13 105.373 175.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.506 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 24.0 ptm -167.83 154.27 7.76 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.524 0.515 . . . . 1.8 110.514 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.586 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 36.2 mt -129.08 115.25 35.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.982 -0.554 . . . . 0.43 110.797 166.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.652 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 74.7 mtp180 . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.646 . . . . 3.13 110.539 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 9.5 tt0 . . . . . 0 N--CA 1.416 -2.151 0 CA-C-O 121.165 0.507 . . . . 1.86 111.938 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 70.0 t -151.93 128.89 2.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.091 -0.959 . . . . 0.41 109.191 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.746 ' HG2' ' CE ' ' A' ' 186' ' ' MET . 32.6 ttp180 -92.63 102.3 14.72 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.114 -0.948 . . . . 2.8 108.518 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.46 147.9 36.97 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.821 0.82 . . . . 0.29 111.859 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.536 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 10.1 tpt180 -114.36 100.68 8.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.929 -1.487 . . . . 1.71 110.318 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.666 HD21 HD21 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -88.87 96.03 10.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.736 -0.839 . . . . 0.69 108.736 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 117.38 31.67 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.125 0.964 . . . . 0.26 111.316 -171.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.724 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -89.88 135.74 33.46 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.225 -1.807 . . . . 0.72 110.487 -179.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -78.95 65.67 4.2 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.362 -1.718 . . . . 1.09 106.362 164.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.3 -99.32 1.18 Allowed Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 118.986 -1.578 . . . . 0.47 110.61 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.46 -24.86 42.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 113.075 0.768 . . . . 0.83 113.075 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -131.27 129.08 41.09 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.299 -0.96 . . . . 1.21 110.934 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.724 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.3 tt -53.14 129.32 30.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.457 -1.701 . . . . 0.64 110.049 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.68 -37.75 6.33 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.591 -0.731 . . . . 0.29 110.189 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.7 p -148.12 165.04 32.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.092 -0.504 . . . . 0.33 111.422 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.591 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.7 mm -117.53 149.01 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 105.226 -2.138 . . . . 0.76 105.226 163.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -138.89 128.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.461 0.648 . . . . 0.35 110.065 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.475 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 34.1 t-20 -80.97 102.84 10.4 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.829 -1.174 . . . . 1.77 107.829 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.746 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 38.0 mtm -66.35 -0.73 2.82 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 113.053 0.76 . . . . 0.55 113.053 -166.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 10.7 pt-20 -79.33 -40.95 29.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.127 0.965 . . . . 1.02 111.018 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.493 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 67.6 m-20 -112.27 -26.31 8.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.148 -1.387 . . . . 1.4 109.484 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 78.2 32.15 0.36 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.611 -2.086 . . . . 1.33 107.872 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 0.1 OUTLIER -91.43 164.55 13.78 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 113.471 -1.695 . . . . 2.28 109.119 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 76.1 mt-30 -85.05 136.02 33.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.491 -0.777 . . . . 1.36 110.132 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.591 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -107.3 90.99 3.47 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 118.86 -0.591 . . . . 1.18 110.177 -175.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.44 -59.2 0.0 OUTLIER Glycine 0 N--CA 1.47 0.91 0 C-N-CA 125.039 1.304 . . . . 1.28 116.268 147.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.445 ' HD2' ' NH1' ' A' ' 196' ' ' ARG . 0.3 OUTLIER -164.86 171.55 14.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.879 -1.661 . . . . 2.8 108.125 174.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -140.36 130.03 24.31 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.356 0.526 . . . . 0.6 109.66 162.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.645 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -120.43 130.53 54.38 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.667 -0.646 . . . . 4.77 110.659 -170.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.732 HD13 ' HG ' ' A' ' 127' ' ' LEU . 68.1 mt -136.55 171.37 14.59 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.799 1.037 . . . . 1.61 113.799 -166.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 114.415 -1.266 . . . . 2.66 110.451 -176.05 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 13.3 mtm180 . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.711 0.634 . . . . 4.32 112.711 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.594 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 24.9 ttt -141.82 135.54 29.72 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.493 -0.776 . . . . 2.59 111.974 -168.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 ' HE1' ' A' ' 124' ' ' MET . 2.0 m -118.18 106.4 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 122.268 1.032 . . . . 0.74 112.953 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -160.1 106.73 1.59 Allowed 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 105.749 -1.945 . . . . 1.38 105.749 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.837 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 3.5 mp -97.13 111.41 23.66 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.474 -0.935 . . . . 1.33 108.474 -173.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 117' ' ' MET . 21.0 tt0 -143.72 107.38 5.05 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-N 114.963 -1.017 . . . . 1.93 110.549 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.509 ' HD3' HD12 ' A' ' 183' ' ' ILE . 29.5 Cg_exo -36.75 129.03 0.49 Allowed 'Trans proline' 0 CA--C 1.515 -0.427 0 C-N-CA 124.476 3.451 . . . . 0.65 113.427 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.9 t70 75.41 50.1 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.685 1.231 . . . . 0.72 109.768 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.649 ' HE3' HD13 ' A' ' 180' ' ' LEU . 13.1 ptt? -122.47 157.24 32.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 113.789 -1.551 . . . . 1.67 110.116 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.3 m -100.01 113.9 26.81 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.299 -1.0 . . . . 0.58 108.299 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -142.75 159.84 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 116.046 -0.524 . . . . 0.65 111.457 -165.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.483 ' H ' HG13 ' A' ' 119' ' ' ILE . 49.2 m -143.06 179.87 6.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.914 -0.314 . . . . 0.44 110.167 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.862 ' HG2' HG21 ' A' ' 147' ' ' VAL . 6.9 mtmp? -59.14 -28.12 66.27 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.677 -0.86 . . . . 2.33 108.677 166.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.608 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 4.4 t-20 -85.73 -17.34 36.19 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.996 -1.456 . . . . 1.32 114.446 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.594 ' HG3' ' HB3' ' A' ' 110' ' ' MET . 1.2 tp10 -84.39 -62.28 1.6 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.498 -1.297 . . . . 2.06 107.498 169.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.843 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 14.8 mmt -57.82 -15.81 9.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.627 -2.078 . . . . 3.13 111.765 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 14.6 p -43.19 -41.88 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 122.176 0.989 . . . . 0.37 110.191 175.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.737 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -69.27 -41.58 76.67 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.047 -1.433 . . . . 0.63 113.224 177.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.778 HD23 HD23 ' A' ' 128' ' ' LEU . 1.1 tt -49.41 -34.3 16.07 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.528 0.68 . . . . 1.79 111.387 167.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.843 ' HG ' ' O ' ' A' ' 124' ' ' MET . 13.9 mt -85.43 -32.53 22.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.158 -0.928 . . . . 0.38 108.824 -171.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.63 -36.53 84.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.11 -1.405 . . . . 1.96 109.814 167.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.7 -42.91 63.7 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.871 -1.513 . . . . 0.64 111.977 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -5.84 56.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 123.648 1.689 . . . . 0.59 106.991 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 58.33 55.51 4.97 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 110.761 -2.927 . . . . 1.8 112.473 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.665 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 3.2 t80 -139.56 176.73 8.48 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 113.126 0.787 . . . . 0.52 113.126 -177.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 145' ' ' PHE . 14.1 ptm180 -142.19 150.34 40.89 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.091 -1.078 . . . . 4.54 108.091 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 15.0 tm0? -50.37 143.37 8.94 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.802 1.408 . . . . 1.28 114.802 -166.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.835 HG23 HG22 ' A' ' 146' ' ' THR . 1.3 m -125.65 159.52 33.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 112.805 -1.998 . . . . 1.05 111.875 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -63.31 -35.79 81.52 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.68 1.229 . . . . 1.38 108.089 169.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 139' ' ' MET . 2.3 ttpt -159.34 132.98 7.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.348 -2.205 . . . . 1.44 109.521 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.589 ' HB2' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -118.6 135.42 54.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.262 -0.881 . . . . 0.9 111.199 176.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.569 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -156.9 97.61 1.7 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.954 1.359 . . . . 0.61 108.892 152.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.569 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -166.12 161.59 12.63 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 112.207 -2.27 . . . . 1.77 106.1 168.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.478 ' HA ' HG22 ' A' ' 155' ' ' ILE . 62.8 Cg_endo -75.67 128.17 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.209 1.273 . . . . 0.62 111.979 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.626 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 99.3 23.29 11.4 Favored Glycine 0 C--N 1.351 1.4 0 C-N-CA 119.975 -1.107 . . . . 0.51 112.35 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.665 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 15.4 mp0 -128.79 172.34 11.37 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.75 -0.463 . . . . 2.16 109.75 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.882 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.9 p90 -163.06 175.11 11.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.237 -1.023 . . . . 0.28 108.237 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.835 HG22 HG23 ' A' ' 136' ' ' VAL . 8.0 p -141.96 126.59 17.93 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 120.11 -0.636 . . . . 0.42 111.598 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.862 HG21 ' HG2' ' A' ' 121' ' ' LYS . 12.4 p -125.56 110.07 23.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.709 0.766 . . . . 0.34 111.849 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -110.03 -58.79 2.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.734 -0.666 . . . . 3.11 110.779 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -163.36 -60.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.922 0.341 . . . . 1.65 111.922 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -92.57 4.36 53.75 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.404 0.52 . . . . 1.68 112.404 -172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.7 p -161.08 155.93 23.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.683 0.754 . . . . 0.37 112.478 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 43.7 mt -115.24 108.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.297 -1.742 . . . . 0.53 106.297 161.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.882 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.6 mp0 -90.59 163.98 14.37 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.521 -2.029 . . . . 1.13 105.521 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 8.7 ptp -165.07 154.31 12.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.83 0.706 . . . . 1.8 111.324 -171.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.675 HG12 ' HG3' ' A' ' 170' ' ' ARG . 34.6 mt -126.25 110.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.615 0.721 . . . . 0.43 111.141 170.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 113.957 -1.474 . . . . 3.13 109.838 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.822 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.9 tt0 . . . . . 0 N--CA 1.436 -1.15 0 N-CA-C 113.419 0.896 . . . . 1.86 113.419 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 41.3 t -152.92 131.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.727 -1.124 . . . . 0.41 109.959 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.675 ' HG3' HG12 ' A' ' 155' ' ' ILE . 5.7 ttm180 -93.39 111.74 23.48 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.82 -0.807 . . . . 2.8 108.82 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.8 141.33 47.44 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.264 -0.974 . . . . 0.29 111.429 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 5.2 tpt180 -102.45 101.31 11.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.134 -1.394 . . . . 1.71 110.665 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -91.36 96.53 10.58 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.787 -0.365 . . . . 0.69 110.055 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 117.65 31.21 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-O 122.472 1.13 . . . . 0.26 111.494 -173.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -85.88 131.84 34.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 112.632 -2.076 . . . . 0.72 109.784 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 35.8 t70 -75.91 65.85 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.716 -1.587 . . . . 1.09 106.716 164.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.71 -99.26 1.74 Allowed Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 119.104 -1.522 . . . . 0.47 110.223 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -88.54 -17.62 29.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 113.01 0.744 . . . . 0.83 113.01 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -133.28 126.62 31.86 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 119.163 -1.015 . . . . 1.21 110.693 -168.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.688 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.1 tt -52.93 129.47 30.47 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.458 -1.701 . . . . 0.64 110.629 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -38.34 6.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.992 -1.004 . . . . 0.29 109.755 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.1 p -147.72 157.69 43.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.819 -0.628 . . . . 0.33 111.245 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.8 mt -124.86 146.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.707 -1.96 . . . . 0.76 105.707 166.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 43.1 t -136.56 133.58 49.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.448 0.642 . . . . 0.35 109.947 -175.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 1.9 t-20 -79.43 94.0 5.47 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.712 -1.588 . . . . 1.77 106.712 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.572 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 47.6 mtm -66.38 -1.97 4.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.995 0.809 . . . . 0.55 113.095 -162.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.0 pt-20 -81.45 -39.29 25.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.127 0.965 . . . . 1.02 110.682 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.48 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 9.1 m120 -108.43 -26.46 10.46 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.779 -1.555 . . . . 1.4 109.117 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.5 t30 75.48 32.02 0.74 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.338 -2.21 . . . . 1.33 108.416 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.9 ptm180 -93.73 155.22 17.36 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.197 -1.365 . . . . 2.28 109.234 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -77.7 131.19 37.59 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.909 -1.041 . . . . 1.36 108.636 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -105.63 89.53 3.12 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.469 -0.892 . . . . 1.18 110.548 -170.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -57.74 0.0 OUTLIER Glycine 0 N--CA 1.467 0.718 0 C-N-CA 125.376 1.465 . . . . 1.28 116.48 146.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.609 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 18.1 p90 -163.88 175.43 10.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.153 -1.523 . . . . 2.8 109.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.837 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.5 t80 -149.08 100.22 3.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.378 0.608 . . . . 0.6 110.445 159.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.609 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 5.2 mmm180 -95.63 141.87 28.61 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 120.628 -1.295 . . . . 4.77 111.666 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.535 ' HG ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -109.82 173.33 6.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.202 1.556 . . . . 1.61 115.202 -175.381 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 CA--C 1.535 0.387 0 CA-C-N 112.806 -1.997 . . . . 2.66 110.559 178.513 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 115.849 1.796 . . . . 4.32 115.849 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.673 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 16.7 tpt -139.35 117.01 11.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.035 -1.066 . . . . 2.59 112.65 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.634 ' HB ' HD12 ' A' ' 197' ' ' LEU . 15.9 m -111.5 107.41 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.42 1.105 . . . . 0.74 112.965 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.436 ' C ' HD12 ' A' ' 113' ' ' LEU . 40.3 t30 -160.14 136.16 8.58 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 113.667 -1.606 . . . . 1.38 106.985 168.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 9.0 mp -114.65 100.2 8.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.121 0.486 . . . . 1.33 109.829 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -156.93 97.54 2.08 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-N 115.23 -0.895 . . . . 1.93 109.816 -169.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.849 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 9.6 Cg_exo -34.27 149.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.796 1 C-N-CA 127.396 5.398 . . . . 0.65 115.356 -173.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 29.1 t70 70.55 31.26 2.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.216 -1.356 . . . . 0.72 108.877 -174.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.6 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 8.3 ptp -110.27 154.15 23.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.691 -1.14 . . . . 1.67 109.733 175.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -106.51 76.61 1.14 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.849 -1.167 . . . . 0.58 107.849 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.627 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 1.5 tt -104.15 159.25 5.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.152 -1.386 . . . . 0.65 110.507 -165.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.488 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 37.7 m -141.76 179.91 6.57 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.738 -0.785 . . . . 0.44 110.425 -168.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.953 ' HG2' HG21 ' A' ' 147' ' ' VAL . 14.5 mttp -64.52 -20.77 66.42 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.025 -1.102 . . . . 2.33 108.025 169.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.672 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t30 -84.46 -25.05 29.22 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.11 -1.405 . . . . 1.32 113.936 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.673 ' HA ' ' H ' ' A' ' 110' ' ' MET . 27.5 mt-10 -86.45 -53.9 4.73 Favored 'General case' 0 N--CA 1.412 -2.369 0 O-C-N 120.694 -1.254 . . . . 2.06 108.671 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.826 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.1 mmt -60.62 -18.25 52.08 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.129 -1.85 . . . . 3.13 111.478 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.677 HG13 ' HE3' ' A' ' 126' ' ' LYS . 9.2 p -44.75 -44.17 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-O 121.953 0.882 . . . . 0.37 110.534 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.677 ' HE3' HG13 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -67.66 -41.98 82.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.297 -1.319 . . . . 0.63 113.082 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.564 HD23 ' HB3' ' A' ' 197' ' ' LEU . 2.9 tm? -50.67 -34.67 27.45 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.666 0.604 . . . . 1.79 110.415 169.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.826 ' HG ' ' O ' ' A' ' 124' ' ' MET . 16.3 mt -84.92 -36.74 21.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.659 0.743 . . . . 0.38 109.572 -170.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -64.02 -32.74 74.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.179 -1.373 . . . . 1.96 109.988 168.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.59 -39.85 51.32 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.683 -1.599 . . . . 0.64 111.975 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 127' ' ' LEU . 0.3 OUTLIER -89.71 -5.3 57.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 124.021 1.867 . . . . 0.59 106.397 -178.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 58.35 51.57 8.17 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 110.488 -3.051 . . . . 1.8 112.361 170.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.826 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.6 t80 -135.47 175.4 9.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.278 0.561 . . . . 0.52 112.097 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.85 151.6 48.23 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.204 -1.406 . . . . 4.54 107.204 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.461 ' HB2' HG12 ' A' ' 147' ' ' VAL . 9.7 tm0? -49.67 138.45 14.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.686 1.231 . . . . 1.28 112.704 -170.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.66 ' CG1' HG22 ' A' ' 146' ' ' THR . 15.0 p -134.82 145.72 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 112.597 -2.092 . . . . 1.05 110.613 -162.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.97 -34.62 72.02 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.772 1.272 . . . . 1.38 109.493 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 11.2 ttpt -160.46 129.57 4.92 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 112.31 -2.223 . . . . 1.44 109.015 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.651 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -114.41 121.76 44.55 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.622 -0.717 . . . . 0.9 111.009 -179.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.429 ' HA ' HD11 ' A' ' 155' ' ' ILE . 1.7 t -158.14 98.39 1.58 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 122.946 1.355 . . . . 0.61 110.062 153.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.553 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.4 OUTLIER -164.42 161.82 15.74 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 112.552 -2.113 . . . . 1.77 106.328 163.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.512 ' HB3' ' NE2' ' A' ' 168' ' ' GLN . 38.4 Cg_exo -60.71 114.55 2.19 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.332 1.355 . . . . 0.62 111.569 173.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 104.6 32.53 4.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 120.396 -0.906 . . . . 0.51 113.625 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.826 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -131.48 169.84 15.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.697 -0.482 . . . . 2.16 109.697 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.851 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.7 p90 -167.35 165.74 14.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.982 -1.118 . . . . 0.28 107.982 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.66 HG22 ' CG1' ' A' ' 136' ' ' VAL . 17.2 p -134.47 126.86 30.3 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.743 -0.783 . . . . 0.42 111.05 173.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.953 HG21 ' HG2' ' A' ' 121' ' ' LYS . 10.5 p -116.81 112.28 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.591 0.71 . . . . 0.34 111.242 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.74 132.75 3.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.361 -0.836 . . . . 3.11 111.101 -176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 58.56 -88.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.474 0.916 . . . . 1.65 113.474 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -124.57 23.0 8.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.526 0.565 . . . . 1.68 112.526 -170.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.1 p -160.27 149.72 17.63 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.826 1.047 . . . . 0.37 113.826 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 147' ' ' VAL . 28.8 mt -113.33 107.57 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 113.392 -1.731 . . . . 0.53 106.56 159.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.851 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 4.2 mt-10 -92.73 170.16 9.92 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.871 -1.9 . . . . 1.13 105.871 175.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 20.7 ptp -167.6 166.32 14.1 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 123.887 0.742 . . . . 1.8 109.708 -171.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.805 HG22 ' HG2' ' A' ' 168' ' ' GLN . 6.4 mt -128.0 92.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.984 0.897 . . . . 0.43 108.733 165.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.901 ' HG2' HD22 ' A' ' 197' ' ' LEU . 12.3 tpp180 . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 113.738 -1.573 . . . . 3.13 112.28 -168.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.805 ' HG2' HG22 ' A' ' 155' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.424 -1.74 0 N-CA-C 112.945 0.72 . . . . 1.86 112.945 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 1.9 t -137.05 132.9 47.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 112.966 0.728 . . . . 0.41 112.966 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 154' ' ' MET . 20.9 ttt180 -88.03 110.11 20.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 116.128 -0.487 . . . . 2.8 109.738 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.44 138.67 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.735 0.779 . . . . 0.29 111.661 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.772 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 12.9 tpt180 -103.17 99.57 9.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.181 -1.372 . . . . 1.71 111.088 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 5.8 mp -91.26 104.5 17.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.388 -0.597 . . . . 0.69 109.388 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.7 114.64 28.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.656 1.217 . . . . 0.26 111.849 -173.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -86.12 131.32 34.28 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 112.516 -2.129 . . . . 0.72 109.45 -178.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.557 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 35.3 t70 -75.61 67.27 2.07 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.634 -1.617 . . . . 1.09 106.634 165.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.37 -98.76 1.27 Allowed Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 119.017 -1.563 . . . . 0.47 110.281 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -82.89 -24.59 33.1 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.852 0.686 . . . . 0.83 112.852 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.557 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 8.0 p-80 -131.74 126.42 34.42 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 119.717 -0.793 . . . . 1.21 111.374 -165.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.35 127.9 26.44 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.661 -1.608 . . . . 0.64 111.058 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -108.14 -38.91 5.64 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.869 -1.059 . . . . 0.29 110.516 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.439 ' O ' HG13 ' A' ' 183' ' ' ILE . 24.0 p -146.03 168.46 20.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.26 -0.427 . . . . 0.33 111.12 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.772 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 2.4 mt -140.82 143.12 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.748 -1.945 . . . . 0.76 105.748 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.7 t -137.06 136.35 47.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.228 0.537 . . . . 0.35 110.154 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.526 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 36.0 t-20 -86.29 100.58 12.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 108.088 -1.079 . . . . 1.77 108.088 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.463 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 39.1 mtm -64.34 -2.38 2.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 114.021 1.119 . . . . 0.55 114.021 -165.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.526 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.7 pt-20 -80.82 -44.13 18.94 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.861 0.838 . . . . 1.02 110.79 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.505 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 86.5 m-20 -106.45 -25.57 11.81 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.997 -1.456 . . . . 1.4 108.942 -176.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.2 27.8 1.93 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.326 -2.215 . . . . 1.33 107.599 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.476 ' HD2' HD22 ' A' ' 188' ' ' ASN . 0.1 OUTLIER -84.12 166.81 17.33 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.478 -1.692 . . . . 2.28 108.823 178.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -88.25 145.2 26.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.715 1.245 . . . . 1.36 112.67 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.626 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 1.7 m-85 -116.46 -169.34 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.282 -2.235 . . . . 1.18 105.359 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.849 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 134.94 -0.72 3.72 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.256 -1.138 . . . . 1.28 110.256 -163.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -148.65 97.63 2.76 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.138 -1.531 . . . . 2.8 108.369 154.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.3 t80 -132.15 118.96 20.26 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.004 -0.739 . . . . 0.6 109.004 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.422 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 9.0 mmt180 -105.81 142.49 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.941 -0.392 . . . . 4.77 109.941 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.901 HD22 ' HG2' ' A' ' 156' ' ' ARG . 33.7 mt -113.42 154.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.933 -0.576 . . . . 1.61 111.404 -171.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.675 ' HB3' ' NH1' ' A' ' 156' ' ' ARG . 13.4 t70 . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 109.297 -0.631 . . . . 2.66 109.297 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 52.6 mtm180 . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 107.818 -1.179 . . . . 4.32 107.818 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.52 ' O ' ' HB2' ' A' ' 126' ' ' LYS . 12.4 tpt -143.69 159.74 41.95 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.068 -1.053 . . . . 2.59 113.589 -166.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 127' ' ' LEU . 2.6 m -133.33 102.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 122.637 1.208 . . . . 0.74 109.475 159.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -164.22 111.6 1.1 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.691 -1.141 . . . . 1.38 108.194 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.682 ' HB3' HD13 ' A' ' 183' ' ' ILE . 4.4 mt -96.4 103.87 15.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.498 -0.481 . . . . 1.33 110.009 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.62 ' H ' ' HE2' ' A' ' 117' ' ' MET . 25.3 tt0 -155.88 106.15 2.12 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 119.817 -0.753 . . . . 1.93 110.63 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.586 ' HD3' ' CA ' ' A' ' 193' ' ' GLY . 18.8 Cg_exo -35.33 144.91 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.78 1 C-N-CA 125.94 4.426 . . . . 0.65 115.721 -175.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 67.74 40.19 2.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.055 -1.43 . . . . 0.72 109.536 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.633 ' HE3' HD13 ' A' ' 180' ' ' LEU . 10.9 ptt? -113.63 154.05 27.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.438 -1.255 . . . . 1.67 109.416 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -102.9 93.08 4.85 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.98 -1.119 . . . . 0.58 107.98 -173.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.656 HD13 ' HE2' ' A' ' 124' ' ' MET . 2.2 tt -126.54 162.05 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 114.601 -1.181 . . . . 0.65 110.945 -163.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.587 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.8 m -142.55 179.36 7.01 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.771 -0.826 . . . . 0.44 108.771 -169.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.855 ' HG2' HG21 ' A' ' 147' ' ' VAL . 13.0 mtpp -53.95 -35.24 61.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.06 -0.718 . . . . 2.33 109.06 166.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.937 ' O ' HG12 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -81.87 -32.52 31.01 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.433 -1.258 . . . . 1.32 112.623 -177.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.592 ' CB ' HG13 ' A' ' 119' ' ' ILE . 19.8 mt-10 -85.5 -20.7 29.29 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 119.653 -1.905 . . . . 2.06 109.167 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.764 ' HG3' HD12 ' A' ' 152' ' ' ILE . 18.7 mmt -85.4 -18.72 32.86 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.072 -1.422 . . . . 3.13 110.881 166.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.937 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.6 p -54.12 -36.28 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 CA-C-O 121.749 0.785 . . . . 0.37 111.285 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.921 ' HE3' HG13 ' A' ' 125' ' ' VAL . 1.5 mmpt? -71.44 -40.2 70.54 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.787 -1.097 . . . . 0.63 112.0 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.749 ' N ' HG12 ' A' ' 111' ' ' VAL . 1.5 tm? -49.57 -36.05 22.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.777 0.798 . . . . 1.79 109.163 166.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' A' ' 124' ' ' MET . 24.4 mt -86.11 -34.35 20.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.394 -0.821 . . . . 0.38 110.08 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 126' ' ' LYS . 2.9 tp10 -58.76 -34.89 71.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.184 -1.371 . . . . 1.96 109.216 167.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -73.69 -37.79 65.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.508 -1.678 . . . . 0.64 112.128 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 128' ' ' LEU . 10.8 t -89.18 -5.26 57.85 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 123.819 1.771 . . . . 0.59 107.079 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 56.82 53.26 8.41 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.048 -2.796 . . . . 1.8 112.71 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.777 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.1 t80 -136.37 176.99 8.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.209 -0.597 . . . . 0.52 112.181 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 41.5 ttt180 -134.37 155.24 50.61 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 4.54 107.603 172.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' A' ' 135' ' ' GLN . 0.2 OUTLIER -50.42 140.24 14.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.623 1.201 . . . . 1.28 112.89 -169.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.7 p -141.14 136.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.77 -2.014 . . . . 1.05 109.487 -166.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.5 t -59.43 -30.9 68.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 122.46 1.124 . . . . 1.38 109.578 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -159.22 120.12 3.24 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 112.858 -1.974 . . . . 1.44 108.95 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.657 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -111.22 120.63 42.93 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.074 -1.421 . . . . 0.9 110.167 -177.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.28 96.17 2.02 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.275 1.512 . . . . 0.61 109.067 157.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.566 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.2 OUTLIER -166.69 163.04 11.2 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 111.586 -2.552 . . . . 1.77 105.124 165.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.6 127.8 13.6 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 CA-C-N 120.63 1.261 . . . . 0.62 111.791 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 97.03 30.12 7.64 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 120.381 -0.914 . . . . 0.51 113.909 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.777 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -128.0 174.46 9.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.295 0.547 . . . . 2.16 110.125 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.897 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 p90 -169.06 163.93 11.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.273 -1.01 . . . . 0.28 108.273 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.736 HG22 HG13 ' A' ' 136' ' ' VAL . 22.3 p -132.86 126.35 32.02 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.176 -0.609 . . . . 0.42 110.956 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.855 HG21 ' HG2' ' A' ' 121' ' ' LYS . 6.1 p -112.18 110.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 120.026 -0.669 . . . . 0.34 111.801 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -132.45 43.58 2.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.433 -0.803 . . . . 3.11 111.456 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.54 -54.34 0.67 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.531 0.937 . . . . 1.65 113.531 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -80.98 -15.09 57.19 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.393 0.616 . . . . 1.68 110.288 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.2 p -164.74 154.6 13.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.154 -0.93 . . . . 0.37 111.441 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.764 HD12 ' HG3' ' A' ' 124' ' ' MET . 28.4 mt -114.67 110.87 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 113.496 -1.683 . . . . 0.53 106.555 164.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.897 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -88.95 174.87 7.68 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.53 -1.656 . . . . 1.13 106.53 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 28.2 ptm -168.89 159.34 9.45 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 123.501 0.501 . . . . 1.8 110.734 -172.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.4 mt -130.92 110.17 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.098 -0.501 . . . . 0.43 111.321 167.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.763 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 1.4 tpt180 . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.605 -0.725 . . . . 3.13 110.042 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.763 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.3 tt0 . . . . . 0 N--CA 1.426 -1.645 0 N-CA-C 115.203 1.556 . . . . 1.86 115.203 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 51.1 t -153.5 125.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 113.748 -1.569 . . . . 0.41 110.448 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HG3' HG12 ' A' ' 155' ' ' ILE . 4.1 ttm180 -84.52 110.63 18.83 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.467 -0.568 . . . . 2.8 109.467 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HB3' ' CG ' ' A' ' 154' ' ' MET . . . -116.27 147.71 41.23 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.729 -0.788 . . . . 0.29 111.603 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.785 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.4 tpp180 -109.77 98.97 8.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.552 -1.203 . . . . 1.71 110.84 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CE ' ' A' ' 124' ' ' MET . 1.4 mp -88.7 94.34 9.87 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.438 -0.949 . . . . 0.69 108.438 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.02 120.45 35.24 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 122.443 1.116 . . . . 0.26 111.672 -170.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-30 -90.91 130.07 36.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.746 -2.025 . . . . 0.72 109.962 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.57 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 30.7 t70 -78.68 64.83 3.78 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.224 -1.769 . . . . 1.09 106.224 165.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.99 -99.7 0.96 Allowed Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 119.332 -1.414 . . . . 0.47 110.735 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.65 -25.54 49.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.865 0.691 . . . . 0.83 112.865 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 6.8 p-80 -133.84 127.18 32.08 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.917 -0.713 . . . . 1.21 110.587 -167.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.0 tt -54.75 130.85 42.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.126 -1.397 . . . . 0.64 110.194 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.15 -39.16 6.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.93 -1.032 . . . . 0.29 109.827 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.8 p -152.56 169.51 22.47 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.029 -0.532 . . . . 0.33 111.244 -173.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.785 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mt -135.81 144.34 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.191 -2.151 . . . . 0.76 105.191 167.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 47.5 t -138.64 140.17 39.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 117.992 0.36 . . . . 0.35 110.296 -174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.606 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 37.5 t-20 -81.15 107.91 14.35 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.32 -1.363 . . . . 1.77 107.32 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.431 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 59.3 mtm -69.16 -1.52 8.04 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 112.586 0.587 . . . . 0.55 112.586 -166.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.606 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 12.1 pt-20 -85.26 -44.54 12.79 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.753 0.787 . . . . 1.02 111.237 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.533 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.7 m-20 -106.37 -26.09 11.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.513 -1.222 . . . . 1.4 109.093 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 188' ' ' ASN . 13.7 t30 77.31 31.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.536 -2.12 . . . . 1.33 107.304 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.458 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 ptm180 -89.0 159.24 17.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.736 -1.575 . . . . 2.28 108.889 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.75 149.77 25.53 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.208 1.004 . . . . 1.36 112.732 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.92 -174.04 3.48 Favored 'General case' 0 CA--C 1.472 -2.039 0 CA-C-N 113.246 -1.797 . . . . 1.18 107.754 -173.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.618 ' HA2' HD12 ' A' ' 183' ' ' ILE . . . 129.9 24.92 0.94 Allowed Glycine 1 N--CA 1.393 -4.177 0 CA-C-N 114.101 -1.409 . . . . 1.28 112.725 -178.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.36 94.69 2.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.452 -1.874 . . . . 2.8 106.824 145.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.679 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -129.99 101.36 5.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.693 -0.854 . . . . 0.6 108.693 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 3.2 mpt_? -105.35 127.36 52.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.191 0.52 . . . . 4.77 110.888 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.595 HD12 HD22 ' A' ' 127' ' ' LEU . 4.5 mt -104.15 172.55 6.74 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.434 -0.803 . . . . 1.61 111.9 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.445 -0.718 0 CA-C-N 114.268 -1.333 . . . . 2.66 108.66 173.427 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HB3' ' HE3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 114.731 1.382 . . . . 4.32 114.731 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.509 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 34.7 ttp -142.45 124.86 15.63 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.35 -0.94 . . . . 2.59 111.793 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.9 m -110.7 104.91 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-O 122.817 1.294 . . . . 0.74 113.128 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -160.01 109.9 1.83 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 112.587 -2.097 . . . . 1.38 106.054 165.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.808 HD21 HD21 ' A' ' 173' ' ' LEU . 4.3 mp -99.51 123.69 44.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.825 -0.805 . . . . 1.33 108.825 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -152.22 100.37 2.83 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.499 -0.926 . . . . 1.93 108.499 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.489 ' HD3' HD12 ' A' ' 183' ' ' ILE . 24.5 Cg_exo -35.43 137.66 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.366 1 C-N-CA 125.361 4.041 . . . . 0.65 114.314 -173.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.2 47.57 0.28 Allowed 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.488 1.137 . . . . 0.72 109.795 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.504 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 5.8 ptp -122.36 156.31 34.22 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.537 -1.211 . . . . 1.67 110.867 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.2 m -102.7 77.74 1.63 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.334 1.064 . . . . 0.58 108.471 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.509 HG22 ' HB2' ' A' ' 180' ' ' LEU . 15.2 tt -106.7 168.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 113.287 -1.779 . . . . 0.65 109.482 -171.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.513 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.8 m -137.59 162.9 32.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.223 -0.591 . . . . 0.44 109.464 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.649 ' HG2' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.34 -26.52 4.97 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 122.009 0.909 . . . . 2.33 108.817 170.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.695 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 4.0 t-20 -82.79 -14.69 53.94 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.826 -1.988 . . . . 1.32 114.535 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.513 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -84.7 -63.63 1.3 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.74 -1.225 . . . . 2.06 109.969 168.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.706 ' CE ' HD23 ' A' ' 173' ' ' LEU . 0.0 OUTLIER -64.28 -9.87 20.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.074 -0.966 . . . . 3.13 110.727 174.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.695 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 12.4 p -41.7 -41.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.853 0.835 . . . . 0.37 110.62 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.503 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.3 mmpt? -66.13 -37.31 85.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.807 -1.088 . . . . 0.63 113.116 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.808 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.5 tm? -54.2 -33.58 58.54 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.618 0.723 . . . . 1.79 109.894 167.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.763 ' HB3' ' CE2' ' A' ' 145' ' ' PHE . 15.9 mt -82.44 -34.96 27.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.452 -0.944 . . . . 0.38 108.452 -172.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -60.14 -39.33 85.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.843 -1.526 . . . . 1.96 109.943 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 132' ' ' GLN . . . -70.32 -42.76 71.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.989 -1.459 . . . . 0.64 112.544 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.446 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -88.6 -0.62 57.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 124.284 1.992 . . . . 0.59 105.812 -177.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 130' ' ' ALA . 11.5 mm-40 57.01 49.51 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 110.628 -2.987 . . . . 1.8 111.856 170.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.993 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 1.9 t80 -141.31 174.49 10.49 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 119.484 -0.886 . . . . 0.52 113.198 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 23.4 ptt-85 -137.49 158.15 45.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.142 -1.39 . . . . 4.54 107.585 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.69 140.42 14.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.194 0.997 . . . . 1.28 112.523 -171.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.805 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.9 p -139.85 134.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 113.512 -1.676 . . . . 1.05 110.192 -163.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.02 -33.36 68.89 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.7 1.238 . . . . 1.38 109.602 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.589 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -160.14 131.35 5.82 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 112.308 -2.224 . . . . 1.44 107.801 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.541 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 1.4 ptt? -119.0 137.93 53.18 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 115.023 -0.99 . . . . 0.9 111.127 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.49 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -162.31 98.58 1.03 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 122.34 1.067 . . . . 0.61 109.846 152.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.423 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -167.62 155.75 8.5 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 113.371 -1.74 . . . . 1.77 106.74 163.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.522 ' HA ' HG22 ' A' ' 155' ' ' ILE . 19.0 Cg_endo -61.27 119.62 6.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.051 1.167 . . . . 0.62 110.017 169.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.446 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 93.67 44.17 3.73 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.476 -1.345 . . . . 0.51 112.744 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.993 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.4 mt-10 -145.57 148.85 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.326 -0.99 . . . . 2.16 108.326 172.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.805 ' O ' HG12 ' A' ' 136' ' ' VAL . 40.7 p90 -152.85 156.78 39.65 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.758 -0.83 . . . . 0.28 108.758 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.75 HG22 HG13 ' A' ' 136' ' ' VAL . 21.3 p -126.04 126.28 43.99 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.679 -0.692 . . . . 0.42 110.663 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.649 HG21 ' HG2' ' A' ' 121' ' ' LYS . 9.1 p -125.08 109.88 23.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.966 -1.016 . . . . 0.34 111.511 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -110.27 -66.1 1.1 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.17 -0.468 . . . . 3.11 110.775 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.39 -61.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.076 0.399 . . . . 1.65 112.076 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -93.13 -1.78 56.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.615 0.598 . . . . 1.68 112.615 -171.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.4 p -163.28 152.6 14.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.529 0.937 . . . . 0.37 113.529 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.533 HD12 ' CG ' ' A' ' 124' ' ' MET . 20.7 mt -109.97 110.94 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 113.508 -1.678 . . . . 0.53 107.259 164.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -97.92 107.43 19.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.857 -1.164 . . . . 1.13 107.857 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 7.9 ptm -115.7 139.42 50.15 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.625 0.726 . . . . 1.8 112.124 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.64 HG23 ' HG3' ' A' ' 168' ' ' GLN . 68.4 mt -99.13 108.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.636 -1.165 . . . . 0.43 109.535 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.72 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 37.9 ttp180 . . . . . 0 C--N 1.31 -1.11 0 CA-C-N 114.689 -1.141 . . . . 3.13 109.978 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.72 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 113.386 0.884 . . . . 1.86 113.386 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.455 ' N ' ' HG2' ' A' ' 168' ' ' GLN . 44.0 t -151.21 128.7 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 114.834 -1.075 . . . . 0.41 109.192 173.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HG3' HG12 ' A' ' 155' ' ' ILE . 32.6 mtm180 -91.14 109.35 20.6 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 120.941 0.4 . . . . 2.8 110.386 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -114.15 134.14 55.1 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.956 0.884 . . . . 0.29 111.544 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.8 tpp180 -95.0 98.04 10.4 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 113.569 -1.651 . . . . 1.71 110.75 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.808 HD21 HD21 ' A' ' 113' ' ' LEU . 2.8 mp -86.21 93.28 9.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.079 -0.711 . . . . 0.69 109.079 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 114.25 25.92 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 122.012 0.911 . . . . 0.26 111.497 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-85 -87.02 131.48 34.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.446 -1.707 . . . . 0.72 110.197 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.7 t70 -77.38 65.38 2.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.567 -1.642 . . . . 1.09 106.567 164.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.29 -98.54 1.25 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.911 -1.614 . . . . 0.47 110.379 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.71 -22.93 37.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.906 0.706 . . . . 0.83 112.906 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -133.89 128.42 34.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 119.685 -0.806 . . . . 1.21 111.431 -168.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 5.6 tt -52.77 125.93 18.39 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.899 -1.5 . . . . 0.64 109.648 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.11 -37.74 6.51 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.408 -0.814 . . . . 0.29 109.442 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.4 p -146.13 161.23 40.65 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.533 -0.758 . . . . 0.33 111.001 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.4 mt -128.59 145.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.214 -2.143 . . . . 0.76 105.214 167.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.6 t -142.22 132.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.392 0.615 . . . . 0.35 109.998 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 32.3 t-20 -79.21 105.26 10.41 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 107.495 -1.298 . . . . 1.77 107.495 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.514 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 38.6 mtm -66.95 -1.48 4.1 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.782 0.676 . . . . 0.55 112.642 -167.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.59 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.9 pt-20 -79.71 -44.14 21.35 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.85 0.833 . . . . 1.02 110.819 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.59 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 70.6 m-20 -107.49 -26.59 10.86 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.293 -1.321 . . . . 1.4 109.454 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 188' ' ' ASN . 53.8 t30 77.02 33.13 0.46 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.534 -2.121 . . . . 1.33 107.586 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.5 ptm180 -91.83 161.47 14.84 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.581 -1.645 . . . . 2.28 109.18 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.62 137.76 32.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.103 -0.953 . . . . 1.36 109.358 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -110.85 89.92 3.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.779 -0.769 . . . . 1.18 110.795 -174.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.54 -58.69 0.0 OUTLIER Glycine 0 N--CA 1.469 0.863 0 C-N-CA 125.173 1.368 . . . . 1.28 116.233 145.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 23.6 p90 -164.07 174.4 11.37 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.952 -1.624 . . . . 2.8 107.709 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.762 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.7 t80 -138.31 101.59 4.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.637 0.732 . . . . 0.6 110.626 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -81.92 137.52 35.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.834 -0.621 . . . . 4.77 110.09 -177.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.808 HD13 ' HG ' ' A' ' 127' ' ' LEU . 92.5 mt -134.24 170.48 15.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.493 0.923 . . . . 1.61 113.493 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 114.268 -1.333 . . . . 2.66 109.874 -178.707 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 115.084 1.513 . . . . 4.32 115.084 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.774 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 57.4 ttm -142.3 110.87 6.13 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.153 -0.619 . . . . 2.59 112.326 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.8 m -107.81 106.66 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-O 122.459 1.123 . . . . 0.74 113.08 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -158.46 108.64 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.185 -1.825 . . . . 1.38 107.008 163.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.761 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.8 mp -95.18 116.85 29.27 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.059 -0.719 . . . . 1.33 109.059 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -148.3 107.34 3.6 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 119.766 -0.774 . . . . 1.93 110.176 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.535 ' HG3' HG12 ' A' ' 183' ' ' ILE . 37.7 Cg_exo -35.43 130.49 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 124.287 3.325 . . . . 0.65 113.799 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 24.3 t70 68.83 54.33 0.48 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.512 1.149 . . . . 0.72 110.01 -174.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.702 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 14.1 ptt? -121.73 156.18 33.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.972 -1.467 . . . . 1.67 110.364 172.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.51 96.37 6.69 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.496 -0.927 . . . . 0.58 108.496 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.83 HD13 ' HE2' ' A' ' 124' ' ' MET . 15.8 tt -136.98 169.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.613 -1.176 . . . . 0.65 109.831 -165.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 124' ' ' MET . 20.2 m -139.75 175.94 9.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.809 0.731 . . . . 0.44 111.118 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.638 ' H ' ' HD2' ' A' ' 121' ' ' LYS . 3.2 mptt -62.34 -19.82 63.74 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.123 0.963 . . . . 2.33 108.556 169.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.71 ' O ' HG12 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -81.5 -23.44 37.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.31 -1.768 . . . . 1.32 112.627 177.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.774 ' HA ' ' H ' ' A' ' 110' ' ' MET . 19.6 mt-10 -88.45 -44.01 11.04 Favored 'General case' 0 N--CA 1.408 -2.556 0 O-C-N 120.812 -1.18 . . . . 2.06 108.93 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.83 ' HE2' HD13 ' A' ' 119' ' ' ILE . 14.1 mmt -63.89 -18.76 64.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.96 -1.473 . . . . 3.13 110.557 169.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -48.96 -41.57 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-O 122.089 0.947 . . . . 0.37 110.287 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.524 ' CE ' HG13 ' A' ' 125' ' ' VAL . 8.7 mmpt? -66.67 -38.21 86.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.204 -1.362 . . . . 0.63 113.404 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.888 HD13 HD13 ' A' ' 197' ' ' LEU . 13.5 tp -49.85 -40.15 41.46 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.857 0.837 . . . . 1.79 110.114 166.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.2 mt -82.44 -30.84 29.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.016 -0.993 . . . . 0.38 109.259 -167.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.49 -39.3 94.08 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.844 -1.526 . . . . 1.96 110.241 165.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -72.3 -41.93 66.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.497 -1.683 . . . . 0.64 112.083 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER -97.0 6.79 47.98 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 124.558 2.123 . . . . 0.59 105.784 -177.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 46.29 50.67 12.02 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 110.023 -3.262 . . . . 1.8 113.008 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.559 ' HB3' ' CD2' ' A' ' 145' ' ' PHE . 2.8 t80 -136.07 175.03 9.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.879 -0.728 . . . . 0.52 112.437 -173.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 2.2 tmm_? -137.05 147.96 46.49 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.459 -1.682 . . . . 4.54 106.459 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.537 ' N ' ' HD2' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -47.92 140.7 6.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.846 1.308 . . . . 1.28 113.388 -170.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.8 p -140.88 137.73 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 112.638 -2.074 . . . . 1.05 109.423 -163.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -59.29 -33.22 70.82 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.343 1.068 . . . . 1.38 109.057 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.16 129.01 5.63 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.997 -1.91 . . . . 1.44 109.082 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.656 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -118.66 129.62 55.4 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.293 -1.321 . . . . 0.9 111.59 -172.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 1.8 t -160.57 99.33 1.28 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 122.907 1.337 . . . . 0.61 110.867 155.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.496 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.14 162.32 14.19 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.737 -2.029 . . . . 1.77 105.985 161.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.96 120.47 8.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.102 1.201 . . . . 0.62 110.379 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.02 48.56 3.32 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.548 -1.31 . . . . 0.51 112.964 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.55 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 31.7 mt-10 -142.25 167.51 21.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.343 -0.614 . . . . 2.16 109.343 169.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.871 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 46.8 p90 -167.76 163.13 14.18 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.234 -1.024 . . . . 0.28 108.234 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.737 HG22 HG13 ' A' ' 136' ' ' VAL . 25.7 p -130.34 125.89 35.78 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.822 -0.751 . . . . 0.42 111.147 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.651 HG23 HG12 ' A' ' 152' ' ' ILE . 7.7 p -115.24 110.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 122.002 0.906 . . . . 0.34 111.133 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -122.73 31.16 6.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.101 -0.954 . . . . 3.11 110.784 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.91 -47.04 0.66 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.485 -0.78 . . . . 1.65 112.211 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -81.67 -16.29 51.79 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.102 0.477 . . . . 1.68 110.569 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.44 ' HB3' HG23 ' A' ' 174' ' ' THR . 1.8 p -162.49 154.21 18.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.434 -0.803 . . . . 0.37 112.296 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.675 HD12 ' HG3' ' A' ' 124' ' ' MET . 20.2 mt -117.98 107.68 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.696 -1.593 . . . . 0.53 107.346 165.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.871 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.8 mp0 -90.9 168.35 11.76 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.176 -2.157 . . . . 1.13 105.176 174.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.04 157.9 10.01 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.783 0.677 . . . . 1.8 110.291 -169.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 140' ' ' THR . 15.1 mt -127.15 109.99 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 115.425 -0.807 . . . . 0.43 110.347 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.725 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 3.9 tpt180 . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 115.029 -0.987 . . . . 3.13 109.675 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.725 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 9.4 tt0 . . . . . 0 N--CA 1.425 -1.722 0 N-CA-C 115.473 1.657 . . . . 1.86 115.473 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 46.5 t -153.08 131.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 113.998 -1.456 . . . . 0.41 109.856 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.616 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 35.9 mtm180 -87.14 116.63 25.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.07 -0.514 . . . . 2.8 110.192 168.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.54 153.1 38.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.613 0.721 . . . . 0.29 111.414 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.723 ' CB ' ' HB ' ' A' ' 184' ' ' VAL . 0.0 OUTLIER -120.57 101.8 8.0 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.264 -1.335 . . . . 1.71 111.147 -172.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.601 HD21 HD21 ' A' ' 113' ' ' LEU . 1.1 mp -90.72 90.12 7.81 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.443 -0.577 . . . . 0.69 109.443 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -94.0 125.03 38.39 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.297 1.046 . . . . 0.26 111.139 -175.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 24.4 m-85 -98.45 136.54 38.44 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.158 -1.837 . . . . 0.72 111.354 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 181' ' ' ALA . 47.5 m-20 -78.28 64.74 3.47 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.813 -1.551 . . . . 1.09 106.813 161.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.24 -99.27 1.17 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 118.71 -1.71 . . . . 0.47 110.599 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.26 -20.49 32.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.913 0.708 . . . . 0.83 112.913 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.16 123.08 27.78 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 119.001 -1.08 . . . . 1.21 110.082 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -56.53 134.48 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.2 -1.818 . . . . 0.64 110.799 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.415 ' HB2' ' OD2' ' A' ' 176' ' ' ASP . . . -106.03 -41.43 5.38 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.509 -1.223 . . . . 0.29 110.517 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.7 p -150.51 158.88 44.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.342 -0.39 . . . . 0.33 111.606 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.564 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.8 mm -109.98 150.01 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 104.855 -2.276 . . . . 0.76 104.855 163.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.723 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 42.3 t -133.6 131.31 57.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 118.761 0.71 . . . . 0.35 110.255 177.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.43 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.0 t-20 -80.42 94.34 6.16 Favored 'General case' 0 CA--C 1.476 -1.873 0 N-CA-C 106.8 -1.556 . . . . 1.77 106.8 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.616 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.0 mtm -63.68 -2.53 1.76 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 124.149 0.905 . . . . 0.55 113.39 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.4 pt-20 -83.5 -41.46 17.96 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.784 0.802 . . . . 1.02 110.672 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.451 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.6 m-20 -102.73 -25.93 13.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.262 -1.335 . . . . 1.4 108.549 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.8 t30 73.97 32.82 1.03 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.936 -2.393 . . . . 1.33 107.887 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.8 ptm180 -95.75 162.43 13.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.701 -1.59 . . . . 2.28 109.466 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 77.1 mt-30 -80.83 127.81 32.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.183 -0.917 . . . . 1.36 109.535 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.564 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -100.82 93.01 5.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.747 -0.644 . . . . 1.18 110.303 -171.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 20.87 -58.23 0.0 OUTLIER Glycine 0 N--CA 1.471 0.975 0 N-CA-C 116.542 1.377 . . . . 1.28 116.542 148.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 192' ' ' PHE . 34.0 p90 -162.99 175.14 11.45 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.296 -1.452 . . . . 2.8 108.755 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.761 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -145.06 127.95 16.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.556 -0.535 . . . . 0.6 109.556 156.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.548 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 1.6 mpt_? -112.02 141.56 45.53 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 120.88 -1.138 . . . . 4.77 111.507 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.888 HD13 HD13 ' A' ' 127' ' ' LEU . 40.6 mt -136.72 163.42 30.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.702 -0.681 . . . . 1.61 112.162 -172.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 114.866 -1.061 . . . . 2.66 110.214 -177.494 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.697 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 32.4 mtt180 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.404 -0.961 . . . . 4.32 108.404 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.3 ttt -142.75 132.24 23.67 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.194 -1.003 . . . . 2.59 113.531 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' VAL . 32.6 m -124.22 101.6 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 123.148 1.452 . . . . 0.74 111.399 164.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.509 ' C ' HD12 ' A' ' 113' ' ' LEU . 43.0 t30 -162.51 119.99 2.06 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 105.007 -2.22 . . . . 1.38 105.007 170.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.754 HD23 HD11 ' A' ' 173' ' ' LEU . 5.6 mp -109.45 80.21 1.29 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.298 -1.001 . . . . 1.33 108.298 -172.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.552 ' H ' ' CE ' ' A' ' 117' ' ' MET . 27.4 tt0 -123.98 111.02 29.07 Favored Pre-proline 0 C--N 1.29 -2.02 0 C-N-CA 118.946 -1.102 . . . . 1.93 110.295 -169.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.504 ' HG3' HG12 ' A' ' 183' ' ' ILE . 39.2 Cg_exo -35.78 131.98 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 124.886 3.724 . . . . 0.65 114.298 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 28.7 t70 72.76 50.03 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.552 1.168 . . . . 0.72 110.457 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.552 ' CE ' ' H ' ' A' ' 114' ' ' GLU . 10.6 ptp -122.84 155.57 36.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.166 -1.379 . . . . 1.67 110.924 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -96.67 85.58 3.88 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.933 0.873 . . . . 0.58 108.959 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -110.18 163.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.397 -1.274 . . . . 0.65 109.924 -172.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.636 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.5 m -140.87 173.92 11.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.673 -0.492 . . . . 0.44 109.673 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.822 ' HG2' HG21 ' A' ' 147' ' ' VAL . 44.2 mttp -53.99 -32.74 55.02 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 108.575 -0.898 . . . . 2.33 108.575 164.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.627 ' O ' HG12 ' A' ' 125' ' ' VAL . 41.6 t30 -84.24 -19.19 34.33 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 114.053 -1.43 . . . . 1.32 114.733 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.636 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.3 mp0 -84.9 -63.28 1.36 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 119.755 -1.841 . . . . 2.06 107.183 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.751 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -56.36 -13.47 2.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 112.858 -1.974 . . . . 3.13 111.361 172.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 122' ' ' ASN . 14.5 p -43.19 -43.07 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.2 1.0 . . . . 0.37 110.117 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.697 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.7 -37.54 82.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.115 -1.402 . . . . 0.63 112.774 176.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -50.94 -33.83 26.11 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.723 0.773 . . . . 1.79 110.873 168.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 127' ' ' LEU . 16.0 mt -84.55 -32.62 23.75 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.931 -1.032 . . . . 0.38 109.229 -172.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.23 -35.0 77.27 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.352 -1.295 . . . . 1.96 109.644 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.26 -42.04 72.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.252 -1.794 . . . . 0.64 111.904 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.571 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.6 t -90.33 -2.66 58.01 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 123.384 1.564 . . . . 0.59 107.368 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 55.23 54.85 8.21 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 110.974 -2.83 . . . . 1.8 112.103 172.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.732 ' CZ ' ' HG3' ' A' ' 144' ' ' GLU . 3.8 t80 -138.97 177.85 7.59 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 113.095 0.776 . . . . 0.52 113.095 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.426 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -141.31 139.27 33.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.539 -1.282 . . . . 4.54 107.539 177.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.6 OUTLIER -49.06 139.47 10.51 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.35 1.241 . . . . 1.28 114.35 -168.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.781 HG23 HG22 ' A' ' 146' ' ' THR . 3.8 m -124.23 156.41 31.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.933 -1.939 . . . . 1.05 111.52 -175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -59.67 -37.48 78.87 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.516 1.15 . . . . 1.38 107.958 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -158.46 134.97 9.45 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 112.611 -2.086 . . . . 1.44 109.397 -177.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.562 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.05 136.42 54.58 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.0 -1.0 . . . . 0.9 111.311 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.7 t -159.0 100.59 1.57 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.684 1.231 . . . . 0.61 109.675 151.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.54 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -163.62 170.15 7.56 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.82 -1.991 . . . . 1.77 106.534 165.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.5 117.13 3.66 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.661 1.574 . . . . 0.62 112.604 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 105.94 36.53 2.73 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.947 -0.644 . . . . 0.51 112.366 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.732 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 12.8 mp0 -130.95 176.82 7.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.171 -0.307 . . . . 2.16 110.171 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.885 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -166.56 175.95 7.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.0 -0.741 . . . . 0.28 109.0 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.781 HG22 HG23 ' A' ' 136' ' ' VAL . 61.7 p -140.98 126.32 18.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.967 -0.56 . . . . 0.42 110.898 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.822 HG21 ' HG2' ' A' ' 121' ' ' LYS . 14.4 p -125.41 126.44 70.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.435 0.636 . . . . 0.34 112.241 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -132.36 -74.69 0.51 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.009 -0.541 . . . . 3.11 110.26 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.05 -50.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.893 0.331 . . . . 1.65 111.893 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.88 -11.47 55.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.418 -0.355 . . . . 1.68 111.516 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 10.9 p -165.13 154.72 12.94 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.868 0.842 . . . . 0.37 112.915 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.763 HG12 HG23 ' A' ' 147' ' ' VAL . 63.2 mt -114.61 108.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.597 -1.631 . . . . 0.53 106.597 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.885 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.24 166.61 13.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.703 -1.962 . . . . 1.13 105.703 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 7.6 ptm -167.53 151.67 6.59 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 124.014 0.821 . . . . 1.8 110.183 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.549 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.3 mt -128.24 113.57 30.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.159 -0.473 . . . . 0.43 110.439 172.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.773 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 13.1 mtp-105 . . . . . 0 C--N 1.316 -0.881 0 O-C-N 123.347 0.404 . . . . 3.13 110.613 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.773 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 25.4 tt0 . . . . . 0 N--CA 1.413 -2.279 0 N-CA-C 113.02 0.748 . . . . 1.86 113.02 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 61.9 t -154.96 124.43 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.131 -1.395 . . . . 0.41 109.364 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 50.5 mtm180 -81.58 124.74 29.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.548 -0.538 . . . . 2.8 109.548 166.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -129.05 137.18 51.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.654 0.74 . . . . 0.29 110.346 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.552 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 7.1 tpp180 -104.82 106.54 17.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.195 -1.366 . . . . 1.71 110.936 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.754 HD11 HD23 ' A' ' 113' ' ' LEU . 5.1 mp -92.31 98.21 11.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.3 -0.63 . . . . 0.69 109.3 174.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.57 120.99 40.86 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.188 0.994 . . . . 0.26 111.499 -171.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -88.57 134.96 33.72 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.953 -1.93 . . . . 0.72 110.229 -177.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 37.4 t70 -77.21 66.15 2.94 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.676 -1.602 . . . . 1.09 106.676 163.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.81 -98.97 1.73 Allowed Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 118.801 -1.666 . . . . 0.47 110.233 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.65 -26.02 30.24 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.878 0.695 . . . . 0.83 112.878 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -128.37 128.81 45.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.442 -0.903 . . . . 1.21 110.865 -166.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.741 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.2 tt -52.14 129.13 26.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.433 -1.712 . . . . 0.64 110.546 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.91 -39.32 5.8 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.04 -0.982 . . . . 0.29 110.059 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 167.37 24.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.144 -0.48 . . . . 0.33 111.853 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' A' ' 195' ' ' PHE . 2.0 mm -118.6 147.8 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 105.444 -2.058 . . . . 0.76 105.444 164.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -139.82 128.34 26.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.579 0.704 . . . . 0.35 110.072 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.459 ' CB ' ' HG2' ' A' ' 190' ' ' ARG . 2.4 t-20 -69.4 105.13 2.48 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 107.523 -1.288 . . . . 1.77 107.523 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.686 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 6.7 mtm -65.33 -3.56 4.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.845 0.683 . . . . 0.55 112.845 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.49 ' HG3' ' ND2' ' A' ' 188' ' ' ASN . 11.2 pt-20 -96.12 -37.44 10.59 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.695 0.76 . . . . 1.02 111.303 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 187' ' ' GLU . 48.9 m-80 -104.4 -26.53 12.39 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.541 -1.208 . . . . 1.4 109.893 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 75.39 31.83 0.76 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.745 -2.025 . . . . 1.33 108.362 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 13.5 ptt180 -92.93 156.46 16.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.454 -1.248 . . . . 2.28 109.503 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -84.69 127.44 34.1 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.87 -1.059 . . . . 1.36 109.692 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.556 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -103.77 92.81 4.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.918 -0.713 . . . . 1.18 110.451 -171.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 18.27 -58.5 0.0 OUTLIER Glycine 0 N--CA 1.468 0.826 0 N-CA-C 115.905 1.122 . . . . 1.28 115.905 145.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -163.32 174.21 12.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.043 -1.578 . . . . 2.8 108.399 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.688 ' HB3' HD22 ' A' ' 113' ' ' LEU . 1.9 t80 -142.82 152.71 42.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.086 -1.079 . . . . 0.6 108.086 156.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.42 147.53 34.75 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 122.058 -0.401 . . . . 4.77 111.422 -172.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.479 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 5.4 mt -132.87 172.43 12.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.636 0.976 . . . . 1.61 113.636 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-N 113.399 -1.728 . . . . 2.66 108.667 169.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HB2' ' HG3' ' A' ' 126' ' ' LYS . 3.4 ptm180 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 119.209 -0.424 . . . . 4.32 110.642 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.425 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 52.3 ttp -141.14 125.52 17.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 118.306 -1.358 . . . . 2.59 113.732 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 111' ' ' VAL . 26.8 m -114.0 101.53 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 122.763 1.268 . . . . 0.74 110.947 167.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.435 ' C ' HD12 ' A' ' 113' ' ' LEU . 53.0 t30 -163.02 109.75 1.19 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.576 -1.647 . . . . 1.38 106.763 171.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.603 ' CG ' HD21 ' A' ' 173' ' ' LEU . 4.9 mp -104.02 77.38 1.43 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.937 -0.764 . . . . 1.33 108.937 -169.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -121.81 107.64 35.7 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 119.342 -0.943 . . . . 1.93 110.311 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.532 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.4 Cg_exo -34.04 130.25 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.542 3.494 . . . . 0.65 114.407 -172.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 23.1 t0 77.72 39.22 0.18 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.456 1.122 . . . . 0.72 110.811 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.635 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -115.05 155.51 26.88 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.867 -1.06 . . . . 1.67 110.577 172.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 m -92.91 86.6 5.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.964 0.887 . . . . 0.58 109.205 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.63 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.7 tt -116.46 162.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.076 -1.42 . . . . 0.65 109.718 -171.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.682 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.6 m -142.26 178.03 7.85 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.96 -0.756 . . . . 0.44 108.96 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.817 ' HG2' HG21 ' A' ' 147' ' ' VAL . 28.9 mtpt -57.45 -28.58 63.47 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 108.525 -0.917 . . . . 2.33 108.525 163.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.583 ' O ' HG12 ' A' ' 125' ' ' VAL . 32.9 t30 -85.32 -18.44 33.83 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-N 113.851 -1.522 . . . . 1.32 114.774 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.682 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.0 mp0 -86.9 -62.08 1.58 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 119.82 -1.8 . . . . 2.06 108.289 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.822 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.7 tpt -53.58 -17.03 1.8 Allowed 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 112.8 -2.0 . . . . 3.13 110.779 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.593 HG13 ' HE3' ' A' ' 126' ' ' LYS . 14.9 p -43.98 -44.92 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.288 1.042 . . . . 0.37 110.447 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HE3' HG13 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -69.18 -36.29 77.19 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.937 -1.483 . . . . 0.63 112.838 177.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.76 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -51.1 -35.08 33.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 122.028 0.918 . . . . 1.79 110.54 168.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.822 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.2 mt -84.82 -28.6 26.0 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.754 -1.112 . . . . 0.38 109.152 -171.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.69 -20.47 50.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.136 -1.393 . . . . 1.96 110.341 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -80.62 -43.87 19.82 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.07 -1.423 . . . . 0.64 111.215 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.91 -6.17 54.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 123.653 1.692 . . . . 0.59 107.094 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.12 56.41 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 110.976 -2.829 . . . . 1.8 112.945 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.732 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -135.15 176.72 8.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.615 -0.721 . . . . 0.52 111.817 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 65.7 ttt180 -136.98 149.95 47.84 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.126 -1.435 . . . . 4.54 107.126 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -48.88 137.0 13.24 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.737 1.256 . . . . 1.28 112.836 -170.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.6 p -137.6 140.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 112.349 -2.205 . . . . 1.05 109.677 -164.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 m -63.5 -31.72 72.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.096 0.951 . . . . 1.38 109.3 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -152.6 117.72 5.19 Favored 'General case' 0 CA--C 1.485 -1.539 0 CA-C-N 113.352 -1.749 . . . . 1.44 110.661 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.664 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -109.59 117.88 35.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 113.81 -1.541 . . . . 0.9 110.12 179.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -151.12 95.59 2.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.24 1.495 . . . . 0.61 108.399 156.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.53 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -168.31 155.87 7.63 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 111.546 -2.57 . . . . 1.77 105.029 168.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.476 ' HA ' HG22 ' A' ' 155' ' ' ILE . 14.6 Cg_exo -71.17 123.6 9.77 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.526 1.484 . . . . 0.62 112.18 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.688 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 106.15 20.14 9.48 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 120.579 -0.82 . . . . 0.51 111.781 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.732 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.8 mp0 -125.99 173.82 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.807 -0.442 . . . . 2.16 109.807 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.885 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 47.6 p90 -168.42 168.17 11.38 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.506 -1.294 . . . . 0.28 107.506 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.683 HG22 HG13 ' A' ' 136' ' ' VAL . 34.9 p -133.19 127.27 33.43 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.713 -0.795 . . . . 0.42 110.499 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.879 HG23 HG12 ' A' ' 152' ' ' ILE . 10.7 p -122.93 121.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.715 -0.794 . . . . 0.34 112.861 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -111.02 -77.47 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.973 . . . . 3.11 109.74 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -176.73 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.261 -0.881 . . . . 1.65 109.092 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.45 -19.32 39.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.97 -1.014 . . . . 1.68 110.128 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 21.0 p -160.6 155.03 23.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.149 -0.932 . . . . 0.37 111.751 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.879 HG12 HG23 ' A' ' 147' ' ' VAL . 53.4 mt -121.11 113.82 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.487 -1.671 . . . . 0.53 106.487 163.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.885 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -89.82 169.99 10.79 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.374 -1.713 . . . . 1.13 106.374 175.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.23 150.54 5.36 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 123.802 0.689 . . . . 1.8 110.672 -174.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.6 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.3 mt -128.71 119.47 49.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.763 -0.653 . . . . 0.43 109.938 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.71 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 82.6 mtp180 . . . . . 0 C--N 1.32 -0.695 0 O-C-N 123.458 0.474 . . . . 3.13 110.719 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.71 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 5.3 tt0 . . . . . 0 N--CA 1.425 -1.685 0 CA-C-O 121.301 0.572 . . . . 1.86 112.064 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 53.7 t -153.69 130.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.712 -1.131 . . . . 0.41 108.711 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.703 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 51.4 mtm180 -87.25 122.82 31.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.225 0.536 . . . . 2.8 110.152 169.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -130.25 128.45 41.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.091 0.948 . . . . 0.29 110.791 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.543 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 9.0 tpp180 -96.26 120.88 37.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.496 -1.683 . . . . 1.71 110.251 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.603 HD21 ' CG ' ' A' ' 113' ' ' LEU . 7.4 mp -111.54 103.99 12.36 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.422 0.63 . . . . 0.69 111.045 174.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.75 124.87 47.01 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.777 -1.101 . . . . 0.26 111.284 -174.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -97.9 139.6 33.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.137 -1.847 . . . . 0.72 110.683 -175.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.1 64.06 4.81 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 106.754 -1.573 . . . . 1.09 106.754 160.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.84 -98.82 0.64 Allowed Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 118.78 -1.676 . . . . 0.47 110.926 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.41 -25.47 59.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.939 0.718 . . . . 0.83 112.939 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -136.28 133.89 37.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.768 -0.773 . . . . 1.21 109.824 -169.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -60.1 138.79 57.81 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.115 -1.402 . . . . 0.64 110.0 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.34 -45.21 4.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.043 -0.98 . . . . 0.29 110.513 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.8 p -148.66 158.8 44.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 111.698 0.259 . . . . 0.33 111.698 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.555 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.2 mm -107.42 148.32 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 104.966 -2.235 . . . . 0.76 104.966 165.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.5 t -140.05 126.88 23.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.532 0.682 . . . . 0.35 110.077 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -69.72 107.48 3.49 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.356 -1.349 . . . . 1.77 107.356 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.703 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 20.3 mtm -64.66 -8.33 14.01 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 112.862 0.69 . . . . 0.55 112.862 -165.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -91.66 -41.83 10.51 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.768 0.794 . . . . 1.02 111.45 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -98.24 -25.47 14.86 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.391 -1.277 . . . . 1.4 109.381 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.1 t30 70.09 35.47 2.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.912 -2.404 . . . . 1.33 108.015 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.5 ptm180 -96.42 157.78 15.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.604 -1.634 . . . . 2.28 108.833 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 87.8 mt-30 -85.94 129.43 34.84 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.336 -0.847 . . . . 1.36 109.221 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.555 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -104.1 91.91 4.15 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.259 -0.576 . . . . 1.18 110.547 -170.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.33 -59.09 0.0 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 116.26 1.264 . . . . 1.28 116.26 147.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 192' ' ' PHE . 26.2 p90 -164.75 171.08 14.74 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.639 -1.281 . . . . 2.8 109.137 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.575 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -139.19 151.87 46.92 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.842 -1.17 . . . . 0.6 107.842 159.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.697 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.23 148.46 36.48 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.906 -0.496 . . . . 4.77 110.465 -175.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.599 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 3.5 mt -130.15 172.07 12.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.282 1.039 . . . . 1.61 113.728 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-N 113.207 -1.815 . . . . 2.66 108.249 170.546 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.114 -0.699 . . . . 4.32 109.114 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.581 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 26.2 ttt -144.23 136.92 26.93 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.423 -0.511 . . . . 2.59 111.882 -170.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 126' ' ' LYS . 2.0 m -119.8 104.4 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 122.569 1.175 . . . . 0.74 113.41 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -159.74 108.23 1.76 Allowed 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.939 -1.937 . . . . 1.38 106.895 163.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.823 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.2 mp -98.17 113.21 25.05 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.517 0.675 . . . . 1.33 109.295 -173.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -139.97 100.77 7.17 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.76 -1.109 . . . . 1.93 109.031 -173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.48 ' HD3' HD12 ' A' ' 183' ' ' ILE . 23.5 Cg_exo -35.12 133.68 0.19 Allowed 'Trans proline' 0 CA--C 1.515 -0.46 0 C-N-CA 124.452 3.435 . . . . 0.65 113.997 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 31.4 t70 74.74 47.06 0.12 Allowed 'General case' 0 CA--C 1.529 0.135 0 O-C-N 124.583 1.177 . . . . 0.72 109.91 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.589 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 12.4 ptt? -121.12 155.79 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.266 -1.333 . . . . 1.67 110.339 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 179' ' ' HIS . 56.5 m -101.59 102.75 13.52 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.532 -0.914 . . . . 0.58 108.532 -176.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.71 HD13 ' HE3' ' A' ' 124' ' ' MET . 16.6 tt -138.93 167.76 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.212 -0.904 . . . . 0.65 110.64 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.6 m -140.84 174.33 10.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.765 0.711 . . . . 0.44 110.785 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.514 ' HA ' HD11 ' A' ' 152' ' ' ILE . 11.9 mttp -57.49 -26.19 60.91 Favored 'General case' 0 C--O 1.211 -0.944 0 N-CA-C 109.089 -0.708 . . . . 2.33 109.089 165.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 40.6 t30 -84.44 -17.1 40.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.316 -1.311 . . . . 1.32 114.052 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.581 ' CG ' ' HB3' ' A' ' 110' ' ' MET . 1.8 tt0 -87.18 -60.25 2.03 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.658 -1.238 . . . . 2.06 107.658 168.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.848 ' SD ' HD12 ' A' ' 152' ' ' ILE . 61.2 mtt -54.86 -15.91 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.832 -1.985 . . . . 3.13 111.906 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.576 HG13 ' HE3' ' A' ' 126' ' ' LYS . 12.9 p -44.16 -40.63 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 122.141 0.972 . . . . 0.37 109.967 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.659 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.77 -40.7 84.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.066 -1.425 . . . . 0.63 112.743 176.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -49.74 -33.71 16.97 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.686 0.755 . . . . 1.79 111.041 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 127' ' ' LEU . 14.6 mt -85.96 -34.27 20.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.856 -1.065 . . . . 0.38 109.607 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.59 -34.6 76.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.448 -1.251 . . . . 1.96 109.854 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.89 67.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.512 -1.676 . . . . 0.64 111.451 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.415 ' O ' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -89.64 -0.42 57.51 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 123.976 1.846 . . . . 0.59 106.969 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 55.75 54.6 8.03 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 111.079 -2.782 . . . . 1.8 112.693 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 2.7 t80 -141.38 174.93 10.08 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.022 -0.535 . . . . 0.52 111.864 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -137.1 156.46 48.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.949 -1.13 . . . . 4.54 107.949 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.415 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.86 139.73 16.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.31 1.052 . . . . 1.28 112.172 -170.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.0 p -138.61 142.5 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 112.998 -1.91 . . . . 1.05 110.205 -164.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.12 -33.41 69.11 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.519 1.152 . . . . 1.38 109.616 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 1.4 ttpt -160.54 129.19 4.73 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 112.521 -2.127 . . . . 1.44 108.262 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.62 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -116.32 128.86 55.91 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.919 -0.582 . . . . 0.9 111.541 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.426 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.0 OUTLIER -161.68 98.56 1.11 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.551 1.167 . . . . 0.61 110.279 157.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.452 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -166.66 167.07 8.39 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 112.891 -1.959 . . . . 1.77 105.833 161.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.59 127.76 21.63 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 120.866 1.044 . . . . 0.62 110.416 170.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 131' ' ' THR . . . 86.25 42.69 6.52 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.428 -1.367 . . . . 0.51 112.96 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 28.2 mt-10 -140.76 166.15 25.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.843 -0.428 . . . . 2.16 109.843 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.721 ' O ' HG12 ' A' ' 136' ' ' VAL . 46.2 p90 -167.85 161.46 13.1 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.825 -0.806 . . . . 0.28 108.825 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.601 HG23 ' SD ' ' A' ' 139' ' ' MET . 71.4 p -123.35 130.73 53.13 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.284 0.564 . . . . 0.42 110.461 171.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 152' ' ' ILE . 9.8 p -120.54 108.53 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.984 0.897 . . . . 0.34 110.374 172.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -109.62 -68.2 0.94 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 3.11 110.296 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.6 -53.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.933 0.346 . . . . 1.65 111.933 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -102.17 1.83 36.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.545 0.572 . . . . 1.68 112.545 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 2.8 p -163.93 153.16 14.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.554 0.693 . . . . 0.37 112.807 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.848 HD12 ' SD ' ' A' ' 124' ' ' MET . 52.6 mt -112.11 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.287 -1.324 . . . . 0.53 107.683 165.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 2.4 mt-10 -95.65 103.22 15.09 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.371 -0.831 . . . . 1.13 109.325 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -113.62 166.65 11.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.396 -0.82 . . . . 1.8 111.848 -169.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.61 HG12 ' HG3' ' A' ' 170' ' ' ARG . 14.7 mt -127.63 106.64 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 114.616 -1.175 . . . . 0.43 110.297 173.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.721 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 53.4 ttt180 . . . . . 0 C--N 1.32 -0.702 0 O-C-N 124.025 0.828 . . . . 3.13 110.08 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.721 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 121.306 0.574 . . . . 1.86 112.413 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 59.6 t -151.45 127.43 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.049 -0.978 . . . . 0.41 110.154 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.61 ' HG3' HG12 ' A' ' 155' ' ' ILE . 8.6 mtt180 -82.8 110.74 18.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.059 -0.519 . . . . 2.8 109.901 169.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.97 137.63 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.992 0.901 . . . . 0.29 111.693 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 3.7 tpp180 -101.83 101.35 11.79 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.74 -1.573 . . . . 1.71 110.798 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.685 HD23 ' SD ' ' A' ' 124' ' ' MET . 2.9 mp -88.97 92.24 9.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.425 -0.583 . . . . 0.69 109.425 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.02 39.6 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.532 1.158 . . . . 0.26 111.902 -171.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-85 -88.81 137.58 32.19 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.647 -2.069 . . . . 0.72 110.89 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.9 t70 -81.93 65.1 6.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.987 -1.857 . . . . 1.09 105.987 160.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 73.59 -99.43 1.01 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 118.66 -1.733 . . . . 0.47 110.743 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -75.96 -26.99 57.34 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 112.773 0.657 . . . . 0.83 112.773 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.429 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 13.1 p-80 -133.12 129.74 38.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.862 -0.735 . . . . 1.21 111.181 -168.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.9 tt -52.6 126.52 19.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.286 -1.325 . . . . 0.64 109.756 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -103.0 -38.7 7.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.432 -0.803 . . . . 0.29 109.453 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.2 p -147.16 161.5 40.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.284 -0.871 . . . . 0.33 110.463 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 24.9 mt -126.17 147.66 30.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 104.212 -2.514 . . . . 0.76 104.212 167.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 3.8 t -136.71 134.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.855 -0.738 . . . . 0.35 111.692 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.596 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 12.1 m120 -72.53 97.74 2.17 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.424 -1.695 . . . . 1.77 106.424 174.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.522 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 46.1 mtm -65.95 -2.91 4.39 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.277 0.561 . . . . 0.55 112.345 -168.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.596 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 14.1 pt-20 -74.38 -42.85 58.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.046 0.927 . . . . 1.02 110.829 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -105.41 -25.52 12.33 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.277 -1.329 . . . . 1.4 108.814 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.7 t30 73.47 36.47 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 111.834 -2.439 . . . . 1.33 108.063 -174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 11.5 ptt180 -100.1 161.14 13.8 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.466 -1.243 . . . . 2.28 110.337 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -76.93 134.42 38.93 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.082 -0.963 . . . . 1.36 110.666 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -105.77 91.14 3.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.888 -0.577 . . . . 1.18 110.206 -174.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.46 -57.47 0.0 OUTLIER Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.68 1.432 . . . . 1.28 116.68 144.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -162.52 176.26 10.61 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.297 -1.451 . . . . 2.8 109.129 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.823 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 10.9 t80 -149.34 100.43 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.445 0.64 . . . . 0.6 110.197 156.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -98.86 139.18 34.92 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.546 -0.721 . . . . 4.77 111.128 -175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 127' ' ' LEU . 2.0 mt -109.81 172.44 6.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 113.639 0.977 . . . . 1.61 113.639 -175.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 N--CA 1.443 -0.815 0 CA-C-N 113.382 -1.736 . . . . 2.66 109.276 -179.851 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.561 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 21.3 mtm180 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 119.285 -0.388 . . . . 4.32 110.112 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.577 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 34.8 tpp -141.57 133.04 26.8 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.703 -1.599 . . . . 2.59 115.209 -169.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.594 HG12 ' HE1' ' A' ' 124' ' ' MET . 17.3 m -121.11 107.84 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.111 0.958 . . . . 0.74 113.126 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -158.64 109.7 2.12 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.262 -1.384 . . . . 1.38 107.262 167.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.668 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 5.8 mp -95.34 101.16 12.87 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.205 0.526 . . . . 1.33 110.315 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -145.56 95.74 4.92 Favored Pre-proline 0 N--CA 1.429 -1.502 0 C-N-CA 119.781 -0.768 . . . . 1.93 109.455 -174.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.667 ' HD3' HD12 ' A' ' 183' ' ' ILE . 1.0 OUTLIER -33.53 142.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.589 1 C-N-CA 126.356 4.704 . . . . 0.65 115.422 -174.331 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.1 40.06 0.74 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.698 -1.592 . . . . 0.72 109.197 -170.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.592 ' HE3' HD13 ' A' ' 180' ' ' LEU . 9.6 ptt? -118.09 154.84 31.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 113.993 -1.458 . . . . 1.67 109.734 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.5 m -101.46 81.04 2.14 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.298 1.047 . . . . 0.58 108.593 -175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.669 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -104.88 161.94 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.464 -1.698 . . . . 0.65 109.871 -169.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.56 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 23.1 m -143.34 179.3 7.17 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 119.634 -0.826 . . . . 0.44 110.583 -173.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.627 ' HG2' HG21 ' A' ' 147' ' ' VAL . 1.2 mttm -61.62 -24.77 66.92 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.79 -1.189 . . . . 2.33 107.79 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.746 ' O ' HG12 ' A' ' 125' ' ' VAL . 4.3 t30 -83.77 -24.19 31.2 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 114.102 -1.408 . . . . 1.32 113.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.577 ' HA ' ' H ' ' A' ' 110' ' ' MET . 0.9 OUTLIER -80.48 -60.63 2.24 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.153 -2.217 . . . . 2.06 106.769 175.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.822 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.4 mmt -57.86 -17.26 15.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.767 -2.015 . . . . 3.13 111.943 173.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.4 p -43.5 -42.16 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 122.0 0.905 . . . . 0.37 110.518 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.561 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.93 -37.66 81.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.366 -1.288 . . . . 0.63 113.806 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.74 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.9 tm? -56.34 -34.15 66.32 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.455 0.645 . . . . 1.79 109.943 167.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.822 ' HG ' ' O ' ' A' ' 124' ' ' MET . 11.8 mt -84.06 -31.38 25.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.948 0.88 . . . . 0.38 108.932 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.5 -31.25 68.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.796 -1.547 . . . . 1.96 110.043 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -72.75 -44.56 61.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.956 -1.474 . . . . 0.64 111.387 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.412 ' O ' ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -92.94 -1.43 56.71 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.294 -1.743 . . . . 0.59 106.294 -177.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.94 50.8 15.97 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.696 -2.502 . . . . 1.8 111.826 169.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.838 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.8 t80 -129.92 175.22 9.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.506 0.67 . . . . 0.52 112.125 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -141.1 149.54 41.72 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.305 -1.739 . . . . 4.54 106.305 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.783 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 20.7 tm0? -51.26 140.97 15.75 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.952 1.358 . . . . 1.28 113.765 -167.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.6 p -136.93 144.91 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 112.27 -2.241 . . . . 1.05 110.51 -161.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -59.07 -34.2 71.7 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 122.684 1.231 . . . . 1.38 109.095 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 2.3 ttpt -159.55 128.61 5.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.57 -2.105 . . . . 1.44 109.104 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.612 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.14 124.31 50.02 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.47 -0.786 . . . . 0.9 111.165 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.8 t -158.13 97.92 1.55 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.678 1.228 . . . . 0.61 109.68 153.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.604 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -166.23 161.05 12.59 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 112.699 -2.046 . . . . 1.77 106.469 164.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.36 116.79 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 121.404 1.403 . . . . 0.62 111.259 173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.598 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 108.32 21.44 7.65 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 119.804 -1.189 . . . . 0.51 113.087 -173.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.838 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 11.5 mp0 -134.48 159.44 41.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.256 0.528 . . . . 2.16 111.647 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.79 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.0 p90 -163.57 167.86 20.78 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.999 -1.111 . . . . 0.28 107.999 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.636 HG22 HG13 ' A' ' 136' ' ' VAL . 6.0 p -133.34 126.93 32.43 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.768 -0.773 . . . . 0.42 111.56 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.783 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.8 p -125.56 127.45 71.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.401 0.619 . . . . 0.34 112.142 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -133.71 -77.06 0.48 Allowed 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.008 -0.433 . . . . 3.11 110.088 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.44 -57.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.376 -0.375 . . . . 1.65 111.31 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -90.74 3.9 53.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.618 0.599 . . . . 1.68 112.618 -173.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.0 p -167.93 152.01 6.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.017 0.913 . . . . 0.37 113.292 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.641 HG12 HG23 ' A' ' 147' ' ' VAL . 42.0 mt -114.5 109.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 113.608 -1.633 . . . . 0.53 106.694 161.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.79 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.5 mp0 -91.91 159.54 15.71 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 105.427 -2.064 . . . . 1.13 105.427 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.665 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 17.8 ptp -164.16 162.43 22.77 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.828 0.705 . . . . 1.8 110.785 -172.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.777 HG23 ' HG3' ' A' ' 168' ' ' GLN . 11.9 mt -111.35 108.27 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.008 -0.997 . . . . 0.43 110.531 163.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 195' ' ' PHE . 12.7 tpt180 . . . . . 0 CA--C 1.506 -0.741 0 CA-C-N 113.511 -1.677 . . . . 3.13 110.076 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.777 ' HG3' HG23 ' A' ' 155' ' ' ILE . 7.0 tt0 . . . . . 0 N--CA 1.437 -1.091 0 N-CA-C 113.292 0.849 . . . . 1.86 113.292 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 156' ' ' ARG . 53.9 t -154.4 120.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.053 -1.43 . . . . 0.41 109.212 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 154' ' ' MET . 0.0 OUTLIER -76.84 114.23 15.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.55 -0.537 . . . . 2.8 109.55 170.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.05 131.86 54.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.883 -1.127 . . . . 0.29 110.761 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.77 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.1 tpp180 -93.32 97.66 10.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.174 -1.375 . . . . 1.71 110.45 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -87.28 91.46 8.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.853 -0.425 . . . . 0.69 109.853 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.4 114.67 27.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.551 1.167 . . . . 0.26 111.936 -173.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.751 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -82.75 134.32 35.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.556 -2.111 . . . . 0.72 110.11 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 34.0 t70 -77.14 66.16 2.89 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.649 -1.611 . . . . 1.09 106.649 163.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.5 -98.09 1.63 Allowed Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 118.678 -1.725 . . . . 0.47 110.158 -174.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -92.23 -13.43 30.49 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.384 0.883 . . . . 0.83 113.384 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -136.09 125.07 24.23 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 119.109 -1.036 . . . . 1.21 110.899 -171.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.751 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.4 tt -53.61 127.67 26.31 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.217 -1.811 . . . . 0.64 111.047 -176.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.45 -38.32 6.22 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.079 -0.964 . . . . 0.29 110.283 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -147.26 166.96 25.46 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.918 -0.583 . . . . 0.33 110.734 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.77 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 32.6 mt -137.12 145.17 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 106.348 -1.723 . . . . 0.76 106.348 168.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 47.5 t -139.11 134.49 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 109.533 -0.543 . . . . 0.35 109.533 -174.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.671 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 42.2 t-20 -81.12 103.81 11.18 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.439 -1.319 . . . . 1.77 107.439 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.525 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 33.5 mtm -67.04 -2.51 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.875 0.695 . . . . 0.55 112.875 -165.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.671 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.7 pt-20 -83.55 -41.93 17.37 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 122.055 0.931 . . . . 1.02 111.06 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.527 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 0.9 OUTLIER -108.26 -25.36 11.08 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.255 -1.339 . . . . 1.4 109.313 -177.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 75.56 32.59 0.7 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 112.365 -2.198 . . . . 1.33 107.69 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.8 ptm180 -88.86 162.28 16.24 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 113.673 -1.603 . . . . 2.28 109.633 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -88.98 139.67 30.22 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.609 -1.178 . . . . 1.36 113.128 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 5.3 m-85 -105.74 -166.45 1.21 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.889 -1.959 . . . . 1.18 107.691 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.592 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 138.22 -9.17 3.54 Favored Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 107.791 -2.123 . . . . 1.28 107.791 -147.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.9 109.32 2.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.045 -1.077 . . . . 2.8 111.071 155.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.8 t80 -125.12 137.75 54.17 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.228 -0.92 . . . . 0.6 109.342 163.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.662 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.2 mpt_? -123.07 146.4 47.73 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.069 -0.394 . . . . 4.77 110.52 -176.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.74 HD13 ' HG ' ' A' ' 127' ' ' LEU . 38.2 mt -137.48 171.1 14.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.869 0.366 . . . . 1.61 111.757 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.609 -0.723 . . . . 2.66 109.62 -178.605 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 112.026 0.38 . . . . 4.32 112.026 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 54.2 ttm -143.04 138.33 29.89 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.847 0.684 . . . . 2.59 112.847 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.12 102.12 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 122.524 1.154 . . . . 0.74 112.819 166.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -163.08 109.06 1.14 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.95 -1.87 . . . . 1.38 105.95 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.948 HD13 HD21 ' A' ' 173' ' ' LEU . 40.3 mt -93.16 113.58 25.85 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.425 -0.51 . . . . 1.33 110.022 -169.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 117' ' ' MET . 38.5 tt0 -138.78 104.77 7.5 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.512 -0.475 . . . . 1.93 110.773 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.495 ' HD3' HD12 ' A' ' 183' ' ' ILE . 31.5 Cg_exo -36.59 128.88 0.46 Allowed 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 124.032 3.155 . . . . 0.65 113.317 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.8 t70 71.94 50.84 0.23 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 122.6 1.19 . . . . 0.72 110.026 -173.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.583 ' HE3' HD13 ' A' ' 180' ' ' LEU . 14.0 ptt? -121.45 155.75 34.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.232 -1.349 . . . . 1.67 110.51 174.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.93 85.93 3.89 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.814 0.816 . . . . 0.58 109.682 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.694 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -111.23 161.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.598 -1.183 . . . . 0.65 110.083 -173.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.733 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.9 m -141.44 176.6 8.74 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.125 -0.695 . . . . 0.44 109.125 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.65 ' HG2' HG21 ' A' ' 147' ' ' VAL . 7.3 mtpp -55.8 -30.55 61.53 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.439 -0.578 . . . . 2.33 109.439 166.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.613 ' O ' HG12 ' A' ' 125' ' ' VAL . 57.5 t30 -86.02 -17.49 35.11 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.979 1.474 . . . . 1.32 114.979 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.733 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.7 mp0 -85.4 -62.63 1.49 Allowed 'General case' 0 N--CA 1.425 -1.703 0 O-C-N 120.581 -1.325 . . . . 2.06 107.749 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.778 ' SD ' HD22 ' A' ' 173' ' ' LEU . 3.6 ttm -59.9 -13.26 10.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.03 -1.895 . . . . 3.13 111.23 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 122' ' ' ASN . 14.8 p -42.81 -41.82 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 122.075 0.941 . . . . 0.37 110.306 171.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.618 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -68.87 -39.32 79.9 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.391 -1.277 . . . . 0.63 112.549 177.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.775 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -49.07 -34.0 12.79 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.639 0.733 . . . . 1.79 110.968 168.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.6 mt -84.91 -30.34 24.43 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.934 -1.03 . . . . 0.38 109.529 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.9 -19.23 52.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.046 -1.434 . . . . 1.96 110.502 170.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.38 -40.91 25.64 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.981 -1.463 . . . . 0.64 110.788 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 128' ' ' LEU . 15.0 t -91.53 2.69 56.26 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.25 1.5 . . . . 0.59 107.407 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 43.99 54.41 5.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 111.438 -2.619 . . . . 1.8 112.948 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.741 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.6 t80 -134.27 177.45 7.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.813 -0.63 . . . . 0.52 111.087 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -136.29 148.63 48.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.777 -1.194 . . . . 4.54 107.777 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.38 135.2 17.91 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.745 1.26 . . . . 1.28 111.374 -172.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.3 p -128.3 133.11 67.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 112.58 -2.1 . . . . 1.05 109.006 -165.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -58.97 -31.85 69.12 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.736 1.255 . . . . 1.38 109.496 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 136' ' ' VAL . 4.1 tmmm? -160.33 132.66 6.26 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 112.297 -2.229 . . . . 1.44 107.498 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.657 ' HB2' ' CD ' ' A' ' 144' ' ' GLU . 8.6 ptt? -115.35 133.04 56.4 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.868 -1.06 . . . . 0.9 112.993 -168.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.46 ' HA ' ' OE1' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -162.51 100.36 1.04 Allowed 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.992 0.901 . . . . 0.61 108.668 152.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.61 150.01 7.56 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.825 -1.534 . . . . 1.77 108.83 169.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.54 134.57 41.85 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.197 1.265 . . . . 0.62 110.036 170.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.43 54.21 5.19 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.898 -1.144 . . . . 0.51 111.873 -173.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.741 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -144.73 178.15 8.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.691 -0.195 . . . . 2.16 110.636 177.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.852 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 53.0 p90 -168.84 170.64 9.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.222 -1.029 . . . . 0.28 108.222 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 139' ' ' MET . 19.0 p -132.98 126.74 32.64 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.148 -0.621 . . . . 0.42 110.864 171.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.747 HG23 HG12 ' A' ' 152' ' ' ILE . 8.7 p -124.64 112.76 33.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.693 0.758 . . . . 0.34 112.004 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -116.7 -66.02 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.772 -0.649 . . . . 3.11 110.596 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.65 -69.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.276 . . . . 1.65 111.634 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -83.07 10.9 7.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 112.439 0.533 . . . . 1.68 112.439 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -170.42 151.14 3.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.925 0.869 . . . . 0.37 112.792 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.747 HG12 HG23 ' A' ' 147' ' ' VAL . 59.7 mt -120.28 115.74 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.707 -1.588 . . . . 0.53 106.961 165.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.852 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 6.9 mp0 -89.64 176.01 7.04 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.558 -1.275 . . . . 1.13 107.558 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 12.8 ptm -169.23 160.82 9.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.76 0.663 . . . . 1.8 111.208 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' A' ' 170' ' ' ARG . 29.3 mt -127.78 115.06 38.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 122.76 0.424 . . . . 0.43 110.81 165.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.781 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 77.6 mtp180 . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 116.399 -0.364 . . . . 3.13 110.52 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.781 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.8 tt0 . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 115.342 1.608 . . . . 1.86 115.342 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 78.9 t -154.58 129.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 113.067 -1.878 . . . . 0.41 109.229 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.875 ' HG2' ' HE3' ' A' ' 186' ' ' MET . 16.0 ttm180 -91.86 102.33 14.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.908 -0.775 . . . . 2.8 108.908 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -105.34 143.74 33.1 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.244 -0.983 . . . . 0.29 112.054 -173.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 11.7 tpp180 -99.95 113.62 26.31 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.947 -1.479 . . . . 1.71 110.206 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.948 HD21 HD13 ' A' ' 113' ' ' LEU . 7.2 mp -107.7 102.14 11.39 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.039 -0.664 . . . . 0.69 110.578 175.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.65 125.33 47.06 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 114.938 -1.028 . . . . 0.26 111.721 -170.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-30 -89.51 133.26 34.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.855 -1.975 . . . . 0.72 110.212 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.2 t70 -74.25 65.78 1.22 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.609 -1.626 . . . . 1.09 106.609 161.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.07 -98.27 1.59 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.673 -1.727 . . . . 0.47 110.368 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -86.92 -20.31 27.55 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.094 0.775 . . . . 0.83 113.094 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -133.15 130.67 39.5 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.742 -0.783 . . . . 1.21 110.727 -169.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.694 ' HB2' HG22 ' A' ' 119' ' ' ILE . 4.4 tt -52.64 129.35 29.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.933 -1.485 . . . . 0.64 110.803 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.61 -38.24 6.2 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.873 -1.058 . . . . 0.29 109.816 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.3 p -148.34 158.29 44.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.841 -0.618 . . . . 0.33 111.502 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.648 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 17.1 mt -125.02 146.58 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 105.827 -1.916 . . . . 0.76 105.827 167.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.5 t -142.09 135.44 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.665 0.745 . . . . 0.35 110.743 -171.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.24 95.95 7.1 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.497 -1.297 . . . . 1.77 107.497 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.875 ' HE3' ' HG2' ' A' ' 170' ' ' ARG . 28.3 mtm -62.35 -2.94 1.15 Allowed 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 114.028 1.122 . . . . 0.55 114.028 -164.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 9.6 pt-20 -81.53 -43.33 18.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.822 0.82 . . . . 1.02 110.705 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.546 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.3 m-20 -105.7 -25.7 12.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.314 -1.312 . . . . 1.4 109.034 -177.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 75.72 31.77 0.71 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.316 -2.22 . . . . 1.33 108.318 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 4.0 ptm180 -91.01 156.12 18.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.147 -1.388 . . . . 2.28 109.778 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.99 132.82 35.4 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.729 -1.123 . . . . 1.36 109.72 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -107.45 91.29 3.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.796 -0.762 . . . . 1.18 111.35 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -58.1 0.0 OUTLIER Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.506 1.362 . . . . 1.28 116.506 145.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 192' ' ' PHE . 99.7 m-85 -160.34 175.52 12.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.916 -1.642 . . . . 2.8 107.435 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.892 ' HB3' HD12 ' A' ' 113' ' ' LEU . 2.1 t80 -142.77 145.41 33.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.244 -1.021 . . . . 0.6 108.244 153.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.632 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -130.52 138.57 50.28 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.15 -0.969 . . . . 4.77 110.798 -171.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 196' ' ' ARG . 2.3 mt -125.52 171.29 10.64 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 113.533 0.938 . . . . 1.61 113.533 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.446 -0.635 0 CA-C-N 113.205 -1.816 . . . . 2.66 110.057 176.555 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.513 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 2.0 mtt180 . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 109.241 -0.651 . . . . 4.32 109.241 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.6 mtt -138.82 127.28 23.07 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.498 -0.881 . . . . 2.59 112.687 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.4 m -121.32 103.22 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 122.496 1.141 . . . . 0.74 112.139 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -161.1 108.35 1.48 Allowed 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.402 -1.726 . . . . 1.38 106.77 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 mp -97.07 78.94 2.81 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.493 -0.929 . . . . 1.33 108.493 -174.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -113.66 95.58 37.39 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.429 -0.805 . . . . 1.93 110.279 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.576 ' HG3' HG12 ' A' ' 183' ' ' ILE . 25.3 Cg_exo -33.68 125.87 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.523 3.482 . . . . 0.65 114.147 -171.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.1 t70 77.62 48.62 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 124.813 1.321 . . . . 0.72 110.125 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.71 154.95 36.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.832 -1.076 . . . . 1.67 110.42 171.173 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -94.6 93.77 7.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.477 -0.783 . . . . 0.58 109.037 -170.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.495 HG21 ' HE2' ' A' ' 117' ' ' MET . 19.7 tt -139.74 169.97 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 114.68 -1.146 . . . . 0.65 110.729 -166.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.625 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 m -137.98 174.25 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.947 -0.761 . . . . 0.44 108.947 -177.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.611 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -66.67 -19.31 65.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.179 -1.045 . . . . 2.33 108.179 169.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.555 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 1.8 t30 -83.68 -18.06 39.29 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-N 114.401 -1.272 . . . . 1.32 113.596 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.6 mp0 -86.25 -54.94 4.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 120.483 -1.385 . . . . 2.06 107.32 167.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.713 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.2 mmt -53.8 -13.56 0.74 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.974 -1.921 . . . . 3.13 111.771 168.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 14.9 p -43.36 -42.78 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 122.31 1.052 . . . . 0.37 109.58 171.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -65.37 -39.66 92.58 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.715 -1.584 . . . . 0.63 112.939 176.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -51.25 -32.49 24.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.731 0.777 . . . . 1.79 110.94 170.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 127' ' ' LEU . 16.7 mt -85.83 -33.42 21.32 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.005 -0.998 . . . . 0.38 109.568 -172.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.43 ' OE2' ' HE2' ' A' ' 126' ' ' LYS . 2.8 mt-10 -72.26 -23.71 61.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.982 -1.463 . . . . 1.96 110.011 169.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -76.94 -44.3 32.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.679 -1.6 . . . . 0.64 111.598 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -86.28 -6.57 58.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.538 1.637 . . . . 0.59 107.538 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 58.59 53.46 6.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 111.156 -2.747 . . . . 1.8 112.348 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.727 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.9 t80 -136.3 176.35 8.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.882 -0.599 . . . . 0.52 111.769 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 22.9 tpt180 -135.59 152.14 50.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.043 -1.466 . . . . 4.54 107.043 175.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.68 137.65 15.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.579 1.18 . . . . 1.28 112.512 -170.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.7 p -135.35 142.0 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.519 -2.128 . . . . 1.05 109.751 -166.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.71 -34.12 70.96 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.684 1.23 . . . . 1.38 109.129 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 5.5 ttpt -159.86 126.14 4.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.424 -2.171 . . . . 1.44 108.385 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.65 ' SD ' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -112.68 130.14 56.15 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.606 -0.725 . . . . 0.9 110.536 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.9 OUTLIER -158.4 98.15 1.53 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.836 1.303 . . . . 0.61 109.431 152.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -164.93 167.2 10.12 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 112.23 -2.259 . . . . 1.77 106.048 167.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.26 126.18 11.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.426 1.417 . . . . 0.62 112.102 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 95.72 26.04 12.42 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 120.438 -0.887 . . . . 0.51 113.415 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.727 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 6.1 mp0 -126.82 171.42 11.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.1 0.45 . . . . 2.16 110.439 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.681 ' O ' HG12 ' A' ' 136' ' ' VAL . 43.1 p90 -168.4 165.09 12.82 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.481 -0.933 . . . . 0.28 108.481 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.65 HG23 ' SD ' ' A' ' 139' ' ' MET . 53.9 p -126.29 128.95 47.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.029 -0.532 . . . . 0.42 110.659 171.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.482 ' CG1' ' HG3' ' A' ' 135' ' ' GLN . 8.5 p -112.76 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.513 0.673 . . . . 0.34 111.093 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -122.95 36.96 4.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.523 -0.762 . . . . 3.11 110.484 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.38 -54.51 0.67 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.446 -0.797 . . . . 1.65 112.687 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -87.26 -10.43 52.43 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.895 0.379 . . . . 1.68 111.517 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -161.61 141.99 10.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.904 0.859 . . . . 0.37 112.716 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.611 HD11 ' HA ' ' A' ' 121' ' ' LYS . 35.4 mt -112.56 109.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.576 -1.647 . . . . 0.53 108.033 169.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 23.6 mt-10 -101.74 103.07 13.81 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.765 -0.828 . . . . 1.13 108.765 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 23.4 ptm -106.66 163.87 12.55 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.301 -0.863 . . . . 1.8 111.764 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.647 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 47.2 mt -130.08 112.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.166 -0.924 . . . . 0.43 110.817 168.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.671 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 56.6 mtm180 . . . . . 0 C--N 1.318 -0.77 0 CA-C-N 116.291 -0.413 . . . . 3.13 110.357 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.431 -1.408 0 CA-C-O 121.255 0.55 . . . . 1.86 112.48 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 55.5 t -153.09 129.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.128 -0.942 . . . . 0.41 109.663 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.974 ' HG2' ' HE3' ' A' ' 186' ' ' MET . 9.3 ttt180 -88.6 107.55 18.97 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 109.202 -0.666 . . . . 2.8 109.202 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.53 137.14 53.42 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 119.275 -0.97 . . . . 0.29 111.986 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 15.5 tpp85 -99.09 107.37 19.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.762 -1.563 . . . . 1.71 111.455 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 151' ' ' SER . 4.7 mp -94.25 96.27 9.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.055 -0.52 . . . . 0.69 109.912 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -98.08 118.15 34.04 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.539 1.161 . . . . 0.26 110.9 -178.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 41.9 m-85 -92.31 127.04 37.65 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 112.847 -1.979 . . . . 0.72 110.038 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 17.3 t70 -75.73 65.59 1.91 Allowed 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.643 -1.614 . . . . 1.09 106.643 167.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.32 -100.18 0.78 Allowed Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.404 -1.379 . . . . 0.47 110.897 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.44 -21.63 48.88 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.24 0.829 . . . . 0.83 113.24 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.445 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 16.3 p-80 -135.82 128.65 31.12 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 119.822 -0.751 . . . . 1.21 110.287 -170.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.9 tt -60.26 130.03 44.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.294 -1.321 . . . . 0.64 109.664 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -103.02 -40.93 6.28 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.675 -0.693 . . . . 0.29 110.74 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 158.49 43.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.167 0.432 . . . . 0.33 112.167 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.615 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 3.1 mm -115.28 148.28 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 105.139 -2.171 . . . . 0.76 105.139 164.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.1 t -139.05 126.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.41 0.624 . . . . 0.35 110.33 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.595 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.6 t-20 -78.1 99.05 5.99 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.488 -1.301 . . . . 1.77 107.488 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.974 ' HE3' ' HG2' ' A' ' 170' ' ' ARG . 32.8 mtm -64.36 -2.17 2.08 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.816 1.043 . . . . 0.55 113.816 -166.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.595 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.9 pt-20 -80.36 -43.05 21.77 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.039 0.923 . . . . 1.02 110.645 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.524 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 7.8 m120 -109.03 -25.63 10.6 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.995 -1.457 . . . . 1.4 109.579 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 77.56 27.35 0.62 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.689 -2.05 . . . . 1.33 108.044 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.72 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 33.9 mtp180 -74.04 160.67 30.96 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.76 -1.564 . . . . 2.28 109.68 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 96.4 mt-30 -95.38 118.07 31.46 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.484 -1.234 . . . . 1.36 108.462 175.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.615 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -93.63 91.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.748 -0.781 . . . . 1.18 110.552 -166.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.98 -57.39 0.0 OUTLIER Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.277 1.418 . . . . 1.28 116.407 145.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 192' ' ' PHE . 48.3 p90 -163.73 174.73 11.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.701 -1.75 . . . . 2.8 107.584 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.722 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.0 t80 -151.41 98.69 2.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.28 0.562 . . . . 0.6 109.595 158.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.497 ' O ' ' HD2' ' A' ' 196' ' ' ARG . 2.8 ppt_? -90.29 145.57 24.88 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.412 -0.805 . . . . 4.77 111.222 -176.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 127' ' ' LEU . 1.8 mt -119.0 171.82 7.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.027 0.917 . . . . 1.61 113.291 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 113.439 -1.709 . . . . 2.66 110.165 176.186 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 13.8 mmt180 . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.816 0.673 . . . . 4.32 112.816 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.772 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.5 tpt -139.94 124.63 18.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.392 0.886 . . . . 2.59 113.392 -165.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.65 HG11 ' N ' ' A' ' 127' ' ' LEU . 0.6 OUTLIER -126.66 107.65 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 114.21 1.189 . . . . 0.74 114.21 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -157.86 107.03 2.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.158 -1.793 . . . . 1.38 106.158 163.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.8 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.2 mp -85.68 112.66 21.23 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.728 -0.669 . . . . 1.33 110.781 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 33.2 tt0 -156.43 102.07 2.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 114.957 -1.019 . . . . 1.93 109.911 -176.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.696 ' HD3' ' CD1' ' A' ' 183' ' ' ILE . 9.7 Cg_exo -30.48 138.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 125.654 4.236 . . . . 0.65 114.593 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.6 t70 76.05 40.98 0.24 Allowed 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.778 1.299 . . . . 0.72 109.331 -171.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.545 ' HE3' HD13 ' A' ' 180' ' ' LEU . 11.9 ptt? -121.63 154.94 36.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.401 -1.272 . . . . 1.67 109.623 174.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.61 87.36 2.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.836 -1.172 . . . . 0.58 107.836 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.689 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.2 tt -111.08 157.18 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.084 -1.416 . . . . 0.65 110.316 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.79 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.9 m -141.24 176.76 8.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.12 -0.696 . . . . 0.44 109.12 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.831 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 5.8 mtpm? -56.27 -28.26 58.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.266 0.555 . . . . 2.33 109.511 165.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.6 t30 -84.26 -19.04 34.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.062 1.134 . . . . 1.32 114.062 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.79 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -88.22 -62.01 1.59 Allowed 'General case' 0 N--CA 1.415 -2.197 0 O-C-N 120.769 -1.207 . . . . 2.06 108.931 176.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.966 ' HG3' HG21 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -58.11 -16.69 14.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 112.994 -1.912 . . . . 3.13 110.382 172.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 11.3 p -42.63 -43.33 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.288 1.042 . . . . 0.37 110.712 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.529 ' CE ' HG13 ' A' ' 125' ' ' VAL . 10.1 mmpt? -69.65 -35.92 75.61 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.22 -1.354 . . . . 0.63 113.132 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.65 ' N ' HG11 ' A' ' 111' ' ' VAL . 9.0 tt -52.92 -34.04 53.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.571 0.7 . . . . 1.79 110.085 168.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 124' ' ' MET . 6.3 mt -83.86 -34.31 24.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.471 -0.937 . . . . 0.38 108.471 -171.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.97 -33.23 75.55 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.919 -1.491 . . . . 1.96 109.728 169.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -72.75 -45.95 56.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.967 -1.47 . . . . 0.64 111.766 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.87 -1.73 58.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 123.747 1.737 . . . . 0.59 107.741 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 55.5 54.46 8.45 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 110.817 -2.902 . . . . 1.8 112.666 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 3.2 t80 -137.84 175.67 9.38 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.52 112.455 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 30.1 tpt180 -139.17 151.95 47.02 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.57 -1.27 . . . . 4.54 107.57 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 1.5 tm0? -49.22 142.4 7.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.335 1.064 . . . . 1.28 113.05 -168.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.6 p -141.6 139.98 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 113.215 -1.811 . . . . 1.05 110.169 -163.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -59.8 -32.31 70.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.511 1.148 . . . . 1.38 109.791 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -159.35 127.78 5.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.754 -2.021 . . . . 1.44 108.825 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.684 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -117.49 124.02 47.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.728 -1.124 . . . . 0.9 111.098 -177.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.715 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.3 t -158.7 95.23 1.3 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 123.236 1.493 . . . . 0.61 110.473 154.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.715 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.39 155.39 16.99 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 111.71 -2.495 . . . . 1.77 105.706 163.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.13 126.05 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.15 1.233 . . . . 0.62 110.807 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.8 45.04 3.74 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 119.878 -1.153 . . . . 0.51 112.995 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.572 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 37.0 mt-10 -141.88 174.45 10.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.903 0.351 . . . . 2.16 110.534 173.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.868 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -170.47 164.7 8.6 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.66 -1.237 . . . . 0.28 107.66 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.676 HG22 ' CG1' ' A' ' 136' ' ' VAL . 1.1 p -134.41 129.17 34.92 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 119.328 -0.949 . . . . 0.42 110.757 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' A' ' 121' ' ' LYS . 10.6 p -122.58 109.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.878 0.846 . . . . 0.34 111.832 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -106.89 -72.33 0.72 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.299 -0.864 . . . . 3.11 110.031 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.61 -53.97 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.72 0.295 . . . . 1.65 111.75 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -82.68 -12.63 57.46 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.491 -0.322 . . . . 1.68 111.721 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 15.9 p -160.33 153.26 21.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.13 0.967 . . . . 0.37 112.397 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.966 HG21 ' HG3' ' A' ' 124' ' ' MET . 74.6 mt -110.99 114.24 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.33 -1.759 . . . . 0.53 107.002 165.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.2 mp0 -90.59 165.85 13.52 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.978 -1.86 . . . . 1.13 105.978 174.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.639 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -167.64 156.76 9.87 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 124.123 0.89 . . . . 1.8 109.818 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.594 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 13.5 mt -127.28 105.44 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.054 -0.521 . . . . 0.43 110.19 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.804 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.2 ttt-85 . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 115.159 -0.928 . . . . 3.13 109.919 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.804 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.3 tt0 . . . . . 0 N--CA 1.433 -1.294 0 CA-C-O 121.393 0.616 . . . . 1.86 112.399 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 45.6 t -153.23 129.55 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.074 . . . . 0.41 109.519 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.634 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 27.5 mtm180 -82.82 118.32 23.33 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.049 -0.523 . . . . 2.8 109.847 168.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.3 131.05 56.35 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.654 0.74 . . . . 0.29 111.27 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.766 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 8.8 tpp180 -98.21 100.71 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.376 -1.283 . . . . 1.71 111.104 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.8 mp -87.0 92.38 9.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.175 -0.305 . . . . 0.69 110.175 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.83 120.83 35.7 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 122.626 1.203 . . . . 0.26 111.635 -175.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-30 -86.93 136.21 33.02 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.792 -2.004 . . . . 0.72 111.049 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.677 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 39.9 t0 -78.82 65.19 3.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.076 -1.824 . . . . 1.09 106.076 161.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.93 1.52 Allowed Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 118.944 -1.598 . . . . 0.47 110.497 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -82.42 -27.47 31.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.723 0.638 . . . . 0.83 112.723 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -129.85 129.54 44.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.77 0.795 . . . . 1.21 110.615 -167.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.689 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.9 tt -53.38 128.9 30.18 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.449 -1.705 . . . . 0.64 111.235 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.12 -38.35 6.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.83 -1.077 . . . . 0.29 110.047 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.7 p -146.15 162.58 37.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.655 -0.702 . . . . 0.33 110.648 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.766 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 26.8 mt -134.31 145.2 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 105.735 -1.95 . . . . 0.76 105.735 167.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 43.1 t -136.98 135.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 109.683 -0.488 . . . . 0.35 109.683 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.626 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 47.2 t-20 -76.94 108.08 9.73 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 106.809 -1.552 . . . . 1.77 106.809 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.634 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 36.3 mtm -67.94 -2.41 7.44 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.545 -0.462 . . . . 0.55 111.976 -169.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.626 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.0 pt-20 -85.65 -45.98 11.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.482 0.658 . . . . 1.02 111.321 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.592 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -102.16 -26.24 13.42 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 114.802 -1.09 . . . . 1.4 109.36 -176.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 185' ' ' ASN . 52.7 t30 76.48 27.16 0.83 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 112.446 -2.161 . . . . 1.33 107.559 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 17.6 ptt180 -84.56 162.85 19.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.14 -1.391 . . . . 2.28 109.249 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -91.98 139.14 30.94 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.562 1.172 . . . . 1.36 112.734 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 2.6 m-85 -100.75 -165.73 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.908 -1.951 . . . . 1.18 108.324 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.629 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.14 -5.64 3.61 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.644 -2.183 . . . . 1.28 107.644 -148.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -153.79 119.43 5.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.928 -1.136 . . . . 2.8 111.333 157.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.8 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 5.1 t80 -140.77 100.58 3.88 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.17 -0.678 . . . . 0.6 109.17 161.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -102.13 110.47 22.44 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.466 -0.771 . . . . 4.77 111.203 -170.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.45 HD23 HD13 ' A' ' 113' ' ' LEU . 4.1 mm? -82.96 168.2 17.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.548 0.69 . . . . 1.61 112.45 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 114.439 -1.255 . . . . 2.66 108.074 172.05 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.41 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 44.1 mtt180 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.73 -0.841 . . . . 4.32 108.73 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.45 ' HB2' ' HG3' ' A' ' 123' ' ' GLU . 21.9 mmt -140.85 135.82 31.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 113.787 1.032 . . . . 2.59 113.787 -166.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.401 HG11 HD12 ' A' ' 197' ' ' LEU . 0.3 OUTLIER -135.57 105.68 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.447 1.118 . . . . 0.74 113.876 172.043 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -160.01 107.75 1.67 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.955 -1.93 . . . . 1.38 105.809 161.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.9 mp -87.67 108.7 19.22 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.987 -0.746 . . . . 1.33 108.987 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.2 tt0 -142.78 112.33 5.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.309 -0.956 . . . . 1.93 111.123 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.1 Cg_exo -35.9 127.79 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.012 3.141 . . . . 0.65 113.016 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.3 t70 75.74 43.83 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 O-C-N 124.476 1.11 . . . . 0.72 110.536 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.646 ' HE3' HD13 ' A' ' 180' ' ' LEU . 16.7 ptt? -114.06 154.99 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.818 -1.083 . . . . 1.67 110.14 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -102.77 98.56 8.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.15 -1.056 . . . . 0.58 108.15 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.624 HG13 ' CB ' ' A' ' 123' ' ' GLU . 1.5 tt -134.34 168.68 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 114.821 -1.081 . . . . 0.65 110.573 -164.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.665 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.3 m -141.36 175.55 9.57 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 -174.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.576 ' HA ' HD11 ' A' ' 152' ' ' ILE . 19.1 mttp -57.62 -32.72 67.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.304 -0.998 . . . . 2.33 108.304 164.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.713 ' O ' HG12 ' A' ' 125' ' ' VAL . 34.6 t30 -83.02 -19.35 37.11 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 113.78 -1.555 . . . . 1.32 114.2 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.665 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.1 mp0 -82.49 -57.83 3.18 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.542 -1.974 . . . . 2.06 106.74 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.669 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 2.3 tpp -54.99 -13.76 1.24 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.381 -1.736 . . . . 3.13 111.969 170.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 122' ' ' ASN . 13.1 p -45.24 -39.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 122.246 1.022 . . . . 0.37 110.09 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.685 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -66.76 -40.12 88.14 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.93 -1.487 . . . . 0.63 112.685 176.041 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -49.63 -33.34 15.12 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.378 0.608 . . . . 1.79 111.172 167.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 127' ' ' LEU . 7.1 mt -83.97 -37.75 21.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.246 -0.888 . . . . 0.38 109.187 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.2 -43.26 92.26 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.288 -1.324 . . . . 1.96 110.221 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.44 -45.09 80.99 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.29 -1.777 . . . . 0.64 112.056 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.3 t -86.4 -2.63 58.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 123.664 1.697 . . . . 0.59 107.155 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 53.44 51.02 16.12 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.13 -2.759 . . . . 1.8 112.584 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.779 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -136.97 176.5 8.65 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.093 0.473 . . . . 0.52 111.782 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.8 153.84 49.62 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.758 -1.201 . . . . 4.54 107.758 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 19.3 tm0? -51.03 139.05 18.39 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.539 1.161 . . . . 1.28 112.341 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.8 p -136.67 140.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 112.718 -2.037 . . . . 1.05 109.781 -164.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -58.95 -32.22 69.42 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.347 1.07 . . . . 1.38 109.439 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 27.3 ttpt -160.88 121.29 2.8 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.962 -1.927 . . . . 1.44 109.109 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.653 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -109.88 118.64 37.01 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.996 -1.002 . . . . 0.9 110.894 -177.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.08 96.52 2.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.948 1.356 . . . . 0.61 108.993 157.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.522 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -166.39 169.52 6.38 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.04 -2.345 . . . . 1.77 105.548 167.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.87 125.12 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.486 1.457 . . . . 0.62 112.471 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 94.54 38.18 5.08 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 120.654 -0.784 . . . . 0.51 113.311 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.779 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 9.4 mp0 -131.69 173.44 11.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 122.604 -0.351 . . . . 2.16 110.079 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.869 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.9 p90 -169.0 166.65 11.01 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.601 -1.259 . . . . 0.28 107.601 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.699 HG22 HG13 ' A' ' 136' ' ' VAL . 11.9 p -134.52 126.49 29.47 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.739 -0.784 . . . . 0.42 110.751 173.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.774 HG23 HG12 ' A' ' 152' ' ' ILE . 11.1 p -117.68 110.29 30.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.827 0.823 . . . . 0.34 111.121 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -106.25 -75.82 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 3.11 110.204 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.68 -58.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.469 . . . . 1.65 110.545 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -92.24 7.49 42.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.122 -0.49 . . . . 1.68 111.924 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -161.25 152.14 18.33 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.938 0.875 . . . . 0.37 112.612 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.774 HG12 HG23 ' A' ' 147' ' ' VAL . 67.6 mt -120.32 109.9 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.371 -1.741 . . . . 0.53 106.742 163.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.11 170.96 9.88 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.292 -1.744 . . . . 1.13 106.292 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.648 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 10.6 ptm -167.29 158.18 11.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.679 0.612 . . . . 1.8 110.869 -173.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.593 HG12 ' HG3' ' A' ' 170' ' ' ARG . 13.0 mt -129.27 112.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.466 -0.788 . . . . 0.43 110.501 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.803 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 34.6 mtp180 . . . . . 0 CA--C 1.502 -0.889 0 C-N-CA 120.033 -0.667 . . . . 3.13 109.748 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.803 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 51.7 tt0 . . . . . 0 N--CA 1.42 -1.945 0 N-CA-C 114.692 1.367 . . . . 1.86 114.692 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 66.2 t -153.06 131.38 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.377 -1.283 . . . . 0.41 109.884 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.593 ' HG3' HG12 ' A' ' 155' ' ' ILE . 17.3 mtm180 -91.38 111.56 23.11 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.097 -0.502 . . . . 2.8 110.395 169.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.75 146.99 41.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.026 0.917 . . . . 0.29 111.619 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.501 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 7.3 tpt180 -111.77 103.79 12.08 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.586 -1.643 . . . . 1.71 110.323 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.653 HD23 ' SD ' ' A' ' 124' ' ' MET . 5.5 mp -92.77 94.33 8.92 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.755 -0.461 . . . . 0.69 109.755 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.68 127.85 40.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.582 1.182 . . . . 0.26 111.83 -173.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.728 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-85 -94.16 135.46 35.51 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 112.653 -2.067 . . . . 0.72 110.801 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 18.7 t70 -80.99 64.39 5.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.925 -1.88 . . . . 1.09 105.925 162.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.72 -99.51 1.13 Allowed Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.219 -1.467 . . . . 0.47 111.004 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.66 -24.69 41.66 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.721 0.637 . . . . 0.83 112.721 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -132.34 128.64 38.13 Favored 'General case' 0 N--CA 1.426 -1.666 0 C-N-CA 119.577 -0.849 . . . . 1.21 110.645 -170.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.8 tt -53.92 130.72 38.38 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.585 -1.643 . . . . 0.64 110.26 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.609 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.93 -38.48 6.04 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.443 -0.799 . . . . 0.29 110.499 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -146.03 164.31 32.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.189 -0.46 . . . . 0.33 111.785 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.535 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.6 mm -116.45 148.93 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 105.114 -2.18 . . . . 0.76 105.114 164.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.7 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.1 t -139.78 128.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.416 0.627 . . . . 0.35 109.844 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.587 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 46.6 t-20 -75.94 111.55 11.44 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 107.123 -1.436 . . . . 1.77 107.123 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.54 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.2 mtm -70.22 -1.22 9.64 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.478 -0.489 . . . . 0.55 112.101 -169.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.587 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 7.4 pt-20 -83.18 -45.8 13.48 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.614 0.721 . . . . 1.02 111.265 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.527 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -103.67 -25.81 13.01 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.948 -1.023 . . . . 1.4 109.236 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 185' ' ' ASN . 47.6 t-20 74.28 36.17 0.68 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 112.278 -2.237 . . . . 1.33 107.127 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.7 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 7.2 ptm180 -93.27 161.53 14.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.422 -1.717 . . . . 2.28 109.387 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 78.4 mt-30 -88.17 125.23 34.51 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.99 -1.004 . . . . 1.36 109.46 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.535 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.7 92.28 4.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.884 -0.579 . . . . 1.18 110.446 -170.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.82 -58.03 0.0 OUTLIER Glycine 0 N--CA 1.469 0.881 0 C-N-CA 125.066 1.317 . . . . 1.28 116.334 146.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' PHE . 38.4 p90 -163.62 175.38 10.68 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.347 -1.426 . . . . 2.8 108.685 175.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.5 t80 -140.79 154.56 46.31 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.911 -1.144 . . . . 0.6 107.911 157.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.719 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -136.04 139.74 43.31 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.636 -0.665 . . . . 4.77 109.992 -170.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -114.41 172.49 6.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 114.967 1.469 . . . . 1.61 114.967 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.444 -0.755 0 CA-C-N 111.902 -2.408 . . . . 2.66 108.723 176.792 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.856 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 72.6 mtt180 . . . . . 0 CA--C 1.497 -1.093 0 N-CA-C 108.529 -0.915 . . . . 4.32 108.529 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.683 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 27.0 ttt -143.89 131.1 20.72 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.96 -1.018 . . . . 2.59 113.203 -163.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.7 m -116.58 105.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 122.301 1.048 . . . . 0.74 112.883 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -159.92 106.22 1.61 Allowed 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.292 -1.776 . . . . 1.38 106.247 165.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.829 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.7 mp -97.3 111.52 23.73 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 119.958 -0.697 . . . . 1.33 109.528 -172.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -140.0 104.84 6.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.223 -0.899 . . . . 1.93 109.856 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.516 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 13.1 Cg_exo -33.63 129.74 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 125.157 3.905 . . . . 0.65 114.21 -172.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.6 t70 79.61 44.01 0.06 Allowed 'General case' 0 C--N 1.341 0.214 0 O-C-N 124.967 1.417 . . . . 0.72 110.529 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.652 ' SD ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.35 155.65 34.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.876 -1.056 . . . . 1.67 110.774 173.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 29.2 m -93.36 77.87 4.47 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 122.282 1.039 . . . . 0.58 109.547 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.712 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -96.17 161.09 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.496 -1.684 . . . . 0.65 109.296 -174.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.54 ' H ' HG13 ' A' ' 119' ' ' ILE . 7.6 m -141.78 177.09 8.41 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 118.612 0.642 . . . . 0.44 109.925 -173.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.8 ' HG2' HG21 ' A' ' 147' ' ' VAL . 34.3 mttp -53.42 -33.66 54.8 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.149 -1.056 . . . . 2.33 108.149 163.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.856 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 41.1 t30 -81.88 -18.85 42.36 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 114.311 -1.313 . . . . 1.32 114.177 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.683 ' HA ' ' H ' ' A' ' 110' ' ' MET . 3.4 tt0 -85.64 -62.18 1.59 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.151 -1.593 . . . . 2.06 107.918 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.755 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -58.74 -16.78 18.24 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.455 -1.702 . . . . 3.13 111.143 172.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.6 p -42.81 -42.73 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.99 0.9 . . . . 0.37 111.071 176.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.593 ' CE ' HG13 ' A' ' 125' ' ' VAL . 10.5 mmpt? -67.7 -41.15 84.03 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.44 -1.254 . . . . 0.63 112.154 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.5 tm? -53.12 -32.44 47.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.396 0.617 . . . . 1.79 110.392 167.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' A' ' 124' ' ' MET . 26.2 mt -82.16 -34.0 29.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.756 0.789 . . . . 0.38 109.066 -171.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.18 -37.25 85.17 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.235 -1.348 . . . . 1.96 110.164 167.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -68.6 -41.94 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.675 -1.602 . . . . 0.64 112.512 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.4 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.13 -1.52 57.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 124.176 1.941 . . . . 0.59 106.107 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 56.13 55.19 7.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 110.714 -2.948 . . . . 1.8 111.927 170.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 2.5 t80 -138.3 174.94 10.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.479 0.657 . . . . 0.52 112.407 -176.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 134' ' ' ARG . 20.1 ptt85 -141.86 147.61 37.44 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.948 -1.501 . . . . 4.54 106.948 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.83 135.05 20.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.763 1.268 . . . . 1.28 112.455 -171.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.5 p -134.37 141.04 44.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.386 -2.188 . . . . 1.05 110.14 -162.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -58.74 -34.28 71.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.493 1.139 . . . . 1.38 109.61 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -160.12 128.5 4.81 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.782 -2.008 . . . . 1.44 109.101 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.602 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -118.43 133.79 55.59 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.838 -1.074 . . . . 0.9 111.612 -173.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.552 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.8 t -162.92 100.21 0.99 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.491 1.138 . . . . 0.61 110.957 153.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.3 OUTLIER -164.51 160.67 15.86 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 113.161 -1.836 . . . . 1.77 106.211 161.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.441 ' HA ' HG22 ' A' ' 155' ' ' ILE . 23.3 Cg_exo -62.94 120.92 8.61 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 121.055 1.17 . . . . 0.62 109.839 170.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.4 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 95.54 38.37 4.75 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 119.716 -1.231 . . . . 0.51 113.102 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 42.1 mt-10 -140.94 167.55 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.889 -0.411 . . . . 2.16 109.889 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.74 ' CD2' HD22 ' A' ' 128' ' ' LEU . 51.3 p90 -167.67 163.43 14.41 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.395 -0.965 . . . . 0.28 108.395 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.513 HG22 HG13 ' A' ' 136' ' ' VAL . 53.6 p -128.87 127.34 41.65 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.061 0.457 . . . . 0.42 110.703 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 121' ' ' LYS . 11.8 p -121.51 116.65 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.555 0.693 . . . . 0.34 111.813 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.519 ' HG3' ' H ' ' A' ' 149' ' ' ALA . 11.0 pt20 -117.43 -62.34 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.863 -0.608 . . . . 3.11 111.247 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.519 ' H ' ' HG3' ' A' ' 148' ' ' GLN . . . -168.97 -63.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 1.65 110.791 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -83.0 4.65 25.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.365 -0.379 . . . . 1.68 111.798 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 16.4 p -165.47 150.0 8.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.978 0.894 . . . . 0.37 112.992 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.734 HG12 HG23 ' A' ' 147' ' ' VAL . 65.6 mt -116.5 107.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.333 -1.758 . . . . 0.53 106.326 160.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.537 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 5.5 mt-10 -99.42 102.2 13.7 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.57 -0.9 . . . . 1.13 108.57 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 8.6 ptm -109.38 156.94 19.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.157 -0.929 . . . . 1.8 112.149 -170.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.63 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.8 mt -123.5 119.07 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.322 -1.308 . . . . 0.43 109.991 172.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.7 mtm180 . . . . . 0 C--N 1.32 -0.681 0 O-C-N 123.437 0.461 . . . . 3.13 110.444 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.63 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 6.6 tt0 . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 113.276 0.843 . . . . 1.86 113.276 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 43.1 t -153.23 128.53 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.979 -1.01 . . . . 0.41 109.542 174.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.584 ' HB3' ' HE2' ' A' ' 186' ' ' MET . 15.0 mtt180 -89.86 114.09 25.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 120.9 0.381 . . . . 2.8 110.469 170.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.79 129.86 56.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.342 1.067 . . . . 0.29 111.278 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.5 tpt180 -96.09 100.28 11.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.219 -1.809 . . . . 1.71 110.925 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 151' ' ' SER . 10.7 mp -85.08 93.96 8.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.737 -0.468 . . . . 0.69 109.737 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.573 HG23 ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -94.59 113.44 25.26 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.504 1.145 . . . . 0.26 111.687 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -82.77 135.43 34.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.679 -2.055 . . . . 0.72 110.347 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 36.9 t70 -76.59 65.85 2.47 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.345 -1.724 . . . . 1.09 106.345 161.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 -98.37 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 118.877 -1.63 . . . . 0.47 110.78 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.79 -17.56 37.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.505 0.928 . . . . 0.83 113.505 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -139.45 130.27 26.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.506 -0.877 . . . . 1.21 110.628 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.712 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 4.8 tt -53.66 128.51 29.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.122 -1.399 . . . . 0.64 110.568 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -100.89 -39.02 7.98 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.717 -1.129 . . . . 0.29 108.994 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 26.2 p -150.8 158.96 44.78 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.475 -0.784 . . . . 0.33 110.592 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 16.1 mt -120.29 146.67 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 105.063 -2.199 . . . . 0.76 105.063 168.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 22.6 t -138.77 129.73 34.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.36 0.6 . . . . 0.35 110.152 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.593 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.3 t-20 -75.15 101.94 4.77 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 106.817 -1.549 . . . . 1.77 106.817 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.584 ' HE2' ' HB3' ' A' ' 170' ' ' ARG . 36.2 mtm -65.51 -3.09 3.95 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.653 0.595 . . . . 0.55 112.516 -167.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.593 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 8.5 pt-20 -80.1 -43.62 21.4 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.756 0.789 . . . . 1.02 110.813 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.588 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 8.9 m120 -104.91 -25.72 12.48 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 114.464 -1.244 . . . . 1.4 109.367 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 58.0 t30 76.19 33.29 0.57 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 112.59 -2.096 . . . . 1.33 107.873 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.641 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.3 ptm180 -96.14 157.6 15.82 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 2.28 109.846 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.6 126.53 31.84 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.814 -1.084 . . . . 1.36 109.308 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.23 90.5 3.94 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.321 -0.552 . . . . 1.18 110.875 -168.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.27 -57.75 0.0 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 116.635 1.414 . . . . 1.28 116.635 145.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.519 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 3.4 p90 -164.08 175.58 10.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.525 -1.337 . . . . 2.8 109.671 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.829 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.3 t80 -148.34 103.42 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.206 0.526 . . . . 0.6 110.899 159.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.519 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 1.6 mmm180 -95.45 133.65 39.18 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.441 -0.787 . . . . 4.77 110.465 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 127' ' ' LEU . 69.0 mt -122.89 171.44 9.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 114.388 1.255 . . . . 1.61 114.388 -166.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.22 -0.476 0 CA-C-N 113.935 -1.484 . . . . 2.66 110.554 -176.161 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.745 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 122.218 1.008 . . . . 4.32 113.36 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 15.6 tpt -142.44 129.92 21.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.61 -1.177 . . . . 2.59 111.786 -175.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.56 102.63 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.731 1.253 . . . . 0.74 111.904 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -162.44 109.59 1.3 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.111 -1.859 . . . . 1.38 106.244 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.789 HD12 ' HB3' ' A' ' 195' ' ' PHE . 52.2 mt -96.38 108.04 20.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.418 -0.586 . . . . 1.33 109.418 -175.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 2.6 tm-20 -142.88 110.14 5.58 Favored Pre-proline 0 C--N 1.309 -1.192 0 C-N-CA 119.298 -0.961 . . . . 1.93 110.442 -175.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.492 ' HG3' HG12 ' A' ' 183' ' ' ILE . 27.9 Cg_exo -35.11 126.61 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 124.25 3.3 . . . . 0.65 113.777 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 22.3 t0 75.9 49.61 0.07 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.762 1.267 . . . . 0.72 110.37 -174.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.656 ' HE3' HD13 ' A' ' 180' ' ' LEU . 13.5 ptt? -119.27 155.71 31.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.983 -1.462 . . . . 1.67 109.529 172.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 179' ' ' HIS . 8.0 m -101.76 83.88 2.47 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.365 -0.976 . . . . 0.58 108.365 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -109.0 161.41 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.821 -1.536 . . . . 0.65 110.071 -170.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.742 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.4 m -142.79 174.17 10.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.623 -0.881 . . . . 0.44 108.623 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.975 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 19.4 mtpp -54.93 -28.37 50.52 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.671 0.748 . . . . 2.33 109.723 163.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.581 ' O ' HG12 ' A' ' 125' ' ' VAL . 32.4 t30 -85.93 -18.68 32.01 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 114.692 1.367 . . . . 1.32 114.692 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.742 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.0 OUTLIER -86.09 -62.91 1.41 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.565 1.174 . . . . 2.06 108.134 171.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.975 ' SD ' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -58.12 -14.04 6.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 112.347 -2.206 . . . . 3.13 110.871 173.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 122' ' ' ASN . 12.1 p -41.89 -42.32 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.91 0.862 . . . . 0.37 109.637 170.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.745 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -68.37 -39.96 81.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.579 -1.191 . . . . 0.63 113.834 174.456 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.572 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -49.9 -32.2 14.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.446 0.641 . . . . 1.79 111.0 170.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 124' ' ' MET . 8.6 mt -85.67 -37.68 19.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 0.38 108.984 -172.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.61 -36.19 77.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.94 -1.482 . . . . 1.96 109.672 168.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.66 -41.27 65.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.879 -1.509 . . . . 0.64 112.208 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.703 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.5 t -89.04 -0.77 57.71 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 123.255 1.502 . . . . 0.59 107.641 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 52.16 52.21 14.79 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.173 -2.739 . . . . 1.8 112.337 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.765 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.3 t80 -138.99 176.19 8.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.52 112.022 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -139.18 153.0 47.84 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.682 -1.229 . . . . 4.54 107.682 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.641 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 17.8 tm0? -50.84 138.95 17.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.535 1.16 . . . . 1.28 112.591 -169.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.5 p -136.22 140.94 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.802 -1.999 . . . . 1.05 109.972 -163.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -58.35 -32.77 68.85 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.714 1.245 . . . . 1.38 109.478 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 7.0 ttpt -160.22 127.12 4.36 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 112.417 -2.174 . . . . 1.44 108.663 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -112.91 124.02 51.65 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.227 -0.897 . . . . 0.9 110.767 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.16 97.88 1.82 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.99 1.376 . . . . 0.61 109.105 154.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.584 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -165.64 169.51 6.94 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 112.251 -2.249 . . . . 1.77 105.662 166.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.88 123.9 7.71 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 120.777 1.313 . . . . 0.62 112.311 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 98.25 39.76 3.66 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 120.678 -0.772 . . . . 0.51 113.279 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.765 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 12.4 mp0 -135.48 173.78 11.33 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 122.829 0.452 . . . . 2.16 110.585 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.882 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.3 p90 -169.19 168.62 9.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.245 -1.02 . . . . 0.28 108.245 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.587 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 40.5 p -135.27 126.46 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.357 -0.537 . . . . 0.42 111.955 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 152' ' ' ILE . 14.8 p -125.37 129.05 73.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.956 -0.565 . . . . 0.34 111.804 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.493 ' HA ' ' OE1' ' A' ' 148' ' ' GLN . 6.1 tp60 -144.2 -70.18 0.3 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.326 -0.55 . . . . 3.11 111.534 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.28 -67.46 0.54 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 1.65 112.633 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -87.27 -11.76 48.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.807 0.669 . . . . 1.68 112.807 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 20.6 p -165.05 157.77 16.15 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.873 0.844 . . . . 0.37 112.933 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 147' ' ' VAL . 50.2 mt -114.61 115.76 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.079 -1.419 . . . . 0.53 107.613 167.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.882 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.3 mp0 -89.33 171.39 9.79 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 106.51 -1.663 . . . . 1.13 106.51 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.623 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 26.7 ptm -167.96 154.16 7.49 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.739 0.649 . . . . 1.8 110.348 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.568 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.5 mt -128.75 114.32 32.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.33 -0.395 . . . . 0.43 110.826 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.709 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 10.0 mtp-105 . . . . . 0 C--N 1.316 -0.863 0 C-N-CA 120.664 -0.414 . . . . 3.13 111.209 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.709 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.2 tt0 . . . . . 0 N--CA 1.42 -1.961 0 N-CA-C 114.412 1.264 . . . . 1.86 114.412 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 44.2 t -154.5 130.29 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.707 -1.588 . . . . 0.41 109.99 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.649 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 35.7 mtm180 -86.9 114.77 23.81 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 116.189 -0.46 . . . . 2.8 110.325 168.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -117.0 132.43 56.71 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.844 0.83 . . . . 0.29 111.289 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.556 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 11.5 tpp180 -99.28 109.08 21.76 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.039 -1.437 . . . . 1.71 111.034 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 113' ' ' LEU . 5.4 mp -91.59 91.48 8.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.12 -0.491 . . . . 0.69 109.968 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.7 125.59 37.39 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.283 1.04 . . . . 0.26 111.844 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 2.0 m-85 -89.59 138.15 31.72 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.953 -1.93 . . . . 0.72 111.579 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.3 t70 -81.96 64.99 6.89 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 105.833 -1.914 . . . . 1.09 105.833 159.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.16 -98.75 1.02 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 118.892 -1.623 . . . . 0.47 111.144 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.34 -25.57 46.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.521 0.563 . . . . 0.83 112.521 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 118' ' ' THR . 7.1 p80 -135.46 132.88 37.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.369 0.604 . . . . 1.21 110.132 -168.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.713 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -54.59 134.02 46.62 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.1 -1.409 . . . . 0.64 110.617 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.605 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.78 -41.54 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.925 -1.034 . . . . 0.29 110.081 -176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 p -147.21 163.8 35.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.027 -0.533 . . . . 0.33 111.705 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 195' ' ' PHE . 1.6 mm -111.14 148.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.144 -2.169 . . . . 0.76 105.144 165.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.8 t -141.51 131.79 25.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.407 0.622 . . . . 0.35 109.947 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.583 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 40.7 t-20 -79.44 110.11 14.43 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.124 -1.065 . . . . 1.77 108.124 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.649 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 16.3 mtp -65.91 -2.46 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.036 0.754 . . . . 0.55 113.036 -171.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.583 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 8.3 pt-20 -81.18 -42.53 20.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.817 0.818 . . . . 1.02 111.153 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.49 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 6.1 m-20 -111.24 -26.55 9.11 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.391 -1.277 . . . . 1.4 109.738 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.2 t30 76.28 34.47 0.5 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.519 -2.128 . . . . 1.33 107.642 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 5.2 ptm180 -90.31 162.92 14.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.427 -1.715 . . . . 2.28 108.641 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -88.02 140.17 29.77 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.727 -0.67 . . . . 1.36 110.001 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.519 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -114.08 92.31 3.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.701 -0.666 . . . . 1.18 110.523 -176.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.08 -58.63 0.0 OUTLIER Glycine 0 N--CA 1.469 0.839 0 N-CA-C 116.15 1.22 . . . . 1.28 116.15 146.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 192' ' ' PHE . 35.0 p90 -163.42 174.23 12.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.702 -1.249 . . . . 2.8 109.25 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.789 ' HB3' HD12 ' A' ' 113' ' ' LEU . 1.4 t80 -140.31 154.45 46.8 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.201 -0.666 . . . . 0.6 109.201 159.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.666 ' H ' ' HD2' ' A' ' 196' ' ' ARG . 0.1 OUTLIER -138.53 153.97 48.76 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.806 -0.559 . . . . 4.77 111.933 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.585 HD21 ' HE1' ' A' ' 154' ' ' MET . 5.1 mt -129.55 172.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.425 1.268 . . . . 1.61 114.425 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.443 -0.814 0 CA-C-N 112.38 -2.191 . . . . 2.66 111.03 -175.715 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 113.68 0.993 . . . . 4.32 113.68 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.423 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 16.2 tpt -141.37 132.57 26.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.332 -0.547 . . . . 2.59 112.015 -173.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 13.3 m -121.88 104.29 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 122.814 1.292 . . . . 0.74 113.037 171.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.407 ' O ' ' HE1' ' A' ' 117' ' ' MET . 63.1 t30 -161.01 110.72 1.67 Allowed 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 105.011 -2.218 . . . . 1.38 105.011 166.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.597 HD21 ' SD ' ' A' ' 124' ' ' MET . 59.1 mt -97.16 115.22 27.16 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.967 -0.693 . . . . 1.33 110.963 -174.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.478 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 21.9 tt0 -155.34 91.26 2.86 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 121.649 0.738 . . . . 1.93 109.279 -173.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.759 ' HD3' HD12 ' A' ' 183' ' ' ILE . 0.3 OUTLIER -31.49 144.22 0.03 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.76 1 C-N-CA 126.671 4.914 . . . . 0.65 115.536 -175.946 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.3 t70 78.05 36.61 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 113.757 -1.565 . . . . 0.72 109.057 -170.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.433 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 7.2 ptp -121.09 155.43 34.46 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.768 -1.106 . . . . 1.67 111.09 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.7 m -101.37 84.47 2.62 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.224 -1.028 . . . . 0.58 108.224 -175.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.721 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -110.03 163.91 6.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.055 -1.43 . . . . 0.65 109.854 -168.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.647 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.8 m -140.87 177.41 8.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.064 -0.655 . . . . 0.44 109.913 -172.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.621 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -60.97 -27.07 68.01 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 108.145 -1.057 . . . . 2.33 108.145 165.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.591 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER -84.54 -17.73 37.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.996 -1.456 . . . . 1.32 114.416 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.647 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.9 mp0 -85.48 -62.39 1.54 Allowed 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 120.56 -1.337 . . . . 2.06 108.421 170.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.779 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 mmt -57.02 -16.52 7.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.166 -1.834 . . . . 3.13 111.901 173.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.621 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 14.9 p -42.34 -42.82 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.219 1.009 . . . . 0.37 110.797 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.674 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -67.83 -41.24 83.3 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.947 -1.478 . . . . 0.63 113.087 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.507 HD23 ' HB3' ' A' ' 197' ' ' LEU . 2.9 tm? -52.61 -32.73 43.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.29 0.567 . . . . 1.79 110.273 167.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.8 mt -82.34 -35.92 27.4 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.442 0.639 . . . . 0.38 109.541 -172.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -44.7 86.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.664 -1.153 . . . . 1.96 109.944 164.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -65.09 -39.64 93.46 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.209 -1.814 . . . . 0.64 112.636 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 128' ' ' LEU . 2.8 t -93.19 3.92 54.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.191 -1.781 . . . . 0.59 106.191 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.84 52.24 9.88 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 110.84 -2.891 . . . . 1.8 111.88 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 2.6 t80 -136.7 175.17 9.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 119.901 -0.72 . . . . 0.52 112.725 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -139.67 149.9 44.26 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.664 -1.606 . . . . 4.54 106.664 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -49.92 141.52 10.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.534 1.159 . . . . 1.28 113.136 -169.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.1 p -139.91 141.46 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.957 -1.929 . . . . 1.05 110.07 -162.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m -58.85 -34.59 71.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 122.607 1.194 . . . . 1.38 109.232 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -160.81 130.29 4.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.491 -2.141 . . . . 1.44 109.259 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.672 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -119.08 125.82 50.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.624 -1.171 . . . . 0.9 112.117 -172.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.491 ' HA ' HD11 ' A' ' 155' ' ' ILE . 1.7 t -160.64 99.79 1.28 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.931 1.348 . . . . 0.61 110.865 156.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.504 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -165.73 157.89 12.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 105.501 -2.037 . . . . 1.77 105.501 163.379 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -61.13 113.68 1.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.088 1.424 . . . . 0.62 109.727 171.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.416 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 105.45 47.71 1.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.214 -0.993 . . . . 0.51 113.272 -175.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.582 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 44.3 mt-10 -145.73 170.7 15.97 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 122.532 0.333 . . . . 2.16 110.264 172.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.863 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 49.8 p90 -167.8 165.31 14.09 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.918 -1.141 . . . . 0.28 107.918 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.667 HG22 HG13 ' A' ' 136' ' ' VAL . 35.9 p -132.17 126.11 32.83 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.862 -0.735 . . . . 0.42 110.843 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.747 HG23 HG12 ' A' ' 152' ' ' ILE . 8.6 p -125.18 169.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.798 -0.637 . . . . 0.34 111.413 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 18.7 tm0? 78.05 75.56 0.06 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.637 0.775 . . . . 3.11 110.215 176.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -177.85 -94.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.373 -1.285 . . . . 1.65 109.167 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -135.68 11.89 3.43 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.13 0.491 . . . . 1.68 110.443 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 3.3 p -165.8 158.06 14.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.37 112.265 -171.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.747 HG12 HG23 ' A' ' 147' ' ' VAL . 38.5 mt -107.69 106.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 106.458 -1.682 . . . . 0.53 106.458 159.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.863 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.7 mt-10 -91.07 164.18 14.04 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 104.779 -2.304 . . . . 1.13 104.779 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 19.2 ptp -166.06 164.0 18.16 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.871 0.732 . . . . 1.8 110.221 -170.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.823 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.2 mt -127.95 94.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.854 0.835 . . . . 0.43 110.698 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.713 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 1.3 tmt_? . . . . . 0 N--CA 1.438 -1.072 0 CA-C-N 114.496 -1.229 . . . . 3.13 111.857 -173.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.503 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 2.6 pm0 . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 114.821 1.415 . . . . 1.86 114.821 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 4.0 t -155.5 127.69 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 113.706 -1.588 . . . . 0.41 110.334 -169.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 154' ' ' MET . 22.2 mtm180 -93.63 115.24 27.7 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.583 0.23 . . . . 2.8 110.551 171.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -112.9 130.2 56.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.93 0.872 . . . . 0.29 110.904 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.75 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.8 tpt180 -96.09 98.48 10.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.762 -1.563 . . . . 1.71 110.901 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 7.0 mp -88.49 97.8 11.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 110.169 -0.308 . . . . 0.69 110.169 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.427 HG23 ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -97.19 117.11 30.67 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.576 1.179 . . . . 0.26 111.672 -173.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -85.45 131.92 34.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.689 -2.05 . . . . 0.72 110.03 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.2 t70 -76.9 65.3 2.56 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.199 -1.778 . . . . 1.09 106.199 164.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.96 -98.55 0.88 Allowed Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 119.138 -1.506 . . . . 0.47 110.526 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.71 -26.34 54.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.88 0.696 . . . . 0.83 112.88 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.476 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 5.7 p-80 -137.34 130.02 30.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.636 0.732 . . . . 1.21 111.187 -167.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.721 ' HB2' HG22 ' A' ' 119' ' ' ILE . 5.3 tt -53.13 127.75 25.31 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.93 -1.487 . . . . 0.64 110.87 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -39.39 5.88 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.253 -0.885 . . . . 0.29 110.186 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.8 p -145.96 166.66 25.38 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.965 -0.562 . . . . 0.33 110.885 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.759 HD12 ' HD3' ' A' ' 115' ' ' PRO . 38.5 mt -136.59 145.48 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 106.025 -1.843 . . . . 0.76 106.025 169.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 38.8 t -139.16 132.94 39.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.295 0.569 . . . . 0.35 109.996 -173.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.471 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 0.2 OUTLIER -80.55 103.34 10.33 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.577 -1.268 . . . . 1.77 107.577 -176.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 29.5 mtm -65.92 -1.59 3.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 123.861 0.726 . . . . 0.55 112.722 -166.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 11.7 pt-20 -77.13 -45.62 26.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.015 0.912 . . . . 1.02 110.696 174.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 190' ' ' ARG . 27.0 t-20 -108.65 -26.31 10.43 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.125 -1.398 . . . . 1.4 109.249 -174.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.3 t30 78.09 26.93 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.654 -2.066 . . . . 1.33 107.109 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.471 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 16.7 ptt180 -85.0 160.64 20.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.841 -1.527 . . . . 2.28 109.651 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.66 141.41 28.54 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.457 -1.247 . . . . 1.36 113.518 -172.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.695 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 5.8 m-85 -106.85 -166.56 1.18 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 112.635 -2.075 . . . . 1.18 107.092 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.549 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.55 -10.72 3.75 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.591 -2.203 . . . . 1.28 107.591 -149.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 196' ' ' ARG . 27.4 p90 -155.76 105.39 2.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.196 -1.002 . . . . 2.8 111.267 156.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.0 t80 -119.57 132.75 55.8 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.13 -0.981 . . . . 0.6 109.325 166.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.583 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.1 mpt_? -115.92 146.35 42.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.867 -0.42 . . . . 4.77 109.867 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 33.0 mt -127.73 162.78 25.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.431 -0.35 . . . . 1.61 111.577 -171.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 2.66 110.61 -177.466 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.985 -0.376 . . . . 4.32 109.985 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.72 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 9.2 ttt -137.65 97.64 3.49 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 118.098 -1.441 . . . . 2.59 113.748 -163.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 127' ' ' LEU . 1.6 m -101.42 107.79 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 113.548 0.944 . . . . 0.74 113.548 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -159.2 110.88 2.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.922 -1.881 . . . . 1.38 105.922 166.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.804 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.4 mp -100.72 116.15 31.94 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.461 -0.496 . . . . 1.33 110.406 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 0.3 OUTLIER -154.01 90.24 3.3 Favored Pre-proline 0 N--CA 1.432 -1.371 0 N-CA-C 109.089 -0.708 . . . . 1.93 109.089 -177.187 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.729 ' HD3' HD12 ' A' ' 183' ' ' ILE . 1.3 Cg_exo -29.04 144.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 1 C-N-CA 126.755 4.97 . . . . 0.65 116.467 -175.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.9 t70 74.68 37.66 0.52 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.791 -1.55 . . . . 0.72 108.781 -172.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.443 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 5.8 ptp -120.9 155.88 33.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.199 -1.364 . . . . 1.67 110.893 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.1 m -101.33 82.25 2.3 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 122.42 1.105 . . . . 0.58 108.33 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.532 HG13 ' CB ' ' A' ' 123' ' ' GLU . 17.8 tt -121.54 165.11 17.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.349 -1.75 . . . . 0.65 108.668 -169.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.526 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 4.2 m -140.1 175.66 9.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.713 -0.795 . . . . 0.44 111.405 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.653 ' HG2' HG21 ' A' ' 147' ' ' VAL . 1.8 mptt -59.95 -20.14 55.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.044 -0.98 . . . . 2.33 108.91 169.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.705 ' O ' HG12 ' A' ' 125' ' ' VAL . 9.2 t30 -83.03 -21.87 33.71 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 114.062 -1.426 . . . . 1.32 112.757 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.72 ' HA ' ' H ' ' A' ' 110' ' ' MET . 1.2 mp0 -85.94 -48.46 8.68 Favored 'General case' 0 N--CA 1.408 -2.533 0 O-C-N 120.01 -1.681 . . . . 2.06 107.825 173.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.745 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -62.59 -18.03 61.32 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 113.762 -1.563 . . . . 3.13 111.264 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -47.34 -40.74 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 122.324 1.059 . . . . 0.37 110.569 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.598 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -66.94 -41.04 87.63 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.872 -1.513 . . . . 0.63 113.351 177.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.723 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.9 tm? -52.11 -34.93 46.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.532 0.682 . . . . 1.79 110.156 168.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 124' ' ' MET . 18.0 mt -83.23 -36.24 24.76 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.783 0.801 . . . . 0.38 109.054 -170.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.82 -39.64 92.49 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.114 -1.403 . . . . 1.96 109.468 167.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -67.34 -43.29 81.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.306 -1.315 . . . . 0.64 112.252 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.458 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.52 2.98 56.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 124.373 2.035 . . . . 0.59 106.336 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 56.09 46.37 21.76 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 110.341 -3.118 . . . . 1.8 112.409 169.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.922 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -136.77 174.88 10.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.84 -0.744 . . . . 0.52 112.753 -173.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.426 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 31.8 ttm180 -142.97 154.72 44.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.016 -1.476 . . . . 4.54 107.016 177.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 13.6 tm0? -49.43 142.88 7.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.593 1.187 . . . . 1.28 113.714 -167.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 145' ' ' PHE . 13.3 p -142.97 142.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 112.752 -2.022 . . . . 1.05 110.304 -163.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 -34.05 70.01 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.718 1.247 . . . . 1.38 109.17 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -158.86 123.05 3.98 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.508 -2.133 . . . . 1.44 108.653 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.682 ' SD ' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -111.2 128.55 55.95 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.095 -0.957 . . . . 0.9 110.209 -178.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.596 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -160.89 99.15 1.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.756 1.265 . . . . 0.61 109.97 158.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.596 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -165.18 168.52 8.38 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 112.595 -2.093 . . . . 1.77 105.618 162.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.462 ' HG3' ' OE1' ' A' ' 168' ' ' GLN . 14.9 Cg_exo -66.02 119.25 6.25 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 N-CA-C 109.192 -1.118 . . . . 0.62 109.192 167.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.458 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 90.94 47.96 3.5 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.513 -1.327 . . . . 0.51 113.161 -171.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.922 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.1 mt-10 -150.62 147.17 27.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.845 -0.798 . . . . 2.16 108.845 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.733 ' O ' HG12 ' A' ' 136' ' ' VAL . 38.4 p90 -154.19 160.64 41.96 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.729 -0.841 . . . . 0.28 108.729 -177.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.682 HG23 ' SD ' ' A' ' 139' ' ' MET . 39.1 p -125.24 127.64 47.06 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.496 0.665 . . . . 0.42 110.606 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.653 HG21 ' HG2' ' A' ' 121' ' ' LYS . 12.8 p -121.43 113.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.187 -0.915 . . . . 0.34 110.911 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -111.53 -80.78 0.58 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.62 -0.718 . . . . 3.11 110.321 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.09 -54.84 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.72 -0.673 . . . . 1.65 110.049 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -96.47 8.24 44.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 1.68 112.264 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.688 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 23.1 p -164.13 147.01 9.34 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.947 1.092 . . . . 0.37 113.947 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 147' ' ' VAL . 54.9 mt -115.03 107.8 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 112.907 -1.951 . . . . 0.53 106.852 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.544 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 6.4 mt-10 -102.29 103.68 14.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.466 -0.939 . . . . 1.13 108.466 -176.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.454 ' SD ' ' HE1' ' A' ' 195' ' ' PHE . 6.0 ptm -117.04 155.19 29.64 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.928 -1.033 . . . . 1.8 112.465 -167.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.632 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 38.4 mt -118.79 124.41 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 114.482 -1.235 . . . . 0.43 110.307 170.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 58.6 mtm180 . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 109.67 -0.493 . . . . 3.13 109.67 173.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.669 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 49.3 tt0 . . . . . 0 N--CA 1.423 -1.812 0 N-CA-C 114.46 1.282 . . . . 1.86 114.46 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 31.0 t -153.59 133.81 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.884 -1.507 . . . . 0.41 110.081 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 18.5 mtm180 -94.8 115.67 27.78 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.962 -0.563 . . . . 2.8 110.397 168.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.33 134.17 55.13 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.075 0.94 . . . . 0.29 112.161 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.761 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 16.2 tpt180 -96.25 95.74 8.31 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.22 -1.809 . . . . 1.71 110.255 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.755 HD21 HD21 ' A' ' 113' ' ' LEU . 3.9 mp -87.31 95.88 10.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.171 -0.677 . . . . 0.69 109.171 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.44 111.01 22.98 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.377 1.084 . . . . 0.26 111.556 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.753 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 52.7 m-85 -87.28 129.71 34.88 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.992 -1.913 . . . . 0.72 110.438 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 35.5 t70 -78.85 66.12 4.24 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 106.539 -1.652 . . . . 1.09 106.539 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.27 -99.32 1.18 Allowed Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 119.227 -1.463 . . . . 0.47 110.329 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.71 -24.82 33.43 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.937 0.717 . . . . 0.83 112.937 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.506 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 9.5 p-80 -130.49 123.03 28.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.636 0.731 . . . . 1.21 110.763 -166.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.753 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.9 tt -54.11 128.52 31.11 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.772 -1.558 . . . . 0.64 110.883 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.39 -39.06 6.01 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.105 -0.952 . . . . 0.29 110.33 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 115' ' ' PRO . 19.3 p -149.4 163.31 38.1 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.214 -0.448 . . . . 0.33 111.092 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.761 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 44.5 mt -136.43 145.44 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 105.889 -1.893 . . . . 0.76 105.889 168.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 49.1 t -138.86 136.77 43.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.821 -0.437 . . . . 0.35 109.821 -174.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.603 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.0 t-20 -85.31 97.66 10.08 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.511 -1.292 . . . . 1.77 107.511 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.544 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 57.6 mtm -64.61 -3.1 2.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 124.182 0.926 . . . . 0.55 113.239 -162.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.0 pt-20 -80.53 -40.6 25.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.855 0.836 . . . . 1.02 110.802 177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.506 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 77.0 m-20 -113.58 -25.29 8.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.287 -1.324 . . . . 1.4 109.335 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 80.72 28.57 0.22 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.733 -2.031 . . . . 1.33 108.283 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.603 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 0.6 OUTLIER -83.28 155.57 23.56 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.656 -1.611 . . . . 2.28 110.637 176.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -84.74 140.97 30.88 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.641 -1.163 . . . . 1.36 112.917 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.668 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 3.9 m-85 -103.27 -166.67 1.29 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.942 -1.936 . . . . 1.18 107.97 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 136.09 -2.38 3.58 Favored Glycine 0 CA--C 1.482 -1.986 0 N-CA-C 107.736 -2.146 . . . . 1.28 107.736 -151.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.47 ' O ' ' HD2' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -156.81 100.06 1.88 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 113.698 -1.251 . . . . 2.8 111.903 151.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.804 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 t80 -116.68 100.78 8.06 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.87 -1.132 . . . . 0.6 109.952 168.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -96.88 138.49 34.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.295 -0.412 . . . . 4.77 110.579 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.723 HD13 ' HG ' ' A' ' 127' ' ' LEU . 45.8 mt -132.42 160.68 35.68 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.255 0.55 . . . . 1.61 112.189 -170.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.229 -0.896 . . . . 2.66 109.375 175.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 69.3 mtm . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.851 0.358 . . . . 26.27 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.07 129.72 3.48 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.841 -0.695 . . . . 24.15 111.62 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 t 57.99 57.13 4.25 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.518 0.675 . . . . 23.64 110.013 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 m -87.79 96.03 10.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.644 -0.707 . . . . 22.83 110.612 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -88.69 112.98 23.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.754 -0.657 . . . . 22.11 109.433 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -91.0 -158.12 0.54 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.419 -0.355 . . . . 22.07 111.093 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.4 m80 65.86 51.64 1.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.198 0.523 . . . . 20.59 110.603 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -91.02 76.6 6.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.052 -0.522 . . . . 18.44 110.885 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -81.96 102.03 10.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.025 -0.534 . . . . 17.98 109.838 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -69.97 136.51 50.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.254 -0.43 . . . . 17.87 110.399 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 p -82.77 84.1 7.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.044 -0.526 . . . . 16.77 110.487 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 m -68.07 97.74 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.915 -0.584 . . . . 16.32 110.121 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.57 54.14 1.59 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.637 -0.792 . . . . 14.63 111.357 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.7 tp -75.06 75.05 2.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.278 0.561 . . . . 15.68 110.609 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.44 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 59.0 t -87.49 -53.25 0.39 Allowed Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.67 -0.695 . . . . 12.69 110.737 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.44 ' HD2' ' H ' ' A' ' 101' ' ' VAL . 60.9 Cg_endo -71.56 175.81 8.98 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.753 1.636 . . . . 12.08 111.867 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 74.42 -32.1 0.23 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.58 0.752 . . . . 12.18 111.667 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.57 -173.83 22.28 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.179 -0.534 . . . . 8.55 112.211 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.5 t -80.64 130.62 35.21 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.277 -0.638 . . . . 8.07 109.277 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -135.58 62.85 1.62 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.079 0.466 . . . . 7.76 110.965 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 63.0 mtt -100.15 -52.89 3.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.198 -0.667 . . . . 6.12 109.198 173.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.82 -31.76 2.75 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-O 118.816 -0.991 . . . . 1.91 114.722 169.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 7.1 ptm180 -17.26 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.638 1.347 . . . . 4.32 114.638 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.414 ' HB3' ' HG2' ' A' ' 123' ' ' GLU . 60.9 ttp -140.44 121.74 14.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.557 -0.457 . . . . 2.59 111.515 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 105.7 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 122.246 1.022 . . . . 0.74 113.566 173.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -159.79 106.2 1.63 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.248 -2.13 . . . . 1.38 105.248 159.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.708 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 11.5 mt -82.8 103.64 12.44 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.425 -0.51 . . . . 1.33 110.169 -171.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -145.08 99.46 4.62 Favored Pre-proline 0 N--CA 1.429 -1.492 0 C-N-CA 119.37 -0.932 . . . . 1.93 110.431 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.797 ' HD3' HD12 ' A' ' 183' ' ' ILE . 0.5 OUTLIER -34.14 139.0 0.09 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.644 1 C-N-CA 125.668 4.245 . . . . 0.65 115.011 -178.84 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.4 t70 77.22 35.56 0.34 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 113.834 -1.53 . . . . 0.72 109.408 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.505 ' HE3' HD13 ' A' ' 180' ' ' LEU . 10.8 ptt? -114.56 155.13 27.06 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.401 -1.272 . . . . 1.67 109.879 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 179' ' ' HIS . 21.4 m -101.71 103.74 14.52 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.079 -1.082 . . . . 0.58 108.079 -175.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.605 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.4 tt -136.56 166.66 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 115.277 -0.874 . . . . 0.65 110.566 -165.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.618 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 13.6 m -141.42 176.24 9.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.738 -0.838 . . . . 0.44 108.738 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.542 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -28.0 68.85 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.53 -0.915 . . . . 2.33 108.53 166.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.606 ' O ' HG12 ' A' ' 125' ' ' VAL . 0.3 OUTLIER -84.23 -19.14 34.44 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.127 -1.397 . . . . 1.32 113.485 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.618 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.5 mt-10 -87.6 -54.22 4.38 Favored 'General case' 0 N--CA 1.422 -1.839 0 O-C-N 120.444 -1.41 . . . . 2.06 108.994 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.762 ' SD ' HD23 ' A' ' 173' ' ' LEU . 2.1 tpp -59.76 -16.36 27.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.767 -1.56 . . . . 3.13 111.147 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 122' ' ' ASN . 15.0 p -43.81 -41.24 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 122.185 0.993 . . . . 0.37 110.228 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.535 ' HG2' ' HA ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -65.3 -42.54 92.96 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 113.927 -1.488 . . . . 0.63 113.031 176.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.643 HD23 HD23 ' A' ' 128' ' ' LEU . 0.8 OUTLIER -50.82 -33.88 25.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.814 0.816 . . . . 1.79 110.595 169.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 124' ' ' MET . 20.2 mt -84.6 -35.87 22.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.553 -1.203 . . . . 0.38 109.654 -171.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.36 -24.95 63.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.483 -1.235 . . . . 1.96 110.31 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -76.41 -42.13 45.27 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.504 -1.225 . . . . 0.64 110.924 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.697 HG22 ' HA ' ' A' ' 128' ' ' LEU . 14.4 t -87.11 1.31 53.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 123.531 1.634 . . . . 0.59 107.32 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 46.39 51.98 11.11 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 110.924 -2.853 . . . . 1.8 112.249 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.632 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.9 t80 -135.31 176.5 8.62 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 112.478 0.548 . . . . 0.52 112.478 -172.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.542 ' HD3' ' N ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -140.21 142.06 35.88 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.947 -1.501 . . . . 4.54 106.947 177.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.597 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 14.6 tm0? -48.98 142.16 6.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 114.26 1.208 . . . . 1.28 114.26 -168.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.725 HG23 HG22 ' A' ' 146' ' ' THR . 3.1 m -125.5 155.62 34.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.779 -2.01 . . . . 1.05 110.953 -176.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -61.36 -35.74 78.29 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 122.737 1.256 . . . . 1.38 108.446 171.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.442 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 5.6 tmmm? -159.87 133.18 6.94 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.65 -2.068 . . . . 1.44 109.816 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.565 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.34 135.86 54.88 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.577 -1.192 . . . . 0.9 111.31 -177.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.719 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 1.6 t -161.57 97.89 1.1 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 122.668 1.223 . . . . 0.61 110.718 149.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.719 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.07 161.73 20.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 112.7 -2.045 . . . . 1.77 106.313 164.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -64.38 130.94 28.3 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 121.299 1.332 . . . . 0.62 111.4 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.612 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 89.88 49.3 3.38 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 120.306 -0.95 . . . . 0.51 112.948 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.632 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 48.7 mt-10 -141.09 178.1 7.61 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.907 0.384 . . . . 2.16 111.357 175.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.868 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 50.2 p90 -165.73 175.59 8.68 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.063 -1.088 . . . . 0.28 108.063 169.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.725 HG22 HG23 ' A' ' 136' ' ' VAL . 25.6 p -142.3 126.13 17.1 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.471 0.653 . . . . 0.42 111.169 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.597 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.7 p -125.37 109.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.235 -0.893 . . . . 0.34 109.886 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -142.61 -60.8 0.44 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.65 -0.42 . . . . 3.11 111.607 -171.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.92 -92.43 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.49 0.552 . . . . 1.65 112.49 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -104.83 -0.11 27.53 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.11 0.481 . . . . 1.68 111.173 -171.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 174' ' ' THR . 5.2 p -146.82 160.05 42.76 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.314 0.857 . . . . 0.37 113.314 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.617 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 60.5 mt -110.53 109.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 106.816 -1.55 . . . . 0.53 106.816 162.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.8 mp0 -89.38 175.91 7.13 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.015 -1.476 . . . . 1.13 107.015 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.636 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 25.6 ptm -168.67 154.66 6.76 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 123.496 0.498 . . . . 1.8 111.108 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.585 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 21.7 mt -127.62 110.16 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.753 -0.658 . . . . 0.43 110.309 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.815 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 28.2 mtp180 -63.87 106.39 1.0 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.186 -0.461 . . . . 3.13 110.759 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.612 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 63.6 ttt180 -71.15 147.56 93.54 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 107.617 -1.253 . . . . 6.16 107.617 170.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -47.2 125.97 11.02 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 121.235 1.29 . . . . 2.1 110.602 168.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.544 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 22.4 m-85 -128.35 132.98 48.58 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.302 -1.317 . . . . 1.83 108.448 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -95.66 76.72 3.26 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.744 1.259 . . . . 3.66 111.116 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.484 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 18.1 m-85 -115.82 139.52 25.01 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 113.614 -1.63 . . . . 3.54 108.957 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.0 Cg_exo -57.71 -31.24 91.57 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 124.472 3.448 . . . . 4.48 112.632 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -98.49 -7.83 27.74 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.786 -1.097 . . . . 5.26 111.108 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.1 m -159.88 98.72 1.35 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.446 -0.343 . . . . 3.43 111.404 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.66 97.58 2.75 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.597 0.713 . . . . 3.34 109.717 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -146.42 -175.29 4.72 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.873 -1.058 . . . . 3.14 110.894 -173.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.37 173.49 54.87 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 114.264 -1.335 . . . . 1.11 112.14 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.815 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.6 tt0 -62.49 152.73 33.75 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 113.41 -1.395 . . . . 1.86 113.502 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 50.1 t -154.37 133.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.689 -1.141 . . . . 0.41 109.519 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 154' ' ' MET . 8.5 mtm180 -91.12 115.16 27.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.814 0.34 . . . . 2.8 110.399 169.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.04 145.39 43.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.812 0.815 . . . . 0.29 111.353 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.761 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.2 tpt180 -111.49 98.66 7.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.838 -1.528 . . . . 1.71 110.501 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.762 HD23 ' SD ' ' A' ' 124' ' ' MET . 4.5 mp -91.76 94.48 9.37 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.247 -0.279 . . . . 0.69 110.247 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -98.1 126.26 43.47 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 122.438 1.114 . . . . 0.26 111.653 -171.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.2 m-85 -89.82 138.34 31.57 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 112.859 -1.973 . . . . 0.72 111.07 -177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.9 t70 -79.39 64.49 4.29 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.027 -1.842 . . . . 1.09 106.027 160.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.7 -98.37 1.05 Allowed Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 118.879 -1.629 . . . . 0.47 110.713 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -79.14 -24.8 43.09 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.023 0.749 . . . . 0.83 113.023 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 118' ' ' THR . 1.9 p80 -134.68 129.99 35.63 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.951 -0.7 . . . . 1.21 110.844 -169.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.27 128.15 27.13 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.743 -1.572 . . . . 0.64 110.546 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.23 -41.48 5.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.492 -0.776 . . . . 0.29 110.486 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.1 p -145.49 166.86 24.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.226 -0.443 . . . . 0.33 110.921 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.797 HD12 ' HD3' ' A' ' 115' ' ' PRO . 39.5 mt -136.18 145.45 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 106.108 -1.812 . . . . 0.76 106.108 169.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 45.0 t -137.26 140.17 42.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.277 0.56 . . . . 0.35 110.186 -174.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.485 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.1 t-20 -81.13 100.97 9.34 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 107.733 -1.21 . . . . 1.77 107.733 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.551 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 49.3 mtm -64.27 -2.76 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.403 0.89 . . . . 0.55 113.403 -164.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.461 ' HG3' ' OD1' ' A' ' 188' ' ' ASN . 10.9 pt-20 -91.92 -40.06 11.36 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.812 0.815 . . . . 1.02 111.225 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 187' ' ' GLU . 5.8 m-20 -105.78 -25.36 12.22 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.449 -1.251 . . . . 1.4 109.495 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 73.86 33.91 0.95 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 112.429 -2.169 . . . . 1.33 108.041 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 3.9 ptm180 -93.33 161.88 14.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.03 -1.441 . . . . 2.28 110.082 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -87.3 140.84 29.13 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.542 -1.208 . . . . 1.36 113.518 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.624 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 8.8 m-85 -106.44 -166.02 1.14 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.834 -1.984 . . . . 1.18 107.286 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.568 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.99 -6.73 3.46 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 107.83 -2.108 . . . . 1.28 107.83 -149.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -154.71 112.61 3.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.878 -1.161 . . . . 2.8 111.507 157.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.708 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t80 -129.18 101.6 6.09 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.702 -0.799 . . . . 0.6 109.965 162.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -100.06 128.75 46.1 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.03 -1.044 . . . . 4.77 111.948 -171.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.436 ' CD1' HD12 ' A' ' 127' ' ' LEU . 8.9 mt -107.76 171.27 7.49 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.174 -0.466 . . . . 1.61 111.129 173.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -116.28 97.68 50.13 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 108.727 -0.842 . . . . 2.66 108.727 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -46.49 118.52 2.6 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.503 2.802 . . . . 2.01 115.253 -168.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 125.35 1.46 . . . . 5.19 110.166 170.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.658 ' N ' ' HG ' ' A' ' 90' ' ' SER . 23.1 ptt? . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 111.382 0.141 . . . . 26.27 111.382 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.06 -93.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 24.15 111.966 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.6 t -82.62 63.8 6.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.385 0.612 . . . . 23.64 109.674 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.658 ' HG ' ' N ' ' A' ' 87' ' ' MET . 17.1 m -112.28 20.0 17.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.997 -0.547 . . . . 22.83 111.478 -175.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -107.75 96.03 6.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.078 0.466 . . . . 22.11 110.252 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -81.85 135.05 35.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.571 -0.529 . . . . 22.07 109.571 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -75.55 105.89 6.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.37 -0.377 . . . . 20.59 110.161 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -138.23 38.4 2.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.005 0.431 . . . . 18.44 111.139 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -142.33 152.59 43.09 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.756 -0.461 . . . . 17.98 109.756 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -55.41 107.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.528 0.518 . . . . 17.87 110.163 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.2 m -97.84 126.31 43.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.817 -0.629 . . . . 16.77 111.213 -174.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.8 m -143.52 158.66 43.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.532 -0.758 . . . . 16.32 109.28 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' HA3' ' HG2' ' A' ' 102' ' ' PRO . . . -158.23 152.83 24.02 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.159 -1.02 . . . . 14.63 112.736 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.0 tp -79.47 -46.0 18.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.086 0.47 . . . . 15.68 110.023 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.505 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 51.3 t -90.36 -53.15 0.31 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.711 -0.677 . . . . 12.69 111.035 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 61.9 Cg_endo -75.28 55.76 4.2 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.908 1.739 . . . . 12.08 111.685 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -83.71 91.98 7.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.641 -0.709 . . . . 12.18 110.371 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -173.77 -146.7 5.66 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.383 -0.687 . . . . 8.55 111.383 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.2 m 72.89 -44.19 0.59 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.627 0.771 . . . . 8.07 111.606 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -83.28 43.1 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.989 0.423 . . . . 7.76 111.121 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 93.0 mmm -117.87 138.06 52.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.043 -0.526 . . . . 6.12 110.139 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 123' ' ' GLU . . . 86.29 -32.53 3.83 Favored Glycine 0 C--O 1.22 -0.748 0 CA-C-N 116.039 -0.528 . . . . 1.91 113.122 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.55 ' NH1' HG21 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -53.08 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.824 0.85 . . . . 4.32 111.263 175.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.649 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 48.2 tpp -143.63 138.78 29.24 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.361 -0.536 . . . . 2.59 110.961 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -126.77 104.84 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-O 122.374 1.083 . . . . 0.74 113.059 177.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -158.85 107.76 1.92 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 112.962 -1.926 . . . . 1.38 106.177 167.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 195' ' ' PHE . 6.6 mt -91.3 100.62 13.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.5 -0.48 . . . . 1.33 110.111 -173.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -150.34 109.44 3.19 Favored Pre-proline 0 N--CA 1.437 -1.09 0 CA-C-O 121.377 0.608 . . . . 1.93 109.677 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.858 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 10.6 Cg_exo -34.77 146.3 0.05 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.849 1 C-N-CA 126.876 5.05 . . . . 0.65 115.43 -173.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.57 39.61 2.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.089 -1.414 . . . . 0.72 109.019 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.59 ' HE1' HD22 ' A' ' 113' ' ' LEU . 10.5 ptt? -117.57 154.37 31.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.655 -1.157 . . . . 1.67 109.485 174.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.1 m -101.81 79.33 1.9 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.152 0.977 . . . . 0.58 108.599 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.755 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -97.1 156.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 113.936 -1.484 . . . . 0.65 109.384 -171.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 124' ' ' MET . 10.8 m -141.95 174.15 10.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.156 -0.683 . . . . 0.44 109.156 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.641 ' HA ' ' CE ' ' A' ' 124' ' ' MET . 35.2 mtpt -49.43 -33.49 14.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.38 0.609 . . . . 2.33 110.175 168.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.603 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 63.0 t30 -84.49 -16.18 43.34 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.335 1.235 . . . . 1.32 114.335 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.649 ' CG ' ' HB3' ' A' ' 110' ' ' MET . 6.2 tt0 -86.31 -60.53 1.97 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.374 -1.453 . . . . 2.06 107.894 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.79 ' SD ' HD21 ' A' ' 128' ' ' LEU . 0.5 OUTLIER -54.7 -17.59 3.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.457 -1.701 . . . . 3.13 111.105 173.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 13.7 p -42.35 -40.57 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-O 122.018 0.914 . . . . 0.37 110.34 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.636 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.7 -42.72 81.55 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.129 -1.396 . . . . 0.63 113.699 177.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.67 HD12 HD23 ' A' ' 128' ' ' LEU . 2.8 tm? -50.86 -34.78 29.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.568 0.699 . . . . 1.79 110.359 168.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 ' SD ' ' A' ' 124' ' ' MET . 7.3 mt -85.36 -34.86 21.69 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.568 -0.742 . . . . 0.38 110.143 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.29 -25.77 66.21 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.154 -1.385 . . . . 1.96 110.778 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -77.38 -45.39 26.11 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.978 -1.464 . . . . 0.64 111.272 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.97 -5.99 46.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 123.637 1.684 . . . . 0.59 107.471 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 57.54 55.34 5.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 110.983 -2.826 . . . . 1.8 112.464 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.724 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.5 t80 -132.15 176.38 8.43 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.853 0.686 . . . . 0.52 112.853 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.415 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 58.2 ttt180 -142.86 141.57 31.6 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.949 -1.5 . . . . 4.54 106.949 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -49.04 144.79 4.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 115.627 1.714 . . . . 1.28 115.627 -165.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 146' ' ' THR . 3.1 m -129.51 162.67 36.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 112.223 -2.262 . . . . 1.05 110.862 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -73.0 -35.55 66.84 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.591 -1.263 . . . . 1.38 107.591 167.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -145.46 124.84 13.06 Favored 'General case' 0 CA--C 1.491 -1.319 0 CA-C-N 112.795 -2.002 . . . . 1.44 110.513 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.581 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -117.93 128.87 55.23 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.093 -1.412 . . . . 0.9 110.047 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 96.03 1.68 Allowed 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 123.044 1.402 . . . . 0.61 109.364 155.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.586 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -167.61 161.26 10.16 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 111.979 -2.373 . . . . 1.77 105.771 167.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.19 126.32 9.77 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.675 1.583 . . . . 0.62 111.865 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 103.43 19.41 12.41 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 119.904 -1.141 . . . . 0.51 112.328 -173.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.724 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 13.4 mp0 -128.33 173.19 10.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.661 0.267 . . . . 2.16 110.682 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.841 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 54.9 p90 -165.9 175.85 8.31 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.707 -1.22 . . . . 0.28 107.707 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.867 HG22 HG23 ' A' ' 136' ' ' VAL . 3.5 p -138.1 132.59 32.29 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 120.227 -0.589 . . . . 0.42 110.823 170.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 135' ' ' GLN . 14.6 p -124.14 109.82 23.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 122.347 1.07 . . . . 0.34 111.813 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -99.18 -74.99 0.57 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.523 -1.217 . . . . 3.11 109.313 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -173.62 -46.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.016 -0.993 . . . . 1.65 109.328 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -83.36 -11.42 57.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.408 -0.814 . . . . 1.68 111.236 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 14.6 p -158.89 152.28 22.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.125 0.964 . . . . 0.37 112.829 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.611 HG21 ' SD ' ' A' ' 124' ' ' MET . 68.5 mt -116.59 113.72 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 112.977 -1.92 . . . . 0.53 107.554 164.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -92.88 165.56 12.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.565 -1.643 . . . . 1.13 106.565 173.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.626 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 14.5 ptp -166.37 151.43 8.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 123.835 0.71 . . . . 1.8 110.764 -176.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.688 HG12 ' HG3' ' A' ' 170' ' ' ARG . 7.5 mt -129.63 110.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.65 -0.705 . . . . 0.43 110.265 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 33.7 mtp180 -68.2 101.26 1.14 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.483 -0.487 . . . . 3.13 110.354 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.571 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 50.1 ttt180 -54.44 146.56 32.68 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 107.052 -1.462 . . . . 6.16 107.052 166.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -70.89 124.75 10.9 Favored 'Trans proline' 0 N--CA 1.432 -2.146 0 CA-C-N 120.316 1.148 . . . . 2.1 109.23 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 17.5 m-85 -118.19 163.1 17.15 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.126 -1.397 . . . . 1.83 108.396 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -110.9 76.93 1.0 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.27 1.033 . . . . 3.66 111.239 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 34.2 m-85 -116.5 147.85 40.56 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 114.153 -1.385 . . . . 3.54 110.354 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 31.8 Cg_exo -59.04 -31.95 96.57 Favored 'Trans proline' 0 CA--C 1.501 -1.146 0 C-N-CA 125.009 3.806 . . . . 4.48 113.651 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -95.44 -13.53 24.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.23 -0.896 . . . . 5.26 111.008 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.439 ' HB2' ' OD1' ' A' ' 198' ' ' ASP . 21.5 m -157.67 103.09 1.9 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.989 -0.55 . . . . 3.43 111.574 -172.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -147.11 86.38 1.63 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.894 0.854 . . . . 3.34 109.022 173.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.08 -170.3 3.59 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.208 -1.36 . . . . 3.14 111.11 -173.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -70.72 155.36 52.86 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.879 -0.601 . . . . 1.11 112.624 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.569 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -60.63 164.4 4.63 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.632 -0.784 . . . . 1.86 112.715 -178.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 95.4 t -151.86 127.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 115.179 -0.918 . . . . 0.41 110.089 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.688 ' HG3' HG12 ' A' ' 155' ' ' ILE . 3.7 mtm180 -85.77 115.46 23.43 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.468 -0.787 . . . . 2.8 110.262 169.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 153' ' ' GLU . . . -116.44 139.8 50.05 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.313 -0.955 . . . . 0.29 111.591 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.751 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 13.2 tpt180 -104.48 98.57 8.32 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.982 -1.463 . . . . 1.71 110.781 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 151' ' ' SER . 8.3 mp -88.16 103.25 15.58 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 110.237 -0.283 . . . . 0.69 110.237 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.21 119.57 39.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.4 1.095 . . . . 0.26 111.675 -175.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.548 ' CZ ' HG23 ' A' ' 119' ' ' ILE . 2.0 m-85 -83.31 140.6 32.37 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 112.955 -1.93 . . . . 0.72 111.147 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.7 t70 -80.23 65.2 5.3 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.065 -1.828 . . . . 1.09 106.065 159.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.84 -97.99 1.27 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 118.572 -1.775 . . . . 0.47 110.697 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.87 -25.38 40.7 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.032 0.753 . . . . 0.83 113.032 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -132.81 129.69 38.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.972 0.891 . . . . 1.21 111.726 -167.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.755 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.0 tm? -51.07 120.59 5.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.872 -1.967 . . . . 0.64 109.868 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -106.14 -37.25 6.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.764 -0.653 . . . . 0.29 110.63 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.411 ' C ' HG13 ' A' ' 183' ' ' ILE . 17.7 p -143.88 164.38 30.73 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 116.102 -0.499 . . . . 0.33 110.742 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.751 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 21.1 mt -138.93 143.97 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 105.831 -1.914 . . . . 0.76 105.831 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 30.3 t -132.79 135.34 57.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.946 0.403 . . . . 0.35 110.472 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.535 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 1.8 m120 -76.24 101.1 5.29 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 107.131 -1.433 . . . . 1.77 107.131 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.628 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 41.1 mtm -67.38 -1.41 4.71 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.34 0.59 . . . . 0.55 111.654 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 16.9 pt-20 -73.85 -43.96 57.01 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.193 -0.912 . . . . 1.02 110.988 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -113.26 -25.67 8.75 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.228 -1.351 . . . . 1.4 109.367 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 75.53 36.47 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 112.179 -2.282 . . . . 1.33 107.858 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 185' ' ' ASN . 12.2 ptt180 -97.33 170.7 8.9 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-N 114.167 -1.379 . . . . 2.28 108.819 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -86.05 144.92 27.3 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.433 1.111 . . . . 1.36 113.916 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.572 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -116.91 -166.79 1.2 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 105.222 -2.14 . . . . 1.18 105.222 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.858 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 136.19 8.19 1.62 Allowed Glycine 0 N--CA 1.412 -2.934 0 N-CA-C 109.994 -1.242 . . . . 1.28 109.994 -160.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.433 ' HB2' ' NH1' ' A' ' 196' ' ' ARG . 20.7 p90 -152.39 101.95 2.71 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.151 -1.525 . . . . 2.8 110.438 151.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.725 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 3.9 t80 -118.45 99.75 7.03 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.892 -0.781 . . . . 0.6 108.892 168.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.433 ' NH1' ' HB2' ' A' ' 194' ' ' PHE . 1.4 mpt_? -100.62 123.06 44.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 4.77 111.33 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -93.1 172.57 8.22 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.336 1.606 . . . . 1.61 115.336 -170.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 164' ' ' SER . 13.9 m-20 -92.71 118.74 68.07 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-N 112.813 -1.994 . . . . 2.66 110.031 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.693 ' O ' ' HD3' ' A' ' 200' ' ' ARG . 82.5 Cg_exo -45.25 127.74 9.26 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 124.466 3.444 . . . . 2.01 114.924 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.693 ' HD3' ' O ' ' A' ' 199' ' ' PRO . 13.2 mmt180 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.395 -0.812 . . . . 5.19 109.729 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 120.635 0.255 . . . . 26.27 111.009 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.81 -25.61 7.91 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.972 -0.632 . . . . 24.15 111.664 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 t -88.3 100.3 12.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.752 -0.462 . . . . 23.64 109.752 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.5 t -88.01 -24.61 23.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.038 -0.528 . . . . 22.83 110.637 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.5 m80 65.19 32.64 9.94 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.407 -0.815 . . . . 22.11 110.805 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -109.25 137.23 47.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 22.07 110.726 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 62.16 89.77 0.08 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 124.034 0.834 . . . . 20.59 111.184 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -69.29 122.92 19.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.244 -0.651 . . . . 18.44 109.244 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 98' ' ' SER . 2.4 t-160 -65.11 -19.73 66.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.181 -0.463 . . . . 17.98 111.092 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t60 69.35 -85.56 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.51 0.724 . . . . 17.87 112.034 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.0 m -71.97 -43.54 64.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.244 0.545 . . . . 16.77 110.235 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 95' ' ' HIS . 19.4 t -99.91 -175.99 3.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.923 -0.769 . . . . 16.32 108.923 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.27 -132.19 2.53 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.127 -0.789 . . . . 14.63 111.127 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.71 168.75 14.95 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.595 -0.52 . . . . 15.68 109.595 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.565 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 95.4 t -73.26 -53.93 4.51 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 120.91 -0.316 . . . . 12.69 111.786 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 11.2 Cg_exo -70.72 124.31 10.57 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.698 1.599 . . . . 12.08 111.562 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -107.72 114.08 27.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.456 -0.338 . . . . 12.18 110.245 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.84 -170.86 39.03 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.964 -0.636 . . . . 8.55 111.864 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.7 t -68.13 -22.13 64.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.88 0.371 . . . . 8.07 110.43 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -92.48 107.71 19.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.335 -0.393 . . . . 7.76 110.219 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 89.2 mtp -64.57 -36.27 83.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.176 0.512 . . . . 6.12 110.298 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.33 3.37 89.84 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-N 115.322 -0.853 . . . . 1.91 112.743 175.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 22.4 mtt180 -136.62 78.71 1.72 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.361 -1.348 . . . . 4.32 107.361 173.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.804 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.3 tpt -143.58 118.06 9.71 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 114.162 1.171 . . . . 2.59 114.162 -160.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 127' ' ' LEU . 0.8 OUTLIER -104.19 109.29 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 C-N-CA 119.246 -0.982 . . . . 0.74 112.681 179.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -155.03 109.82 3.0 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.146 -1.798 . . . . 1.38 106.146 167.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.1 mp -98.33 113.69 25.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.596 -0.89 . . . . 1.33 108.596 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 15.1 tt0 -146.09 108.99 4.3 Favored Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.732 -0.787 . . . . 1.93 109.79 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HG3' HG12 ' A' ' 183' ' ' ILE . 33.3 Cg_exo -35.76 130.83 0.32 Allowed 'Trans proline' 0 C--N 1.33 -0.407 0 C-N-CA 124.903 3.735 . . . . 0.65 114.473 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.8 t70 73.71 45.47 0.24 Allowed 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 122.403 1.097 . . . . 0.72 110.624 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.484 ' HE3' ' HB3' ' A' ' 114' ' ' GLU . 6.1 ptp -121.28 158.57 27.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.286 -1.324 . . . . 1.67 111.416 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 m -102.29 100.14 10.29 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.779 -0.823 . . . . 0.58 108.779 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.596 HG21 ' HE1' ' A' ' 124' ' ' MET . 12.2 tt -137.93 169.3 18.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.97 -1.013 . . . . 0.65 109.577 -167.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.533 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 15.5 m -139.88 175.33 9.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.821 0.737 . . . . 0.44 111.45 -173.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.679 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -61.24 -20.6 63.02 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.49 -0.929 . . . . 2.33 108.49 167.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.759 ' O ' HG12 ' A' ' 125' ' ' VAL . 6.3 t30 -83.17 -22.64 33.19 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 113.979 -1.464 . . . . 1.32 112.475 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.804 ' HA ' ' H ' ' A' ' 110' ' ' MET . 1.1 mp0 -84.28 -50.01 8.25 Favored 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 120.025 -1.672 . . . . 2.06 107.923 173.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.764 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -61.67 -18.51 59.83 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.511 -1.222 . . . . 3.13 111.268 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.1 p -47.28 -41.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.114 0.959 . . . . 0.37 110.808 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.536 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.2 mmpt? -69.93 -36.97 75.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.323 -1.308 . . . . 0.63 112.771 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.732 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.4 tm? -55.42 -33.88 63.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.686 0.755 . . . . 1.79 110.27 167.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.764 ' HG ' ' O ' ' A' ' 124' ' ' MET . 17.4 mt -84.36 -32.6 24.14 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.95 0.881 . . . . 0.38 109.189 -172.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.98 -39.43 89.57 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.901 -1.499 . . . . 1.96 110.219 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 200' ' ' ARG . . . -70.5 -43.19 70.2 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.524 -1.671 . . . . 0.64 112.283 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.49 3.9 54.57 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 124.538 2.113 . . . . 0.59 106.281 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 130' ' ' ALA . 17.9 mt-30 52.35 49.16 21.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 110.262 -3.154 . . . . 1.8 112.679 168.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.981 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -139.24 175.74 9.3 Favored 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 119.759 -0.776 . . . . 0.52 112.778 -172.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.41 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 79.6 ttt180 -138.69 155.11 48.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.558 -1.275 . . . . 4.54 107.558 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.492 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -49.17 141.36 8.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.427 1.108 . . . . 1.28 113.375 -168.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.834 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.3 p -143.39 135.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.033 -1.894 . . . . 1.05 109.931 -164.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -33.52 70.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.233 1.016 . . . . 1.38 109.475 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -151.8 121.57 7.01 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 113.109 -1.86 . . . . 1.44 109.697 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.594 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -111.09 122.75 48.68 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.188 -1.369 . . . . 0.9 110.855 -177.469 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.3 OUTLIER -158.94 97.16 1.39 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.824 1.297 . . . . 0.61 109.769 161.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.446 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -166.65 165.2 9.95 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 112.508 -2.133 . . . . 1.77 106.127 161.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 157' ' ' ARG . 27.8 Cg_exo -62.61 116.74 3.72 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 120.973 1.115 . . . . 0.62 109.885 167.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.42 47.25 3.83 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.834 -1.174 . . . . 0.51 113.424 -171.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.981 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.3 mt-10 -142.41 147.96 37.04 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.769 -0.826 . . . . 2.16 108.769 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.855 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 35.5 p90 -152.59 159.22 43.26 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.432 -0.951 . . . . 0.28 108.432 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.704 HG22 HG13 ' A' ' 136' ' ' VAL . 3.6 p -126.95 127.66 45.19 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.92 -0.712 . . . . 0.42 110.954 175.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.629 HG23 HG12 ' A' ' 152' ' ' ILE . 8.6 p -111.81 110.42 32.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-O 121.908 0.861 . . . . 0.34 111.322 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -113.65 16.01 18.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.909 -1.041 . . . . 3.11 110.738 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.65 -50.05 0.7 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.81 0.694 . . . . 1.65 111.28 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -81.88 -5.21 58.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.13 0.49 . . . . 1.68 110.175 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -166.39 144.87 5.53 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.444 -0.798 . . . . 0.37 112.073 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.679 HD11 ' HA ' ' A' ' 121' ' ' LYS . 37.2 mt -116.1 112.47 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.279 -1.328 . . . . 0.53 107.684 164.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.855 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 65.7 mt-10 -90.82 163.54 14.39 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.373 -2.084 . . . . 1.13 105.373 175.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.506 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 24.0 ptm -167.83 154.27 7.76 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.524 0.515 . . . . 1.8 110.514 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.586 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 36.2 mt -129.08 115.25 35.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.982 -0.554 . . . . 0.43 110.797 166.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.652 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 74.7 mtp180 -62.28 106.66 0.77 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.646 . . . . 3.13 110.539 175.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.548 ' HA ' ' HB3' ' A' ' 142' ' ' PRO . 73.5 ttt180 -69.88 140.47 88.87 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 106.828 -1.545 . . . . 6.16 106.828 164.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -48.12 125.13 11.3 Favored 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 121.309 1.339 . . . . 2.1 111.432 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 9.3 m-85 -128.63 123.41 33.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.824 -1.534 . . . . 1.83 107.248 176.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.05 74.17 5.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.444 1.116 . . . . 3.66 111.653 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.495 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 99.3 m-85 -122.03 142.89 37.5 Favored Pre-proline 0 C--N 1.306 -1.323 0 CA-C-N 113.904 -1.498 . . . . 3.54 110.076 172.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 37.7 Cg_exo -56.62 -32.45 90.41 Favored 'Trans proline' 0 CA--C 1.499 -1.251 0 C-N-CA 124.837 3.691 . . . . 4.48 113.494 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -81.2 -23.7 37.97 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.041 -0.981 . . . . 5.26 111.333 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 66.6 m -156.32 98.29 1.83 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.625 -0.716 . . . . 3.43 110.105 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -148.63 87.13 1.55 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 122.003 0.906 . . . . 3.34 110.077 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -134.36 -171.43 2.76 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.065 -1.425 . . . . 3.14 109.009 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.61 174.81 55.1 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 119.774 -1.203 . . . . 1.11 110.974 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 9.5 tt0 -58.25 148.78 26.09 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 114.268 -0.966 . . . . 1.86 111.938 173.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 70.0 t -151.93 128.89 2.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.091 -0.959 . . . . 0.41 109.191 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.746 ' HG2' ' CE ' ' A' ' 186' ' ' MET . 32.6 ttp180 -92.63 102.3 14.72 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.114 -0.948 . . . . 2.8 108.518 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.46 147.9 36.97 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.821 0.82 . . . . 0.29 111.859 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.536 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 10.1 tpt180 -114.36 100.68 8.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.929 -1.487 . . . . 1.71 110.318 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.666 HD21 HD21 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -88.87 96.03 10.54 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.736 -0.839 . . . . 0.69 108.736 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 117.38 31.67 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.125 0.964 . . . . 0.26 111.316 -171.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.724 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -89.88 135.74 33.46 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.225 -1.807 . . . . 0.72 110.487 -179.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -78.95 65.67 4.2 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.362 -1.718 . . . . 1.09 106.362 164.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.3 -99.32 1.18 Allowed Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 118.986 -1.578 . . . . 0.47 110.61 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.46 -24.86 42.13 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 113.075 0.768 . . . . 0.83 113.075 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -131.27 129.08 41.09 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.299 -0.96 . . . . 1.21 110.934 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.724 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.3 tt -53.14 129.32 30.76 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.457 -1.701 . . . . 0.64 110.049 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.68 -37.75 6.33 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.591 -0.731 . . . . 0.29 110.189 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.7 p -148.12 165.04 32.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.092 -0.504 . . . . 0.33 111.422 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.591 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.7 mm -117.53 149.01 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 105.226 -2.138 . . . . 0.76 105.226 163.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -138.89 128.98 32.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.461 0.648 . . . . 0.35 110.065 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.475 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 34.1 t-20 -80.97 102.84 10.4 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.829 -1.174 . . . . 1.77 107.829 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.746 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 38.0 mtm -66.35 -0.73 2.82 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 113.053 0.76 . . . . 0.55 113.053 -166.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 10.7 pt-20 -79.33 -40.95 29.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.127 0.965 . . . . 1.02 111.018 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.493 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 67.6 m-20 -112.27 -26.31 8.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.148 -1.387 . . . . 1.4 109.484 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 78.2 32.15 0.36 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.611 -2.086 . . . . 1.33 107.872 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 0.1 OUTLIER -91.43 164.55 13.78 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 113.471 -1.695 . . . . 2.28 109.119 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 76.1 mt-30 -85.05 136.02 33.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.491 -0.777 . . . . 1.36 110.132 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.591 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -107.3 90.99 3.47 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 118.86 -0.591 . . . . 1.18 110.177 -175.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.44 -59.2 0.0 OUTLIER Glycine 0 N--CA 1.47 0.91 0 C-N-CA 125.039 1.304 . . . . 1.28 116.268 147.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.445 ' HD2' ' NH1' ' A' ' 196' ' ' ARG . 0.3 OUTLIER -164.86 171.55 14.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.879 -1.661 . . . . 2.8 108.125 174.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.67 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -140.36 130.03 24.31 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.356 0.526 . . . . 0.6 109.66 162.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.645 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -120.43 130.53 54.38 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.667 -0.646 . . . . 4.77 110.659 -170.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.732 HD13 ' HG ' ' A' ' 127' ' ' LEU . 68.1 mt -136.55 171.37 14.59 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 113.799 1.037 . . . . 1.61 113.799 -166.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 199' ' ' PRO . 33.8 t70 -109.51 99.81 38.98 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 114.415 -1.266 . . . . 2.66 110.451 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 198' ' ' ASP . 10.5 Cg_endo -56.68 130.43 39.91 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.483 2.122 . . . . 2.01 112.999 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 130' ' ' ALA . 68.5 mtt85 . . . . . 0 C--O 1.242 0.703 0 CA-C-N 115.388 -0.824 . . . . 5.19 111.436 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.8 ptm . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.236 -0.283 . . . . 26.27 110.236 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.92 159.48 9.4 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.864 -0.684 . . . . 24.15 112.024 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.8 m 55.81 63.94 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 23.64 111.158 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.3 m -63.35 132.41 51.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 22.83 110.259 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -118.86 145.23 45.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.822 0.344 . . . . 22.11 110.587 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -79.11 88.36 4.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.97 -0.559 . . . . 22.07 110.631 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -88.23 37.66 0.82 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.034 -0.53 . . . . 20.59 110.734 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 69.86 90.83 0.09 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.275 -0.875 . . . . 18.44 112.683 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -87.09 -23.44 24.9 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.336 -0.616 . . . . 17.98 109.336 170.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -136.84 178.45 7.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.41 -0.814 . . . . 17.87 109.971 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.1 t -76.46 121.81 23.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.652 -0.499 . . . . 16.77 109.652 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.9 p -69.53 82.2 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.404 0.621 . . . . 16.32 111.162 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.08 -25.54 0.7 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.416 -0.811 . . . . 14.63 111.645 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -97.09 8.86 43.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.676 0.274 . . . . 15.68 110.732 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 58.0 t -65.88 118.56 53.16 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.85 -0.614 . . . . 12.69 110.375 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 101' ' ' VAL . 26.1 Cg_exo -62.14 161.64 25.81 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.082 2.521 . . . . 12.08 112.195 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -67.39 96.11 0.48 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 12.18 110.333 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.85 -11.84 70.32 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.486 -0.779 . . . . 8.55 111.675 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.2 m 64.02 -74.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.505 0.722 . . . . 8.07 111.018 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -137.09 87.92 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.949 -0.76 . . . . 7.76 108.949 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.539 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 59.7 mtt -73.39 -79.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.095 0.474 . . . . 6.12 110.825 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.67 -31.32 5.9 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-O 118.774 -1.015 . . . . 1.91 112.989 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 13.3 mtm180 14.15 80.74 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.922 1.289 . . . . 4.32 112.711 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.594 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 24.9 ttt -141.82 135.54 29.72 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.493 -0.776 . . . . 2.59 111.974 -168.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 ' HE1' ' A' ' 124' ' ' MET . 2.0 m -118.18 106.4 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-O 122.268 1.032 . . . . 0.74 112.953 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -160.1 106.73 1.59 Allowed 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 105.749 -1.945 . . . . 1.38 105.749 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.837 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 3.5 mp -97.13 111.41 23.66 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.474 -0.935 . . . . 1.33 108.474 -173.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 117' ' ' MET . 21.0 tt0 -143.72 107.38 5.05 Favored Pre-proline 0 C--N 1.299 -1.624 0 CA-C-N 114.963 -1.017 . . . . 1.93 110.549 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.509 ' HD3' HD12 ' A' ' 183' ' ' ILE . 29.5 Cg_exo -36.75 129.03 0.49 Allowed 'Trans proline' 0 CA--C 1.515 -0.427 0 C-N-CA 124.476 3.451 . . . . 0.65 113.427 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.9 t70 75.41 50.1 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.685 1.231 . . . . 0.72 109.768 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.649 ' HE3' HD13 ' A' ' 180' ' ' LEU . 13.1 ptt? -122.47 157.24 32.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 113.789 -1.551 . . . . 1.67 110.116 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.3 m -100.01 113.9 26.81 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.299 -1.0 . . . . 0.58 108.299 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -142.75 159.84 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 116.046 -0.524 . . . . 0.65 111.457 -165.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.483 ' H ' HG13 ' A' ' 119' ' ' ILE . 49.2 m -143.06 179.87 6.78 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.914 -0.314 . . . . 0.44 110.167 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.862 ' HG2' HG21 ' A' ' 147' ' ' VAL . 6.9 mtmp? -59.14 -28.12 66.27 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.677 -0.86 . . . . 2.33 108.677 166.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.608 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 4.4 t-20 -85.73 -17.34 36.19 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.996 -1.456 . . . . 1.32 114.446 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.594 ' HG3' ' HB3' ' A' ' 110' ' ' MET . 1.2 tp10 -84.39 -62.28 1.6 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.498 -1.297 . . . . 2.06 107.498 169.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.843 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 14.8 mmt -57.82 -15.81 9.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 112.627 -2.078 . . . . 3.13 111.765 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 14.6 p -43.19 -41.88 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 122.176 0.989 . . . . 0.37 110.191 175.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.737 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -69.27 -41.58 76.67 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.047 -1.433 . . . . 0.63 113.224 177.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.778 HD23 HD23 ' A' ' 128' ' ' LEU . 1.1 tt -49.41 -34.3 16.07 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.528 0.68 . . . . 1.79 111.387 167.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.843 ' HG ' ' O ' ' A' ' 124' ' ' MET . 13.9 mt -85.43 -32.53 22.27 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.158 -0.928 . . . . 0.38 108.824 -171.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -64.63 -36.53 84.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.11 -1.405 . . . . 1.96 109.814 167.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.7 -42.91 63.7 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.871 -1.513 . . . . 0.64 111.977 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -5.84 56.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 123.648 1.689 . . . . 0.59 106.991 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 58.33 55.51 4.97 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 110.761 -2.927 . . . . 1.8 112.473 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.665 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 3.2 t80 -139.56 176.73 8.48 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 113.126 0.787 . . . . 0.52 113.126 -177.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 145' ' ' PHE . 14.1 ptm180 -142.19 150.34 40.89 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.091 -1.078 . . . . 4.54 108.091 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 15.0 tm0? -50.37 143.37 8.94 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 114.802 1.408 . . . . 1.28 114.802 -166.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.835 HG23 HG22 ' A' ' 146' ' ' THR . 1.3 m -125.65 159.52 33.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 112.805 -1.998 . . . . 1.05 111.875 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -63.31 -35.79 81.52 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.68 1.229 . . . . 1.38 108.089 169.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 139' ' ' MET . 2.3 ttpt -159.34 132.98 7.28 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.348 -2.205 . . . . 1.44 109.521 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.589 ' HB2' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -118.6 135.42 54.45 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.262 -0.881 . . . . 0.9 111.199 176.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.569 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -156.9 97.61 1.7 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 122.954 1.359 . . . . 0.61 108.892 152.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.569 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -166.12 161.59 12.63 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 112.207 -2.27 . . . . 1.77 106.1 168.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.559 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 62.8 Cg_endo -75.67 128.17 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.209 1.273 . . . . 0.62 111.979 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.626 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 99.3 23.29 11.4 Favored Glycine 0 C--N 1.351 1.4 0 C-N-CA 119.975 -1.107 . . . . 0.51 112.35 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.665 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 15.4 mp0 -128.79 172.34 11.37 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.75 -0.463 . . . . 2.16 109.75 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.882 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.9 p90 -163.06 175.11 11.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 108.237 -1.023 . . . . 0.28 108.237 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.835 HG22 HG23 ' A' ' 136' ' ' VAL . 8.0 p -141.96 126.59 17.93 Favored 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 120.11 -0.636 . . . . 0.42 111.598 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.862 HG21 ' HG2' ' A' ' 121' ' ' LYS . 12.4 p -125.56 110.07 23.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.709 0.766 . . . . 0.34 111.849 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -110.03 -58.79 2.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.734 -0.666 . . . . 3.11 110.779 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -163.36 -60.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.922 0.341 . . . . 1.65 111.922 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -92.57 4.36 53.75 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.404 0.52 . . . . 1.68 112.404 -172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.7 p -161.08 155.93 23.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.683 0.754 . . . . 0.37 112.478 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 173' ' ' LEU . 43.7 mt -115.24 108.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 106.297 -1.742 . . . . 0.53 106.297 161.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.882 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.6 mp0 -90.59 163.98 14.37 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.521 -2.029 . . . . 1.13 105.521 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 8.7 ptp -165.07 154.31 12.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.83 0.706 . . . . 1.8 111.324 -171.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.675 HG12 ' HG3' ' A' ' 170' ' ' ARG . 34.6 mt -126.25 110.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 121.615 0.721 . . . . 0.43 111.141 170.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 0.2 OUTLIER -68.24 92.97 0.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.957 -1.474 . . . . 3.13 109.838 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.62 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 34.1 ttp180 -68.13 138.53 92.26 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 108.175 -1.046 . . . . 6.16 108.175 176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -47.88 123.77 8.99 Favored 'Trans proline' 0 N--CA 1.433 -2.067 0 C-N-CA 120.95 1.1 . . . . 2.1 109.971 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 19.6 m-85 -118.79 129.75 55.41 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.945 -1.48 . . . . 1.83 107.642 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 6.6 p-10 -86.58 76.69 9.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 122.763 1.268 . . . . 3.66 111.724 -173.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 92.2 m-85 -114.53 146.87 36.83 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 113.116 -1.856 . . . . 3.54 108.899 171.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.7 Cg_exo -59.76 -33.77 96.18 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 C-N-CA 124.528 3.485 . . . . 4.48 113.348 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -86.4 -18.51 31.6 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.999 -1.0 . . . . 5.26 111.425 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.465 ' HB2' ' OD1' ' A' ' 198' ' ' ASP . 67.3 m -156.07 109.44 2.7 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.839 -0.619 . . . . 3.43 111.216 -173.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 160' ' ' ASP . 23.4 tptp -142.62 97.0 3.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.601 -0.888 . . . . 3.34 108.601 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -138.93 176.62 8.53 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.627 -1.17 . . . . 3.14 112.469 -167.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.94 149.95 31.86 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 113.93 -1.486 . . . . 1.11 112.723 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.822 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.9 tt0 -56.26 153.51 9.36 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 113.419 0.896 . . . . 1.86 113.419 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 41.3 t -152.92 131.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.727 -1.124 . . . . 0.41 109.959 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.675 ' HG3' HG12 ' A' ' 155' ' ' ILE . 5.7 ttm180 -93.39 111.74 23.48 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.82 -0.807 . . . . 2.8 108.82 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.8 141.33 47.44 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.264 -0.974 . . . . 0.29 111.429 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 5.2 tpt180 -102.45 101.31 11.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.134 -1.394 . . . . 1.71 110.665 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -91.36 96.53 10.58 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.787 -0.365 . . . . 0.69 110.055 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 117.65 31.21 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-O 122.472 1.13 . . . . 0.26 111.494 -173.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -85.88 131.84 34.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 112.632 -2.076 . . . . 0.72 109.784 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.567 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 35.8 t70 -75.91 65.85 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.716 -1.587 . . . . 1.09 106.716 164.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.71 -99.26 1.74 Allowed Glycine 0 N--CA 1.428 -1.86 0 C-N-CA 119.104 -1.522 . . . . 0.47 110.223 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -88.54 -17.62 29.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 113.01 0.744 . . . . 0.83 113.01 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -133.28 126.62 31.86 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 119.163 -1.015 . . . . 1.21 110.693 -168.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.688 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.1 tt -52.93 129.47 30.47 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.458 -1.701 . . . . 0.64 110.629 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -38.34 6.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.992 -1.004 . . . . 0.29 109.755 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.1 p -147.72 157.69 43.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.819 -0.628 . . . . 0.33 111.245 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.8 mt -124.86 146.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.707 -1.96 . . . . 0.76 105.707 166.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 43.1 t -136.56 133.58 49.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.448 0.642 . . . . 0.35 109.947 -175.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 1.9 t-20 -79.43 94.0 5.47 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.712 -1.588 . . . . 1.77 106.712 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.572 ' SD ' ' HB2' ' A' ' 172' ' ' ARG . 47.6 mtm -66.38 -1.97 4.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.995 0.809 . . . . 0.55 113.095 -162.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.0 pt-20 -81.45 -39.29 25.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.127 0.965 . . . . 1.02 110.682 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.48 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 9.1 m120 -108.43 -26.46 10.46 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.779 -1.555 . . . . 1.4 109.117 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.5 t30 75.48 32.02 0.74 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 112.338 -2.21 . . . . 1.33 108.416 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.9 ptm180 -93.73 155.22 17.36 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 114.197 -1.365 . . . . 2.28 109.234 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -77.7 131.19 37.59 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.909 -1.041 . . . . 1.36 108.636 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.0 OUTLIER -105.63 89.53 3.12 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.469 -0.892 . . . . 1.18 110.548 -170.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -57.74 0.0 OUTLIER Glycine 0 N--CA 1.467 0.718 0 C-N-CA 125.376 1.465 . . . . 1.28 116.48 146.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.609 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 18.1 p90 -163.88 175.43 10.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.153 -1.523 . . . . 2.8 109.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.837 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.5 t80 -149.08 100.22 3.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.378 0.608 . . . . 0.6 110.445 159.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.609 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 5.2 mmm180 -95.63 141.87 28.61 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 120.628 -1.295 . . . . 4.77 111.666 -170.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.535 ' HG ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -109.82 173.33 6.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.202 1.556 . . . . 1.61 115.202 -175.381 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.554 ' HB3' ' HD2' ' A' ' 199' ' ' PRO . 5.2 m-20 -98.19 176.75 1.87 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 112.806 -1.997 . . . . 2.66 110.559 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 198' ' ' ASP . 36.9 Cg_exo -44.91 172.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 123.919 3.079 . . . . 2.01 116.12 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.565 ' OXT' ' HG2' ' A' ' 200' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.884 1.674 . . . . 5.19 112.91 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.723 0.297 . . . . 26.27 110.476 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.18 36.28 1.21 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.587 -0.816 . . . . 24.15 112.481 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.0 p -91.44 -50.51 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.068 0.461 . . . . 23.64 110.012 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.7 m -104.0 73.09 1.13 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.816 -0.629 . . . . 22.83 109.945 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.4 m80 67.2 108.83 0.04 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.284 -0.871 . . . . 22.11 111.296 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -74.07 11.6 0.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.786 -0.643 . . . . 22.07 111.684 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -84.67 -2.69 57.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.221 -0.659 . . . . 20.59 109.221 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -101.58 54.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 18.44 111.283 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -89.02 -43.73 10.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.333 . . . . 17.98 111.014 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -84.87 98.8 10.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.987 0.422 . . . . 17.87 109.94 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -74.88 134.0 41.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.954 -0.567 . . . . 16.77 111.388 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.6 m 56.82 50.85 11.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.628 -0.715 . . . . 16.32 111.435 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.22 13.74 0.15 Allowed Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.659 -0.7 . . . . 14.63 112.092 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.4 mt -116.05 -41.51 3.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.103 0.477 . . . . 15.68 110.283 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.482 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 56.9 t -81.34 -50.84 0.92 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.668 -0.696 . . . . 12.69 111.912 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 40.1 Cg_endo -66.74 105.81 1.0 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.035 1.823 . . . . 12.08 112.509 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.46 48.31 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.064 -0.717 . . . . 12.18 109.064 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.88 46.53 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.703 -0.681 . . . . 8.55 111.909 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.4 m -89.69 -9.08 50.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.092 0.472 . . . . 8.07 110.825 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -114.6 20.71 15.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.163 0.506 . . . . 7.76 109.678 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.51 ' HG3' ' OD1' ' A' ' 122' ' ' ASN . 13.2 tpt -102.57 55.87 0.78 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.603 -0.726 . . . . 6.12 110.618 -175.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.12 -34.3 0.3 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.696 -0.684 . . . . 1.91 114.14 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 107' ' ' MET . 0.0 OUTLIER 10.31 80.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.849 1.796 . . . . 4.32 115.849 170.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.673 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 16.7 tpt -139.35 117.01 11.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.035 -1.066 . . . . 2.59 112.65 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.634 ' HB ' HD12 ' A' ' 197' ' ' LEU . 15.9 m -111.5 107.41 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.42 1.105 . . . . 0.74 112.965 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.436 ' C ' HD12 ' A' ' 113' ' ' LEU . 40.3 t30 -160.14 136.16 8.58 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 113.667 -1.606 . . . . 1.38 106.985 168.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 9.0 mp -114.65 100.2 8.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.121 0.486 . . . . 1.33 109.829 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -156.93 97.54 2.08 Favored Pre-proline 0 N--CA 1.436 -1.156 0 CA-C-N 115.23 -0.895 . . . . 1.93 109.816 -169.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.849 ' CD ' ' HA2' ' A' ' 193' ' ' GLY . 9.6 Cg_exo -34.27 149.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.796 1 C-N-CA 127.396 5.398 . . . . 0.65 115.356 -173.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 29.1 t70 70.55 31.26 2.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.216 -1.356 . . . . 0.72 108.877 -174.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.6 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 8.3 ptp -110.27 154.15 23.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.691 -1.14 . . . . 1.67 109.733 175.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -106.51 76.61 1.14 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.849 -1.167 . . . . 0.58 107.849 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.627 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 1.5 tt -104.15 159.25 5.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.152 -1.386 . . . . 0.65 110.507 -165.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.488 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 37.7 m -141.76 179.91 6.57 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 119.738 -0.785 . . . . 0.44 110.425 -168.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.953 ' HG2' HG21 ' A' ' 147' ' ' VAL . 14.5 mttp -64.52 -20.77 66.42 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.025 -1.102 . . . . 2.33 108.025 169.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.672 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t30 -84.46 -25.05 29.22 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.11 -1.405 . . . . 1.32 113.936 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.673 ' HA ' ' H ' ' A' ' 110' ' ' MET . 27.5 mt-10 -86.45 -53.9 4.73 Favored 'General case' 0 N--CA 1.412 -2.369 0 O-C-N 120.694 -1.254 . . . . 2.06 108.671 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.826 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.1 mmt -60.62 -18.25 52.08 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 113.129 -1.85 . . . . 3.13 111.478 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.677 HG13 ' HE3' ' A' ' 126' ' ' LYS . 9.2 p -44.75 -44.17 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-O 121.953 0.882 . . . . 0.37 110.534 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.677 ' HE3' HG13 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -67.66 -41.98 82.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.297 -1.319 . . . . 0.63 113.082 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.564 HD23 ' HB3' ' A' ' 197' ' ' LEU . 2.9 tm? -50.67 -34.67 27.45 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.666 0.604 . . . . 1.79 110.415 169.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.826 ' HG ' ' O ' ' A' ' 124' ' ' MET . 16.3 mt -84.92 -36.74 21.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.659 0.743 . . . . 0.38 109.572 -170.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -64.02 -32.74 74.4 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.179 -1.373 . . . . 1.96 109.988 168.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 200' ' ' ARG . . . -76.59 -39.85 51.32 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.683 -1.599 . . . . 0.64 111.975 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.644 ' HA ' ' CZ ' ' A' ' 159' ' ' PHE . 0.3 OUTLIER -89.71 -5.3 57.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 124.021 1.867 . . . . 0.59 106.397 -178.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 58.35 51.57 8.17 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 110.488 -3.051 . . . . 1.8 112.361 170.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.826 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.6 t80 -135.47 175.4 9.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.278 0.561 . . . . 0.52 112.097 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -137.85 151.6 48.23 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.204 -1.406 . . . . 4.54 107.204 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.461 ' HB2' HG12 ' A' ' 147' ' ' VAL . 9.7 tm0? -49.67 138.45 14.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.686 1.231 . . . . 1.28 112.704 -170.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.66 ' CG1' HG22 ' A' ' 146' ' ' THR . 15.0 p -134.82 145.72 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 112.597 -2.092 . . . . 1.05 110.613 -162.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.97 -34.62 72.02 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.772 1.272 . . . . 1.38 109.493 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 11.2 ttpt -160.46 129.57 4.92 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 112.31 -2.223 . . . . 1.44 109.015 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.651 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -114.41 121.76 44.55 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.622 -0.717 . . . . 0.9 111.009 -179.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.429 ' HA ' HD11 ' A' ' 155' ' ' ILE . 1.7 t -158.14 98.39 1.58 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 122.946 1.355 . . . . 0.61 110.062 153.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.553 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.4 OUTLIER -164.42 161.82 15.74 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 112.552 -2.113 . . . . 1.77 106.328 163.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.512 ' HB3' ' NE2' ' A' ' 168' ' ' GLN . 38.4 Cg_exo -60.71 114.55 2.19 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 121.332 1.355 . . . . 0.62 111.569 173.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 104.6 32.53 4.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 120.396 -0.906 . . . . 0.51 113.625 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.826 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -131.48 169.84 15.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.697 -0.482 . . . . 2.16 109.697 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.851 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.7 p90 -167.35 165.74 14.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.982 -1.118 . . . . 0.28 107.982 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.66 HG22 ' CG1' ' A' ' 136' ' ' VAL . 17.2 p -134.47 126.86 30.3 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.743 -0.783 . . . . 0.42 111.05 173.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.953 HG21 ' HG2' ' A' ' 121' ' ' LYS . 10.5 p -116.81 112.28 38.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.591 0.71 . . . . 0.34 111.242 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.74 132.75 3.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.361 -0.836 . . . . 3.11 111.101 -176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 58.56 -88.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.474 0.916 . . . . 1.65 113.474 172.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -124.57 23.0 8.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.526 0.565 . . . . 1.68 112.526 -170.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.1 p -160.27 149.72 17.63 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.826 1.047 . . . . 0.37 113.826 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 147' ' ' VAL . 28.8 mt -113.33 107.57 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 CA-C-N 113.392 -1.731 . . . . 0.53 106.56 159.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.851 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 4.2 mt-10 -92.73 170.16 9.92 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.871 -1.9 . . . . 1.13 105.871 175.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 20.7 ptp -167.6 166.32 14.1 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 123.887 0.742 . . . . 1.8 109.708 -171.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.805 HG22 ' HG2' ' A' ' 168' ' ' GLN . 6.4 mt -128.0 92.47 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.984 0.897 . . . . 0.43 108.733 165.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.901 ' HG2' HD22 ' A' ' 197' ' ' LEU . 12.3 tpp180 -128.48 85.18 2.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.738 -1.573 . . . . 3.13 112.28 -168.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.816 ' H ' ' HG3' ' A' ' 168' ' ' GLN . 6.0 mmt180 -136.56 -179.06 0.97 Allowed Pre-proline 0 C--N 1.276 -2.615 0 N-CA-C 106.821 -1.548 . . . . 6.16 106.821 158.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.67 ' CB ' ' HB2' ' A' ' 166' ' ' GLU . 73.9 Cg_exo -39.95 132.63 1.97 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 122.471 2.114 . . . . 2.1 114.519 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.644 ' CZ ' ' HA ' ' A' ' 131' ' ' THR . 25.5 m-85 -95.68 167.69 11.13 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.774 -2.466 . . . . 1.83 108.628 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -74.56 76.47 1.98 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 122.042 0.925 . . . . 3.66 111.282 174.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 159' ' ' PHE . 59.2 m-85 -90.38 149.0 40.25 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 114.166 -1.379 . . . . 3.54 108.266 169.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.78 -36.26 81.77 Favored 'Trans proline' 0 CA--C 1.491 -1.674 0 C-N-CA 124.434 3.422 . . . . 4.48 112.736 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -98.71 -11.87 21.54 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 113.9 -1.5 . . . . 5.26 111.1 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 56.7 m -162.7 107.85 1.16 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.565 -0.743 . . . . 3.43 110.386 -173.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.571 ' HB3' ' HA ' ' A' ' 160' ' ' ASP . 13.8 ptpt -134.15 105.53 6.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.796 0.807 . . . . 3.34 110.138 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.67 ' HB2' ' CB ' ' A' ' 158' ' ' PRO . 7.1 mm-40 -129.73 -173.62 3.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.625 -1.171 . . . . 3.14 111.457 -177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -81.37 127.69 8.05 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-N 114.299 -1.319 . . . . 1.11 113.103 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.816 ' HG3' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -80.12 170.44 16.44 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 112.945 0.72 . . . . 1.86 112.945 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 1.9 t -137.05 132.9 47.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 112.966 0.728 . . . . 0.41 112.966 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 154' ' ' MET . 20.9 ttt180 -88.03 110.11 20.36 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 116.128 -0.487 . . . . 2.8 109.738 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.44 138.67 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.735 0.779 . . . . 0.29 111.661 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.772 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 12.9 tpt180 -103.17 99.57 9.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.181 -1.372 . . . . 1.71 111.088 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 5.8 mp -91.26 104.5 17.04 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 109.388 -0.597 . . . . 0.69 109.388 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.7 114.64 28.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.656 1.217 . . . . 0.26 111.849 -173.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -86.12 131.32 34.28 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 112.516 -2.129 . . . . 0.72 109.45 -178.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.557 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 35.3 t70 -75.61 67.27 2.07 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.634 -1.617 . . . . 1.09 106.634 165.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.37 -98.76 1.27 Allowed Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 119.017 -1.563 . . . . 0.47 110.281 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -82.89 -24.59 33.1 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.852 0.686 . . . . 0.83 112.852 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.557 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 8.0 p-80 -131.74 126.42 34.42 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 119.717 -0.793 . . . . 1.21 111.374 -165.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.7 tt -53.35 127.9 26.44 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.661 -1.608 . . . . 0.64 111.058 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 115' ' ' PRO . . . -108.14 -38.91 5.64 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.869 -1.059 . . . . 0.29 110.516 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.439 ' O ' HG13 ' A' ' 183' ' ' ILE . 24.0 p -146.03 168.46 20.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.26 -0.427 . . . . 0.33 111.12 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.772 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 2.4 mt -140.82 143.12 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 105.748 -1.945 . . . . 0.76 105.748 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 52.7 t -137.06 136.35 47.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.228 0.537 . . . . 0.35 110.154 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.526 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 36.0 t-20 -86.29 100.58 12.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 108.088 -1.079 . . . . 1.77 108.088 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.463 ' CE ' ' HG2' ' A' ' 170' ' ' ARG . 39.1 mtm -64.34 -2.38 2.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 114.021 1.119 . . . . 0.55 114.021 -165.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.526 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.7 pt-20 -80.82 -44.13 18.94 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.861 0.838 . . . . 1.02 110.79 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.505 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 86.5 m-20 -106.45 -25.57 11.81 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.997 -1.456 . . . . 1.4 108.942 -176.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 73.2 27.8 1.93 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 112.326 -2.215 . . . . 1.33 107.599 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.476 ' HD2' HD22 ' A' ' 188' ' ' ASN . 0.1 OUTLIER -84.12 166.81 17.33 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 113.478 -1.692 . . . . 2.28 108.823 178.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -88.25 145.2 26.0 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.715 1.245 . . . . 1.36 112.67 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.626 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 1.7 m-85 -116.46 -169.34 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 112.282 -2.235 . . . . 1.18 105.359 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.849 ' HA2' ' CD ' ' A' ' 115' ' ' PRO . . . 134.94 -0.72 3.72 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.256 -1.138 . . . . 1.28 110.256 -163.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -148.65 97.63 2.76 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.138 -1.531 . . . . 2.8 108.369 154.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.596 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.3 t80 -132.15 118.96 20.26 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.004 -0.739 . . . . 0.6 109.004 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.422 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 9.0 mmt180 -105.81 142.49 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.941 -0.392 . . . . 4.77 109.941 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.901 HD22 ' HG2' ' A' ' 156' ' ' ARG . 33.7 mt -113.42 154.19 27.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.933 -0.576 . . . . 1.61 111.404 -171.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.675 ' HB3' ' NH1' ' A' ' 156' ' ' ARG . 13.4 t70 -94.72 112.11 56.75 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.297 -0.631 . . . . 2.66 109.297 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 198' ' ' ASP . 11.9 Cg_endo -57.41 125.77 19.87 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.893 2.395 . . . . 2.01 113.679 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 130' ' ' ALA . 2.0 mpp_? . . . . . 0 C--O 1.248 1.02 0 O-C-N 124.589 1.181 . . . . 5.19 113.081 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.778 0.323 . . . . 26.27 110.783 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.8 -106.81 2.98 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.769 -0.729 . . . . 24.15 112.406 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.5 t -84.77 73.34 10.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.296 0.57 . . . . 23.64 110.181 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 t -79.6 104.43 10.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.652 -0.704 . . . . 22.83 109.689 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -83.53 85.17 7.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 22.11 111.198 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -83.27 114.43 21.38 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.558 -0.534 . . . . 22.07 109.558 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -79.61 128.3 33.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.369 -0.378 . . . . 20.59 110.566 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 61.31 43.36 10.8 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.62 0.575 . . . . 18.44 110.267 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -78.08 121.16 23.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.917 -0.583 . . . . 17.98 110.268 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -91.25 103.41 16.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.852 -0.613 . . . . 17.87 109.983 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.1 t -81.23 -26.05 36.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.207 -0.451 . . . . 16.77 110.258 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.1 m 61.36 -171.17 0.15 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.567 -0.742 . . . . 16.32 111.234 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.423 ' H ' HD12 ' A' ' 100' ' ' LEU . . . -161.39 35.61 0.39 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.744 -0.741 . . . . 14.63 112.363 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD12 ' H ' ' A' ' 99' ' ' GLY . 5.1 mp -118.7 -97.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.605 -0.517 . . . . 15.68 109.605 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.476 ' HB ' ' CD ' ' A' ' 102' ' ' PRO . 94.9 t -83.68 -52.89 0.57 Allowed Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.57 -0.9 . . . . 12.69 108.57 169.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 101' ' ' VAL . 58.3 Cg_endo -74.05 128.91 12.69 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.486 1.458 . . . . 12.08 110.026 164.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -152.64 36.34 0.5 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.303 0.573 . . . . 12.18 110.153 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.55 -149.92 35.82 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.653 -0.784 . . . . 8.55 111.365 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.4 t 66.3 -78.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.615 0.366 . . . . 8.07 111.045 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -105.83 92.32 4.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.975 0.417 . . . . 7.76 110.028 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.1 mtt -90.71 -177.79 5.09 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.489 -0.56 . . . . 6.12 109.489 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.13 13.17 69.3 Favored Glycine 0 C--O 1.216 -0.982 0 C-N-CA 120.226 -0.988 . . . . 1.91 112.578 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 52.6 mtm180 -131.0 113.74 14.34 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 107.818 -1.179 . . . . 4.32 107.818 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.52 ' O ' ' HB2' ' A' ' 126' ' ' LYS . 12.4 tpt -143.69 159.74 41.95 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.068 -1.053 . . . . 2.59 113.589 -166.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.749 HG12 ' N ' ' A' ' 127' ' ' LEU . 2.6 m -133.33 102.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 122.637 1.208 . . . . 0.74 109.475 159.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -164.22 111.6 1.1 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.691 -1.141 . . . . 1.38 108.194 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.682 ' HB3' HD13 ' A' ' 183' ' ' ILE . 4.4 mt -96.4 103.87 15.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.498 -0.481 . . . . 1.33 110.009 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.62 ' H ' ' HE2' ' A' ' 117' ' ' MET . 25.3 tt0 -155.88 106.15 2.12 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 119.817 -0.753 . . . . 1.93 110.63 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.586 ' HD3' ' CA ' ' A' ' 193' ' ' GLY . 18.8 Cg_exo -35.33 144.91 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.78 1 C-N-CA 125.94 4.426 . . . . 0.65 115.721 -175.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.5 t70 67.74 40.19 2.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.055 -1.43 . . . . 0.72 109.536 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.633 ' HE3' HD13 ' A' ' 180' ' ' LEU . 10.9 ptt? -113.63 154.05 27.85 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.438 -1.255 . . . . 1.67 109.416 172.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -102.9 93.08 4.85 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.98 -1.119 . . . . 0.58 107.98 -173.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.656 HD13 ' HE2' ' A' ' 124' ' ' MET . 2.2 tt -126.54 162.05 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 114.601 -1.181 . . . . 0.65 110.945 -163.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.587 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.8 m -142.55 179.36 7.01 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.771 -0.826 . . . . 0.44 108.771 -169.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.855 ' HG2' HG21 ' A' ' 147' ' ' VAL . 13.0 mtpp -53.95 -35.24 61.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.06 -0.718 . . . . 2.33 109.06 166.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.937 ' O ' HG12 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -81.87 -32.52 31.01 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.433 -1.258 . . . . 1.32 112.623 -177.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.592 ' CB ' HG13 ' A' ' 119' ' ' ILE . 19.8 mt-10 -85.5 -20.7 29.29 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 119.653 -1.905 . . . . 2.06 109.167 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.764 ' HG3' HD12 ' A' ' 152' ' ' ILE . 18.7 mmt -85.4 -18.72 32.86 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.072 -1.422 . . . . 3.13 110.881 166.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.937 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.6 p -54.12 -36.28 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 CA-C-O 121.749 0.785 . . . . 0.37 111.285 -168.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.921 ' HE3' HG13 ' A' ' 125' ' ' VAL . 1.5 mmpt? -71.44 -40.2 70.54 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.787 -1.097 . . . . 0.63 112.0 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.749 ' N ' HG12 ' A' ' 111' ' ' VAL . 1.5 tm? -49.57 -36.05 22.53 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.777 0.798 . . . . 1.79 109.163 166.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' A' ' 124' ' ' MET . 24.4 mt -86.11 -34.35 20.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.394 -0.821 . . . . 0.38 110.08 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 126' ' ' LYS . 2.9 tp10 -58.76 -34.89 71.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.184 -1.371 . . . . 1.96 109.216 167.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -73.69 -37.79 65.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.508 -1.678 . . . . 0.64 112.128 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 128' ' ' LEU . 10.8 t -89.18 -5.26 57.85 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 123.819 1.771 . . . . 0.59 107.079 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 56.82 53.26 8.41 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 111.048 -2.796 . . . . 1.8 112.71 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.777 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.1 t80 -136.37 176.99 8.19 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.209 -0.597 . . . . 0.52 112.181 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.409 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 41.5 ttt180 -134.37 155.24 50.61 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.603 -1.258 . . . . 4.54 107.603 172.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' A' ' 135' ' ' GLN . 0.2 OUTLIER -50.42 140.24 14.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 122.623 1.201 . . . . 1.28 112.89 -169.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.774 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.7 p -141.14 136.46 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 112.77 -2.014 . . . . 1.05 109.487 -166.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.5 t -59.43 -30.9 68.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 122.46 1.124 . . . . 1.38 109.578 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -159.22 120.12 3.24 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 112.858 -1.974 . . . . 1.44 108.95 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.657 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -111.22 120.63 42.93 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.074 -1.421 . . . . 0.9 110.167 -177.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.28 96.17 2.02 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.275 1.512 . . . . 0.61 109.067 157.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.566 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.2 OUTLIER -166.69 163.04 11.2 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 111.586 -2.552 . . . . 1.77 105.124 165.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.622 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 56.2 Cg_endo -71.6 127.8 13.6 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 CA-C-N 120.63 1.261 . . . . 0.62 111.791 174.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.75 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 97.03 30.12 7.64 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 120.381 -0.914 . . . . 0.51 113.909 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.777 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.3 mp0 -128.0 174.46 9.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.295 0.547 . . . . 2.16 110.125 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.897 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 p90 -169.06 163.93 11.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.273 -1.01 . . . . 0.28 108.273 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.736 HG22 HG13 ' A' ' 136' ' ' VAL . 22.3 p -132.86 126.35 32.02 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.176 -0.609 . . . . 0.42 110.956 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.855 HG21 ' HG2' ' A' ' 121' ' ' LYS . 6.1 p -112.18 110.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 120.026 -0.669 . . . . 0.34 111.801 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -132.45 43.58 2.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.433 -0.803 . . . . 3.11 111.456 -174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.54 -54.34 0.67 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.531 0.937 . . . . 1.65 113.531 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -80.98 -15.09 57.19 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.393 0.616 . . . . 1.68 110.288 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.2 p -164.74 154.6 13.69 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.154 -0.93 . . . . 0.37 111.441 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.764 HD12 ' HG3' ' A' ' 124' ' ' MET . 28.4 mt -114.67 110.87 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 113.496 -1.683 . . . . 0.53 106.555 164.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.897 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -88.95 174.87 7.68 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.53 -1.656 . . . . 1.13 106.53 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 28.2 ptm -168.89 159.34 9.45 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 123.501 0.501 . . . . 1.8 110.734 -172.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.4 mt -130.92 110.17 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.098 -0.501 . . . . 0.43 111.321 167.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.763 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 1.4 tpt180 -65.52 91.27 0.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.605 -0.725 . . . . 3.13 110.042 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.75 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 66.9 ttt180 -64.25 133.65 95.71 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 114.978 -1.01 . . . . 6.16 108.525 172.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.78 124.45 14.57 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 120.815 1.01 . . . . 2.1 110.601 170.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.614 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 9.3 m-85 -124.92 126.56 45.71 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.227 -1.768 . . . . 1.83 106.227 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.75 75.88 6.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.893 1.33 . . . . 3.66 111.515 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.483 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 65.8 m-85 -119.47 142.89 33.47 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 113.453 -1.703 . . . . 3.54 109.039 171.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.4 Cg_exo -57.58 -30.88 90.1 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 124.648 3.565 . . . . 4.48 113.096 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.27 -14.98 34.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.046 -0.979 . . . . 5.26 111.286 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.451 ' HB3' HH12 ' A' ' 156' ' ' ARG . 58.8 m -161.65 100.56 1.16 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.001 -0.545 . . . . 3.43 111.274 -174.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 86.4 tttt -147.48 97.28 2.82 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.674 0.75 . . . . 3.34 110.014 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -132.81 161.83 33.11 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.557 -1.201 . . . . 3.14 111.43 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.94 151.54 32.02 Favored Glycine 0 CA--C 1.498 -1.017 0 CA-C-N 114.21 -1.359 . . . . 1.11 111.374 172.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.763 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.3 tt0 -44.87 142.1 1.91 Allowed 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 115.203 1.556 . . . . 1.86 115.203 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 51.1 t -153.5 125.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 113.748 -1.569 . . . . 0.41 110.448 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HG3' HG12 ' A' ' 155' ' ' ILE . 4.1 ttm180 -84.52 110.63 18.83 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.467 -0.568 . . . . 2.8 109.467 168.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HB3' ' CG ' ' A' ' 154' ' ' MET . . . -116.27 147.71 41.23 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.729 -0.788 . . . . 0.29 111.603 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.785 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.4 tpp180 -109.77 98.97 8.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.552 -1.203 . . . . 1.71 110.84 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.686 HD23 ' CE ' ' A' ' 124' ' ' MET . 1.4 mp -88.7 94.34 9.87 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.438 -0.949 . . . . 0.69 108.438 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.02 120.45 35.24 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 122.443 1.116 . . . . 0.26 111.672 -170.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-30 -90.91 130.07 36.89 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 112.746 -2.025 . . . . 0.72 109.962 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.57 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . 30.7 t70 -78.68 64.83 3.78 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.224 -1.769 . . . . 1.09 106.224 165.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.99 -99.7 0.96 Allowed Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 119.332 -1.414 . . . . 0.47 110.735 -175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.65 -25.54 49.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.865 0.691 . . . . 0.83 112.865 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 6.8 p-80 -133.84 127.18 32.08 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.917 -0.713 . . . . 1.21 110.587 -167.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.0 tt -54.75 130.85 42.25 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.126 -1.397 . . . . 0.64 110.194 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.15 -39.16 6.04 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.93 -1.032 . . . . 0.29 109.827 -176.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.8 p -152.56 169.51 22.47 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.029 -0.532 . . . . 0.33 111.244 -173.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.785 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mt -135.81 144.34 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.191 -2.151 . . . . 0.76 105.191 167.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 47.5 t -138.64 140.17 39.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 117.992 0.36 . . . . 0.35 110.296 -174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.606 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 37.5 t-20 -81.15 107.91 14.35 Favored 'General case' 0 CA--C 1.481 -1.682 0 N-CA-C 107.32 -1.363 . . . . 1.77 107.32 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.431 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 59.3 mtm -69.16 -1.52 8.04 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 112.586 0.587 . . . . 0.55 112.586 -166.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.606 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 12.1 pt-20 -85.26 -44.54 12.79 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.753 0.787 . . . . 1.02 111.237 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.533 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.7 m-20 -106.37 -26.09 11.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.513 -1.222 . . . . 1.4 109.093 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 188' ' ' ASN . 13.7 t30 77.31 31.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.536 -2.12 . . . . 1.33 107.304 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.458 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 4.6 ptm180 -89.0 159.24 17.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.736 -1.575 . . . . 2.28 108.889 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.75 149.77 25.53 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.208 1.004 . . . . 1.36 112.732 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.92 -174.04 3.48 Favored 'General case' 0 CA--C 1.472 -2.039 0 CA-C-N 113.246 -1.797 . . . . 1.18 107.754 -173.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.618 ' HA2' HD12 ' A' ' 183' ' ' ILE . . . 129.9 24.92 0.94 Allowed Glycine 1 N--CA 1.393 -4.177 0 CA-C-N 114.101 -1.409 . . . . 1.28 112.725 -178.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -139.36 94.69 2.82 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.452 -1.874 . . . . 2.8 106.824 145.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.679 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -129.99 101.36 5.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.693 -0.854 . . . . 0.6 108.693 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 3.2 mpt_? -105.35 127.36 52.93 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.191 0.52 . . . . 4.77 110.888 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.595 HD12 HD22 ' A' ' 127' ' ' LEU . 4.5 mt -104.15 172.55 6.74 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.434 -0.803 . . . . 1.61 111.9 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.25 104.51 9.92 Favored Pre-proline 0 N--CA 1.445 -0.718 0 CA-C-N 114.268 -1.333 . . . . 2.66 108.66 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.96 125.14 17.32 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.042 2.494 . . . . 2.01 113.144 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.409 ' NE ' ' HD3' ' A' ' 126' ' ' LYS . 6.5 mpt_? . . . . . 0 C--O 1.242 0.691 0 CA-C-N 115.262 -0.881 . . . . 5.19 110.986 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.026 -0.361 . . . . 26.27 110.026 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.54 -107.12 2.04 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.918 -0.658 . . . . 24.15 111.486 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.6 m -92.07 162.99 14.13 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.715 -0.476 . . . . 23.64 109.715 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.2 p -62.91 -70.76 0.19 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.588 0.233 . . . . 22.83 110.729 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.8 t60 51.77 67.76 0.91 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.783 -0.644 . . . . 22.11 110.396 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -88.0 133.84 33.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.196 0.522 . . . . 22.07 110.674 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.61 121.74 25.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.549 -0.75 . . . . 20.59 110.861 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -114.79 21.6 14.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.278 0.561 . . . . 18.44 110.405 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 99' ' ' GLY . 55.8 m-70 -133.83 71.54 1.46 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.473 -0.785 . . . . 17.98 109.608 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -72.24 -65.76 0.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.771 -0.65 . . . . 17.87 111.492 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.2 m -92.0 -45.7 8.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.88 0.371 . . . . 16.77 110.747 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.7 m -108.59 135.29 50.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.324 -0.398 . . . . 16.32 110.638 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 95' ' ' HIS . . . 103.51 102.12 2.7 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.832 -0.699 . . . . 14.63 111.55 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.2 tp -86.97 -32.4 20.1 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.948 0.404 . . . . 15.68 110.522 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.4 m -86.14 133.54 40.66 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.041 -0.527 . . . . 12.69 111.688 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.22 78.91 2.74 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.768 2.312 . . . . 12.08 111.904 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -83.55 158.91 21.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.01 -0.541 . . . . 12.18 110.489 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.63 -156.27 8.27 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.403 -0.679 . . . . 8.55 111.403 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.6 t -82.78 60.27 5.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.388 0.613 . . . . 8.07 110.087 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -130.64 41.9 3.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.725 -0.67 . . . . 7.76 109.401 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.577 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 54.4 ttm 66.45 -86.88 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.195 -0.911 . . . . 6.12 110.876 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.52 ' C ' ' HD3' ' A' ' 109' ' ' ARG . . . 105.42 -29.28 11.77 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-O 118.955 -0.914 . . . . 1.91 113.543 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.52 ' HD3' ' C ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER 14.21 79.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.731 1.382 . . . . 4.32 114.731 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.509 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 34.7 ttp -142.45 124.86 15.63 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.35 -0.94 . . . . 2.59 111.793 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.9 m -110.7 104.91 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 CA-C-O 122.817 1.294 . . . . 0.74 113.128 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -160.01 109.9 1.83 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 112.587 -2.097 . . . . 1.38 106.054 165.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.808 HD21 HD21 ' A' ' 173' ' ' LEU . 4.3 mp -99.51 123.69 44.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.825 -0.805 . . . . 1.33 108.825 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -152.22 100.37 2.83 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.499 -0.926 . . . . 1.93 108.499 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.489 ' HD3' HD12 ' A' ' 183' ' ' ILE . 24.5 Cg_exo -35.43 137.66 0.15 Allowed 'Trans proline' 0 C--O 1.235 0.366 1 C-N-CA 125.361 4.041 . . . . 0.65 114.314 -173.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.2 47.57 0.28 Allowed 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 122.488 1.137 . . . . 0.72 109.795 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.504 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 5.8 ptp -122.36 156.31 34.22 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.537 -1.211 . . . . 1.67 110.867 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.2 m -102.7 77.74 1.63 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.334 1.064 . . . . 0.58 108.471 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.509 HG22 ' HB2' ' A' ' 180' ' ' LEU . 15.2 tt -106.7 168.34 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 113.287 -1.779 . . . . 0.65 109.482 -171.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.513 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.8 m -137.59 162.9 32.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.223 -0.591 . . . . 0.44 109.464 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.649 ' HG2' HG21 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.34 -26.52 4.97 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 122.009 0.909 . . . . 2.33 108.817 170.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.695 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 4.0 t-20 -82.79 -14.69 53.94 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.826 -1.988 . . . . 1.32 114.535 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.513 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -84.7 -63.63 1.3 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.74 -1.225 . . . . 2.06 109.969 168.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.706 ' CE ' HD23 ' A' ' 173' ' ' LEU . 0.0 OUTLIER -64.28 -9.87 20.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.074 -0.966 . . . . 3.13 110.727 174.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.695 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 12.4 p -41.7 -41.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.853 0.835 . . . . 0.37 110.62 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.503 ' CE ' HG13 ' A' ' 125' ' ' VAL . 9.3 mmpt? -66.13 -37.31 85.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.807 -1.088 . . . . 0.63 113.116 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.808 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.5 tm? -54.2 -33.58 58.54 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.618 0.723 . . . . 1.79 109.894 167.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.763 ' HB3' ' CE2' ' A' ' 145' ' ' PHE . 15.9 mt -82.44 -34.96 27.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.452 -0.944 . . . . 0.38 108.452 -172.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -60.14 -39.33 85.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.843 -1.526 . . . . 1.96 109.943 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.612 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -70.32 -42.76 71.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.989 -1.459 . . . . 0.64 112.544 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.446 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -88.6 -0.62 57.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 124.284 1.992 . . . . 0.59 105.812 -177.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 130' ' ' ALA . 11.5 mm-40 57.01 49.51 13.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 110.628 -2.987 . . . . 1.8 111.856 170.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.993 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 1.9 t80 -141.31 174.49 10.49 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 119.484 -0.886 . . . . 0.52 113.198 -173.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 23.4 ptt-85 -137.49 158.15 45.01 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.142 -1.39 . . . . 4.54 107.585 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.69 140.42 14.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.194 0.997 . . . . 1.28 112.523 -171.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.805 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.9 p -139.85 134.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 113.512 -1.676 . . . . 1.05 110.192 -163.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m -58.02 -33.36 68.89 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.7 1.238 . . . . 1.38 109.602 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.589 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -160.14 131.35 5.82 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 112.308 -2.224 . . . . 1.44 107.801 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.541 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 1.4 ptt? -119.0 137.93 53.18 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 115.023 -0.99 . . . . 0.9 111.127 -174.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.49 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -162.31 98.58 1.03 Allowed 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 122.34 1.067 . . . . 0.61 109.846 152.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.423 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -167.62 155.75 8.5 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 113.371 -1.74 . . . . 1.77 106.74 163.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.522 ' HA ' HG22 ' A' ' 155' ' ' ILE . 19.0 Cg_endo -61.27 119.62 6.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.051 1.167 . . . . 0.62 110.017 169.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.45 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 93.67 44.17 3.73 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 119.476 -1.345 . . . . 0.51 112.744 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.993 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.4 mt-10 -145.57 148.85 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.326 -0.99 . . . . 2.16 108.326 172.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.805 ' O ' HG12 ' A' ' 136' ' ' VAL . 40.7 p90 -152.85 156.78 39.65 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 108.758 -0.83 . . . . 0.28 108.758 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.75 HG22 HG13 ' A' ' 136' ' ' VAL . 21.3 p -126.04 126.28 43.99 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.679 -0.692 . . . . 0.42 110.663 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.649 HG21 ' HG2' ' A' ' 121' ' ' LYS . 9.1 p -125.08 109.88 23.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.966 -1.016 . . . . 0.34 111.511 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -110.27 -66.1 1.1 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.17 -0.468 . . . . 3.11 110.775 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -152.39 -61.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.076 0.399 . . . . 1.65 112.076 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -93.13 -1.78 56.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.615 0.598 . . . . 1.68 112.615 -171.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 11.4 p -163.28 152.6 14.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.529 0.937 . . . . 0.37 113.529 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.533 HD12 ' CG ' ' A' ' 124' ' ' MET . 20.7 mt -109.97 110.94 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 113.508 -1.678 . . . . 0.53 107.259 164.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -97.92 107.43 19.92 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.857 -1.164 . . . . 1.13 107.857 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 7.9 ptm -115.7 139.42 50.15 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.625 0.726 . . . . 1.8 112.124 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.64 HG23 ' HG3' ' A' ' 168' ' ' GLN . 68.4 mt -99.13 108.06 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 114.636 -1.165 . . . . 0.43 109.535 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.72 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 37.9 ttp180 -68.22 97.14 0.69 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.689 -1.141 . . . . 3.13 109.978 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.466 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 33.0 ttp180 -56.15 142.11 67.4 Favored Pre-proline 0 CA--C 1.514 -0.417 0 N-CA-C 107.264 -1.384 . . . . 6.16 107.264 169.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -46.72 124.92 8.97 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 120.981 1.121 . . . . 2.1 110.459 172.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 25.4 m-85 -120.95 131.64 54.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.933 -1.485 . . . . 1.83 108.523 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -89.13 76.6 7.7 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.43 1.109 . . . . 3.66 112.46 -169.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.65 ' HB2' ' O ' ' A' ' 164' ' ' SER . 96.2 m-85 -78.74 142.58 61.36 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 113.952 -1.477 . . . . 3.54 108.07 164.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 34.5 Cg_exo -58.2 -36.39 97.85 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 124.219 3.279 . . . . 4.48 112.37 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -99.84 -10.5 21.7 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.073 -0.967 . . . . 5.26 111.561 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.65 ' O ' ' HB2' ' A' ' 161' ' ' PHE . 20.2 m -150.72 99.82 2.77 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.347 0.499 . . . . 3.43 112.347 -167.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -142.57 105.35 4.52 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.91 -0.774 . . . . 3.34 108.91 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -135.93 -170.67 2.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.67 -1.15 . . . . 3.14 110.649 -167.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.42 179.6 52.89 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.4 -1.273 . . . . 1.11 111.931 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.72 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -55.37 158.63 3.1 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 113.464 -1.368 . . . . 1.86 113.386 175.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.455 ' N ' ' HG2' ' A' ' 168' ' ' GLN . 44.0 t -151.21 128.7 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 114.834 -1.075 . . . . 0.41 109.192 173.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HG3' HG12 ' A' ' 155' ' ' ILE . 32.6 mtm180 -91.14 109.35 20.6 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 120.941 0.4 . . . . 2.8 110.386 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -114.15 134.14 55.1 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.956 0.884 . . . . 0.29 111.544 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.8 tpp180 -95.0 98.04 10.4 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 113.569 -1.651 . . . . 1.71 110.75 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.808 HD21 HD21 ' A' ' 113' ' ' LEU . 2.8 mp -86.21 93.28 9.01 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.079 -0.711 . . . . 0.69 109.079 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.24 114.25 25.92 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 122.012 0.911 . . . . 0.26 111.497 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.4 m-85 -87.02 131.48 34.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.446 -1.707 . . . . 0.72 110.197 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.7 t70 -77.38 65.38 2.93 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.567 -1.642 . . . . 1.09 106.567 164.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.29 -98.54 1.25 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.911 -1.614 . . . . 0.47 110.379 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.71 -22.93 37.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.906 0.706 . . . . 0.83 112.906 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -133.89 128.42 34.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 119.685 -0.806 . . . . 1.21 111.431 -168.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 5.6 tt -52.77 125.93 18.39 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.899 -1.5 . . . . 0.64 109.648 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.11 -37.74 6.51 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.408 -0.814 . . . . 0.29 109.442 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.4 p -146.13 161.23 40.65 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.533 -0.758 . . . . 0.33 111.001 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 20.4 mt -128.59 145.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.214 -2.143 . . . . 0.76 105.214 167.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.6 t -142.22 132.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 121.392 0.615 . . . . 0.35 109.998 -172.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 32.3 t-20 -79.21 105.26 10.41 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 107.495 -1.298 . . . . 1.77 107.495 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.514 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 38.6 mtm -66.95 -1.48 4.1 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.782 0.676 . . . . 0.55 112.642 -167.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.59 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.9 pt-20 -79.71 -44.14 21.35 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.85 0.833 . . . . 1.02 110.819 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.59 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 70.6 m-20 -107.49 -26.59 10.86 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 114.293 -1.321 . . . . 1.4 109.454 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 188' ' ' ASN . 53.8 t30 77.02 33.13 0.46 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 112.534 -2.121 . . . . 1.33 107.586 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.5 ptm180 -91.83 161.47 14.84 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.581 -1.645 . . . . 2.28 109.18 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.62 137.76 32.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.103 -0.953 . . . . 1.36 109.358 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -110.85 89.92 3.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.779 -0.769 . . . . 1.18 110.795 -174.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.54 -58.69 0.0 OUTLIER Glycine 0 N--CA 1.469 0.863 0 C-N-CA 125.173 1.368 . . . . 1.28 116.233 145.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 23.6 p90 -164.07 174.4 11.37 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.952 -1.624 . . . . 2.8 107.709 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.762 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.7 t80 -138.31 101.59 4.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.637 0.732 . . . . 0.6 110.626 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -81.92 137.52 35.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.834 -0.621 . . . . 4.77 110.09 -177.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.808 HD13 ' HG ' ' A' ' 127' ' ' LEU . 92.5 mt -134.24 170.48 15.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.493 0.923 . . . . 1.61 113.493 -171.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 161' ' ' PHE . 32.2 t70 -100.57 120.75 55.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.268 -1.333 . . . . 2.66 109.874 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.549 ' HB2' ' NH1' ' A' ' 200' ' ' ARG . 36.7 Cg_endo -68.41 123.0 10.04 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.778 1.652 . . . . 2.01 112.46 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.612 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.286 1.034 . . . . 5.19 112.984 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 121.012 0.434 . . . . 26.27 110.629 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.55 75.72 2.34 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.033 -0.603 . . . . 24.15 112.303 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 92' ' ' HIS . 9.5 t 63.79 48.38 3.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.328 0.585 . . . . 23.64 109.758 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 m -58.96 -63.53 1.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.326 -0.852 . . . . 22.83 110.933 -176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -103.87 42.3 1.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.17 -0.468 . . . . 22.11 110.52 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.422 ' HB2' ' OG ' ' A' ' 89' ' ' SER . 81.1 m-70 -131.3 -78.46 0.52 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.392 -0.367 . . . . 22.07 110.273 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.2 t60 55.5 77.52 0.22 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.513 0.508 . . . . 20.59 110.899 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 49.6 m170 64.15 90.12 0.09 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.785 -0.643 . . . . 18.44 111.24 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -80.71 85.03 6.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.071 0.462 . . . . 17.98 110.245 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -137.73 68.66 1.4 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 17.87 110.015 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.1 t -99.19 129.0 45.4 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.271 -0.422 . . . . 16.77 110.271 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.5 p 50.12 51.14 17.27 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.305 0.642 . . . . 16.32 111.6 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.08 -25.69 75.22 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.936 -0.574 . . . . 14.63 112.704 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 100' ' ' LEU . 33.5 tp 63.38 29.93 15.57 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.466 0.65 . . . . 15.68 110.34 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.91 82.67 67.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.881 -0.6 . . . . 12.69 111.53 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.72 -8.22 13.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.567 2.178 . . . . 12.08 112.731 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -99.49 -39.19 8.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.696 -0.229 . . . . 12.18 110.921 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.9 144.02 4.91 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.382 -0.913 . . . . 8.55 112.509 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 106' ' ' HIS . 29.2 p -110.09 10.98 23.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.827 -0.435 . . . . 8.07 109.827 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 105' ' ' SER . 27.4 m-70 72.46 -55.52 0.67 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.349 -0.841 . . . . 7.76 111.957 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.408 ' C ' ' H ' ' A' ' 109' ' ' ARG . 94.5 mmm 73.84 -31.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.599 0.76 . . . . 6.12 110.877 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 106' ' ' HIS . . . 73.48 -32.3 0.83 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-O 119.338 -0.701 . . . . 1.91 114.16 169.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.408 ' H ' ' C ' ' A' ' 107' ' ' MET . 0.7 OUTLIER -15.38 82.61 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.825 1.65 . . . . 4.32 115.084 179.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.774 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 57.4 ttm -142.3 110.87 6.13 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.153 -0.619 . . . . 2.59 112.326 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.8 m -107.81 106.66 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-O 122.459 1.123 . . . . 0.74 113.08 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -158.46 108.64 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 113.185 -1.825 . . . . 1.38 107.008 163.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.761 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.8 mp -95.18 116.85 29.27 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.059 -0.719 . . . . 1.33 109.059 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -148.3 107.34 3.6 Favored Pre-proline 0 C--N 1.299 -1.606 0 C-N-CA 119.766 -0.774 . . . . 1.93 110.176 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.535 ' HG3' HG12 ' A' ' 183' ' ' ILE . 37.7 Cg_exo -35.43 130.49 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 124.287 3.325 . . . . 0.65 113.799 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 24.3 t70 68.83 54.33 0.48 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.512 1.149 . . . . 0.72 110.01 -174.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.702 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 14.1 ptt? -121.73 156.18 33.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.972 -1.467 . . . . 1.67 110.364 172.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.51 96.37 6.69 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.496 -0.927 . . . . 0.58 108.496 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.83 HD13 ' HE2' ' A' ' 124' ' ' MET . 15.8 tt -136.98 169.73 19.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.613 -1.176 . . . . 0.65 109.831 -165.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.591 ' O ' ' HG2' ' A' ' 124' ' ' MET . 20.2 m -139.75 175.94 9.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.809 0.731 . . . . 0.44 111.118 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.638 ' H ' ' HD2' ' A' ' 121' ' ' LYS . 3.2 mptt -62.34 -19.82 63.74 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.123 0.963 . . . . 2.33 108.556 169.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.71 ' O ' HG12 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -81.5 -23.44 37.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.31 -1.768 . . . . 1.32 112.627 177.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.774 ' HA ' ' H ' ' A' ' 110' ' ' MET . 19.6 mt-10 -88.45 -44.01 11.04 Favored 'General case' 0 N--CA 1.408 -2.556 0 O-C-N 120.812 -1.18 . . . . 2.06 108.93 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.83 ' HE2' HD13 ' A' ' 119' ' ' ILE . 14.1 mmt -63.89 -18.76 64.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.96 -1.473 . . . . 3.13 110.557 169.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -48.96 -41.57 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-O 122.089 0.947 . . . . 0.37 110.287 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.524 ' CE ' HG13 ' A' ' 125' ' ' VAL . 8.7 mmpt? -66.67 -38.21 86.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.204 -1.362 . . . . 0.63 113.404 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.888 HD13 HD13 ' A' ' 197' ' ' LEU . 13.5 tp -49.85 -40.15 41.46 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.857 0.837 . . . . 1.79 110.114 166.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.2 mt -82.44 -30.84 29.79 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.016 -0.993 . . . . 0.38 109.259 -167.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.49 -39.3 94.08 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.844 -1.526 . . . . 1.96 110.241 165.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.679 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -72.3 -41.93 66.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.497 -1.683 . . . . 0.64 112.083 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER -97.0 6.79 47.98 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 124.558 2.123 . . . . 0.59 105.784 -177.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 46.29 50.67 12.02 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 110.023 -3.262 . . . . 1.8 113.008 167.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.559 ' HB3' ' CD2' ' A' ' 145' ' ' PHE . 2.8 t80 -136.07 175.03 9.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.879 -0.728 . . . . 0.52 112.437 -173.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' A' ' 135' ' ' GLN . 2.2 tmm_? -137.05 147.96 46.49 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.459 -1.682 . . . . 4.54 106.459 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.537 ' N ' ' HD2' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -47.92 140.7 6.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.846 1.308 . . . . 1.28 113.388 -170.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.8 p -140.88 137.73 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 112.638 -2.074 . . . . 1.05 109.423 -163.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -59.29 -33.22 70.82 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.343 1.068 . . . . 1.38 109.057 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.16 129.01 5.63 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.997 -1.91 . . . . 1.44 109.082 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.656 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -118.66 129.62 55.4 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.293 -1.321 . . . . 0.9 111.59 -172.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 1.8 t -160.57 99.33 1.28 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 122.907 1.337 . . . . 0.61 110.867 155.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.496 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.14 162.32 14.19 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.737 -2.029 . . . . 1.77 105.985 161.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.508 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 18.2 Cg_endo -60.96 120.47 8.2 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 121.102 1.201 . . . . 0.62 110.379 169.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.476 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 91.02 48.56 3.32 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.548 -1.31 . . . . 0.51 112.964 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.55 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 31.7 mt-10 -142.25 167.51 21.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.343 -0.614 . . . . 2.16 109.343 169.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.871 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 46.8 p90 -167.76 163.13 14.18 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.234 -1.024 . . . . 0.28 108.234 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.737 HG22 HG13 ' A' ' 136' ' ' VAL . 25.7 p -130.34 125.89 35.78 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.822 -0.751 . . . . 0.42 111.147 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.651 HG23 HG12 ' A' ' 152' ' ' ILE . 7.7 p -115.24 110.54 32.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 122.002 0.906 . . . . 0.34 111.133 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -122.73 31.16 6.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.101 -0.954 . . . . 3.11 110.784 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 72.91 -47.04 0.66 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.485 -0.78 . . . . 1.65 112.211 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -81.67 -16.29 51.79 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.102 0.477 . . . . 1.68 110.569 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.44 ' HB3' HG23 ' A' ' 174' ' ' THR . 1.8 p -162.49 154.21 18.34 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.434 -0.803 . . . . 0.37 112.296 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.675 HD12 ' HG3' ' A' ' 124' ' ' MET . 20.2 mt -117.98 107.68 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.696 -1.593 . . . . 0.53 107.346 165.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.871 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.8 mp0 -90.9 168.35 11.76 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.176 -2.157 . . . . 1.13 105.176 174.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.04 157.9 10.01 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 123.783 0.677 . . . . 1.8 110.291 -169.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 140' ' ' THR . 15.1 mt -127.15 109.99 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 115.425 -0.807 . . . . 0.43 110.347 169.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.725 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 3.9 tpt180 -70.44 92.35 0.81 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.029 -0.987 . . . . 3.13 109.675 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.581 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 28.1 ttt180 -65.22 139.77 97.67 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.406 -0.816 . . . . 6.16 109.145 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.483 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 1.9 Cg_endo -48.8 125.55 13.07 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 121.409 1.406 . . . . 2.1 110.251 166.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.581 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 19.0 m-85 -121.14 153.15 37.88 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.446 -1.252 . . . . 1.83 108.263 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -99.73 76.67 2.0 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 122.72 1.248 . . . . 3.66 111.792 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 89.5 m-85 -114.51 143.6 30.21 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 113.885 -1.507 . . . . 3.54 109.194 171.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 37.1 Cg_exo -59.5 -32.73 96.74 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 124.526 3.484 . . . . 4.48 112.623 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -93.62 -16.37 24.41 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.687 -1.142 . . . . 5.26 111.121 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.8 m -148.96 105.39 3.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.853 -0.612 . . . . 3.43 111.885 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -147.51 101.87 3.4 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.772 -0.825 . . . . 3.34 108.772 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -142.87 171.22 14.35 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.568 -1.197 . . . . 3.14 112.662 -169.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -81.94 151.61 30.56 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 113.503 -1.681 . . . . 1.11 113.047 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.725 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 9.4 tt0 -45.28 147.62 0.74 Allowed 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 115.473 1.657 . . . . 1.86 115.473 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 46.5 t -153.08 131.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 113.998 -1.456 . . . . 0.41 109.856 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.616 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 35.9 mtm180 -87.14 116.63 25.35 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.07 -0.514 . . . . 2.8 110.192 168.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.54 153.1 38.45 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.613 0.721 . . . . 0.29 111.414 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.723 ' CB ' ' HB ' ' A' ' 184' ' ' VAL . 0.0 OUTLIER -120.57 101.8 8.0 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.264 -1.335 . . . . 1.71 111.147 -172.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.601 HD21 HD21 ' A' ' 113' ' ' LEU . 1.1 mp -90.72 90.12 7.81 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.443 -0.577 . . . . 0.69 109.443 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -94.0 125.03 38.39 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.297 1.046 . . . . 0.26 111.139 -175.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 24.4 m-85 -98.45 136.54 38.44 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.158 -1.837 . . . . 0.72 111.354 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 181' ' ' ALA . 47.5 m-20 -78.28 64.74 3.47 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.813 -1.551 . . . . 1.09 106.813 161.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.24 -99.27 1.17 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 118.71 -1.71 . . . . 0.47 110.599 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.26 -20.49 32.11 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.913 0.708 . . . . 0.83 112.913 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.16 123.08 27.78 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 119.001 -1.08 . . . . 1.21 110.082 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -56.53 134.48 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.2 -1.818 . . . . 0.64 110.799 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.415 ' HB2' ' OD2' ' A' ' 176' ' ' ASP . . . -106.03 -41.43 5.38 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.509 -1.223 . . . . 0.29 110.517 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 13.7 p -150.51 158.88 44.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.342 -0.39 . . . . 0.33 111.606 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.564 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.8 mm -109.98 150.01 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 104.855 -2.276 . . . . 0.76 104.855 163.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.723 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 42.3 t -133.6 131.31 57.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 118.761 0.71 . . . . 0.35 110.255 177.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.43 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.0 t-20 -80.42 94.34 6.16 Favored 'General case' 0 CA--C 1.476 -1.873 0 N-CA-C 106.8 -1.556 . . . . 1.77 106.8 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.616 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.0 mtm -63.68 -2.53 1.76 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 124.149 0.905 . . . . 0.55 113.39 -163.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 12.4 pt-20 -83.5 -41.46 17.96 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.784 0.802 . . . . 1.02 110.672 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.451 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.6 m-20 -102.73 -25.93 13.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.262 -1.335 . . . . 1.4 108.549 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.8 t30 73.97 32.82 1.03 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 111.936 -2.393 . . . . 1.33 107.887 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 1.8 ptm180 -95.75 162.43 13.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.701 -1.59 . . . . 2.28 109.466 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 77.1 mt-30 -80.83 127.81 32.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.183 -0.917 . . . . 1.36 109.535 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.564 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -100.82 93.01 5.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.747 -0.644 . . . . 1.18 110.303 -171.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 20.87 -58.23 0.0 OUTLIER Glycine 0 N--CA 1.471 0.975 0 N-CA-C 116.542 1.377 . . . . 1.28 116.542 148.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 192' ' ' PHE . 34.0 p90 -162.99 175.14 11.45 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.296 -1.452 . . . . 2.8 108.755 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.761 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.7 t80 -145.06 127.95 16.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.556 -0.535 . . . . 0.6 109.556 156.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.548 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 1.6 mpt_? -112.02 141.56 45.53 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 120.88 -1.138 . . . . 4.77 111.507 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.888 HD13 HD13 ' A' ' 127' ' ' LEU . 40.6 mt -136.72 163.42 30.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.702 -0.681 . . . . 1.61 112.162 -172.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 199' ' ' PRO . 1.9 m-20 -112.57 114.03 50.27 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.866 -1.061 . . . . 2.66 110.214 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 198' ' ' ASP . 12.1 Cg_endo -57.35 128.67 30.45 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.877 2.385 . . . . 2.01 113.892 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.679 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 53.4 mtm180 . . . . . 0 C--O 1.252 1.192 0 CA-C-N 114.775 -1.102 . . . . 5.19 112.316 173.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.265 -0.272 . . . . 26.27 110.265 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.79 -62.62 0.17 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.504 -0.638 . . . . 24.15 111.504 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 p 48.43 80.44 0.06 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.492 0.717 . . . . 23.64 112.094 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.5 t -63.27 -42.14 99.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.003 -0.544 . . . . 22.83 110.744 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -125.63 -19.02 5.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.637 -0.256 . . . . 22.11 110.834 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 69.44 -62.14 0.42 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.653 0.781 . . . . 22.07 111.863 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.96 -67.05 1.02 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.837 0.351 . . . . 20.59 110.367 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -144.77 -175.16 4.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.202 -0.454 . . . . 18.44 110.501 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -57.39 132.6 53.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.017 0.437 . . . . 17.98 110.456 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -70.6 -7.21 42.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.829 -0.623 . . . . 17.87 112.008 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 m -60.32 -31.27 70.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.074 0.464 . . . . 16.77 110.291 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m -96.8 82.82 3.33 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.998 -0.547 . . . . 16.32 109.832 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.21 61.31 0.46 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.833 -0.622 . . . . 14.63 112.127 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.5 tp -62.65 -48.4 79.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.908 0.385 . . . . 15.68 110.141 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.4 m -100.7 139.8 20.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.975 -0.557 . . . . 12.69 110.556 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.22 -177.79 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.876 2.384 . . . . 12.08 111.803 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 72.54 -55.99 0.66 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.32 0.648 . . . . 12.18 111.196 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.7 -150.45 12.59 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.493 -0.643 . . . . 8.55 111.493 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.0 t -130.0 -57.91 1.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.984 0.421 . . . . 8.07 109.899 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -120.93 33.67 5.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 7.76 110.003 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 mpt? 67.38 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.623 -0.717 . . . . 6.12 110.999 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.16 16.65 68.93 Favored Glycine 0 C--O 1.224 -0.522 0 C-N-CA 120.544 -0.836 . . . . 1.91 111.994 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.697 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 32.4 mtt180 -139.43 112.08 7.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.404 -0.961 . . . . 4.32 108.404 171.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.3 ttt -142.75 132.24 23.67 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.194 -1.003 . . . . 2.59 113.531 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' VAL . 32.6 m -124.22 101.6 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 123.148 1.452 . . . . 0.74 111.399 164.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.509 ' C ' HD12 ' A' ' 113' ' ' LEU . 43.0 t30 -162.51 119.99 2.06 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 105.007 -2.22 . . . . 1.38 105.007 170.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.754 HD23 HD11 ' A' ' 173' ' ' LEU . 5.6 mp -109.45 80.21 1.29 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.298 -1.001 . . . . 1.33 108.298 -172.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.552 ' H ' ' CE ' ' A' ' 117' ' ' MET . 27.4 tt0 -123.98 111.02 29.07 Favored Pre-proline 0 C--N 1.29 -2.02 0 C-N-CA 118.946 -1.102 . . . . 1.93 110.295 -169.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' HG3' HG12 ' A' ' 183' ' ' ILE . 39.2 Cg_exo -35.78 131.98 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 124.886 3.724 . . . . 0.65 114.298 -174.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 28.7 t70 72.76 50.03 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.552 1.168 . . . . 0.72 110.457 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.552 ' CE ' ' H ' ' A' ' 114' ' ' GLU . 10.6 ptp -122.84 155.57 36.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.166 -1.379 . . . . 1.67 110.924 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.9 m -96.67 85.58 3.88 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.933 0.873 . . . . 0.58 108.959 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -110.18 163.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 114.397 -1.274 . . . . 0.65 109.924 -172.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.636 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.5 m -140.87 173.92 11.02 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.673 -0.492 . . . . 0.44 109.673 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.822 ' HG2' HG21 ' A' ' 147' ' ' VAL . 44.2 mttp -53.99 -32.74 55.02 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 108.575 -0.898 . . . . 2.33 108.575 164.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.627 ' O ' HG12 ' A' ' 125' ' ' VAL . 41.6 t30 -84.24 -19.19 34.33 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 114.053 -1.43 . . . . 1.32 114.733 -178.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.636 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.3 mp0 -84.9 -63.28 1.36 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 119.755 -1.841 . . . . 2.06 107.183 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.751 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -56.36 -13.47 2.23 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 112.858 -1.974 . . . . 3.13 111.361 172.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 122' ' ' ASN . 14.5 p -43.19 -43.07 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 122.2 1.0 . . . . 0.37 110.117 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.697 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.7 -37.54 82.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.115 -1.402 . . . . 0.63 112.774 176.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -50.94 -33.83 26.11 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.723 0.773 . . . . 1.79 110.873 168.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.779 HD23 HD23 ' A' ' 127' ' ' LEU . 16.0 mt -84.55 -32.62 23.75 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.931 -1.032 . . . . 0.38 109.229 -172.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.23 -35.0 77.27 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.352 -1.295 . . . . 1.96 109.644 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.572 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -70.26 -42.04 72.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.252 -1.794 . . . . 0.64 111.904 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.571 HG22 ' HA ' ' A' ' 128' ' ' LEU . 11.6 t -90.33 -2.66 58.01 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 123.384 1.564 . . . . 0.59 107.368 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 55.23 54.85 8.21 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 110.974 -2.83 . . . . 1.8 112.103 172.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.732 ' CZ ' ' HG3' ' A' ' 144' ' ' GLU . 3.8 t80 -138.97 177.85 7.59 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 113.095 0.776 . . . . 0.52 113.095 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.426 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -141.31 139.27 33.59 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.539 -1.282 . . . . 4.54 107.539 177.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.6 OUTLIER -49.06 139.47 10.51 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 114.35 1.241 . . . . 1.28 114.35 -168.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.781 HG23 HG22 ' A' ' 146' ' ' THR . 3.8 m -124.23 156.41 31.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 112.933 -1.939 . . . . 1.05 111.52 -175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -59.67 -37.48 78.87 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.516 1.15 . . . . 1.38 107.958 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.8 OUTLIER -158.46 134.97 9.45 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 112.611 -2.086 . . . . 1.44 109.397 -177.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.562 ' CB ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -120.05 136.42 54.58 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.0 -1.0 . . . . 0.9 111.311 -179.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.7 t -159.0 100.59 1.57 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.684 1.231 . . . . 0.61 109.675 151.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.54 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -163.62 170.15 7.56 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.82 -1.991 . . . . 1.77 106.534 165.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.5 117.13 3.66 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.661 1.574 . . . . 0.62 112.604 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.601 ' CA ' ' HB2' ' A' ' 157' ' ' ARG . . . 105.94 36.53 2.73 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 120.947 -0.644 . . . . 0.51 112.366 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.732 ' HG3' ' CZ ' ' A' ' 133' ' ' TYR . 12.8 mp0 -130.95 176.82 7.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.171 -0.307 . . . . 2.16 110.171 -177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.885 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -166.56 175.95 7.65 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.0 -0.741 . . . . 0.28 109.0 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.781 HG22 HG23 ' A' ' 136' ' ' VAL . 61.7 p -140.98 126.32 18.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.967 -0.56 . . . . 0.42 110.898 171.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.822 HG21 ' HG2' ' A' ' 121' ' ' LYS . 14.4 p -125.41 126.44 70.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.435 0.636 . . . . 0.34 112.241 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -132.36 -74.69 0.51 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.009 -0.541 . . . . 3.11 110.26 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -155.05 -50.33 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.893 0.331 . . . . 1.65 111.893 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.88 -11.47 55.55 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.418 -0.355 . . . . 1.68 111.516 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 10.9 p -165.13 154.72 12.94 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.868 0.842 . . . . 0.37 112.915 -174.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.763 HG12 HG23 ' A' ' 147' ' ' VAL . 63.2 mt -114.61 108.3 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.597 -1.631 . . . . 0.53 106.597 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.885 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.24 166.61 13.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.703 -1.962 . . . . 1.13 105.703 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 7.6 ptm -167.53 151.67 6.59 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 124.014 0.821 . . . . 1.8 110.183 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.549 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.3 mt -128.24 113.57 30.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.159 -0.473 . . . . 0.43 110.439 172.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.773 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 13.1 mtp-105 -62.71 107.29 0.93 Allowed 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.347 0.404 . . . . 3.13 110.613 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.601 ' HB2' ' CA ' ' A' ' 143' ' ' GLY . 59.5 ttp180 -65.49 141.82 98.12 Favored Pre-proline 0 C--N 1.315 -0.933 0 N-CA-C 107.075 -1.454 . . . . 6.16 107.075 165.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -47.28 126.0 11.21 Favored 'Trans proline' 0 N--CA 1.438 -1.737 0 C-N-CA 121.302 1.335 . . . . 2.1 110.767 171.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 13.5 m-85 -124.22 137.84 54.48 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.016 -1.447 . . . . 1.83 107.658 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -110.72 74.79 0.89 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.687 1.232 . . . . 3.66 111.176 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 88.0 m-85 -120.65 156.93 55.52 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 113.568 -1.651 . . . . 3.54 109.828 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 31.2 Cg_exo -60.8 -31.36 91.7 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 124.386 3.391 . . . . 4.48 113.054 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -93.56 -15.07 25.81 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.116 -0.947 . . . . 5.26 111.01 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 161' ' ' PHE . 17.2 p -149.34 105.65 3.51 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.734 -0.666 . . . . 3.43 111.046 -174.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -147.27 85.07 1.58 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.27 1.033 . . . . 3.34 109.588 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.557 ' HG3' ' NH1' ' A' ' 156' ' ' ARG . 10.5 pt-20 -165.23 153.33 11.49 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 113.371 -1.741 . . . . 3.14 106.493 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.26 -132.19 0.42 Allowed Glycine 0 C--N 1.303 -1.257 0 CA-C-O 122.817 1.232 . . . . 1.11 113.539 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.773 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 25.4 tt0 -89.57 143.6 26.68 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 112.721 -1.74 . . . . 1.86 113.02 -167.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 61.9 t -154.96 124.43 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.131 -1.395 . . . . 0.41 109.364 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 50.5 mtm180 -81.58 124.74 29.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.548 -0.538 . . . . 2.8 109.548 166.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -129.05 137.18 51.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.654 0.74 . . . . 0.29 110.346 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.552 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 7.1 tpp180 -104.82 106.54 17.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.195 -1.366 . . . . 1.71 110.936 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.754 HD11 HD23 ' A' ' 113' ' ' LEU . 5.1 mp -92.31 98.21 11.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.3 -0.63 . . . . 0.69 109.3 174.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.57 120.99 40.86 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 122.188 0.994 . . . . 0.26 111.499 -171.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -88.57 134.96 33.72 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.953 -1.93 . . . . 0.72 110.229 -177.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 37.4 t70 -77.21 66.15 2.94 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.676 -1.602 . . . . 1.09 106.676 163.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.81 -98.97 1.73 Allowed Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 118.801 -1.666 . . . . 0.47 110.233 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.65 -26.02 30.24 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.878 0.695 . . . . 0.83 112.878 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -128.37 128.81 45.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.442 -0.903 . . . . 1.21 110.865 -166.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.741 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.2 tt -52.14 129.13 26.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.433 -1.712 . . . . 0.64 110.546 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.91 -39.32 5.8 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.04 -0.982 . . . . 0.29 110.059 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 167.37 24.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.144 -0.48 . . . . 0.33 111.853 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' A' ' 195' ' ' PHE . 2.0 mm -118.6 147.8 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 105.444 -2.058 . . . . 0.76 105.444 164.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 24.1 t -139.82 128.34 26.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.579 0.704 . . . . 0.35 110.072 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.459 ' CB ' ' HG2' ' A' ' 190' ' ' ARG . 2.4 t-20 -69.4 105.13 2.48 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 107.523 -1.288 . . . . 1.77 107.523 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.686 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 6.7 mtm -65.33 -3.56 4.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.845 0.683 . . . . 0.55 112.845 -166.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.49 ' HG3' ' ND2' ' A' ' 188' ' ' ASN . 11.2 pt-20 -96.12 -37.44 10.59 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.695 0.76 . . . . 1.02 111.303 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.49 ' ND2' ' HG3' ' A' ' 187' ' ' GLU . 48.9 m-80 -104.4 -26.53 12.39 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.541 -1.208 . . . . 1.4 109.893 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 75.39 31.83 0.76 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.745 -2.025 . . . . 1.33 108.362 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 13.5 ptt180 -92.93 156.46 16.92 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.454 -1.248 . . . . 2.28 109.503 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -84.69 127.44 34.1 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.87 -1.059 . . . . 1.36 109.692 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.556 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -103.77 92.81 4.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 119.918 -0.713 . . . . 1.18 110.451 -171.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 18.27 -58.5 0.0 OUTLIER Glycine 0 N--CA 1.468 0.826 0 N-CA-C 115.905 1.122 . . . . 1.28 115.905 145.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -163.32 174.21 12.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.043 -1.578 . . . . 2.8 108.399 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.688 ' HB3' HD22 ' A' ' 113' ' ' LEU . 1.9 t80 -142.82 152.71 42.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.086 -1.079 . . . . 0.6 108.086 156.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.42 147.53 34.75 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 122.058 -0.401 . . . . 4.77 111.422 -172.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.479 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 5.4 mt -132.87 172.43 12.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.636 0.976 . . . . 1.61 113.636 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.91 106.56 31.57 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 113.399 -1.728 . . . . 2.66 108.667 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -50.64 126.18 17.49 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.826 2.351 . . . . 2.01 113.612 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.572 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 79.6 mtp180 . . . . . 0 C--O 1.252 1.196 0 CA-C-N 115.016 -0.993 . . . . 5.19 111.994 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.46 ' SD ' ' HA2' ' A' ' 177' ' ' GLY . 66.2 mtt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.75 0.309 . . . . 26.27 110.249 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.86 63.15 4.12 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.756 -0.735 . . . . 24.15 112.143 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.2 m -87.01 -4.59 59.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.799 0.333 . . . . 23.64 111.206 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.4 t -75.65 -27.91 58.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 22.83 110.322 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.1 t60 74.35 -59.97 0.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.39 0.676 . . . . 22.11 111.215 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -87.89 104.87 17.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.969 0.414 . . . . 22.07 110.056 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -79.47 146.99 32.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.152 -0.684 . . . . 20.59 109.152 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -93.05 -90.04 0.19 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.814 -0.354 . . . . 18.44 111.486 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 26.9 m170 51.01 81.81 0.06 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.208 0.318 . . . . 17.98 110.469 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -59.95 123.39 16.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.027 0.441 . . . . 17.87 111.06 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -90.85 132.38 35.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.803 -0.635 . . . . 16.77 110.053 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 t -77.68 2.22 17.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.876 0.369 . . . . 16.32 110.264 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 103' ' ' ARG . . . -84.42 -13.64 72.98 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 121.004 -0.617 . . . . 14.63 111.982 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp 63.05 -80.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.215 0.606 . . . . 15.68 112.287 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.681 ' H ' ' HD2' ' A' ' 102' ' ' PRO . 84.3 t -125.09 -56.36 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.295 -0.411 . . . . 12.69 111.961 -174.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.681 ' HD2' ' H ' ' A' ' 101' ' ' VAL . 1.8 Cg_endo -43.35 -42.22 10.41 Favored 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.993 2.462 . . . . 12.08 112.805 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.434 ' HB3' ' HA3' ' A' ' 99' ' ' GLY . 47.4 ttt180 -90.32 97.41 11.17 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.723 -0.473 . . . . 12.18 109.723 174.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.75 58.82 4.89 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.052 -0.594 . . . . 8.55 112.496 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.4 p -80.96 85.45 6.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.047 0.451 . . . . 8.07 110.744 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -101.28 -32.82 10.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.98 -0.554 . . . . 7.76 110.931 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 63.2 mtt 63.64 -153.87 0.32 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.864 -0.607 . . . . 6.12 109.834 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.74 -10.76 73.82 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.646 -0.787 . . . . 1.91 112.212 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HB2' ' HG3' ' A' ' 126' ' ' LYS . 3.4 ptm180 -140.49 99.09 3.56 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 122.954 0.501 . . . . 4.32 110.642 168.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.425 ' HB3' ' HG3' ' A' ' 123' ' ' GLU . 52.3 ttp -141.14 125.52 17.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 118.306 -1.358 . . . . 2.59 113.732 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 111' ' ' VAL . 26.8 m -114.0 101.53 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 122.763 1.268 . . . . 0.74 110.947 167.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.435 ' C ' HD12 ' A' ' 113' ' ' LEU . 53.0 t30 -163.02 109.75 1.19 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.576 -1.647 . . . . 1.38 106.763 171.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.603 ' CG ' HD21 ' A' ' 173' ' ' LEU . 4.9 mp -104.02 77.38 1.43 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.937 -0.764 . . . . 1.33 108.937 -169.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -121.81 107.64 35.7 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 119.342 -0.943 . . . . 1.93 110.311 -171.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.532 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.4 Cg_exo -34.04 130.25 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.542 3.494 . . . . 0.65 114.407 -172.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 23.1 t0 77.72 39.22 0.18 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 122.456 1.122 . . . . 0.72 110.811 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.635 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -115.05 155.51 26.88 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.867 -1.06 . . . . 1.67 110.577 172.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 m -92.91 86.6 5.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.964 0.887 . . . . 0.58 109.205 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.63 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.7 tt -116.46 162.14 14.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 114.076 -1.42 . . . . 0.65 109.718 -171.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.682 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.6 m -142.26 178.03 7.85 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.96 -0.756 . . . . 0.44 108.96 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.817 ' HG2' HG21 ' A' ' 147' ' ' VAL . 28.9 mtpt -57.45 -28.58 63.47 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 108.525 -0.917 . . . . 2.33 108.525 163.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.583 ' O ' HG12 ' A' ' 125' ' ' VAL . 32.9 t30 -85.32 -18.44 33.83 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-N 113.851 -1.522 . . . . 1.32 114.774 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.682 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.0 mp0 -86.9 -62.08 1.58 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 119.82 -1.8 . . . . 2.06 108.289 170.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.822 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.7 tpt -53.58 -17.03 1.8 Allowed 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 112.8 -2.0 . . . . 3.13 110.779 172.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.593 HG13 ' HE3' ' A' ' 126' ' ' LYS . 14.9 p -43.98 -44.92 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.288 1.042 . . . . 0.37 110.447 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.593 ' HE3' HG13 ' A' ' 125' ' ' VAL . 0.6 OUTLIER -69.18 -36.29 77.19 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 113.937 -1.483 . . . . 0.63 112.838 177.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.76 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -51.1 -35.08 33.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 122.028 0.918 . . . . 1.79 110.54 168.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.822 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.2 mt -84.82 -28.6 26.0 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.754 -1.112 . . . . 0.38 109.152 -171.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.69 -20.47 50.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.136 -1.393 . . . . 1.96 110.341 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 200' ' ' ARG . . . -80.62 -43.87 19.82 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.07 -1.423 . . . . 0.64 111.215 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.91 -6.17 54.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 123.653 1.692 . . . . 0.59 107.094 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.12 56.41 3.34 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 110.976 -2.829 . . . . 1.8 112.945 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.732 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -135.15 176.72 8.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.615 -0.721 . . . . 0.52 111.817 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 65.7 ttt180 -136.98 149.95 47.84 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.126 -1.435 . . . . 4.54 107.126 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -48.88 137.0 13.24 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.737 1.256 . . . . 1.28 112.836 -170.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.6 p -137.6 140.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 CA-C-N 112.349 -2.205 . . . . 1.05 109.677 -164.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.4 m -63.5 -31.72 72.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.096 0.951 . . . . 1.38 109.3 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -152.6 117.72 5.19 Favored 'General case' 0 CA--C 1.485 -1.539 0 CA-C-N 113.352 -1.749 . . . . 1.44 110.661 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.664 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -109.59 117.88 35.11 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 113.81 -1.541 . . . . 0.9 110.12 179.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.1 OUTLIER -151.12 95.59 2.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.24 1.495 . . . . 0.61 108.399 156.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.53 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -168.31 155.87 7.63 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 111.546 -2.57 . . . . 1.77 105.029 168.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.479 ' O ' ' HD3' ' A' ' 157' ' ' ARG . 14.6 Cg_exo -71.17 123.6 9.77 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.526 1.484 . . . . 0.62 112.18 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.688 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 106.15 20.14 9.48 Favored Glycine 0 C--N 1.348 1.219 0 C-N-CA 120.579 -0.82 . . . . 0.51 111.781 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.732 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 7.8 mp0 -125.99 173.82 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.807 -0.442 . . . . 2.16 109.807 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.885 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 47.6 p90 -168.42 168.17 11.38 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 107.506 -1.294 . . . . 0.28 107.506 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.683 HG22 HG13 ' A' ' 136' ' ' VAL . 34.9 p -133.19 127.27 33.43 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.713 -0.795 . . . . 0.42 110.499 172.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.879 HG23 HG12 ' A' ' 152' ' ' ILE . 10.7 p -122.93 121.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.715 -0.794 . . . . 0.34 112.861 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -111.02 -77.47 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.973 . . . . 3.11 109.74 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -176.73 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.261 -0.881 . . . . 1.65 109.092 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.45 -19.32 39.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.97 -1.014 . . . . 1.68 110.128 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 21.0 p -160.6 155.03 23.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.149 -0.932 . . . . 0.37 111.751 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.879 HG12 HG23 ' A' ' 147' ' ' VAL . 53.4 mt -121.11 113.82 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.487 -1.671 . . . . 0.53 106.487 163.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.885 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.0 OUTLIER -89.82 169.99 10.79 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.374 -1.713 . . . . 1.13 106.374 175.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 9.0 ptm -168.23 150.54 5.36 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 123.802 0.689 . . . . 1.8 110.672 -174.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.6 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.3 mt -128.71 119.47 49.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.763 -0.653 . . . . 0.43 109.938 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.71 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 82.6 mtp180 -67.21 112.9 4.74 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.458 0.474 . . . . 3.13 110.719 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.568 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 14.8 tpt180 -72.22 133.83 83.18 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 107.616 -1.253 . . . . 6.16 107.616 166.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.419 ' HD2' ' HD2' ' A' ' 157' ' ' ARG . 1.8 Cg_endo -46.89 126.01 10.54 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 121.205 1.27 . . . . 2.1 110.642 167.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 17.3 m-85 -121.17 145.51 47.75 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.236 -1.347 . . . . 1.83 107.716 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.36 73.78 1.23 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.616 1.198 . . . . 3.66 111.13 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.508 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 97.0 m-85 -120.99 149.92 52.1 Favored Pre-proline 0 C--N 1.306 -1.286 0 CA-C-N 113.766 -1.561 . . . . 3.54 109.902 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.2 Cg_exo -62.12 -30.38 82.31 Favored 'Trans proline' 0 CA--C 1.503 -1.053 0 C-N-CA 124.532 3.488 . . . . 4.48 112.783 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.24 -11.72 22.37 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.691 -1.14 . . . . 5.26 110.967 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.8 m -145.37 99.66 3.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.861 -0.609 . . . . 3.43 111.348 -173.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 166' ' ' GLU . 5.6 tppp? -149.17 99.77 2.97 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.41 -0.589 . . . . 3.34 109.41 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 165' ' ' LYS . 7.0 mt-10 -149.76 174.6 12.43 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.214 -0.903 . . . . 3.14 109.611 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.63 175.91 54.77 Favored Glycine 0 C--N 1.298 -1.543 0 CA-C-N 114.388 -1.278 . . . . 1.11 111.21 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.71 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 5.3 tt0 -58.26 152.13 17.97 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.133 -1.034 . . . . 1.86 112.064 172.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 53.7 t -153.69 130.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.712 -1.131 . . . . 0.41 108.711 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.703 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 51.4 mtm180 -87.25 122.82 31.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.225 0.536 . . . . 2.8 110.152 169.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -130.25 128.45 41.63 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 122.091 0.948 . . . . 0.29 110.791 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.543 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 9.0 tpp180 -96.26 120.88 37.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.496 -1.683 . . . . 1.71 110.251 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.603 HD21 ' CG ' ' A' ' 113' ' ' LEU . 7.4 mp -111.54 103.99 12.36 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.422 0.63 . . . . 0.69 111.045 174.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.75 124.87 47.01 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.777 -1.101 . . . . 0.26 111.284 -174.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -97.9 139.6 33.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.137 -1.847 . . . . 0.72 110.683 -175.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -80.1 64.06 4.81 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 106.754 -1.573 . . . . 1.09 106.754 160.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.46 ' HA2' ' SD ' ' A' ' 87' ' ' MET . . . 69.84 -98.82 0.64 Allowed Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 118.78 -1.676 . . . . 0.47 110.926 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.41 -25.47 59.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 112.939 0.718 . . . . 0.83 112.939 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -136.28 133.89 37.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.768 -0.773 . . . . 1.21 109.824 -169.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -60.1 138.79 57.81 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.115 -1.402 . . . . 0.64 110.0 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -106.34 -45.21 4.34 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.043 -0.98 . . . . 0.29 110.513 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.8 p -148.66 158.8 44.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 111.698 0.259 . . . . 0.33 111.698 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.555 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.2 mm -107.42 148.32 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 104.966 -2.235 . . . . 0.76 104.966 165.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 29.5 t -140.05 126.88 23.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.532 0.682 . . . . 0.35 110.077 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -69.72 107.48 3.49 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.356 -1.349 . . . . 1.77 107.356 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.703 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 20.3 mtm -64.66 -8.33 14.01 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 112.862 0.69 . . . . 0.55 112.862 -165.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -91.66 -41.83 10.51 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.768 0.794 . . . . 1.02 111.45 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -98.24 -25.47 14.86 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.391 -1.277 . . . . 1.4 109.381 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.1 t30 70.09 35.47 2.17 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.912 -2.404 . . . . 1.33 108.015 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.5 ptm180 -96.42 157.78 15.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.604 -1.634 . . . . 2.28 108.833 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 87.8 mt-30 -85.94 129.43 34.84 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.336 -0.847 . . . . 1.36 109.221 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.555 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -104.1 91.91 4.15 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.259 -0.576 . . . . 1.18 110.547 -170.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.33 -59.09 0.0 OUTLIER Glycine 0 N--CA 1.467 0.71 0 N-CA-C 116.26 1.264 . . . . 1.28 116.26 147.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 192' ' ' PHE . 26.2 p90 -164.75 171.08 14.74 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.639 -1.281 . . . . 2.8 109.137 173.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.575 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.6 t80 -139.19 151.87 46.92 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.842 -1.17 . . . . 0.6 107.842 159.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.697 ' N ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -143.23 148.46 36.48 Favored 'General case' 0 C--N 1.312 -1.056 0 O-C-N 121.906 -0.496 . . . . 4.77 110.465 -175.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.599 ' CD1' ' HG ' ' A' ' 127' ' ' LEU . 3.5 mt -130.15 172.07 12.17 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.282 1.039 . . . . 1.61 113.728 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -97.74 114.13 64.55 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 113.207 -1.815 . . . . 2.66 108.249 170.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.07 124.51 16.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.176 2.584 . . . . 2.01 114.087 -169.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.859 0 O-C-N 124.395 1.06 . . . . 5.19 112.506 177.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 120.62 0.248 . . . . 26.27 110.475 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.97 71.95 2.33 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.884 -0.674 . . . . 24.15 111.625 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.5 t -142.5 119.06 11.0 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.05 -0.352 . . . . 23.64 110.05 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.7 t -84.0 93.03 7.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.125 -0.489 . . . . 22.83 110.171 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -74.91 106.92 6.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.295 -0.632 . . . . 22.11 109.295 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -82.01 39.31 0.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 22.07 111.904 -171.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -151.43 150.19 30.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.45 -0.574 . . . . 20.59 109.45 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -83.6 62.71 6.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.45 -0.341 . . . . 18.44 110.199 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 52.46 65.06 1.62 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.716 -0.675 . . . . 17.98 110.564 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -110.2 56.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.452 0.644 . . . . 17.87 109.327 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.403 ' HB3' HD21 ' A' ' 100' ' ' LEU . 19.4 m -124.37 70.48 1.11 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.57 -0.741 . . . . 16.77 111.12 -173.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.3 m -67.71 147.54 52.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.144 -0.48 . . . . 16.32 110.412 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.15 -42.9 1.79 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 14.63 112.114 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.43 ' H ' HD23 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -101.68 41.91 1.17 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.415 0.626 . . . . 15.68 110.146 178.209 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -164.69 119.06 1.0 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.251 -0.886 . . . . 12.69 110.233 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.6 168.43 24.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.578 2.185 . . . . 12.08 111.691 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 62.26 61.22 1.33 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.522 0.677 . . . . 12.18 109.98 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.28 -142.77 46.39 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.518 -0.765 . . . . 8.55 112.147 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.1 m -120.05 41.91 3.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.147 0.498 . . . . 8.07 109.806 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -57.17 134.55 55.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.416 -0.811 . . . . 7.76 110.417 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 109' ' ' ARG . 22.9 mmt -81.26 -39.17 25.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.716 -0.675 . . . . 6.12 110.698 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 123' ' ' GLU . . . 78.92 -31.74 1.99 Allowed Glycine 0 C--O 1.217 -0.968 0 CA-C-N 115.383 -0.826 . . . . 1.91 111.884 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.4 OUTLIER -73.17 99.55 2.85 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.327 1.051 . . . . 4.32 109.114 174.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.581 ' HB3' ' CG ' ' A' ' 123' ' ' GLU . 26.2 ttt -144.23 136.92 26.93 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.423 -0.511 . . . . 2.59 111.882 -170.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 126' ' ' LYS . 2.0 m -119.8 104.4 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 122.569 1.175 . . . . 0.74 113.41 174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -159.74 108.23 1.76 Allowed 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.939 -1.937 . . . . 1.38 106.895 163.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.823 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.2 mp -98.17 113.21 25.05 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.517 0.675 . . . . 1.33 109.295 -173.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -139.97 100.77 7.17 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.76 -1.109 . . . . 1.93 109.031 -173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' HD3' HD12 ' A' ' 183' ' ' ILE . 23.5 Cg_exo -35.12 133.68 0.19 Allowed 'Trans proline' 0 CA--C 1.515 -0.46 0 C-N-CA 124.452 3.435 . . . . 0.65 113.997 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 31.4 t70 74.74 47.06 0.12 Allowed 'General case' 0 CA--C 1.529 0.135 0 O-C-N 124.583 1.177 . . . . 0.72 109.91 -175.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.589 ' CE ' ' HA ' ' A' ' 113' ' ' LEU . 12.4 ptt? -121.12 155.79 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.266 -1.333 . . . . 1.67 110.339 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 179' ' ' HIS . 56.5 m -101.59 102.75 13.52 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.532 -0.914 . . . . 0.58 108.532 -176.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.71 HD13 ' HE3' ' A' ' 124' ' ' MET . 16.6 tt -138.93 167.76 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.212 -0.904 . . . . 0.65 110.64 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.6 m -140.84 174.33 10.62 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.765 0.711 . . . . 0.44 110.785 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.514 ' HA ' HD11 ' A' ' 152' ' ' ILE . 11.9 mttp -57.49 -26.19 60.91 Favored 'General case' 0 C--O 1.211 -0.944 0 N-CA-C 109.089 -0.708 . . . . 2.33 109.089 165.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 40.6 t30 -84.44 -17.1 40.28 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.316 -1.311 . . . . 1.32 114.052 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.7 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 1.8 tt0 -87.18 -60.25 2.03 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.658 -1.238 . . . . 2.06 107.658 168.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.848 ' SD ' HD12 ' A' ' 152' ' ' ILE . 61.2 mtt -54.86 -15.91 2.28 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.832 -1.985 . . . . 3.13 111.906 171.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.576 HG13 ' HE3' ' A' ' 126' ' ' LYS . 12.9 p -44.16 -40.63 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-O 122.141 0.972 . . . . 0.37 109.967 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.659 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 1.0 OUTLIER -67.77 -40.7 84.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.066 -1.425 . . . . 0.63 112.743 176.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -49.74 -33.71 16.97 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.686 0.755 . . . . 1.79 111.041 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 127' ' ' LEU . 14.6 mt -85.96 -34.27 20.9 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.856 -1.065 . . . . 0.38 109.607 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.59 -34.6 76.07 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.448 -1.251 . . . . 1.96 109.854 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.89 67.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.512 -1.676 . . . . 0.64 111.451 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.421 ' HA ' ' HZ ' ' A' ' 159' ' ' PHE . 0.5 OUTLIER -89.64 -0.42 57.51 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 123.976 1.846 . . . . 0.59 106.969 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 55.75 54.6 8.03 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 111.079 -2.782 . . . . 1.8 112.693 170.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 2.7 t80 -141.38 174.93 10.08 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.022 -0.535 . . . . 0.52 111.864 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -137.1 156.46 48.35 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.949 -1.13 . . . . 4.54 107.949 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.415 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.86 139.73 16.47 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.31 1.052 . . . . 1.28 112.172 -170.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.0 p -138.61 142.5 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 112.998 -1.91 . . . . 1.05 110.205 -164.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.12 -33.41 69.11 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-O 122.519 1.152 . . . . 1.38 109.616 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 1.4 ttpt -160.54 129.19 4.73 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 112.521 -2.127 . . . . 1.44 108.262 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.62 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -116.32 128.86 55.91 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.919 -0.582 . . . . 0.9 111.541 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.426 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.0 OUTLIER -161.68 98.56 1.11 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.551 1.167 . . . . 0.61 110.279 157.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.452 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -166.66 167.07 8.39 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 112.891 -1.959 . . . . 1.77 105.833 161.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.494 ' HB3' ' HD2' ' A' ' 158' ' ' PRO . 24.4 Cg_exo -62.59 127.76 21.63 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 120.866 1.044 . . . . 0.62 110.416 170.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.721 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 86.25 42.69 6.52 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.428 -1.367 . . . . 0.51 112.96 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 28.2 mt-10 -140.76 166.15 25.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.843 -0.428 . . . . 2.16 109.843 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.721 ' O ' HG12 ' A' ' 136' ' ' VAL . 46.2 p90 -167.85 161.46 13.1 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.825 -0.806 . . . . 0.28 108.825 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.601 HG23 ' SD ' ' A' ' 139' ' ' MET . 71.4 p -123.35 130.73 53.13 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.284 0.564 . . . . 0.42 110.461 171.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.436 HG23 HG12 ' A' ' 152' ' ' ILE . 9.8 p -120.54 108.53 23.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 121.984 0.897 . . . . 0.34 110.374 172.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -109.62 -68.2 0.94 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 3.11 110.296 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.6 -53.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.933 0.346 . . . . 1.65 111.933 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -102.17 1.83 36.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.545 0.572 . . . . 1.68 112.545 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 2.8 p -163.93 153.16 14.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.554 0.693 . . . . 0.37 112.807 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.848 HD12 ' SD ' ' A' ' 124' ' ' MET . 52.6 mt -112.11 104.67 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.287 -1.324 . . . . 0.53 107.683 165.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 2.4 mt-10 -95.65 103.22 15.09 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.371 -0.831 . . . . 1.13 109.325 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -113.62 166.65 11.32 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.396 -0.82 . . . . 1.8 111.848 -169.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.61 HG12 ' HG3' ' A' ' 170' ' ' ARG . 14.7 mt -127.63 106.64 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 114.616 -1.175 . . . . 0.43 110.297 173.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.721 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 53.4 ttt180 -68.05 91.02 0.33 Allowed 'General case' 0 C--N 1.32 -0.702 0 O-C-N 124.025 0.828 . . . . 3.13 110.08 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.721 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 64.0 ttt180 -58.75 139.15 86.48 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.471 -0.786 . . . . 6.16 109.911 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 142' ' ' PRO . 4.8 Cg_endo -50.73 125.04 14.75 Favored 'Trans proline' 0 N--CA 1.437 -1.835 0 C-N-CA 121.155 1.236 . . . . 2.1 110.228 167.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.595 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 25.9 m-85 -117.46 121.42 40.98 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.231 -1.35 . . . . 1.83 107.976 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 11.8 p-10 -81.26 77.29 8.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.815 1.293 . . . . 3.66 111.511 -173.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 83.3 m-85 -115.9 145.21 34.27 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 113.165 -1.834 . . . . 3.54 108.983 171.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.4 Cg_exo -59.19 -31.63 95.65 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 124.683 3.588 . . . . 4.48 113.47 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -87.27 -17.93 31.38 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.894 -1.048 . . . . 5.26 111.404 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 72.2 m -157.69 112.25 2.65 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.824 -0.625 . . . . 3.43 111.469 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 160' ' ' ASP . 23.6 tptp -142.08 97.82 3.21 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.913 0.863 . . . . 3.34 108.995 172.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -126.94 175.3 8.17 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.344 -1.298 . . . . 3.14 112.401 -168.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.09 147.08 28.55 Favored Glycine 0 C--N 1.312 -0.781 0 CA-C-N 113.82 -1.536 . . . . 1.11 111.632 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.721 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.9 OUTLIER -58.41 158.32 7.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.306 0.574 . . . . 1.86 112.413 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 59.6 t -151.45 127.43 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.049 -0.978 . . . . 0.41 110.154 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.61 ' HG3' HG12 ' A' ' 155' ' ' ILE . 8.6 mtt180 -82.8 110.74 18.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.059 -0.519 . . . . 2.8 109.901 169.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.97 137.63 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.992 0.901 . . . . 0.29 111.693 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 3.7 tpp180 -101.83 101.35 11.79 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.74 -1.573 . . . . 1.71 110.798 -176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.685 HD23 ' SD ' ' A' ' 124' ' ' MET . 2.9 mp -88.97 92.24 9.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.425 -0.583 . . . . 0.69 109.425 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.07 122.02 39.6 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 122.532 1.158 . . . . 0.26 111.902 -171.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-85 -88.81 137.58 32.19 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.647 -2.069 . . . . 0.72 110.89 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.9 t70 -81.93 65.1 6.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.987 -1.857 . . . . 1.09 105.987 160.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 73.59 -99.43 1.01 Allowed Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 118.66 -1.733 . . . . 0.47 110.743 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -75.96 -26.99 57.34 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 112.773 0.657 . . . . 0.83 112.773 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.429 ' CB ' ' HA ' ' A' ' 118' ' ' THR . 13.1 p-80 -133.12 129.74 38.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.862 -0.735 . . . . 1.21 111.181 -168.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 4.9 tt -52.6 126.52 19.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.286 -1.325 . . . . 0.64 109.756 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -103.0 -38.7 7.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.432 -0.803 . . . . 0.29 109.453 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.2 p -147.16 161.5 40.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.284 -0.871 . . . . 0.33 110.463 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 24.9 mt -126.17 147.66 30.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 104.212 -2.514 . . . . 0.76 104.212 167.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 3.8 t -136.71 134.11 48.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.855 -0.738 . . . . 0.35 111.692 -174.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.596 ' HB3' ' HG2' ' A' ' 187' ' ' GLU . 12.1 m120 -72.53 97.74 2.17 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.424 -1.695 . . . . 1.77 106.424 174.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.522 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 46.1 mtm -65.95 -2.91 4.39 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.277 0.561 . . . . 0.55 112.345 -168.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.596 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 14.1 pt-20 -74.38 -42.85 58.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.046 0.927 . . . . 1.02 110.829 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -105.41 -25.52 12.33 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.277 -1.329 . . . . 1.4 108.814 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.7 t30 73.47 36.47 0.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 111.834 -2.439 . . . . 1.33 108.063 -174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 11.5 ptt180 -100.1 161.14 13.8 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.466 -1.243 . . . . 2.28 110.337 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -76.93 134.42 38.93 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.082 -0.963 . . . . 1.36 110.666 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -105.77 91.14 3.62 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.888 -0.577 . . . . 1.18 110.206 -174.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.46 -57.47 0.0 OUTLIER Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.68 1.432 . . . . 1.28 116.68 144.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -162.52 176.26 10.61 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.297 -1.451 . . . . 2.8 109.129 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.823 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 10.9 t80 -149.34 100.43 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.445 0.64 . . . . 0.6 110.197 156.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -98.86 139.18 34.92 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.546 -0.721 . . . . 4.77 111.128 -175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 127' ' ' LEU . 2.0 mt -109.81 172.44 6.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 113.639 0.977 . . . . 1.61 113.639 -175.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.425 ' HA ' ' HD2' ' A' ' 199' ' ' PRO . 35.9 m-20 -122.22 99.69 43.05 Favored Pre-proline 0 N--CA 1.443 -0.815 0 CA-C-N 113.382 -1.736 . . . . 2.66 109.276 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 198' ' ' ASP . 17.7 Cg_endo -59.04 156.31 34.72 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.705 2.27 . . . . 2.01 112.878 -176.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.631 ' HD3' ' OXT' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.185 -0.912 . . . . 5.19 110.804 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 110.07 -0.345 . . . . 26.27 110.07 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.55 85.14 0.23 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.936 -0.649 . . . . 24.15 112.062 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.5 p -74.6 149.44 40.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.718 0.294 . . . . 23.64 110.511 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.7 t -78.45 89.34 4.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.186 0.517 . . . . 22.83 110.136 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -139.24 151.93 46.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.768 -0.651 . . . . 22.11 110.27 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -94.05 117.4 30.05 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.446 -0.575 . . . . 22.07 109.446 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -83.43 -53.28 5.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.264 -0.425 . . . . 20.59 111.391 -175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -135.09 112.24 10.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.518 -0.31 . . . . 18.44 110.479 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -160.33 -173.01 3.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.152 -0.685 . . . . 17.98 109.152 178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 65.85 40.01 4.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.339 0.59 . . . . 17.87 109.962 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.5 p -129.51 164.02 24.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.233 -0.894 . . . . 16.77 110.378 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.6 m -96.12 75.28 3.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.19 0.519 . . . . 16.32 110.631 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.38 69.04 0.92 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.915 -0.66 . . . . 14.63 113.023 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 65.99 102.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.417 0.627 . . . . 15.68 111.209 176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.1 t -111.06 107.2 57.66 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.705 -0.679 . . . . 12.69 109.87 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.79 130.47 26.27 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.844 2.362 . . . . 12.08 112.17 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -146.87 44.67 1.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.536 0.684 . . . . 12.18 109.45 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.86 32.1 81.73 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 110.814 -0.914 . . . . 8.55 110.814 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -89.2 123.96 33.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.273 -0.464 . . . . 8.07 111.154 -172.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -79.51 -24.64 42.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.323 0.582 . . . . 7.76 109.432 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.0 mmt -133.23 -74.22 0.49 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.283 -0.871 . . . . 6.12 109.098 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.11 22.15 79.23 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 119.48 -1.343 . . . . 1.91 112.454 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.561 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 21.3 mtm180 -140.28 79.73 1.72 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 122.942 0.497 . . . . 4.32 110.112 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.577 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 34.8 tpp -141.57 133.04 26.8 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.703 -1.599 . . . . 2.59 115.209 -169.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.594 HG12 ' HE1' ' A' ' 124' ' ' MET . 17.3 m -121.11 107.84 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-O 122.111 0.958 . . . . 0.74 113.126 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -158.64 109.7 2.12 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.262 -1.384 . . . . 1.38 107.262 167.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.668 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 5.8 mp -95.34 101.16 12.87 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.205 0.526 . . . . 1.33 110.315 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -145.56 95.74 4.92 Favored Pre-proline 0 N--CA 1.429 -1.502 0 C-N-CA 119.781 -0.768 . . . . 1.93 109.455 -174.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.667 ' HD3' HD12 ' A' ' 183' ' ' ILE . 1.0 OUTLIER -33.53 142.9 0.05 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.589 1 C-N-CA 126.356 4.704 . . . . 0.65 115.422 -174.331 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 37.8 t70 72.1 40.06 0.74 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.698 -1.592 . . . . 0.72 109.197 -170.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.592 ' HE3' HD13 ' A' ' 180' ' ' LEU . 9.6 ptt? -118.09 154.84 31.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 113.993 -1.458 . . . . 1.67 109.734 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.5 m -101.46 81.04 2.14 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.298 1.047 . . . . 0.58 108.593 -175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.669 HG22 ' HB2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -104.88 161.94 4.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.464 -1.698 . . . . 0.65 109.871 -169.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.56 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 23.1 m -143.34 179.3 7.17 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 119.634 -0.826 . . . . 0.44 110.583 -173.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.627 ' HG2' HG21 ' A' ' 147' ' ' VAL . 1.2 mttm -61.62 -24.77 66.92 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 107.79 -1.189 . . . . 2.33 107.79 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.746 ' O ' HG12 ' A' ' 125' ' ' VAL . 4.3 t30 -83.77 -24.19 31.2 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 114.102 -1.408 . . . . 1.32 113.615 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.577 ' HA ' ' H ' ' A' ' 110' ' ' MET . 0.9 OUTLIER -80.48 -60.63 2.24 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 119.153 -2.217 . . . . 2.06 106.769 175.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.822 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 26.4 mmt -57.86 -17.26 15.23 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.767 -2.015 . . . . 3.13 111.943 173.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.4 p -43.5 -42.16 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 122.0 0.905 . . . . 0.37 110.518 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.561 ' CG ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -67.93 -37.66 81.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.366 -1.288 . . . . 0.63 113.806 178.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.74 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.9 tm? -56.34 -34.15 66.32 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.455 0.645 . . . . 1.79 109.943 167.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.822 ' HG ' ' O ' ' A' ' 124' ' ' MET . 11.8 mt -84.06 -31.38 25.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.948 0.88 . . . . 0.38 108.932 -170.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.5 -31.25 68.28 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.796 -1.547 . . . . 1.96 110.043 169.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.595 ' HA ' ' OXT' ' A' ' 200' ' ' ARG . . . -72.75 -44.56 61.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.956 -1.474 . . . . 0.64 111.387 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.45 ' HA ' ' HZ ' ' A' ' 159' ' ' PHE . 0.6 OUTLIER -92.94 -1.43 56.71 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.294 -1.743 . . . . 0.59 106.294 -177.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.94 50.8 15.97 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 111.696 -2.502 . . . . 1.8 111.826 169.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.838 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.8 t80 -129.92 175.22 9.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.506 0.67 . . . . 0.52 112.125 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -141.1 149.54 41.72 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.305 -1.739 . . . . 4.54 106.305 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.783 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 20.7 tm0? -51.26 140.97 15.75 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 122.952 1.358 . . . . 1.28 113.765 -167.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.6 p -136.93 144.91 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 112.27 -2.241 . . . . 1.05 110.51 -161.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -59.07 -34.2 71.7 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 122.684 1.231 . . . . 1.38 109.095 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 2.3 ttpt -159.55 128.61 5.23 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 112.57 -2.105 . . . . 1.44 109.104 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.612 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.14 124.31 50.02 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.47 -0.786 . . . . 0.9 111.165 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.8 t -158.13 97.92 1.55 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.678 1.228 . . . . 0.61 109.68 153.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.604 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -166.23 161.05 12.59 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 112.699 -2.046 . . . . 1.77 106.469 164.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.401 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 23.9 Cg_exo -65.36 116.79 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 121.404 1.403 . . . . 0.62 111.259 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.598 ' O ' ' HB2' ' A' ' 133' ' ' TYR . . . 108.32 21.44 7.65 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 119.804 -1.189 . . . . 0.51 113.087 -173.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.838 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 11.5 mp0 -134.48 159.44 41.12 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.256 0.528 . . . . 2.16 111.647 -177.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.79 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.0 p90 -163.57 167.86 20.78 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 107.999 -1.111 . . . . 0.28 107.999 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.636 HG22 HG13 ' A' ' 136' ' ' VAL . 6.0 p -133.34 126.93 32.43 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.768 -0.773 . . . . 0.42 111.56 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.783 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 14.8 p -125.56 127.45 71.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.401 0.619 . . . . 0.34 112.142 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -133.71 -77.06 0.48 Allowed 'General case' 0 C--N 1.318 -0.779 0 O-C-N 122.008 -0.433 . . . . 3.11 110.088 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.44 -57.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.376 -0.375 . . . . 1.65 111.31 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -90.74 3.9 53.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.618 0.599 . . . . 1.68 112.618 -173.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 13.0 p -167.93 152.01 6.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 122.017 0.913 . . . . 0.37 113.292 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.641 HG12 HG23 ' A' ' 147' ' ' VAL . 42.0 mt -114.5 109.25 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 113.608 -1.633 . . . . 0.53 106.694 161.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.79 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.5 mp0 -91.91 159.54 15.71 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 105.427 -2.064 . . . . 1.13 105.427 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.665 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 17.8 ptp -164.16 162.43 22.77 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.828 0.705 . . . . 1.8 110.785 -172.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.777 HG23 ' HG3' ' A' ' 168' ' ' GLN . 11.9 mt -111.35 108.27 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.008 -0.997 . . . . 0.43 110.531 163.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 195' ' ' PHE . 12.7 tpt180 -45.17 112.19 0.41 Allowed 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 113.511 -1.677 . . . . 3.13 110.076 177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.996 ' HB2' ' CE2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -43.78 98.41 0.18 Allowed Pre-proline 0 C--N 1.318 -0.768 0 O-C-N 125.7 1.875 . . . . 6.16 114.791 -163.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.499 ' HG3' ' HA ' ' A' ' 168' ' ' GLN . 9.0 Cg_endo -94.64 123.17 0.37 Allowed 'Trans proline' 0 N--CA 1.435 -1.923 0 C-N-CA 122.984 2.456 . . . . 2.1 110.312 164.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.996 ' CE2' ' HB2' ' A' ' 157' ' ' ARG . 12.3 m-85 -148.34 151.53 35.5 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.28 -1.378 . . . . 1.83 107.28 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -92.3 78.16 5.12 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.647 1.213 . . . . 3.66 111.307 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 58.3 m-85 -115.9 144.33 32.51 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 113.817 -1.538 . . . . 3.54 109.036 173.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.8 Cg_exo -59.05 -31.08 94.95 Favored 'Trans proline' 0 CA--C 1.501 -1.173 0 C-N-CA 124.619 3.546 . . . . 4.48 112.908 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -95.67 -11.65 26.81 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.82 -1.082 . . . . 5.26 111.416 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.2 m -161.2 103.99 1.28 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.385 -0.37 . . . . 3.43 111.539 -174.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -147.35 90.39 1.87 Allowed 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.973 0.892 . . . . 3.34 110.035 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -110.06 172.82 6.64 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.096 -1.411 . . . . 3.14 111.729 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.62 138.53 19.71 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 114.561 -1.199 . . . . 1.11 113.079 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.777 ' HG3' HG23 ' A' ' 155' ' ' ILE . 7.0 tt0 -62.78 148.95 45.3 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.478 -0.861 . . . . 1.86 113.292 177.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 156' ' ' ARG . 53.9 t -154.4 120.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.053 -1.43 . . . . 0.41 109.212 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 154' ' ' MET . 0.0 OUTLIER -76.84 114.23 15.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.55 -0.537 . . . . 2.8 109.55 170.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.05 131.86 54.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.883 -1.127 . . . . 0.29 110.761 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.77 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 7.1 tpp180 -93.32 97.66 10.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.174 -1.375 . . . . 1.71 110.45 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.9 mp -87.28 91.46 8.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.853 -0.425 . . . . 0.69 109.853 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.4 114.67 27.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-O 122.551 1.167 . . . . 0.26 111.936 -173.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.751 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-30 -82.75 134.32 35.13 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.556 -2.111 . . . . 0.72 110.11 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 34.0 t70 -77.14 66.16 2.89 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.649 -1.611 . . . . 1.09 106.649 163.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.5 -98.09 1.63 Allowed Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 118.678 -1.725 . . . . 0.47 110.158 -174.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -92.23 -13.43 30.49 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.384 0.883 . . . . 0.83 113.384 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -136.09 125.07 24.23 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 119.109 -1.036 . . . . 1.21 110.899 -171.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.751 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.4 tt -53.61 127.67 26.31 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.217 -1.811 . . . . 0.64 111.047 -176.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.45 -38.32 6.22 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.079 -0.964 . . . . 0.29 110.283 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -147.26 166.96 25.46 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.918 -0.583 . . . . 0.33 110.734 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.77 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 32.6 mt -137.12 145.17 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 106.348 -1.723 . . . . 0.76 106.348 168.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 47.5 t -139.11 134.49 41.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 109.533 -0.543 . . . . 0.35 109.533 -174.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.671 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 42.2 t-20 -81.12 103.81 11.18 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.439 -1.319 . . . . 1.77 107.439 -177.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.525 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 33.5 mtm -67.04 -2.51 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 112.875 0.695 . . . . 0.55 112.875 -165.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.671 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.7 pt-20 -83.55 -41.93 17.37 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 122.055 0.931 . . . . 1.02 111.06 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.527 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 0.9 OUTLIER -108.26 -25.36 11.08 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.255 -1.339 . . . . 1.4 109.313 -177.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 75.56 32.59 0.7 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 112.365 -2.198 . . . . 1.33 107.69 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 6.8 ptm180 -88.86 162.28 16.24 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 113.673 -1.603 . . . . 2.28 109.633 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -88.98 139.67 30.22 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.609 -1.178 . . . . 1.36 113.128 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.684 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 5.3 m-85 -105.74 -166.45 1.21 Allowed 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 112.889 -1.959 . . . . 1.18 107.691 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.592 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 138.22 -9.17 3.54 Favored Glycine 0 CA--C 1.485 -1.827 0 N-CA-C 107.791 -2.123 . . . . 1.28 107.791 -147.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -155.9 109.32 2.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.045 -1.077 . . . . 2.8 111.071 155.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.8 t80 -125.12 137.75 54.17 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.228 -0.92 . . . . 0.6 109.342 163.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.662 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.2 mpt_? -123.07 146.4 47.73 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 122.069 -0.394 . . . . 4.77 110.52 -176.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.74 HD13 ' HG ' ' A' ' 127' ' ' LEU . 38.2 mt -137.48 171.1 14.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.869 0.366 . . . . 1.61 111.757 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.453 ' CB ' ' HE ' ' A' ' 157' ' ' ARG . 12.5 t70 -113.86 111.13 48.53 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.609 -0.723 . . . . 2.66 109.62 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.04 126.26 20.53 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.414 2.076 . . . . 2.01 113.099 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.595 ' OXT' ' HA ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.252 0 CA-C-N 115.047 -0.979 . . . . 5.19 111.62 -176.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.724 -0.472 . . . . 26.27 109.724 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.85 -83.62 1.26 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.658 -0.782 . . . . 24.15 111.659 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.3 m 54.03 50.89 15.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.156 0.503 . . . . 23.64 111.414 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -65.81 -38.58 89.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.921 -0.581 . . . . 22.83 110.718 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -114.0 23.75 12.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.244 0.545 . . . . 22.11 110.853 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -118.73 132.97 56.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.616 -0.72 . . . . 22.07 109.209 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 39.8 m80 63.99 30.89 14.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.53 0.681 . . . . 20.59 109.659 -172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -121.4 111.94 17.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.196 -0.911 . . . . 18.44 109.472 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -79.68 146.15 32.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.4 -0.364 . . . . 17.98 110.894 -176.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -83.49 163.52 20.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.136 -0.69 . . . . 17.87 109.136 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.1 m 63.86 94.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.657 0.598 . . . . 16.77 110.989 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 27.1 t -65.21 120.91 13.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.12 -0.491 . . . . 16.32 110.068 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.485 ' HA3' ' SD ' ' A' ' 107' ' ' MET . . . 92.36 -78.71 1.2 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.087 -0.578 . . . . 14.63 112.534 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 99' ' ' GLY . 50.2 tp 74.7 -54.65 0.67 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.651 0.781 . . . . 15.68 110.905 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 35.4 m -83.5 150.16 59.36 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.168 -0.469 . . . . 12.69 110.287 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 101' ' ' VAL . 5.7 Cg_exo -78.45 48.92 2.88 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.872 2.381 . . . . 12.08 112.481 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -87.97 70.29 9.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.257 0.551 . . . . 12.18 110.223 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.91 141.48 7.39 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.851 -0.69 . . . . 8.55 112.065 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 122' ' ' ASN . 8.7 t -83.97 76.31 10.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.039 0.447 . . . . 8.07 110.031 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -136.63 7.33 3.02 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.023 0.379 . . . . 7.76 112.023 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.489 ' H ' HD21 ' A' ' 122' ' ' ASN . 3.8 ptt? -140.92 147.16 38.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.732 0.301 . . . . 6.12 111.041 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.1 -10.57 37.06 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.033 -0.603 . . . . 1.91 112.049 -171.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -26.97 106.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.852 1.261 . . . . 4.32 112.026 167.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 54.2 ttm -143.04 138.33 29.89 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.847 0.684 . . . . 2.59 112.847 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.12 102.12 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 122.524 1.154 . . . . 0.74 112.819 166.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -163.08 109.06 1.14 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 105.95 -1.87 . . . . 1.38 105.95 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.948 HD13 HD21 ' A' ' 173' ' ' LEU . 40.3 mt -93.16 113.58 25.85 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.425 -0.51 . . . . 1.33 110.022 -169.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 117' ' ' MET . 38.5 tt0 -138.78 104.77 7.5 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 120.512 -0.475 . . . . 1.93 110.773 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.495 ' HD3' HD12 ' A' ' 183' ' ' ILE . 31.5 Cg_exo -36.59 128.88 0.46 Allowed 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 124.032 3.155 . . . . 0.65 113.317 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.8 t70 71.94 50.84 0.23 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 122.6 1.19 . . . . 0.72 110.026 -173.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.583 ' HE3' HD13 ' A' ' 180' ' ' LEU . 14.0 ptt? -121.45 155.75 34.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.232 -1.349 . . . . 1.67 110.51 174.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.93 85.93 3.89 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.814 0.816 . . . . 0.58 109.682 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.694 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -111.23 161.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.598 -1.183 . . . . 0.65 110.083 -173.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.733 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.9 m -141.44 176.6 8.74 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.125 -0.695 . . . . 0.44 109.125 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.65 ' HG2' HG21 ' A' ' 147' ' ' VAL . 7.3 mtpp -55.8 -30.55 61.53 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.439 -0.578 . . . . 2.33 109.439 166.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.613 ' O ' HG12 ' A' ' 125' ' ' VAL . 57.5 t30 -86.02 -17.49 35.11 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.979 1.474 . . . . 1.32 114.979 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.733 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.7 mp0 -85.4 -62.63 1.49 Allowed 'General case' 0 N--CA 1.425 -1.703 0 O-C-N 120.581 -1.325 . . . . 2.06 107.749 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.778 ' SD ' HD22 ' A' ' 173' ' ' LEU . 3.6 ttm -59.9 -13.26 10.07 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.03 -1.895 . . . . 3.13 111.23 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 122' ' ' ASN . 14.8 p -42.81 -41.82 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 122.075 0.941 . . . . 0.37 110.306 171.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.618 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.5 OUTLIER -68.87 -39.32 79.9 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.391 -1.277 . . . . 0.63 112.549 177.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.775 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -49.07 -34.0 12.79 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.639 0.733 . . . . 1.79 110.968 168.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 124' ' ' MET . 14.6 mt -84.91 -30.34 24.43 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.934 -1.03 . . . . 0.38 109.529 -172.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.9 -19.23 52.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.046 -1.434 . . . . 1.96 110.502 170.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.38 -40.91 25.64 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.981 -1.463 . . . . 0.64 110.788 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 128' ' ' LEU . 15.0 t -91.53 2.69 56.26 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 123.25 1.5 . . . . 0.59 107.407 175.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 43.99 54.41 5.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 111.438 -2.619 . . . . 1.8 112.948 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.741 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 4.6 t80 -134.27 177.45 7.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.813 -0.63 . . . . 0.52 111.087 -174.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -136.29 148.63 48.07 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.777 -1.194 . . . . 4.54 107.777 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.38 135.2 17.91 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 122.745 1.26 . . . . 1.28 111.374 -172.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.3 p -128.3 133.11 67.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 112.58 -2.1 . . . . 1.05 109.006 -165.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -58.97 -31.85 69.12 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.736 1.255 . . . . 1.38 109.496 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 136' ' ' VAL . 4.1 tmmm? -160.33 132.66 6.26 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 112.297 -2.229 . . . . 1.44 107.498 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.657 ' HB2' ' CD ' ' A' ' 144' ' ' GLU . 8.6 ptt? -115.35 133.04 56.4 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.868 -1.06 . . . . 0.9 112.993 -168.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.46 ' HA ' ' OE1' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -162.51 100.36 1.04 Allowed 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.992 0.901 . . . . 0.61 108.668 152.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -165.61 150.01 7.56 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 113.825 -1.534 . . . . 1.77 108.83 169.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.54 134.57 41.85 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.197 1.265 . . . . 0.62 110.036 170.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.668 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 76.43 54.21 5.19 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.898 -1.144 . . . . 0.51 111.873 -173.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.741 ' HA ' ' CG ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -144.73 178.15 8.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.691 -0.195 . . . . 2.16 110.636 177.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.852 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 53.0 p90 -168.84 170.64 9.03 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.222 -1.029 . . . . 0.28 108.222 176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 139' ' ' MET . 19.0 p -132.98 126.74 32.64 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.148 -0.621 . . . . 0.42 110.864 171.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.747 HG23 HG12 ' A' ' 152' ' ' ILE . 8.7 p -124.64 112.76 33.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.693 0.758 . . . . 0.34 112.004 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -116.7 -66.02 1.13 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.772 -0.649 . . . . 3.11 110.596 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.65 -69.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.276 . . . . 1.65 111.634 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -83.07 10.9 7.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 112.439 0.533 . . . . 1.68 112.439 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -170.42 151.14 3.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.925 0.869 . . . . 0.37 112.792 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.747 HG12 HG23 ' A' ' 147' ' ' VAL . 59.7 mt -120.28 115.74 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 113.707 -1.588 . . . . 0.53 106.961 165.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.852 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 6.9 mp0 -89.64 176.01 7.04 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.558 -1.275 . . . . 1.13 107.558 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 12.8 ptm -169.23 160.82 9.86 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.76 0.663 . . . . 1.8 111.208 178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' A' ' 170' ' ' ARG . 29.3 mt -127.78 115.06 38.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 122.76 0.424 . . . . 0.43 110.81 165.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.781 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 77.6 mtp180 -71.51 91.83 1.08 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.399 -0.364 . . . . 3.13 110.52 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.668 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 36.9 ttp180 -59.87 136.36 90.26 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 107.086 -1.45 . . . . 6.16 107.086 168.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -47.58 125.11 10.49 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.348 1.365 . . . . 2.1 111.15 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 165' ' ' LYS . 11.7 m-85 -123.15 122.84 39.42 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.892 -1.503 . . . . 1.83 107.177 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -97.15 76.75 2.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.798 1.285 . . . . 3.66 110.997 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 97.3 m-85 -116.66 149.48 43.96 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 113.548 -1.66 . . . . 3.54 110.009 175.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 52.8 Cg_exo -56.72 -33.71 94.49 Favored 'Trans proline' 0 CA--C 1.495 -1.464 0 C-N-CA 124.919 3.746 . . . . 4.48 112.912 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.19 -9.52 25.56 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.095 -1.411 . . . . 5.26 111.208 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 48.7 m -162.03 104.03 1.15 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.83 -0.623 . . . . 3.43 110.865 -174.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 86.7 tttt -147.61 102.33 3.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.495 0.664 . . . . 3.34 109.985 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -147.16 159.77 43.23 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.82 -1.082 . . . . 3.14 111.514 -174.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.34 152.77 34.61 Favored Glycine 0 CA--C 1.496 -1.113 0 CA-C-N 113.41 -1.723 . . . . 1.11 112.324 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.781 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.8 tt0 -45.03 141.48 2.25 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 115.342 1.608 . . . . 1.86 115.342 -177.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 78.9 t -154.58 129.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 113.067 -1.878 . . . . 0.41 109.229 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 1.029 ' HG2' ' HE3' ' A' ' 186' ' ' MET . 16.0 ttm180 -91.86 102.33 14.92 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.908 -0.775 . . . . 2.8 108.908 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -105.34 143.74 33.1 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 119.244 -0.983 . . . . 0.29 112.054 -173.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 11.7 tpp180 -99.95 113.62 26.31 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.947 -1.479 . . . . 1.71 110.206 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.948 HD21 HD13 ' A' ' 113' ' ' LEU . 7.2 mp -107.7 102.14 11.39 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.039 -0.664 . . . . 0.69 110.578 175.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.65 125.33 47.06 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-N 114.938 -1.028 . . . . 0.26 111.721 -170.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-30 -89.51 133.26 34.66 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.855 -1.975 . . . . 0.72 110.212 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.2 t70 -74.25 65.78 1.22 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.609 -1.626 . . . . 1.09 106.609 161.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.07 -98.27 1.59 Allowed Glycine 0 N--CA 1.425 -2.09 0 C-N-CA 118.673 -1.727 . . . . 0.47 110.368 -175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -86.92 -20.31 27.55 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.094 0.775 . . . . 0.83 113.094 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -133.15 130.67 39.5 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 119.742 -0.783 . . . . 1.21 110.727 -169.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.694 ' HB2' HG22 ' A' ' 119' ' ' ILE . 4.4 tt -52.64 129.35 29.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 113.933 -1.485 . . . . 0.64 110.803 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.61 -38.24 6.2 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.873 -1.058 . . . . 0.29 109.816 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.3 p -148.34 158.29 44.01 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.841 -0.618 . . . . 0.33 111.502 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.648 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 17.1 mt -125.02 146.58 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 105.827 -1.916 . . . . 0.76 105.827 167.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.5 t -142.09 135.44 28.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.665 0.745 . . . . 0.35 110.743 -171.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.24 95.95 7.1 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 107.497 -1.297 . . . . 1.77 107.497 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 1.029 ' HE3' ' HG2' ' A' ' 170' ' ' ARG . 28.3 mtm -62.35 -2.94 1.15 Allowed 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 114.028 1.122 . . . . 0.55 114.028 -164.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 9.6 pt-20 -81.53 -43.33 18.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.822 0.82 . . . . 1.02 110.705 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.546 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.3 m-20 -105.7 -25.7 12.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.314 -1.312 . . . . 1.4 109.034 -177.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 75.72 31.77 0.71 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.316 -2.22 . . . . 1.33 108.318 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 4.0 ptm180 -91.01 156.12 18.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.147 -1.388 . . . . 2.28 109.778 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.99 132.82 35.4 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.729 -1.123 . . . . 1.36 109.72 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 194' ' ' PHE . 0.1 OUTLIER -107.45 91.29 3.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.796 -0.762 . . . . 1.18 111.35 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.42 -58.1 0.0 OUTLIER Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.506 1.362 . . . . 1.28 116.506 145.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 192' ' ' PHE . 99.7 m-85 -160.34 175.52 12.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.916 -1.642 . . . . 2.8 107.435 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.892 ' HB3' HD12 ' A' ' 113' ' ' LEU . 2.1 t80 -142.77 145.41 33.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.244 -1.021 . . . . 0.6 108.244 153.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.632 ' HD3' ' C ' ' A' ' 195' ' ' PHE . 0.4 OUTLIER -130.52 138.57 50.28 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.15 -0.969 . . . . 4.77 110.798 -171.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 196' ' ' ARG . 2.3 mt -125.52 171.29 10.64 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 113.533 0.938 . . . . 1.61 113.533 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.429 ' HA ' ' HD2' ' A' ' 199' ' ' PRO . 18.2 t70 -77.45 125.41 86.22 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 113.205 -1.816 . . . . 2.66 110.057 176.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.605 ' O ' ' HD3' ' A' ' 200' ' ' ARG . 1.6 Cg_endo -47.73 126.07 12.13 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.155 3.236 . . . . 2.01 114.746 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.605 ' HD3' ' O ' ' A' ' 199' ' ' PRO . 6.7 mmt180 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.533 -0.746 . . . . 5.19 109.801 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.6 tmm? . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.679 -0.489 . . . . 26.27 109.679 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.39 130.27 9.86 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.714 -0.755 . . . . 24.15 111.9 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.1 p -74.93 -31.61 61.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.885 0.374 . . . . 23.64 111.201 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 m -77.71 73.93 4.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.221 0.534 . . . . 22.83 111.075 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -73.56 -18.23 61.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.841 -0.618 . . . . 22.11 110.421 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -75.17 84.67 2.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 22.07 110.534 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -138.56 135.08 34.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.158 -0.473 . . . . 20.59 110.437 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -87.26 102.53 14.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.899 -0.592 . . . . 18.44 110.531 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -112.27 85.13 2.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.122 0.487 . . . . 17.98 110.193 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -89.58 -32.06 17.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.857 -0.61 . . . . 17.87 110.348 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.1 m -71.89 88.92 1.05 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.96 -0.564 . . . . 16.77 110.553 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.0 t -137.16 27.19 2.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.835 -0.621 . . . . 16.32 110.004 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.22 -156.27 18.54 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.694 -0.765 . . . . 14.63 111.844 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 58.66 32.42 22.15 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.282 0.563 . . . . 15.68 110.528 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.41 97.21 35.09 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.612 -0.722 . . . . 12.69 110.76 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -89.97 -2.44 5.57 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.723 2.282 . . . . 12.08 112.438 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -111.54 126.65 55.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.057 -0.519 . . . . 12.18 110.781 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.77 -60.73 4.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.853 -0.689 . . . . 8.55 112.251 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.31 137.17 58.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 8.07 111.382 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -69.42 -29.42 67.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 7.76 109.882 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 49.2 ttm -80.7 143.86 32.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.918 -0.583 . . . . 6.12 109.456 173.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.24 17.32 16.08 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 120.485 -0.864 . . . . 1.91 111.518 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.513 ' HA ' ' HG2' ' A' ' 126' ' ' LYS . 2.0 mtt180 -137.31 90.79 2.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.241 -0.651 . . . . 4.32 109.241 170.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.6 mtt -138.82 127.28 23.07 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.498 -0.881 . . . . 2.59 112.687 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.4 m -121.32 103.22 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 122.496 1.141 . . . . 0.74 112.139 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -161.1 108.35 1.48 Allowed 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.402 -1.726 . . . . 1.38 106.77 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.722 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.9 mp -97.07 78.94 2.81 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.493 -0.929 . . . . 1.33 108.493 -174.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -113.66 95.58 37.39 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.429 -0.805 . . . . 1.93 110.279 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.576 ' HG3' HG12 ' A' ' 183' ' ' ILE . 25.3 Cg_exo -33.68 125.87 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.523 3.482 . . . . 0.65 114.147 -171.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.1 t70 77.62 48.62 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 124.813 1.321 . . . . 0.72 110.125 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.71 154.95 36.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.832 -1.076 . . . . 1.67 110.42 171.173 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -94.6 93.77 7.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.477 -0.783 . . . . 0.58 109.037 -170.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.495 HG21 ' HE2' ' A' ' 117' ' ' MET . 19.7 tt -139.74 169.97 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 114.68 -1.146 . . . . 0.65 110.729 -166.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.625 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 12.1 m -137.98 174.25 10.77 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.947 -0.761 . . . . 0.44 108.947 -177.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.611 ' HA ' HD11 ' A' ' 152' ' ' ILE . 0.5 OUTLIER -66.67 -19.31 65.73 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.179 -1.045 . . . . 2.33 108.179 169.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.555 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 1.8 t30 -83.68 -18.06 39.29 Favored 'General case' 0 C--O 1.2 -1.552 0 CA-C-N 114.401 -1.272 . . . . 1.32 113.596 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.625 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.6 mp0 -86.25 -54.94 4.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 120.483 -1.385 . . . . 2.06 107.32 167.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.713 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.2 mmt -53.8 -13.56 0.74 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.974 -1.921 . . . . 3.13 111.771 168.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 122' ' ' ASN . 14.9 p -43.36 -42.78 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 122.31 1.052 . . . . 0.37 109.58 171.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -65.37 -39.66 92.58 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.715 -1.584 . . . . 0.63 112.939 176.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -51.25 -32.49 24.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.731 0.777 . . . . 1.79 110.94 170.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 127' ' ' LEU . 16.7 mt -85.83 -33.42 21.32 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.005 -0.998 . . . . 0.38 109.568 -172.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.43 ' OE2' ' HE2' ' A' ' 126' ' ' LYS . 2.8 mt-10 -72.26 -23.71 61.25 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.982 -1.463 . . . . 1.96 110.011 169.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.466 ' HA ' ' HG3' ' A' ' 200' ' ' ARG . . . -76.94 -44.3 32.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.679 -1.6 . . . . 0.64 111.598 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.8 t -86.28 -6.57 58.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.538 1.637 . . . . 0.59 107.538 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 58.59 53.46 6.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 111.156 -2.747 . . . . 1.8 112.348 173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.727 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 1.9 t80 -136.3 176.35 8.78 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.882 -0.599 . . . . 0.52 111.769 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 22.9 tpt180 -135.59 152.14 50.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.043 -1.466 . . . . 4.54 107.043 175.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HG3' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -49.68 137.65 15.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.579 1.18 . . . . 1.28 112.512 -170.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.7 p -135.35 142.0 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 112.519 -2.128 . . . . 1.05 109.751 -166.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -58.71 -34.12 70.96 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.684 1.23 . . . . 1.38 109.129 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 5.5 ttpt -159.86 126.14 4.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.424 -2.171 . . . . 1.44 108.385 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.65 ' SD ' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -112.68 130.14 56.15 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.606 -0.725 . . . . 0.9 110.536 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 155' ' ' ILE . 0.9 OUTLIER -158.4 98.15 1.53 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.836 1.303 . . . . 0.61 109.431 152.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.1 OUTLIER -164.93 167.2 10.12 Favored Pre-proline 0 C--N 1.312 -1.033 0 CA-C-N 112.23 -2.259 . . . . 1.77 106.048 167.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.476 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 59.5 Cg_endo -72.26 126.18 11.47 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.426 1.417 . . . . 0.62 112.102 174.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.605 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 95.72 26.04 12.42 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 120.438 -0.887 . . . . 0.51 113.415 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.727 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 6.1 mp0 -126.82 171.42 11.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.1 0.45 . . . . 2.16 110.439 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.681 ' O ' HG12 ' A' ' 136' ' ' VAL . 43.1 p90 -168.4 165.09 12.82 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.481 -0.933 . . . . 0.28 108.481 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.65 HG23 ' SD ' ' A' ' 139' ' ' MET . 53.9 p -126.29 128.95 47.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 116.029 -0.532 . . . . 0.42 110.659 171.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.482 ' CG1' ' HG3' ' A' ' 135' ' ' GLN . 8.5 p -112.76 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.513 0.673 . . . . 0.34 111.093 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -122.95 36.96 4.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.523 -0.762 . . . . 3.11 110.484 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 71.38 -54.51 0.67 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.446 -0.797 . . . . 1.65 112.687 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -87.26 -10.43 52.43 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.895 0.379 . . . . 1.68 111.517 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 1.6 p -161.61 141.99 10.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.904 0.859 . . . . 0.37 112.716 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.611 HD11 ' HA ' ' A' ' 121' ' ' LYS . 35.4 mt -112.56 109.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 113.576 -1.647 . . . . 0.53 108.033 169.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 145' ' ' PHE . 23.6 mt-10 -101.74 103.07 13.81 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.765 -0.828 . . . . 1.13 108.765 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 23.4 ptm -106.66 163.87 12.55 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.301 -0.863 . . . . 1.8 111.764 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.647 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 47.2 mt -130.08 112.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.166 -0.924 . . . . 0.43 110.817 168.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.671 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 56.6 mtm180 -64.34 113.16 3.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.291 -0.413 . . . . 3.13 110.357 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.605 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 79.6 ttt180 -73.72 135.82 77.71 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 107.051 -1.462 . . . . 6.16 107.051 166.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -49.5 125.3 13.63 Favored 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 120.873 1.049 . . . . 2.1 110.146 170.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 24.9 m-85 -117.19 145.77 43.66 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.283 -1.326 . . . . 1.83 108.556 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -97.4 76.31 2.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.544 1.164 . . . . 3.66 111.666 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.512 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 77.0 m-85 -115.98 142.5 29.26 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 113.663 -1.608 . . . . 3.54 108.965 171.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 37.4 Cg_exo -58.73 -28.92 88.12 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 124.769 3.646 . . . . 4.48 113.11 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.45 -10.26 25.72 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.936 -1.029 . . . . 5.26 111.421 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.441 ' HB2' ' OD1' ' A' ' 198' ' ' ASP . 48.9 m -158.22 106.4 1.97 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.2 0.524 . . . . 3.43 111.435 -175.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -147.53 82.66 1.53 Allowed 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.874 0.845 . . . . 3.34 108.807 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -118.63 -177.06 3.22 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.251 -1.34 . . . . 3.14 111.829 -169.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.44 154.89 37.07 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 114.521 -1.218 . . . . 1.11 111.789 173.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 0.7 OUTLIER -54.25 153.88 4.91 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.415 -0.892 . . . . 1.86 112.48 176.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 55.5 t -153.09 129.42 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.128 -0.942 . . . . 0.41 109.663 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.974 ' HG2' ' HE3' ' A' ' 186' ' ' MET . 9.3 ttt180 -88.6 107.55 18.97 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 109.202 -0.666 . . . . 2.8 109.202 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.53 137.14 53.42 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 119.275 -0.97 . . . . 0.29 111.986 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 15.5 tpp85 -99.09 107.37 19.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.762 -1.563 . . . . 1.71 111.455 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 151' ' ' SER . 4.7 mp -94.25 96.27 9.47 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.055 -0.52 . . . . 0.69 109.912 174.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.0 OUTLIER -98.08 118.15 34.04 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.539 1.161 . . . . 0.26 110.9 -178.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 41.9 m-85 -92.31 127.04 37.65 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 112.847 -1.979 . . . . 0.72 110.038 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 17.3 t70 -75.73 65.59 1.91 Allowed 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.643 -1.614 . . . . 1.09 106.643 167.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.32 -100.18 0.78 Allowed Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.404 -1.379 . . . . 0.47 110.897 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -78.44 -21.63 48.88 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 113.24 0.829 . . . . 0.83 113.24 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.445 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 16.3 p-80 -135.82 128.65 31.12 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 119.822 -0.751 . . . . 1.21 110.287 -170.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 3.9 tt -60.26 130.03 44.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.294 -1.321 . . . . 0.64 109.664 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -103.02 -40.93 6.28 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.675 -0.693 . . . . 0.29 110.74 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.6 p -146.86 158.49 43.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.167 0.432 . . . . 0.33 112.167 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.615 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 3.1 mm -115.28 148.28 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 105.139 -2.171 . . . . 0.76 105.139 164.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 25.1 t -139.05 126.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.41 0.624 . . . . 0.35 110.33 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.595 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.6 t-20 -78.1 99.05 5.99 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 107.488 -1.301 . . . . 1.77 107.488 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.974 ' HE3' ' HG2' ' A' ' 170' ' ' ARG . 32.8 mtm -64.36 -2.17 2.08 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.816 1.043 . . . . 0.55 113.816 -166.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.595 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 10.9 pt-20 -80.36 -43.05 21.77 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.039 0.923 . . . . 1.02 110.645 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.524 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 7.8 m120 -109.03 -25.63 10.6 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.995 -1.457 . . . . 1.4 109.579 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 77.56 27.35 0.62 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.689 -2.05 . . . . 1.33 108.044 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.72 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 33.9 mtp180 -74.04 160.67 30.96 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-N 113.76 -1.564 . . . . 2.28 109.68 175.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 96.4 mt-30 -95.38 118.07 31.46 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.484 -1.234 . . . . 1.36 108.462 175.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.615 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -93.63 91.11 6.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.748 -0.781 . . . . 1.18 110.552 -166.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.98 -57.39 0.0 OUTLIER Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.277 1.418 . . . . 1.28 116.407 145.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 192' ' ' PHE . 48.3 p90 -163.73 174.73 11.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 112.701 -1.75 . . . . 2.8 107.584 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.722 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.0 t80 -151.41 98.69 2.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.28 0.562 . . . . 0.6 109.595 158.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.497 ' O ' ' HD2' ' A' ' 196' ' ' ARG . 2.8 ppt_? -90.29 145.57 24.88 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.412 -0.805 . . . . 4.77 111.222 -176.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 127' ' ' LEU . 1.8 mt -119.0 171.82 7.98 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.027 0.917 . . . . 1.61 113.291 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.441 ' OD1' ' HB2' ' A' ' 164' ' ' SER . 8.8 m-20 -76.6 134.98 68.79 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 113.439 -1.709 . . . . 2.66 110.165 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.608 ' O ' ' HD3' ' A' ' 200' ' ' ARG . 3.6 Cg_endo -50.33 126.41 17.5 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 124.21 3.273 . . . . 2.01 114.802 -172.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 199' ' ' PRO . 23.9 mmt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-N 115.556 -0.747 . . . . 5.19 109.606 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.711 ' N ' ' HG ' ' A' ' 90' ' ' SER . 69.9 mtm . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.842 0.353 . . . . 26.27 110.737 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.96 -58.17 4.01 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.819 -0.705 . . . . 24.15 112.881 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.5 m -95.27 2.67 54.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.173 0.511 . . . . 23.64 110.766 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.711 ' HG ' ' N ' ' A' ' 87' ' ' MET . 2.3 p -70.98 133.94 46.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.748 . . . . 22.83 110.611 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.564 ' HA ' ' O ' ' A' ' 97' ' ' SER . 36.1 m80 -105.14 -0.66 26.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.246 0.546 . . . . 22.11 110.487 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -134.87 60.51 1.7 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.629 -0.714 . . . . 22.07 109.523 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -99.18 -44.91 6.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.766 -0.652 . . . . 20.59 109.314 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -163.52 110.43 1.15 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.495 -0.928 . . . . 18.44 108.495 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.43 ' HB3' ' H ' ' A' ' 96' ' ' HIS . 32.1 m170 63.74 -152.72 0.32 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.374 -0.602 . . . . 17.98 109.374 -170.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.43 ' H ' ' HB3' ' A' ' 95' ' ' HIS . 84.8 t60 -82.19 91.36 6.7 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.803 -0.443 . . . . 17.87 109.803 175.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 91' ' ' HIS . 16.3 m -75.57 91.28 2.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.79 -0.641 . . . . 16.77 110.86 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 p -97.49 16.22 20.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.977 -0.556 . . . . 16.32 110.925 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.09 -85.77 0.17 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.413 -0.675 . . . . 14.63 111.413 -176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 50.35 57.28 6.76 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.989 0.424 . . . . 15.68 111.116 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.2 m -71.64 128.73 89.39 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.046 -0.524 . . . . 12.69 111.11 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.32 108.89 1.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.621 2.214 . . . . 12.08 112.186 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.4 ttp-105 -69.32 -26.35 64.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.654 -0.703 . . . . 12.18 109.742 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.56 146.45 12.53 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.145 -0.934 . . . . 8.55 111.454 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.1 p -77.55 68.87 3.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.449 0.643 . . . . 8.07 110.13 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.569 ' HB3' ' SD ' ' A' ' 107' ' ' MET . 89.2 m-70 -120.35 -80.52 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.805 -0.634 . . . . 7.76 111.327 -176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 106' ' ' HIS . 4.2 mpp? -134.95 -174.15 3.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.326 -0.397 . . . . 6.12 110.953 -175.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.9 17.09 11.39 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 118.383 -1.232 . . . . 1.91 114.537 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 13.8 mmt180 14.18 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.842 1.257 . . . . 4.32 112.816 175.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.772 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 15.5 tpt -139.94 124.63 18.27 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.392 0.886 . . . . 2.59 113.392 -165.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.65 HG11 ' N ' ' A' ' 127' ' ' LEU . 0.6 OUTLIER -126.66 107.65 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 114.21 1.189 . . . . 0.74 114.21 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -157.86 107.03 2.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 106.158 -1.793 . . . . 1.38 106.158 163.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.8 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 7.2 mp -85.68 112.66 21.23 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.728 -0.669 . . . . 1.33 110.781 -168.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 33.2 tt0 -156.43 102.07 2.03 Favored Pre-proline 0 N--CA 1.432 -1.328 0 CA-C-N 114.957 -1.019 . . . . 1.93 109.911 -176.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.696 ' HD3' ' CD1' ' A' ' 183' ' ' ILE . 9.7 Cg_exo -30.48 138.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.763 1 C-N-CA 125.654 4.236 . . . . 0.65 114.593 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.6 t70 76.05 40.98 0.24 Allowed 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 124.778 1.299 . . . . 0.72 109.331 -171.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.545 ' HE3' HD13 ' A' ' 180' ' ' LEU . 11.9 ptt? -121.63 154.94 36.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.401 -1.272 . . . . 1.67 109.623 174.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.4 m -103.61 87.36 2.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.836 -1.172 . . . . 0.58 107.836 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.689 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.2 tt -111.08 157.18 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.084 -1.416 . . . . 0.65 110.316 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.79 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 1.9 m -141.24 176.76 8.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.12 -0.696 . . . . 0.44 109.12 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.831 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 5.8 mtpm? -56.27 -28.26 58.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.266 0.555 . . . . 2.33 109.511 165.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.6 t30 -84.26 -19.04 34.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.062 1.134 . . . . 1.32 114.062 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.79 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -88.22 -62.01 1.59 Allowed 'General case' 0 N--CA 1.415 -2.197 0 O-C-N 120.769 -1.207 . . . . 2.06 108.931 176.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.966 ' HG3' HG21 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -58.11 -16.69 14.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 112.994 -1.912 . . . . 3.13 110.382 172.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 11.3 p -42.63 -43.33 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.288 1.042 . . . . 0.37 110.712 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.529 ' CE ' HG13 ' A' ' 125' ' ' VAL . 10.1 mmpt? -69.65 -35.92 75.61 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.22 -1.354 . . . . 0.63 113.132 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.65 ' N ' HG11 ' A' ' 111' ' ' VAL . 9.0 tt -52.92 -34.04 53.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.571 0.7 . . . . 1.79 110.085 168.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 124' ' ' MET . 6.3 mt -83.86 -34.31 24.64 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.471 -0.937 . . . . 0.38 108.471 -171.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.97 -33.23 75.55 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.919 -1.491 . . . . 1.96 109.728 169.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 200' ' ' ARG . . . -72.75 -45.95 56.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.967 -1.47 . . . . 0.64 111.766 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.41 ' HA ' ' HZ ' ' A' ' 159' ' ' PHE . 0.4 OUTLIER -89.87 -1.73 58.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 123.747 1.737 . . . . 0.59 107.741 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 55.5 54.46 8.45 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 110.817 -2.902 . . . . 1.8 112.666 172.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.572 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 3.2 t80 -137.84 175.67 9.38 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.941 -0.572 . . . . 0.52 112.455 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.402 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 30.1 tpt180 -139.17 151.95 47.02 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.57 -1.27 . . . . 4.54 107.57 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 1.5 tm0? -49.22 142.4 7.26 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.335 1.064 . . . . 1.28 113.05 -168.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 145' ' ' PHE . 11.6 p -141.6 139.98 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.64 0 CA-C-N 113.215 -1.811 . . . . 1.05 110.169 -163.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -59.8 -32.31 70.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.511 1.148 . . . . 1.38 109.791 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -159.35 127.78 5.1 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 112.754 -2.021 . . . . 1.44 108.825 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.684 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -117.49 124.02 47.74 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.728 -1.124 . . . . 0.9 111.098 -177.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.715 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.3 t -158.7 95.23 1.3 Allowed 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 123.236 1.493 . . . . 0.61 110.473 154.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.715 ' HD3' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -162.39 155.39 16.99 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 111.71 -2.495 . . . . 1.77 105.706 163.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.524 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 27.8 Cg_exo -61.13 126.05 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 121.15 1.233 . . . . 0.62 110.807 173.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.504 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 92.8 45.04 3.74 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 119.878 -1.153 . . . . 0.51 112.995 -172.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.572 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 37.0 mt-10 -141.88 174.45 10.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.903 0.351 . . . . 2.16 110.534 173.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.868 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.8 p90 -170.47 164.7 8.6 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 107.66 -1.237 . . . . 0.28 107.66 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.676 HG22 ' CG1' ' A' ' 136' ' ' VAL . 1.1 p -134.41 129.17 34.92 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 119.328 -0.949 . . . . 0.42 110.757 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' A' ' 121' ' ' LYS . 10.6 p -122.58 109.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.878 0.846 . . . . 0.34 111.832 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -106.89 -72.33 0.72 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.299 -0.864 . . . . 3.11 110.031 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -160.61 -53.97 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.72 0.295 . . . . 1.65 111.75 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -82.68 -12.63 57.46 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.491 -0.322 . . . . 1.68 111.721 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 15.9 p -160.33 153.26 21.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.13 0.967 . . . . 0.37 112.397 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.966 HG21 ' HG3' ' A' ' 124' ' ' MET . 74.6 mt -110.99 114.24 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 113.33 -1.759 . . . . 0.53 107.002 165.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.2 mp0 -90.59 165.85 13.52 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.978 -1.86 . . . . 1.13 105.978 174.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.639 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 4.3 ppp? -167.64 156.76 9.87 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 124.123 0.89 . . . . 1.8 109.818 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.594 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 13.5 mt -127.28 105.44 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 116.054 -0.521 . . . . 0.43 110.19 171.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.804 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.2 ttt-85 -73.53 88.35 1.64 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.159 -0.928 . . . . 3.13 109.919 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.524 ' HB2' ' C ' ' A' ' 142' ' ' PRO . 53.4 ttt180 -60.55 144.11 89.28 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.064 -0.971 . . . . 6.16 109.854 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 1.4 Cg_endo -48.28 126.36 13.6 Favored 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 121.757 1.638 . . . . 2.1 110.938 166.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 165' ' ' LYS . 13.0 m-85 -125.78 136.57 53.29 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.927 -1.509 . . . . 1.83 106.927 175.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.27 74.34 3.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.645 1.212 . . . . 3.66 111.449 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.499 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 72.6 m-85 -120.69 148.9 49.28 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 113.524 -1.671 . . . . 3.54 110.023 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 32.7 Cg_exo -59.44 -31.84 95.43 Favored 'Trans proline' 0 CA--C 1.502 -1.087 0 C-N-CA 124.749 3.633 . . . . 4.48 113.513 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -88.47 -22.96 23.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.065 -0.971 . . . . 5.26 111.42 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.5 m -154.36 102.04 2.41 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.345 -0.843 . . . . 3.43 111.252 -170.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 64.7 tttm -147.83 98.02 2.9 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.701 -0.681 . . . . 3.34 109.337 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -144.87 179.36 7.38 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.702 -1.136 . . . . 3.14 111.636 -170.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.35 154.04 38.09 Favored Glycine 0 CA--C 1.502 -0.729 0 CA-C-N 114.32 -1.309 . . . . 1.11 111.623 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.804 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 1.3 tt0 -59.63 153.46 19.95 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.393 0.616 . . . . 1.86 112.399 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 45.6 t -153.23 129.55 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.838 -1.074 . . . . 0.41 109.519 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.634 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 27.5 mtm180 -82.82 118.32 23.33 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.049 -0.523 . . . . 2.8 109.847 168.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -118.3 131.05 56.35 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.654 0.74 . . . . 0.29 111.27 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.766 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 8.8 tpp180 -98.21 100.71 12.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.376 -1.283 . . . . 1.71 111.104 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 9.8 mp -87.0 92.38 9.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.175 -0.305 . . . . 0.69 110.175 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.83 120.83 35.7 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 122.626 1.203 . . . . 0.26 111.635 -175.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.6 m-30 -86.93 136.21 33.02 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.792 -2.004 . . . . 0.72 111.049 -176.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.677 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 39.9 t0 -78.82 65.19 3.98 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 106.076 -1.824 . . . . 1.09 106.076 161.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.93 1.52 Allowed Glycine 0 N--CA 1.427 -1.926 0 C-N-CA 118.944 -1.598 . . . . 0.47 110.497 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -82.42 -27.47 31.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.723 0.638 . . . . 0.83 112.723 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -129.85 129.54 44.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.77 0.795 . . . . 1.21 110.615 -167.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.689 ' HB2' HG22 ' A' ' 119' ' ' ILE . 3.9 tt -53.38 128.9 30.18 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.449 -1.705 . . . . 0.64 111.235 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.12 -38.35 6.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.83 -1.077 . . . . 0.29 110.047 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.7 p -146.15 162.58 37.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.655 -0.702 . . . . 0.33 110.648 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.766 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 26.8 mt -134.31 145.2 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 105.735 -1.95 . . . . 0.76 105.735 167.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 43.1 t -136.98 135.18 48.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 109.683 -0.488 . . . . 0.35 109.683 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.626 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 47.2 t-20 -76.94 108.08 9.73 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 106.809 -1.552 . . . . 1.77 106.809 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.634 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 36.3 mtm -67.94 -2.41 7.44 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.545 -0.462 . . . . 0.55 111.976 -169.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.626 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 7.0 pt-20 -85.65 -45.98 11.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.482 0.658 . . . . 1.02 111.321 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.592 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -102.16 -26.24 13.42 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-N 114.802 -1.09 . . . . 1.4 109.36 -176.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 185' ' ' ASN . 52.7 t30 76.48 27.16 0.83 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 112.446 -2.161 . . . . 1.33 107.559 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 17.6 ptt180 -84.56 162.85 19.67 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.14 -1.391 . . . . 2.28 109.249 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -91.98 139.14 30.94 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.562 1.172 . . . . 1.36 112.734 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.687 ' HB2' ' HB ' ' A' ' 183' ' ' ILE . 2.6 m-85 -100.75 -165.73 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.908 -1.951 . . . . 1.18 108.324 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.629 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.14 -5.64 3.61 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.644 -2.183 . . . . 1.28 107.644 -148.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -153.79 119.43 5.25 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.928 -1.136 . . . . 2.8 111.333 157.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.8 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 5.1 t80 -140.77 100.58 3.88 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.17 -0.678 . . . . 0.6 109.17 161.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -102.13 110.47 22.44 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 121.466 -0.771 . . . . 4.77 111.203 -170.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.45 HD23 HD13 ' A' ' 113' ' ' LEU . 4.1 mm? -82.96 168.2 17.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.548 0.69 . . . . 1.61 112.45 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -103.89 96.18 8.87 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.439 -1.255 . . . . 2.66 108.074 172.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -49.07 125.21 12.84 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.131 2.554 . . . . 2.01 113.828 -170.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.726 0 CA-C-N 114.64 -1.164 . . . . 5.19 111.602 -177.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.749 0.309 . . . . 26.27 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.93 -80.11 1.59 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.676 -0.774 . . . . 24.15 112.329 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.7 t -152.93 37.57 0.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.388 0.614 . . . . 23.64 109.988 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 m -89.48 97.35 11.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.912 -0.585 . . . . 22.83 110.743 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -124.48 73.69 1.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.365 -0.38 . . . . 22.11 110.679 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -130.34 -33.84 1.66 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.58 -0.282 . . . . 22.07 111.114 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -149.12 136.98 20.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.069 -0.345 . . . . 20.59 110.069 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -152.13 112.53 4.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.225 0.536 . . . . 18.44 110.252 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -126.9 12.84 7.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.758 -0.656 . . . . 17.98 109.493 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -129.67 19.35 5.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.842 -0.617 . . . . 17.87 110.323 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.7 p -96.98 71.18 2.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.908 -0.587 . . . . 16.77 111.11 -176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.1 p -90.44 -8.09 51.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.88 -0.6 . . . . 16.32 110.552 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.65 -127.1 8.86 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.94 -0.647 . . . . 14.63 111.99 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.41 -17.4 54.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.072 0.463 . . . . 15.68 110.728 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 99.2 t -67.3 125.37 90.96 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.97 -0.559 . . . . 12.69 110.114 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.79 156.75 31.24 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.001 2.467 . . . . 12.08 111.818 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 103' ' ' ARG . 1.5 mpt_? -110.75 -40.19 4.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.443 -0.344 . . . . 12.18 111.061 -175.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.75 36.22 4.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.604 -0.807 . . . . 8.55 112.774 -176.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 107' ' ' MET . 4.3 p -81.01 -33.96 33.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.646 0.26 . . . . 8.07 111.503 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 68.6 -18.0 0.18 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.112 0.782 . . . . 7.76 113.112 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 105' ' ' SER . 54.9 ttm -67.57 100.24 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.869 0.366 . . . . 6.12 110.259 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.45 14.02 62.46 Favored Glycine 0 C--O 1.215 -1.072 0 CA-C-N 115.826 -0.624 . . . . 1.91 111.869 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.41 ' HB3' ' CG ' ' A' ' 126' ' ' LYS . 44.1 mtt180 -138.91 102.66 4.61 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.887 0.875 . . . . 4.32 108.73 175.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.45 ' HB2' ' HG3' ' A' ' 123' ' ' GLU . 21.9 mmt -140.85 135.82 31.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 113.787 1.032 . . . . 2.59 113.787 -166.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.401 HG11 HD12 ' A' ' 197' ' ' LEU . 0.3 OUTLIER -135.57 105.68 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.447 1.118 . . . . 0.74 113.876 172.043 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -160.01 107.75 1.67 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.955 -1.93 . . . . 1.38 105.809 161.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 2.9 mp -87.67 108.7 19.22 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.987 -0.746 . . . . 1.33 108.987 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 117' ' ' MET . 40.2 tt0 -142.78 112.33 5.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 119.309 -0.956 . . . . 1.93 111.123 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.512 ' HG3' HG12 ' A' ' 183' ' ' ILE . 29.1 Cg_exo -35.9 127.79 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.012 3.141 . . . . 0.65 113.016 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 38.3 t70 75.74 43.83 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 O-C-N 124.476 1.11 . . . . 0.72 110.536 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.646 ' HE3' HD13 ' A' ' 180' ' ' LEU . 16.7 ptt? -114.06 154.99 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.818 -1.083 . . . . 1.67 110.14 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -102.77 98.56 8.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.15 -1.056 . . . . 0.58 108.15 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.624 HG13 ' CB ' ' A' ' 123' ' ' GLU . 1.5 tt -134.34 168.68 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 114.821 -1.081 . . . . 0.65 110.573 -164.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.665 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 8.3 m -141.36 175.55 9.57 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 -174.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.576 ' HA ' HD11 ' A' ' 152' ' ' ILE . 19.1 mttp -57.62 -32.72 67.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.304 -0.998 . . . . 2.33 108.304 164.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.713 ' O ' HG12 ' A' ' 125' ' ' VAL . 34.6 t30 -83.02 -19.35 37.11 Favored 'General case' 0 C--O 1.198 -1.632 0 CA-C-N 113.78 -1.555 . . . . 1.32 114.2 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.665 ' HB2' ' H ' ' A' ' 120' ' ' SER . 2.1 mp0 -82.49 -57.83 3.18 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 119.542 -1.974 . . . . 2.06 106.74 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.669 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 2.3 tpp -54.99 -13.76 1.24 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.381 -1.736 . . . . 3.13 111.969 170.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 122' ' ' ASN . 13.1 p -45.24 -39.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 122.246 1.022 . . . . 0.37 110.09 175.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.685 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -66.76 -40.12 88.14 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.93 -1.487 . . . . 0.63 112.685 176.041 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 128' ' ' LEU . 0.6 OUTLIER -49.63 -33.34 15.12 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.378 0.608 . . . . 1.79 111.172 167.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 127' ' ' LEU . 7.1 mt -83.97 -37.75 21.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.246 -0.888 . . . . 0.38 109.187 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.2 -43.26 92.26 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.288 -1.324 . . . . 1.96 110.221 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.44 -45.09 80.99 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.29 -1.777 . . . . 0.64 112.056 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 128' ' ' LEU . 12.3 t -86.4 -2.63 58.6 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 123.664 1.697 . . . . 0.59 107.155 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 53.44 51.02 16.12 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 111.13 -2.759 . . . . 1.8 112.584 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.779 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.2 t80 -136.97 176.5 8.65 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.093 0.473 . . . . 0.52 111.782 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.8 153.84 49.62 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.758 -1.201 . . . . 4.54 107.758 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 19.3 tm0? -51.03 139.05 18.39 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 122.539 1.161 . . . . 1.28 112.341 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.8 p -136.67 140.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 CA-C-N 112.718 -2.037 . . . . 1.05 109.781 -164.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 t -58.95 -32.22 69.42 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 122.347 1.07 . . . . 1.38 109.439 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 27.3 ttpt -160.88 121.29 2.8 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.962 -1.927 . . . . 1.44 109.109 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.653 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -109.88 118.64 37.01 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.996 -1.002 . . . . 0.9 110.894 -177.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.08 96.52 2.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.948 1.356 . . . . 0.61 108.993 157.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.522 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -166.39 169.52 6.38 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 112.04 -2.345 . . . . 1.77 105.548 167.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.522 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 3.3 Cg_exo -77.87 125.12 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.486 1.457 . . . . 0.62 112.471 175.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.662 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 94.54 38.18 5.08 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 120.654 -0.784 . . . . 0.51 113.311 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.779 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 9.4 mp0 -131.69 173.44 11.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 122.604 -0.351 . . . . 2.16 110.079 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.869 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 48.9 p90 -169.0 166.65 11.01 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 107.601 -1.259 . . . . 0.28 107.601 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.699 HG22 HG13 ' A' ' 136' ' ' VAL . 11.9 p -134.52 126.49 29.47 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.739 -0.784 . . . . 0.42 110.751 173.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.774 HG23 HG12 ' A' ' 152' ' ' ILE . 11.1 p -117.68 110.29 30.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.827 0.823 . . . . 0.34 111.121 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -106.25 -75.82 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 3.11 110.204 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.68 -58.06 0.08 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.169 -0.469 . . . . 1.65 110.545 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -92.24 7.49 42.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.122 -0.49 . . . . 1.68 111.924 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 17.8 p -161.25 152.14 18.33 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.938 0.875 . . . . 0.37 112.612 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.774 HG12 HG23 ' A' ' 147' ' ' VAL . 67.6 mt -120.32 109.9 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 113.371 -1.741 . . . . 0.53 106.742 163.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 2.2 mp0 -90.11 170.96 9.88 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.292 -1.744 . . . . 1.13 106.292 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.648 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 10.6 ptm -167.29 158.18 11.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 123.679 0.612 . . . . 1.8 110.869 -173.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.593 HG12 ' HG3' ' A' ' 170' ' ' ARG . 13.0 mt -129.27 112.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.466 -0.788 . . . . 0.43 110.501 168.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.803 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 34.6 mtp180 -71.95 99.72 2.3 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 120.033 -0.667 . . . . 3.13 109.748 177.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.662 ' HB2' ' N ' ' A' ' 143' ' ' GLY . 61.8 ttt180 -65.64 137.59 96.4 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 107.33 -1.359 . . . . 6.16 107.33 171.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -47.1 123.9 8.18 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 120.61 0.873 . . . . 2.1 110.009 169.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 22.7 m-85 -120.26 155.47 33.18 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.865 -1.516 . . . . 1.83 108.613 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -108.33 73.49 0.88 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.768 1.271 . . . . 3.66 111.049 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.482 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 92.8 m-85 -121.49 147.08 46.76 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 113.69 -1.596 . . . . 3.54 110.376 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 31.2 Cg_exo -59.08 -30.03 92.17 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 124.556 3.504 . . . . 4.48 112.847 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -98.18 -7.03 30.17 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.975 -1.011 . . . . 5.26 111.336 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 57.5 m -161.19 99.63 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.167 -0.469 . . . . 3.43 111.621 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 64.1 tttm -148.41 91.95 1.96 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.608 0.718 . . . . 3.34 109.78 174.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -155.26 -177.75 6.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.859 -1.064 . . . . 3.14 112.122 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.59 156.42 38.78 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.36 -0.837 . . . . 1.11 113.502 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.803 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 51.7 tt0 -49.82 147.63 3.63 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.215 -1.493 . . . . 1.86 114.692 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 66.2 t -153.06 131.38 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.377 -1.283 . . . . 0.41 109.884 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.593 ' HG3' HG12 ' A' ' 155' ' ' ILE . 17.3 mtm180 -91.38 111.56 23.11 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.097 -0.502 . . . . 2.8 110.395 169.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.75 146.99 41.43 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.026 0.917 . . . . 0.29 111.619 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.501 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 7.3 tpt180 -111.77 103.79 12.08 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.586 -1.643 . . . . 1.71 110.323 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.653 HD23 ' SD ' ' A' ' 124' ' ' MET . 5.5 mp -92.77 94.33 8.92 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.755 -0.461 . . . . 0.69 109.755 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.68 127.85 40.94 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 122.582 1.182 . . . . 0.26 111.83 -173.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.728 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.3 m-85 -94.16 135.46 35.51 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 112.653 -2.067 . . . . 0.72 110.801 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 18.7 t70 -80.99 64.39 5.73 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 105.925 -1.88 . . . . 1.09 105.925 162.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.72 -99.51 1.13 Allowed Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.219 -1.467 . . . . 0.47 111.004 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.66 -24.69 41.66 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.721 0.637 . . . . 0.83 112.721 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -132.34 128.64 38.13 Favored 'General case' 0 N--CA 1.426 -1.666 0 C-N-CA 119.577 -0.849 . . . . 1.21 110.645 -170.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.8 tt -53.92 130.72 38.38 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 113.585 -1.643 . . . . 0.64 110.26 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.609 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.93 -38.48 6.04 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.443 -0.799 . . . . 0.29 110.499 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.7 p -146.03 164.31 32.52 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.189 -0.46 . . . . 0.33 111.785 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.535 ' HB ' ' CB ' ' A' ' 192' ' ' PHE . 1.6 mm -116.45 148.93 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 105.114 -2.18 . . . . 0.76 105.114 164.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.7 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.1 t -139.78 128.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.416 0.627 . . . . 0.35 109.844 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.587 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 46.6 t-20 -75.94 111.55 11.44 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 107.123 -1.436 . . . . 1.77 107.123 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.54 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 47.2 mtm -70.22 -1.22 9.64 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.478 -0.489 . . . . 0.55 112.101 -169.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.587 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 7.4 pt-20 -83.18 -45.8 13.48 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.614 0.721 . . . . 1.02 111.265 176.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.527 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 5.9 m-20 -103.67 -25.81 13.01 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 114.948 -1.023 . . . . 1.4 109.236 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 185' ' ' ASN . 47.6 t-20 74.28 36.17 0.68 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 112.278 -2.237 . . . . 1.33 107.127 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.7 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 7.2 ptm180 -93.27 161.53 14.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.422 -1.717 . . . . 2.28 109.387 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 78.4 mt-30 -88.17 125.23 34.51 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.99 -1.004 . . . . 1.36 109.46 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.535 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.7 92.28 4.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.884 -0.579 . . . . 1.18 110.446 -170.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.82 -58.03 0.0 OUTLIER Glycine 0 N--CA 1.469 0.881 0 C-N-CA 125.066 1.317 . . . . 1.28 116.334 146.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' PHE . 38.4 p90 -163.62 175.38 10.68 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 113.347 -1.426 . . . . 2.8 108.685 175.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 1.5 t80 -140.79 154.56 46.31 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.911 -1.144 . . . . 0.6 107.911 157.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.719 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -136.04 139.74 43.31 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.636 -0.665 . . . . 4.77 109.992 -170.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.675 HD12 ' HA ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -114.41 172.49 6.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 114.967 1.469 . . . . 1.61 114.967 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.453 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 9.9 p-10 -98.93 172.4 4.77 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 111.902 -2.408 . . . . 2.66 108.723 176.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 198' ' ' ASP . 81.3 Cg_exo -46.43 144.51 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.579 2.186 . . . . 2.01 113.548 172.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.352 0 CA-C-O 118.325 -0.845 . . . . 5.19 109.879 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 110.009 -0.367 . . . . 26.27 110.009 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 68.66 39.43 86.32 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.745 -0.942 . . . . 24.15 110.745 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -79.65 54.31 1.77 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.224 0.535 . . . . 23.64 111.615 -173.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.0 p -77.34 -47.71 19.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.832 -0.622 . . . . 22.83 109.5 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -169.8 -78.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.465 -0.789 . . . . 22.11 109.346 174.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 36.6 m80 53.04 -164.08 0.09 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.433 0.458 . . . . 22.07 111.641 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -68.7 -43.92 75.04 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.044 -0.354 . . . . 20.59 110.044 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 74.5 t60 65.8 -82.69 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.601 -0.727 . . . . 18.44 112.024 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 94' ' ' HIS . 59.0 m-70 69.78 131.44 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.447 0.699 . . . . 17.98 111.606 -174.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -83.38 83.4 7.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.782 -0.644 . . . . 17.87 109.546 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.1 p -69.99 -69.22 0.36 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.555 -0.748 . . . . 16.77 111.499 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 m 57.42 57.42 4.4 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.178 0.513 . . . . 16.32 110.902 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.86 -95.75 0.11 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.965 -0.636 . . . . 14.63 112.154 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.21 -61.88 1.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.528 0.204 . . . . 15.68 110.912 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.7 m -95.95 109.03 44.51 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.049 0.452 . . . . 12.69 111.424 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.91 -4.28 14.73 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.579 2.186 . . . . 12.08 112.885 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -95.87 -36.77 10.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.803 0.335 . . . . 12.18 111.143 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.85 -135.58 37.94 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.005 -0.616 . . . . 8.55 112.379 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.6 m 61.41 -80.99 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.337 0.655 . . . . 8.07 111.957 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -93.54 67.12 3.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.318 0.58 . . . . 7.76 110.607 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.8 mtm -71.4 126.26 29.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.765 -0.652 . . . . 6.12 111.437 -174.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.02 -30.9 9.47 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 115.787 -0.642 . . . . 1.91 112.343 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.856 ' HA ' ' O ' ' A' ' 122' ' ' ASN . 72.6 mtt180 -87.31 91.84 8.86 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.529 -0.915 . . . . 4.32 108.529 177.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.683 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 27.0 ttt -143.89 131.1 20.72 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.96 -1.018 . . . . 2.59 113.203 -163.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 2.7 m -116.58 105.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 122.301 1.048 . . . . 0.74 112.883 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -159.92 106.22 1.61 Allowed 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.292 -1.776 . . . . 1.38 106.247 165.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.829 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.7 mp -97.3 111.52 23.73 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 119.958 -0.697 . . . . 1.33 109.528 -172.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -140.0 104.84 6.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.223 -0.899 . . . . 1.93 109.856 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.516 ' O ' ' HB3' ' A' ' 116' ' ' ASP . 13.1 Cg_exo -33.63 129.74 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 125.157 3.905 . . . . 0.65 114.21 -172.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 35.6 t70 79.61 44.01 0.06 Allowed 'General case' 0 C--N 1.341 0.214 0 O-C-N 124.967 1.417 . . . . 0.72 110.529 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.652 ' SD ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -121.35 155.65 34.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.876 -1.056 . . . . 1.67 110.774 173.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 29.2 m -93.36 77.87 4.47 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 122.282 1.039 . . . . 0.58 109.547 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.712 ' CG2' ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -96.17 161.09 2.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 113.496 -1.684 . . . . 0.65 109.296 -174.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.54 ' H ' HG13 ' A' ' 119' ' ' ILE . 7.6 m -141.78 177.09 8.41 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 118.612 0.642 . . . . 0.44 109.925 -173.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.8 ' HG2' HG21 ' A' ' 147' ' ' VAL . 34.3 mttp -53.42 -33.66 54.8 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.149 -1.056 . . . . 2.33 108.149 163.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.856 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 41.1 t30 -81.88 -18.85 42.36 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 114.311 -1.313 . . . . 1.32 114.177 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.683 ' HA ' ' H ' ' A' ' 110' ' ' MET . 3.4 tt0 -85.64 -62.18 1.59 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.151 -1.593 . . . . 2.06 107.918 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.755 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -58.74 -16.78 18.24 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.455 -1.702 . . . . 3.13 111.143 172.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 122' ' ' ASN . 9.6 p -42.81 -42.73 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 121.99 0.9 . . . . 0.37 111.071 176.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.593 ' CE ' HG13 ' A' ' 125' ' ' VAL . 10.5 mmpt? -67.7 -41.15 84.03 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.44 -1.254 . . . . 0.63 112.154 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.5 tm? -53.12 -32.44 47.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.396 0.617 . . . . 1.79 110.392 167.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' A' ' 124' ' ' MET . 26.2 mt -82.16 -34.0 29.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.756 0.789 . . . . 0.38 109.066 -171.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.18 -37.25 85.17 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.235 -1.348 . . . . 1.96 110.164 167.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -68.6 -41.94 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.675 -1.602 . . . . 0.64 112.512 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.4 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.13 -1.52 57.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 124.176 1.941 . . . . 0.59 106.107 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 56.13 55.19 7.03 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 110.714 -2.948 . . . . 1.8 111.927 170.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 2.5 t80 -138.3 174.94 10.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.479 0.657 . . . . 0.52 112.407 -176.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 134' ' ' ARG . 20.1 ptt85 -141.86 147.61 37.44 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.948 -1.501 . . . . 4.54 106.948 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.83 135.05 20.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.763 1.268 . . . . 1.28 112.455 -171.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 145' ' ' PHE . 12.5 p -134.37 141.04 44.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.386 -2.188 . . . . 1.05 110.14 -162.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.0 m -58.74 -34.28 71.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 122.493 1.139 . . . . 1.38 109.61 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -160.12 128.5 4.81 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 112.782 -2.008 . . . . 1.44 109.101 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.602 ' HB2' ' HB3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -118.43 133.79 55.59 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.838 -1.074 . . . . 0.9 111.612 -173.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.552 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.8 t -162.92 100.21 0.99 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.491 1.138 . . . . 0.61 110.957 153.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.3 OUTLIER -164.51 160.67 15.86 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 113.161 -1.836 . . . . 1.77 106.211 161.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.527 ' CB ' ' HA ' ' A' ' 157' ' ' ARG . 23.3 Cg_exo -62.94 120.92 8.61 Favored 'Trans proline' 0 C--N 1.328 -0.511 0 C-N-CA 121.055 1.17 . . . . 0.62 109.839 170.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.4 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 95.54 38.37 4.75 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 119.716 -1.231 . . . . 0.51 113.102 -170.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 139' ' ' MET . 42.1 mt-10 -140.94 167.55 21.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.889 -0.411 . . . . 2.16 109.889 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.74 ' CD2' HD22 ' A' ' 128' ' ' LEU . 51.3 p90 -167.67 163.43 14.41 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.395 -0.965 . . . . 0.28 108.395 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.513 HG22 HG13 ' A' ' 136' ' ' VAL . 53.6 p -128.87 127.34 41.65 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.061 0.457 . . . . 0.42 110.703 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 121' ' ' LYS . 11.8 p -121.51 116.65 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.555 0.693 . . . . 0.34 111.813 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.519 ' HG3' ' H ' ' A' ' 149' ' ' ALA . 11.0 pt20 -117.43 -62.34 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.863 -0.608 . . . . 3.11 111.247 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.519 ' H ' ' HG3' ' A' ' 148' ' ' GLN . . . -168.97 -63.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 1.65 110.791 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -83.0 4.65 25.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.365 -0.379 . . . . 1.68 111.798 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 16.4 p -165.47 150.0 8.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.978 0.894 . . . . 0.37 112.992 177.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.734 HG12 HG23 ' A' ' 147' ' ' VAL . 65.6 mt -116.5 107.86 23.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 113.333 -1.758 . . . . 0.53 106.326 160.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.537 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 5.5 mt-10 -99.42 102.2 13.7 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.57 -0.9 . . . . 1.13 108.57 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' A' ' 145' ' ' PHE . 8.6 ptm -109.38 156.94 19.42 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.157 -0.929 . . . . 1.8 112.149 -170.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.63 ' CG2' ' HG3' ' A' ' 168' ' ' GLN . 28.8 mt -123.5 119.07 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.322 -1.308 . . . . 0.43 109.991 172.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 46.7 mtm180 -65.57 119.58 11.36 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.437 0.461 . . . . 3.13 110.444 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 142' ' ' PRO . 56.6 ttp180 -68.58 145.22 96.96 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 105.273 -2.121 . . . . 6.16 105.273 162.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -45.84 124.0 6.63 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 CA-C-N 120.782 1.315 . . . . 2.1 111.211 175.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 18.3 m-85 -129.59 151.02 50.66 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.617 -1.629 . . . . 1.83 107.41 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -107.95 81.34 1.48 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.246 1.022 . . . . 3.66 112.347 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 198' ' ' ASP . 36.8 m-85 -87.98 145.37 36.3 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 114.326 -1.306 . . . . 3.54 108.721 170.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.1 Cg_exo -60.23 -29.36 88.84 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 124.328 3.352 . . . . 4.48 112.432 175.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.5 -10.28 22.33 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.538 -1.21 . . . . 5.26 111.44 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.4 t -160.57 101.47 1.34 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.227 0.537 . . . . 3.43 110.559 -173.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -134.53 86.75 2.29 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.327 1.061 . . . . 3.34 109.377 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -144.51 -170.62 3.42 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-N 113.666 -1.607 . . . . 3.14 108.471 -175.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.36 -129.17 0.65 Allowed Glycine 0 N--CA 1.434 -1.471 0 CA-C-O 123.186 1.437 . . . . 1.11 113.36 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.63 ' HG3' ' CG2' ' A' ' 155' ' ' ILE . 6.6 tt0 -83.97 152.79 24.26 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 111.812 -2.194 . . . . 1.86 113.276 -167.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 43.1 t -153.23 128.53 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 114.979 -1.01 . . . . 0.41 109.542 174.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.546 ' HB3' ' CE ' ' A' ' 186' ' ' MET . 15.0 mtt180 -89.86 114.09 25.79 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 120.9 0.381 . . . . 2.8 110.469 170.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -116.79 129.86 56.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.342 1.067 . . . . 0.29 111.278 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 9.5 tpt180 -96.09 100.28 11.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.219 -1.809 . . . . 1.71 110.925 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 151' ' ' SER . 10.7 mp -85.08 93.96 8.74 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.737 -0.468 . . . . 0.69 109.737 172.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.573 HG23 ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -94.59 113.44 25.26 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-O 122.504 1.145 . . . . 0.26 111.687 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -82.77 135.43 34.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.679 -2.055 . . . . 0.72 110.347 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 36.9 t70 -76.59 65.85 2.47 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.345 -1.724 . . . . 1.09 106.345 161.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 76.95 -98.37 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 118.877 -1.63 . . . . 0.47 110.78 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.79 -17.56 37.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.505 0.928 . . . . 0.83 113.505 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -139.45 130.27 26.12 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.506 -0.877 . . . . 1.21 110.628 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.712 ' HB2' ' CG2' ' A' ' 119' ' ' ILE . 4.8 tt -53.66 128.51 29.65 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.122 -1.399 . . . . 0.64 110.568 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -100.89 -39.02 7.98 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.717 -1.129 . . . . 0.29 108.994 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 26.2 p -150.8 158.96 44.78 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.475 -0.784 . . . . 0.33 110.592 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 16.1 mt -120.29 146.67 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 105.063 -2.199 . . . . 0.76 105.063 168.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 22.6 t -138.77 129.73 34.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.36 0.6 . . . . 0.35 110.152 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.593 ' OD1' ' HG2' ' A' ' 187' ' ' GLU . 44.3 t-20 -75.15 101.94 4.77 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 106.817 -1.549 . . . . 1.77 106.817 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.546 ' CE ' ' HB3' ' A' ' 170' ' ' ARG . 36.2 mtm -65.51 -3.09 3.95 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 123.653 0.595 . . . . 0.55 112.516 -167.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.593 ' HG2' ' OD1' ' A' ' 185' ' ' ASN . 8.5 pt-20 -80.1 -43.62 21.4 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.756 0.789 . . . . 1.02 110.813 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.588 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 8.9 m120 -104.91 -25.72 12.48 Favored 'General case' 0 CA--C 1.495 -1.14 0 CA-C-N 114.464 -1.244 . . . . 1.4 109.367 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 58.0 t30 76.19 33.29 0.57 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 112.59 -2.096 . . . . 1.33 107.873 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.641 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 2.3 ptm180 -96.14 157.6 15.82 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 113.707 -1.588 . . . . 2.28 109.846 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.6 126.53 31.84 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.814 -1.084 . . . . 1.36 109.308 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -102.23 90.5 3.94 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.321 -0.552 . . . . 1.18 110.875 -168.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.27 -57.75 0.0 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 116.635 1.414 . . . . 1.28 116.635 145.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.519 ' HB2' ' HD3' ' A' ' 196' ' ' ARG . 3.4 p90 -164.08 175.58 10.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.525 -1.337 . . . . 2.8 109.671 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.829 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.3 t80 -148.34 103.42 3.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.206 0.526 . . . . 0.6 110.899 159.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.519 ' HD3' ' HB2' ' A' ' 194' ' ' PHE . 1.6 mmm180 -95.45 133.65 39.18 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 121.441 -0.787 . . . . 4.77 110.465 -173.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 127' ' ' LEU . 69.0 mt -122.89 171.44 9.21 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 114.388 1.255 . . . . 1.61 114.388 -166.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.459 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 19.0 t70 -101.32 111.28 63.44 Favored Pre-proline 0 C--O 1.22 -0.476 0 CA-C-N 113.935 -1.484 . . . . 2.66 110.554 -176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.44 139.31 17.32 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.602 2.201 . . . . 2.01 113.224 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.576 ' HD3' ' O ' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.5 -0.773 . . . . 5.19 111.157 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 110.053 -0.351 . . . . 26.27 110.053 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 144.24 -85.8 0.18 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.633 -0.794 . . . . 24.15 112.28 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.9 m 69.23 -72.26 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.272 0.629 . . . . 23.64 111.044 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.5 m -86.01 137.88 32.38 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.987 -0.375 . . . . 22.83 109.987 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -68.8 102.83 1.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.356 -0.384 . . . . 22.11 110.543 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -81.58 123.57 28.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 22.07 110.026 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -72.46 -25.59 61.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.132 0.492 . . . . 20.59 110.161 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -115.61 119.22 35.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.725 -0.843 . . . . 18.44 108.725 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -92.69 172.17 8.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.018 0.437 . . . . 17.98 111.398 -174.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -133.85 122.19 22.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.569 -0.742 . . . . 17.87 109.872 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.9 t -71.71 -53.26 14.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.912 -0.586 . . . . 16.77 110.013 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.8 p 45.34 51.66 9.32 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.175 0.59 . . . . 16.32 111.999 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.17 -148.31 21.33 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.653 -0.784 . . . . 14.63 111.998 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.29 -18.66 45.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.013 0.435 . . . . 15.68 109.899 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 p -110.91 100.01 44.76 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.492 0.663 . . . . 12.69 110.468 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -88.25 61.39 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.828 2.352 . . . . 12.08 112.242 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.404 HH12 ' CD ' ' A' ' 123' ' ' GLU . 40.7 ttt180 -101.31 126.63 48.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.228 -0.442 . . . . 12.18 110.895 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -122.32 80.88 0.34 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.138 -0.785 . . . . 8.55 111.138 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.8 t -98.5 172.62 7.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 8.07 110.37 -175.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -135.23 -50.39 0.75 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.699 -0.682 . . . . 7.76 109.979 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.3 mmt -79.4 -52.23 8.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.728 -0.669 . . . . 6.12 110.662 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 123' ' ' GLU . . . 75.58 -31.86 1.21 Allowed Glycine 0 C--O 1.226 -0.378 0 CA-C-N 115.652 -0.703 . . . . 1.91 114.066 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.745 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -35.51 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.58 1.152 . . . . 4.32 113.36 177.411 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 15.6 tpt -142.44 129.92 21.28 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.61 -1.177 . . . . 2.59 111.786 -175.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.9 m -118.56 102.63 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-O 122.731 1.253 . . . . 0.74 111.904 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -162.44 109.59 1.3 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.111 -1.859 . . . . 1.38 106.244 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.789 HD12 ' HB3' ' A' ' 195' ' ' PHE . 52.2 mt -96.38 108.04 20.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.418 -0.586 . . . . 1.33 109.418 -175.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 2.6 tm-20 -142.88 110.14 5.58 Favored Pre-proline 0 C--N 1.309 -1.192 0 C-N-CA 119.298 -0.961 . . . . 1.93 110.442 -175.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.492 ' HG3' HG12 ' A' ' 183' ' ' ILE . 27.9 Cg_exo -35.11 126.61 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 124.25 3.3 . . . . 0.65 113.777 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 22.3 t0 75.9 49.61 0.07 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 122.762 1.267 . . . . 0.72 110.37 -174.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.656 ' HE3' HD13 ' A' ' 180' ' ' LEU . 13.5 ptt? -119.27 155.71 31.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.983 -1.462 . . . . 1.67 109.529 172.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 179' ' ' HIS . 8.0 m -101.76 83.88 2.47 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.365 -0.976 . . . . 0.58 108.365 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -109.0 161.41 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 113.821 -1.536 . . . . 0.65 110.071 -170.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.742 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.4 m -142.79 174.17 10.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.623 -0.881 . . . . 0.44 108.623 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.975 ' HA ' ' SD ' ' A' ' 124' ' ' MET . 19.4 mtpp -54.93 -28.37 50.52 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.671 0.748 . . . . 2.33 109.723 163.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.581 ' O ' HG12 ' A' ' 125' ' ' VAL . 32.4 t30 -85.93 -18.68 32.01 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 114.692 1.367 . . . . 1.32 114.692 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.742 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.0 OUTLIER -86.09 -62.91 1.41 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.565 1.174 . . . . 2.06 108.134 171.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.975 ' SD ' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -58.12 -14.04 6.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 112.347 -2.206 . . . . 3.13 110.871 173.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 122' ' ' ASN . 12.1 p -41.89 -42.32 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.91 0.862 . . . . 0.37 109.637 170.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.745 ' CG ' ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -68.37 -39.96 81.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.579 -1.191 . . . . 0.63 113.834 174.456 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.572 HD23 HD23 ' A' ' 128' ' ' LEU . 0.7 OUTLIER -49.9 -32.2 14.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.446 0.641 . . . . 1.79 111.0 170.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 124' ' ' MET . 8.6 mt -85.67 -37.68 19.18 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 0.38 108.984 -172.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.61 -36.19 77.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.94 -1.482 . . . . 1.96 109.672 168.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.66 -41.27 65.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.879 -1.509 . . . . 0.64 112.208 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.703 HG22 ' HA ' ' A' ' 128' ' ' LEU . 13.5 t -89.04 -0.77 57.71 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 123.255 1.502 . . . . 0.59 107.641 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 52.16 52.21 14.79 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 111.173 -2.739 . . . . 1.8 112.337 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.765 ' CE1' ' HG3' ' A' ' 144' ' ' GLU . 2.3 t80 -138.99 176.19 8.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.52 112.022 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -139.18 153.0 47.84 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.682 -1.229 . . . . 4.54 107.682 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.641 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 17.8 tm0? -50.84 138.95 17.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.535 1.16 . . . . 1.28 112.591 -169.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.5 p -136.22 140.94 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 112.802 -1.999 . . . . 1.05 109.972 -163.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -58.35 -32.77 68.85 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 122.714 1.245 . . . . 1.38 109.478 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 7.0 ttpt -160.22 127.12 4.36 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 112.417 -2.174 . . . . 1.44 108.663 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -112.91 124.02 51.65 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.227 -0.897 . . . . 0.9 110.767 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.16 97.88 1.82 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.99 1.376 . . . . 0.61 109.105 154.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.584 ' HG3' ' CD ' ' A' ' 144' ' ' GLU . 0.1 OUTLIER -165.64 169.51 6.94 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 112.251 -2.249 . . . . 1.77 105.662 166.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.561 ' C ' ' HB2' ' A' ' 157' ' ' ARG . 60.5 Cg_endo -75.88 123.9 7.71 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 120.777 1.313 . . . . 0.62 112.311 173.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.538 ' N ' ' HB2' ' A' ' 157' ' ' ARG . . . 98.25 39.76 3.66 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 120.678 -0.772 . . . . 0.51 113.279 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.765 ' HG3' ' CE1' ' A' ' 133' ' ' TYR . 12.4 mp0 -135.48 173.78 11.33 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 122.829 0.452 . . . . 2.16 110.585 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.882 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 51.3 p90 -169.19 168.62 9.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.245 -1.02 . . . . 0.28 108.245 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.587 ' OG1' ' HB2' ' A' ' 153' ' ' GLU . 40.5 p -135.27 126.46 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.357 -0.537 . . . . 0.42 111.955 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 152' ' ' ILE . 14.8 p -125.37 129.05 73.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.956 -0.565 . . . . 0.34 111.804 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.493 ' HA ' ' OE1' ' A' ' 148' ' ' GLN . 6.1 tp60 -144.2 -70.18 0.3 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.326 -0.55 . . . . 3.11 111.534 176.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.28 -67.46 0.54 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 1.65 112.633 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -87.27 -11.76 48.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.807 0.669 . . . . 1.68 112.807 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 20.6 p -165.05 157.77 16.15 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.873 0.844 . . . . 0.37 112.933 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 147' ' ' VAL . 50.2 mt -114.61 115.76 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.325 0 CA-C-N 114.079 -1.419 . . . . 0.53 107.613 167.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.882 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.3 mp0 -89.33 171.39 9.79 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 106.51 -1.663 . . . . 1.13 106.51 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.623 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 26.7 ptm -167.96 154.16 7.49 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 123.739 0.649 . . . . 1.8 110.348 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.568 HG12 ' CG ' ' A' ' 170' ' ' ARG . 15.5 mt -128.75 114.32 32.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.33 -0.395 . . . . 0.43 110.826 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.709 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 10.0 mtp-105 -72.11 95.76 1.68 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.664 -0.414 . . . . 3.13 111.209 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.561 ' HB2' ' C ' ' A' ' 142' ' ' PRO . 35.9 ttm180 -59.24 131.29 87.47 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.488 -1.671 . . . . 6.16 106.488 163.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -49.95 123.72 11.32 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 CA-C-N 119.844 0.98 . . . . 2.1 110.962 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 6.4 m-85 -124.77 130.89 53.29 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.215 -1.811 . . . . 1.83 106.744 174.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.97 86.76 4.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.531 1.158 . . . . 3.66 111.642 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 72.3 m-85 -116.52 150.97 46.46 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 113.803 -1.544 . . . . 3.54 109.757 172.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 36.2 Cg_exo -60.16 -30.04 90.44 Favored 'Trans proline' 0 CA--C 1.502 -1.117 0 C-N-CA 124.781 3.654 . . . . 4.48 113.174 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.08 -7.94 28.7 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.954 -1.021 . . . . 5.26 111.312 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.4 m -158.48 109.01 2.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.033 0.444 . . . . 3.43 110.999 -176.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -148.02 100.74 3.22 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.613 0.721 . . . . 3.34 109.411 174.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -148.65 164.26 34.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.535 -1.211 . . . . 3.14 110.793 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.58 160.19 45.18 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 113.798 -1.547 . . . . 1.11 111.947 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.709 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 8.2 tt0 -47.06 140.65 4.8 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 114.412 1.264 . . . . 1.86 114.412 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 44.2 t -154.5 130.29 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.707 -1.588 . . . . 0.41 109.99 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.649 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 35.7 mtm180 -86.9 114.77 23.81 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 116.189 -0.46 . . . . 2.8 110.325 168.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -117.0 132.43 56.71 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.844 0.83 . . . . 0.29 111.289 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.556 ' HB3' ' HB ' ' A' ' 184' ' ' VAL . 11.5 tpp180 -99.28 109.08 21.76 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.039 -1.437 . . . . 1.71 111.034 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.616 HD11 HD13 ' A' ' 113' ' ' LEU . 5.4 mp -91.59 91.48 8.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.12 -0.491 . . . . 0.69 109.968 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.7 125.59 37.39 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 122.283 1.04 . . . . 0.26 111.844 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 2.0 m-85 -89.59 138.15 31.72 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 112.953 -1.93 . . . . 0.72 111.579 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 30.3 t70 -81.96 64.99 6.89 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 105.833 -1.914 . . . . 1.09 105.833 159.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.16 -98.75 1.02 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 118.892 -1.623 . . . . 0.47 111.144 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.34 -25.57 46.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.521 0.563 . . . . 0.83 112.521 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' A' ' 118' ' ' THR . 7.1 p80 -135.46 132.88 37.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.369 0.604 . . . . 1.21 110.132 -168.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.713 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.1 tt -54.59 134.02 46.62 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.1 -1.409 . . . . 0.64 110.617 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.605 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.78 -41.54 5.19 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.925 -1.034 . . . . 0.29 110.081 -176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 p -147.21 163.8 35.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.027 -0.533 . . . . 0.33 111.705 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 195' ' ' PHE . 1.6 mm -111.14 148.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 105.144 -2.169 . . . . 0.76 105.144 165.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 19.8 t -141.51 131.79 25.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.407 0.622 . . . . 0.35 109.947 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.583 ' CG ' ' HG2' ' A' ' 187' ' ' GLU . 40.7 t-20 -79.44 110.11 14.43 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.124 -1.065 . . . . 1.77 108.124 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.649 ' HB2' ' HB3' ' A' ' 170' ' ' ARG . 16.3 mtp -65.91 -2.46 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.036 0.754 . . . . 0.55 113.036 -171.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.583 ' HG2' ' CG ' ' A' ' 185' ' ' ASN . 8.3 pt-20 -81.18 -42.53 20.67 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.817 0.818 . . . . 1.02 111.153 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.49 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 6.1 m-20 -111.24 -26.55 9.11 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.391 -1.277 . . . . 1.4 109.738 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.2 t30 76.28 34.47 0.5 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 112.519 -2.128 . . . . 1.33 107.642 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 184' ' ' VAL . 5.2 ptm180 -90.31 162.92 14.94 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.427 -1.715 . . . . 2.28 108.641 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -88.02 140.17 29.77 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.727 -0.67 . . . . 1.36 110.001 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.519 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 0.1 OUTLIER -114.08 92.31 3.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 118.701 -0.666 . . . . 1.18 110.523 -176.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 19.08 -58.63 0.0 OUTLIER Glycine 0 N--CA 1.469 0.839 0 N-CA-C 116.15 1.22 . . . . 1.28 116.15 146.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 192' ' ' PHE . 35.0 p90 -163.42 174.23 12.18 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.702 -1.249 . . . . 2.8 109.25 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.789 ' HB3' HD12 ' A' ' 113' ' ' LEU . 1.4 t80 -140.31 154.45 46.8 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.201 -0.666 . . . . 0.6 109.201 159.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.666 ' H ' ' HD2' ' A' ' 196' ' ' ARG . 0.1 OUTLIER -138.53 153.97 48.76 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.806 -0.559 . . . . 4.77 111.933 -178.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.585 HD21 ' HE1' ' A' ' 154' ' ' MET . 5.1 mt -129.55 172.72 11.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.425 1.268 . . . . 1.61 114.425 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.453 ' OD2' ' HD2' ' A' ' 159' ' ' PHE . 3.2 m-20 -85.7 137.93 35.85 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 112.38 -2.191 . . . . 2.66 111.03 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.74 ' O ' ' HD2' ' A' ' 200' ' ' ARG . 8.1 Cg_endo -54.83 136.61 72.64 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.13 3.22 . . . . 2.01 114.481 -176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.74 ' HD2' ' O ' ' A' ' 199' ' ' PRO . 14.2 mmm180 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.883 -0.579 . . . . 5.19 109.83 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 121.017 0.437 . . . . 26.27 110.238 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.25 -111.96 0.5 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.576 -0.61 . . . . 24.15 111.576 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' HD2' ' A' ' 91' ' ' HIS . 24.0 t 58.29 40.05 24.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.953 0.406 . . . . 23.64 110.932 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.8 m 70.43 12.58 7.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.571 -0.74 . . . . 22.83 112.147 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.415 ' HD2' ' O ' ' A' ' 89' ' ' SER . 10.5 p80 -152.32 59.9 0.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.54 0.686 . . . . 22.11 110.603 175.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -59.2 -27.82 66.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.73 -0.668 . . . . 22.07 110.571 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -154.45 156.35 36.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.01 -0.541 . . . . 20.59 109.76 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -85.34 151.29 24.14 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.754 -0.461 . . . . 18.44 109.754 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -58.54 -74.92 0.06 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.568 0.581 . . . . 17.98 112.568 -167.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -85.88 -1.11 56.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 17.87 111.144 -174.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 m -80.64 -17.85 49.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.167 0.508 . . . . 16.77 109.893 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.8 m -94.94 79.69 3.64 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.957 -0.565 . . . . 16.32 110.427 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.95 -164.0 18.44 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.665 -0.698 . . . . 14.63 111.595 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.9 mt -92.53 122.26 34.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.272 -0.269 . . . . 15.68 110.272 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 p 37.4 88.7 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.736 0 O-C-N 124.515 1.134 . . . . 12.69 113.324 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.79 66.22 6.7 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.841 2.361 . . . . 12.08 112.446 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -68.09 -63.32 1.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.205 -0.452 . . . . 12.18 111.488 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.18 59.67 4.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 8.55 112.666 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.481 ' HA ' ' CD ' ' A' ' 109' ' ' ARG . 50.6 m -96.53 80.97 3.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.091 0.472 . . . . 8.07 111.354 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -95.74 49.3 1.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.079 -0.509 . . . . 7.76 109.766 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 53.6 tpp 65.46 98.08 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.225 0.824 . . . . 6.12 113.225 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.36 -28.87 12.14 Favored Glycine 0 C--O 1.224 -0.502 0 CA-C-O 118.565 -1.13 . . . . 1.91 114.87 168.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.481 ' CD ' ' HA ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -20.32 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.68 0.993 . . . . 4.32 113.68 175.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.423 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 16.2 tpt -141.37 132.57 26.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.332 -0.547 . . . . 2.59 112.015 -173.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 197' ' ' LEU . 13.3 m -121.88 104.29 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 122.814 1.292 . . . . 0.74 113.037 171.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.407 ' O ' ' HE1' ' A' ' 117' ' ' MET . 63.1 t30 -161.01 110.72 1.67 Allowed 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 105.011 -2.218 . . . . 1.38 105.011 166.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.597 HD21 ' SD ' ' A' ' 124' ' ' MET . 59.1 mt -97.16 115.22 27.16 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.967 -0.693 . . . . 1.33 110.963 -174.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.478 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 21.9 tt0 -155.34 91.26 2.86 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 121.649 0.738 . . . . 1.93 109.279 -173.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.759 ' HD3' HD12 ' A' ' 183' ' ' ILE . 0.3 OUTLIER -31.49 144.22 0.03 OUTLIER 'Trans proline' 0 CA--C 1.509 -0.76 1 C-N-CA 126.671 4.914 . . . . 0.65 115.536 -175.946 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 33.3 t70 78.05 36.61 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 113.757 -1.565 . . . . 0.72 109.057 -170.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.433 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 7.2 ptp -121.09 155.43 34.46 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.768 -1.106 . . . . 1.67 111.09 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.7 m -101.37 84.47 2.62 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.224 -1.028 . . . . 0.58 108.224 -175.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.721 HG22 ' HB2' ' A' ' 180' ' ' LEU . 1.1 tt -110.03 163.91 6.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 114.055 -1.43 . . . . 0.65 109.854 -168.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.647 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 3.8 m -140.87 177.41 8.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.064 -0.655 . . . . 0.44 109.913 -172.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.621 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -60.97 -27.07 68.01 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 108.145 -1.057 . . . . 2.33 108.145 165.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.591 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER -84.54 -17.73 37.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.996 -1.456 . . . . 1.32 114.416 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.647 ' HB2' ' H ' ' A' ' 120' ' ' SER . 1.9 mp0 -85.48 -62.39 1.54 Allowed 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 120.56 -1.337 . . . . 2.06 108.421 170.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.779 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.5 mmt -57.02 -16.52 7.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.166 -1.834 . . . . 3.13 111.901 173.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.621 ' HB ' ' O ' ' A' ' 121' ' ' LYS . 14.9 p -42.34 -42.82 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.219 1.009 . . . . 0.37 110.797 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.674 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -67.83 -41.24 83.3 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.947 -1.478 . . . . 0.63 113.087 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.507 HD23 ' HB3' ' A' ' 197' ' ' LEU . 2.9 tm? -52.61 -32.73 43.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.29 0.567 . . . . 1.79 110.273 167.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' A' ' 124' ' ' MET . 15.8 mt -82.34 -35.92 27.4 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.442 0.639 . . . . 0.38 109.541 -172.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 200' ' ' ARG . 0.5 OUTLIER -57.77 -44.7 86.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.664 -1.153 . . . . 1.96 109.944 164.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -65.09 -39.64 93.46 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.209 -1.814 . . . . 0.64 112.636 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 128' ' ' LEU . 2.8 t -93.19 3.92 54.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 106.191 -1.781 . . . . 0.59 106.191 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.84 52.24 9.88 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 110.84 -2.891 . . . . 1.8 111.88 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 144' ' ' GLU . 2.6 t80 -136.7 175.17 9.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 119.901 -0.72 . . . . 0.52 112.725 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -139.67 149.9 44.26 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.664 -1.606 . . . . 4.54 106.664 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.7 OUTLIER -49.92 141.52 10.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.534 1.159 . . . . 1.28 113.136 -169.028 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 145' ' ' PHE . 14.1 p -139.91 141.46 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.957 -1.929 . . . . 1.05 110.07 -162.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.9 m -58.85 -34.59 71.77 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 122.607 1.194 . . . . 1.38 109.232 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -160.81 130.29 4.9 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 112.491 -2.141 . . . . 1.44 109.259 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.672 ' HB2' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -119.08 125.82 50.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.624 -1.171 . . . . 0.9 112.117 -172.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.491 ' HA ' HD11 ' A' ' 155' ' ' ILE . 1.7 t -160.64 99.79 1.28 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 122.931 1.348 . . . . 0.61 110.865 156.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.504 ' H ' HD12 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -165.73 157.89 12.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 105.501 -2.037 . . . . 1.77 105.501 163.379 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -61.13 113.68 1.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.088 1.424 . . . . 0.62 109.727 171.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.416 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 105.45 47.71 1.1 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.214 -0.993 . . . . 0.51 113.272 -175.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.582 ' HA ' ' CD1' ' A' ' 133' ' ' TYR . 44.3 mt-10 -145.73 170.7 15.97 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 122.532 0.333 . . . . 2.16 110.264 172.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.863 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 49.8 p90 -167.8 165.31 14.09 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.918 -1.141 . . . . 0.28 107.918 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.667 HG22 HG13 ' A' ' 136' ' ' VAL . 35.9 p -132.17 126.11 32.83 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.862 -0.735 . . . . 0.42 110.843 175.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.747 HG23 HG12 ' A' ' 152' ' ' ILE . 8.6 p -125.18 169.07 17.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.798 -0.637 . . . . 0.34 111.413 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 18.7 tm0? 78.05 75.56 0.06 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.637 0.775 . . . . 3.11 110.215 176.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -177.85 -94.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.373 -1.285 . . . . 1.65 109.167 175.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -135.68 11.89 3.43 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.13 0.491 . . . . 1.68 110.443 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 3.3 p -165.8 158.06 14.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.457 0.646 . . . . 0.37 112.265 -171.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.747 HG12 HG23 ' A' ' 147' ' ' VAL . 38.5 mt -107.69 106.51 20.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 106.458 -1.682 . . . . 0.53 106.458 159.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.863 ' O ' ' HB2' ' A' ' 145' ' ' PHE . 1.7 mt-10 -91.07 164.18 14.04 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 104.779 -2.304 . . . . 1.13 104.779 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.593 ' O ' ' HA ' ' A' ' 170' ' ' ARG . 19.2 ptp -166.06 164.0 18.16 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.871 0.732 . . . . 1.8 110.221 -170.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.823 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 10.2 mt -127.95 94.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.854 0.835 . . . . 0.43 110.698 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.713 ' O ' ' HD3' ' A' ' 156' ' ' ARG . 1.3 tmt_? -127.94 97.59 4.86 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.496 -1.229 . . . . 3.13 111.857 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.619 ' HB3' ' HA ' ' A' ' 168' ' ' GLN . 9.0 tpt180 -128.65 163.89 41.98 Favored Pre-proline 0 C--N 1.292 -1.891 0 N-CA-C 104.852 -2.277 . . . . 6.16 104.852 153.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.447 ' HD2' ' HG3' ' A' ' 157' ' ' ARG . 19.2 Cg_exo -43.02 126.0 4.37 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 CA-C-N 120.611 1.254 . . . . 2.1 111.068 165.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.573 ' HB2' ' CE2' ' A' ' 161' ' ' PHE . 85.9 m-85 -79.54 169.46 17.99 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 112.772 -2.013 . . . . 1.83 109.829 -175.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 165' ' ' LYS . 6.4 p-10 -69.1 77.9 0.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.458 1.123 . . . . 3.66 112.014 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 159' ' ' PHE . 31.2 m-85 -114.08 153.05 46.31 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 113.619 -1.628 . . . . 3.54 109.229 172.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 38.4 Cg_exo -60.63 -34.29 92.42 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 124.284 3.323 . . . . 4.48 113.124 176.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -92.12 -11.28 36.1 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.073 -0.967 . . . . 5.26 111.759 -176.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 58.4 m -161.27 111.79 1.7 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.128 -1.064 . . . . 3.43 108.128 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 160' ' ' ASP . 25.8 tptp -137.96 103.58 5.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.683 0.754 . . . . 3.34 110.207 -174.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -134.61 162.92 30.94 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.411 -1.268 . . . . 3.14 111.611 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 157' ' ' ARG . . . -81.21 127.31 7.84 Favored Glycine 0 CA--C 1.494 -1.232 0 CA-C-N 114.048 -1.433 . . . . 1.11 111.089 172.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.619 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 2.6 pm0 -53.16 -176.19 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 114.821 1.415 . . . . 1.86 114.821 -173.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 4.0 t -155.5 127.69 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 113.706 -1.588 . . . . 0.41 110.334 -169.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 154' ' ' MET . 22.2 mtm180 -93.63 115.24 27.7 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.583 0.23 . . . . 2.8 110.551 171.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -112.9 130.2 56.19 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.93 0.872 . . . . 0.29 110.904 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.75 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 10.8 tpt180 -96.09 98.48 10.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.762 -1.563 . . . . 1.71 110.901 -177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 152' ' ' ILE . 7.0 mp -88.49 97.8 11.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 110.169 -0.308 . . . . 0.69 110.169 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.427 HG23 ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -97.19 117.11 30.67 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.576 1.179 . . . . 0.26 111.672 -173.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 1.1 m-85 -85.45 131.92 34.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.689 -2.05 . . . . 0.72 110.03 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 38.2 t70 -76.9 65.3 2.56 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.199 -1.778 . . . . 1.09 106.199 164.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 72.96 -98.55 0.88 Allowed Glycine 0 N--CA 1.426 -2.028 0 C-N-CA 119.138 -1.506 . . . . 0.47 110.526 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -76.71 -26.34 54.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.88 0.696 . . . . 0.83 112.88 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.476 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 5.7 p-80 -137.34 130.02 30.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.636 0.732 . . . . 1.21 111.187 -167.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.721 ' HB2' HG22 ' A' ' 119' ' ' ILE . 5.3 tt -53.13 127.75 25.31 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.93 -1.487 . . . . 0.64 110.87 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.51 -39.39 5.88 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.253 -0.885 . . . . 0.29 110.186 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.8 p -145.96 166.66 25.38 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.965 -0.562 . . . . 0.33 110.885 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.759 HD12 ' HD3' ' A' ' 115' ' ' PRO . 38.5 mt -136.59 145.48 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 106.025 -1.843 . . . . 0.76 106.025 169.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 190' ' ' ARG . 38.8 t -139.16 132.94 39.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.295 0.569 . . . . 0.35 109.996 -173.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.471 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 0.2 OUTLIER -80.55 103.34 10.33 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.577 -1.268 . . . . 1.77 107.577 -176.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 29.5 mtm -65.92 -1.59 3.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 123.861 0.726 . . . . 0.55 112.722 -166.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 11.7 pt-20 -77.13 -45.62 26.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.015 0.912 . . . . 1.02 110.696 174.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 190' ' ' ARG . 27.0 t-20 -108.65 -26.31 10.43 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.125 -1.398 . . . . 1.4 109.249 -174.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.3 t30 78.09 26.93 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 112.654 -2.066 . . . . 1.33 107.109 -174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.471 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 16.7 ptt180 -85.0 160.64 20.0 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.841 -1.527 . . . . 2.28 109.651 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.66 141.41 28.54 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.457 -1.247 . . . . 1.36 113.518 -172.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.695 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 5.8 m-85 -106.85 -166.56 1.18 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 112.635 -2.075 . . . . 1.18 107.092 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.549 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 137.55 -10.72 3.75 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 107.591 -2.203 . . . . 1.28 107.591 -149.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 196' ' ' ARG . 27.4 p90 -155.76 105.39 2.4 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.196 -1.002 . . . . 2.8 111.267 156.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.0 t80 -119.57 132.75 55.8 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.13 -0.981 . . . . 0.6 109.325 166.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.583 ' HD2' ' C ' ' A' ' 195' ' ' PHE . 3.1 mpt_? -115.92 146.35 42.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.867 -0.42 . . . . 4.77 109.867 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . 33.0 mt -127.73 162.78 25.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.431 -0.35 . . . . 1.61 111.577 -171.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -94.27 163.21 23.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 2.66 110.61 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -45.26 148.01 2.11 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.151 2.567 . . . . 2.01 113.23 173.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.486 ' O ' ' HD2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.855 -0.611 . . . . 5.19 110.731 -174.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.1 ttm . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.945 -0.391 . . . . 26.27 109.945 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.08 24.39 57.63 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.893 -0.67 . . . . 24.15 111.86 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 4.9 m -84.25 157.72 21.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.755 0.312 . . . . 23.64 110.819 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.1 m -85.27 102.57 13.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.719 -0.475 . . . . 22.83 109.719 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 49.7 t60 62.13 71.99 0.52 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.381 0.61 . . . . 22.11 109.841 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 89' ' ' SER . 33.9 t60 -76.53 82.7 3.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.511 -0.768 . . . . 22.07 110.239 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 -155.87 0.63 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.494 -0.776 . . . . 20.59 109.759 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 71.54 -77.95 0.05 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.319 0.648 . . . . 18.44 109.62 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -147.29 -74.33 0.2 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.435 -0.95 . . . . 17.98 108.435 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -135.76 -58.86 0.77 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.045 -0.724 . . . . 17.87 109.045 172.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 m 57.21 68.29 0.87 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.504 -0.771 . . . . 16.77 112.19 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 p -94.18 -12.29 28.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.966 -0.561 . . . . 16.32 110.516 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.61 70.44 0.8 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.888 -0.672 . . . . 14.63 112.244 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.5 tp -70.08 120.21 15.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.762 0.315 . . . . 15.68 110.593 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.14 97.37 38.64 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 121.082 0.468 . . . . 12.69 110.702 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.79 -178.49 3.13 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.709 2.273 . . . . 12.08 111.98 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -64.21 -64.13 0.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.404 -0.591 . . . . 12.18 109.404 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.02 159.54 19.04 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.886 -0.673 . . . . 8.55 112.996 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 p -127.68 138.85 52.94 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.146 -0.316 . . . . 8.07 110.146 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.468 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 32.6 m80 64.35 78.17 0.29 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.539 0.524 . . . . 7.76 110.378 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 27.1 mmt -62.19 117.97 6.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.979 -0.555 . . . . 6.12 111.053 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.93 -8.61 59.58 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.999 -0.619 . . . . 1.91 112.402 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HB2' ' CG ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -140.59 75.12 1.49 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.447 0.699 . . . . 4.32 109.985 173.354 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.72 ' H ' ' HA ' ' A' ' 123' ' ' GLU . 9.2 ttt -137.65 97.64 3.49 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 118.098 -1.441 . . . . 2.59 113.748 -163.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 127' ' ' LEU . 1.6 m -101.42 107.79 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 113.548 0.944 . . . . 0.74 113.548 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -159.2 110.88 2.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 105.922 -1.881 . . . . 1.38 105.922 166.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.804 ' HB2' ' O ' ' A' ' 195' ' ' PHE . 4.4 mp -100.72 116.15 31.94 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.461 -0.496 . . . . 1.33 110.406 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 115' ' ' PRO . 0.3 OUTLIER -154.01 90.24 3.3 Favored Pre-proline 0 N--CA 1.432 -1.371 0 N-CA-C 109.089 -0.708 . . . . 1.93 109.089 -177.187 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.729 ' HD3' HD12 ' A' ' 183' ' ' ILE . 1.3 Cg_exo -29.04 144.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 1 C-N-CA 126.755 4.97 . . . . 0.65 116.467 -175.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 36.9 t70 74.68 37.66 0.52 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 113.791 -1.55 . . . . 0.72 108.781 -172.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.443 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 5.8 ptp -120.9 155.88 33.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.199 -1.364 . . . . 1.67 110.893 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.1 m -101.33 82.25 2.3 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 122.42 1.105 . . . . 0.58 108.33 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.532 HG13 ' CB ' ' A' ' 123' ' ' GLU . 17.8 tt -121.54 165.11 17.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.349 -1.75 . . . . 0.65 108.668 -169.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.526 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 4.2 m -140.1 175.66 9.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.713 -0.795 . . . . 0.44 111.405 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.653 ' HG2' HG21 ' A' ' 147' ' ' VAL . 1.8 mptt -59.95 -20.14 55.89 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.044 -0.98 . . . . 2.33 108.91 169.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.705 ' O ' HG12 ' A' ' 125' ' ' VAL . 9.2 t30 -83.03 -21.87 33.71 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 114.062 -1.426 . . . . 1.32 112.757 176.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.72 ' HA ' ' H ' ' A' ' 110' ' ' MET . 1.2 mp0 -85.94 -48.46 8.68 Favored 'General case' 0 N--CA 1.408 -2.533 0 O-C-N 120.01 -1.681 . . . . 2.06 107.825 173.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.745 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 mpt? -62.59 -18.03 61.32 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 113.762 -1.563 . . . . 3.13 111.264 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 122' ' ' ASN . 11.7 p -47.34 -40.74 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 122.324 1.059 . . . . 0.37 110.569 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.598 ' HA ' ' CE ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -66.94 -41.04 87.63 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.872 -1.513 . . . . 0.63 113.351 177.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.723 ' HG ' HD13 ' A' ' 197' ' ' LEU . 2.9 tm? -52.11 -34.93 46.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.532 0.682 . . . . 1.79 110.156 168.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 124' ' ' MET . 18.0 mt -83.23 -36.24 24.76 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.783 0.801 . . . . 0.38 109.054 -170.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.82 -39.64 92.49 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.114 -1.403 . . . . 1.96 109.468 167.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 127' ' ' LEU . . . -67.34 -43.29 81.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.306 -1.315 . . . . 0.64 112.252 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.458 ' OG1' ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -91.52 2.98 56.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 124.373 2.035 . . . . 0.59 106.336 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 56.09 46.37 21.76 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 110.341 -3.118 . . . . 1.8 112.409 169.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.922 ' CE1' ' HG2' ' A' ' 144' ' ' GLU . 2.9 t80 -136.77 174.88 10.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.84 -0.744 . . . . 0.52 112.753 -173.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.426 ' N ' ' CG ' ' A' ' 133' ' ' TYR . 31.8 ttm180 -142.97 154.72 44.33 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.016 -1.476 . . . . 4.54 107.016 177.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 13.6 tm0? -49.43 142.88 7.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.593 1.187 . . . . 1.28 113.714 -167.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 145' ' ' PHE . 13.3 p -142.97 142.03 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 112.752 -2.022 . . . . 1.05 110.304 -163.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 -34.05 70.01 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.718 1.247 . . . . 1.38 109.17 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -158.86 123.05 3.98 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.508 -2.133 . . . . 1.44 108.653 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.682 ' SD ' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -111.2 128.55 55.95 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.095 -0.957 . . . . 0.9 110.209 -178.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.596 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 1.2 t -160.89 99.15 1.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 122.756 1.265 . . . . 0.61 109.97 158.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.596 ' HD2' ' O ' ' A' ' 140' ' ' THR . 0.0 OUTLIER -165.18 168.52 8.38 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 112.595 -2.093 . . . . 1.77 105.618 162.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.516 ' HB3' ' HA ' ' A' ' 157' ' ' ARG . 14.9 Cg_exo -66.02 119.25 6.25 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 N-CA-C 109.192 -1.118 . . . . 0.62 109.192 167.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.458 ' HA2' ' OG1' ' A' ' 131' ' ' THR . . . 90.94 47.96 3.5 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.513 -1.327 . . . . 0.51 113.161 -171.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.922 ' HG2' ' CE1' ' A' ' 133' ' ' TYR . 2.1 mt-10 -150.62 147.17 27.09 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.845 -0.798 . . . . 2.16 108.845 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.733 ' O ' HG12 ' A' ' 136' ' ' VAL . 38.4 p90 -154.19 160.64 41.96 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.729 -0.841 . . . . 0.28 108.729 -177.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.682 HG23 ' SD ' ' A' ' 139' ' ' MET . 39.1 p -125.24 127.64 47.06 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.496 0.665 . . . . 0.42 110.606 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.653 HG21 ' HG2' ' A' ' 121' ' ' LYS . 12.8 p -121.43 113.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.187 -0.915 . . . . 0.34 110.911 176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -111.53 -80.78 0.58 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.62 -0.718 . . . . 3.11 110.321 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.09 -54.84 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.72 -0.673 . . . . 1.65 110.049 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -96.47 8.24 44.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.964 -0.562 . . . . 1.68 112.264 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.688 ' HA ' ' O ' ' A' ' 173' ' ' LEU . 23.1 p -164.13 147.01 9.34 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.947 1.092 . . . . 0.37 113.947 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 147' ' ' VAL . 54.9 mt -115.03 107.8 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 112.907 -1.951 . . . . 0.53 106.852 163.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.544 ' HG2' ' SD ' ' A' ' 186' ' ' MET . 6.4 mt-10 -102.29 103.68 14.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.466 -0.939 . . . . 1.13 108.466 -176.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.454 ' SD ' ' HE1' ' A' ' 195' ' ' PHE . 6.0 ptm -117.04 155.19 29.64 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.928 -1.033 . . . . 1.8 112.465 -167.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.632 ' HA ' ' O ' ' A' ' 169' ' ' VAL . 38.4 mt -118.79 124.41 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 114.482 -1.235 . . . . 0.43 110.307 170.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 168' ' ' GLN . 58.6 mtm180 -75.35 117.27 16.97 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.67 -0.493 . . . . 3.13 109.67 173.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.558 ' HB3' ' CE1' ' A' ' 159' ' ' PHE . 19.3 ttm180 -79.37 138.8 55.52 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 107.081 -1.452 . . . . 6.16 107.081 167.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -49.15 124.66 11.98 Favored 'Trans proline' 0 N--CA 1.438 -1.736 0 C-N-CA 121.019 1.146 . . . . 2.1 110.987 171.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 157' ' ' ARG . 14.1 m-85 -124.45 124.13 41.65 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.759 -1.564 . . . . 1.83 107.426 176.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.98 75.34 4.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.646 1.213 . . . . 3.66 111.253 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 69.5 m-85 -118.27 145.61 37.51 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 113.717 -1.583 . . . . 3.54 110.153 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 161' ' ' PHE . 33.3 Cg_exo -60.28 -26.76 83.41 Favored 'Trans proline' 0 CA--C 1.501 -1.141 0 C-N-CA 124.824 3.682 . . . . 4.48 113.355 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -94.08 -17.99 22.26 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.768 -1.106 . . . . 5.26 111.252 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.504 ' CB ' ' HB2' ' A' ' 198' ' ' ASP . 69.9 m -159.92 105.25 1.56 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.558 -0.746 . . . . 3.43 110.593 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 159' ' ' PHE . 60.5 tttm -147.05 102.98 3.56 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.498 0.666 . . . . 3.34 109.964 176.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -146.46 169.76 18.25 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 122.177 0.989 . . . . 3.14 112.046 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -81.35 158.38 39.72 Favored Glycine 0 N--CA 1.435 -1.424 0 CA-C-N 112.868 -1.969 . . . . 1.11 111.985 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.669 ' HA ' ' O ' ' A' ' 156' ' ' ARG . 49.3 tt0 -44.89 145.24 0.99 Allowed 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.541 -1.329 . . . . 1.86 114.46 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 155' ' ' ILE . 31.0 t -153.59 133.81 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 113.884 -1.507 . . . . 0.41 110.081 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 186' ' ' MET . 18.5 mtm180 -94.8 115.67 27.78 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.962 -0.563 . . . . 2.8 110.397 168.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -121.33 134.17 55.13 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.075 0.94 . . . . 0.29 112.161 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.761 ' O ' ' HA ' ' A' ' 183' ' ' ILE . 16.2 tpt180 -96.25 95.74 8.31 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.22 -1.809 . . . . 1.71 110.255 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.755 HD21 HD21 ' A' ' 113' ' ' LEU . 3.9 mp -87.31 95.88 10.15 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.171 -0.677 . . . . 0.69 109.171 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.44 111.01 22.98 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 122.377 1.084 . . . . 0.26 111.556 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.753 ' HA ' ' HA ' ' A' ' 180' ' ' LEU . 52.7 m-85 -87.28 129.71 34.88 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.992 -1.913 . . . . 0.72 110.438 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 181' ' ' ALA . 35.5 t70 -78.85 66.12 4.24 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 106.539 -1.652 . . . . 1.09 106.539 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.27 -99.32 1.18 Allowed Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 119.227 -1.463 . . . . 0.47 110.329 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.71 -24.82 33.43 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.937 0.717 . . . . 0.83 112.937 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.506 ' CD2' ' HB3' ' A' ' 176' ' ' ASP . 9.5 p-80 -130.49 123.03 28.77 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.636 0.731 . . . . 1.21 110.763 -166.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.753 ' HA ' ' HA ' ' A' ' 175' ' ' PHE . 1.9 tt -54.11 128.52 31.11 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.772 -1.558 . . . . 0.64 110.883 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 176' ' ' ASP . . . -106.39 -39.06 6.01 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.105 -0.952 . . . . 0.29 110.33 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 115' ' ' PRO . 19.3 p -149.4 163.31 38.1 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.214 -0.448 . . . . 0.33 111.092 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.761 ' HA ' ' O ' ' A' ' 172' ' ' ARG . 44.5 mt -136.43 145.44 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 105.889 -1.893 . . . . 0.76 105.889 168.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 172' ' ' ARG . 49.1 t -138.86 136.77 43.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.821 -0.437 . . . . 0.35 109.821 -174.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.603 ' HB3' ' HG2' ' A' ' 190' ' ' ARG . 2.0 t-20 -85.31 97.66 10.08 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 107.511 -1.292 . . . . 1.77 107.511 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.544 ' SD ' ' HG2' ' A' ' 153' ' ' GLU . 57.6 mtm -64.61 -3.1 2.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 124.182 0.926 . . . . 0.55 113.239 -162.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 188' ' ' ASN . 8.0 pt-20 -80.53 -40.6 25.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.855 0.836 . . . . 1.02 110.802 177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.506 ' N ' ' HG3' ' A' ' 187' ' ' GLU . 77.0 m-20 -113.58 -25.29 8.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.287 -1.324 . . . . 1.4 109.335 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 80.72 28.57 0.22 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.733 -2.031 . . . . 1.33 108.283 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.603 ' HG2' ' HB3' ' A' ' 185' ' ' ASN . 0.6 OUTLIER -83.28 155.57 23.56 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.656 -1.611 . . . . 2.28 110.637 176.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -84.74 140.97 30.88 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.641 -1.163 . . . . 1.36 112.917 -176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.668 ' CB ' ' HB ' ' A' ' 183' ' ' ILE . 3.9 m-85 -103.27 -166.67 1.29 Allowed 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.942 -1.936 . . . . 1.18 107.97 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 115' ' ' PRO . . . 136.09 -2.38 3.58 Favored Glycine 0 CA--C 1.482 -1.986 0 N-CA-C 107.736 -2.146 . . . . 1.28 107.736 -151.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.47 ' O ' ' HD2' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -156.81 100.06 1.88 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 113.698 -1.251 . . . . 2.8 111.903 151.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.804 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 4.2 t80 -116.68 100.78 8.06 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.87 -1.132 . . . . 0.6 109.952 168.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -96.88 138.49 34.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.295 -0.412 . . . . 4.77 110.579 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.723 HD13 ' HG ' ' A' ' 127' ' ' LEU . 45.8 mt -132.42 160.68 35.68 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.255 0.55 . . . . 1.61 112.189 -170.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 164' ' ' SER . 20.3 t70 -96.8 115.7 65.8 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.229 -0.896 . . . . 2.66 109.375 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -62.84 126.4 18.05 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.703 1.602 . . . . 2.01 113.536 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.409 ' OXT' ' HG2' ' A' ' 200' ' ' ARG . 28.7 ttt180 . . . . . 0 C--O 1.25 1.122 0 O-C-N 124.71 1.256 . . . . 5.19 113.722 165.138 . . . . . . . . 1 1 . 1 stop_ save_